Methods and compositions for amino acid production

Abstract

Methods and compositions for amino acid production using genetically modified bacteria are disclosed.

Description

TECHNICAL FIELD

This invention relates to microbiology and molecular biology, and more particularly to methods and compositions for amino acid production.

BACKGROUND

Industrial fermentation of bacteria is used to produce commercially useful metabolites such as amino acids, nucleotides, vitamins, and antibiotics. Many of the bacterial production strains that are used in these fermentation processes have been generated by random mutagenesis and selection of mutants (Demain, A. L. Trends Biotechnol. 18:26-31, 2000). Accumulation of secondary mutations in mutagenized production strains and derivatives of these strains can reduce the efficiency of metabolite production due to altered growth and stress-tolerance properties. The availability of genomic information for production strains and related bacterial organisms provides an opportunity to construct new production strains by the introduction of cloned nucleic acids into naive, unmanipulated host strains, thereby allowing amino acid production in the absence of deleterious mutations (Ohnishi, J., et al. Appl Microbiol Biotechnol. 58:217-223, 2002). Similarly, this information provides an opportunity for identifying and overcoming the limitations of existing production strains.

SUMMARY

The present invention relates to compositions and methods for production of amino acids and related metabolites in bacteria. In various embodiments, the invention features bacterial strains that are engineered to increase the production of amino acids and related metabolites of the aspartic acid family. The strains can be engineered to harbor one or more nucleic acid molecules (e.g., recombinant nucleic acid molecules) encoding a polypeptide (e.g., a polypeptide that is heterologous or homologous to the host cell) and/or they may be engineered to increase or decrease expression and/or activity of polypeptides (e.g., by mutation of endogenous nucleic acid sequences). These polypeptides, which can be expressed by various methods familiar to those skilled in the art, include variant polypeptides, such as variant polypeptides with reduced feedback inhibition. These variant polypeptides may exhibit reduced feedback inhibition by a product or intermediate of an amino acid biosynthetic pathway, such as S-adenosylmethionine, lysine, threonine or methionine, relative to wild type forms of the proteins. Also featured are the variant polypeptides encoded by the nucleic acids, as well as bacterial cells comprising the nucleic acids and the polypeptides. Combinations of nucleic acids, and cells that include the combinations of nucleic acids, are also provided herein. The invention also relates to improved bacterial production strains, including, without limitation, strains of coryneform bacteria and Enterobacteriaceae (e.g., Escherichia coli (E. coli)).

Bacterial polypeptides that regulate the production of an amino acid from the aspartic acid family of amino acids or related metabolites include, for example, polypeptides involved in the metabolism of methionine, threonine, isoleucine, aspartate, lysine, cysteine and sulfur, such as enzymes that catalyze the conversion of intermediates of amino acid biosynthetic pathways to other intermediates and/or end product, and polypeptides that directly regulate the expression and/or function of such enzymes. The following list is only a partial list of polypeptides involved in amino acid synthesis: homoserine O-acetyltransferase, O-acetylhomoserine sulfhydrylase, methionine adenosyltransferase, cystathionine beta-lyase, O-succinylhomoserine (thio)-lyase/O-acetylhomoserine (thio)-lyase, the McbR gene product, homocysteine methyltransferase, aspartokinases, pyruvate carboxylase, phosphoenolpyruvate carboxylase, aspartate aminotransferase, aspartate semialdehyde dehydrogenase, homoserine dehydrogenase, dihydrodipicolinate synthase, dihydrodipicolinate reductase, N-succinyl-LL-diaminopimelate aminotransferase, tetrahydrodipicolinate N-succinyltransferase, N-succinyl-LL-diaminopimelate desuccinylase, diaminopimelate epimerase, diaminopimelate decarboxylase, diaminopimelate dehydrogenase, glutamate dehydrogenase, 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase, serine hydroxymethyltransferase, 5,1 0-methylenetetrahydrofolate reductase, serine O-acetyltransferase, D-3-phosphoglycerate dehydrogenase, and homoserine kinase.

Heterologous proteins may be encoded by genes of any bacterial organism other than the host bacterial species. The heterologous genes can be genes from the following, non-limiting list of bacteria: Mycobacterium smegmatis; Amycolatopsis mediterranei; Streptomyces coelicolor; Thermobifida fusca; Erwinia chrysanthemi; Shewanella oneidensis; Lactobacillus plantarum; Bifidobacterium longum; Bacillus sphaericus; and Pectobacterium chrysanthemi. Of course, heterologous genes for host strains from the Enterobacteriaceae family also include genes from coryneform bacteria. Likewise, heterologous genes for host strains of coryneform bacteria also include genes from Enterobacteriaceae family members. In certain embodiments, the host strain is Escherichia coli and the heterologous gene is a gene of a species other than a coryneform bacteria. In certain embodiments, the host strain is a coryneform bacteria and the heterologous gene is a gene of a species other than Escherichia coli. In certain embodiments, the host strain is Escherichia coli and the heterologous gene is a gene of a species other than Corynebacterium glutamicum. In certain embodiments, the host strain is Corynebacterium glutamicum and the heterologous gene is a gene of a species other than Escherichia coli.

In various embodiments, the polypeptide is encoded by a gene obtained from an organism of the order Actinomycetales. In various embodiments, the heterologous nucleic acid molecule is obtained from Mycobacterium smegmatis, Streptomyces coelicolor, Thermobifida fusca, Amycolatopsis mediterranei, or a coryneform bacteria. In various embodiments, the heterologous protein is encoded by a gene obtained from an organism of the family Enterobacteriaceae. In various embodiments, the heterologous nucleic acid molecule is obtained from Erwinia chysanthemi or Escherichia coli.

In various embodiments, the host bacterium (e.g., coryneform bacterium or bacterium of the family Enterobacteriaceae) also has increased levels of a polypeptide encoded by a gene from the host bacterium (e.g., from a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium). Increased levels of a polypeptide encoded by a gene from the host bacterium may result from one of the following: introduction of additional copies of a gene from the host bacterium under the naturally occurring promoter; introduction of additional copies of a gene from the host bacterium under the control of a promoter, e.g., a promoter more optimal for amino acid production than the naturally occurring promoter, either from the host or a heterologous organism; or the replacement of the naturally occurring promoter for the gene from the host bacterium with a promoter more optimal for amino acid production, either from the host or a heterologous organism. Vectors used to generate increased levels of a protein may be integrated into the host genome or exist as an episomal plasmid.

In various embodiments, the host bacterium has reduced activity of a polypeptide (e.g., a polypeptide involved in amino acid synthesis, e.g., an endogenous polypeptide) (e.g., decreased relative to a control). Reducing the activity of particular polypeptides involved in amino acid synthesis can facilitate enhanced production of particular amino acids and related metabolites. In one embodiment, expression of a dihydrodipicolinate synthase polypeptide is deficient in the bacterium (e.g., an endogenous dapA gene in the bacterium is mutated or deleted). In various embodiments, expression of one or more of the following polypeptides is deficient: an mcbR gene product, homoserine dehydrogenase, homoserine kinase, methionine adenosyltransferase, homoserine O-acetyltransferase, and phosphoenolpyruvate carboxykinase.

In various embodiments the nucleic acid molecule comprises a promoter, including, for example, the lac, trc, trcRBS, phoA, tac, or λP_L/λP_R promoter from E. coli (or derivatives thereof) or the phoA, gpd, rplM, or rpsJ promoter from a coryneform bacteria.

In one aspect, the invention features a host bacterium (e.g., a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium) comprising at least one (two, three, or four) of: (a) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial aspartokinase polypeptide or a functional variant thereof; (b) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (d) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial pyruvate carboxylase polypeptide or a functional variant thereof; (e) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof; (f) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (g) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine O-acetyltransferase polypeptide or a functional variant thereof; (h) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; (i) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial methionine adenosyltransferase polypeptide or a functional variant thereof; (j) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial mcbR gene product polypeptide or a functional variant thereof; (k) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-succinylhomoserine/acetylhomoserine (thiol)-lyase polypeptide or a functional variant thereof; (l) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial cystathionine beta-lyase polypeptide or a functional variant thereof; (m) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; and (n) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof.

In various embodiments, the nucleic acid molecule is an isolated nucleic acid molecule (e.g., the nucleic acid molecule is free of nucleotide sequences that naturally flank the sequence in the organism from which the nucleic acid molecule is derived, e.g., the nucleic acid molecule is a recombinant nucleic acid molecule).

In various embodiments, the bacterium comprises nucleic acid molecules comprising sequences encoding two or more distinct heterologous bacterial polypeptides, wherein each of the heterologous polypeptides encodes the same type of polypeptide (e.g., the bacterium comprises nucleic acid molecules comprising sequences encoding an aspartokinase from a first species, and sequences encoding an aspartokinase from a second species.)

In various embodiments, the polypeptide is selected from an Enterobacteriaceae polypeptide, an Actinomycetes polypeptide, or a variant thereof. In various embodiments, the polypeptide is a polypeptide of one of the following Actinomycetes species: Mycobacterium smegmatis, Streptomyces coelicolor, Thermobifida fusca, Amycolatopsis mediterranei and coryneform bacteria, including Corynebacterium glutamicum. In various embodiments, the polypeptide is a polypeptide of one of the following Enterobacteriaceae species: Erwinia chysanthemi and Escherichia coli.

In various embodiments, the polypeptide is a variant polypeptide with reduced feedback inhibition (e.g., relative to a wild-type form of the polypeptide). In various embodiments, the bacterium further comprises additional heterologous bacterial gene products involved in amino acid production. In various embodiments, the bacterium further comprises a nucleic acid molecule encoding a heterologous bacterial polypeptide described herein (e.g., a nucleic acid molecule encoding a heterologous bacterial homoserine dehydrogenase polypeptide). In various embodiments, the bacterium further comprises a nucleic acid molecule encoding a homologous bacterial polypeptide (i.e., a bacterial polypeptide that is native to the host species or a functional variant thereof), such as a bacterial polypeptide described herein. The homologous bacterial polypeptide can be expressed at high levels and/or conditionally expressed. For example, the nucleic acid encoding the homologous bacterial polypeptide can be operably linked to a promoter that allows expression of the polypeptide over wild-type levels, and/or the nucleic acid may be present in multiple copies in the bacterium.

In various embodiments the heterologous bacterial aspartokinase or functional variant thereof is chosen from: (a) a Mycobacterium smegmatis aspartokinase polypeptide or a functional variant thereof, (b) an Amycolatopsis mediterranei aspartokinase polypeptide or a functional variant thereof, (c) a Streptomyces coelicolor aspartokinase polypeptide or a functional variant thereof, (d) a Thermobifidafusca aspartokinase polypeptide or a functional variant thereof, (e) an Erwinia chrysanthemi aspartokinase polypeptide or a functional variant thereof, and (f) a Shewanella oneidensis aspartokinase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial aspartokinase polypeptide is an Escherichia coli aspartokinase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial aspartokinase polypeptide is a Corynebacterium glutamicum aspartokinase polypeptide or a functional variant thereof. In certain embodiments the heterologous bacterial asparatokinase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide or functional variant thereof is chosen from: (a) a Mycobacterium smegmatis aspartate semialdehyde dehydrogenase polypeptide r a functional variant thereof, (b) an Amycolatopsis mediterranei asp artate semi aldehyde dehydrogenase polypeptide or a functional variant thereof, (c) a Streptomyces coelicolor aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof, and (d) a Thermobifida fusca aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide is an Escherichia coli aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide is a Corynebacterium glutamicum aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof. In various embodiments the heterologous bacterial phosphoenolpyruvate carboxylase polypeptide or functional variant thereof is chosen from: (a) a Mycobacterium smegmatis phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof, (b) a Streptomyces coelicolor phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof, (c) a Thermobifida fusca phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof, and (d) an Erwinia chrysanthemi phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial phosphoenolpyruvate carboxylase polypeptide is an Escherichia coli phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial phosphoenolpyruvate carboxylase polypeptide is a Corynebacterium glutamicum phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof.

In various embodiments the heterologous bacterial pyruvate carboxylase polypeptide or functional variant thereof is chosen from: (a) a Mycobacterium smegmatis pyruvate carboxylase polypeptide or a functional variant thereof, (b) a Streptomyces coelicolor pyruvate carboxylase polypeptide or a functional variant thereof, and (c) a Thermobifida fusca pyruvate carboxylase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial pyruvate carboxylase polypeptide is a Corynebacterium glutamicum pyruvate carboxylase or a functional variant thereof.

In various embodiments the bacterium is chosen from a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium. Coryneform bacteria include, without limitation, Corynebacterium glutamicum, Corynebacterium acetoglutamicum, Corynebacterium melassecola, Corynebacterium thermoaminogenes, Brevibacterium lactofermentum, Brevibacterium lactis, and Brevibacterium flavum.

In various embodiments: the Mycobacterium smegmatis aspartokinase polypeptide comprises SEQ ID NO: 1 or a variant sequence thereof, the Amycolatopsis mediterranei aspartokinase polypeptide comprises SEQ ID NO:2 or a variant sequence thereof, the Streptomyces coelicolor aspartokinase polypeptide comprises SEQ ID NO:3 or a variant sequence thereof, the Thermobifida fusca aspartokinase polypeptide comprises SEQ ID NO:4 or a variant sequence thereof, the Erwinia chrysanthemi aspartokinase polypeptide comprises SEQ ID NO:5 or a variant sequence thereof, and the Shewanella oneidensis aspartokinase polypeptide comprises SEQ ID NO:6 or a variant sequence thereof, the Escherichia coli aspartokinase polypeptide comprises SEQ ID NO: 203 or a variant sequence thereof, the Corynebacterium glutamicum aspartokinase polypeptide comprises SEQ ID NO: 202 or a variant sequence thereof, the Corynebacterium glutamicum aspartate semialdehyde dehydrogenase polypeptide comprises SEQ ID NO:204 or a variant sequence thereof, the Escherichia coli aspartate semialdehyde dehydrogenase polypeptide comprises SEQ ID NO: 205 or a variant sequence thereof, the Mycobacterium smegmatis phosphoenolpyruvate carboxylase polypeptide or functional variant thereof comprises an amino acid sequence at least 80% identical to SEQ ID NO:8 (M. leprae phosphoenolpyruvate carboxylase) (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:8), the Streptomyces coelicolor phosphoenolpyruvate carboxylase polypeptide comprises SEQ ID NO:9 or a variant sequence thereof, the Thermobifida fusca phosphoenolpyruvate carboxylase polypeptide comprises SEQ ID NO:7 or a variant sequence thereof, the Erwinia chrysanthemi phosphoenolpyruvate carboxylase polypeptide comprises SEQ ID NO:10 or a variant sequence thereof, the Mycobacterium smegmatis pyruvate carboxylase polypeptide comprises SEQ ID NO:13 or a variant sequence thereof, the Streptomyces coelicolor pyruvate carboxylase polypeptide comprises SEQ ID NO: 12 or a variant sequence thereof, and the Corynebacterium glutamicum pyruvate carboxylase polypeptide comprises SEQ ID NO:208 or a variant sequence thereof.

In various embodiments, the Mycobacterium smegmatis aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a Group 1 amino acid residue at position 279; a serine changed to a Group 6 amino acid residue at position 301; a threonine changed to a Group 2 amino acid residue at position 311; and a glycine changed to a Group 3 amino acid residue at position 345; the Mycobacterium smegmatis aspartokinase comprises at least one amino acid change chosen from: an alanine changed to a proline at position 279, a serine changed to a tyrosine at position 301, a threonine changed to an isoleucine at position 311, and a glycine changed to an aspartate at position 345.

In various embodiments, the Amycolatopsis mediterranei aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a Group 1 amino acid residue at position 279; a serine changed to a Group 6 amino acid residue at position 301 ;a threonine changed to a Group 2 amino acid residue at position 311; and a glycine changed to a Group 3 amino acid residue at position 345.

In various embodiments the Amycolatopsis mediterranei aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a proline at position 279; a serine changed to a tyrosine at position 301; a threonine changed to an isoleucine at position 311; and a glycine changed to an aspartate at position 345.

In various embodiments the Streptomyces coelicolor aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a Group 1 amino acid residue at position 282; a serine changed to a Group 6 amino acid residue at position 304; a serine changed to a Group 2 amino acid residue at position 314; and a glycine changed to a Group 3 amino acid residue at position 348.

In various embodiments the Streptomyces coelicolor aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a proline at position 282; a serine changed to a tyrosine at position 304; a serine changed to an isoleucine at position 314; and a glycine changed to an aspartate at position 348.

In various embodiments the Erwinia chrysanthemi aspartokinase polypeptide comprises at least one amino acid change chosen from: a glycine changed to a Group 3 amino acid residue at position 328; a leucine changed to a Group 6 amino acid residue at position 330; a serine changed to a Group 2 amino acid residue at position 350; and a valine changed to a Group 2 amino acid residue other than valine at position 352.

In various embodiments the Erwinia chrysanthemi aspartokinase polypeptide comprises at least one amino acid change chosen from: a glycine changed to an aspartate at position 328; a leucine changed to a phenylalanine at position 330; a serine changed to an isoleucine at position 350; and a valine changed to a methionine at position 352.

In various embodiments the Shewanella oneidensis aspartokinase polypeptide comprises at least one amino acid change chosen from: a glycine changed to a Group 3 amino acid residue at position 323; a leucine changed to a Group 6 amino acid residue at position 325; a serine changed to a Group 2 amino acid residue at position 345; and a valine changed to a Group 2 amino acid residue other than valine at position 347.

In various embodiments the Shewanella oneidensis aspartokinase polypeptide comprises at least one amino acid change chosen from: a glycine changed to an aspartate at position 323; a leucine changed to a phenylalanine at position 325; a serine changed to an isoleucine at position 345; and a valine changed to a methionine at position 347.

In various embodiments the Corynebacterium glutamicum aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a Group 1 amino acid other than alanine at position 279; a serine changed to a Group 6 amino acid residue at position 301; a threonine changed to a Group 2 amino acid residue at position 311; and a glycine changed to a Group 3 amino acid residue at position 345.

In various embodiments the Corynebacterium glutamicum aspartokinase polypeptide comprises at least one amino acid change chosen from: an alanine changed to a proline at position 279; a serine changed to a tyrosine at position 301; a threonine changed to an isoleucine at position 311; and a glycine changed to an aspartate at position 345.

In various embodiments the Escherichia coli aspartokinase polypeptide comprises at least one amino acid change chosen from: a glycine changed to a Group 3 amino acid residue at position 323; a leucine changed to a Group 6 amino acid residue at position 325; a serine changed to a Group 2 amino acid residue at position 345; and a valine changed to a Group 2 amino acid residue other than valine at position 347.

In various embodiments the Escherichia coli aspartokinase polypeptide comprises at least one amino acid change chosen from: a glycine changed to an aspartate at position 323; a leucine changed to a phenylalanine at position 325; a serine changed to an isoleucine at position 345; and a valine changed to a methionine at position 347.

In various embodiments, the Corynebacterium glutamicum pyruvate carboxylase polypeptide or variant thereof comprises a proline changed to Group 4 amino acid residue at position 458. In various embodiments, the Corynebacterium glutamicum pyruvate carboxylase polypeptide or variant thereof comprises a proline changed to a serine at position 458.

In various embodiments, the Mycobacterium smegmatis pyruvate carboxylase polypeptide or variant thereof comprises a proline changed to Group 4 amino acid residue at position 448. In various embodiments, the Mycobacterium smegmatis pyruvate carboxylase polypeptide or variant thereof comprises a proline changed to a serine at position 448.

In various embodiments, the Streptomyces coelicolor pyruvate carboxylase polypeptide or variant thereof comprises a proline changed to Group 4 amino acid residue at position 449. In various embodiments, the Streptomyces coelicolor pyruvate carboxylase polypeptide or variant thereof comprises a proline changed to a serine at position 449.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial dihydrodipicolinate synthase or a functional variant thereof.

In various embodiments the heterologous bacterial dihydrodipicolinate synthase polypeptide or functional variant thereof is chosen from: a Mycobacterium smegmatis dihydrodipicolinate synthase polypeptide or a functional variant thereof; a Streptomyces coelicolor dihydrodipicolinate synthase polypeptide or a functional variant thereof; a Thermobifida fusca dihydrodipicolinate synthase polypeptide or a functional variant thereof; and an Erwinia chrysanthemi dihydrodipicolinate synthase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial dihydrodipicolinate synthase polypeptide or functional variant thereof with reduced feedback inhibition is an Escherichia coli dihydrodipicolinate synthase polypeptide or a functional variant thereof. In certain embodiments the heterologous bacterial dihydrodipicolinate synthase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments, the Mycobacterium smegmatis dihydrodipicolinate synthase polypeptide is at least 80% identical to SEQ ID NO:15 or SEQ ID NO:16 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO: 15 or SEQ ID NO: 16); the Streptomyces coelicolor dihydrodipicolinate synthase polypeptide comprises SEQ ID NO: 17 or a variant sequence thereof; the Thermobifida fusca dihydrodipicolinate synthase polypeptide comprises SEQ ID NO: 14 or a variant sequence thereof; and the Erwinia chrysanthemi dihydrodipicolinate synthase polypeptide comprises SEQ ID NO: 18 or a variant sequence thereof.

In various embodiments the Erwinia chrysanthemi dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an asparagine changed to a Group 2 amino acid residue at position 80; a leucine changed to a Group 6 amino acid residue at position 88; and a histidine changed to a Group 6 amino acid residue at position 118.

In various embodiments the Erwinia chrysanthemi dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an asparagine changed to an isoleucine at position 80; a leucine changed to a phenylalanine at position 88; and a histidine changed to a tyrosine at position 118.

In various embodiments, the Streptomyces coelicolor dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an asparagine changed to a Group 2 amino acid residue at position 89; a leucine changed to a Group 6 amino acid residue at position 97; and a histidine changed to a Group 6 amino acid residue at position 127.

In various embodiments the Streptomyces coelicolor dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an asparagine changed to an isoleucine at position 89; a leucine changed to a phenylalanine at position 97; and a histidine changed to a tyrosine at position 127.

In various embodiments the Mycobacterium smegmatis dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an amino acid residue corresponding to tyrosine 90 of SEQ ID NO: 16 changed to a Group 2 amino acid residue; an amino acid residue corresponding to leucine 98 of SEQ ID NO: 16 changed to a Group 6 amino acid residue; and an amino acid residue corresponding to histidine 128 of SEQ ID NO:16 changed to a Group 6 amino acid residue.

In various embodiments the Mycobacterium smegmatis dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an amino acid residue corresponding to tyrosine 90 of SEQ ID NO:16 changed to an isoleucine; an amino acid residue corresponding to leucine 98 of SEQ ID NO: 16 changed to a phenylalanine; and an amino acid residue corresponding to histidine 128 of SEQ ID NO:16 changed to a histidine.

In various embodiments the Escherichia coli dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an asparagine changed to a Group 2 amino acid residue at position 80; an alanine changed to a Group 2 amino acid residue at position 81; a glutamatate changed to a Group 5 amino acid residue at position 84; a leucine changed to a Group 6 amino acid residue at position 88; and a histidine changed to a Group 6 amino acid at position 118.

In various embodiments the Escherichia coli dihydrodipicolinate synthase polypeptide comprises at least one amino acid change chosen from: an asparagine changed to an isoleucine at position 80; an alanine changed to a valine at position 81; a glutamate changed to a lysine at position 84; a leucine changed to a phenylalanine at position 88; and a histidine changed to a tyrosine at position 118. 378; and an alteration that truncates the homoserine dehydrogenase protein after the lysine amino acid residue at position 428. In one embodiment, the Corynebacterium glutamicum or Brevibacterium lactofermentum homoserine dehydrogenase polypeptide is encoded by the hom^dr sequence described in WO93/09225 SEQ ID NO. 3.

In various embodiments the Corynebacterium glutamicum or Brevibacterium lactofermentum homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a leucine changed to a phenylalanine at position 23; valine changed to an alanine at position 59; a valine changed to an isoleucine at position 104; and a glycine changed to a glutamic acid at position 378.

In various embodiments the Mycobacterium smegmatis homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a valine change to a Group 6 amino acid residue at position 10; a valine changed to a Group 1 amino acid residue at position 46; and a glycine changed to Group 3 amino acid residue at position 364.

In various embodiments the Mycobacterium smegmatis homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a valine changed to a phenylalanine at position 10; valine changed to an alanine at position 46; and a glycine changed to a glutamic acid at position 378.

In various embodiments the Streptomyces coelicolor homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a leucine change to a Group 6 amino acid residue at position 10; a valine changed to a Group 1 amino acid residue at position 46; a glycine changed to Group 3 amino acid residue at position 362; an alteration that truncates the homoserine dehydrogenase protein after the arginine amino acid residue at position 412In various embodiments the Streptomyces coelicolor homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a leucine changed to a phenylalanine at position 10; a valine changed to an alanine at position 46; and a glycine changed to a glutamic acid at position 362.

In various embodiments the Thermobifida fusca homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a leucine change to a Group 6 amino acid residue at position 192; a valine changed to a Group 1 amino acid residue at position 228; a glycine changed to Group 3 amino acid residue at position 545. In various embodiments, the Thermobifida fusca homoserine dehydrogenase polypeptide is truncated after the arginine amino acid residue at position 595.

In various embodiments the Thermobifida fusca homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a leucine changed to a phenylalanine at 5 position 192; valine changed to an alanine at position 228; and a glycine changed to a glutamic acid at position 545.

In various embodiments the Escherichia coli homoserine dehydrogenase polypeptidecomprises at least one amino acid change in SEQ ID NO:211 chosen from: a glycine changed to a Group 3 amino acid residue at position 330; and a serine changed to a Group 6 amino acid residue at position 352.

In various embodiments the Escherichia coli homoserine dehydrogenase polypeptide comprises at least one amino acid change in SEQ ID NO:211, ,chosen from: a glycine changed to an aspartate at position 330; and a serine changed to a phenylalanine at position 352.

The invention also features: a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid that encodes a heterologous bacterial O-homoserine acetyltransferase polypeptide or a functional variant thereof.

In various embodiments the heterologous bacterial O-homoserine acetyltransferase polypeptide is chosen from: a Mycobacterium smegmatis O-homoserine acetyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor O-homoserine acetyltransferase polypeptide or a functional variant thereof; a Thermobifida fusca O-homoserine acetyltransferase polypeptide or a functional variant thereof; and an Erwinia chrysanthemi O-homoserine acetyltransferase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial O-homoserine acetyltransferase polypeptide is an O-homoserine acetyltransferase polypeptide from Corynebacterium glutamicum or a functional variant thereof. In certain embodiments the heterologous O-homoserine acetyltransferase polypeptide or functional variant thereof has reduced feedback inhibition. In various embodiments the Mycobacterium smegmatis O-homoserine acetyltransferase polypeptide is at least 80% identical to SEQ ID NO:22 or SEQ ID NO:23 (e.g., a sequence at least 80%, 85%, 30 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:22 or SEQ ID NO:23); the heterologous bacterial O-homoserine acetyltransferase polypeptide is a

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial homoserine dehydrogenase or a functional variant thereof.

In various embodiments the heterologous bacterial homoserine dehydrogenase polypeptide is chosen from: (a) a Mycobacterium smegmatis homoserine dehydrogenase polypeptide or functional variant thereof; (b) a Streptomyces coelicolor homoserine dehydrogenase polypeptide or a functional variant thereof; (c) a Thermobifida fusca homoserine dehydrogenase polypeptide or a functional variant thereof; and (d) an Erwinia chrysanthemi homoserine dehydrogenase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial homoserine dehydrogenase polypeptide is a homoserine dehydrogenase polypeptide from a coryneform bacteria or a functional variant thereof (e.g., a Corynebacterium glutamicum homoserine dehydrogenase polypeptide or functional variant thereof, or a Brevibacterium lactofermentum homoserine dehydrogenase polypeptide or functional variant thereof). In certain embodiments, the heterologous homoserine dehydrogenase polypeptide or functional variant thereof is an Escherichia coli homoserine dehydrogenase polypeptide or a functional variant thereof. In certain embodiments the heterologous homoserine dehydrogenase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the heterologous bacterial homoserine dehydrogenase polypeptide is a Streptomyces coelicolor homoserine dehydrogenase polypeptide or functional variant thereof with reduced feedback inhibition; the Streptomyces coelicolor homoserine dehydrogenase polypeptide comprises SEQ ID NO: 19 or a variant sequence thereof; the Thermobifida fusca homoserine dehydrogenase polypeptide comprises SEQ ID NO:21 or a variant sequence thereof; the Corynebacterium glutamicum and Brevibacterium lactofermentum homoserine dehydrogenases polypeptide comprise SEQ ID NO:209 or a variant sequence thereof; and the Escherichia coli homoserine dehydrogenase polypeptide comprises either SEQ ID NO:210, SEQ ID NO:21 1, or a variant sequence thereof

In various embodiments the Corynebacterium glutamicum or Brevibacterium lactofermentum homoserine dehydrogenase polypeptide comprises at least one amino acid change chosen from: a leucine change to a Group 6 amino acid residue at position 23; a valine changed to a Group 1 amino acid residue at position 59; a valine changed to another Group 2 amino acid residue at position 104; a glycine changed to Group 3 amino acid residue at position Thermobifida fusca O-homoserine acetyltransferase polypeptide or functional variant thereof; the Thermobifida fusca O-homoserine acetyltransferase polypeptide comprises SEQ ID NO:24 or a variant sequence thereof; the heterologous bacterial O-homoserine acetyltransferase polypeptide is a Corynebacterium glutamicum O-homoserine acetyltransferase polypeptide or functional variant thereof; the C. glutamicum O-homoserine acetyltransferase polypeptide comprises SEQ ID NO:212 or a variant sequence thereof; or the heterologous bacterial O-homoserine acetyltransferase polypeptide is a Escherichia coli O-homoserine acetyltransferase polypeptide or functional variant thereof; the Escherichia coli O-homoserine acetyltransferase polypeptide comprises SEQ ID NO:213 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial O-acetylhomoserine sulfhydrylase or a functional variant thereof.

In various embodiments the heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide is chosen from: (a) a Mycobacterium smegmatis O-acetylhomoserine sulfhydrylase polypeptide or functional variant thereof; (b) a Streptomyces coelicolor O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; and (c) a Thermobifida fusca O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial O-acetylhomoserine sulffiydrylase polypeptide is an O-acetylhomoserine sulfhydrylase polypeptide from Corynebacterium glutamicum or a functional variant thereof. In certain embodiments the heterologous O-acetylhomoserine sulfhydrylase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the Mycobacterium smegmatis O-acetylhomoserine sulfhydrylase polypeptide is at least 80% identical to SEQ ID NO:26 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:26); the Thermobifida fusca O-acetylhomoserine sulfhydrylase polypeptide comprises SEQ ID NO:25 or a variant sequence thereof; and the Corynebacterium glutamicum heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide comprises SEQ ID NO:214 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial methionine adenosyltransferase or a functional variant thereof.

In various embodiments the heterologous bacterial methionine adenosyltransferase polypeptide is chosen from: a Mycobacterium smegmatis methionine adenosyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor methionine adenosyltransferase polypeptide or a functional variant thereof; a Thermobifida fusca methionine adenosyltransferase polypeptide or a functional variant thereof; and an Erwinia chrysanthemi methionine adenosyltransferase polypeptide or a functional variant thereof. In certain embodiments, the heterologous bacterial methionine adenosyltransferase polypeptide is a methionine adenosyltransferase polypeptide from Corynebacterium glutamicum or a functional variant thereof. In certain embodiments, the heterologous bacterial methionine adenosyltransferase polypeptide is a methionine adenosyltransferase polypeptide from Escherichia coli or a functional variant thereof. In certain embodiments the heterologous methionine adenosyltransferase polypeptide or functional variant thereof has reduced feedback inhibition In various embodiments the Mycobacterium smegmatis O-methionine adenosyltransferase polypeptide is at least 80% identical to SEQ ID NO:27 or SEQ ID NO:28 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:27 or SEQ ID NO:28); the Streptomyces coelicolor methionine adenosyltransferase polypeptide comprises SEQ ID NO:30 or a variant sequence thereof; the heterologous bacterial methionine adenosyltransferase polypeptide is a Thermobifida fusca methionine adenosyltransferase or functional variant thereof; the Thermobifida fusca methionine adenosyltransferase polypeptide comprises SEQ ID NO:29 or a variant sequence thereof; the Corynebacterium glutamicum heterologous bacterial methionine adenosyltransferase comprises SEQ ID NO:215 or a variant sequence thereof; and the Escherichia coli heterologous bacterial methionine adenosyltransferase polypeptide comprises SEQ ID NO:216 or a variant sequence thereof.

In various embodiments the bacterium further comprises a nucleic acid molecule encoding a heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof.

In various embodiments the heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof is chosen from: a Mycobacterium smegmatis dihydrodipicolinate synthase polypeptide or a functional variant thereof; a Streptomyces coelicolor dihydrodipicolinate synthase polypeptide or a functional variant thereof; a Thermobifida fusca dihydrodipicolinate synthase polypeptide or a functional variant thereof; an Erwinia chrysanthemi dihydrodipicolinate synthase polypeptide or a functional variant thereof; an Escherichia coli dihydrodipicolinate synthase polypeptide or a functional variant thereof; and a Corynebacterium glutamicum dihydrodipicolinate synthase polypeptide or a functional variant thereof. In certain embodiments the heterologous dihydrodipicolinate synthase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the bacterium further comprises at least one of: (a) a nucleic acid molecule encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (b) a nucleic acid molecule encoding a heterologous bacterial O-homoserine acetyltransferase polypeptide or a functional variant thereof; (c) a nucleic acid molecule encoding a heterologous O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof. In certain embodiments one or more of the heterologous polypeptides or functional variants thereof has reduced feedback inhibition.

In various embodiments the heterologous bacterial homoserine dehydrogenase polypeptide is chosen from: a Mycobacterium smegmatis homoserine dehydrogenase polypeptide or functional variant thereof; a Streptomyces coelicolor homoserine dehydrogenase polypeptide or a functional variant thereof; a Thermobifida fusca homoserine dehydrogenase polypeptide or a functional variant thereof; an Escherichia coli homoserine dehydrogenase polypeptide or a functional variant thereof; a Corynebacterium glutamicum homoserine dehydrogenase polypeptide or a functional variant thereof; and an Erwinia chrysanthemi homoserine dehydrogenase polypeptide or a functional variant thereof. In certain embodiments the heterologous homoserine dehydrogenase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the heterologous bacterial O-homoserine acetyltransferase polypeptide is chosen from: a Mycobacterium smegmatis O-homoserine acetyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor O-homoserine acetyltransferase polypeptide or a functional variant thereof; a Thermobifida fusca O-homoserine acetyltransferase polypeptide or a functional variant thereof; an Erwinia chrysanthemi O-homoserine acetyltransferase polypeptide or a functional variant thereof; an Escherichia coli O-homoserine acetyltransferase polypeptide or a functional variant thereof; and a Corynebacterium glutamicum O-homoserine acetyltransferase polypeptide or a functional variant thereof. In certain embodiments the heterologous O-homoserine acetyltransferase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide is chosen from: a Mycobacterium smegmatis O-acetylhomoserine sulfhydrylase or functional variant thereof; a Streptomyces coelicolor O-acetylhomoserine sulhydrylase polypeptide or a functional variant thereof; a Thermobifida fusca O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; and a Corynebacterium glutamicum O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof. In certain embodiments the heterologous O-acetylhomoserine sulfhydrylase polypeptide or functional variant thereof has reduced feedback inhibition.

In various embodiments the bacterium further comprises a nucleic acid molecule encoding a heterologous bacterial methionine adenosyltransferase polypeptide (e.g., a Mycobacterium smegmatis methionine adenosyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor methionine adenosyltransferase polypeptide or a functional variant thereof; a Thermobifida fusca methionine adenosyltransferase polypeptide or a functional variant thereof; an Erwinia chrysanthemi methionine adenosyltransferase polypeptide or a functional variant thereof; an Escherichia coli methionine adenosyltransferase polypeptide or a functional variant thereof; or a Corynebacterium glutamicum methionine adenosyltransferase polypeptide or a functional variant thereof).

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising at least two of: (a) a nucleic acid molecule encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (b) a nucleic acid molecule encoding a heterologous bacterial O-homoserine acetyltransferase polypeptide or a functional variant thereof; and (c) a nucleic acid molecule encoding a heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof. In certain embodiments one or more of the heterologous bacterial polypetides or functional variants thereof has reduced feedback inhibition

In another aspect, the invention features an Escherichia coli or coryneform bacterium comprising at least one or two of: (a) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartokinase polypeptide or a functional variant thereof; (b) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; and (d) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof. In various embodiments, the genetically altered nucleic acid molecule is a genomic nucleic acid molecule (e.g., a genomic nucleic acid molecule in which a mutation has been introduced, e.g., into a coding or regulatory region of a gene). In various embodiments, the nucleic acid molecule is a recombinant nucleic acid molecule.

In various embodiments, at least one of the at least two genetically altered nucleic acid molecules encodes a heterologous polypeptide. In one embodiment, the bacterium comprises (a) and (b), (a) and (c), (a) and (d), (b) and (c), (b) and (d), or (c) and (d). In one embodiment,the bacterium comprises at least three of (a)-(e). In one embodiment, the bacterium has reduced activity of one or more of the following polypeptides, relative to a control: (a) a homoserine dehydrogenase polypeptide; (b) a homoserine kinase polypeptide; and (c) a phosphoenolpyruvate carboxykinase polypeptide. In one embodiment, the bacterium comprises a mutation in an endogenous hom gene or an endogenous thrB gene (e.g., a mutation that reduces activity of the polypeptide encoded by the gene (e.g., a mutation in a catalytic region) or a mutation that reduces expression of the polypeptide encoded by the gene (e.g., the mutation causes premature termination of the polypeptide), or a mutation which decreases transcript or protein stability or half life. In one embodiment, the bacterium comprises a mutation in an endogenous hom gene and an endogeous thrB gene. In one embodiment,the bacterium comprises a mutation in an endogenous pck gene.

In another aspect, the invention features an Escherichia coli or coryneform bacterium comprising at least one or two of: (a) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (b) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartokinase polypeptide or a functional variant thereof: (c) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (d) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (e) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial homoserine O-acetyltransferase polypeptide or a functional variant thereof; (f) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; (g) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; (h) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial O-succinylhomoserine (thio)-lyase polypeptide or a functional variant thereof; (i) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof; (j) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial methionine adenosyltransferase polypeptide or a functional variant thereof; (k) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial serine hydroxylmethyltransferase polypeptide or a functional variant thereof; and (l) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial cystathionine beta-lyase polypeptide or a functional variant thereof.

In various embodiments, at least one of the at least two genetically altered nucleic acid molecules encodes a heterologous polypeptide. In various embodiments, the bacterium comprises (a) and at least one of (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), and (1). In various embodiments, the bacterium comprises (b) and at least one of (c), (d), (e), (f), (g), (h), (i), (j), (k), and (1). In various embodiments, the bacterium comprises (c) and at least one of (d), (e), (f), (g), (h), (i), (j), (k), and (1). In various embodiments, the bacterium comprises (d) and at least one of (e), (f), (g), (h), (i), (j), (k), and (1). In various embodiments, the bacterium comprises (e) and at least one of (f), (g), (h), (i), (j), (k), and (l). In various embodiments, the bacterium comprises (f) and at least one of (g), (h), (i), (j), (k), and (l). In various embodiments, the bacterium comprises (g) and at least one of (h), (i), (j), (k), and (l). In various embodiments, the bacterium comprises (h) and at least one of (i), (j), (k), and (l). In various embodiments, the bacterium comprises (i) and at least one of (j) (k), and (l). In various embodiments, the bacterium comprises (j) and at least one of (k), and (l). In various embodiments, the bacterium comprises (k) and (l). In various embodiments,the bacterium comprises at least three of (a)-(l).

In some embodiments, the bacterium has reduced activity of one or more of the following polypeptides, relative to a control: (a) a homoserine kinase polypeptide; (b) a phosphoenolpyruvate carboxykinase polypeptide; (c) a homoserine dehydrogenase polypeptide; and (d) a mcbR gene product polypeptide, e.g., the bacterium comprises a mutation in an endogenous hom gene, an endogenous thrB gene, an endogenous pck gene, or an endogenous mcbR gene, or combinations thereof.

In another aspect, the invention features an Escherichia coli or coryneform bacterium comprising at least two of: (a) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (b) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartokinase polypeptide or a functional variant thereof; (c) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof (d) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial homoserine dehydrogenase polypeptide or a functional variant thereof.

In various embodiments, at least one of the at least two polypeptides encodes a heterologous polypeptide.

In various embodiments, the bacterium comprises (a) and (b), (a) and (c), (a) and (d), (b) and (c), (b) and (d), or (c) and (d); or the bacterium comprises at least three of (a)-(d).

In various embodiments, the bacterium has reduced activity of one or more of the following polypeptides, relative to a control: (a) a phosphoenolpyruvate carboxykinase polypeptide; and (b) a mcbR gene product polypeptide, e.g., the bacterium comprises a mutation in an endogenous pck gene or an endogenous mcbR gene, e.g.,the bacterium comprises a mutation in an endogenous pck gene and an endogenous mcbR gene.

The invention also features a method of producing an amino acid or a related metabolite, the method comprising: cultivating a bacterium (e.g., a bacterium described herein) according to under conditions that allow the amino acid the metabolite to be produced, and collecting a composition that comprises the amino acid or related metabolite from the culture. The method can further include fractionating at least a portion of the culture to obtain a fraction enriched in the amino acid or the metabolite.

The invention also features a method for producing L-lysine, the method comprising: cultivating a bacterium described herein under conditions that allow L-lysine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-lysine).

In another aspect, the invention features a method for the preparation of animal feed additives comprising an aspartate-derived amino acid(s), the method comprising two or more of the following steps:

• • (a) cultivating a bacterium (e.g., a bacterium described herein) under conditions that allow the aspartate-derived amino acid(s) to be produced;
  • (b) collecting a composition that comprises at least a portion of the aspartate-derived amino acid(s);
  • (c) concentrating of the collected composition to enrich for the aspartate-derived amino acid(s); and
  • (d) optionally, adding of one or more substances to obtain the desired animal feed additive.

The substances that can be added include, e.g., conventional organic or inorganic auxiliary substances or carriers, such as gelatin, cellulose derivatives (e.g., cellulose ethers), silicas, silicates, stearates, grits, brans, meals, starches, gums, alginates sugars or others, and/or mixed and stabilized with conventional thickeners or binders.

In various embodiments, the composition that is collected lacks bacterial cells. In various embodiments, the composition that is collected contains less than 10%, 5%, 1%, 0.5% of the bacterial cells that result from cultivating the bacterium. In various embodiments, the composition comprises at least 1% (e.g., at least 1%, 5%, 10%, 20%, 40%, 50%, 75%, 80%, 90%, 95%, or to 100%) of that bacterial cells that result from cultivating the bacterium.

The invention features a method for producing L-methionine, the method comprising: cultivating a bacterium described herein under conditions that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

The invention features a method for producing S-adenosyl-L-methionine (S-AM), the method comprising: cultivating a bacterium described herein under conditions that allow S-adenosyl-L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in S-AM). The invention features a method for producing L-threonine or L-isoleucine, the method comprising: cultivating a bacterium described herein under conditions that allow L-threonine or L-isoleucine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-threonine or L-isoleucine). The invention also features methods for producing homoserine, O-acetylhomoserine, and derivatives thereof, the method comprising: cultivating a bacterium described herein under conditions that allow homoserine, O-acetylhomoserine, or derivatives thereof to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in homoserine, O-acetylhomoserine, or derivatives thereof).

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial cystathionine beta-lyase polypeptide (e.g., a Mycobacterium smegmatis cystathionine beta-lyase polypeptide or functional variant thereof; a Bifidobacterium longum cystathionine beta-lyase polypeptide or a functional variant thereof; a Lactobacillus plantarum cystathionine beta-lyase polypeptide or a functional variant thereof; a Corynebacterium glutamicum cystathionine beta-lyase polypeptide or a functional variant thereof; an Escherichia coli cystathionine beta-lyase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis cystathionine beta-lyase polypeptide comprises a sequence at least 80% identical to SEQ ID NO:59 (e.g., a sequence at 25 least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:59), or a variant sequence thereof; the Bifidobacterium longum cystathionine beta-lyase polypeptide comprises SEQ ID NO:60 or a variant sequence thereof; the Lactobacillus plantarum cystathionine beta-lyase polypeptide comprises SEQ ID NO:61 or a variant sequence thereof; the Corynebacterium glutamicum cystathionine beta-lyase polypeptide comprises SEQ ID NO:217 or a variant sequence thereof; and the Escherichia coli cystathionine beta-lyase polypeptide comprises SEQ ID NO:218 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial glutamate dehydrogenase polypeptide (e.g., a Streptomyces coelicolor glutamate dehydrogenase or functional variant thereof; a Thermobifida fusca glutamate dehydrogenase polypeptide or a functional variant thereof; a Lactobacillus plantarum glutamate dehydrogenase polypeptide or a functional variant thereof; a Corynebacterium glutamicum glutamate dehydrogenase polypeptide or a functional variant thereof; a Escherichia coli glutamate dehydrogenase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis glutamate dehydrogenase polypeptide comprises SEQ ID NO:62 or a variant sequence thereof; the Thermobifida fusca glutamate dehydrogenase polypeptide comprises SEQ ID NO:63 or a variant sequence thereof; the Lactobacillus plantarum glutamate dehydrogenase polypeptide comprises SEQ ID NO:65 or a variant sequence thereof; the Corynebacterium glutamicum glutamate dehydrogenase polypeptide comprises SEQ ID NO:219 or a variant sequence thereof; and the Escherichia coli glutamate dehydrogenase polypeptide comprises SEQ ID NO:220 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial diaminopimelate dehydrogenase polypeptide or a functional variant thereof (e.g., a Bacillus sphaericus diaminopimelate dehydrogenase polypeptide or a functional variant thereof; a Corynebacterium glutamicum glutamate dehydrogenase polypeptide or a functional variant thereof).

In various embodiments the Bacillus sphaericus diaminopimelate dehydrogenase polypeptide comprises SEQ ID NO:65 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial detergent sensitivity rescuer polypeptide (e.g., a Mycobacterium smegmatis detergent sensitivity rescuer polypeptide or functional variant thereof; a Streptomyces coelicolor detergent sensitivity rescuer polypeptide or a functional variant thereof; a Thermobifida fusca detergent sensitivity rescuer polypeptide or a functional variant thereof; a Corynebacterium glutamicum detergent sensitivity rescuer polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis detergent sensitivity rescuer polypeptide comprises a sequence at least 80% identical to either SEQ ID NO:68, SEQ ID NO:69 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98more identical), or a variant sequence thereof; the heterologous bacterial detergent sensitivity rescuer polypeptide is a Streptomyces coelicolor detergent sensitivity rescuer polypeptide or functional variant thereof; the Streptomyces coelicolor detergent sensitivity rescuer polypeptide comprises SEQ ID NO:67 or a variant sequence thereof; the Thermobifida fusca detergent sensitivity rescuer polypeptide comprises SEQ ID NO:66 or a variant sequence thereof; and the Corynebacterium glutamicum detergent sensitivity rescuer polypeptide comprises SEQ ID NO:221 or a variant sequence thereof.The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide (e.g., a Mycobacterium smegmatis 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; a Thermobifida fusca 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; a Lactobacillus plantarum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; a Corynebacterium glutamicum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; a Escherichia coli 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide comprises a sequence at least 80% identical to SEQ ID NO:72, SEQ ID NO:73 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical), or a variant sequence thereof; the Streptomyces coelicolor 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide comprises SEQ ID NO:71 or a variant sequence thereof; the Thermobifida fusca 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide comprises SEQ ID NO:70 or a variant sequence thereof; the Lactobacillus plantarum 5 -methyltetrahydrofolate homocysteine methyltransferase polypeptide comprises SEQ ID NO:74 or a variant sequence thereof; the Corynebacterium glutamicum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide comprises SEQ ID NO: 222 or a variant sequence thereof; and the Escherichia coli 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide comprises SEQ ID NO:223 or a variant sequence thereof The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide (e.g., a Mycobacterium smegmatis 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or functional variant thereof; a Corynebacterium glutamicum 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof; an Escherichia coli 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide is at least 80% identical to SEQ ID NO:75 or SEQ ID NO:76 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:75 or SEQ ID NO:76); the Streptomyces coelicolor 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide comprises SEQ ID NO:77 or a variant sequence thereof; the Corynebacterium glutamicum 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide comprises SEQ ID NO:224 or a variant sequence thereof; and the Escherichia coli 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide comprises SEQ ID NO:225 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial serine hydroxymethyltransferas polypeptide (e.g., a Mycobacterium smegmatis serine hydroxymethyltransferase polypeptide or functional variant thereof; a Streptomyces coelicolor serine hydroxymethyltransferase polypeptide or a functional variant thereof; a Thermobifida fusca serine hydroxymethyltransferase polypeptide or a functional variant thereof; a Lactobacillus plantarum serine hydroxymethyltransferase polypeptide or a functional variant thereof; a Corynebacterium glutamicum serine hydroxymethyltransferase polypeptide or a functional variant thereof; an Escherichia coli serine hydroxymethyltransferase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis serine hydroxymethyltransferase polypeptide is at least 80% identical to SEQ ID NO:80 or SEQ ID NO:81 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:80 or SEQ ID NO:81); the Streptomyces coelicolor serine hydroxymethyltransferase polypeptide comprises SEQ ID NO:78 or a variant sequence thereof; the Thermobifida fusca serine hydroxymethyltransferase polypeptide comprises SEQ ID NO:79 or a variant sequence thereof; the Lactobacillus plantarum serine hydroxymethyltransferase polypeptide comprises SEQ ID NO:82 or a variant sequence thereof; the Corynebacterium glutamicum serine hydroxymethyltransferase polypeptide comprises SEQ ID NO:226 or a variant sequence thereof; and the Escherichia coli serine hydroxymethyltransferase polypeptide comprises SEQ ID NO:227 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial 5,10-methylenetetrahydrofolate reductase polypeptide (e.g., a Streptomyces coelicolor 5,1 0-methylenetetrahydrofolate reductase polypeptide or a functional variant thereof; a Thermobifida fusca 5,10-methylenetetrahydrofolate reductase polypeptide or a functional variant thereof; a Corynebacterium glutamicum 5,1 0-methylenetetrahydrofolate reductase polypeptide or a functional variant thereof; an Escherichia coli 5,10-methylenetetrahydrofolate reductase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Streptomyces coelicolor 5,1 0-methylenetetrahydrofolate reductase polypeptide comprises SEQ ID NO:84 or a variant sequence thereof; the Thermobifida fusca 5,10-methylenetetrahydrofolate reductase polypeptide comprises SEQ ID NO: 83 or a variant sequence thereof; the Corynebacterium glutamicum 5,10-methylenetetrahydrofolate reductase polypeptide comprises SEQ ID NO: 228 or a variant sequence thereof; and the Escherichia coli 5,10-methylenetetrahydrofolate reductase polypeptide comprises SEQ ID NO: 229 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial serine O-acetyltransferase polypeptide (e.g., a Mycobacterium smegmatis serine O-acetyltransferase polypeptide or functional variant thereof; a Lactobacillus plantarum serine O-acetyltransferase polypeptide or a functional variant thereof; a Corynebacterium glutamicum serine O-acetyltransferase polypeptide or a functional variant thereof; an Escherichia coli serine O-acetyltransferase polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis serine O-acetyltransferase polypeptide is at least 80% identical to SEQ ID NO:85 or SEQ ID NO:86 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:85 or SEQ ID NO:86); the Lactobacillus plantarum serine O-acetyltransferase polypeptide comprises SEQ ID NO:87 or a variant sequence thereof; the Corynebacterium glutamicum serine O-acetyltransferase polypeptide comprises SEQ ID NO:230 or a variant sequence thereof; and the Escherichia coli serine O-acetyltransferase polypeptide comprises SEQ ID NO:231 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial D-3-phosphoglycerate dehydrogenase polypeptide (e.g., a Mycobacterium smegmatis D-3-phosphoglycerate dehydrogenase polypeptide or functional variant thereof; a Streptomyces coelicolor D-3-phosphoglycerate dehydrogenase polypeptide or a functional variant thereof; a Thermobifida fusca D-3-phosphoglycerate dehydrogenase polypeptide or a functional variant thereof; a Lactobacillus plantarum D-3-phosphoglycerate dehydrogenase polypeptide or a functional variant thereof; a Corynebacterium glutamicum D-3-phosphoglycerate dehydrogenase polypeptide or a functional variant thereof; an Escherichia coli D-3-phosphoglycerate dehydrogenase polypeptide or a functional vaant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis D-3-phosphoglycerate dehydrogenase polypeptide is at least 80% identical to SEQ ID NO:88 or SEQ ID NO:89 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:88 or SEQ ID NO:89); the Streptomyces coelicolor D-3-phosphoglycerate dehydrogenase polypeptide comprises SEQ ID NO:91 or a variant sequence thereof; the Thermobifida fusca D-3-phosphoglycerate dehydrogenase polypeptide comprises SEQ ID NO:90 or a variant sequence thereof; the Lactobacillus plantarum D-3-phosphoglycerate dehydrogenase polypeptide comprises SEQ ID NO:92 or a variant sequence thereof; the Corynebacterium glutamicum serine O-acetyltransferase polypeptide comprises SEQ ID NO:232 or a variant sequence thereof; and the Escherichia coli serine O-acetyltransferase polypeptide comprises SEQ ID NO:233 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial lysine exporter polypeptide (e.g., a Corynebacterium glutamicum lysine exporter polypeptide or functional variant thereof; a Mycobacterium smegmatis lysine exporter polypeptide or functional variant thereof; a Streptomyces coelicolor lysine exporter polypeptide or a functional variant thereof; an Escherichia coli lysine exporter polypeptide or functional variant thereof or a Lactobacillus plantarum lysine exporter protein or a functional variant thereof) or functional variant thereof.

In various embodiments the Mycobacterium smegmatis lysine exporter polypeptide is at least 80% identical to SEQ ID NO:93 or SEQ ID NO:94 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:93 or SEQ ID NO:94); the Streptomyces coelicolor lysine exporter polypeptide comprises SEQ ID NO:95 or a variant sequence thereof; the Lactobacillus plantarum lysine exporter polypeptide comprises SEQ ID NO:96 or a variant sequence thereof; the Corynebacterium glutamicum lysine exporter polypeptide comprises SEQ ID NO:234 or a variant sequence thereof; and the Escherichia coli lysine exporter polypeptide comprises SEQ ID NO:237 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a bacterial O-succinylhomoserine (thio)-lyase/O-acetylhomoserine (thio)-lyase polypeptide (e.g., a Corynebacterium glutamicum O-succinylhomoserine (thio)-lyase polypeptide or functional variant thereof; a Mycobacterium smegmatis O-succinylhomoserine (thio)-lyase polypeptide or functional variant thereof; a Streptomyces coelicolor O-succinylhomoserine (thio)-lyase polypeptide or a functional variant thereof; a Thermobifida fusca O-succinylhomoserine (thio)-lyase polypeptide or a functional variant thereof; an Escherichia coli O-succinylhomoserine (thio)-lyase polypeptide or a functional variant thereof; or a Lactobacillus plantarum O-succinylhomoserine (thio)-lyase polyp eptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Mycobacterium smegmatis O-succinylhomoserine (thio)-lyase polypeptide is at least 80% identical to SEQ ID NO:97 or SEQ ID NO:98 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO:97 or SEQ ID NO:98); the Streptomyces coelicolor O-succinylhomoserine (thio)-lyase polypeptide comprises SEQ ID NO:99 or a variant sequence thereof; the Thermobifida fusca O-succinylhomoserine (thio)-lyase polypeptide comprises SEQ ID NO:100 or a variant sequence thereof; the Lactobacillus plantarum O-succinylhomoserine (thio)-lyase polypeptide comprises SEQ ID NO: 101 or a variant sequence thereof; the Corynebacterium glutamicum O-succinylhomoserine (thio)-lyase polypeptide comprises SEQ ID NO:235 or a variant sequence thereof; and the Escherichia coli O-succinylhomoserine (thio)-lyase polypeptide comprises SEQ ID NO:236 or a variant sequence thereof.

The invention features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes a threonine efflux polypeptide (e.g. a Corynebacterium glutamicum threonine efflux polypeptide or a functional variant thereof; a homolog of the Corynebacterium glutamicum threonine efflux polypeptide or a functional variant thereof; a Streptomyces coelicolor putative threonine efflux polypeptide or a functional variant thereof) or functional variant thereof.

In various embodiments the Corynebacterium glutamicum threonine efflux polypeptide comprises SEQ ID NO: 196 or a variant sequence thereof; the homolog of the Corynebacterium glutamicum threonine efflux polypeptide comprises a homolog of SEQ ID NO: 196 or a variant sequence thereof; and the Streptomyces coelicolor putative threonine efflux polypeptide comprises SEQ ID NO: 102 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes C. glutamicum hypothetical polypeptide (SEQ ID NO: 198), a bacterial homolog of C. glutamicum hypothetical polypeptide (SEQ ID NO: 198), (e.g., a Mycobacterium smegmatis hypothetical polypeptide or functional variant thereof; a Streptomyces coelicolor hypothetical polypeptide or a functional variant thereof; a Thermobifida fusca hypothetical polypeptide or a functional variant thereof; an Escherichia coli hypothetical polypeptide or a functional variant thereof; or a Lactobacillus plantarum hypothetical polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the the bacterial homolog is: a Mycobacterium smegmatis hypothetical polypeptide at least 80% identical to SEQ ID NO:104 or SEQ ID NO:105 (e.g., a sequence at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to SEQ ID NO: 104 or SEQ ID NO: 105); the Streptomyces coelicolor hypothetical polypeptide comprises SEQ ID NO:103 or a variant sequence thereof; the Thermobifida fusca hypothetical polypeptide comprises SEQ ID NO106 or a variant sequence thereof; the Lactobacillus plantarum hypothetical polypeptide comprises SEQ ID NO:107 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes C. glutamicum putative membrane polypeptide (SEQ ID NO:201), a bacterial homolog of C. glutamicum putative membrane polypeptide (SEQ ID NO:201), (e.g., a Streptomyces coelicolor putative membrane polypeptide or a functional variant thereof; a Thermobifida fusca putative membrane polypeptide or a functional variant thereof; an Erwinia chrysanthemi putative membrane polypeptide or a functional variant thereof; an Escherichia coli putative membrane polypeptide or a functional variant thereof; a Lactobacillus plantarum putative membrane polypeptide or a functional variant thereof; or a Pectobacterium chrysanthemi putative membrane polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Streptomyces coelicolor putative membrane polypeptide comprises SEQ ID NO:111, SEQ ID NO: 112, SEQ ID NO: 113, SEQ ID NO: 114, oravariant sequence thereof; the Thermobifida fusca putative membrane polypeptide comprises SEQ ID NO: 108, SEQ ID NO: 109, SEQ ID NO: 110, or a variant sequence thereof; the Erwinia chrysanthemi putative membrane polypeptide comprises SEQ ID NO: 115 or a variant sequence thereof; the Pectobacterium chrysanthemi putative membrane polypeptide comprises SEQ ID NO:116 or a variant sequence thereof; the Lactobacillus plantarum putative membrane polypeptide comprises SEQ ID NO:1 17, SEQ ID NO:1 18, SEQ ID NO:1 19, or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes C. glutamicum drug permease polypeptide (SEQ ID NO:199), a bacterial homolog of C. glutamicum drug permease polypeptide (SEQ ID NO: 199), (e.g., a Streptomyces coelicolor drug permease polypeptide or a functional variant thereof; a Thermobifida fusca drug permease polypeptide or a functional variant thereof; an Escherichia coli drug permease polypeptide or a functional variant thereof;or a Lactobacillus plantarum drug permease polypeptide or a functional variant thereof) or a functional variant thereof.

In various embodiments the Streptomyces coelicolor drug permease polypeptide comprises SEQ ID NO: 120, SEQ ID NO: 121, or a variant sequence thereof; the Thermobifida fusca drug permease polypeptide comprises SEQ ID NO: 122, SEQ ID NO: 123, or a variant sequence thereof; the Lactobacillus plantarum drug permease polypeptide comprises SEQ ID NO: 124 or a variant sequence thereof.

The invention also features a coryneform bacterium or a bacterium of the family Enterobacteriaceae such as an Escherichia coli bacterium comprising a nucleic acid molecule that encodes C. glutamicum hypothetical membrane polypeptide (SEQ iID NO: 197), a bacterial homolog of C. glutamicum hypothetical membrane polypeptide (SEQ ID NO: 197), (e.g., a Thermobifida fusca hypothetical membrane polypeptide or a functional variant thereof).

In various embodiments the Thermobifida fusca hypothetical membrane polypeptide comprises SEQ ID NO:125 or a variant sequence thereof.

As mentioned above, the invention also provides nucleic acids encoding variant bacterial proteins. Nucleic acids that include sequences encoding variant bacterial polypeptides can be expressed in the organism from which the sequence was derived, or they can be expressed in an organism other than the organism from which they were derived (e.g., heterologous organisms).

In one aspect, the invention features an isolated nucleic acid (e.g., a nucleic acid expression vector) that encodes a variant of a bacterial polypeptide (e.g., a variant of a wild-type bacterial polypeptide) that regulates the production of one or more amino acids from the aspartic acid family of amino acids or related metabolites. The bacterial polypeptide can include, for example, the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine. The variant of the bacterial polypeptide includes an amino acid change relative to the bacterial protein, e.g., at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360, or at an amino acid within 8, 5, 3, 2, or 1 residue of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In one embodiment, variant of the bacterial polypeptide is otherwise identical in amino acid sequence to the bacterial protein, or at least 80%, 85%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99%, or more identical to the bacterial polypeptide, e.g., the variant comprises fewer than 50, 40, 25, 15, 10, 7, 5, 3, 2, or 1 changes relative to the bacterial polypeptide.

Alternatively, or in addition, the bacterial polypeptide includes the following amino acid sequence: L₁-X₂-X₃-G₄-G₅-X₆-F₇-X₈-X₉-X₁₀-X₁₁ (SEQ ID NO:361), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid,wherein X₈ is selected from valine, leucine, isoleucine, and aspartate, and wherein X₁₁ is selected from valine, leucine, isoleucine, phenylalanine, and methionine; and the variant of the bacterial protein includes an amino acid change e.g., at one or more of L₁, G₄, X₈, X₁₁, or at an amino acid residue within 8, 5, 3, 2, or 1 residue of L₁, G₄, X₈, or X₁₁ of SEQ ID NO: 361).

In various embodiments, feedback inhibition of the variant of the bacterial polypeptide by S-adenosylmethionine is reduced, e.g., relative to the bacterial polypeptide (e.g., relative to a wild-type bacterial protein) or relative to a reference protein.

Amino acid changes in the variant of the bacterial polypeptide can be changes to alanine (e.g., wherein the original residue is other than an alanine) or non-conservative changes. The changes can be conservative changes.

The invention also features polypeptides encoded by the nucleic acids described herein, e.g., a polypeptide encoded by a nucleic acid that encodes a variant of a bacterial polypeptide (e.g., a variant of a wild-type bacterial polypeptide) that regulates the production of one or more amino acids from the aspartic acid family of amino acids or related metabolites, wherein the bacterial polypeptide includes SEQ ID NO:360 or SEQ ID NO:361, and wherein the variant includes an amino acid change relative to the bacterial polypeptide.

Also provided is a method for making a nucleic acid encoding a variant of a bacterial polypeptide that regulates the production of one or more amino acids from the aspartic acid family of amino acids or related metabolites. The method includes, for example, identifying a motif in the amino acid sequence of a wild-type form of the bacterial polypeptide, and constructing a nucleic acid that encodes a variant wherein one or more amino acid residues (e.g., one, two, three, four, or five residues) within and/or near (e.g., within 10, 8, 7, 5, 3, 2, or 1 residues) the motif is changed.

In various embodiments, the motif in the bacterial polypeptide includes the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X_X12-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_23l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine. In various embodiments, one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360 is changed. In one embodiment, the variant of the bacterial polypeptide is otherwise identical in amino acid sequence to the bacterial polypeptide. In various embodiments, the motif in the bacterial polypeptide includes the following amino acid sequence: L₁-X₂-X₃-G₄-G₅-X₆-F₇-X₈-X₉- X₁₀-X₁₁ (SEQ ID NO:361), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein X₈ is selected from valine, leucine, isoleucine, and aspartate, and wherein X₁₁ is selected from valine, leucine, isoleucine, phenylalanine, and methionine. In various embodiments, one or more of L₁, G₄, X₈, X₁₁ of SEQ ID NO: 361 is changed. In one embodiment, the variant of the bacterial polypeptide is otherwise identical in amino acid sequence to the bacterial protein.

The invention also features a bacterium that includes a nucleic acid described herein, e.g., a nucleic acid that encodes a variant of a bacterial polypeptide (e.g., a variant of a wild-type bacterial polypeptide) that regulates the production of one or more amino acids from the aspartic acid family of amino acids or related metabolites, wherein the bacterial polypeptide includes SEQ ID NO:360 or SEQ ID NO:361, and wherein the variant includes an amino acid change relative to the bacterial polypeptide. The bacterium can be a genetically modified bacterium, e.g., a bacterium that has been modified to include the nucleic acid (e.g., by transformation of the nucleic acid, e.g., wherein the nucleic acid is episomal, or wherein the nucleic acid integrates into the genome of the bacterium, either at a random location, or at a specifically targeted location), and/or that has been modified within its genome (e.g., modified such that an endogenous gene has been altered by mutagenesis or replaced by recombination, or modified to include a heterologous promoter upstream of an endogenous gene.

The invention also features a method for producing an amino acid or a related metabolite. The methods can include, for example: cultivating a bacterium (e.g., a genetically modified bacterium) that includes a nucleic acid encoding a variant of a bacterial polypeptide (e.g., a variant of a wild-type bacterial polypeptide) that regulates the production of one or more amino acids from the aspartic acid family of amino acids or related metabolites, wherein the bacterial polypeptide includes SEQ ID NO:360 or SEQ ID NO:361, and wherein the variant includes an amino acid change relative to the bacterial polypeptide. The bacterium is cultivated under conditions in which the nucleic acid is expressed and that allow the amino acid (or related metabolite(s)) to be produced, and a composition that includes the amino acid (or related metabolite(s)) is collected. The composition can include, for example, culture supernatants, heat or otherwise killed cells, or purified amino acid.

In one aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide. In certain embodiments, the variant bacterial homoserine O-acetyltransferase polypeptide exhibits reduced feedback inhibition, e.g., relative to a wild-type form of the bacterial homoserine O-acetyltransferase polypeptide. In various embodiments, the nucleic acid encodes a homoserine O-acetyltransferase polypeptide with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial homoserine O-acetyltransferase polypeptide is chosen from: a Corynebacterium glutamicum homoserine O-acetyltransferase polypeptide, a Mycobacterium smegmatis homoserine O-acetyltransferase polypeptide, a Thermobifida fusca homoserine O-acetyltransferase polypeptide, an Amycolatopsis mediterranei homoserine O-acetyltransferase polypeptide, a Streptomyces coelicolor homoserine O-acetyltransferase polypeptide, an Erwinia chrysanthemi homoserine O-acetyltransferase polypeptide, a Shewanella oneidensis homoserine O-acetyltransferase polypeptide, a Mycobacterium tuberculosis homoserine O-acetyltransferase polypeptide, an Escherichia coli homoserine O-acetyltransferase polypeptide, a Corynebacterium acetoglutamicum homoserine O-acetyltransferase polypeptide, a Corynebacterium melassecola homoserine O-acetyltransferase polypeptide, a Corynebacterium thermoaminogenes homoserine O-acetyltransferase polypeptide, a Brevibacterium lactofermentum homoserine O-acetyltransferase polypeptide, a Brevibacterium lactis homoserine O-acetyltransferase polypeptide, and a Brevibacterium flavum homoserine O-acetyltransferase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a variant of a homoserine O-acetyltransferase polypeptide including the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant homoserine O-acetyltransferase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a C. glutamicum homoserine O-acetyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:212: Glycine 231, Lysine 233, Phenylalanine 251, Valine 253, and Aspartate 269. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a T fusca homoserine O-acetyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:24: Glycine 81, Aspartate 287, Phenylalanine 269.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is an E. coli homoserine O-acetyltransferase polypeptide including an amino acid change at Glutamate 252 of SEQ ID NO:213.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a mycobacterial homoserine O-acetyltransferase polypeptide including an amino acid change in a residue corresponding to one or more of the following residues of M leprae homoserine O-acetyltransferase polypeptide set forth in SEQ ID NO: 23: Glycine 73, Aspartate 278, and Tyrosine 260. In various embodiments, the variant bacterial homoserine O-acetyltransferase polypeptide is a variant of a M. smegmatis homoserine O-acetyltransferase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is an M. tuberculosis homoserine O-acetyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:22: Glycine 73, Tyrosine 260, and Aspartate 278.

The invention also features polypeptides encoded by, and bacteria including, the nucleic acids encoding variant bacterial homoserine O-acetyltransferases. In various embodiments, the bacteria are coryneform bacteria. The bacteria can further include nucleic acids encoding other variant bacterial proteins (e.g., variant bacterial proteins involved in amino acid production, e.g., variant bacterial proteins described herein).

In another aspect, the invention features a method for producing L-methionine or related intermediates such as O-acetyl homoserine, cystathionine, homocysteine, methionine, SAM and derivatives thereof, the method including: cultivating a genetically modified bacterium including a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase under conditions in which the nucleic acid is expressed and that allow L-methionine (or related intermediate) to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide. In certain embodiments, the variant bacterial homoserine O-acetylhomoserine sulfhydrylase polypeptide exhibits reduced feedback inhibition, e.g., relative to a wild-type form of the bacterial O-acetylhomoserine sulfhydrylase polypeptide.

In various embodiments, the nucleic acid encodes an O-acetylhomoserine sulfhydrylase polypeptide with reduced feedback inhibition by S-adenosylmethionine.

In various embodiments, the bacterial O-acetylhomoserine sulfhydrylase polypeptide is chosen from: a Corynebacterium glutamicum homoserine O-acetylhomoserine sulfhydrylase polypeptide, a Mycobacterium smegmatis homoserine O-acetylhomoserine sulfhydrylase polypeptide, a Thermobifida fusca O-acetylhomoserine sulfhydrylase polypeptide, an Amycolatopsis mediterranei O-acetylhomoserine sulfhydrylase polypeptide, a Streptomyces coelicolor O-acetylhomoserine sulfhydrylase polypeptide, an Erwinia chrysanthemi homoserine O-acetylhomoserine sulfhydrylase polypeptide, a Shewanella oneidensis O-acetylhomoserine sulfhydrylase polypeptide, a Mycobacterium tuberculosis O-acetylhomoserine sulfhydrylase polypeptide, an Escherichia coli O-acetylhomoserine sulfhydrylase polypeptide, a Corynebacterium acetoglutamicum O-acetylhomoserine sulfhydrylase polypeptide, a Corynebacterium melassecola O-acetylhomoserine sulfhydrylase polypeptide, a Corynebacterium thermoaminogenes O-acetylhomoserine sulfhydrylase polypeptide, a Brevibacterium lactofermentum O-acetylhomoserine sulfhydrylase polypeptide, a Brevibacterium lactis O-acetylhomoserine sulfhydrylase polypeptide, and a Brevibacterium flavum O-acetylhomoserine sulfhydrylase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a variant of an O-acetylhomoserine sulfhydrylase polypeptide including the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant O-acetylhomoserine sulfhydrylase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360.

In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a variant of a O-acetylhomoserine sulffiydrylase polypeptide including the following amino acid sequence: L₁-X₂-X₃-G₄-G₅-X₆-F₇-X₈-X₉-X₁₀-X₁₁ (SEQ ID NO:361), wherein X is any amino acid, wherein X₈ is selected from valine, leucine, isoleucine, and aspartate, and wherein X₁₁ is selected from valine, leucine, isoleucine, phenylalanine, and methionine; wherein the variant of the bacterial polypeptide includes an amino acid change at one or more of L₁, G₄, X₈, X₁₁ of SEQ ID NO:361.

In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a C. glutamicum O-acetylhomoserine sufhydrylase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:214: Glycine 227, Leucine 229, Aspartate 231, Glycine 232, Glycine 233, Phenylalanine 235, Aspartate 236, Valine 239, Phenylalanine 368, Aspartate 370, Aspartate 383, Glycine 346, and Lysine 348. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulffiydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a T. fusca O-acetylhomoserine sulfhydrylase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:25: Glycine 240, Aspartate 244, Phenylalanine 379, and Aspartate 394.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a M. smegmatis O-acetylhomoserine sulfhydrylase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:287: Glycine 303, Aspartate 307, Phenylalanine 439, Aspartate 454.

In another aspect, the invention features a polypeptide encoded by a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase.

In another aspect, the invention features a bacterium comprising the nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., a variant bacterial polypeptide described herein).

In another aspect, the invention features a method for producing L-methionine or related intermediates (e.g., homocysteine, methionine, S-AM, or derivatives thereof), the method comprising: cultivating a genetically modified bacterium comprising the nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide under conditions in which the nucleic acid is expressed and that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial mcbR gene product. In various embodiments, the variant bacterial mcbR gene product exhibits reduced feedback inhibition relative to a wild-type form of the mcbR gene product. In various embodiments, the nucleic acid encodes a mcbR gene product with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial mcbR gene product is chosen from: a Corynebacterium glutamicum mcbR gene product, a Corynebacterium acetoglutamicum mcbR gene product, a Corynebacterium melassecola mcbR gene product, and a Corynebacterium thermoaminogenes mcbR gene product.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial mcbR gene product, wherein the variant mcbR gene product is a variant of an mcbR gene product including the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant mcbR gene product includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial mcbR gene product, wherein the variant mcbR gene product is a C. glutamicum mcbR gene product including an amino acid change in one or more of the following residues of SEQ ID NO:363: Glycine 92, Lysine 94, Phenylalanine 116, Glycine 118, and Aspartate 134. In various embodiments, the amino acid change is a change to an alanine.

The invention also features a polypeptide encoded by the nucleic acids encoding a variant bacterial mcbR gene product.

The invention also features a bacterium including the nucleic acids encoding a variant bacterial mcbR gene product. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein).

The invention also features methods for producing L-methionine, the method including: cultivating a genetically modified bacterium including a nucleic acid encoding a variant bacterial mcbR gene product under conditions in which the nucleic acid is expressed and that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial aspartokinase polypeptide. In various embodiments, the variant bacterial aspartokinase polypeptide exhibits reduced feedback inhibition relative to a wild-type form of the bacterial aspartokinase polypeptide. In various embodiments, the nucleic acid encodes an aspartokinase polypeptide with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial aspartokinase polypeptide is chosen from: a Corynebacterium glutamicum aspartokinase polypeptide, a Mycobacterium smegmatis aspartokinase polypeptide, a Thermobifida fusca aspartokinase polypeptide, an Amycolatopsis mediterranei aspartokinase polypeptide, a Streptomyces coelicolor aspartokinase polypeptide, an Erwinia chrysanthemi aspartokinase polypeptide, a Shewanella oneidensis aspartokinase polypeptide, a Mycobacterium tuberculosis aspartokinase polypeptide, an Escherichia coli aspartokinase polypeptide, a Corynebacterium acetoglutamicum aspartokinase polypeptide, a Corynebacterium melassecola aspartokinase polypeptide, a Corynebacterium thermoaminogenes aspartokinase polypeptide, a Brevibacterium lactofermentum aspartokinase polypeptide, a Brevibacterium lactis aspartokinase polypeptide, and a Brevibacterium flavum aspartokinase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial aspartokinase polypeptide, wherein the variant aspartokinase polypeptide is a variant of an aspartokinase polypeptide including the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X_X6-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), w wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant aspartokinase includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial aspartokinase polypeptide, wherein the aspartokinase polypeptide is a C. glutamicum aspartokinase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:202: Glycine 208, Lysine 210, Phenylalanine 223, Valine 225, and Aspartate 236. In various embodiments, the amino acid change is a change to an alanine.

The invention also features a polypeptide encoded by the nucleic acid encoding a variant bacterial aspartokinase polypeptide.

The invention also features a bacterium including the nucleic acid encoding a variant bacterial aspartokinase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein). In various embodiments, the bacterium further comprises one or more nucleic acid molecules (e.g., recombinant nucleic acid molecules) encoding a polypeptide involved in amino acid production (e.g., a polypeptide that is heterologous or homologous to the host cell, or a variant thereof). In various embodiments, the bacterium further comprises mutations in an endogenous sequence that result in increased or decreased activity of a polypeptide involved in amino acid production (e.g., by mutation of an endogenous sequence encoding the polypeptide involved in amino acid production or a sequence that regulates expression of the polypeptide, e.g., a promoter sequence).

The invention also features a method for producing an amino acid, the method including: cultivating a genetically modified bacterium including the nucleic acid encoding a variant bacterial aspartokinase polypeptide under conditions in which the nucleic acid is expressed and that allow the amino acid to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in the amino acid).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-succinylhomoserine/acetylhomoserine (thiol)-lyase polypeptide (O-succinylhomoserine (thiol)-lyase). In various embodiments, the variant O-succinylhomoserine (thiol)-lyase exhibits reduced feedback inhibition relative to a wild-type form of the O-succinylhomoserine (thiol)-lyase polypeptide. In various embodiments, the nucleic acid encodes an O-succinylhomoserine (thiol)-lyase polypeptide with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial O-succinylhomoserine (thiol)-lyase polypeptide is chosen from: a Corynebacterium glutamicum O-succinylhomoserine (thiol)-lyase polypeptide, a Mycobacterium smegmatis O-succinylhomoserine (thiol)-lyase polypeptide, a Thermobifida fusca O-succinylhomoserine (thiol)-lyase polypeptide, an Amycolatopsis mediterranei O-succinylhomoserine (thiol)-lyase polypeptide, a Streptomyces coelicolor O-succinylhomoserine (thiol)-lyase polypeptide, an Erwinia chrysanthemi O-succinylhomoserine (thiol)-lyase polypeptide, a Shewanella oneidensis O-succinylhomoserine (thiol)-lyase polypeptide, a Mycobacterium tuberculosis O-succinylhomoserine (thiol)-lyase polypeptide, an Escherichia coli O-succinylhomoserine (thiol)-lyase polypeptide, a Corynebacterium acetoglutamicum O-succinylhomoserine (thiol)-lyase polypeptide, a Corynebacterium melassecola O-succinylhomoserine (thiol)-lyase polypeptide, a Corynebacterium thermoaminogenes O-succinylhomoserine (thiol)-lyase polypeptide, a Brevibacterium lactofermentum O-succinylhomoserine (thiol)-lyase polypeptide, a Brevibacterium lactis O-succinylhomoserine (thiol)-lyase polypeptide, and a Brevibacterium flavum O-succinylhomoserine (thiol)-lyase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase polypeptide, wherein the variant O-succinylhomoserine (thiol)-lyase polypeptide is a variant of an O-succinylhomoserine (thiol)-lyase polypeptide including the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant O-succinylhomoserine (thiol)-lyase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase polypeptide, wherein the variant O-succinylhomoserine (thiol)-lyase polypeptide is a C. glutamicum O-succinylhomoserine (thiol)-lyase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:235: Glycine 72, Lysine 74, Phenylalanine 90, isoleucine 92, and Aspartate 105. In various embodiments, the amino acid change is a change to an alanine.

The invention also features a polypeptide encoded by a nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase polypeptide.

The invention also features a bacterium including a nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein).

The invention also features a method for producing L-methionine, the method including: cultivating a genetically modified bacterium including a nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase polypeptide under conditions in which the nucleic acid is expressed and that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial cystathionine beta-lyase polypeptide. In various embodiments, the variant cystathionine beta-lyase polypeptide exhibits reduced feedback inhibition relative to a wild-type form of the cystathionine beta-lyase polypeptide. In various embodiments, the nucleic acid encodes a cystathionine beta-lyase polypeptide with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial cystathionine beta-lyase polypeptide is chosen from: a Corynebacterium glutamicum cystathionine beta-lyase polypeptide, a Mycobacterium smegmatis cystathionine beta-lyase polypeptide, a Thermobifida fusca cystathionine beta-lyase polypeptide, an Amycolatopsis mediterranei cystathionine beta-lyase polypeptide, a Streptomyces coelicolor cystathionine beta-lyase polypeptide, an Erwinia chrysanthemi cystathionine beta-lyase polypeptide, a Shewanella oneidensis cystathionine beta-lyase polyp eptide, a Mycobacterium tuberculosis cystathionine beta-lyase polyp eptide, an Escherichia coli cystathionine beta-lyase polypeptide, a Corynebacterium acetoglutamicum cystathionine beta-lyase polypeptide, a Corynebacterium melassecola cystathione beta-lyase polypeptide, a Corynebacterium thermoaminogenes cystathionine beta-lyase polypeptide, a Brevibacterium lactofermentum cystathionine beta-lyase polypeptide, a Brevibacterium lactis cystathionine beta-lyase polypeptide, and a Brevibacteriumflavum cystathionine beta-lyase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial cystathionine beta-lyase polypeptide, wherein the variant cystathionine beta-lyase polypeptide is a variant of a cystathionine beta-lyase polypeptide including the following amino acid sequence: G₁-X₂-X₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant cystathionine beta-lyase includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial cystathionine beta-lyase polypeptide, wherein the variant cystathionine beta-lyase polypeptide is a C. glutamicum cystathionine beta-lyase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:217: Glycine 296, Lysine 298, Phenylalanine 312, Glycine 314 and Aspartate 335. In various embodiments, the amino acid change is a change to an alanine.

The invention also features a polypeptide encoded by a nucleic acid encoding a variant bacterial cystathionine beta-lyase.

The invention also features a bacterium including a nucleic acid encoding a variant bacterial cystathionine beta-lyase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein).

The invention also features a method for producing L-methionine, the method including:

cultivating a genetically modified bacterium including a nucleic acid encoding a variant bacterial cystathionine beta-lyase polypeptide under conditions in which the nucleic acid is expressed and that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide. In various embodiments, the variant 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide exhibits reduced feedback inhibition relative to a wild-type form of the 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide. In various embodiments, the nucleic acid encodes a 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide with reduced feedback inhibition by S-adenosylmethionine polypeptide. In various embodiments, the bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide is chosen from: a Corynebacterium glutamicum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Mycobacterium smegmatis 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Thermobifida fusca 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, an Amycolatopsis mediterranei 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Streptomyces coelicolor 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, an Erwinia chrysanthemi 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Shewanella oneidensis 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Mycobacterium tuberculosis 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, an Escherichia coli 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Corynebacterium acetoglutamicum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Corynebacterium melassecola 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Corynebacterium thermoaminogenes 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Brevibacterium lactofermentum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, a Brevibacterium lactis 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, and a Brevibacterium flavum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, wherein the variant 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide is a variant of a 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide including the following amino acid sequence: G₁-X₂ -K₃ -X₄ -X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆ SEQ ID NO: 362), wherein X is any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, or Z₁₆, of SEQ ID NO:362. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide, wherein the variant 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide is a C. glutamicum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:222:

Glycine 708, Lysine 710, Phenylalanine 725, and Leucine 727. In various embodiments, the amino acid change is a change to an alanine.

The invention also features a polypeptide encoded by the nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase.

The invention also features a bacterium including a nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein).

The invention also features a method for producing L-methionine, the method including: cultivating a genetically modified bacterium including a nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide under conditions in which the nucleic acid is expressed and that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide. In various embodiments, the variant S-adenosylmethionine synthetase polypeptide exhibits reduced feedback inhibition relative to a wild-type form of the S-adenosylmethionine synthetase polypeptide. In various embodiments, the nucleic acid encodes an S-adenosylmethionine synthetase polypeptide with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial S-adenosylmethionine synthetase polypeptide is chosen from: a Corynebacterium glutamicum S-adenosylmethionine synthetase polypeptide, a Mycobacterium smegmatis S-adenosylmethionine synthetase polypeptide, a Thermobifida fusca S-adenosylmethionine synthetase polypeptide, an Amycolatopsis mediterranei S-adenosylmethionine synthetase polypeptide, a Streptomyces coelicolor S-adenosylmethionine synthetase polypeptide, an Erwinia chrysanthemi S-adenosylmethionine synthetase polypeptide, a Shewanella oneidensis S-adenosylmethionine synthetase polypeptide, a Mycobacterium tuberculosis S-adenosylmethionine synthetase polypeptide, an Escherichia coli S-adenosylmethionine synthetase polypeptide, a Corynebacterium acetoglutamicum S-adenosylmethionine synthetase polypeptide, a Corynebacterium melassecola S-adenosylmethionine synthetase polypeptide, a Corynebacterium thermoaminogenes S-adenosylmethionine synthetase polypeptide, a Brevibacterium lactofermentum S-adenosylmethionine synthetase polypeptide, a Brevibacterium lactis S-adenosylmethionine synthetase polypeptide, and a Brevibacterium flavum S-adenosylmethionine synthetase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide, wherein the variant S-adenosylmethionine synthetase polypeptide is a variant of an S-adenosylmethionine synthetase polypeptide including the following amino acid sequence: G₁-X₂-K₃-X_4-X₅-X₆-X_7-X8-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid,wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant S-adenosylmethionine synthetase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360. In various embodiments, the amino acid change is a change to an alanine.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide, wherein the variant S-adenosylmethionine synthetase polypeptide is a C. glutamicum S-adenosylmethionine synthetase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:215: Glycine 263, Lysine 265, Phenylalanine 282, Glycine 284, and Aspartate 291.

In various embodiments, the amino acid change is a change to an alanine.

The invention also features a polypeptide encoded by a nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide.

The invention also features a bacterium including a nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further comprise one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein).

The invention also features a method for producing L-methionine, the method including: cultivating a genetically modified bacterium including a nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide under conditions in which the nucleic acid is expressed and that allow L-methionine to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in L-methionine).

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine kinase polypeptide. In various embodiments, the variant homoserine kinase polypeptide exhibits reduced feedback inhibition relative to a wild-type form of the bacterial homoserine kinase polypeptide. In various embodiments, the nucleic acid encodes a homoserine kinase polypeptide with reduced feedback inhibition by S-adenosylmethionine. In various embodiments, the bacterial homoserine kinase polypeptide is chosen from: a Corynebacterium glutamicum homoserine kinase polypeptide, a Mycobacterium smegmatis homoserine kinase polypeptide, a Thermobifida fusca homoserine kinase polypeptide, an Amycolatopsis mediterranei homoserine kinase polypeptide, a Streptomyces coelicolor homoserine kinase polypeptide, an Erwinia chrysanthemi homoserine kinase polypeptide, a Shewanella oneidensis homoserine kinase polypeptide, a Mycobacterium tuberculosis homoserine kinase polypeptide, an Escherichia coli homoserine kinase polypeptide, a Corynebacterium acetoglutamicum homoserine kinase polypeptide, a Corynebacterium melassecola homoserine kinase polypeptide, a Corynebacterium thermoaminogenes homoserine kinase polypeptide, a Brevibacterium lactofermentum homoserine kinase polypeptide, a Brevibacterium lactis homoserine kinase polypeptide, and a Brevibacterium flavum homoserine kinase polypeptide.

In another aspect, the invention features an isolated nucleic acid encoding a variant bacterial homoserine kinase polypeptide, wherein the homoserine kinase polypeptide is a C. glutamicum homoserine kinase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:364: Glycine 160, Lysine 161, Phenylalanine 186, Alanine 188, and Aspartate 205. In various embodiments, the amino acid change is a change to an alanine, wherein the original residue is other than an alanine.

The invention also features a polypeptide encoded by the nucleic acid encoding a variant bacterial homoserine kinase.

The invention also features a bacterium including the nucleic acid encoding a variant bacterial homoserine kinase polypeptide. In various embodiments, the bacterium is a coryneform bacterium. The bacterium can further include one or more nucleic acids encoding other variant bacterial polypeptides (e.g., variant bacterial polypeptides involved in amino acid production, e.g., variant bacterial polypeptides described herein).

The invention also features a method for producing an amino acid, the method including: cultivating a genetically modified bacterium including the nucleic acid encoding a variant bacterial homoserine kinase polypeptide under conditions in which the nucleic acid is expressed and that allow the amino acid to be produced, and collecting the culture. The culture can be fractionated (e.g., to remove cells and/or to obtain fractions enriched in the amino acid).

In another aspect, the invention features a bacterium including two or more of the following: a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide; a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase; a nucleic acid encoding a variant bacterial McbR gene product polypeptide; a nucleic acid encoding a variant bacterial aspartokinase polypeptide; a nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase polypeptide; a nucleic acid encoding a variant bacterial cystathione beta-lyase polypeptide; a nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide; and a nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase polypeptide.

In various embodiments, the bacterium comprises a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase and a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase. In certain embodiments, at least one of the variant bacterial polypeptides have reduced feedback inhibition (e.g., relative to a wild-type form of the polypeptide).

In another aspect, the invention features a bacterium including two or more of the following: (a) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a variant of a homoserine O-acetyltransferase polypeptide including the following amino acid sequence: G₁-X-X₂-X₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant homoserine O-acetyltransferase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360; (b) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a variant of an O-acetylhomoserine sulfhydrylase polypeptide including the following amino acid sequence: G₁-X₂-K₃-X₄-X₅-X₆-X₇-X₈-X₉-X₁₀-X₁₁-X₁₂-X₁₃-X_13a-X_13b-X_13c-X_13d-X_13e-X_13f-X_13g-X_13h-X_13i-X_13j-X_13k-X_13l-F₁₄-X₁₅-Z₁₆-X₁₇-X₁₈-X₁₉-X₂₀-X₂₁-X_21a-X_21b-X_21c-X_21d-X_21e-X_21f-X_21g-X_21h-X_21i-X_21j-X_21k-X_21l-X_21m-X_21n-X_21o-X_21p-X_21q-X_21r-X_21s-X_21t-D₂₂ (SEQ ID NO:360), wherein each of X₂, X₄-X₁₃, X₁₅, and X₁₇-X₂₀ is, independently, any amino acid, wherein each of X_13a-X_13l is, independently, any amino acid or absent, wherein each of X_21a-X_21t is, independently, any amino acid or absent, and wherein Z₁₆ is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant O-acetylhomoserine sulfhydrylase polypeptide includes an amino acid change at one or more of G₁, K₃, F₁₄, Z₁₆, or D₂₂ of SEQ ID NO:360; and (c) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a variant of a O-acetylhomoserine sulfhydrylase polypeptide including the following amino acid sequence: L₁-X₂-X₃-G₄-G₅-X₆-F₇-X₈-X₉-X₁₀-X₁₁ (SEQ ID NO:361), wherein X is any amino acid, wherein X₈ is selected from valine, leucine, isoleucine, and aspartate, and wherein X₁₁₁ is selected from valine, leucine, isoleucine, phenylalanine, and methionine; wherein the variant of the bacterial protein includes an amino acid change at one or more of L₁, G₄, X₈, X₁₁ of SEQ ID NO:361.

In another aspect, the invention features a bacterium including two or more of the following: (a) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a C. glutamicum homoserine O-acetyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:212: Glycine 231, Lysine 233, Phenylalanine 251, and Valine 253; (b) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a T. fusca homoserine O-acetyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:24: Glycine 81, Aspartate 287, Phenylalanine 269; (c) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is an E. coli homoserine O-acetyltransferase polypeptide including an amino acid change at Glutamate 252 of SEQ ID NO:213; (d) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is a mycobacterial homoserine O-acetyltransferase polypeptide including an amino acid change in a residue corresponding to one or more of the following residues of M. leprae homoserine O-acetyltransferase polypeptide set forth in SEQ ID NO:23: Glycine 73, Aspartate 278, and Tyrosine 260; (e) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase polypeptide, wherein the variant homoserine O-acetyltransferase polypeptide is an M. tuberculosis homoserine O-acetyltransferase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:22: Glycine 73, Tyrosine 260, and Aspartate 278; (f) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a C. glutamicum O-acetylhomoserine sulfhydrylase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:214: Glycine 227, Leucine 229, Aspartate 231, Glycine 232, Glycine 233, Phenylalanine 235, Aspartate 236, Valine 239, Phenylalanine 368, Aspartate 370, Aspartate 383, Glycine 346, and Lycine 348; and (g) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase polypeptide, wherein the variant O-acetylhomoserine sulfhydrylase polypeptide is a T. fusca O-acetylhomoserine sulfhydrylase polypeptide including an amino acid change in one or more of the following residues of SEQ ID NO:25: Glycine 240, Aspartate 244, Phenylalanine 379, and Aspartate 394.

In another aspect, the invention features a bacterium including a nucleic acid encoding an episomal homoserine O-acetyltransferase polypeptide and an episomal O-acetylhomoserine sulfhydrylase polypeptide. In various embodiments, the bacterium is a Corynebacterium. In various embodiments, the episomal homoserine O-acetyltransferase polypeptide and the episomal O-acetylhomoserine sulfhydrylase polypeptide are of the same species as the bacterium (e.g., both are of C. glutamicum). In various embodiments, the episomal homoserine O-acetyltransferase polypeptide and the episomal O-acetylhomoserine sulfhydrylase polypeptide are of a different species than the bacterium. In various embodiments, the episomal homoserine O-acetyltransferase polypeptide is a variant of a bacterial homoserine O-acetyltransferase polypeptide with reduced feedback inhibition relative to a wild-type form of the homoserine O-acetyltransferase polypeptide. In various embodiments, the O-acetylhomoserine sulfhydrylase polypeptide is a variant of a bacterial O-acetylhomoserine sulfhydrylase polypeptide with reduced feedback inhibition relative to a wild-type form of the O-acetylhomoserine sulfhydrylase polypeptide.

“Aspartic acid family of amino acids and related metabolites” encompasses L-aspartate, β-aspartyl phosphate, L-aspartate-β-semialdehyde, L-2,3-dihydrodipicolinate, L-Δ¹-piperideine-2,6-dicarboxylate, N-succinyl-2-amino-6-keto-L-pimelate, N-succinyl-2, 6-L, L-diaminopimelate, L, L-diaminopimelate, D, L-diaminopimelate, L-lysine, homoserine, O-acetyl-L-homoserine, O-succinyl-L-homoserine, cystathionine, L-homocysteine, L-methionine, S-adenosyl-L-methionine, O-phospho-L-homoserine, threonine, 2-oxobutanoate, (S)-2-aceto-2-hydroxybutanoate, (S)-2-hydroxy-3-methyl-3-oxopentanoate, (R)-2,3-Dihydroxy-3-methylpentanoate, (R)-2-oxo-3-methylpentanoate, L-isoleucine, L-asparagine. In various embodiments the aspartic acid family of amino acids and related metabolites encompasses aspartic acid, asparagine, lysine, threonine, methionine, isoleucine, and S-adenosyl-L-methionine. A polypeptide or functional variant thereof with “reduced feedback inhibition” includes a polypeptide that is less inhibited by the presence of an inhibitory factor as compared to a wild-type form of the polypeptide or a polypeptide that is less inhibited by the presence of an inhibitory factor as compared to the corresponding endogenous polypeptide expressed in the organism into which the variant has been introduced. For example, a wild-type aspartokinase from E. coli or C. glutamicum may have 10-fold less activity in the presence of a given concentration of lysine, or lysine plus threonine, respectively. A variant with reduced feedback inhibition may have, for example, 5-fold less, 2-fold less, or wild-type levels of activity in the presence of the same concentration of lysine.

A “functional variant” protein is a protein that is capable of catalyzing the biosynthetic reaction catalyzed by the wild-type protein in the case where the protein is an enzyme, or providing the same biological function of the wild-type protein when that protein is not catalytic. For instance, a functional variant of a protein that normally regulates the transcription of one or more genes would still regulate the transcription of one or more of the same genes when transformed into a bacterium. In certain embodiments, a functional variant protein is at least partially or entirely resistant to feedback inhibition by an amino acid. In certain embodiments, the variant has fewer than 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, or 1 amino acid changes compared to the wild-type protein. In certain embodiments, the amino acid changes are conservative changes. A variant sequence is a nucleotide or amino acid sequence corresponding to a variant polypeptide, e.g., a functional variant polypeptide.

An amino acid that is “corresponding” to an amino acid in a reference sequence occupies a site that is homologous to the site in the reference sequence. Corresponding amino acids can be identified by alignment of related sequences.

As used herein, a “heterologous” nucleic acid or protein is meant to encompass a nucleic acid or protein, or functional variant of a nucleic acid or protein, of an organism (species) other than the host organism (species) used for the production of members of the aspartic acid family of amino acids and related metabolites. In certain embodiments, when the host organism is a coryneform bacteria the heterologous gene will not be obtained from E. coli. In other specific embodiments, when the host organism is E. coli the heterologous gene will not be obtained from a coryneform bacteria.

“Gene”, as used herein, includes coding, promoter, operator, enhancer, terminator, co-transcribed (e.g., sequences from an operon), and other regulatory sequences associated with a particular coding sequence.

As used herein, a “homologous” nucleic acid or protein is meant to encompass a nucleic acid or protein, or functional variant of a nucleic acid or protein, of an organism that is the same species as the host organism used for the production of members of the aspartic acid family of amino acids and related metabolites.

As known to those skilled in the art, certain substitutions of one amino acid for another may be tolerated at one or more amino acid residues of a wild-type enzyme without eliminating the activity or function of the enzyme. As used herein, the term “conservative substitution” refers to the exchange of one amino acid for another in the same conservative substitution grouping in a protein sequence. Conservative amino acid substitutions are known in the art and are generally based on the relative similarity of the amino acid side-chain substituents, for example, their hydrophobicity, hydrophilicity, charge, size, and the like. In one embodiment, conservative substitutions typically include substitutions within the following groups: Group 1: glycine, alanine, and proline; Group 2: valine, isoleucine, leucine, and methionine; Group 3: aspartic acid, glutamic acid, asparagine, glutamine; Group 4: serine, threonine, and cysteine; Group 5: lysine, arginine, and histidine; Group 6: phenylalanine, tyrosine, and tryptophan. Each group provides a listing of amino acids that may be substituted in a protein sequence for any one of the other amino acids in that particular group.

There are several criteria used to establish groupings of amino acids for conservative substitution. For example, the importance of the hydropathic amino acid index in conferring interactive biological function on a protein is generally understood in the art (Kyte and Doolittle, Mol. Biol. 157:105-132 (1982). It is known that certain amino acids may be substituted for other amino acids having a similar hydropathic index or score and still retain a similar biological activity. Amino acid hydrophilicity is also used as a criterion for the establishment of conservative amino acid groupings (see, e.g., U.S. Patent No. 4,554,101).

Information relating to the substitution of one amino acid for another is generally known in the art (see, e.g., Introduction to Protein Architecture: The Structural Biology of Proteins, Lesk, A. M., Oxford University Press; ISBN: 0198504748; Introduction to Protein Structure, Branden, C.-I., Tooze, J., Karolinska Institute, Stockholm, Sweden (Jan. 15, 1999); and Protein Structure Prediction: Methods and Protocols (Methods in Molecular Biology), Webster, D. M.(Editor), August 2000, Humana Press, ISBN: 0896036375).

In some embodiments, the nucleic acid and/or protein sequences of a heterologous sequence and/or host strain gene will be compared, and the homology can be determined. Homology comparisons can be used, for example, to identify corresponding amino acids. The percent identity between the two sequences is a function of the number of identical positions shared by the sequences, taking into account the number of gaps, and the length of each gap, which need to be introduced for optimal alignment of the two sequences. The comparison of sequences and determination of percent identity between two sequences can be accomplished using a mathematical algorithm. For example, the percent identity between two nucleotide sequences can be determined using the algorithm of Needleman and Wunsch ((1970) J. Mol. Biol. 48:444-453) algorithm which has been incorporated into the GAP program in the GCG software package, using either a Blosum 62 matrix and a gap weight of 12, a gap extend penalty of 4, and a frameshift gap penalty of 5.

Generally, to determine the percent identity of two nucleic acid or protein sequences, the sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in one or both of a first and a second nucleic acid or amino acid sequence for optimal alignment and non-homologous sequences can be disregarded for comparison purposes). The length of a test sequence aligned for comparison purposes can be at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100% of the length of the reference sequence. The nucleotides or amino acids at corresponding nucleotide or amino acid positions are then compared. When a position in the first sequence is occupied by the same nucleotide or amino acid as the corresponding position in the second sequence, then the molecules are identical at that position (as used herein “identity” is equivalent to “homology”).

The protein sequences described herein can be used as a “query sequence” to perform a search against a database of non-redundant sequences, for example. Such searches can be performed using the BLASTP and TBLASTN programs (version 2.0) of Altschul, et al. (1990) J. Mol. Biol. 215:403-10. BLAST protein searches can be performed with the BLASTP program, using, for example, the Blosum 62 matrix, a wordlength of 3, and a gap existence cost of 11 and a gap extension penalty of 1. Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information, and default paramenter can be used. Sequences described herein can also be used as query sequences in TBLASTN searches, using specific or default parameters.

The nucleic acid sequences described herein can be used as a “query sequence” to perform a search against a database of non-redundant sequences, for example. Such searches can be performed using the BLASTN and BLASTX programs (version 2.0) of Altschul, et al. (1990) J. Mol. Biol. 215:403-10. BLAST nucleotide searches can be performed with the BLASTN program, score=100, wordlength=11 to evaluate identity at the nucleic acid level. BLAST protein searches can be performed with the BLASTX program, score=50, wordlength=3 to evaluate identity at the protein level. To obtain gapped alignments for comparison purposes, Gapped BLAST can be utilized as described in Altschul et al., (1997) Nucleic Acids Res. 25:3389-3402. When utilizing BLAST and Gapped BLAST programs, the default parameters of the respective programs (e.g., BLASTX and BLASTN) can be used. Alignment of nucleotide sequences for comparison can also be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Nat'l. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection (see, e.g., Current Protocols in Molecular Biology (Ausubel et al., eds. 1995 supplement)).

Nucleic acid sequences can be analyzed for hybridization properties. As used herein, the term “hybridizes under low stringency, medium stringency, high stringency, or very high stringency conditions” describes conditions for hybridization and washing. Guidance for performing hybridization reactions can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6. Aqueous and nonaqueous methods are described in that reference and either can be used. Specific hybridization conditions referred to herein are as follows: 1) low stringency hybridization conditions in 6X sodium chloride/sodium citrate (SSC) at about 45° C., followed by two washes in 0.2×SSC, 0.1% SDS at least at 50° C. (the temperature of the washes can be increased to 55° C. for low stringency conditions); 2) medium stringency hybridization conditions in 6×SSC at about 45° C., followed by one or more washes in 0.2×SSC, 0.1% SDS at 60° C.; 3) high stringency hybridization conditions in 6×SSC at about 45° C., followed by one, two, three, four or more washes in 0.2×SSC, 0.1% SDS at 65° C.) very high stringency hybridization conditions are 0.5M sodium phosphate, 7% SDS at 65° C., followed by one or more washes at 0.2×SSC, 1% SDS at 65° C. Very high stringency conditions (at least 4 or more washes) are the preferred conditions and the ones that should be used unless otherwise specified.

The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.

DESCRIPTION OF DRAWINGS

FIG. 1. is a diagram of the biosynthesis of aspartate amino acid family.

FIG. 2. is a diagram of the methionine biosynthetic pathway.

FIG. 3. is a restriction map of plasmid MB3961 (vector backbone plasmid).

FIG. 4. is a restriction map of plasmid MB4094 (vector backbone plasmid).

FIG. 5. is a restriction map of plasmid MB4083 (hom-thrB deletion construct).

FIG. 6. is a restriction map of plasmid MB4084 (thrB deletion construct).

FIG. 7. is a restriction map of plasmid MB4165 (mcbR deletion construct).

FIG. 8. is a restriction map of plasmid MB4169 (hom-thrB deletion/gpd-M. smegmatis lysC(T311I)-asd replacement construct).

FIG. 9. is a restriction map of plasmid MB4192 (hom-thrB deletion/gpd-S. coelicolor hom(G362E) replacement construct.

FIG. 10. is a restriction map of plasmid MB4276 (pck deletion/gpd-M. smegmatis lysC(T311I)-asd replacement construct).

FIG. 11. is a restriction map of plasmid MB4286 (mcbR deletion/trcRBS-T. fusca metA replacement construct).

FIG. 12A. is a restriction map of plasmid MB4287 (mcbR deletion/trcRBS-C. glutamicum metA (K233A)-metB replacement construct).

FIG. 12B. is a depiction of the nucleotide sequence of the DNA sequence in MB4278 (trcRBS-C. glutamicum metA YH) that spans from the trcRBS promoter to the stop of the metH gene.

FIG. 13 is a graph depicting the results of an assay to determine in vitro O-acetyltransferase activity of C. glutamicum MetA from two C. glutamicum strains, MA-442 and MA-449, in the presence and absence of IPTG.

FIG. 14 is a graph depicting the results of an assay to determine sensitivity of MetA in C. glutamicum strain MA-442 to inhibition by methionine and S-AM.

FIG. 15 is a graph depicting the results of an assay to determine the in vitro O-acetyltransferase activity of T. fusca MetA expressed in C. glutamicum strains MA-456, MA570, MA-578, and MA-479. Rate is a measure of the change in OD412 divided by time per nanograms of protein.

FIG. 16 is a graph depicting the results of an assay to determine in vitro MetY activity of T. fusca MetY expressed in C. glutamicum strains MA-456 and MA-570. Rate is defined as the change in OD412 divided by time per nanograms of protein.

FIG. 17. is a graph depicting the results of an assay to determine lysine production in C. glutamicum and B. lactofermentum strains expressing heterologous wild-type and mutant lysC variants.

FIG. 18 is a graph depicting results from an assay to determine lysine and homoserine production in C. glutamicum strain, MA-0331 in the presence and absence of the S. coelicolor hom G362E variant.

FIG. 19. is a graph depicting results from any assay to determine asparate concentrations in C. glutamicum strains MA-0331 and MA-0463 in the presence and absence of E chrysanthemi ppc.

FIG. 20 is a graph depicting results from an assay to determine lysine production in C. glutamicum strains MA-0331 and MA-0463 transformed with heterologous wild-type dapA genes.

FIG. 21 is a graph depicting results from an assay to determine metabolite levels in C. glutamicum strain MA-1378 and its parent strains.

FIG. 22 is a graph depicting results from an assay to determine homoserine and O-acetylhomoserine levels in C. glutamicum strains MA-0428, MA-0579, MA-1351, MA-1559 grown in the presence or absence of IPTG. IPTG induces expression of the episomal plasmid borne T. fusca metA gene.

FIG. 23. is a graph depicting results from an assay to determine metabolite levels in C. glutamicum strain MA-1559 and its parent strains.

FIG. 24 is a graph depicting methionine concentrations in broths from fermentations of two C. glutamicum strains, MA-622, and MA-699, which express a MetA K233A mutant polypeptide. Production by cells cultured in the presence and absence of IPTG is depicted.

FIG. 25 is a graph depicting methionine concentrations in broths from fermentations of two C. glutamicum strains, MA-622 and MA-699, expressing a MetY D23 1A mutant polypeptide. Production by cells cultured in the presence and absence of IPTG is depicted.

FIG. 26 is a graph depicting methionine concentrations in broths from fermentations of two C. glutamicum strains, MA-622 and MA-699, expressing a C. glutamicum MetY G232A mutant polypeptide. Production by cells cultured in the presence and absence of IPTG is depicted.

FIG. 27 is a graph depicting results from an assay to determine metabolite levels in C. glutamicum strains MA-1 906, MA-2028, MA-1 907, and MA-2025. Strains were grown in the presence and absence of IPTG.

FIG. 28 is a graph depicting results from an assay to determine metabolite levels in C. glutamicum strains MA-1667 and MA-1743. Strains were grown in the presence and absence of IPTG.

FIG. 29 is a graph depicting results from an assay to determine metabolite levels in C. glutamicum strains MA-0569, MA-1688, MA-1421, and MA-1790. Strains were grown in the absence and/or presence of IPTG.

FIG. 30 is a graph depicting results from an assay to determine metabolite levels in C. glutamicum strain MA-1 668 and its parent strains.

DETAILED DESCRIPTION

The invention provides nucleic acids and modified bacteria that comprise nucleic acids encoding proteins that improve fermentative production of aspartate-derived amino acids and intermediate compounds. In particular, nucleic acids and bacteria relevant to the production of L-aspartate, L-lysine, L-methionine, S-adenosyl-L-methionine, threonine, L-isoleucine, homoserine, O-acetyl homoserine, homocysteine, and cystathionine are disclosed. The nucleic acids include genes that encode metabolic pathway proteins that modulate the biosynthesis of these amino acids, intermediates, and related metabolites either directly (e.g., via enzymatic conversion of intermediates) or indirectly (e.g., via transcriptional regulation of enzyme expression or regulation of amino acid export). The nucleic acid sequences encoding the proteins can be derived from bacterial species other than the host organism (species) used for the production of members of the aspartic acid family of amino acids and related metabolites. The invention also provides methods for producing the bacteria and the amino acids, including the production of amino acids for use in animal feed additives.

Modification of the sequences of certain bacterial proteins involved in amino acid production can lead to increased yields of amino acids. Regulated (e.g., reduced or increased) expression of modified or unmodified (e.g., wild type) bacterial enzymes can likewise enhance amino acid production. The methods and compositions described herein apply to bacterial proteins that regulate the production of amino acids and related metabolites, (e.g., proteins involved in the metabolism of methionine, threonine, isoleucine, aspartate, lysine, cysteine and sulfur), and nucleic acids encoding these proteins. These proteins include enzymes that catalyze the conversion of intermediates of amino acid biosynthetic pathways to other intermediates and/or end product, and proteins that directly regulate the expression and/or function of such enzymes. Target proteins for manipulation include those enzymes that are subject to various types of regulation such as repression, attenuation, or feedback-inhibition. Amino acid biosynthetic pathways in bacterial species, information regarding the proteins involved in these pathway, links to sequences of these proteins, and other related resources for identifying proteins for manipulation and/or expression as described herein can be accessed through linked databases described by Error! Hyperlink reference not valid.Bono et al., Genome Research, 8:203-210, 30 1998.

Strategies to manipulate the efficiency of amino acid biosynthesis for commercial production include overexpression, underexpression (including gene disruption or replacement), and conditional expression of specific genes, as well as genetic modification to optimize the activity of proteins. It is possible to reduce the sensitivity of biosynthetic enzymes to inhibitory stimuli, e.g., feedback inhibition due to the presence of biosynthetic pathway end products and intermediates. For example, strains used for commercial production of lysine derived from either coryneform bacteria or Escherichia coli typically display relative insensitivity to feedback inhibition by lysine. Useful coryneform bacterial strains are also relatively resistant to inhibition by threonine. Novel methods and compositions described herein result in enhanced amino acid production. While not bound by theory, these methods and compositions may result in enzymes that are enhanced due to reduced feedback inhibition in the presence of S-adenosylmethionine (S-AM) and/or methionine. Exemplary target genes for manipulation are bacterial dapA, hom, thrB, ppc, pyc, pck, metE, glyA, metA, metY, mcbR, lysC, asd, metB, metC, metH, and metK genes. These target genes can be manipulated individually or in various combinations.

In certain embodiments, it is useful to engineer strains such that the activity of particular genes is reduced (e.g., by mutation or deletion of an endogenous gene). For example, stains with reduced activity of one or more of hom, thrB, pck, or mcbR gene products can exhibit enhanced production of amino acids and related intermediates.

Two central carbon metabolism enzymes that direct carbon flow towards the aspartic acid family of amino acids and related metabolites include phosphoenolpyruvate carboxylase (Ppc) and pyruvate carboxylase (Pyc). The initial steps of biosynthesis of aspartatic acid family amino acids are diagrammed in FIG. 1. Both enzymes catalyze the formation of oxaloacetate, a tricarboxylic acid (TCA) cycle component that is transaminated to aspartic acid. Aspartokinase (which is encoded by lysC in coryneform bacteria) catalyzes the first enzyme reaction in the aspartic acid family of amino acids, and is known to be regulated by both feedback-inhibition and repression. Thus, deregulation of this enzyme is critical for the production of any of the commercially important amino acids and related metabolites of the aspartic acid amino acid pathway (e.g. aspartic acid, asparagine, lysine, methionine, S-adenosyl-L-methionine, threonine, and isoleucine). As critical enzymes for regulating carbon flow towards amino acids derived from aspartate, overexpression (by increasing copy number and/or the use of strong promoters) and/or deregulation of each or both of these enzymes can enhance production of the amino acids listed above.

Other biosynthetic enzymes can be employed to enhance production of specific amino acids. Examples of enzymes involved in L-lysine biosynthesis include: dihydrodipicolinate synthase (DapA), dihydrodipicolinate reductase (DapB), diaminopimelate dehydrogenase (Ddh), and diaminopimelate decarboxylase (LysA). A list of enzymes involved in lysine biosynthesis is provided in Table 1. Overexpression and/or deregulation of each of these enzymes can enhance production of lysine. Overexpression of biosynthetic enzymes can be achieved by increasing copy number of the gene of interest and/or operably linking the gene to apromoter optimal for expression, e.g., a strong or conditional promoter.

Lysine productivity can be enhanced in strains overexpressing general and specific regulatory enzymes. Specific amino acid substitutions in aspartokinase and dihydrodipicolinate synthase in E. coli can lead to increased lysine production by reducing feedback inhibition. Enhanced expression of lysC and/or dapA (either wild-type or feedback-insensitive alleles) can. ncrease lysine production. Similarly, deregulated alleles of heterologous lysC and dapA genes can be expressed in a strain of coryneform bacteria such as Corynebacterium glutamicum. Likewise, overexpression of eitherpyc or ppc can enhance lysine production.

TABLE 1
Genes and enzymes involved in lysine biosynthesis
Gene	Enzyme	Comment
Pyc	Pyruvate Carboxylase	Anaplerotic reaction
Ppc	Phosphoenolpyruvate	Anaplerotic reaction
	Carboxylase
AspC	Aspartate	Converts OAA to Aspartic acid.
	Aminotransferase
LysC	Aspartate Kinase	Depending upon source species,
	(III)	feedback-inhibited by lysine
		or lysine plus threonine, and
		in some strains, repressed by
		lysine.
Asd	Aspartic Semialdehyde
	Dehydrogenase
Hom	Homoserine	Key branch-point between lysine
	Dehydrogenase	and methionine/threonine.
DapA	Dihydrodipicolinate	Catalyzes first committed step
	Synthase	in lysine biosynthesis. Is
		inhibited by lysine in E. coli.
DapB	Dihydrodipicolinate
	Reductase
DapC	N-succinyl-LL-
	diaminopimelate
	Aminotransferase
DapD	Tetrahydrodipicolinate
	N-Succinyltransferase
DapE	N-succinyl-LL-
	diaminopimelate
	Desuccinylase
DapF	Diaminopimelate
	Epimerase
LysA	Diaminopimelate	Last step in lysine biosynthesis
	Decarboxylase
Ddh	Diaminopimelate	Redundant one-step pathway for
	Dehydrogenase	converting tetrahydrodipicolinate
		to meso-diaminopimelate in
		Corynebacteria

Steps in the biosynthesis of methionine are diagrammed in FIG. 2. Examples of enzymes that regulate methionine biosynthesis include: Homoserine dehydrogenase (Hom), O-homoserine acetyltransferase (MetA), and O-acetylhomoserine sulfhydrylase (MetY). Overexpression (by increasing copy number of the gene of interest and/or through the use of strong promoters) and/or deregulation of each of these enzymes can enhance production of methionine.

Methionine adenosyltransferase (MetK) catalyzes the production of S-adenosyl-L-methionine from methionine. Reduction of metK-expressed enzyme activity can prevent the conversion of methionine to S-adenosyl-L-methionine, thus enhancing the yield of methionine from bacterial strains. Conversely, if one wanted to enhance carbon flow from methionine to S-adenosyl-L-methionine, the metK gene could be overexpressed or desensitized to feedback inhibition.

Bacterial Host Strains

Suitable host species for the production of amino acids include bacteria of the family Enterobacteriaceae such as an Escherichia coli bacteria and strains of the genus Corynebacterium. The list below contains examples of species and strains that can be used as host strains for the expression of heterologous genes and the production of amino acids.

• Escherichia coli W3110 F⁻ IN(rrnD-rrnE)1 λ⁻ (E. coli Genetic Stock Center)
• Corynebacterium glutamicum ATCC (American Type Culture Collection) 13032
• Corynebacterium glutamicum ATCC 21526
• Corynebacterium glutamicum ATCC 21543
• Corynebacterium glutamicum ATCC 21608
• Corynebacterium acetoglutamicum ATCC 15806
• Corynebacterium acetoglutamicum ATCC 21491
• Corynebacterium acetoglutamicum NRRL B-11473
• Corynebacterium acetoglutamicum NRRL B-11475
• Corynebacterium acetoacidophilum ATCC 13870
• Corynebacterium melassecola ATCC 17965
• Corynebacterium thermoaminogenes FERM BP-1539
• Brevibacterium lactis
• Brevibacterium lactofermentum ATCC 13869
• Brevibacterium lactofermentum NRRL B-1 1470
• Brevibacterium lactofermentum NRRL B-1 1471
• Brevibacterium lactofermentum ATCC 21799
• Brevibacterium lactofermentum ATCC 31269
• Brevibacterium flavum ATCC 14067
• Brevibacterium flavum ATCC 21269
• Brevibacterium flavum NRRL B-11472
• Brevibacterium flavum NRRL B-11474
• Brevibacterium flavum ATCC 21475
• Brevibacterium divaricatum ATCC 14020 Bacteria Strain for Use a Source of Useful Gene

Suitable species and strains for heterologous bacterial genes include, but are not limited to, these listed below.

• Mycobacterium smegmatis ATCC 700084
• Amycolatopsis mediterranei
• Streptomyces coelicolor A3(2)
• Thermobifida fusca ATCC 27730
• Erwinia chrysanthemi ATCC 11663
• Shewanella oneidensis
• Mycobacterium leprae
• Mycobacterium tuberculosis H37Rv
• Lactobacillus plantarum ATCC 8014
• Bacillus sphaericus

Amino acid sequences of exemplary proteins, which can be used to enhance amino acid production, are provided in Table 16. Nucleotide sequences encoding these proteins are provided in Table 17. The sequences that can be expressed in a host strain are not limited to those sequences provided by the Tables.

Aspartokinases

Aspartokinases (also referred to as aspartate kinases) are enzymes that catalyze the first committed step in the biosynthesis of aspartic acid family amino acids. The level and activity of aspartokinases are typically regulated by one or more end products of the pathway (lysine or lysine plus threonine depending upon the bacterial species), both through feedback inhibition (also referred to as allosteric regulation) and transcriptional control (also called repression). Bacterial homologs of coryneform and E. coli aspartokinases can be used to enhance amino acid production. Coryneform and E. coli aspartokinases can be expressed in heterologous organisms to enhance amino acid production.

Homologs of the LysCprotein from Coryneform bacteria

In Coryneform bacteria, aspartokinase is encoded by the lysC locus. The lysC locus contains two overlapping genes, lysC alpha and lysC beta. LysC alpha and lysC beta code for the 47- and 18-kD subunits of aspartokinase, respectively. A third open-reading frame is adjacent to the lysC locus, and encodes aspartate semialdehyde dehydrogenase (asd). The asd start codon begins 24 base-pairs downstream from the end of the lysC open-reading frame, is expressed as part of the lysC operon.

The primary sequence of aspartokinase proteins and the structure of the lysC loci are conserved across several members of the order Actinomycetales. Examples of organisms that encode both an aspartokinase and an aspartate semialdehyde dehydrogenase that are highly related to the proteins from coryneform bacteria include Mycobacterium smegmatis, Amycolatopsis mediterranei, Streptomyces coelicolor A3(2), and Thermobifida fusca. In some instances these organisms contain the lysC and asd genes arranged as in coryneform bacteria. Table 2 displays the percent identity of proteins from these Actinomycetes to the C. glutamicum aspartokinase and aspartate semialdehyde dehydrogenase proteins.

TABLE 2
Percent Identity of Heterologous Aspartokinase and Aspartate
Semialdehyde Dehydrogenase Proteins to C. glutamicum Proteins
	Aspartokinase	Aspartate Semialdehyde
	(% Identity to	Dehydrogenase (% Identity
Organism	C. glutamicum LysC)	to C. glutamicum Asd)
Mycobacterium	73	68
smegmatis
Amycolatopsis	73	62
mediterranei
Streptomyces	64	50
coelicolor
Thermobifida	64	48
fusca

Isolates of source strains such as Mycobacterium smegmatis, Amycolatopsis mediterranei, Streptomyces coelicolor, and Thermobifida fusca are available. The lysC operons can be amplified from genomic DNA prepared from each source strain, and the resulting PCR product can be ligated into an E. coli/C. glutamicum shuttle vector. The homolog of the aspartokinase enzyme from the source strain can then be introduced into a host strain and expressed.

E. coli Aspartokinase III Homologs

In coryneform bacteria there is concerted feedback inhibition of aspartokinase by lysine and threonine. This is in contrast to E. coli, where there are three distinct aspartokinases that are independently allosterically regulated by lysine, threonine, or methionine. Homologs of the E. coli aspartokinase III (and other isoenzymes) can be used as an alternative source of deregulated aspartokinase proteins. Expression of these enzymes in coryneform bacteria may decrease the complexity of pathway regulation. For example, the aspartokinase III genes are feedback-inhibited only by lysine instead of lysine and threonine. Therefore, the advantages of expressing feedback-resistant alleles of aspartokinase III alleles include: (1) the increased likelihood of complete deregulation; and (2) the possible removal of the need for constructing either “leaky” mutations in hom or threonine auxotrophs that need to be supplemented. These features can result in decreased feedback inhibition by lysine.

Genes encoding aspartokinase III isoenzymes can be isolated from bacteria that are more distantly related to Corynebacteria than the Actinomycetes described above. For example, the E. chysanthemi and S. oneidensis gene products are 77% and 60% identical to the E. coli lysC protein, respectively (and 26% and 35% identical to C. glutamicum LysC). The genes coding for aspartokinase III, or functional variants therof, from the non-Escherichia bacteria, Erwinia chrysanthemi and Shewanella oneidensis can be amplified and ligated into the appropriate shuttle vector for expression in C. glutamicum.

Construction of Deregulated Aspartokinase Alleles

Lysine analogs (e.g. S-(2-aminoethyl)cysteine (AEC)) or high concentrations of lysine (and/or threonine) can be used to identify strains with enhanced production of lysine. A significant portion of the known lysine-resistant strains from both C. glutamicum and E. coli contain mutations at the lysC locus. Importantly, specific amino acid substitutions that confer increased resistance to AEC have been identified, and these substitutions map to well-conserved residues. Specific amino acid substitutions that result in increased lysine productivity, at least in wild-type strains, include, but are not limited to, those listed in Table 3. In many instances, several useful substitutions have been identified at a particular residue. Furthermore, in various examples, strains have been identified that contain more than one lysC mutation. Sequence alignment confirms that the residues previously associated with feedback-resistance (i.e. AEC-resistance) are conserved in a variety of aspartokinase proteins from distantly related bacteria.

TABLE 3
Amino Acid Substitutions That Release
Aspartokinase Feedback Inhibition.
                                 Amino Acid
Organism                         Substitution
Corynebacterium glutamicum (or related species) Ala 279 Pro
″                                Ser 301  Tyr
″                                Thr 311  Ile
″                                Gly 345  Asp
Escherichia coli (many substitutions identified Gly 323  Asp
between amino acids 318-325 and 345-352)
Escherichia coli (many substitutions identified Leu 325  Phe
between amino acids 318-325 and 345-352)
Escherichia coli (many substitutions identified Ser 345  Ile
between amino acids 318-325 and 345-352)
Escherichia coli (many substitutions identified Val 347  Met
between amino acids 318-325 and 345-352)

Standard site-directed mutagenesis techniques can be used to construct aspartokinase variants that are not subject to allosteric regulation. After cloning PCR-amplified lysC or aspartokinase III genes into appropriate shuttle vectors, oligonucleotide-mediated site-directed mutagenesis is use to provide modified alleles that encode substitutions such as those listed in Table 3. Vectors containing either wild-type genes or modified alleles can be be transformed into C. glutamicum alongside control vectors. The resulting transformants can be screened, for example, for lysine productivity, increased resistance to AEC, relative cross-feeding of lysine auxotrophs, or other methods known to those skilled in the art to identify the mutant alleles of most interest. Assays to measure lysine productivity and/or enzyme activity can be used to confirm the screening results and select useful mutant alleles. Techniques such as high pressure liquid chromatography (HPLC) and HPLC-mass spectrometry (MS) assays to quantify levels of members of the aspartic acid family of amino acids and related metabolites are known to those skilled in the art.

Methods for random generating amino acid substitutions within the lysC coding sequence, through methods such as mutagenenic PCR, can be used. These methods are familiar to those skilled in the art; for example, PCR can be performed using the GeneMorph PCR mutagenesis kit (Stratagene, La Jolla, Calif.) according to manufacturer's instructions to achieve medium and high range mutation frequencies.

Evaluation of the heterologous enzymes can be carried out in the presence of the LysC, DapA, Pyc, and Ppc proteins that are endogenous to the host strain. In certain instances, it will be helpful to have reagents to specifically assess the functionality of the heterologous biosynthetic proteins. Phenotypic assays for AEC resistance or enzyme assays can be used to confirm function of wild-type and modified variants of heterologous aspartokinases. The function of cloned heterologous genes can be confirmed by complementation of genetically characterized mutants of E. coli or C. glutamicum. Many of the E. coli strains are publicly available from the E. coli Genetic Stock Center (http://cgsc.biology.yale.edu/top.html). C. glutamicum mutants have also been described.

Dihydrodipicolinate Synthases

Dihydrodipicolinate synthase, encoded by dapa, is the branch point enzyme that commits carbon to lysine biosynthesis rather than threonine/methionine production. DapA converts aspartate-β-semialdehyde to 2,3-dihydrodipicolinate. DapA overexpression has been shown to result in increased lysine production in both E. coli and coryneform bacteria. In E. coli, DapA is allosterically regulated by lysine, whereas existing evidence suggests that C. glutamicum regulation occurs at the level of gene expression. Dihydrodipicolinate synthase proteins are not as well conserved amongst Actinomycetes as compared to LysC proteins.

Both wild-type and deregulated DapA proteins that are homologous to the C. glutamicum protein or the E. coli DapA protein can be expressed to enhance lysine production. Candidate organisms that can be sources of dapa genes are shown in Table 4. The known sequence from M. tuberculosis or M. ieprae can be used to identify homologous genes from M. smegmatis.

TABLE 4
Percent Identity of Dihydrodipicolinate Synthase Proteins.
	% Identity to	% Identity to
Organism	C. glutamicum DapA	E. coli DapA
Corynebacterium glutamicum	100	34
Mycobacterium tuberculosis	59	33
H37Rv *
Streptomyces coelicolor	53	33
Thermobifida fusca	48	33
Erwinia chrysanthemi	34	81
* Can be used for cloning of the M. smegmatis dapA gene.

Amino acid substitutions that relieve feedback inhibition of E. coli DapA by lysine have been described. Examples of such substitutions are listed in Table 5. Some of the residues that can be altered to relieve feedback inhibition are conserved in all of the candidate DapA proteins (e.g. Leu 88, His 118). This sequence conservation suggests that similar substitutions in the proteins from Actinomycetes may further enhance protein function. Site-directed mutagenesis can be employed to engineer deregulated DapA variants.

DapA isolates can be tested for increased lysine production using methods described above. For instance, one could distribute a culture of a lysine-requiring bacterium on a growth medium lacking lysine. A population of dapA mutants obtained by site-directed mutagenesis could then be introduced (through transformation or conjugation) into a wild-type coryneform strain, and subsequently spread onto the agar plate containing the distributed lysine auxotroph. A feedback-resistant dapA mutant would overproduce lysine which would be excreted into the growth medium and satisfy the growth requirement of the auxotroph previously distributed on the agar plate. Therefore a halo of growth of the lysine auxotroph around a dapa mutation-containing colony would indicate the presence of the desired feedback-resistant mutation.

TABLE 5
Amino Acid Substitutions in Dihydrodipicolinate
Synthase That Release Feedback Inhibition.
                          Amino Acid Substitution
                          (using E. coli DapA amino
Organism                  acid # as reference
Glycine max               Asn 80  Ile
Nicotiana sylvestris
Escherichia coli          Ala 81  Val
Zea mays                  Glu 84  Lys
Methylobacillus glycogens Leu 88  Phe
Escherichia coli          His 118  Tyr

Pyruvate and Phosphoenolpyruvate Carboxylases

Pyruvate carboxylase (Pyc) and phosphoenolpyruvate carboxylase (Ppc) catalyze the synthesis of oxaloacetic acid (OAA), the citric acid cycle intermediate that feeds directly into lysine biosynthesis. These anaplerotic reactions have been associated with improved yields of several amino acids, including lysine, and are obviously important to maximize OAA formation. In addition, a variant of the C. glutamicum Pyc protein containing a P458S substitution, has been shown to have increased activity, as demonstrated by increased lysine production. Proline 458 is a highly conserved amino acid position across a broad range of pyruvate carboxylases, including proteins from the Actinomycetes S. coelicolor (amino acid residue 449) and M. smegmatis (amino acid residue 448). Similar amino acid substitutions in these proteins may enhance anaplerotic activity. A third gene, PEP carboxykinase (pck), expresses an enzyme that catalyzes the formation of phosphoenolpyruvate from OAA (for gluconeogenesis), and thus functionally competes with pyc and ppc. Enhancing expression ofpyc and ppc can maximize OAA formation. Reducing or eliminatingpck activity can also improve OAA formation.

Homoserine Dehydrogenase

Homoserine dehydrogenase (Hom) catalyzes the conversion of aspartate semialdehyde to homoserine. Hom is feedback-inhibited by threonine and repressed by methionine in coryneform bacteria. It is thought that this enzyme has greater affinity for aspartate semialdehyde than does the competing dihydrodipicolinate synthase (DapA) reaction in the lysine branch, but slight carbon “spillage” down the threonine pathway may still block Hom activity. Feedback-resistant variants of Hom, overexpression of hom, and/or deregulated transcription of hom, or a combination of any of these approaches, can enhance methionine, threonine, isoleucine, or S-adenosyl-L-methionine production. Decreased Hom activity can enhance lysine production. Bifunctional enzymes with homoserine dehydrogenase activity, such as enzymes encoded by E. coli metL (aspartokinase II-homoserine dehydrogenase II) and thrA (aspartokinase 1-homoserine dehydrogenase I), can also be used to enhance amino acid production.

Targeted amino acid substitutions can be generated either to decrease, but not eliminate, Hom activity or to relieve Hom from feedback inhibition by threonine. Mutations that result in decreased Hom activity are referred to as “leaky” Hom mutations. In the C. glutamicum homoserine dehydrogenase, amino acid residues have been identified that can be mutated to either enhance or decrease Hom activity. Several of these specific amino acids are well-conserved in Hom proteins in other Actinomycetes (see Table 6).

TABLE 6
Amino acid substitutions that result in either “leaky” Hom alleles
or Hom proteins relieved of feedback inhibition by threonine.
C.	Corresponding amino acid residue from
glutamicum	heterologous homoserine dehydrogenase
residue	M. smegmatis	S. coelicolor	T. fusca
Leaky Hom
alleles
L23F	V10	L10	L192
V59A	V46	V46	V228
V104I	I90	I91	I274
Deregulated
Hom alleles
G378E	G364	G362	G545
K428	N/a	R412 truncation	R595 truncation
truncation
homdr*	N/a	R412 (delete bp	R595 (delete bp
		1937 → frameshift	1785 → frameshift
		mutation)	mutation)
*The homdr mutation is described on page 11 of WO 93/09225. This mutation is a single base pair deletion at 1964 bp that disrupts the homdrreading frame at codon 429. This results in a frame shift mutation that induces approximately ten amino acid changes and a premature termination, or truncation, i.e., deletion of approximately the last seven amino acid residues of the polypeptide.

It is believed that this single base deletion in the carboxy terminus of the hom dr gene radically alters the protein sequence of the carboxyl terminus of the enzyme, changing its conformation in such a way that the interaction of threonine with a binding site is prevented.

Homoserine O-Acetyltransferase

Homoserine O-acetyltransferase (MetA) acts at the first committed step in methionine biosynthesis (Park, S. et al., Mol. Cells 8:286-294, 1998). The MetA enzyme catalyzes the conversion of homoserine to O-acetyl-homoserine. MetA is strongly regulated by end products of the methionine biosynthetic pathway. In E. coli, allosteric regulation occurs by both S-AM and methionine, apparently at two separate allosteric sites. Moreover, MetJ and S-AM cause transcriptional repression of metA. In coryneform bacteria, MetA may be allosterically inhibited by methionine and S-AM, similarly to E. coli. MetA synthesis can be repressed by methionine alone. In addition, trifluoromethionine-resistance has been associated with metA in early studies. Reduction of negative regulation by S-AM and methionine can enhance methionine or S-adenosyl-L-methionine production. Increased MetA activity can enhance production of aspartate-derived amino acids such as methionine and S-AM, whereas decreased MetA activity can promote the formation of amino acids such as threonine and isoleucine.

O-Acetylhomoserine Sulfhydrylase

O-Acetylhomoserine sulfhydrylase (MetY) catalyzes the conversion of O-acetyl homoserine to homocysteine. MetY may be repressed by methionine in coryneform bacteria, with a 99% reduction in enzyme activity in the presence of 0.5 mM methionine. It is likely that this inhibition represents the combined effect of allosteric regulation and repression of gene expression. In addition, enzyme activity is inhibited by methionine, homoserine, and O-acetylserine. It is possible that S-AM also modulates MetY activity. Deregulated MetY can enhance methionine or S-AM production.

Homoserine Kinase

Homoserine kinase is encoded by thrB gene, which is part of the hom-thrB operon. ThrB phosphorylates homoserine. Threonine inhibition of homoserine kinase has been observed in several species. Some studies suggest that phosphorylation of homoserine by homoserine kinase may limit threonine biosynthesis under some conditions. Increased ThrB activity can enhance production of aspartate-derived amino acids such as isoleucine and threonine, whereas decreased ThrB activity can promote the formation of amino acids including, but not limited to, lysine and methionine.

Methionine Adenosyltransferase

Methionine adenosyltransferase converts methionine to S-adenosyl-L-methionine (S-AM). Down-regulating methionine adenosyltransferase (MetK) can enhance production of methionine by inhibiting conversion to S-AM. Enhancing expression of metK or activity of MetK can maximize production of S-AM.

O-Succinylhomoserine (thio)-lyase/O-acetylhomoserine (thio)-lyase O-Succinylhomoserine (thio)-lyase (MetB; also known as cystathionine gamma-synthase) catalyzes the conversion of O-succinyl homoserine or O-acetyl homoserine to cystathionine. Increasing expression or activity of MetB can lead to increased methionine or S-AM.

Cystathionine Beta-Lyase

Cystathionine beta-lyase (MetC) can convert cystathionine to homocysteine. Increasing production of homocysteine can lead to increased production of methionine. Thus, increased MetC expression or activity can increase methionine or S-adenosyl-L-methionine production.

Glutamate Dehydrogenase

The enzyme glutamate dehydrogenase, encoded by the gdh gene, catalyses the reductive amination of α-ketoglutarate to yield glutamic acid. Increasing expression or activity of glutamate dehydrogenase can lead to increased lysine, threonine, isoleucine, valine, proline, or tryptophan.

Diaminopimelate Dehydrogenase

Diaminopimelate dehydrogenase, encoded by the ddh gene in coryneform bacteria, catalyzes the the NADPH-dependent reduction of ammonia and L-2-amino-6-oxopimelate to form meso-2,6-diaminopimelate, the direct precursor of L-lysine in the alternative pathway of lysine biosynthesis. Overexpression of diaminopimelate dehydrogenase can increase lysine production.

Detergent Sensitivity Rescuer

Detergent sensitivity rescuer (dtsR1), encoding a protein related to the alpha subunit of acetyl CoA carboxylase, is a surfactant resistance gene. Increasing expression or activity of DtsR1 can lead to increased production of lysine.

5-Methyltetrahydrofolate Homocysteine Methyltransferase

5-Methyltetrahydrofolate homocysteine methyltransferase (MetH) catalyzes the conversion of homocysteine to methionine. This reaction is dependent on cobalamin (vitamin B12). Increasing MetH expression or activity can lead to increased production of methionine or S-adenosyl-L-methionine.

5-Methyltetrahydropteroyltriglutamate-homocysteine Methyltransferase

5-Methyltetrahydropteroyltriglutamate-homocysteine methyltransferase (MetE) also catalyzes the conversion of homocysteine to methionine. Increasing MetE expression or activity can lead to increased production of methionine or S-adenosyl-L-methionine.

Serine Hydroxymethyltransferase

Increasing serine hydroxymethyltransferase (GlyA) expression or activity can lead to enhanced methionine or S-adenosyl-L-methionine production.

5,10-Methylenetetrahydrofolate Reductase

5,10-Methylenetetrahydrofolate reductase (MetF) catalyzes the reduction of methylenetetrahydrofolate to methyltetrahydrofolate, a cofactor for homocysteine methylation to methionine. Increasing expression or activity of MetF can lead to increased methionine or S-adenosyl-L-methionine production.

Serine O-acetyltransferase

Serine O-acetyltransferase (CysE) catalyzes the conversion of serine to O-acetylserine. Increasing expression or activity of CysE can lead to increased expression of methionine or S-adenosyl-L-methionine.

D-3-phosphoglycerate Dehydrogenase

D-3-phosphoglycerate dehydrogenase (SerA) catalyzes the first step in serine biosynthesis, and is allosterically inhibited by serine. Increasing expression or activity of SerA can lead to increased production of methionine or S-adenosyl-L-methionine.

McbR Gene Product

The mcbR gene product of C. glutamicum was identified as a putative transcriptional repressor of the TetR-family and may be involved in the regulation of the metabolic network directing the synthesis of methionine in C. glutamicum (Rey et al., J. Biotechnol. 103(1):51-65, 2003). The mcbR gene product represses expression of metY, metK, cysK, cysl, hom, pyk, ssuD, and possibly other genes. It is possible that McbR represses expression in combination with small molecules such as S-AM or methionine. To date, specific alleles of McbR that prevent binding of either S-AM or methionine have not been identified. Reducing expression of McbR, and/or preventing regulation of McbR by S-AM can enhance amino acid production.

McbR is involved in the regulation of sulfur containing amino acids (e.g., cysteine, methionine). Reduced McbR expression or activity can also enhance production of any of the aspartate family of amino acids that are derived from homoserine (e.g., homoserine, O-acetyl-L-homoserine, O-succinyl-L-homoserine, cystathionine, L-homocysteine, L-methionine, S-adenosyl-L-methionine (S-AM), O-phospho-L-homoserine, threonine, 2-oxobutanoate, (S)-2-aceto-2-hydroxybutanoate, (S)-2-hydroxy-3-methyl-3-oxopentanoate, (R)-2,3-Dihydroxy-3-methylpentanoate, (R)-2-oxo-3-methylpentanoate, and L-isoleucine).

Lysine Exporter Protein

Lysine exporter protein (LysE) is a specific lysine translocator that mediates efflux of lysine from the cell. In C. glutamicum with a deletion in the lysE gene, L-lysine can reach an intracellular concentration of more than 1M. (Erdmann, A., et al. J. Gen Microbiol. 139,:3115-3122, 1993). Overexpression or increased activity of this exporter protein can enhance lysine production.

Efflux Proteins

A substantial number of bacterial genes encode membrane transport proteins. A subset of these membrane transport protein mediate efflux of amino acids from the cell. For example, Corynebacterium glutamicum express a threonine efflux protein. Loss of activity of this protein leads to a high intracellular accumulation of threonine (Simic et al., J. Bacteriol. 183(18):5317-5324, 2001). Increasing expression or activity of efflux proteins can lead to increased production of various amino acids. Useful efflux proteins include proteins of the drug/metabolite transporter family. The C. glutamicum proteins listed in Table 16 or homologs thereof can be used to increase amino acid production.

Isolation of Bacterial Genes

Bacterial genes for expression in host strains can be isolated by methods known in the art. See, for example, Sambrook, J., and Russell, D. W. (Molecular Cloning: A Laboratory Manual, 3nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 2001) for methods of construction of recombinant nucleic acids. Genomic DNA from source strains can be prepared using known methods (see, e.g., Saito, H. and, Miura, K. Biochim Biophys Acta. 72:619-629, 1963) and genes can be amplified from genomic DNA using PCR (U.S. Pats. 4,683,195 and 4,683,202, Saiki, et al. Science 230:350-1354, 1985).

DNA primers to be used for the amplification reaction are those complemental to both 3′-terminals of a double stranded DNA containing an entire region or a partial region of a gene of interest. When only a partial region of a gene is amplified, it is necessary to use such DNA fragments as primers to perform screening of a DNA fragment containing the entire region from a chromosomal DNA library. When the entire region gene is amplified, a PCR reaction solution including DNA fragments containing the amplified gene is subjected to agarose gel electrophoresis, and then a DNA fragment is extracted and cloned into a vector appropriate for expression in bacterial systems.

DNA primers for PCR may be adequately prepared on the basis of, for example, a sequence known in the source strain (Richaud, F. et al., J. Bacteriol. 297,1986). For example, primers that can amplify a region comprising the nucleotide bases coding for the heterologous gene of interest can be used. Synthesis of the primers can be performed by an ordinary method such as a phosphoamidite method (see Tetrahed Lett. 22:1859,1981) by using a commercially available DNA synthesizer (for example, DNA Synthesizer Model 380B produced by Applied Biosystems Inc.). Further, the PCR can be performed by using a commercially available PCR apparatus and Taq DNA polymerase, or other polymerases that display higher fidelity, in accordance with a method designated by the supplier.

Construction of Variant Alleles

Many enzymes that regulate amino acid production are subject to allosteric feedback inhibition by biosynthetic pathway intermediates or end products. Useful variants of these enzymes can be generated by substitution of residues responsible for feedback inhibition. For example, enzymes such as homoserine O-acetyltransferase (encoded by metA) are feedback-inhibited by S-AM. To generate deregulated variants of homoserine O-acetyltransferase, we identified putative S-AM binding residues within the amino acid sequence of homoserine O-acetyltransferase, and then constructed plasmids to express MetA variants containing specific amino acid substitutions that are predicted to confer increased resistance to allosteric regulation by S-AM. Strains expressing these variants showed increased production of methionine (see Examples, below).

Additional putative S-AM binding residues in various enzymes include, but are not limited to, those listed in Tables 9 and 10. One or more of the residues in Tables 9 and 10 can be substituted with a non-conservative residue, or with an alanine (e.g., where the wild type residue is other than an alanine). Sequence alignment confirms that the residues potentially associated with feedback-sensitivity to S-AM are conserved in a variety of MetA and MetY proteins from distantly related bacteria.

Standard site-directed mutagenesis techniques can be used to construct variants that are less sensitive to allosteric regulation. After cloning a PCR-amplified gene or genes into appropriate shuttle vectors, oligonucleotide-mediated site-directed mutagenesis is use to provide modified alleles that encode specific amino acid substitutions. Vectors containing either wild-type genes or modified alleles can be transformed into C. glutamicum, or another suitable host strain, alongside control vectors. The resulting transformants can be screened, for example, for amino acid productivity, increased resistance to feedback inhibition by S-AM, activity of the enzyme of interest, or other methods known to those skilled in the art to identify the variant alleles of most interest. Assays to measure amino acid productivity and/or enzyme activity can be used to confirm the screening results and select useful variant alleles. Techniques such as high pressure liquid chromatography (HPLC) and HPLC-mass spectrometry (MS) assays to quantify levels of amino acids and related metabolites are known to those skilled in the art.

Methods for generating random amino acid substitutions within a coding sequence, through methods such as mutagenenic PCR, can be used (e.g., to generate variants for screening for reduced feedback inhibition, or for introducing further variation into enhanced variant sequences). For example, PCR can be performed using the GeneMorph® PCR mutagenesis kit (Stratagene, La Jolla, Calif.) according to manufacturer's instructions to achieve medium and high range mutation frequencies. Other methods are also known in the art.

Evaluation of enzymes can be carried out in the presence of additional enzymes that are endogenous to the host strain. In certain instances, it will be helpful to have reagents to specifically assess the functionality of a biosynthetic protein that is not endogenous to the organism (e.g., an episomally expressed protein). Phenotypic assays for feedback inhibition or enzyme assays can be used to confirm function of wild-type and variants of biosynthetic enzymes. The function of cloned genes can be confirmed by complementation of genetically characterized mutants of the host organism (e.g., the host E. coli or C. glutamicum bacterium). Many of the E. coli strains are publicly available from the E. coli Genetic Stock Center (http://cgsc.biology.yale.edu/top.html). C. glutamicum mutants have also been described.

Expression of Genes

Bacterial genes can be expressed in host bacterial strains using methods known in the art. In some cases, overexpression of a bacterial gene (e.g., a heterologous and/or variant gene) will enhance amino acid production by the host strain. Overexpression of a gene can be achieved in a variety of ways. For example, multiple copies of the gene can be expressed, or the promoter, regulatory elements, and/or ribosome binding site upstream of a gene (e.g., a variant allele of a gene, or an endogenous gene) can be modified for optimal expression in the host strain. In addition, the presence of even one additional copy of the gene can achieve increased expression, even where the host strain already harbors one or more copies of the corresponding gene native to the host species. The gene can be operably linked to a strong constitutive promoter or an inducible promoter (e.g., trc, lac) and induced under conditions that facilitate maximal amino acid production. Methods to enhance stability of the mRNA are known to those skilled in the art and can be used to ensure consistently high levels of expressed proteins. See, for example, Keasling, J., Trends in Biotechnology 17:452-460, 1999. Optimization of media and culture conditions may also enhance expression of the gene.

Methods for facilitating expression of genes in bacteria have been described. See, for example, Guerrero, C, et al., Gene 138(1-2):35-41, 1994; Eikmanns, B. J., et al. Gene 102(1):93-8, 1991; Schwarzer, A., and Puhler, A. Biotechnol. 9(1):84-7, 1991; Labarre, J., et al., J Bacteriol. 175(4):1001-7, 1993; Malumbres, M., et al. Gene 134(1):15-24, 1993; Jensen, P. R., and Hammer, K. Biotechnol Bioeng. 158(2-3):191-5, 1998; Makrides, S. C. Microbiol Rev. 60(3):512-38, 1996; Tsuchiya et al. Bio/Technology 6:428-431,1988; U.S. Pat. No. 5,965,931; U.S. Pat. No. 4,601,893; and U.S. Pat. No. 5,175,108.

A gene of interest (e.g., a heterologous or variant gene) should be operably linked to an appropriate promoter, such as a native or host strain-derived promoter, a phage promoter, one of the well-characterized E. coli promoters (e.g. tac, trp, phoA, araBAD, or variants thereof etc.). Other suitable promoters are also available. In one embodiment, the heterologous gene is operably linked to a promoter that permits expression of the heterologous gene at levels at least 2-fold, 5-fold, or 10-fold higher than levels of the endogenous homolog in the host strain. Plasmid vectors that aid the process of gene amplification by integration into the chromosome can be used. See, for example, by Reinscheid et al. (Appl. Environ Microbiol. 60: 126-132,1994). In this method, the complete gene is cloned in a plasmid vector that can replicate in a host (typically E. coli), but not in C. glutamicum. These vectors include, for example, pSUP301 (Simon et al., Bio/Technol. 1, 784-79,1983), pK18mob or pK19mob (Schfer et al., Gene 145:69-73, 1994), PGEM-T (Promega Corp., Madison, Wis., USA), pCR2.1 -TOPO (Shuman J Biol Chem. 269:32678-84, 1994; U.S. Pat. No. 5,487,993), pCR.RTM.Blunt (Invitrogen, Groningen, Holland; Bernard et al., J Mol Biol., 234:534-541,1993), pEMI (Schrumpf et al. J Bacteriol. 173:4510-4516, 1991) or pBGS8 (Spratt et al., Gene 41:337-342, 1996). The plasmid vector that contains the gene to be amplified is then transferred into the desired strain of C. glutamicum by conjugation or transformation. The method of conjugation is described, for example, by Schfer et al. (Appl Environ Microbiol. 60:756-759,1994). Methods for transformation are described, for example, by Thierbach et al. (Appl Microbiol Biotechnol. 29:356-362,1988), Dunican and Shivnan (Bio/Technol. 7:1067-1070,1989) and Tauch et al. (FEMS Microbiol Lett. 123:343-347,1994). After homologous recombination by means of a genetic cross over event, the resulting strain contains the desired gene integrated in the host genome.

An appropriate expression plasmid can also contain at least one selectable marker. A selectable marker can be a nucleotide sequence that confers antibiotic resistance in a host cell. These selectable markers include ampicillin, cefazolin, augmentin, cefoxitin, ceftazidime, ceftiofur, cephalothin, enrofloxicin, kanamycin, spectinomycin, streptomycin, tetracycline, ticarcillin, tilmicosin, or chloramphenicol resistance genes. Additional selectable markers include genes that can complement nutritional auxotrophies present in a particular host strain (e.g. leucine, alanine, or homoserine auxotrophies).

In one embodiment, a replicative vector is used for expression of the heterologous gene. An exemplary replicative vector can include the following: a) a selectable marker, e.g., an antibiotic marker, such as kanR (from pACYC184); b) an origin of replication in E. coli, such as the P15a ori (from pACYC 184); c) an origin of replication in C. glutamicum such as that found in pBL1; d) a promoter segment, with or without an accompanying repressor gene; and e) a terminator segment. The promoter segment can be a lac, trc, trcRBS, tac, or λP_L/λP_R (from E. coli), orphoA, gpd, rplM, rpsJ (from C. glutamicum). The repressor gene can be lacIor cI857, for lac, trc, trcRBS, tac and λP_L/λP_R, respectively. The terminator segment can be from E. coli rrnB (from ptrc99a), the T7 terminator (from pET26), or a terminator segment from C. glutamicum.

In another embodiment, an integrative vector is used for expression of the heterologous gene. An exemplary integrative vector can include: a selectable marker, e.g., an antibiotic marker, such as kanR (from pACYC l 84); b) an origin of replication in E. coli, such as the P15a ori (from pACYC184); c) and d) two segments of the C. glutamicum genome that flank the segment to be replaced, such as the pck or hom genes; e) the sacB gene from B. subtilis; f) a promoter segment to control expression of the heterologous gene, with or without an accompanying repressor gene; and g) a terminator segment. The promoter segment can be lac, trc, trcRBS, tac, or λP_L/λP_R (from E. coli), or phoa, gpd, rplM, rpsj (from C. glutamicum). The repressor genes can be lacI or cI, for lac, trc, trcRBS, tac and λP_L/λP_R, respectively. The terminator segment can be from E. coli rrnB (from ptrc99a), the T7 terminator (from pET26), or a terminator segment from C. glutamicum. The possible integrative or replicative plasmids, or reagents used to construct these plasmids, are not limited to those described herein. Other plasmids are familiar to those in the art.

For use of terminator segments from C. glutamicum, the terminator and flanking sequences can be supplied by a single gene segment. In this case, the above elements will be arranged in the following sequence on the plasmid: marker; origin of replication; a segment of the C. glutamicum genome that flanks the segment to be replaced; promoter; C. glutamicum terminator; sacB gene. The sacB gene can also be placed between the origin of replication and the C. glutamicum flanking segment. Integration and excision results in the insertion of only the promoter, terminator, and the gene of interest.

A multiple cloning site can be positioned in one of several possible locations between the plasmid elements described above in order to facilitate insertion of the particular genes of interest (e.g., lysC, etc.) into the plasmid. For both replicative and integrative vectors, the addition of an origin of conjugative transfer, such as RP4 mob, can facilitate gene transfer between E. coli and C. glutamicum.

In one embodiment, a bacterial gene is expressed in a host strain with an episomal plasmid. Suitable plasmids include those that replicate in the chosen host strain, such as a coryneform bacterium. Many known plasmid vectors, such as e.g. pZ1 (Menkel et al., Applied Environ Microbiol. 64:549-554, 1989), pEKEx1 (Eikmanns et al., Gene 102:93-98,1991) or pHS2-1 (Sonnen et al., Gene 107:69-74, 1991) are based on the cryptic plasmids pHM1519, pBL1 or pGA1. Other plasmid vectors that can be used include those based on pCG4 (U.S. Pat. No. 4,489,160), or pNG2 (Serwold-Davis et al., FEMS Microbiol Lett. 66:119-124,1990), or pAG1 (U.S. Pat. No. 5,158,891). Alternatively, the gene or genes may be integrated into chromosome of a host microorganism by a method using transduction, transposon (Berg, D. E. and Berg, C. M., Bio/Technol. 1:417,1983), Mu phage (Japanese Patent Application Laid-open No. 2-109985) or homologous or non-homologous recombination (Experiments in Molecular Genetics, Cold Spring Harbor Lab.,1972).

In addition, it may be advantageous for the production of amino acids to enhance one or more enzymes of the particular biosynthesis pathway, of glycolysis, of anaplerosis, or of amino acid export, using more than one gene or using a gene in combination with other biosynthetic pathway genes.

It also may be advantageous to simultaneously attenuate the expression of particular gene products to maximize production of a particular amino acid. For example, attenuation of metK expression or MetK activity can enhance methionine production by prevention conversion of methionine to S-AM.

Methods of introducing nucleic acids into host cells are known in the art. See, for example, Sambrook, J., and Russell, D. W. Molecular Cloning: A Laboratory Manual, 3^nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 2001. Suitable methods include transformation using calcium chloride (Mandel, M. and Higa, A. J. Mol Biol. 53:159, 1970) and electroporation (Rest, M. E. van der, et al. Appl Microbiol. Biotechnol. 52:541-545, 1999), or conjugation.

Cultivation of Bacteria

The bacteria containing gene(s) of interest (e.g., heterologous genes, variant genes encoding enzymes with reduced feedback inhibition) can be cultured continuously or by a batch fermentation process (batch culture). Other commercially used process variations known to those skilled in the art include fed batch (feed process) or repeated fed batch process (repetitive feed process). A summary of known culture methods is described in the textbook by Chmiel (Bioprozesstechnik 1. Einfuhrung in die Bioverfahrenstechnik (Gustav Fischer Verlag, Stuttgart, 1991)) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).

The culture medium to be used fulfills the requirements of the particular host strains. General descriptions of culture media suitable for various microorganisms can be found in the book “Manual of Methods for General Bacteriology” of the American Society for Bacteriology (Washington D.C., USA, 1981), although those skilled in the art will recognize that the composition of the culture medium is often modified beyond simple growth requirements in order to maximize product formation.

Sugars and carbohydrates, such as e.g., glucose, sucrose, lactose, fructose, maltose, starch and cellulose; oils and fats, such as e.g. soy oil, sunflower oil, groundnut oil and coconut fat; fatty acids, such as e.g. palmitic acid, stearic acid and linoleic acid; alcohols, such as e.g. glycerol and ethanol; and organic acids, such as e.g. acetic acid, can be used as the source of carbon, either individually or as a mixture.

Organic nitrogen-containing compounds, such as peptones, yeast extract, meat extract, malt extract, corn steep liquor, soy protein hydrolysate, soya bean flour and urea, or inorganic compounds, such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate, can be used as the source of nitrogen. The sources of nitrogen can be used individually or as a mixture.

Phosphoric acid, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, or the corresponding sodium-containing salts can be used as the source of phosphorus.

Organic and inorganic sulfur-containing compounds, such as, for example, sulfates, thiosulfates, sulfites, reduced sources such as H₂S, sulfides, derivatives of sulfides, methyl mercaptan, thioglycolytes, thiocyanates, and thiourea, can be used as sulfur sources for the preparation of sulfur-containing amino acids.

The culture medium can also include salts of metals, e.g., magnesium sulfate or iron sulfate, which are necessary for growth. Essential growth substances, such as amino acids and vitamins (e.g. cobalamin), can be employed in addition to the above-mentioned substances. Suitable precursors can moreover be added to the culture medium. The starting substances mentioned can be added to the culture as a single batch, or can be fed in during the culture at multiple points in time.

Basic compounds, such as sodium hydroxide, potassium hydroxide, calcium carbonate, ammonia or aqueous ammonia, or acid compounds, such as phosphoric acid or sulfuric acid, can be employed in a suitable manner to control the pH. Antifoams, such as e.g. fatty acid polyglycol esters, can be employed to control the development of foam. Suitable substances having a selective action, such as e.g. antibiotics, can be added to the medium to maintain the stability of plasmids. To maintain aerobic conditions, oxygen or oxygen-containing gas mixtures, such as e.g. air, are introduced into the culture. The temperature of the culture is typically between 20-45° C. and preferably 25-40° C. Culturing is continued until a maximum of the desired product has formed, usually within 10 hours to 160 hours.

The fermentation broths obtained in this way, can contain a dry weight of 2.5 to 25 wt. % of the amino acid of interest. It also can be advantageous if the fermentation is conducted in such that the growth and metabolism of the production microorganism is limited by the rate of carbohydrate addtion for some portion of the fermentation cycle, preferably at least for 30% of the duration of the fermentation. For example, the concentration of utilizable sugar in the fermentation medium is maintained at <3 g/l during this period.

The fermentation broth can then be further processed. All or some of the biomass can be removed from the fermentation broth by any solid-liquid separation method, such as centrifugation, filtration, decanting or a combination thereof, or it can be left completely in the broth. Water is then removed from the broth by known methods, such as with the aid of a multiple-effect evaporator, thin film evaporator, falling film evaporator, or by reverse osmosis. The concentrated fermentation broth can then be worked up by methods of freeze drying, spray drying, fluidized bed drying, or by other processes to give a preferably free-flowing, finely divided powder.

The free-flowing, finely divided powder can then in turn by converted by suitable compacting or granulating processes into a coarse-grained, readily free-flowing, storable and largely dust-free product. In the granulation or compacting it can be advantageous to use conventional organic or inorganic auxiliary substances or carriers, such as starch, gelatin, cellulose derivatives or similar substances, such as are conventionally used as binders, gelling agents or thickeners in foodstuffs or feedstuffs processing, or further substances, such as, for example, silicas, silicates or stearates.

Alternatively, however, the product can be absorbed on to an organic or inorganic carrier substance which is known and conventional in feedstuffs processing, for example, silicas, silicates, grits, brans, meals, starches, sugars or others, and/or mixed and stabilized with conventional thickeners or binders.

Finally, the product can be brought into a state in which it is stable to digestion by animal stomachs, in particular the stomach of ruminants, by coating processes using film-forming agents, such as, for example, metal carbonates, silicas, silicates, alginates, stearates, starches, gums and cellulose ethers, as described in DE-C-4100920.

If the biomass is separated off during the process, further inorganic solids, for example, those added during the fermentation, are generally removed.

In one aspect of the invention, the biomass can be separated off to the extent of up to 70%, preferably up to 80%, preferably up to 90%, preferably up to 95%, and particularly preferably up to 100%. In another aspect of the invention, up to 20% of the biomass, preferably up to 15%, preferably up to 10%, preferably up to 5%, particularly preferably no biomass is separated off.

Organic substances which are formed or added and are present in the solution of the fermentation broth can be retained or separated by suitable processes. These organic substances include organic by-products that are optionally produced, in addition to the desired L-amino acid, and optionally discharged by the microorganisms employed in the fermentation. These include L-amino acids chosen from the group consisting of L-lysine, L-valine, L-threonine, L-alanine, L-methionine, L-isoleucine, or L-tryptophan. They include vitamins chosen from the group consisting of vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), vitamin B12 (cyanocobalamin), nicotinic acid/nicotinanide and vitamin E (tocopherol). They also include organic acids that carry one to three carboxyl groups, such as, acetic acid, lactic acid, citric acid, malic acid or fumaric acid. Finally, they also include sugars, for example, trehalose. These compounds are optionally desired if they improve the nutritional value of the product.

These organic substances, including L- and/or D-amino acid and/or the racemic mixture D,L-amino acid, can also be added, depending on requirements, as a concentrate or pure substance in solid or liquid form during a suitable process step. These organic substances mentioned can be added individually or as mixtures to the resulting or concentrated fermentation broth, or also during the drying or granulation process. It is likewise possible to add an organic substance or a mixture of several organic substances to the fermentation broth and a further organic substance or a further mixture of several organic substances during a later process step, for example granulation. The product described above can be used as a feed additive, i.e. feed additive, for animal nutrition. For methods of preparing amino acids for use as feed additives, see, e.g., WO 02/18613, the contents of which are herein incorporated by reference.

EXAMPLE 1

Construction of Vectors for Expression of Genes for Enhancing Production of Aspartate-Derived Amino Acids

Plasmids were generated for expression of genes relevant to the production of aspartate-derived amino acids. Many of the target genes are shown in FIG. 1 and 2, which depicts most of the biosynthetic genes directly involved in producing aspartate-derived amino acids. These plasmids, which may either replicate autonomously or integrate into the host C. glutamicum chromosome, were introduced into strains of corynebacteria by electroporation as described (see Follettie, M. T., et al. J. Bacteriol. 167:695-702, 1993). All plasmids contain the kanR gene that confers resistance to the antibiotic kanamycin. Transformants were selected on media containing kanamycin (25 mg/L).

For expression from episomal plasmids, vectors were constructed using derivatives of the cryptic C. glutamicum low-copy pBL1 plasmid (see Santamaria et al. J. Gen. Microbiol. 130:2237-2246, 1984). Episomal plasmids contain sequences that encode a replicase, which enables replication of the plasmid within C. glutamicum; therefore, these plasmids can be propagated without integration into the chromosome. Plasmids MB3961 and MB4094 were the vector backbones used to construct episomal expression plasmids described herein (see FIGS. 3 and 4). Plasmid MB4094 contains an improved origin of replication, relative to MB3961, for use in corynebacteria; therefore, this backbone was used for most studies. Both MB3961 and MB4094 contain regulatory sequences from pTrc99A (see Amann et al., Gene 69:301-315, 1988). The 3′ portion of the lacIq-trc IPTG-inducible promoter cassette resides within the polylinker in such a way that genes of interest can be inserted as fragments containing NcoI-NotI compatible overhangs, with the NcoI site adjacent to the start site of the gene of interest (additional polylinker sites such as KpnI can also be used instead of the NotI site). In addition, useful promoters such as a modified trc promoter (trcRBS) and the C. glutamicum gpd, rplM, and rpsJ promoters can be inserted into the MB3961 and MB4094 backbones on convenient restriction fragments, including NheI-NcoI fragments. The trcRBS promoter contains a modified ribosomal-binding site that was shown to enhance levels of expressed proteins. The sequences of promoters employed in these studies for expression of genes are found in Table 7.

TABLE 7
Promoters used to control expression of genes in corynebacteria.
		SEQ ID
Promoter	Sequence	NO:
Laclq-trc	ctagctacgttgacaccatcgaatggtgcaaaacctttcgcggtatggcatgatagcgcccggaa	297
	gagagtcaattcagggtggtgaatgtgaaaccagtaacgttatacgatgtcgcagagtatgccggt
	gtctcttatcagaccgtttcccgcgtggtgaaccaggccagccacgtttctgcgaaaacgcggga
	aaaagtggaagcggcgatggcggagctgaattacattcccaaccgcgtggcacaacaactggc
	gggcaaacagtcgttgctgattggcgttgccacctccagtctggccctgcacgcgccgtcgcaaa
	ttgtcgcggcgattaaatctcgcgccgatcaactgggtgccagcgtggtggtgtcgatggtagaa
	cgaagcggcgtcgaagcctgtaaagcggcggtgcacaatcttctcgcgcaacgcgtcagtggg
	ctgatcattaactatccgctggatgaccaggatgccattgctgtggaagctgcctgcactaatgttc
	cggcgttatttcttgatgtctctgaccagacacccatcaacagtattattttctcccatgaagacggta
	cgcgactgggcgtggagcatctggtcgcattgggtcaccagcaaatcgcgctgttagcgggccc
	attaagttctgtctcggcgcgtctgcgtctggctggctggcataaatatctcactcgcaatcaaattc
	agccgatagcggaacgggaaggcgactggagtgccatgtccggttttcaacaaaccatgcaaat
	gctgaatgagggcatcgttcccactgcgatgctggttgccaacgatcagatggcgctgggcgca
	atgcgcgccattaccgagtccgggctgcgcgttggtgcggatatctcggtagtgggatacgacga
	taccgaagacagctcatgttatatcccgccgttaaccaccatcaaacaggattttcgcctgctgggg
	caaaccagcgtggaccgcttgctgcaactctctcagggccaggcggtgaagggcaatcagctgt
	tgcccgtctcactggtgaaaagaaaaaccaccctggcgcccaatacgcaaaccgcctctccccg
	cgcgttggccgattcattaatgcagctggcacgacaggtttcccgactggaaagcgggcagtga
	gcgcaacgcaattaatgtgagttagcgcgaattgatctggtttgacagcttatcatcgactgcacgg
	tgcaccaatgcttctggcgtcaggcagccatcggaagctgtggtatggctgtgcaggtcgtaaatc
	actgcataattcgtgtcgctcaaggcgcactcccgttctggataatgttttttgcgccgacatcataa
	cggttctggcaaatattctgaaatgagctgttgacaattaatcatccggctcgtataatgtgtggaatt
	gtgagcggataacaatttcacacaggaaacagac
Laclq-	ctagctacgttgacaccatcgaatggtgcaaaacctttcgcggtatggcatgatagcgcccggaa	298
trcRBS	gagagtcaattcagggtggtgaatgtgaaaccagtaacgttatacgatgtcgcagagtatgccggt
	gtctcttatcagaccgtttcccgcgtggtgaaccaggccagccacgtttctgcgaaaacgcggga
	aaaagtggaagcggcgatggcggagctgaattacattcccaaccgcgtggcacaacaactggc
	gggcaaacagtcgttgctgattggcgttgccacctccagtctggccctgcacgcgccgtcgcaaa
	ttgtcgcggcgattaaatctcgcgccgatcaactgggtgccagcgtggtggtgtcgatggtagaa
	cgaagcggcgtcgaagcctgtaaagcggcggtgcacaatcttctcgcgcaacgcgtcagtggg
	ctgatcattaactatccgctggatgaccaggatgccattgctgtggaagctgcctgcactaatgttc
	cggcgttatttcttgatgtctctgaccagacacccatcaacagtattattttctcccatgaagacggta
	cgcgactgggcgtggagcatctggtcgcattgggtcaccagcaaatcgcgctgttagcgggccc
	attaagttctgtctcggcgcgtctgcgtctggctggctggcataaatatctcactcgcaatcaaattc
	agccgatagcggaacgggaaggcgactggagtgccatgtccggttttcaacaaaccatgcaaat
	gctgaatgagggcatcgttcccactgcgatgctggttgccaacgatcagatggcgctgggcgca
	atgcgcgccattaccgagtccgggctgcgcgttggtgcggatatctcggtagtgggatacgacga
	taccgaagacagctcatgttatatcccgccgttaaccaccatcaaacaggattttcgcctgctgggg
	caaaccagcgtggaccgcttgctgcaactctctcagggccaggcggtgaagggcaatcagctgt
	tgcccgtctcactggtgaaaagaaaaaccaccctggcgcccaatacgcaaaccgcctctccccg
	cgcgttggccgattcattaatgcagctggcacgacaggtttcccgactggaaagcgggcagtga
	gcgcaacgcaattaatgtgagttagcgcgaattgatctggtttgacagcttatcatcgactgcacgg
	tgcaccaatgcttctggcgtcaggcagccatcggaagctgtggtatggctgtgcaggtcgtaaatc
	actgcataattcgtgtcgctcaaggcgcactcccgttctggataatgttttttgcgccgacatcataa
	cggttctggcaaatattctgaaatgagctgttgacaattaatcatccggctcgtataatgtgtggaatt
	gtgagcggataacaatttcacacaggaaacagagaattcaaaggaggacaac
C.	Ctagcctaaaaacgaccgagcctattgggattaccattgaagccagtgtgagttgcatcacattgg	299
glutamicum	cttcaaatctgagactttaatttgtggattcacgggggtgtaatgtagttcataattaaccccattcgg
gpd	gggagcagatcgtagtgcgaacgatttcaggttcgttccctgcaaaaactatttagcgcaagtgttg
	gaaatgcccccgtttggggtcaatgtccatttttgaatgtgtctgtatgattttgcatctgctgcgaaat
	ctttgtttccccgctaaagttgaggacaggttgacacggagttgactcgacgaattatccaatgtga
	gtaggtttggtgcgtgagttggaaaaattcgccatactcgcccttgggttctgtcagctcaagaattc
	ttgagtgaccgatgctctgattgacctaactgcttgacacattgcatttcctacaatctttagaggaga
	cacaac
C.	ctagcggggttgctgcactttttaaaaaggcaaaaaatagcgaaaacacaccccaggtttttcccgt	300
glutamicum	aaccccgctaggctatgcaatttcggtttaacccagtttttcaaagaaggtcactagcttttccgctg
rplM	gtcaccttctttttggtttttcaacgcagagatagtacactttactctttgtgtgtggagtcaaacctccc
	ctttaaggggtgcgcttggacagcaggacaaattcgggtcaccaccggccgccgaatttagcttc
	cttccgaacatattcctggctggcagttctagaccgactaattcaaggagtcattc
C.	ctagctatttcagtgcggggcagtgaaagtaaaaacgcaactttcttacagaacagggttgtctttc	301
glutamicum	agacgactatgtggttaactacttgggctgctttaacacggcgtgaattaaccatgccagttggtaa
rpsJ	ggcaaacatgacaccttcaattggagtcgaggcgcatgaaaatgcacttcaacttcagggggtat
	ccactgaagccgggtgactggtgaaggcggaaccggagaaggggcatggcaaataaacagcg
	gcagttacgttagggcctagatcacgcattttggtcccttccgatttccctgacttcattgttgggttca
	tcgtggagcgttttatttgtacagcgcccgtgatccaatgtcagaagcatttgacaggtcaggttaaa
	cactggcgttgcgcccgagccccaagcccggacaacgttatagagaaagaatgaagcgaattcc
	caccgcttttccaaaatggaagatgtgggacgagcgaggaagaggataagc

Plasmids were also designed to inactivate native C. glutamicum genes by gene deletion. In some instances, these constructs both delete native genes and insert heterologous genes into the host chromosome at the locus of the deletion event. Table 8 lists the endogenous gene that was deleted and the heterologous genes that were introduced, if any. Deletion plasmids contain nucleotide sequences homologous to regions upstream and downstream of the gene that is the target for the deletion event; in some instances these sequences include small amounts of coding sequence of the gene that is to be inactivated. These flanking sequences are used to facilitate homologous recombination. Single cross-over events target the plasmid into the host chromosome at sites upstream or downstream of the gene to be deleted. Deletion plasmids also contain the sacB gene, encoding the levansucrase gene from Bacillus subtilis. Transformants containing integrated plasmids were streaked to BHI medium lacking kanamycin. After 1 day, colonies were streaked onto BHI medium containing 10% sucrose. This protocol selects for strains in which the sacB gene has been excised, since it polymerizes sucrose to form levan that is toxic to C. glutamicum (see Jager, W., et al. J. Bacteriol. 174:5462-5465, 1992). During growth of transformants upon medium containing sucrose, sacB allows for positive selection for recombination events, resulting in either a clean deletion event or removal of all portions of the integrating plasmid except for the cassette that regulates the inducible expression of a particular gene of interest (see Jager, W., et al. J. Bacteriol. 174:5462-5465, 1992). PCR, together with growth on diagnostic media, was used to verify that expected recombination events have occurred in sucrose-resistant colonies. FIGS. 5-12A display deletion plasmids described herein.

TABLE 8
Plasmids used for deletion of C. glutamicum genes, sometimes
in conjunction with insertion of expression cassettes.
		Native gene(s)
	Plasmid	deleted	Element inserted at locus
	MB4083	hom-thrB	None
	MB4084	thrB	None
	MB4165	mcbR	None
	MB4169	hom-thrB	gpd-M. smegmatis
			lysC(T311I)-asd
	MB4192	hom-thrB	gpd-S. coelicolor
			hom(G362E)
	MB4276	pck	gpd-M. smegmatis
			lysC(T311I)-asd
	MB4286	mcbR	trcRBS-T. fusca metA
	MB4287	mcbR	trcRBS-C. glutamicum metA
			(K233A)-metB

EXAMPLE 2

Isolation of Genes for Enhancing Production of Aspartate-Derived Amino Acids

Wild-type alleles of aspartokinase alpha (lysC-alpha) and beta (lysC-beta) and aspartate semialdehyde dehydrogenase (asd) from Mycobacterium smegmatis (homologs of lysC/asd in Corynebacterium glutamicum); genes encoding aspartokinase-asd (lysC-asd), dapA, and hom from Streptomyces coelicolor; metA and metYA from Thermobifida fusca; and dapA and ppc from Erwinia chrysanthemi are obtained by PCR amplification using genomic DNA isolated from each organism. In addition, in some cases the corresponding wild-type allele for each gene is isolated from C. glutamicum. Amplicons are subsequently cloned into pBluescriptSK II⁻ for sequence verification; in particular instances, site-directed mutagenesis to create the activated alleles is also performed in these vectors. Genomic DNA is isolated from M. smegmatis grown in BHI medium for 72 h at 37° C. using QIAGEN Genomic-tips according to the recommendations of the manufacturer kits (Qiagen, Valencia, Calif.). For the isolation of genomic DNA from S. coelicolor, the Salting Out Procedure (as described in Practical Streptomyces Genetics, pp. 169-170, Kieser, T., et. al., John Innes Foundation, Norwich, England 2000) is used on cells grown in TYE media (ATCC medium 1877 ISP Medium 1) for 7 days at 25° C.

To isolate genomic DNA from T. fusca, cells are grown in TYG media (ATCC medium 741) for 5 days at 50° C. The 100 ml culture is spun down (5000 rpm for 10 min at 4° C.) a washed twice with 40 ml 10 mM Tris, 20 mM EDTA pH 8.0. The cell pellet is brought up in a final volume of 40 ml of 10 mMTris, 20 mM EDTA pH 8.0. This suspension is passed through a Microfluidizer (Microfluidics Corporation, Newton Mass.) for 10 cycles and collected. The apparatus is rinsed with an additional 20 ml of buffer and collected. The final volume of lysed cells is 60 ml. DNA is precipitated from the suspension of lysed cells by isopropanol precipitation, and the pellet is resuspended in 2 ml TE pH 8.0. The sample is extracted with phenol/chloroforn and the DNA precipitated once again with isopropanol. To isolate DNA from E. chrysanthemi, genomic DNA was prepared as described for E. coli (Qiagen genomic protocol) using a Genomic Tip 500/G.

For PCR amplification of the M. smegmatis IysC-asd operon, primers are designed according to sequence upstream of the lysC gene and sequence near the stop of asd. The upstream primer is 5′-CCGTGAGCTGCTCGGATGTGACG-3′ (SEQ ID NO:302), the downstream primer is 5′-TCAGAGGTCGGCGGCCAACAGTTCTGC-3′ (SEQ ID NO:303). The genes are amplified using Pfu Turbo (Stratagene, La Jolla, Calif.) in a reaction mixture containing 10 μl 10× Cloned Pfu buffer, 8 μl dNTP mix (2.5 mM each), 2 μl each primer (20 uM), 1 μl Pfu Turbo, 10 ng genomic DNA and water in a final reaction volume of 100 μl. The reaction conditions are 94° C. for 2 min, followed by 28 cycles of 94° C. for 30 sec, 60° C. for 30sec, 72° C. for 9 min. The reaction is completed with a final extension at 72° C. for 4 min, and the reaction is then cooled to 4° C. The resulting product is purified by the Qiagen gel extraction protocol followed by blunt end ligation into the SmaI site of pBluescript SK II−. Ligations are transformed into E. coli DH5α and selected by blue/white screening. Positive transformants are treated to isolate plasmid DNA by Qiagen methods and sequenced. MB3902 is the resulting plasmid containing the expected insert.

Primer pairs for amplifying S. coelicolor genes are: 5′-ACCGCACTTTCCCGAGTGAC-3′ (SEQ ID NO:304) and 5′-TCATCGTCCGCTCTTCCCCT-3′ (lysC-asd) (SEQ ID NO:305); 5′-ATGGCTCCGACCTCCACTCC-3′ (SEQ ID NO:306) and 5′-CGTGCAGAAGCAGTTGTCGT-3′ (dapA) (SEQ ID NO:307); and 5′-TGAGGTCCGAGGGAGGGAAA-3′ (SEQ ID NO:308) and 5′-TTACTCTCCTTCAACCCGCA-3′ (hom) (SEQ ID NO:309). The primer pair for amplifying the metYA operon from T. fusca is 5′- CATCGACTACGCCCGTGTGA-3′ (SEQ ID NO:310) and 5′-TGGCTGTTCTTCACCGCACC-3′ (SEQ ID NO:311). Primer pairs for amplifying E. chrysanthemi genes are: 5′- TTGACCTGACGCTTATAGCG-3′ (SEQ ID NO:312) and 5′-CCTGTACAAAATGTTGGGAG-3′ (dapA) (SEQ ID NO:313); and 5′-ATGAATGAACAATATTCCGCCA-3′ (SEQ ID NO:314) and 5′-TTAGCCGGTATTGCGCATCC-3′ (ppc) (SEQ ID NO:315).

Amplification of genes was done by similar methods as above or by using the TripleMaster PCR System from Eppendorf (Eppendorf, Hamburg, Germany). Blunt end ligations were performed to clone amplicons into the SmaI site of pBluescript SK II−. The resulting plasmids were MB3947 (S. coelicolor lysC-asd), MB3950 (S. coelicolor dapA), MB4066 (S. coelicolor hom), MB4062 (T. fusca metYA), MB3995 (E. chrysanthemi dapA), and MB4077 (E. chrysanthemippc). These plasmids were used for sequence verification of inserts and subsequent cloning into expression vectors; a subset of these vectors was also subjected to site-directed mutagenesis to generate deregulated alleles of specific genes.

EXAMPLE 3

Targeted Substitutions to Enhance the Activity of Genes Involved in the Production of Aspartate-Derived Amino Acids

Site-directed mutagenesis was performed on several of the pBluescript SK II− plasmids containing the heterologous genes described in Example 2. Site-directed mutagenesis was performed using the QuikChange Site-Directed Mutagenesis Kit from Stratagene. For heterologous aspartokinase (lysC/ask) genes, substitution mutations were constructed that correspond to the T311I, S301Y, A279P, and G345D amino acid substitutions in the C. glutamicum protein. These substitutions may decrease feedback inhibition by the combination of lysine and threonine. In all instances, the mutated lysC/ask alleles were expressed in an operon with the heterologous asd gene. Oligonucleotides employed to construct M. smegmatis feedback resistant lysC alleles were: 5′-GGCAAGACCGACATCATATTCACGTGTGCGCGTG-3′ (SEQ ID NO:316) and 5′-CACGCGCACACGTGAATATGATGTCGGTCTTGCC-3′ (T3 11I) (SEQ ID NO:317); 5′-GGTGCTGCAGAACATCTACAAGATCGAGGACGGCAA-3′ (SEQ ID NO:318) and 5′-TTGCCGTCCTCGATCTTGTAGATGTTCTGCAGCACC-3′ (S301Y) (SEQ ID NO:319); 5′-GACGTTCCCGGCTACGCCGCCAAGGTGTTCCGC-3′ (SEQ ID NO:320) and 5′-GCGGAACACCTTGGCGGCGTAGCCGGGAACGTC-3′ (A279P) (SEQ ID NO:321); and 5′-GTACGACGACCACATCGACAAGGTGTCGCTGATCG-3′ (SEQ ID NO:322); and 5′-CGATCAGCGACACCTTGTCGATGTGGTCGTCGTAC-3′ (G345D) (SEQ ID NO:323). Oligonucleotides employed to construct S. coelicolor feedback resistant lysC alleles were: 5′-CGGGCCTGACGGACATCRTCTTCACGCTCCCCAAG-3′ (SEQ ID NO:324) and 5′-CTTGGGGAGCGTGAAGAYGATGTCCGTCAGGCCCG-3′ (S3141/S314V) (SEQ ID NO:325); and 5′-GTCGTGCAGAACGTGTACGCCGCCTCCACGGGC-3′ (SEQ ID NO:326) and 5′-GCCCGTGGAGGCGGCGTACACGTTCTGCACGAC-3′ (S304Y) (SEQ ID NO:327).

Site-directed mutagenesis can be performed to generate deregulated alleles of additional proteins relevant to the production of aspartate-derived amino acids. For example, mutations can be generated that correspond to the V59A, G378E, or carboxy-terminal truncations of the C. glutamicum hom gene. The Transformer Site-Directed Mutagenesis Kit (BD Biosciences Clontech) was used to generate the S. coelicolor hom (G362E) substitution. Oligonucleotides 5′-GTCGACGCGTCTTAAGGCATGCAAGC-3′ (SEQ ID NO:328) and 5′-CGACAAACCGGAAGTGCTCGCCC-3′ (SEQ ID NO:329) were utilized to construct the mutation. Site-directed mutagenesis was also employed to generate specific alleles of the T. fusca and C. glutamicum metA and metY genes (see examples 5 and 6 of the instant specification). Similar strategies can be used to construct deregulated alleles of additional pathway proteins. For example, oligonucleotides 5′-TTCATCGAACAGCGCTCGCACCTGCTGACCGCC-3′ (SEQ ID NO:330) and 5′-GGCGGTCAGCAGGTGCGAGCGCTGTTCGATGAA-3′ (SEQ ID NO:331)can be used to generate a substitution in the S. coelicolor pyc gene that corresponds to the C. glutamicum pyc P458S mutation. Site-directed mutagenesis can also be utilized to introduce substitutions that correspond to deregulated dapA alleles described above.

Wild-type and deregulated alleles of heterologous (and C. glutamicum) genes were then cloned into vectors suitable for expression. In general, PCR was employed using oligonucleotides to facilitate cloning of genes as a NcoI-NotI fragment. DNA sequence analysis was performed to verify that mutations were not introduced during rounds of amplification. In some instances, synthetic operons were constructed in order to express two or more genes, heterologous or endogenous, from the same promoter. As an example, plasmid MB4278 was generated to express the C. glutamicum metA, metY, and metH genes from the trcRBS promoter. FIG. 12B displays the DNA sequence in MB4278 that spans from the trcRBS promoter to the stop of the metH gene; the gene order in this construct is metA YH. The open reading frames in FIG. 12B are shown in uppercase. Note that the construct was engineered such that each open reading frame is preceded by an identical stretch of DNA. This conserved sequence serves as a ribosomal-binding sequence that promotes efficient translation of C. glutamicum proteins. Similar intergenic sequences were used to construct additional synthetic operons.

EXAMPLE 4

Isolation of Additional Threonine-Insensitive Mutants of Homoserine Dehydrogenase

The hom gene cloned from S. coelicolor in Example 2 is subjected to error prone PCR using the GeneMorph® Random Mutagenesis kit obtained from Stratagene. Under the conditions specified in this kit, oligonucleotide primers 5′-CACACGAAGACACCATGATGCGTACGCGTCCGCT-3′ (contains a BbsI site and cleavage yields a NcoI compatible overhang) (SEQ ID NO:332) and 5′-ATAAGAATGCGGCCGCTTACTCTCCTTCAACCCGCA-3′ (contains a NotI site) (SEQ ID NO:333) are used to amplify the hom gene from plasmid MB4066. The resulting mutant population is digested with BbsI and NotI, ligated into NcoI/NotI digested episomal plasmid containing the trcRBS promoter in the MB4094 plasmid backbone, and transformed into C. glutamicum ATCC 13032. The transformed cells are plated on agar plates containing a defined medium for corynebacteria (see Guillouet, S., et al. Appl. Environ. Microbiol. 65:3100-3107, 1999) containing kanamycin (25 mg/L), 20 mg/L of AHV (alpha-amino, beta-hydroxyvaleric acid; a threonine analog) and 0.01 mM IPTG. After 72 h at 30° C., the resulting transformants are subsequently screened for homoserine excretion by replica plating to a defined medium agar plate supplemented with threonine, which was previously spread with ˜10⁶ cells of indicator C. glutamicum strain MA-331 (hom-thrBA). Putative feedback-resistant mutants are identified by a halo of growth of the indicator strain surrounding the replica-plated transformants. From each of these colonies, the hom gene is PCR amplified using the above primer pair, the amplicon is digested as above, and ligated into the episomal plasmid described above. Each of these putative hom mutants is subsequently re-transformed into C. glutamicum ATCC 13032 and plated on minimal medium agar plates containing 25 mg/L kanamycin and 0.01 mM IPTG. One colony from each transformation is replica plated to defined medium for corynebacteria containing 10, 20, 50, and 100 mg/L of AHV, and sorted based on the highest level of resistance to the threonine analog. Representatives from each group are grown in minimal medium to an OD of 2.0, the cells harvested by centrifugation, and homoserine dehydrogenase activity assayed in the presence and absence of 20 mM threonine as referenced in Chassagnole, C., et al., Biochem. J. 356:415-423, 2001. The hom gene is PCR amplified from those cultures showing feedback-resistance and sequenced. The resulting plasmids are used to generate expression plasmids to enhance amino acid production.

EXAMPLE 5

Isolation of Feedback-Resistant Mutants of Homoserine O-Acetyltransferase (metA) and O-Acetylhomoserine Sulfhydrylase (metY)

The heterologous metA gene cloned from T. fusca is subjected to error prone PCR using the GeneMorph® Random Mutagenesis kit obtained from Stratagene. Under the conditions specified in this kit, oligonucleotide primers 5′-CACACACCTGCCACACATGAGTCACGACACCACCCCTCC-3′ (contains a BspMI site and cleavage yields a NcoI compatible overhang) (SEQ ID NO:334) and 5′-ATAAGAATGCGGCCGCTTACTGCGCCAGCAGTTCTT-3′ (contains a NotI site) (SEQ ID NO:335) are used to amplify the metA gene from plasmid MB4062. The resulting mutant amplicon is digested and ligated into the NcoIlNotI digested episomal plasmid described in Example 4, and then transformed into C. glutamicum strain MA-428. MA-428 is a derivative of ATCC 13032 that has been transformed with integrating plasmid MB4192. After selection for recombination events, the resulting strain MA-428 is deleted for hom-thrB in a manner that results in insertion of a deregulated S. coelicolor hom gene. The transformed MA-428 cells described are plated on minimal medium agar plates containing kanamycin (25 mg/L), 0.01 mM IPTG, and 100 μg/ml or 500 μg/ml of trifluoromethionine (TFM; a methionine analog). After 72 h at 30° C., the resulting transformants are subsequently screened for O-acetylhomoserine excretion by replica plating to a minimal agar plate which was previously spread with ˜10⁶ cells of an indicator strain, S. cerevisiae B-7588 (MATa ura3-5Z ura3-58, leu2-3, leu2-112, trp1-289, met2, HIS3+), obtained from ATCC (#204524). Putative feedback-resistant mutants are identified by the excretion of O-acetylhomoserine (OAH), which supports a halo of indicator strain growth surrounding the replica-plated transformants.

From each of these cross-feeding colonies, the metA gene is PCR amplified using the above primer pair, digested with BspMI and NotI, and ligated into the NotI/NcoI digested episomal plasmid described in example 4. Each of these putative metA mutant alleles is subsequently re-transformed into C. glutamicum ATCC 13032 and plated on minimal medium agar plates containing 25 mg/L kanamycin. One colony from each transformation is replica plated to minimal medium containing 100, 200, 500, and 1000 μg/ml of TFM plus 0.01 mM IPTG, and sorted based on the highest level of resistance to the methionine analog. Representatives from each group are grown in minimal medium to an OD of 2.0, the cells harvested by centrifugation, and homoserine O-acetyltransferase activity is determined by the methods described by Kredich and Tomkins (J. Biol. Chem. 241:4955-4965,1966) in the presence and absence of 20 mM methionine or S-AM. The metA gene is PCR amplified from those cultures showing feedback-resistance and sequenced. The resulting plasmids are used to generate expression plasmids to enhance amino acid production. In a similar manner, the metY gene from T. fusca is subjected to mutagenic PCR. Oligonucleotide primers 5′-CACAGGTCTCCCATGGCACTGCGTCCTGACAGGAG-3′ (contains a BsaI site and cleavage yields a NcoI compatible overhang) (SEQ ID NO:336) and 5′-ATAAGAATGCGGCCGCTCACTGGTATGCCTTGGCTG-3′ (contains a NotI site) (SEQ ID NO:337) are used for cloning into the episomal plasmid, as described above, and for carrying out the mutagenesis reaction per the specifications of the GeneMorph® Random Mutagenesis kit obtained from Stratagene. The major difference is that the mutated metYpopulation is transformed into a C. glutamicum strain that already produces high levels of O-acetylhomoserine. This strain, MICmet2, is constructed by transforming MA-428 with a modified version of plasmid MB4286 that contains a deregulated T. fusca metA allele described above under the control of the trcRBS promoter. After transformation the sacB selection system enables the deletion of the endogenous mcbR locus and replacement with the deregulated heterologous metA allele.

The T. fusca metY variant transformed MICmet2 strain is spread onto minimal agar plates containing 25 mg/L of kanamycin, 0.25mM IPTG, and an inhibiting concentration of toxic methionine analog(s) (e.g., ethionine, selenomethionine, TFM); the transfornants can be grown on these 3 different methionine analogs either individually or in double or triple combination). The metY gene is amplified from those colonies growing on the selection plates, the amplicons are digested and ligated into the episomal plasmid described in example 4, and the resulting plasmids are transformed into MICmet2. The transformants are grown on minimal medium agar plates containing 25 mg/L of kanamycin. The resulting colonies are replica-plated to agar plates containing a 10-fold range of the toxic methionine analogs ethionine, TFM, and selenomethionine (plus 0.01 mM IPTG), and sorted on the basis of analog sensitivity. Representatives from each group are grown in minimal medium to an OD of 2.0, the cells are harvested by centrifugation, and O-acetylhomoserine sulfhydrylase enzyme activity is determined by a modified version of the methods of Kredich and Tomkins (J. Biol. Chem. 241:4955-4965,1966) (see example 9) in the presence and absence of 20 mM methionine. The metY gene is PCR amplified from those cultures showing feedback-resistance and sequenced. The resulting plasmids are used to generate expression plasmids to enhance amino acid production. An expression plasmid containing the feedback resistant metY and metA variants from T. fusca is constructed as follows. The T. fusca metYA operon is amplified using oligonucleotides 5′-CACACACATGTCACTGCGTCCTGACAGGAGC-3′ (contains a Pcil site and cleavage yields a NcoI compatible overhang (also changes second codon from Ala>Ser)) (SEQ ID NO:338) and 5′-ATAAGAATGCGGCCGCTTACTGCGCCAGCAGTTCTT -3′ (contains a NotI site) (SEQ ID NO:339). The amplicon is digested with PciI and NotI, and the fragment is ligated into the above episomal plasmid that has been treated sequentially treated with NotI, HaeIII methylase, and NcoI. Site directed mutagenesis, performed using the QuikChange Site-Directed Mutagenesis Kit from Stratagene, is used to incorporate the described substitution mutations in T. fusca metA and metY into a single plasmid that expresses the deregulated alleles as an operon. The resulting plasmid is used to enhance amino acid production.

Minimal medium: 10 g glucose, 1 g NH₄H₂PO₄, 0.2 g KCl, 0.2 g MgSO₄-7H₂O, 30 and 1 ml TE per liter of deionized water (pH 7.2). Trace elements solution (TE) comprises: 88 mg Na₂B₄O₇-10H₂O, 37 mg (NH₄)₆Mo₇O₂₇-4H₂O, 8.8 mg ZnSO₄-7H₂O, 270 mg CuSO₄-5H₂O, 7.2 mg MnCl₂-4H₂O, and 970 mg FeCl₃-6H₂O per liter of deionized water. (When needed to support auxotrophic requirements, amino acids and purines are supplemented to 30 mg/L final concentration.)

EXAMPLE 6

Identification of S-AM-Binding Residues in Bacterial Amino Acid Sequences

Many enzymes that regulate amino acid production are subject to allosteric feedback inhibition by S-AM. We hypothesized that variants of these enzymes with resistance to S-AM regulation (e.g., via resistance to S-AM binding or to S-AM-induced allosteric effects) would be resistant to feedback inhibition. S-AM binding motifs have been identified in bacterial DNA methyltransferases (Roth et al., J. Biol. Chem., 273:17333-17342, 1998). Roth et al. identified a highly conserved amino acid motif in EcoRV α-adenine-N⁶-DNA methyltransferase which appeared to be critical for S-AM binding by the enzyme. We searched for related motifs in the amino acid sequences of the following proteins of C. glutamicum: MetA, MetY, McbR, LysC, MetB, MetC, MetE, MetH, and MetK. Putative S-AM binding motifs were identified in MetA, MetY, McbR, LysC, MetB, MetC, MetH, and MetK. We also identified additional residues in metY that are analogous to a S-AM binding motif in a yeast protein. (Pintard et al., Mol. Cell Biol., 20(4):1370-1381, 2000).

Residues of each protein that may be involved in S-AM binding are listed in Table 9.

TABLE 9
Putative residues involved in S-AM
binding in C. glutamicum proteins
        Putative residue involved
Protein in S-AM binding
MetA    G231
        K233
        F251
        V253
        D269
MetY    G227
        L229
        D231
        G232
        G233
        F235
        D236
        V239
        F368
        D370
        D383
        G346
        K348
McbR    G92
        K94
        F116
        G118
        D134
LysC    G208
        K210
        F223
        V225
        D236
MetB    G72
        K74
        F90
        I92
        D105
MetC    G296
        K298
        F312
        G314
        D335
MetH    G708
        K710
        F725
        L727
MetK    G263
        K265
        F282
        G284
        D291

Alignment of MetA and MetY sequences from other species was used to identify additional putative S-AM-binding residues. These residues are listed in Table 10.

TABLE 10
Putative S-AM binding amino acids in
bacterial MetA and MetY proteins
		Putative residue
		involved in S-AM	Homologous Residue
Protein	Organism	binding	in C. glutamicum
MetY	T. fusca	G240	G227
		D244	D231
		F379	F368
		D394	D383
MetY	M. tuberculosis	G231	G227
		D235	D231
		F367	F368
		D382	D383
MetA	T. fusca	G81	analogous residue
			absent in
			C. glutamicum
		D287	D269
		F269	F251
MetA	E. coli	E252	D269
MetA	M. leprae	G73	analogous residue
			absent in
			C. glutamicum
		D278	D269
		Y260	D269
MetA	M. tuberculosis	G73	analogous residue
			absent in
			C. glutamicum
		Y260	F251
		D278	D269

MetA and MetY genes were cloned from C. glutamicum and T. fusca as described in Example 2. Table 11 lists the plasmids and strains used for the expression of wild-type and mutated alleles of MetA and MetY genes. Tables 12 and 13 list the plasmids used for expression and the oligonucleotides employed for site-directed mutagenesis to generate MetA and MetY variants.

EXAMPLE 7

Preparation of Protein Extracts for MetA and MetY Assays

A single C. glutamicum colony was inoculated into seed culture media (see example 10 below) and grown for 24 hour with agitation at 33 ° C. The seed culture was diluted 1:20 in production soy media (40 mL) (example 10) and grown 8 hours. Following harvest by centrifugation, the pellet was washed lx in 1 volume of water. The pellet was resuspended in 250 μl lysis buffer (1 ml HEPES buffer, pH 7.5, 0.5 ml 1M KOH, 10 μl 0.5M EDTA, water to 5ml), 30 μl protease inhibitor cocktail, and 1 volume of 0.1 mm acid washed glass beads. The mixture was alternately vortexed and held on ice for 15 seconds each for 8 reptitions. After centrifugation for 5′ at 4,000 rpm, the supernatant was removed and re-spun for 20′ at 10,000 rpm. The Bradford assay was used to determine protein concentration in the cleared supernatant.

EXAMPLE 8

Quantifying MetA Activity in C. glutamicum Strains Containing Episomal Plasmids

MetA activity in C. glutamicum expressing endogenous and episomal metA genes was determined. MetA activity was assayed in crude protein extracts using a protocol described by Kredich and Tomkins (J. Biol. Chem.241(21):4955-4965, 1966). Preparation of protein extracts is described in the Example 7. Briefly, 1 μg of protein extract was added to a microtiter plate. Reaction mix (250 μl; 100 mM tris-HCl pH 7.5, 2mM 5,5′-Dithiobis(2-nitrobenzoic acid) (DTN), 2 mM sodium EDTA, 2 mM acetyl CoA, 2 mM homoserine) was added to each well of the microtiter plate. In the course of the reactions, MetA activity liberates CoA from acetyl-CoA. A disulfide interchange occurs between the CoA and DTN to produce thionitrobenzoic acid. The production of thionitrobenzoic acid is followed spectrophotometrically. Absorbance at 412 nm was measured every 5 minutes over a period of 30 minutes. A well without protein extract was included as a control. Inhibition of MetA activity was determined by addition of S-adenosyl methionine (S-AM; 0.02 mM, 0.2 mM, 2 mM) and methionine (.5 mM, 5 mM, 50 mM). Inhibitors were added directly to the reaction mix before it was added to the protein extract. In vitro O-acetyltransferase activity was measured in crude protein extracts derived from C. glutamicum strains MA-442 and MA-449 which contain both endogenous and episomal C. glutamicum MetA and MetY genes. Episomal metA and metY genes were expressed as a synthetic operon; the nucleic acid sequence of the metAY operon is as shown in the metAYH operon of FIG. 12B, only lacking metH sequence. The trcRBS promoter was employed in these episomal plasmids. MA-442 expresses the episomal genes in the order metA-metY. MA-449 expresses the episomal genes in the order metY-metA. Experiments were performed in the presence and absence of IPTG that induces expression of the plasmid borne MetA and MetY genes. FIG. 13 shows a time course of MetA activity. MetA activity was observed only when the genes were in the MetA-MetY (MA-442) configuration in samples from 8 hour and 20 hour cultures. In contrast, MetA activity in extracts from strain MA-449 (MetY-MetA) was not significantly elevated relative to a control sample lacking protein at both 8 hour and 20 hour time points, with and without induction. This data is consistent with Northern blot analysis that showed low expression of metA when the two genes were in the metY-metA orientation.

Next, sensitivity of extracts from strain MA-442 to feedback inhibition was tested. MA-442 extracts were assayed in the presence of 5 mM methionine, 0.2 mM S-AM, or in the absence of additional methionine or S-AM, and MetA activity was assayed as described above. As shown in FIG. 14, MetA activity was reduced in the presence of 5 mM methionine and 0.2 mM S-AM. Thus, reducing allosteric repression of MetA may enhance MetA activity, allowing production of higher levels of methionine. It is possible that allosteric repression would also be observed at much lower levels of methionine or S-AM. Regardless, the levels tested are physiologically relevant levels in strains engineered for the production of amino acids such as methionine. C. glutamicum strains expressing episomal T. fusca MetA (strains MA-578 and MA-579), or both episomal T. fusca MetA and MetY (strains MA-456 and MA-570) were constructed and extracts were prepared from these strains and assayed for MetA activity. The regulatory elements associated with each episomal gene are listed in Table 12. The rate of MetA activity in extracts of each strain was determined by calculating the change in OD₄₁₂ divided by time per ng of protein. The results of these assays are depicted in FIG. 15, which shows that strain MA-578 exhibited a rate of approximately 2.75 units (change in OD₄₁₂ /time/ng protein) under inducing conditions, whereas the rate under non-inducing conditions was approximately 1. Strain MA-579 exhibited a rate of approximately 2.5 under inducing conditions and a rate of approximately 0.4 under non-inducing conditions. Strain MA-456, which expresses metA and metYunder the control of a constitutive promoter, exhibited a rate of approximately 2.2. Strain MA-570 exhibited a rate of approximately 1 under inducing conditions and a rate of 0.3 under non-inducing conditions. The negative control sample (no protein) exhibited a rate of approximately 0.1. These data show that episomal expression of T. fusca metA in C. glutamicum increases the rate of MetA activity. The increase was similar to the increase observed with episomal expression of C. glutamicum MetA in C. glutamicum.

EXAMPLE 9

Quantifying MetY Activity in C. glutamicum Strains Containing Episomal Plasmids

The in vitro activity of episomal T. fusca MetY was determined in several C. glutamicum strains. MetY activity was assayed in C. glutamicum crude protein extracts using a modified protocol of Kredich and Tomkins (J. Biol. Chem., 241(21):4955-4965, 1966). Crude protein extracts were prepared as described. Briefly, 900 μl of reaction mix (50 mM Tris pH 7.5, 1 mM EDTA, 1 mM sodium sulfide nonahydrate (Na₂S), 0.2mM pyridoxal-5-phosphoric acid (PLP) was mixed with 45 μg of protein extract. At time zero, O-acetyl homoserine (OAH; Toronto Research Chemicals Inc) was added to a final concentration of 0.625 mM. 200 μl of the reaction was removed immediately for the zero time point. The remainder of the reaction was incubated at 30° C. Three 200 μl samples were removed at 10 minute intervals. Immediately after removal from 30° C., the reactions were stopped by the addition of 125 μl 1 mM nitrous acid which nitrosates the thiol groups of homocysteine to form S-nitrosothiol. Five minutes later, 30 μl of 0.5% ammonium sulfamate (removes excess nitrous acid) was added and the sample vortexed. Two minutes later, 400 μl of detection solution (1 part 1% HgCl2 in 0.4N HCl, 4 parts 3.44% % sulfanilamide in 0.4N HCl, 2 parts 0.1% 1-naphthylethylenediamine dihydrochloride in 0.4N HCl) was added and the solution vortexed. In the presence of mercuric ion the S-nitrosothiol rapidly decomposes to give nitrous acid, diazotizing the sulfanilamide, which then couples with the naphthylethylenediamine to give a stable azo dye as a chromaphore. After 5 minutes, the solution was transferred to a microtiter dish and the absorbance at 540 nm was measured. A reaction without protein extract was included as a control.

The results of the assays are depicted in FIG. 16. Strain MA-456, which expresses episomal wild type T. fusca metA and metY alleles under the control of a constitutive promoter, exhibited a rate of 0.04. Strain MA-570, which expresses episomal wild type T. fusca metA and metY alleles under the control of an inducible promoter, exhibited a rate of approximately 0.038 under inducing conditions, and a rate of less than 0.01 under non-inducing conditions. Thus, expression of heterologous MetY results in enzyme activity that is significantly elevated over that of the endogenous MetY.

TABLE 11
C. glutamicum strains used to determine activity of MetA and MetY proteins,
and impact of overexpression on production of aspartate-derived amino acids.
			relevant
	relevant		plasmid	episomal	episomal
Strain	strain	episomal	regulatory	metY	metA
Name	genotype	plasmid	sequence	species	species
MA-2	n/a	n/a	n/a	n/a	n/a
(ATCC
13032)
MA-422	ethionine resistant	n/a	n/a	n/a	n/a
	variant of MA-2
MA-428	MA-2 derivative	n/a	n/a	n/a	n/a
	with Δhom- ΔthrB:: C
	glutamicum gpd promoter -
	S. coelicolor hom
	(G362E)a
MA-442	MA-428 derivative	MB-4135b	lacIQ-TrcRBS	Cg wild-type	Cg wild-type
MA-449	MA-428 derivative	MB-4138	lacIQ-TrcRBS	Cg wild-type	Cg wild-type
MA-456	MA-428 derivative	MB-4168	gpd	Tf wild-type	Tf wild-type
MA-570	MA-428 derivative	MB-4199	lacIQ-TrcRBS	Tf wild-type	Tf wild-type
MA-578	MA-428 derivative	MB-4205	gpd	none	Tf wild-type
MA-579	MA-428 derivative	MB-4207	lacIQ-TrcRBS	none	Tf wild-type
MA-622	mcbRΔ derivative of	n/a	n/a	n/a	n/a
	MA-422
MA-641	MA-622 derivative	MB-4136	gpd	Cg wild-type	Cg wild-type
MA-699	MA-622 derivative	n/a	n/a	n/a	n/a
MA-721	MA-622 derivative	MB-4236b	lacIQ-TrcRBS	Cg wild-type	Cg K233A
MA-725	MA-622 derivative	MB-4238b	lacIQ-TrcRBS	Cg D231A	Cg wild-type
MA-727	MA-622 derivative	MB-4239b	lacIQ-TrcRBS	Cg G232A	Cg wild-type
abbreviations - Cg (Coryneform glutamicum), Tf (Thermobifida fusca), lacIQ-TrcRBS (see above) (lacIQ-Trc regulatory sequence from pTrc99A (Amann et al., Gene (1988) 69:301-315)); gpd (C. glutamicum gpd promoter)
athe endogenous hom(thrA)-thrB locus was replaced with the S. coelicolor hom (G362E) sequence under the C. glutamicum gpd (glyceraldehyde-3-phosphate dehydrogenase) promoter
bin this plasmid the gene order is MetA-MetY. Unless otherwise indicated, in other plasmids the gene order is MetY-MetA

TABLE 12
Plasmids and oligos used for site directed mutagenesis
to generate MetA and MetY variants.
Plasmid	oligo 1	oligo 2	Gene	wt/variant	Organism
MB4238	MO4057	MO4058	metY	D231A	C. glutamicum
n/a	MO4045	MO4046	metY	D244A	T. fusca
n/a	MO4041	MO4042	metA	D287A	T. fusca
n/a	MO4049	MO4050	metY	D394A	T. fusca
n/a	MO4039	MO4040	metA	F269A	T. fusca
n/a	MO4047	MO4048	metY	F379A	T. fusca
MB4239	MO4059	MO4060	metY	G232A	C. glutamicum
n/a	MO4043	MO4044	metY	G240A	T. fusca
n/a	MO4037	MO4038	metA	G81A	T. fusca
MB4236	MO4051	MO4052	metA	K233A	C. glutamicum
MB4135	n/a	n/a	metA	wt	C. glutamicum
MB4135	n/a	n/a	metY	wt	C. glutamicum
MB4210	n/a	n/a	metY	wt	T. fusca
MB4210	n/a	n/a	metA	wt	T. fusca

TABLE 13
Sequences of oligos used for site-directed mutagenesis to generate
MetA and MetY variants.
Oligo name	Oligo Sequence	SEQ ID NO:
MO4037	5′ GTAGGCCCGGAAGGCCCCGCGCACCCCAGCCCAGGCTGG 3′	340
MO4038	5′ CCAGCCTGGGCTGGGGTGCGCGGGGCCTTCCGGGCGTAC 3′	341
MO4039	5′ CCGATGGCCGGGGGCGGGGCCGCTGTCGAGTCGTACCTG 3′	342
MO4040	5′ CAGGTACGACTCGACAGCGGCCCGGCCCCCGGCCATCGG 3′	343
MO4041	5′ AAACTCGCCCGCCGGTTCGCCGCGGGCAGCTACGTCGTG 3′	344
MO4042	5′ GACGACGTAGCTGCCCGCGGCGAACCGGCGGGCGAGTTT 3′	345
MO4043	5′ CACGGCACCACGATCGCGGCCATCGTGGTGGACGCCGGC 3′	346
MO4044	5′ GCCGGCGTCCACCACGATGGCCGCGATCGTGGTGCCGTG 3′	347
MO4045	5′ ATCGCGGGCATCGTGGTGGCCGCCGGCACCTTCGACTTC 3′	348
MO4046	5′ GAAGTCGAAGGTGCCGGCGGCCACCACGATGCCCGCGAT 3′	349
MO4047	5′ ATCGAGGCCGGACGCGCCGCCGTGGACGGCACCGAACTG 3′	350
MO4048	5′ CAGTTCGGTGCCGTCCACGGCGGCGCGTCCGGCGTCGAT 3′	351
MO4049	5′ CAGCTCGTCAACATCGGTGCCGTGCGCAGCCTCATCGTC 3′	352
MO4050	5′ GACGATGAGGCTGCGCACGGCACCGATGTTGACGAGCTG 3′	353
MO4051	5′ GACGAACGCTTCGGCACCGCAGCGCAAAAGAACGAAAAC 3′	354
MO4052	5′ GTTTTCGTTCTTTTGGGCTGCGGTGCCGAAGCGTTCGTC 3′	355
MO4057	5′ CTGGGCGGCGTGCTTATCGCCGGCGGAAAGTTCGATTGG 3′	356
MO4058	5′ CCAATCGAACTTTCCGCCGGCGATAAGCACGCCGCCCAG 3′	357
MO4059	5′ GGCGGCGTGCTTATCGACGCCGGAAAGTTCGATTGGACT 3′	358
MO4060	5′ AGTCCAATCGAACTTTCCGGCGTCGATAAGCACGCCGCC 3′	359

EXAMPLE 10

Methods for Producing and Detecting Aspartate-Derived Amino Acids

For shake flask production of aspartate-derived amino acids, each strain was inoculated from an agar plate into 10 ml of Seed Culture Medium in a 125 ml Erlenmeyer flask. The seed culture was incubated at 250 rpm on a shaker for 16 h at 31° C. A culture for monitoring amino acid production was prepared by performing a 1:20 dilution of the seed culture into 10 ml of Batch Production Medium in 125 ml Erlenmeyer flasks. When appropriate, IPTG was added to a set of the cultures to induce expression of the IPTG regulated genes (final concentration 0.25 mM). Methionine fermentations were carried out for 60-66 h at 31° C. with agitation (250 rpm). For the studies reported herein, in nearly all instances, multiple transformants were fermented in parallel, and each transformant was often grown in duplicate. Most reported data points reflect the average of at least two fermentations with a representative transformant, together with control strains that were grown at the same time.

After cultivation, amino acid levels in the resulting broths were determined using liquid chromatography-mass spectrometry (LCMS). Approximately 1 ml of culture was harvested and centrifuged to pellet cells and particulate debris. A fraction of the resulting supernatant was diluted 1:5000 into aqueous 0.1% formic acid and injected in 10 μL portions onto a reverse phase HPLC column (Waters Atlantis C18, 2.1×150 mm). Compounds were eluted at a flow rate of 0.350 mL min⁻¹, using a gradient mixture of 0.1% formic acid in acetonitrile (“B”) and 0.1% formic acid in water (“A”), (1% B→50% B over 4 minutes, hold at 50% B for 0.2 minutes, 50% B→1% over 1 minute, hold at 1% for 1.8 minutes). Eluting compounds were detected with a triple-quadropole mass spectrometer using positive electrospray ionization. The instrument was operated in MRM mode to detect amino acids (lysine: 147→84 (15 eV); methionine: 150→104 (12 eV); threonine/homoserine: 120→74 (10 eV); aspartic acid: 134→88 (15 eV); glutamic acid: 148→84 (15 eV); O-acetylhomoserine: 162→102 (12 eV); and homocysteine: 136→90 (15 eV)). On occasion, additional amino acids were quantified using similar methods (e.g. homocystine, glycine, S-adenosylmethionine). Individual amino acids were quantified by comparison with amino acid standards injected under identical conditions. Using this mass spectrometric method it is not possible to distinguish between homoserine and threonine. Therefore, when necessary, samples were also derivatized with a fluorescent label and subjected to liquid chromatography followed by fluorescent detection. This method was used to both resolve homoserine and threonine as well as to confirm concentrations determined using the LCMS method.

	Seed Culture Medium for Production Assays
	Glucose	100	g/L
	Ammonium acetate	3	g/L
	KH2PO4	1	g/L
	MgSO4-7H2O	0.4	g/L
	FeSO4-7H2O	10	mg/L
	MnSO4-4H2O	10	mg/L
	Biotin	50	μg/L
	Thiamine-HCl	200	μg/L
	Soy protein	15	ml/L
	Hydrolysate
	(total nitrogen 7%)
	Yeast extract	5	g/L
	pH 7.5
	Batch Production Medium for Production Assays
	Glucose	50	g/L
	(NH4)2SO4	45	g/L
	KH2PO4	1	g/L
	MgSO4-7H2O	0.4	g/L
	FeSO4-7H2O	10	mg/L
	MnSO4-4H2O	10	mg/L
	Biotin	50	μg/L
	Thiamine-HCl	200	μg/L
	Soy protein	15	ml/L
	hydrolysate
	(total nitrogen 7%)
	CaCO3	50	g/L
	Cobalamin	1	μg/ml
	pH 7.5
	(cobalamin addition not necessary when lysine is the target aspartate-derived amino acid)

EXAMPLE 11

Heterologous Wild-Type and Mutant lysC Variants Increase Lysine Production in C. glutamicum and B. lactofermentum.

Aspartokinase is often the rate-limiting activity for lysine production in corynebacteria. The primary mechanism for regulating aspartokinase activity is allosteric regulation by the combination of lysine and threonine. Heterologous operons encoding aspartokinases and aspartate semi-aldehyde dehydrogenases were cloned from M. smegmatis and S. coelicolor as described in Example 2. Site-directed mutagenesis was used to generate deregulated alleles (see Example 3), and these modified genes were inserted into vectors suitable for expression in corynebacteria (Example 1). The resulting plasmids, and the wild-type counterparts, were transformed into strains, including wild-type C. glutamicum strain ATCC 13032 and wild-type B. lactofermentum strain ATCC 13869, which were analyzed for lysine production (FIG. 17).

Strains MA-0014, MA-0025, MA-0022, MA-0016, MA-0008 and MA-0019 contain plasmids with the MB3961 backbone (see Example 1). Increased expression, via addition of IPTG to the production medium, of either wild-type or deregulated heterologous lysC-asd operons promoted lysine production. Strain ATCC 13869 is the untransformed control for these strains. The plasmids containing M. smegmatis S301Y, T311I, and G345D alleles were most effective at enhancing lysine production; these alleles were chosen for expression for expression from improved vectors. Improved vectors containing deregulated M. smegmatis alleles were transformed into C. glutamicum (ATCC 13032) to generate strains MA-0333, MA-0334, MA-0336, MA-0361, and MA-0362 (plasmids contain either trcRBS or gpd promoter, MB4094 backbone; see Example 1). Strain ATCC 13032 (A) is the untransformed control for strains MA-0333, MA-0334 and MA-0336. Strain ATCC 13032 (B) is the untransformed control for strains MA-0361 and MA-0362.Strains MA-0333, MA-0334, MA-0336, MA-0361, and MA-0362 all displayed improvement in lysine production. For example, strain MA-0334 produced in excess of 20 g/L lysine from 50 g/L glucose. In addition, the T31 11 and G345D alleles were shown to be effective when expressed from either the trcRBS or gpd promoter.

EXAMPLE 12

S. coelicolor hom G362E Variant Increases Carbon Flow to Homoserine in C. glutamicum Strain, MA-0331

As shown in Example 11, deregulation of aspartokinase increased carbon flow to aspartate-derived amino acids. In principle, aspartokinase activity could be increased by the use of deregulated lysC alleles and/or by elimination of the small molecules that mediate the allosteric regulation (lysine or threonine). FIG. 18 (strain MA-0331) shows that high levels of lysine accumulated in the broth when the hom-thrB locus was inactivated. Hom and thrB encode for homoserine dehydrogenase and homoserine kinase, respectively, two proteins required for the production of threonine. Lysine accumulation was also observed when only the thrB gene was deleted (see strain MA-0933 in FIG. 21 (MA-0933 is one example, though it is not appropriate to directly compare MA-0933 to MA-033 1, as these strains are from different genetic backgrounds).

In order to increase carbon flow to methionine pathway intermediates, a putative deregulated variant of the S. coelicolor hom gene was transformed into MA-0331. Similar strategies were used to engineer strains containing only the thrB deletion. Strains MA-0384, MA-0386, and MA-0389 contain the S. coelicolor homG362E variant under the control of the rplM, gpd, and trcRBS promoters, respectively. These plasmids also contain an additional substitution (G43S) that was introduced as part of the site-directed mutagenesis strategy; subsequent experiments suggested that the G43S substitution does not enhance Hom activity. FIG. 18 shows the results from shake flask experiments performed using strains MA-0331, MA-0384, MA-0386, and MA-0389, in whichbroths were analyzed for aspartate-derived amino acids, including lysine and homoserine. Strains expressing the S. coelicolor homG362E gene display a dramatic decrease in lysine production as well as a significant increase in homoserine levels. Broth levels of homoserine were in excess of 5 g/L in strains such as MA-0389. It is possible that significant levels of homoserine still remain within the cell or that some homoserine has been converted to additional products. Overexpression of deregulated lysC and other genes downstream of hom, together with hom, may increase production of homoserine-based amino acids, including methionine (see below).

EXAMPLE 13

Heterologous Phosphoenolpyruvate Carboxylase (Ppc) Enzymes Increase Carbon Flow to Aspartate-Derived Amino Acids

Phosphoenolpyruvate carboxylase (Ppc), together with pyruvate carboxylase (Pyc), catalyze the synthesis of oxaloacetic acid (OAA), the citric acid cycle intermediate that feeds directly into the production of aspartate-derived amino acids. The wild-type E. chrysanthemi ppc gene was cloned into expression vectors under control of the IPTG inducible trcRBS promoter. This plasmid was transformed into high lysine strains MA-033 1 and MA-0463 (FIG. 19). Strains were grown in the absence or presence of IPTG and analyzed for production of aspartate-derived amino acids, including aspartate. Strain MA-0331 contains the hom-thrBA mutation, whereas MA-0463 contains the M. smegmatis lysC (T311I)-asd operon integrated at the deleted hom-thrB locus; the lysC-asd operon is under control of the C. glutamicum gpd promoter. FIG. 19 shows that the E. chrysanthemippc gene increased the accumulation of aspartate. This difference was even detectable in strains that converted most of the available aspartate into lysine.

EXAMPLE 14

Heterologous Dihydrodipicolinate Synthases (dapA) Enzymes Increase Lysine Production

Dihydrodipicolinate synthase is the branch point enzyme that commits carbon to lysine biosynthesis rather than to the production of homoserine-based amino acids. DapA converts aspartate-B-semialdehyde to 2,3-dihydrodipicolinate. The wild-type E. chrysanthemi and S. coelicolor dapA genes were cloned into expression vectors under the control of the trcRBS and gpd promoters. The resulting plasmids were transformed into strains MA-0331 and MA-0463, two strains that had already been engineered to produce high levels of lysine (see Example 13). MA-0463 was engineered for increased expression of the M. smegmatis lysC(T311I)-asd operon. This manipulation is expected to drive production of aspartate-B-semialdehyde, the substrate for the DapA catalyzed reaction. Strains MA-0481, MA-0482, MA-0472, MA-0501, MA-0502, MA-0492, MA-0497 were grown in shake flask, and the broths were analyzed for aspartate-derived amino acids, including lysine. As shown in FIG. 20, increased expression of either the E. chrysanthemi or S. coelicolor dapA gene increases lysine production in the MA-0331 and MA-0463 backgrounds. Strain MA-0502 produced nearly 35 g/L lysine in a 50 g/L glucose process. It may be possible to engineer further lysine improvements by constructing deregulated variants of these heterologous dapA genes.

EXAMPLE 15

Constructing Strains that Produce High Levels of Homoserine

Strains that produce high levels of homoserine-based amino acids can be generated through a combination of genetic engineering and mutagenesis strategies. As an example, five distinct genetic manipulations were performed to construct MA-1378, a strain that produces >10 g/L homoserine (FIG. 21). To generate MA-1378, wild-type C. glutamicum was first mutated using nitrosoguanidine (NTG) mutagenesis (based on the protocol described in “A short course in bacterial genetics.” J. H. Miller. Cold Spring Harbor Laboratory Press. 1992, page 143) followed by selection of colonies that grew on minimal plates containing high levels of ethionine, a toxic methionine analog. The endogenous mcbR locus was then deleted in one of the resulting ethionine-resistant strains (MA-0422) using plasmid MB4154 in order to generate strain MA-0622. McbR is a transcriptional repressor that regulates the expression of several genes required for the production of sulfur-containing amino acids such as methionine (see Rey, D. A., Puhler, A., and Kalinowski, J., J. Biotechnology 103:51-65, 2003). In several instances we observed that inactivation of McbR generated strains with increased levels of homoserine-based amino acids. Plasmid MB4084 was utilized to delete the thrB locus in MA-0622, causing the accumulation of lysine and homoserine; methionine and methionine pathway intermediates also accumulated to a lesser degree. MA-0933 resulted from this manipulation. As described above, it is believed that the lysine and homoserine accumulation was a result of deregulation of lysC, via the lack of threonine production. In order to further optimize carbon flow to aspartate-B-semialdehyde and downstream amino acids, MA-0933 was transformed with an episomal plasmid expressing the M. smegmatis lysC (T311I)-asd operon (strain MA-162). High homoserine producing strain MA-1 162 was then mutagenized with NTG, and colonies were selected on minimal medium plates containing a level of methionine methylsulfonium chloride (MMSC) that is normally inhibitory to growth. MA-1378 was one such MMSC-resistant strain.

EXAMPLE 16

Heterologous Homoserine Acetyltransferases (MetA) Enzymes Increase Carbon Flow to Homoserine-Based Amino Acids

MetA is the commitment step to methionine biosynthesis. The wild-type T. fusca metA gene was cloned into an expression vector under the control of the trcRBS promoter. This plasmid was transformed into high homoserine producing strains to test for elevated MetA activity (FIGS. 22 and 23). MA-0428, MA-0933, and MA-1514 were example high homoserine producing strains. MA-0428 is a wild-type ATCC 13032 derivative that has been engineered with plasmid MB4192 (see Example 1) to delete the hom-thrB locus and integrate the gpd-S. coelicolor hom(G362E) expression cassette. MA-1514 was constructed by using novobiocin to allow for loss of the M. smegmatis lysC(T311I)-asd operon plasmid from strain MA-1378. This manipulation was performed to allow for transformation with the episomal plasmid containing the T. fusca metA gene and the kanR selectable marker. Strain MA-1559 resulted from the transformation of strain MA-1514 with the T. fusca metA gene under control of the trcRBS promoter. MA-0933 is as described in Example 15. Induction of T. fusca metA expression in each of these high homoserine strains resulted in accumulation of O-acetylhomoserine in culture broths. For example, strain MA-1559 displayed OAH levels in excess of 9 g/L. Additional manipulations can be performed to elicit conversion of OAH to other products, including methionine.

EXAMPLE 17

Effects of metA Variants on Methionine Production in C. glutamicum

C. glutamicum homoserine acetyltransferase (MetA) variants were generated by site-directed mutagenesis of MetA-encoding DNA (Example 6). C. glutamicum strains MA-0622 and MA-0699 were transformed with a high copy plasmid, MB4236, that encodes MetA with a lysine to alanine mutation at position 233 (MetA (K233A)). This plasmid also contains a wild-type copy of the C. glutamicum metY gene. Strain MA-0699 was constructed by transforming MA-0622 with plasmid MB4192 to delete the hom-thrB locus and integrate the gpd- S. coelicolor hom(G362E) expression cassette. metA and metYare expressed in a synthetic metAY operon under control of a modified version of the trc promoter. The strains were cultured in the presence and absence of IPTG induction, and methionine productivity was assayed. Methionine production from each strain is plotted in FIG. 24. As shown, individual transformants of MA-622 and MA-699, when cultured under inducing conditions, each produced over 3000 μM methionine. MA-699 strains, which express an S. coelicolor hom G362E variant under the control of a constitutive promoter, produced over 3000 μM methionine in the absence of IPTG. IPTG induction resulted in an increased methionine production by 1000-2500 μM. These data show that expression of MetA (K233A) enhances methionine production. Manipulation of methionine biosynthesis at multiple points can further enhance production.

EXAMPLE 17

Effects of metY Variants on Methionine Production in C. glutamicum

C. glutamicum O-acetylhomoserine sulfhydrylase (MetY) variants were generated by site-directed mutagenesis of MetY-encoding DNA (Example 6). C. glutamicum strain MA-622 and strain MA-699 were transformed with a high copy plasmid, MB4238, that encodes MetY with an aspartate to alanine mutation at position 231 (MetY (D231A)). This plasmid also contains the wild-type copy of the C. glutamicum metA gene, expressed as in Example 16. The strains were cultured in the presence and absence of IPTG induction, and methionine productivity was assayed. The methionine production from each strain is plotted in FIG. 25. As shown, individual transformants of MA-622, when cultured under conditions in which expression of MetY (D231A) was induced, each produced over 1800 μM methionine. MA-622 strains showed variation in the levels of methionine produced by individual transformants (i.e., transformants 1 and 2 produced approx. 1800 μM methionine when induced, whereas transformants 3 and 4 produced over 4000 μM methionine when induced). MA-699 strains, which express an S. coelicolor Hom variant, produced approximately 3000 μM methionine in the absence of IPTG. IPTG induction increased methionine production by 1500-2000 μM. These data show that expression of MetY (D231A) enhances methionine production. Methionine production was also enhanced in strain MA-699, relative to MA-622. Expression of MetY (D231A) in strain MA-699 further enhanced methionine production in that strain.

A second variant allele of metY was expressed in C. glutamicum and assayed for its effect on methionine production. C. glutamicum strain MA-622 and strain MA-699 were transformed with a high copy plasmid, MB4239, that encodes MetY with a glycine to alanine mutation at position 232 (MetY (G232A)). The strains were cultured in the presence and absence of IPTG induction, and methionine productivity was assayed. The methionine production from each strain is plotted in FIG. 26. As shown, individual transformants of MA-622, when cultured under conditions in which expression of MetY (G232A) was induced, each produced over 1700 μM methionine. MA-699 strains produced approximately 3000 μM methionine in the absence of IPTG. IPTG induction resulted in an increased methionine production by 2000-3000 μM. These data show that expression of MetY (G232A) enhances methionine production. Methionine production was also enhanced in strain MA-699, relative to MA-622. Expression of MetY (G232A) in strain MA-699 further enhanced methionine production in that strain.

EXAMPLE 18

Methionine Production in C. glutamicum Strains Expressing metA and metY Wild-Type and Mutant Alleles

Methionine production was assayed in five different C. glutamicum strains. Four of these strains express a unique combination of episomal C. glutamicum metA and metY alleles, as listed in Table 14. A fifth strain, MA-622, does not contain episomal metA or metY alleles. The amount of methionine produced by each strain (g/L) is listed in Table 14.

The highest levels of methionine production were observed in strains expressing a combination of either a wild-type metA and a variant metY, or a wild-type metY and a variant metA.

TABLE 14
Methionine production in strains expressing
C. glutamicum metA and metY wild-type and mutant alleles
				methionine
Strain	IPTG	metA allele	metY allele	(g/L)
MA-622	−	None	none	0.00
MA-641	−	WT	WT	0.03
MA-721	−	K233A	WT	0.00
MA-721	+	K233A	WT	0.53
MA-725	−	WT	D231A	0
MA-725	+	WT	D231A	0.28
MA-727	−	WT	G232A	0
MA-727	+	WT	G232A	0.37

EXAMPLE 19

Combinations of Genetic Manipulations, Using Both Heterologous and Native Genes, Elicits Production of Aspartate-Derived Amino Acids

As described above, gene combinations may optimize corynebacteria for the production of aspartate-derived amino acids. Below are examples that show how multiple manipulations can increase the production of methionine. FIG. 27 shows the production of several aspartate-derived amino acids by strains MA-2028 and MA-2025 along with titers from their parent strains MA-1906 and MA-1907, respectively. MA-1906 was constructed by using plasmid MB4276 to delete the native pck locus in MA-0622 and replace pck with a cassette for constitutive expression of the M. smegmatis lysC(T311I)-asd operon. MA-1907 was generated by similar transformation of MB4276 into MA-0933. MA-2028 and MA-2025 were constructed by transformation of the respective parents with MB4278, an episomal plasmid for inducible expression of a synthetic C. glutamicum metA YH operon (see Example 3). Parent strains MA-1906 and MA-1907 produce lysine or lysine and homoserine, respectively; methionine and methionine pathway intermediates are also produced by these strains. The scale for lysine and homoserine is on the left y-axis; the scale for methionine and O-acetylhomoserine is on the right y-axis. With IPTG induction, MA-2028 showed a decrease in lysine levels and an increase in methionine levels. MA-2025 also displayed an IPTG-dependent decrease in lysine production, together with increased production of methionine and O-acetylhomoserine. Strain MA-1743 is another example of how combinatorial engineering can be employed to generate strains that produce methionine. MA- 1743 was generated by transformation of MA-1667 with metAYHexpression plasmid MB4278. MA-1667 was constructed by first engineering strain MA-0422 (see Example 15) with plasmid MB4084 to delete thrB, and next using plasmid MB4286 to both delete the mcbR locus and replace mcbR with an expression cassette containing trcRBS-T. fusca metA. In this example and in other examples where trcRBS has been integrated at single copy, expression does not appear to be as tightly regulated as seen with the episomal plasmids (as judged by amino acid production). Thismay be due to decreased levels of the laclq inhibitor protein. IPTG induction of strain MA- 1743 elicits production of methionine and pathway intermediates, including O-acetylhomoserine (FIG. 28; the scale for lysine and homoserine is on the left y-axis; the scale for methionine and O-acetylhomoserine is on the right y-axis).

Strains MA-1688 and MA-1790 are two additional strains that were engineered with multiple genes, including the MB4278 metAYH expression plasmid (see FIG. 29; the scale for lysine and homoserine is on the left y-axis; the scale for methionine and O-acetylhomoserine is on the right y-axis). Transforming MA-0569 with MB4278 generated MA-1688. MA-0569 was constructed by sequentially using MB4192 and MB4165 to first delete the hom-thrB locus and integrate the gpd-S. coelicolor hom(G362E) expression cassette and then delete mcbR. MA-1790 construction required several steps. First, a NTG mutant derivative of MA-0428 was identified based on its ability to allow for growth of a Salmonella metE mutant. In brief, a population of mutagenized MA-0428 cells was plated onto a minimal medium containing threonine and a lawn (>106 cells of the Salmonella metE mutant). The Salmonella metE mutant requires methionine for growth. After visual inspection, the corynebacteria colonies (e.g. MA-0600) surrounded by a halo of Salmonella growth were isolated and subjected to shake flask analysis. Strain MA-600 was next mutagenized to ethionine resistance as described above, and one resulting strain was designated MA-0993. The mcbR locus was then deleted from MA-0993 using plasmid MB4165, and MA-1421 was the product of this manipulation. Transformation of MA-1421 with MB4278 generated MA-1 790. FIG. 29 shows that IPTG induction stimulates methionine production in both MA-1688 and MA-1790, and decreases in lysine and homoserine titers.

FIG. 30 shows the metabolite levels of strain MA-1668 and its parent strains. The scale for lysine and homoserine is on the left y-axis; the scale for methionine and O-acetylhomoserine is on the right y-axis. Strain MA-1668 was generated by transformation of MA-0993 with plasmid MB4287. Manipulation with MB4287 results in deletion of the mcbR locus and replacement with C. glutamicum metA(K233A)-metB. Strain MA-1668 produces approximately 2 g/L methionine, with decreased levels of lysine and homoserine relative to its progenitor strains. Strain MA-1 668 is still amenable to further rounds of molecular manipulation.

Table 15 lists the strains used in these studies. The ‘::’ nomenclature indicates that the expression construct following the ‘::’ is integrated at the named locus prior to the ‘::’. EthR6 and EthR10 represent independently isolated ethionine resistant mutants. The Mcf3 mutation confers the ability to enable a Salmonella metE mutant to grow (see example 19). The Mms13 mutation confers methionine methylsulfonium chloride resistance (see example 15).

TABLE 15
Strains used in studies described herein.
Name    Strain Genotype
MA-0002 is ATCC 13032
MA-0003 is ATCC 13869
MA-0008 lacIq-trc-S. coelicolor lysC-asd(A191V) (episomal)
MA-0014 lacIq-trc-M. smegmatis lysC-asd (episomal)
MA-0016 lacIq-trc-M. smegmatis lysC (G345D)-asd (episomal)
MA-0019 lacIq-trc-S. coelicolor lysC (S314I)-asd (A191V) (episomal)
MA-0022 lacIq-trc-M. smegmatis lysC (T311I)-asd (episomal)
MA-0025 lacIq-trc-M. smegmatis lysC (S301Y)-asd (episomal)
MA-0331 Δhom-ΔthrB
MA-0333 lacIq-trcRBS-M. smegmatis lysC (S301Y)-asd (episomal)
MA-0334 lacIq-trcRBS-M. smegmatis lysC (T311I)-asd (episomal)
MA-0336 lacIq-trcRBS-M. smegmatis lysC (G345D)-asd (episomal)
MA-0361 gpd-M. smegmatis lysC (T311I)-asd (episomal)
MA-0362 gpd-M. smegmatis lysC (G345D)-asd (episomal)
MA-0384 Δhom-ΔthrB + rplM-S. coelicolor hom (G362E; G43S) (episomal)
MA-0386 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) (episomal)
MA-0389 Δhom-ΔthrB + lacIq-trcRBS-S. coelicolor hom (G362E; G43S; K19N) (episomal)
MA-0422 EthR6
MA-0428 Δhom-ΔthrB::gpd-S. coelicolor hom (G362E; G43S)
MA-0442 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) + lacIq-trcRBS-C.
        glutamicum metA-RBS-C. glutamicum metY (episomal)
MA-0449 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) + lacIq-trcRBS-C.
        glutamicum metY-RBS-C. glutamicum metA (episomal)
MA-0456 Δhom-ΔthrB::gpd-S. coelicolor hom (G362E; G43S) + gpd-T. fusca metY-RBS-T.
        fusca metA (episomal)
MA-0463 Δhom-ΔthrB::gpd-M. smegmatis lysC (T311I)-asd
MA-0466 Δhom-ΔthrB + lacIq-trcRBS-E. chrysanthemi ppc (episomal)
MA-0472 Δhom-ΔthrB + gpd-S. coelicolor dapA (episomal)
MA-0477 Δhom-ΔthrB + lacIq-trcRBS-S. coelicolor dapA (episomal)
MA-0481 Δhom-ΔthrB + gpd-E. chrysanthemi dapA (episomal)
MA-0482 Δhom-ΔthrB + lacIq-trcRBS-E. chrysanthemi dapA (episomal)
MA-0486 Δhom-ΔthrB::gpd-M. smegmatis lysC (T311I)-asd + lacIq-trcRBS-E.
        chrysanthemi ppc (episomal)
MA-0492 Δhom-ΔthrB::gpd-M. smegmatis lysC (T311I)-asd + gpd-S. coelicolor dapA
        (episomal)
MA-0497 Δhom-ΔthrB::gpd-M. smegmatis lysC (T311I)-asd + lacIq-trcRBS-S. coelicolor
        dapA (episomal)
MA-0501 Δhom-ΔthrB::gpd-M. smegmatis lysC (T311I)-asd + gpd-E. chrysanthemi dapA
        (episomal)
MA-0502 Δhom-ΔthrB::gpd-M. smegmatis lysC (T311I)-asd + lacIq-trcRBS-E.
        chrysanthemi dapA (episomal)
MA-0569 ΔmcbR + Δhom-ΔthrB::gpd-S. coelicolor hom (G362E; G43S)
MA-0570 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) + lacIq-trcRBS-T. fusca
        metY-RBS-T. fusca metA (episomal)
MA-0578 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) + gpd-T. fusca metA
        (episomal)
MA-0579 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) + lacIq-trcRBS-T. fusca
        metA (episomal)
MA-0600 Δhom-ΔthrB + gpd-S. coelicolor hom (G362E; G43S) + Mcf3
MA-0622 ΔmcbR + EthR6
MA-0641 ΔmcbR + EthR6 + gpd-C. glutamicum metA-RBS-C. glutamicum metY (episomal)
MA-0699 ΔcbR + EthR6 + Δhom-ΔthrB::gpd-S. coelicolor hom (G362E)
MA-0721 ΔmcbR + EthR6 + lacIq-trcRBS-C. glutamicum metA (K233A)-RBS-C.
        glutamicum metY (episomal)
MA-0725 ΔmcbR + EthR6 + lacIq-trcRBS-C. glutamicum metA-RBS-C. glutamicum metY
        (D231A) (episomal)
MA-0727 ΔmcbR + EthR6 + lacIq-trcRBS-C. glutamicum metA-RBS-C. glutamicum metY
        (G232A) (episomal)
MA-0933 ΔthrB + ΔmcbR + EthR6
MA-0993 Δhom-ΔthrB::gpd-S. coelicolor hom (G362E; G43S) + Mcf3 + EthR10
MA-1162 ΔthrB + ΔmcbR + EthR6 + lacIq-trcRBS-M. smegmatis lysC (T311I)-asd (episomal)
MA-1351 ΔthrB + ΔmcbR + EthR6 + lacIq-trcRBS-T. fusca metA (episomal)
MA-1378 ΔthrB + ΔmcbR + EthR6 + Mms13 + lacIq-trcRBS-M. smegmatis lysC (T311I)-asd
MA-1421 Δhom-ΔthrB::gpd S. coelicolor hom (G362E; G43S) + ΔmcbR + Mcf3 + EthR10
MA-1514 ΔthrB + ΔmcbR + EthR6 + Mms13
MA-1559 ΔthrB + ΔmcbR + EthR6 + Mms13 + lacIq-trcRBS-T. fusca metA (episomal)
MA-1667 ΔthrB + EthR6 + ΔmcbR::lacIq-trcRBS-T. fusca metA (episomal)
MA-1668 Δhom-ΔthrB::gpd-S. coelicolor hom (G362E; G43S) + ΔmcbR::lacIq-trcRBS-
        C. glutamicum metA (K233A)-RBS-C. glutamicum metB + Mcf3 + EthR10
MA-1688 ΔmcbR + Δhom-ΔthrB::gpd-S. coelicolor hom (G362E; G43S) + lacIq-trcRBS-C.
        glutamicum metA-RBS-C. glutamicum metY-RBS-C. glutamicum metH
        (episomal)
MA-1743 ΔthrB + ΔmcbR::lacIq-trcRBS-T. fusca metA + EthR6 + lacIq-trcRBS-C.
        glutamicum metA-RBS-C. glutamicum metY-RBS-C. glutamicum metH
        (episomal)
MA-1790 Δhom-ΔthrB::gpd-S. coelicolor hom
        (G362E; G43S) + ΔmcbR + Mcf3 + EthR10 + lacIq-trcRBS-C. glutamicum metA-
        RBS-C. glutamicum-metY-RBS-C. glutamicum-metH (episomal)
MA-1906 ΔmcbR + EthR6 + Δpck::gpd-M. smegmatis lysC (T311I)-asd
MA-1907 ΔmcbR + EthR6 + Δpck::gpd-M. smegmatis lysC (T311I)-asd + ΔthrB
MA-2025 ΔmcbR + EthR6 + Δpck::gpd-M. smegmatis lysC (T311I)-asd + ΔthrB + lacIq-
        trcRBS-C. glutamicum metA-RBS-C. glutamicum metY-RBS-C. glutamicum
        metH (episomal)
MA-2028 ΔmcbR + EthR6 + Δpck::gpd-M. smegmatis lysC (T311I)-asd + lacIq-trcRBS-C.
        glutamicum metA-RBS-C. glutamicum metY-RBS-C. glutamicum metH
        (episomal)

TABLE 16
Amino acid sequences of exemplary heterologous proteins for amino acid
production in Escherichia coli and coryneform bacteria.
The NC number under the Gene column corresponds to the
Genbank ® protein record for the corresponding Corynebacterium
glutamicum gene.
		GenBank ®		SEQ
Gene	Organism	Protein ID	Amino Acid Sequence	ID NO:
lysC	Mycobacterium	CAA78984	MALVVQKYGGSSVADAERIRRVAERIVETKKAGNDVVVVVSA	1
	smegmatis		MGDTTDDLLDLARQVSPAPPPREMDMLLTAGERISNALVAMA
			IESLGAQARSFTGSQAGVITTGTHGNAKIIDVTPGRLRDALD
			EGQIVLVAGFQGVSQDSKDVTTLGRGGSDTTAVAVAAALDAD
			VCEIYTDVDGIFTADPRIVPNARHLDTVSFEEMLEMAACGAK
			VLMLRCVEYARRYNVPIHVRSSYSDKPGTIVKGSIEDIPMED
			AILTGVAHDRSEAKVTVVGLPDVPGYAAKVFRAVAEADVNID
			MVLQNISKIEDGKTDITFTCARDNGPRAVEKLSALKSEIGFS
			QVLYDDHIGKVSLIGAGMRSHPGVTATFCEALAEAGINIDLI
			STSEIRISVLIKDTELDKAVSALHEAFGLGGDDEAVVY
			AGTGR
lysC	Amycolatopsis	AAD49567	MALVVQKYGGSSLESADRIKRVAERIVATKKAGNDVVVVCSA	2
	mediterranei		MGDTTDELLDLAQQVNPAPPEREMDMLLTAGERISNSLVAMA
			IAAQGAEAWSFTGSQAGVVTTSVHGNARIIDVTPSRVTEALD
			QGYIALVAGFQGVAQDTKDITTLGRGGSDTTAVALAAALNAD
			VCEIYSDVDGVYTADPRVVPDAKKLDTVTYEEMLELAASGSK
			ILHLRSVEYARRYGVPIRVRSSYSDKPGTTVTGSIEEIPVEQ
			ALITGVAHDRSEAKITVTGVPDHTGAAARIFRVIADAEIDID
			MVLQNVSSTVSGRTDITFTLSKANGAKAVKELEKVQAEIGFE
			SVLYDDHVGKVSVVGAGMRSHPGVTATFCEALAEAGVNIEII
			NTSEIRISVLIRDAQLDDAVRAIHEAFELGGDEEAVV
			YAGSGR
lysC	Streptomyces	CAB45482	MGLVVQKYGGSSVADAEGIKRVAKRIVEAKKNGNQVVAVVSA	3
	coelicolor		MGDTTDELIDLAEQVSPIPAGRELDMLLTAGERISMALLAMA
			IKNLGHEAQSFTGSQAGVITDSVHNKARIIDVTPGRIRTSVD
			EGNVAIVAGFQGVSQDSKDITTLGRGGSDTTAVALAAALDAD
			VCEIYTDVDGVFTADPRVVPKAKKIDWISFEDMLELAASGSK
			VLLHRCVEYARRYNIPIHVRSSFSGLQGTWVSSEPIKQGEKH
			VEQALISGVAHDTSEAKVTVVGVPDKPGEAAAIFRAIADAQV
			NIDMVVQNVSAASTGLTDISFTLPKSEGRKAIDALEKNRPGI
			GFDSLRYDDQIGKISLVGAGMKSNPGVTADFFTALSDAGVNI
			ELISTSEIRISVVTRKDDVNEAVRAVHTAFGLDSDSDEAVVY
			GGTGR
lysC	Thermobifida	ZP_00057166	MNLRSLDWLVDYREPDSSGAPTVALIVQKYGGSSVADADAIK	4
	fusca		RVAERIVAQKKAGYDVVVVVSAMGDTTDELLDLAKQVSPLPP
			GRELDMLLTAGERISMALVAMAIGNLGYEARSFTGSQAGVIT
			TSLHGNAKIIDVTPGRIRDALAEGAICIVAGFQGVSQDSKDI
			TTLGRGGSDTTAVALAAALNADLCEIYTDVDGVFTADPRIVP
			SARRIPQISYEEMLEMAASGAKILHLRCVEYARRYNIPLNVR
			SSFSQKPGTWVVSEVEETEGMEQPIISGVAHDRSEAKITVVG
			VPDRVGEAAAIFKALADAEINVDMIVQNVSAASTSRTDISFT
			LPADSGQNALAALKKIQDKVGFESLLYNDRIGKVSLIGAGMR
			SYPGVTARFFDAVAREGINIEMISTSEIRISIVVAQDDVDAA
			VAAAHREFQLDADQVEAVVYGGTGR
lysC	Erwinia		MSANTDNSLIIAKFGGTSVADFDAMNRSADIVLSDAQVRVVV	5
	chrysenthemi		LSASAGVTNLLVALAEGLPPSERTAQLEKLRQTQYAIIDRLN
			QPAVIREEIDRMLDNVARLSEAAALATSNALTDELVSHGELI
			STLLFVEILRERNVAAEWFDVRKIMRTNDRFGRAEPDCDALG
			ELTRSQLTPRLAQGLIITQGFIGSEAKGRTTTLGRGGSDYTA
			ALLGEALHASRIDIWTDVPGIYTTDPRVVPSAHRIDQITFEE
			AAEMATFGAKVLHPATLLPAVRSDIPVFVGSSKDPAAGGTLV
			CNNTENPPLFPALALRRKQTLLTLHSLNNLHARGFLAEVFSI
			LARHNISVDLITTSEVNVALTLDTTGSTSTGDSLLSSALLTE
			LSSLCRVEVEENMSLVALIGNQLSQACGVGKEVFGVLEPFNI
			RLICYGASSHNLCFLVPSSDAEQVVQTLHHNLFE
lysC	Shewanella	AAN56424	MLEKRKLSGSKLFVKKFGGTSVGSIERIEVVAEQIAKSAHSG	6
	oneidensis		EQQVLVLSAMAGETNRLFALAAQIDPPASARELDMLVSTGEQ
			ISIALMAMALQRRGIKARSLTGDQVQIHTNSQFGRASIESVD
			TAYLTSLLEQGIVPIVAGFQGIDPNGDVTTLGRGGSDTTAVA
			LAAALRADECQIFTDVSGVFTTDPNIDSSARRLDVIGFDVML
			EMAKLGAKVLHPDSVEYAQRFKVPLRVLSSFEAGQGTLIQFG
			DESELAMAASVQGIAINKALATLTIEGLFTSSERYQALLACL
			ARLEVDVEFITPLKLNEISPVESVSFMLAEAKVDILLHELEV
			LSESLDLGQLIVERQRAKVSLVGKGLQAKVGLLTKMLDVLGN
			ETIHAKLLSTSESKLSTVIDERDLHKAVRALHHAFELNKV
lysC	Corynebacterium	CAD89081	MALVVQKYGGSSLESAERIRNVAERIVATKKAGNDVVVVCSA	202
	glutamicum		MGDTTDELLELAAAVNPVPPAREMDMLLTAGERISNALVAMA
			IESLGAEAQSFTGSQAGVLTTERHGNARIVDVTPGRVREALD
			EGKICIVAGFQGVNKETRDVTTLGRGGSDTTAVALAAALNAD
			VCEIYSDVDGVYTADPRIVPNAQKLEKLSFEEMLELAAVGSK
			ILVLRSVEYAPAFNVPLRVRSSYSNDPGTLIAGSMEDIPVEE
			AVLTGVATDKSEAKVTVLGISDKPGEAAKVFPALADAEINID
			MVLQNVSSVEDGTTDITFTCPRSDGRRAMEILKKLQVQGNWT
			NVLYDDQVGKVSLVGAGMKSHPGVTAEFMEALRDVNVNIELI
			STSEIRISVLIREDDLDAAAPALHEQFQLGGEDEAV
			VYAGTGR
asparto	Escherichia	AAA24095	MSEIVVSKFGGTSVADFDAMNRSADIVLSDANVRLVVLSASA	203
kinase	coli		GITNLLVALAEGLEPGERFEKLDAIRNIQFAILERLRYPNVI
			REEIERLLENITVLAEAAALATSPALTDELVSHGELMSTLLF
			VEILRERDVQAQWFDVRKVMRTNDRFGRAEPDIAALAELAAL
			QLLPRLNEGLVITQGFIGSENKGRTTTLGRGGSDYTAALLAE
			ALHASRVDIWTDVPGIYTTDPRVVSAAKRIDEIAFAEAAEMA
			TFGAKVLHPATLLPAVRSDIPVFVGSSKDPRAGGTLVCNKTE
			NPPLFRALALRRNQTLLTLHSLNMLHSRGFLAEVFGILARHN
			ISVDLITTSEVSVALTLDTTGSTSTGDTLLTQSLLMELSALC
			RVEVEEGLALVALIGNDLSKACGVGKEVFGVLEPFNIRMICY
			GASSHNLCFLVPGEDAEQVVQKLHSNLFE
asd	Corynebacterium	CAA40504	MTTIAVVGATGQVGQVMRTLLEERNFPADTVRFFASPRSAGR	204
	glutamicum		KIEFRGTEIEVEDITQATEESLKDIDVALFSAGGTASKQYAP
			LFAAAGATVVDNSSAWRKDDEVPLIVSEVNPSDKDSLVKGII
			ANPNCTTMAANPVLKPLHDAAGLVKLHVSSYQAVSGSGLAGV
			ETLAKQVAAVGDHNVEFXTHDGQAADAGDVGPYVSPIAYNVLP
			FAGNLVDDGTFETDEEQKLRNESRKILGLPDLKVSGTCVRVP
			VFTGHTLTIHAEFDKAITVDQAQEILGAASGVKLVDVPTPLA
			AAGIDESLVGRIRQDSTVDDNRGLVLVVSGDNLRKGAALNTI
			QIAELLVK
asd	Escherichia	P00353	MKNVGFIGWRGMVGSVLMQRMVEERDFDAIRPVFFSTSQLGQ	205
	coli		AAPSFGGTTGTLQDAFDLEALKALDIIVTCQGGDYTNEIYPK
			LRESGWQGYWIDAASSLRMKDDAIIILDPVNQDVITDGLNNG
			IRTFVGGNCTVSLMLMSLGGLFANDLVDWVSVATYQAASGGG
			ARHMRELLTQMGHLYGHVADELATPSSATLDIERKVTTLTRS
			GELPVDNFGVPLAGSLIPWIDKQLDNGQSREEWKGQAETNKI
			LNTSSVIPVDGLCVRVGALRCHSQAFTIKLKKDVSIPTVEEL
			LAAHNPWAKVVPNDREITMRELTPAAVTGTLTTPVGRLRKLN
			MGPEFLSAFTVGDQLLWGAAEPLRRMLRQLA
ppc	Thermobifida	ZP_00058586	MTRDSARQEMPDQLRRDVRLLGEMLGTVLAESGGQDLLDDVE	7
	fusca		RLRRAVIGAREGTVEGKEITELVASWPLERAKQVARAFTVYF
			HLVNLAEEHHRMRALRERDDAATPQRESLAAAVHSIREDAGP
			ERLRELIAGMEFHPVLTAHPTEARRRAVSTAIQRISAQLERL
			HAAHPGSGAEAEARRRLLEEIDLLWRTSQLRYTKMDPLDEVR
			TAMAAFDETIFTVIPEVYRSLDPALDPEGCGRRPALAKAFVR
			YGSWIGGDRDGNPFVTHEVTREAITIQSEHVLRALENACERI
			GRTHTEYTGLTPPSAELRAALSSARAAYPRLMQEIIKRSPNE
			PHRQLLLLAAERLRATRLRNADLGYPNPEAFLADLRTVQESL
			AAAGAVRQAYGELQNLIWQAETFGFHLAELEIRQHSAVHAAA
			LKEIRAGGELSERTEEVLATLRVVAWIQERFGVEACRRYIVS
			FTQSADDIAAVYELAEHAMPPGKAPILDVIPLFETGADLDAA
			PQVLDGMLRLPAVQRRLEQTGRRMEVMLGYSDSAKDVGPVSA
			TLRLYDAQARLAEWAREHDIKLTLFHGRGGALGRGGGPANRA
			VLAQAPGSVDGRFKVTEQGEVIFARYGQRAIAHRHIEQVGHA
			VLMASTESVQRRAAEAAARFRGMADRIAEAAHAAYRALVDTE
			GFAEWFSRVSPLEELSELRLGSRPARRSAARGLDDLRAIPWV
			FAWTQTRVNLPGWYGLGSGLAAVDDLEALHTAYKEWPLFASL
			LDNAEMSLAKTDRVIAERYLALGGRPELTEQVLAEYDRTREL
			VLKVTRHTRLLENRRVLSRAVDLRNPYVDALSHLQLRALEAL
			RTGEADRLSEEDRNHLERLLLLSVNGVAAGLQNTG
ppc	Mycobacterium	CAC30086	MVEFSDAILEPIGAVQRTRVGREATEPMRADIRLLGTILGDT	8
	leprae (can be		LREQNGDEVFDLVERVRVESFRVRRSEIDRADMARMFSGLDI
	used to clone		HLAIPIIRAFSHFALLANVAEDIHRERRRHIHLDAGEPLRDS
	M. smegmatis		SLAATYAKLDLAKLDSATVADALTGAVVSPVITAHPTETRRR
	gene)		TVFVTQRRITELMRLHAEGHTETADGRSIERELRRQILTLWQ
			TALIRLARLQISDEIDVGLRYYSAALFHVIPQVNSEVRNALR
			ARWPDAELLSGPILQPGSWIGGDRDGNPNVTADVVRRATGSA
			AYTVVAHYLAELTHLEQELSMSARLITVTPELATLAASCQDA
			ACADEPYRRALRVIRGRLSSTAAHILDQQPPNQLGLGLPPYS
			TPAELCADLDTIEASLCTHGAALLADDRLALLREGVGVFGFH
			LCGLDMRQNSDVHEEVVAELLAWAGMHQDYSSLPEDQRVKLL
			VAELGNRRPLVGDRAQLSDLARGELAVLAAAAHAVELYGSAA
			VPNYIISMCQSVSDVLEVAILLKETGLLDASGSQPYCPVGIS
			PLFETIDDLHNGAAILHAMLELPLYRTLVAARGNWQEVMLGY
			SDSNKDGGYLAANWAVYRAELALVDVARKTGIRLRLFHGRGG
			TVGRGGGPSYQAILAQPPGAVNGSLRLTEQGEVIAAKYAEPQ
			IARRNLESLVAATLESTLLDVEGLGDAAESAYAILDEvAGLA
			RRSYAELVNTPGFVDYFQASTPVSEIGSLNIGNRPTSRKPTT
			SIADLRAIPWVLAWSQSRVMLPGWYGTGSAFQQWVAAGPESE
			SQRVEMLHDLYQRWPFFRSVLSNMAQVLAKSDLGLAARYAEL
			VVDEALRRRVFDKIADEHRRTIAIHKLITGHDDLLADNPALA
			RSVFNRFPYLEPLNHLQVELLRRYRSGHDDEMVQRGILLTMN
			GLASALRNSG
ppc	Streptomyces	Q9RNU9	MSSADDQTTTTTSSELRADIRRLGDLLGETLVRQEGPELLEL	9
	coelicolor		VEKVRRLTREDGEAAAELLRGTELETAAKLVRAFSTYFHLAN
			VTEQVHRGRELGAKRAAEGGLLARTADRLKDADPEHLRETVR
			NLNVRPVFTAHPTEAARRSVLNKLRRIAALLDTPVNESDRRR
			LDTRLAENIDLVWQTDELRVVRPEPADEARNAIYYLDELHLG
			AVGDVLEDLTAELERAGVKLPDDTRPLTFGTWIGGDRDGNPN
			VTPQVTWDVLILQHEHGINDALEMIDELRGFLSNSIRYAGAT
			EELLASLQADLERLPEISPRYKRLNAEEPYRLKATCIRQKLE
			NTKQRLAKGTPHEDGRDYLGTAQLIDDLRIVQTSLREHRGGL
			FADGRLARTIRTLAAFGLQLATMDVREHADAHHHALGQLFDR
			LGEESWRYADMPREYRTKLLAKELRSRRPLAPSPAPVDAPGE
			KTLGVFQTVRRALEVFGPEVIESYIISMCQGADDVFAAAVLA
			REAGLIDLHAGWAKIGIVPLLETTDELKAADTILEDLLADPS
			YRRLVALRGDVQEVMLGYSDSSKFGGITTSQWEIHRAQRRLR
			DVAHRYGVRLRLFHGRGGTVGRGGGPTHDAILAQPWGTLEGE
			IKVTEQGEVISDKYLIPALARENLELTVAATLQASALHTAPR
			QSDEALARWDAANDVVSDAAHTAYRHLVEDPDLPTYFLASTP
			VDQLADLHLGSRPSRRPGSGVSLDGLRAIPWVFGWTQSRQIV
			PGWYGVGSGLKALREAGLDTVLDEMHQQWHFFRNFISNVEMT
			LAKTDLRIAQHYVDTLVPDELKHVFDTIKAEHELTVAEVLRV
			TGESELLDADPVLKQTFTIRDAYLDPISYLQVALLGRQREAA
			AANEDPDPLLARALLLTVNGVAAGLRNTG
ppc	Erwinia		MNEQYSAMRSNVSMLGKLLGDTIKDALGANILERVETIRKLS	10
	chrysanthemi		KASPAGSETHRQELLTTLQNLSNDELLPVARAFSQFLNLTNT
			AEQYNSISPHGEAASNPEALATVFRSLKSRDNLSDKDIRDAV
			ESLSIELVLTAHPTEITRRTLIHKLVEVNTCLKQLDHDDLAD
			YERHQIMRRLRQLIAQYWHTDEIRKIRPTPVDEAKWGFAVVE
			NSLWEGVPAFLRELDEQMGKELGYRLFVDSVPVRFTSWMGGD
			RDGNPNVTSEVTRRVLLLSRWKAADLFLRDVQVLVSELSMTT
			CTPELQQLAGGDEVQEPYRELMKALRAQLTATLDYLDARLKD
			EQRMPPKDLLVTNEQLWEPLYACYQSLHACGMGIIADGQLLD
			TLRRVRCFGVPLVRIDVRQESTRHTDALAEITRYLGLGDYES
			WSESDKQAFLIRELNSKRPLLPRQWEPSADTQEVLETCRVIA
			ETPRDSIAAYVISMARTPSDVLAVHLLLKEAGCPYALPVAPL
			FETLDDLNNADSVMIQLLNIDWYRGFIQGKQMVMIGYSDSAK
			DAGVMAASWAQYRAQDALIKTCEKYGIALTLFHGRGGSIGRG
			GAPAHAALLSQPPGSLKGGLRVTEQGEMIRFKFGLPEVTISS
			LSLYTSAILEANLLPPPEPKQEWHHIMNELSRISCDMYRGYV
			RENPDFVPYFRAATPELELGKLPLGSRPAKRRPNGGVESLRA
			IPWIFAWTQNRLMLPAWLGAGAALQKVIDDGHQNQLEAMCRD
			WPFFSTRIGMLEMVFAKAIJLWLAEYYDQRLVDEKLWSLGKQL
			REQLERDIKAVLTISNDDHLMADLPWIAESIALRNVYTDPLN
			VLQAELLHRSRQQETLDPQVEQALMVTIAGVAAGMRNTG
ppc	Coryne-	P12880	MTDFLRDDIRFLGQILGEVIAEQEGQEVYELVEQARLTSFDI	206
	bacterium		AKGNAEMDSLVQVFDGITPAKATPIARAFSHFALLANLAEDL
	glutamicum		YDEELREQALDAGDTPPDSTLDATWLKLNEGNVGAEAVADVL
			RNAEVAPVLTAHPTETRRRTVFDAQKWITTHMRERHALQSAE
			PTARTQSKLDEIEKNIRRRITILWQTALIRVARPRIEDEIEV
			GLRYYKLSLLEEIPRINRDVAVELRERFGEGVPLKPVVKPGS
			WIGGDHDGNPYVTAETVEYSTHPAAETVLKYYARQLHSLEHE
			LSLSDRMNKVTPQLLALADAGHNDVPSRVDEPYRRAVHGVRG
			RILATTAELIGEDAVEGVWFKVFTPYASPEEFLNDALTIDHS
			LRESKDVLIADDRLSVLISAlESFGFNLYALDLRQNSESYED
			VLTELFERAQVTANYRELSEAEKLEVLLKELRSPRPLIPHGS
			DEYSEVTDRELGIFRTASEAVKKFGPRMVPHCIISMASSVTD
			VLEPMVLLKEFGLIAANGDNPRGTVDVIPLFETIEDLQAGAG
			ILDELWKIDLYRNYLLQRDNVQEVMLGYSDSMWGGYFSANW
			ALYDAELQLVELCRSAGVKLRLFHGRGGTVGRGGGPSYDAIL
			AQPRGAVQGSVRITEQGEIISAKYGNPETARRNLEALVSATL
			EASLLDVSELTDHQRAYDIMSEISELSLKKYASLVHEDQGFI
			DYFTQSTPLQEIGSLNIGSRPSSRKQTSSVEDLRAIPWVLSW
			SQSRVMLPGWFGVGTALEQWIGEGEQATQRIAELQTLNESWP
			FFTSVLDNMAQVMSKAELRLAKLYADLIPDTEVAERVYSVIR
			EEYFLTKKMFCVITGSDDLLDDNPLLARSVQRRYPYLLPLNV
			IQVEMMRRYRKGDQSEQVSRNIQLTMNGLSTALRNSG
ppc	Escherichia	P00864	MNEQYSALRSNVSMLGKVLGETIKDALGEHILERVETIRKLS	207
	coli		KSSRAGNDANRQELLTTLQNLSMDELLPVAPAFSQFLNLANT
			AEQYHSISPKGEAASNPEVIARTLRKLK&QPELSEDTIKKAV
			ESLSLELVLTAHPTEITRRTLIHKMVEVNACLKQLDNKDlAD
			YEHNQLMRRLRQLIAQSWHTDEIRKLRPSPVDEAKWGFAVVE
			NSLWQGVPNYLRELNEQLEENLGYKLPVEFVPVRFTSWMGGD
			RDGNPNVTADITRHVLLLSRWKATDLFLKDIQVLVSELSMVE
			ATPELLALVGEEGAAEPYRYLMKNLRSRLMATQAWLEARLKG
			EELPKPEGLLTQNEELWEPLYACYQSLQACGMGIIANGDLLD
			TLRRVKCFGVPLVRIDIRQESTRHTEALGELTRYLGIGDYES
			WSEADKQAFLIRELNSKRPLLPRNWQPSAETREVLDTCQVIA
			EAPOGSIAAYVISMAKTPSDVLAVHLLLKEAGIGFAMPVAPL
			FETLDDLNNANDVMTQLLNIDWYRGLIQGKQMVMIGYSDSAK
			DAGVMAASWAQYQAQDALIKTCEKAGIELTLFHGRGGSIGRG
			GAPAHAALLSQPPGSLKGGLRVTEQGEMIRFKYGLPEITVSS
			LSLYTGAILEANLLPPPEPKESWRRIMDELSVISCDVYRGYV
			RENKDFVPYFRSATPEQELGKLPLGSRPAKRRPTGGVESLRA
			IPWIFAWTQNRLMLPAWLGAGTALQKVVEDGKQSELEAMCRD
			WPFFSTRLGMLEMVFAKADLWLAEYYDQRLVDKALWPLGKEL
			RNLQEEDIKVVLAIANDSHLMADLPWIAESIQLRNIYTDPLN
			VLQAELLHRSRQAEKEGQEPDPRVEQALMVTIAGIA
			AGMRNTG
pyc	Streptomyces	CAB59603	MFRKVLVANRGEIAIRAFRAGYELGARTVAVFPHEDRNSLHR	12
	coelicolor		LKADEAYEIGEQGHPVRAYLSVEEIVRAARRAGADAVYPGYG
			FLSENPELARACEEAGITFVGPSARILELTGNKARAVAAARE
			AGVPVLGSSAPSTDVDELVRAADDVGFPVFVKAVAGGGGRGM
			RRVEEPAQLREAIEAASREAASAFGDSTVFLEKAVVEPRHIE
			VQILADGEGDVIHLFERDCSVQRRHQKVIELAPAPNLDPALR
			ERICADAVNFARQIGYRNAGTVEFLVDRDGNHVFIEMNPRIQ
			VEHTVTEEVTDVDLVQSQLRIAAGQTLADLGLAQENITLRGA
			ALQCRITTEDPANGFRPDTGQISAYRSPGGSGIRLDGGTTHA
			GTEISAHFDSMLVKLSCRGRDFTTAVNRARPAVAEFRIRGVA
			TNIPFLQAVLDDPDFQAGRVTTSFIEQRPHLLTARHSADRGT
			KLLTYLADVTVNKPHGERPELVDPLTKLPTASAGEPPAGSRQ
			LLAELGPEGFARRLRESSTIGVTDTTFRDAHQSLLATRVRTK
			DMLAVAPVVARTLPQLLSLECWGGATYDVALRFLAEDPWERL
			AALREAVPNLCLQMLLRGRNTVGYTPYPTEVTDAFVQEAAAT
			GIDIFRIFDALNDVEQMRPAIEAVRQTGSAVAEVALCYTADL
			SDPSERLYTLDYYLRLAEQIVNAGAHVLAVKDMAGLLRAPAA
			ATLVSALRREFDLPVHLHTHDTTGGQLATYLAAIQAGADAVD
			GAVASMAGTTSQPSLSAIVAATDHTERPTGLDLQAVGDLEPY
			WESVRKVYAPFEAGLASPTGRVYHHEIPGGQLSNLRTQAVAL
			GLGDRFEDIEAMYAAADRMLGRLVKVTPSSKVVGDLALHLVG
			AGVSPADFEQDPDRFDIPDSVVGFLRGELGTPPGGWPEPFRS
			KALRGRAEARPLAELSEDDRDGLGKDRRATLNRLLFPGPARE
			FDTHRASYGDTSILDSKDFFYGLRPGKEYTVDLDPGVRLLIE
			LQAVGDADERGMRTVMSSLNGQLRPIQVRDRSAATDVPVTEK
			ADRANPGHVAAPFAGVVTLAVAEGDEVEAGATVATIEAMKME
			ASITAPKSGTVTRLAINRIQQVEGGDLLVQLA
pyc	Mycobacterium	AAG30411.1	MISKVLVANRGEIAIRAFRAAYEMGIATVAVYPYEDRNSLHR	13
	smegmatis		LKADESYQIGEVGHPVRAYLSVDEIIRVAKHSGADAVYPGYG
			FLSENPDLAAKCAEAGITFVGPSAEVLQLTGNKAPAIAAARA
			AGLPVLSSSEPSSSVDELMAAAADMEFPLFVKAVSGGGGRGM
			RRVTDRESLAEAIEAASREAESAFGDASVYLEQAVLNPRHIE
			VQILADGAGNVMHLFERDCSVQRRHQKVVELAPAPNLSDELR
			QQICADAVAFARQIGYSCAGTVEFLLDERGHHVFIECNPRIQ
			VEHTVTEEITDVDLVSSQLRIAAGETLADLGLSQDRLVVRGA
			AMQCRITTEVPANGFRPDTGRITAYRSPGGAGIRLDGGTNLG
			ARISAHFDSMLVKLTCRGRDFSAAASRARRALAEFRIRGVST
			NIPFLQAVIDDPDFPAGRVTTSFIDDRPHLLTSRSPADRGTR
			ILNYLADITVNKPHGERPSTVYPQDKLPPLDLQAPPPAGSKQ
			RLVELGPEGFAGWLRESKAVGVTDTTFRDAHQSLLATRVRTT
			GLLMVAPYVARSMPQLLSIECWGGATYDVALRFLKEDPWERL
			AALRESVPNICLQMLLRGRNTVGYTPYPELVTSAFVEEAAAT
			GIDIFRIFDALNNVESMRPAIDAVRETGSTIAEVAMCYTGDL
			SDPAENLYTLDYYLKLAEQIVEAGAHVLAIKDMAGLLPAPAA
			HTLVSALRSRFDLPVHVHTHDTPGGQLATYLAAWSAGADAVD
			GASAPMAGTTSQPALSSIVAAAAHTQYDTGLDLRAVCDLEPY
			WEAVRKVYAPFESGLPGPTGRVYTHEIPGGQLSNLRQQAIAL
			GLGDRFEEIEANYAAADRVLGRLVKVTPSSKVVGDLALALVG
			AGITAEEFAEDPAKYDIPDSVIGFLRGELGDPPGGWPEPLRT
			KALQGRGPARPVEKLTADDEALLAQPGPKRQAALNRLLFPGP
			TAEFEAHRETYGDTSSLSANQFFYGLRYGEEHRVQLERGVEL
			LIGLEAISEADERGMRTVMCIINGQLRPVLVRDRSIASEVPA
			AEKADRNNADHIAAPFAGVVTVGVAEGDSVDAGQTIATIEAM
			KMEAAITAPKAGTVARVAVAATAQVEGGDLLVVVS
pyc	Coryne-	CAA70739	MSTHTSSTLPAFKKILVANRGEIAVRAFRAALETGAATVAIY	208
	bacterium		PREDRGSFHRSFASEAVRIGTEGSPVKAYLDIDEIIGAAKKV
	glutamicum		KADAIYPGYGFLSENAQLARECAENGITFIGPTPEVLDLTGD
			KSRAVTAAKKAGLPVLAESTPSKNIDEIVKSAEGQTYPIFVK
			AVAGGGGRGMRFVASPDELRKLATEASREAEAAFGDGAVYVE
			RAVINPQHIEVQILGDHTGEVVHLYERDCSLQRRHQKVVEIA
			PAQHLDPELRDRICADAVKFCRSIGYQGAGTVEFLVDEKGNH
			VFIEMNPRIQVEHTVTEEVTEVDLVKAQMRLAAGATLKELGL
			TQDKIKTHGAALQCRITTEDPNNGFRPDTGTITAYRSPOGAG
			VRLDGAAQLGGEITAHFDSMLVKMTCRGSDFETAVAPAQRAL
			AEFTVSGVATNIGFLRALLREEDFTSKRIATGFIADHPHLLQ
			APPADDEQGRILDYLADVTVNKPHGVRPKDVAAPIDKLPNIK
			DLPLPRGSRDRLKQLGPAAFARDLREQDALAVTDTTFRDAHQ
			SLLATRVRSFALKPAAEAVAKLTPELLSVEAWGGATYDVANR
			FLFEDPWDRLDELREAMPNVNIQMLLRGRNTVGYTPYPDSVC
			RAFVKEAASSGVDIFRIFDALNDVSQMRPAIDAVLETNTAVA
			EVANAYSGDLSDPNEKLYTLDYYLKMAEEIVKSGAHILAIKD
			MAGLLRPAAVTKLVTALRREFDLPVHVHTHDTAGGQLATYFA
			AAQAGADAVDGASAPLSGTTSQPSLSAIVAAFAHTRRDTGLS
			LEAVSDLEPYWEAVRGLYLPFESGTPGPTGRVYRHEIPGGQL
			SNLRAQATALGLADRFELIEDNYAAVNEMLGRPTKVTPSSKV
			VGDLALHLVGAGVDPADFAADPQKYDIPDSVIAFLRGELGNP
			PGGWPEPLRTRALEGRSEGKAPLTEVPEEEQAHLDADDSKER
			RNSLNRLLFPKPTEEFLEHRRRFGNTSALDDREFFYGLVEGR
			ETLIRLPDVRTPLLVRLDAISEPDDKGMRNVVANVNGQIRPM
			RVRDRSVESVTATAEKADSSNKGHVAAPFAGVVTVTVAEGDE
			VKAGDAVAIIEAMKMEATITASVDGKIDRVVVPAATKVEGGD
			LIVVVS
dapA	Thermobifida	ZP_00058970	MVGSTTPNAPFGQMLTANITPMLDNGEVDYDGVARLATYLVD	14
	fusca		EQRNDGLIVNGTTGESATTSDEEKERILRTVIDAVGDRATIV
			AGAGSNDTRHSIELARTAERAGADGLLLVTPYYNRPPQEGLL
			RHFTAIADATGLPIMLYDIPGRTGTPIDSETLVRLAEHPRIV
			ANKDAKDDLGASSWVMSRTDLAYYSGSDMLNLPLLSIGAAGF
			VSVVGHVVGSELHDMIDAYRAGDVARALDIHRRLIPVYRGMF
			RTQGVITTKAVLAMFGLPAGVVRAPLLDASPELKELLREDLA
			MAGVKGPTGLASAHEDAASGREAERLTEGTA
dapA	Mycobacterium	CAC30464	MTTVGFDVPARLGTLLTANVTPFDADGSVDTAAATRLANRLV	15
	leprae (can be		DAGCDGLVLSGTTGESPTTTDDEKLQLLRVVLEAVGDRARVI
	used to clone		AGAGSYDTAHSVRLVKACAGEGAHGLLVVTPYYSKPPQTGLF
	M. smegmatis		AHFTAVADATELPVLLYDTPGRSVVPIEPDTIRALASHPNIV
	gene)		GVKEAKADLYSGARIMADTGLAYYSGDDALNLPWLAVGAIGF
			ISVISHLAAGQLRELLSAFGSGDITTARKINVAIGPLCSAMD
			RLGGVTMSKAGLRLQGIDVGDPRLPQMPATAEQIDELAVDMR
			AASVLR
dapA	Mycobacterium	CAA15549	MTTVGFDVAARLGTLLTAMVTPFSGDGSLDTATAARLANHLV	16
	tuberculosis		DQGCDGLVVSGTTGESPTTTDGEKIELLRAVLEAVGDRARVI
	(can be used to		AGAGTYDTAHSIRLAKACAAEGAHGLLVVTPYYSKPPQRGLQ
	clone M.		AHFTAVADATELPMLLYDIPGRSAVPIEPDTIRALASHPNIV
	smegmatis		GVKDAKADLHSGAQIMADTGLAYYSGDDALNLPWLAMGATGF
	gene)		ISVIAHLAAGQLRELLSAFGSGDIATARKINIAVAPLCNAMS
			RLGGVTLSKAGLRLQGIDVGDPRLPQVAATPEQIDALAADMR
			AASVLR
dapA	Streptomyces	CAA20295	MAPTSTPQTPFGRVLTAMVTPFTADGALDLDGAQRLAAHLVD	17
	coelicolor		AGNDGLIINGTTGESPTTSDAEKADLVRAVVEAVGDRAHVVA
			GVGTNNTQHSIELARAAERVGAHGLLLVTPYYNKPPQEGLYL
			HFTAIADAAGLPVMLYDIPGRSGVPINTETLVRLAEHPRIVA
			NKDAKGDLGRASWAIARSGLAWYSGDDMLNLPLLAVGAVGFV
			SVVGHVVTPELRAMVDAHVAGDVQKALEIHQKLLPVFTGMFR
			TQGVMTTKGALALQGLPAGPLRAPMVGLTPEETEQLKIDLAA
			GGVQL
dapA	Erwinia		MFTGSIVALVTPMDDKGAVDRASLKKLIDYHVASGTSAIVSV	18
	chrysanthemi		GTTGESATLSHDEHGDVVMLTLELSDGRIPVIAGTGANSTAE
			AISLTQRFNDTGVAGCLTVTPYYNKPTQNGLFLHFKAIAEHT
			DLPQILYNVPSRTGCDMLPETVARLSEIKNIVAIKEATGNLS
			RVSQIQELVHEDFILLSGDDASSLDFMQLGGDGVISVTANIA
			AREMAALCELAAQGNFVEARRLNQRLMPLHQKLFVEPNPIPV
			KWACKALGLMATDTLRLPMTPLTDAGRDVMEQAMKQAGLL
dapA	Coryne-	C40626	MSTGLTAKTGVEHFGTVGVAMVTPFTESGDIDIAAGREVAAY	126
	bacterium		LVDKGLDSLVLAGTTGESPTTTAAEKLELLKAVREEVGDRAK
	glutamicum		LIAGVGTNNTRTSVELAEAAASAGADGLLVVTPYYSKPSQEG
			LLAHFGAIAAATEVPICLYDIPGRSGIPIESDTMRRLSELPT
			ILAVKDAKGDLVAATSLIKETGLAWYSGDDPLNLVWLALGGS
			GFISVIGHAAPTALRELYTSFEEGDLVRAREINAKLSPLVAA
			QGRLGGVSLAKAALRLQGINVGDPRLPIMAPNEQELEALRED
			MKKAGVL
dapA	Escherichia	NP_416973	MFTGSIVAIVTPMDEKGNVCRASLKKLIDYHVASGTSAIVSV	127
	coli		GTTGESATLNHDEHADVVMMTLDLADGR
			IPVIAGTGANATAEAISLTQRFNDSGIVGCLTVTPYYNRPSQ
			EGLYQHFKAIAEHTDLPQILYNVPSRTGCDLLPETVGRLAKV
			KNIIGIKEATGNLTRVNQIKELVSDDFVLLSGDDASALDFMQ
			LGGHGVISVTANVAARDMAQMCKLAAEGHFAEARVINQRLMP
			LHNKLFVEPNPIPVKWACKELGLVATDTLRLPMTPITDSGRE
			TVRAALKHAGLL
hom	Streptomyces	CAC33918	MRTRPLKVALLGCGVVGSKVARIMTTHAADLAARIGAPVELA	19
	coelicolor		GVAVRRPDKVREGIDPALVTTDATALVKRGDIDVVVEVIGGI
			EPARTLITTAFAHGASVVSANKALIAQDGAALHAAADEHGKD
			LYYEAAVAGAIPLIRPLRESLAGDKVNRVLGIVNGTTNFILD
			AMDSTGAGYQEALDEATALGYAEADPTADVEGFDAAAKAAIL
			AGIAFHTRVRLDDVYREGMTEVTAADFASAKEMGCTIKLLAI
			CERAADGGSVTARVHPAMIPLSHPLANVREAYNAVFVESDAA
			GQLMFYGPGAGGSPTASAVLGDLVAVCRNRLGGATGPGESAY
			AALPVSPMGDVVTRYHISLDVADKPGVLAQVATVFAEHGVSI
			DTVRQSGKDGEASLVVVTHRASDAALGGTVEALRKLDTVRGV
			ASIMRVEGE
hom	Mycobacterium	AAD32592	MSKKPIGVAVLGLGNVGSEVVRIIADSADDLAARIGAPLELR	20
	smegmatis		GVGVRRVADDRGVPTELLTDDIDALVSRDDVDIVVEVMGPVE
			PARKAILSALEQGKSVVTANKALMAMSTGELAQAAEKAHVDL
			YFEAAVAGAIPVIRPLTQSLAGDTVRRVAGIVNGTTNYILSE
			MDSTGADYTSALADASALGYAEADPTADVEGYDAAAKAAILA
			SIAFHTRVTADDVYREGITTVSAEDFASAPALGCTIKLLAIC
			ERLTSDEGKDRVSARVYPALVPLTHPLAAVNGAFNAVVVEAE
			AAGRLMFYGQGAGGAPTAFAVMGDVVMAARNRVQGGRGPRES
			KYAKLPIAPIGFIPTRYYVISIMNVADRPGVLSAVAAEF
hom	Thermobifida	ZP_00058460	MRRPEPAGAADRGRTRPRHRRTGGHHPLRGRHGQGRGGDPHL	21
	fusca		CQCRRRYERQHPHPAVRCGVHLCAGLAAQRRRADAVPPGRQA
			LRERRHRRARPLPPCRPASRRPGSSGRHRRLLLLHGQQLQPR
			APACRGRGPREERPRPGATG~RRRPVAAGRRLSSGRRRSGHH
			DEVLDTDNERRNGSHPLMALKVALLGCGVVGSQVVRLLNEQS
			RELAERIGTPLEIGGIAVRRLDRARGTGVDPDLLTTDANGLV
			TRDDIDLVVEVIGGIEPARSLILAAIQKGKSVVTANKALLAE
			DGATTHAAAREAGVDVYYEASVAGAIPLLRPLRDSLAGDRVN
			RVLGIVNGTTNYILDRMDSLGAGFTESLEEAQALGYAEADPT
			ADVEGFDAAAKAAILARLAFHTPVTAADVHREGITEVSAADI
			ASAKAMGCVVKLLAICQRSDDGSSIGVRVHPVMLPREHPLAS
			VKGAYNAVFVEAESAGQLMFYGAGAGGVPTASAVLGDLVAVA
			RNRLARTFVADGRADAKLPVHPMGETITSYHVALDVADRPGV
			LAGVAKVFAANGVSIKHVRQEGRGDDAQLVLVSHTAPDAALA
			RTVEQLRNHEDVRAVASVMRVETFDNER
hom	Coryne-	CAA68614	MTSASAPSFNPGKGPGSAVGIALLGFGTVGTEVMRLMTEYGD	209
	bacterium		ELAHRIGGPLEVRGIAVSDISKPREGVAPELLTEDAFALIER
	glutamicum		EDVDIVVEVIGGIEYPREVVLAALKAGKSVVTANKALVAAHS
			AELADAAEAANVDLYFEAAVAGAIPVVGPLRRSLAGDQIQSV
			MGIVNGTTNFILDAMDSTGADYADSLAEATRLGYAEADPTAD
			VEGHDAASKAAILASIAFHTRVTADDVYCEGISNISAADIEA
			AQQAGHTIKLLAICEKFTNKEGKSAISARVHPTLLPVSHPLA
			SVNKSFNAIFVEAEAAGRLMFYGNGAGGAPTASAVLGDVVGA
			ARNKVHGGRAPGESTYANLPIADFGETTTRYHLDMDVEDRVG
			VLAELASLFSEQGISLRTIRQEERDDDARLIVVTHSALESDL
			SRTVELLKAKPVVKAINSVIRLERD
metL	Escherichia	CAA23585	SVIAQAGAKGRQLHKFGGSSLADVKCYLRVAGIMAEYSQPDD	210
(bifunctional;	coli		MMVVSAAGSTTNRLISWLKLSQTDRLSAHQVQQTLRRYQCDL
contains			ISGLLPAEEADSLISAFVSDLERLAALLDSGINDAVYAEVVG
hom			HGEVWSARLMSAVLNQQGLPAAWLDAREFLRAERAAQPQVDE
activity)			GLSYPLLQQLLVQHPGKRLVVTGFISRNNAGETVLLGRNGSD
			YSATQIGALAGVSRVTIWSDVAGVYSADPRKVKDACLLPLLR
			LDEASELARLAAPVLHARTLQPVSGSEIDLQLRCSYTPDQGS
			TRIERVLASGTGARIVTSHDDVCLIEFQVPASQDFKLGHKEI
			DQILKRAQVRPLAVGVHNDRQLLQFCYTSEVADSALKILDEA
			GLPGELRLRQGLALVAMVGAGVTRNPLHCHRFWQQLKGQPVE
			FTWQSDDGISLVAVLRTGPTESLIQGLHQSVFPAEKRIGLVL
			FGKGNIGSRWLELFAREQSTLSARTGFEFVLAGVVDSRRSLL
			SYDGLDASRALAFFNDEAVEQDEESLFLWMRAHPYDDLVVLD
			VTASQQLADQYLDFASHGFHVISANKLAGASDSNKYRQIHDA
			FEKTGRHWLYNATVGAGLPINHTVRDLIDSGDTILSISGIFS
			GTLSWLFLQFDGSVPFTELVDQAWQQGLTEPDPRDDLSGKDV
			SRKLVILAREAGYNIEPDQVRVESLVPAHCEGGSIDHFFENG
			DELNEQMVQRLEAAREMGLVLRYVARFDANGKARVGVEAVRE
			DHPLRSLLPCDNVFAIESRWYRDNPLVIRGPGAGRDVTAGAI
			QSDINRLAQLL
thrA	Escherichia	AAA97301	MRVLKFGGTSVANAERFLRVADILESNARQGQVATVLSAPAK	211
(bifunctional;	coli		ITNHLVAMIEKTISGQDALPNISDAERIFAELLTGLAAAQPG
contain			FPLAQLKTFVDQEFAQIKHVLHGISLLGQCPDSINAALICRG
hom			EKMSIATMAGVLEARGHNVTVIDPVEKLLAVGHYLESTVDIA
activity			ESTRRIAASRIPADHMVLMAGFTAGNEKGELVVLGRNGSDYS
			AAVLAACLRADCCETWTDVDGVYTCDPRQVPDARLLKSMSYQ
			EAMELSYFGAKVLHPRTITPIAQFQIPCLIKNTGNPQAPGTL
			IGASRDEDELPVKGISNLNNMAMFSVSGPGMKGMVGMAARVF
			AANSRARISVVLITQSSSEYSISFCVPQSDCVRAERANQEEF
			YLELKEGLLEPLAVTERLAIISVVGDGMRTLRGISAKFFAAL
			ARANINIVAIAQGSSERSISVVVNNDDATTGVRVTHQMLFNT
			DOVIEVFVIGVGGVGGALLEQLKRQQSWLKNKNIDLRVCGVA
			NSKALLTNVHGLNLENWQEELAQAKEPFNLGRLIRLVKEYHL
			LNPVIVDCTSSQAVADQYADFLREGFHVVTPNKKANTSSMDY
			YHQLRYAAEKSRRKFLYDTNVGAGLPVIENLQNLLNAGDELM
			KFSGILSGSLSYIFGKLDEGMSFSEATTLAREMGYTEPDPRD
			DLSGMDVARKLLILARETGRELELADIEIEPVLPAEFNAEGD
			VAAFMANLSQLDDLFAARVAKARDEGKVLRYVGNIDEDGVCR
			VKIAEVDGNDPLFKVKNGENALAFYSHYYQPLPLVLRGYGAG
			NDVTAAGVFADLLRTLSWKLGV
metA	Mycobacterium	CAA17113	MTISDVPTQTLPAEGEIGLIDVGSLQLESGAVIDDVCIAVQR	22
	tuberculosis		WGKLSPARDNVVVVLHALTGDSHITGPAGPGHPTPGWWDGVA
	(can be used to		GPGAPIDTTRWCAVATNVLGGCRGSTGPSSLARDGKPWGSRF
	clone M.		PLISIRDQVQADVAALAALGITEVAAVVGGSMGGARALEWVV
	smegmatis		GYPDRVRAGLLLAVGARATADQIGTQTTQIAAIKADPDWQSG
	gene)		DYHETGPAPDAGLRLARRFAHLTYRGEIELDTRFANHNQGNE
			DPTAGGRYAVQSYLEHQGDKLLSRFDAGSYVILTEALNSHDV
			GRGRGGVSAALRACPVPVVVGGITSDRLYPLRLQQELADLLP
			GCAGLRVVESVYGHDGFLVETEAVGELIRQTLGLAD
			REGACRR
metA	Mycobacterium	CAB10992	MTISKVPTQKLPAEGEVGLVDIGSLTTESGAVIDDVCIAVQR	23
	leprae (can be		WGELSPTRDNVVMVLHALTGDSHITGPAGPGHPTPGWWDWIA
	used to clone		GPGAPIDTNRWCAIATNVLGGCRGSTGPSSLARDGKPWGSRF
	M. smegmatis		PLISIRDQVEADIAALAANGITKVAAVVGGSMGGARALEWII
	gene)		GHPDQVPAGLLLAVGVRATADQIGTQTTQIAAIKTDPNWQGG
			DYYETGRAPENGLTIARRFAHLTYRSEVELDTRFANNNQGNE
			DPATGGRYAVQSYLEHQGDKLLARFDAGSYVVLTETLNSHDV
			GRGRGGIGTALRGCPVPVVVGGITSDRLYPLRLQQELAEMLP
			GCTGLQVVDSTYGHDGFLVESEAVGKLIRQTLELADVGSKED
			ACSQ
metA	Thermobifida	ZP_00058188	MSHDTTPPLPATGAWREGDPPGDRRWVELSEPLPLETGGELP	24
	fusca		GVRLAYETWGSLNEDRSNAVLVLHALTGDSHVVGPEGPGHPS
			PGWWEGIIGPGLALDTDRYFVVAPNVLGGCQGSTGPSSTAPD
			GRPWGSRFPRITIRDTVPAEFALLREFGIHSWAAVLGGSMGG
			MRALEWAATYPERVRRLLLLASPAASSAQQIAWAAPQLHAIR
			SDPYWHGGDYYDRPGPGPVTGMGIARRIAHITYRGATEFDER
			FGRNPQDGEDPMAGGRFAVESYLDHHAVKLARRFDAGSYVVL
			TQAMNTHDVGRGRGGVAQALRRVTARTMVAGVSSDFLYPLAQ
			QQELADGIPGADEVRVIESASGHDGFLTEINQVSVLI
			KELLAQ
metA	Corynebacterium	AAC06035	MPTLAPSGQLEIQAIGDVSTEAGAIITNAEIAYHRWGEYRVD	212
	glutamicum		KEGRSNVLIEHALTGDSNAADWWAADLLGPGKAINTDIYCVI
			CTNVIGGCNGSTGPGSMHPDGNFWGWRFPATSIRDQVNAEKQ
			FLDALGITTVAAVVLLGGSMGGARTLEWAAMYPETVGAAAVL
			AVSARASAWQIGIQSAQIKAIENDHHWHEGNYYESGCNPATG
			LGAARRIAHLTYRGELEIDERFGTKAQKNENPLGPYRKPDQR
			FAVESYLDYQADKLVQRFDAGSYVLLTDALNRHDIGRDRGGL
			NKALESIKVPVLVAGVDTDILYPYHQQEHLSRNLGNLLAMAK
			IVSPVGHDAFLTESRQMDRIVRNFFSLISPDEDNPSTYIEFY
			I
metA	Escherichia	NP_418437	MPIRVPDELPAVNFLREENVFVMTTSRASGQEIRPLKVLILN	213
	coli		LMPKKIETENQFLRLLSNSPLQVDIQLLRIDSRESRNTPAEH
			LNNFYCNFEDIQDQNFDGLIVTGAPLGLVEFNDVAYWPQIKQ
			VLEWSKDHVTSTLFVCWAVQAALNILYGIPKQTRTEKLSGVY
			EHHILHPHALLTRGFDDSFLAFHSRYADFPAALIRDYTDLEI
			LAETEEGDAYLFASKDKRIAFVTGHPEYDAQTLAQEFFRDVE
			AGLDPDVPYNYFPHNDPQNTPRASWRSHGNLLFTNWLNYYVY
			QITPYDLRHMNPTLD
metA	T. fusca	n/a	MSHDTTPPLPATGAWREGDPPGDRRWVELSEPLPLETGGELP	281
F269A			GVRLAYETWGSLNEDRSNAVLVLHALTGDSHVVGPEGPGHPS
			PGWWEGIIGPGLALDTDRYFVVAPNVLGGCQGSTGPSSTAPD
			GRPWGSRFPRITIRDTVRAEFALLREFGIHSWAAVLGGSMGG
			MRALEWAATYPERVRRLLLLASPAASSAQQIAWAAPQLHAIR
			SDPYWHGGDYYDRPGPGPVTGMGIARRIAHITYRGATEFDER
			FGRNPQDGEDPMAGGRAAVESYLDHHAVKLARRFDAGSYVVL
			TQAMNTHDVGRGRGGVAQALRRVTARTMVAGVSSDFLYPLAQ
			QQELADGIPGADEVRVIESASGHDGFLTEINQVSVLIKELLA
			Q
metY	T. fusca	n/a	MALRPDRSIMTAEDTTPESTAADKWSFETKQIHAGAAPDPAT	282
F379A			NARATPIYQTTSYVFRDTQHGADLFSLAEPGNIYTRIMNPTQ
			DVLEKRVAALEGGVAAVAFASGSAAITAAVLNLAGAGDHIVS
			SPSLYGGTYNLFRYTLPKLGIEVTFIKDQDDLDEWPAAARDN
			TKLFFAETLPNPANNVLDVRAVADVAHEVGVPLMVDNTVPTP
			YLQRPIDHGADIVVHSATKFLGGHGTTIAGIVVDAGTFDFGA
			HGDRFPGFVEPDPSYHGLKYWEALGPGAYAAKLRVQLLRDTG
			AAISPFNSFLILQGIETLSLRMERHVANAQALAEWLESRDEV
			AKVYYPGLPSSPYYEAAKKYLPKGAGAIVSFELHGGIEAGHA
			AVDGTELFSQLVNIGDVRSLIVHPASTTHSQLTPEEQLASGV
			TPGLVRLSVGLEHVDDLRADLEAGLRAAKAYQ
metY	C. glutamicum	N/a	MPKYDNSNADQWGFETRSIHAGQSVDAQTSARNLPIYQSTAF	283
G232A			VFDSAEHAKQRFALEDLGPVYSRLTNPTVEALENRIASLEGG
			VHAVAFSSGQAATTNAILNLAGAGDHIVTSPRLYGGTETLFL
			ITLNRLGIDVSFVENPDDPESWQAAVQPNTKAFFGETFANPQ
			ADVLDIPAVAEVAHRNSVPLIIDNTIATAALVRPLELGADVV
			VASLTKFYTGNGSGLGGVLIDAGKFDWTVEKDGKPVFPYFVT
			PDAAYHGLKYADLGAPAFGLKVRVGLLRDTGSTLSAFNAWAA
			VQGIDTLSLRLERHNENAIKVAEFLNNHEKVEKVNFAGLKDS
			PWYATKEKLGLKYTGSVLTFEIKGGKDEAWAFIDALKLHSNL
			ANIGDVRSLVVHPATTTHSQSDEAGLARAGVTQSTVRLSVGI
			ETIDDIIADLEGGFAAI
metY	T. fusca	n/a	MALRPDRSIMTAEDTTPESTAADKWSFETKQIHAGAAPDPAT	284
G240A			NARATPIYQTTSYVFRDTQHGADLFSLAEPGNIYTRIMNPTQ
			DVLEKRVAALEGGVAAVAFASGSAAITAAVLNLAGAGDHIVS
			SPSLYGGTYNLFRYTLPKLGIEVTFIKDQDDLDEWHAAARDN
			TKLFFAETLPNPANNVLDVRAVADVAHEVGVPLMVDNTVPTP
			YLQRPIDHGADIVVHSATKFLGGHGTTIAAIVVDAGTFDFGA
			HGDRFPGFVEPDPSYHGLKYWEALGPGAYAAKLRVQLLRDTG
			AAISPFNSFLILQGIETLSLRNERHVANAQALAEWLESRDEV
			AKVYYPGLPSSPYYEAAKKYLPKGAGAIVSFELHGGIEAGRA
			FVDGTELFSQLVNIGDVRSLIVHPASTTHSQLTPEEQLASGV
			TPGLVRLSVGLEHVDDLRADLEAGLRAAKAYQ
metA	T. fusca	n/a	MSHDTTPPLPATGAWREGDPPGDRRWVELSEPLPLETGGELP	285
G81A			GVRLAYETWGSLNEDRSNAVLVLHALTGDSHVVGPEGPAHPS
			PGWWEGIIGPGLALDTDRYFVVAPNVLGGCQGSTGPSSTAPD
			GRPWGSRFPRITIRDTVRAEFALLREFGIHSWAAVLGGSMGG
			MRALEWAATYPERVRRLLLLASPAASSAQQIAWAAPQLHAIR
			SDPYWHGGDYYDRPGPGPVTGMGIARRIAHITYRGATEFDER
			FGRNPODGEDPMAGGRFAVESYLDHHAVKLARRFDAGSYVVL
			TQAMNTHDVGRGRGGVAQALRRVTARTMVAGVSSDFLYPLAQ
			QQELADGIPGADEVRVIESASGHDGFLTEINQVSVLIKELLA
			Q
metA	C. glutamicum	n/a	MPTLAPSGQLEIQAIGDVSTEAGAIITNAEIAYHRWGEYRVD	286
K233A			KEGRSNVVLIEHALTGDSNAADWWADLLGPGKAINTDIYCVI
			CTNVIGGCNGSTGPGSMHPDGNFWGNRFPATSIRDQVNAEKQ
			FLDALGITTVAAVLGGSMGGARTLEWAANYPETVGAAAVLAV
			SARASAWQIGIQSAQIKAIENDHHWHEGNYYESGCNPATGLG
			AARRIAHLTYRGELEIDERFGTAAQKNENPLGPYRKPDQRFA
			VESYLDYQADKLVQRFDAGSYVLLTDALNRHDIGRDRGGLNK
			ALESIKVPVLVAGVDTDILYPYHQQEHLSRNLGNLLAMAKIV
			SPVGHDAFLTESRQMDRIVRNFFSLISPDEDNPSTYIEFYI
metY	Thermobifide	ZP_00058187	MALRPDRSIMTAEDTTPESTAADKWSFETKQIHAGAAPDPAT	25
	fusca		NARATPIYQTTSYVFRDTQHGADLFSLAEPGNIYTRIMNPTQ
			DVLEKRVAALEGGVAAVAFASGSAAITAAVLNLAGAGDHIVS
			SPSLYGGTYNLFRYTLPKLGIEVTFIKDQDDLDEWRAAARDN
			TKLFFAETLPNPANNVLDVPAVADVAHEVGVPLMVDNTVPTP
			YLQRPIDHGADIVVHSATKFLGGHGTTIAGIVVDAGTFDFGA
			HGDRFPGFVEPDPSYHGLKYWEALGPGAYAAKLRVQLLRDTG
			AAISPFNSFLILQGIETLSLRMERHVANAQALAEWLESRDEV
			AKVYYPGLPSSPYYEAAKKYLPKGAGAIVSFELHGGIEAGRA
			FVDGTELFSQLVNIGDVRSLIVHPASTTHSQLTPEEQLASGV
			TPGLVRLSVGLEHVDDLRADLEAGLRAAKAYQ
metY	Mycobacterium	CAA17112	MSADSNSTDADPTAHWSFETKQIHAGQHPDPTTNARALPIYA	26
	tuberculosis		TTSYTFDDTAHAAALFGLEIPGNIYTRIGNPTTDVVEQRIAA
			LEGGVAALFLSSGQAAETFAILNLAGAGDHIVSSPRLYGGTY
			NLFHYSLAKLGIEVSFVDDPDDLDTWQAAVRPNTKAFFAETI
			SNPQIDLLDTPAVSEVAHRNGVPLIVDNTIATPYLIQPLAQG
			ADIVVHSATKYLGGHGAAIAGVIVDGGNFDWTQGRFPGFTTP
			DPSYHGVVFAELGPPAFALKARVQLLRDYGSAASPFNAFLVA
			QGLETLSLRIERHVANAQRVAEFLAARDDVLSVNYAGLPSSP
			WHERAKRLAPKGTGAVLSFELAGGIEAGKAFVNALKLHSHVA
			NIGDVRSLVIHPASTTHAQLSPAEQLATGVSPGLVRLAVGIE
			GIDDILADLELGFAAARRFSADPQSVAAF
metY	M. smegmatis		MVDGFLRRPQGKRGSAGSGPRETGKPDGGQPCVVVREPFTPT	287
			RGVHLYVRTRVRLALGAGRPAAFTPHSPPSSRRRPSMTTPDP
			TENWSFETKQIHAGQSPDSATHARALPIYQTTSYTFDDTSHA
			AALFGLEVPGNIYTRIGNPTTDVVEQRIAALEGGVAALFLSS
			GQAAETFAILNIAKAGDHIVSSPRLYGGTYNLLHYTLPKLGI
			ETTFVENPDDLESWRAAVRPNTKAFFAETISNPQIDILDIPN
			VAAIAHEAGVPLIVDNTIATPYLIQPIAHGADIVVHSATKYL
			GGHGSAIAGVIVDGGTFDWTNGKFPGFTEPDPSYHGVVFAEL
			GAPAYALKARVQLLRDLGSAAAPFNAFLIAQGLETLSLRVER
			HVANAQKVAHFLENHPDVSSVNYAGLPSSPWYELGRKLAPKG
			TGAVLAFELSGGLEAGKAFVNALTLHSHVANIGDVRSLVIHP
			ASTTHQQLSPEEQLSTGVTPGLVRLAVGLEGIDDIIADLEQG
			FAAARPFSGAAQTAQTV
metY	Corynebacterium	AAG49653	MPKYDNSNADQWGFETRSIHAGOSVDAQTSARNLPIYQSTAF	214
	glutamicum		VFDSAEHAKQRFALEDLGPVYSRLTNPTVEALENRIASLEGG
			VHAVAFSSGQAATTNAILNLAGAGDHIVTSPRLYGGTETLFL
			ITLNRLGIDVSFVENPDDPESWQAAVQPNTKAFFGETFANPQ
			ADVLDIPAVAEVAHRNSVPLIIDNTIATAALVRPLELGADVV
			VASLTKFYTGNGSGLGGVLIDGGKFDWTVEKDGKPVFPYFVT
			PDAAYHGLKYADLGAPAFGLKVRVGLLRDTGSTLSAFNAWAA
			VQGIDTLSLRLERHNENAIKVAEFLNNHEKVEKVNFAGLKDS
			PWYATKEKLGLKYTGSVLTFEIKGGKDEAWAFIDALKLHSNL
			ANIGDVRSLVVHPATTTHSQSDEAGLARAGVTQSTVRLSVGI
			ETIDDIIADLEGGFAAI
MetY	C. glutamicum	N/a	MPKYDNSNADQWGFETRSIHAGQSVDAQTSARNLPIYQSTAF	288
D231A			VFDSAEHAKQRFALEDLGPVYSRLTNPTVEALENRIASLEGG
			VHAVAFSSGQAATTNAILNLAGAGDHIVTSPRLYGGTETLFL
			ITLNRLGIDVSFVENPDDPESWQAAVQPNTKAFFGETFANPQ
			ADVLDIPAVAEVAHRNSVPLIIDNTIATAALVRPLELGADVV
			VASLTKFYTGNGSGLGGVLIAGGKFDWTVEKDGKPVFPYFVT
			PDAAYHGLKYADLGAPAFGLKVRVGLLRDTGSTLSAFNAWAA
			VQGIDTLSLRLERHNENAIKVAEFLNNHEKVEKVNFAGLKDS
			PWYATKEKLGLKYTGSVLTFEIKGGKDEAWAFIDALKLHSNL
			ANIGDVRSLVVHPATTTHSQSDEAGLARAGVTQSTVRLSVGI
			ETIDDIIADLEGGFAAI
metY	T. fusca	n/a	MALRPDRSIMTAEDTTPESTAADKWSFETKQIHAGAAPDPAT	289
D244A			NARATPIYQTTSYVFRDTQHGADLFSLAEPGNIYTRINNPTQ
			DVLEKRVAALEGGVAAVAFASGSAAITAAVLNLAGAGDHIVS
			SPSLYGGTYNLFRYTLPKLGIEVTFIKDQDDLDEWRAAARDN
			TKLFFAETLPNPANNVLDVRAVADVAHEVGVPLMVDNTVPTP
			YLQRPIDHGADIVVHSATKFLGGHGTTIAGIVVAAGTFDFGA
			HGDRFPGFVEPDPSYHGLKYWEALGPGAYAAKLRVQLLRDTG
			AAISPFNSFLILQGIETLSLRMERHVANAQALAEWLESRDEV
			AKVYYPGLPSSPYYEAAKKYLPKGAGAIVSFELEGGIEAGRA
			FVDGTELFSQLVNIGDVRSLIVHPASTTHSQLTPEEQLASGV
			TPGLVRLSVGLEHVDDLRADLEAGLRAAKAYQ
MetA	T. fusca	n/a	MSHDTTPPLPATGAWREGDPPGDRRWVELSEPLPLETGGELP	290
D287A			GVRLAYETWGSLNEDRSNAVLVLHALTGDSHVVGPEGPGHPS
			PGWWEGIIGPGLALDTDRYFVVAPNVLGGCQGSTGPSSTAPD
			GRPWGSRFPRITIRDTVRAEFALLREFGIHSWAAVLGGSMGG
			MRALEWAATYPERVRRLLLLASPAASSAQQIAWAAPQLHAIR
			SDPYWHGGDYYDRPGPGPVTGMGIARRIAHITYRGATEFDER
			FGRNPQDGEDPMAGGRFAVESYLDHHAVKLARRFAAGSYVVL
			TQANNTHDVGRGRGGVAQALRRVTARTMVAGVSSDFLYPLAQ
			QQELADGIPGADEVRVIESASGHDGFLTEINQVSVLIKELLA
			Q
metY	T. fusca	n/a	MALRPDRSIMTAEDTTPESTAADKWSFETKQIHAGAAPDPAT	291
D394A		NARATPIYQTTSYVFRDTQHGADLFSLAEPGNIYTRIMNPTQ
			DVLEKRVAALEGGVAAVAFASGSAAITAAVLNLAGAGDHIVS
			SPSLYGGTYNLFRYTLPKLGIEVTFIKDQDDLDEWRAAARDN
			TKLFFAETLPNPANNVLDVRAVADVAHEVGVPLMVDNTVPTP
			YLQRPIDHGADIVVHSATKFLGGHGTTIAGIVVDAGTFDFGA
			HGDRFPGFVEPDPSYHGLKYWEALGPGAYAAKLRVQLLRDTG
			AAISPFNSFLILQGIETLSLRMERHVANAQALAEWLESRDEV
			AKVYYPGLPSSPYYEAAKKYLPKGAGAIVSFELHGGIEAGRA
			FVDGTELFSQLVNIGAVRSLIVHPASTTHSQLTPEEQLASGV
			TPGLVRLSVGLEHVDDLRADLEAGLRAAKAYQ
metK	Mycobacterium	CAB02194	MSEKGRLFTSESVTEGHPDKICDAISDSVLDALLAADPRSRV	27
	tuberculosis		AVETLVTTGQVHVVGEVTTSAKEAFADITNTVRARILEIGYD
	(can be used to		SSDKGFDGATCGVNIGIGAQSPDIAQGVDTAHEARVEGAADP
	clone M.		LDSQGAGDQGLMFGYAINATPELMPLPIALAHRLSRRLTEVR
	smegmatis		KNGVLPYLRPDGKTQVTIAYEDNVPVRLDTVVISTQHAADID
	gene)		LEKTLDPDIREKVLMTVLDDLAHETLDASTVRVLVNPTGKFV
			LGGPMGDAGLTGRKIIVDTYGGWARHGGGAFSGKDPSKVDRS
			AAYAMRWVAKNVVAAGLAERVEVQVAYAIGKAAPVGLFVETF
			GTETEDPVKIEKAIGEVFDLRPGAIIRDLNLLRPIYAPTAAY
			GHFGRTDVELPWEQLDKVDDLKRAI
metK	Mycobacterium	CAC30052	MSEKGRLFTSESVTEGHPDKICDAISDSILDALLAEDPCSRV	28
	leprae (can be		AVETLVTTGQVHVVGEVTTLAKTAFADISNTVRERILDIGYD
	used to clone		SSDKGFDGASCGVNIGIGAQSSDIAQGVNTAHEVRVEGAADP
	M. smegmatis		LDAQGAGDQGLMFGYAINDTPELMPLPIALAHRLARRLTEVR
	gene)		KNGVLPYLRSDGKTQVTIAYEDNVPVRLDTVVISTQHAAGVD
			LDATLAPDIREKVLNTVIDDLSHDTLDVSSVRVLVNPTGKFV
			LGGPMGDAGLTGRKIIVDTYGGWARHGGGAFSGKDPSKVDRS
			AAYAMRWVAKNIVAAGLAERIEVQVAYAIGKAAPVGLFVETF
			GTEAVDPAKIEKAIGEVFDLRPGAIIRDLHLLRPIYAQTAAY
			GHFGRTDVELPWEQLNKVDDLKRAI
metK	Thermobifida	ZP_00057715	MSRRLFTSESVTEGHPDKIADQISDAILDSMLRDDPHSRVAV	29
	fusca		ETLITTGLVHVAGEVTTSTYVDIPTIIREKILEIGYDSSAKG
			FDGASCGVSVSIGGQSPDIAQGVDNAYEAREEEIFDDLDRQG
			AGDQGLMFGYAPELMPLPITLAHALSQRLAEVRRDGTIPYLR
			PDGKTQVTVEYDGNRNNETPVRLDTVVVSSQHAPDIDLRELL
			TPDIKEHVVDPVVARYNLEADNYRLLVNPTGRFEIGGPMGDA
			GLTGRKIIVDTYGGYARHGGGAFSGKDPSKVDRSAAYATRWV
			AKNIVAAGLADRVEVQVAYAIGKAHPVGVFLETFGTEKVAPE
			QLEKAVLEVFDLRPAAIIRDLDLLRPIYSQTSVYGHFGRELP
			DFTWERTDRVDALKAAVGA
metK	Streptomyces	CAB76898	MSRRLFTSESVTEGHPDKIADQISDTILDALLREDPTSRVAV	30
	coelicolor		ETLITTGLVHVAGEVTTKAYADIANLVRGKILEIGYDSSKKG
			FDGASCGVSVSIGAQSPDIAQGVDTAYENRVEGDEDELDRQG
			AGDQGLMFGYASDETPTLMPLPVFLAHRLSKRLSEVRKNGTI
			PYLRPDGKTQVTIEYDGDKAVRLDTVVVSSQHASDIDLESLL
			APDIKEFVVEPELKALLEDGIKIDTENYRLLVNPTGRFEIGG
			PMGDAGLTGRKIIIDTYGGMARHGGGAFSGKDPSKVDRSAAY
			ANRWVAKNVVAAGLAARCEVQVAYAIGKAEPVGLFVETFGTA
			KVDTEKIEKAIDEVFDLRPAAIIRALDLLRPIYAQTAAYGHF
			GRELPDFTWERTDRVDALREAAGL
metK	Coryne-	BAB98996	MAQPTAVRLFTSESVTEGHPDKICDAISDTILDALLEKDPQS	215
	bacterium		RVAVETVVTTGIVHVVGEVRTSAYVEIPQLVRNKLIEIGFNS
	glutamicum		SEVGFDGRTCGVSVSIGEQSQEIADGVDNSDEARTNGDVEED
			DRAGAGDQGLMFGYATNETEEYMPLPIALAHRLSRRLTQVRK
			EGIVPHLRPDGKTQVTFAYDAQDRPSHLDTVVISTQHDPEVD
			RAWLETQLREHVIDWVIKDAGIEDLATGEITVLINPSGSFIL
			GGPMGDAGLTGRKIIVDTYGGMARHGGGAFSGKDPSKVDRSA
			AYAMRWVAKNIVAAGLADRAEVQVAYAIGRAKPVGLYVETFD
			TNKEGLSDEQIQAAVLEVFDLRPAAIIRELDLLRPIYADTAA
			YGHFGRTDLDLPWEAIDRVDELPAALKLA
metK	Escherichia	AAA69109	MAKNLFTSESVSEGHPDKIADQISDAVLDAILEQDPKARVAC	216
	coli		ETYVKTGMVLVGGEITTSAWVDIEEITRNTVREIGYVHSDMG
			FDANSCAVLSAIGKQSPDINQGVDRADPLEQGAGDQGLMFGY
			ATNETDVLMPAPITYAHRLVQRQAEVRKNGTLPWLRPDAKSQ
			VTFQYDDGKIVGIDAVVLSTQHSEEIDQKSLQEAVMEEIIKP
			ILPAEWLTSATKFFINPTGRFVIGGPMGDCGLTGRKIIVDTY
			GGMARHGGGAFSGKDPSKVDRSAAYAARYVAKNIVAAGLADR
			CEIQVSYAIGVAEPTSIMVETFGTEKVPSEQLTLLVREFFDL
			RPYGLIQMLDLLHPIYKETAAYGHFGREHFPWEKTDKAQLLR
			DAAGLK
metC	Mycobacterium	CAA16256	MQDSIFNLLTEEQLRGRNTLKWNYFGPDVVPLWLAEMDFPTA	59
	tuberculosis		PAVLDGVPACVDNEEFGYPPLGEDSLPRATADWCRQRYGWCP
	this to clone		RPDWVRVVPDVLKGMEVVVEFLTRPESPVALPVPAYMPFFDV
	M. smegmatis		LHVTGRQRVEVPMVQQDSGRYLLDLDALQAAFVRGAGSVIIC
	gene)		NPNNPLGTAFTEAELPAIVDIAARHGARVIADEIWAPVVYGS
			RHVAAASVSEAAAEVVVTLVSASKGWNLPGLMCAQVILSNRR
			DAHDWDRINMLHRMGASTVGIRAMIAAYHHGESWLDELLPYL
			RANRDHLARALPELAPGVEVNAPDGTYLSWVDFRALALPSEP
			AEYLLSKAKVALSPGIPFGAAVGSGFARLNFATTRAILDRAI
			EAIAAALRDIID
metC	Bifidobacterium	P_00121229	MSMNNIPQSTTVSNATADVSCFDANHIDVTTIEDLKQVGSDK	60
	longum		WTRYPGCIGAFIAEMDYGLAPCVAEAIEEATERGALGYIPDP
			WKKEVARSCAAWQRRYGWDVDPTCIRPVPDVLEAFEVFLREI
			VRAGNSIVVPTPAYMPFLSVPRLYGVEVLEIPMLCAGASESS
			GRNDEWLFDFDAIEQAFANGCHAFVLCNPHNPIGKVLTREEM
			LRLSDLAAKYNVRIFSDEIHAPFVYQGHTHVPFASINRQTAM
			QAFTSTSASKSFNIPGTKCAQVILTNPDDLELWMRNAEWSEH
			QTATIGAIATTAAYDGGAAWFEGVMAYIERNIALVNEQMRTR
			FAKVRYVEPQGTYIAWLDFSPLGIGDPANYFFKKANVALTDG
			RECGEVGRGCVRMNFAMPYPLLEECFDRMAAALEADGLL
metC	Lactobacillus	CAD65601	MQYDFNKVINRRGTYSTQWDYIQDRFGRSDILPFSISDTDFP	61
	plantarum		VPVGVQEALEQRIKHPIYGYTRWNNEDYKNSIINWFSSQNQV
			TINPDWILYSPSVVFSIATFIRMKSAVGESVAVFTPMYDAFY
			HVIEDNQRVLAPVRLGSAQQDYSIDWDTLKAVLKQTATKILL
			LTNPHNPTGKVFSDDELKHIVALCQQyNVFIISDDIHKDIVY
			QKAAYTPVTEFTTKNVVLCCSATKTFNTPGLIGAYLFEPEAE
			LREMFLCELKQKNALSSASILGIESQMAAYNTGSDYLVQLIT
			YLQNNFDYLSTFLKSQLPEIRFKQPEATYLAWMDVSQLGLTA
			EKLQDKLVNTGRVGIMSGTTYGDSHYLRMNIACPISKLQEGL
			KRMEYGIRS
metC	Coryne-	AAK69425	MRFPELEELKNRRTLKWTRFPEDVLPLWVAESDFGTCPQLKE	217
	bacterium		AMADAVEREVFGYPPDATGLNDALTGFYERRYGFGPNPESVF
	glutamicum		AIPDVVRGLKLAIEHFTKPGSAIIVPLPAYPPFIELPKVTGR
			QAIYIDAHEYDLKEIEKAFADGAGSLLFCNPHNPLGTVFSEE
			YIRELTDIAAKYDARIIVDEIHAPLVYEGTHVVAAGVSENAA
			NTCITITATSKAWNTAGLKCAQIFFSNEADVKAWKNLSDITR
			DGVSILGLIAAETVYNEGEEFLDESIQILKDNRDFAAAELEK
			LGVKVYAPDSTYLMWLDFAGTKIEEAPSKILREEGKVMLNDG
			AAFGGFTTCARLNFACSRETLEEGLRRIASVL
metC	Escherichia	P06721	MADKKLDTQLVNAGRSKKYTLGAVNSVIQRASSLVFDSVEAK	218
	coli		KHATRNRANGELFYGRRGTLTHFSLQQANCELEGGAGCVLFP
			CGAAAVANSILAFIEQGDHVLMTNTAYEPSQDFCSKILSKLG
			VTTSWFDPLIGADIVKHLQPNTKIVFLESPGSITMEVHDVPA
			IVAAVRSVVPDAIIMIDNTWAAGVLFKALDFGIDVSIQAATK
			YLVGHSDAMIGTAVCNARCWEQLRENAYLMGQMVDADTAYIT
			SRGLRTLGVRLRQHHESSLKVAEWLAEHPQVARVNHPALPGS
			KGHEFWKRDFTGSSGLFSFVLKKKLNNEELANYLDNFSLFSM
			AYSWGGYESLILANQPEHIAAIRPQGEIDFSGTLIRLHIGLE
			DVDDLIADLDAGFARIV
pck	C. glutamicum		MTTAAIRGLQGEAPTKNKELLNWIADAVELFQPEAVVFVDGS	292
			QAEWDRMAEDLVEAGTLIKLNEEKRPNSYLARSNPSDVARVE
			SRTFICSEKEEDAGPTNNWAPPQAMKDEMSKHYAGSMKGRTM
			YVVPFCMGPISDPDPKLGVQLTDSEYVVMSMRIMTRMGIEAL
			DKIGANGSFVRCLHSVGAPLEPGQEDVAWPCNDTKYITQFPE
			TKEIWSYGSGYGGNAILAKKCYALRIASVMAREEGWMAEHML
			ILKLINPEGKAYHIAAAFPSACGKTNLAMITPTIPGWTAQVV
			GDDIAWLKLREDGLYAVNPENGFFGVAPGTNYASNPIANKTM
			EPGNTLFTNVALTDDGDIWWEGMDGDAPAHLIDWMGNDWTPE
			SDENAAHPNSRYCVAIDQSPAAAPEFNDWEGVKIDAILFGGR
			RADTVPLVTQTYDWEHGTMVGALLASGQTAASAEAKVGTLRH
			DPMAMLPFIGYNAGEYLQNWIDMGNKGGDKMPSIFLVNWFRR
			GEDGRFLWPGFGDNSRVLKWVIDRIEGHVGADETVVGHTAKA
			EDLDLDGLDTPIEDVKEALTAPAEQWANDVEDNAEYLTFLGP
			RVPAEVHSQFDALKARISAAHA
pck	E. coli		MRVNNGLTPQELEAYGISDVHDIVYNPSYDLLYQEELDPSLT	293
			GYERGVLTNLGAVAVDTGIFTGRSPKDKYIVRDDTTRDTFWW
			ADKGKGKNDNKPLSPETWQHLKGLVTRQLSGKRLFVVDAFCG
			ANPDTRLSVRFITEVAWQAHFVKNMFIRPSDEELAGFKPDFI
			VMNGAKCTNPQWKEQGLNSENFVAFNLTERMQLIGGTWYGGE
			MKKGMFSMMNYLLPLKGIASMHCSANVGEKGDVAVFFGLSGT
			GKTTLSTDPKRRLIGDDEHGWDDDGVFNFEGGCYAKTIKLSK
			EAEPEIYNAIRRDALLENVTVREDGTIDFDDGSKTENTRVSY
			PIYHIDNIVKPVSKAGHATKVIFLTADAFGVLPPVSRLTADQ
			TQYHFLSGFTAKLAGTERGITEPTPTFSACFGAAFLSLHPTQ
			YAEVLVKRMQAAGAQAYLVNTGWNGTGKRISIKDTPAIIDAI
			LNGSLDNAETFTLPMFNLAIPTELPGVDTKILDPRNTYASPE
			QWQEKAETLAKLFIDNFDKYTDTPAGAALVAAGPKL
gdh	Strepto-	CAB82051	MPAVPERAPVTTRSETQSTLDHLLTEIELRNPAQPEFHQAAH	62
	mycescoelicolor		EVLETLAPVVAARPEYAEPGLIERLVEPERQVMFRVPWQDDQ
			GRVRVNRGFRVEFNSALGPYKGGLRFHPSVNLGVIKFLGFEQ
			IFKNALTGLGIGGGKGGSDFDPHGRSDAEVMRFCQSFMTELY
			RHIGEHTDVPAGDIGVGGREIGYLFGQYRRITNRWESGVLTG
			KGQGWGGSLIRPEATGYGNVLFAAAMLRERGEDLEGQTAVVS
			GSGNVAIYTIEKLTALGANAVTCSDSSGYVVDEKGIDLDLLK
			QIKEVERGRVDAYAERRGASARFVPGGSVWDVPADLALPSAT
			QNELDENAAATLVRNGVKAVSEGAMMPTTPEAVHLLQKAGVA
			FGPGKAANAGGVAVSALEMAQNHARTSWTAARVEEELADIMT
			SIHTTCHETAERYDAPGDYVTGANIAGFERVADAMLAQGVI
gdh	Thermobifida	ZP_00057948	MRPEPEATMSANLDEKLSPIYEEILRRNPGEVEFHQAVREVL	63
	fusca		ECLGPVVAKNPDISHAKTIERLCEPERQLIFRVPWMDDSGEI
			HVNRGFRVEFSSSLGPYKGGLRFHPSVNLSIIKFLGFEQIFK
			NSLTGLPIGGAKGGSDFDPKGRSDAEIMRFCQSFMTELYRHL
			GEHTDVPAGDIGVGQREIGYLFGQYKRITNRYESGVFTGKGL
			SWGGSQVRREATGYGCVLFTAEMLRARGDSLEGKRVSVSGSG
			NVAIYAIEKAQQLGAHVVTCSDSNGYVVDEKGIDLELLKQVK
			EVERGRVSDYAKRRGSHVRYIDSSSSSVWEVPCDIALPCATQ
			NELTGRDAITLVRNGVGAVAEGANMPTTPEGIRVFAEAGVAF
			APGKAANAGGVATSALEMQQNASRDSWSFEYTEKRLAEIMRH
			IHDTCYETAERYGRPGDYVAGANIAAFEIVAEANLAQGLI
gdh	Lactobacilus	CAD63684	MSQATDYVQHVYQVIEHRDPNQTEFLEAINDVFKTITPVLEQ	64
	plantarum		HPEYIEANILERLTEPERIIQFRVPWLDDAGHARVNRGFRVQ
			FNSAIGPYKGGLRLHPSVNLSIVKFLGFEQIFKNALTGLPIG
			GGKGGSDFDPKGKSDNEIMRFCQSFMTELSKYIGLDTDVPAG
			DIGVGGREIGFLYGQYKRLRGADRGVLTGKGLNYGGSLARTE
			ATGYGLAYYTNEMLKANQLSFPGQRVAISGAGNVAIYAIQKV
			EELGGKVITCSDSNGYVIDENGIDFKIVKQIKEVERGRIKDY
			ADRVASASYYEGSVWDAQVAYDIALPCATQNEISGDQAKNLI
			ANGAKVVAEGANMPSSPEAIATYQAASLLYGPAKAANAGGVA
			VSALEMSQNSMRLSWTFEEVDNRLKQIMQDIFAHSVAAADEY
			HVSGDYLSGANIAGFTKVADAMLAQGLV
gdh	Coryne-	CAA42048	MTVDEQVSNYYDMLLKRNAGEPEFHQAVAEVLESLKLVLEKD	219
	bacterium		PHYADYGLIQRLCEPERQLIFRVPWVDDQGQVHVNRGFRVQF
	glutamicum		NSALGPYKGGLRFHPSVNLGIVKFLGFEQIFKNSLTGLPIGG
			GKGGSDFDPKGKSDLEIMRFCQSFMTELHRHIGEYRDVPAGD
			IGVGGREIGYLFGHYRRMANQHESGVLTGKGLTWGGSLVRTE
			ATGYGCVYFVSEMIKAKGESISGQKIIVSGSGNVATYAIEKA
			QELGATVIGFSDSSGWVHTPNGVDVAKLREIKEVRRARVSVY
			ADEVEGATYHTDGSIWDLKCDIALPCATQNELNGENAKTLAD
			NGCRFVAEGANMPSTPEAVEVFRERDIRFGPGKATPEAVEVF
			RERDIRFGPGKAVNVGGVATSALEMQQNASRETCAETAAEYG
			HENDYVVGANIAGFKKVADAMLAQGVI
gdh	Escherichia	BAA15550	MDQTYSLESFLNHVQKRDPNQTEFAQAVREVMTTLWPFLEQN	220
	coli		PKYRQMSLLERLVEPERVIQFRVVWVDDRNQIQVNRAWRVQF
			SSAIGPYKGGMRFHPSVNLSILKFLGFEQTFKNALTTLPMGG
			GKGGSDFDPKGKSEGEVMRFCQALMTELYRHLGADTDVPAGD
			IGVGGREVGFMAGMMKKLSNNTACVFTGKGLSFGGSLIRPEA
			TGYGLVYFTEAMLKRHGMGFEGMRVSVSGSGNVAQYAIEKAN
			EFGARVITASDSSGTVVDESGFTKEKLARLIEIKASRDGRVA
			DYAKEFGLVYLEGQQPWSLPVDIALPCATQNELDVDAAHQLI
			ANGVKAVAEGANMPTTIEATELFQQAGVLFAPGKAANAGGVA
			TSGLEMAQNAARLGWKAEKVDARLHHIMLDIHHACVEHGGEG
			EQTNYVQGANIAGFVKVADANLAQGVI
ddh	Bacillus	BAB07799	MSAIRVGIVGYGNLGRGVEFAISQNPDMELVAVFTRRDPSTV	65
	sphaericus		SVASNASVYLVDDAEKFQDDIDVMILCGGSATDLPEQGPHFA
			QWFNTIDSFDTHAKIPEFFDAVDAAAQKSGKVSVISVGWDPG
			LFSLNRVLGEAVLPVGTTYTFWGDGLSQGHSDAVRRIEGVKN
			AVQYTLPIKDAVERVRNGENPELTTREKHARECWVVLEEGAD
			APKVEQEIVTMPNYFDEYNTTVNFISEDEFNANHTGMPHGGF
			VIRSGESGANDKQILEFSLKLESNPNFTSSVLVAYARAAHRL
			SQAGEKGAKTVFDIPFGLLSPKSAAQLRKELL
dtsR1	Thermobifida	ZP_00058587	MATQAPEPLPADQIDIRTTAGKLADLQRRRYEAVHAGSEPAV	66
	fusca		AKQHAKGKMTARERIDALLDPGSFVEFDAFARHRSTNFGLEK
			NRPYGDGVVTGYGTIDGRPVAVFSQDVTVFGGSLGEVYGEKI
			VKVLDHALKTGCPVIGINEGGGARIQEGVVALGLYAEIFKRN
			THASGVIPQISLVMGAAAGGHVYSPALTDFIVMVDQTSQMFI
			TGPDVIKTVTGEDVTMEELGGARTHNTKSGVAHYMASDEHDA
			LEYVKALLSYLPSNNLDEPPVEPVQVTLEVTEEDRELDTFIP
			DSANQPYDMRRVIEHIVDDGEFLEVHELFAQNIIVGFGRVEG
			HPVGVVANQPMNLAGCLDIDASEKAARFVRTCDAFNIPVLTL
			VDVPGFLPGTDQEFGGIIRRGAKLLYAYAEATVPLVTIITRK
			AFGGAYDVMGSKHLGADINLAWPTAQIAVMGAQGAVNILHRR
			TLAAADDVEATRAQLIAEYEDTLLNPYSAAERGYVDSVIMPS
			ETRTSVIKALRALRGKRKQLPPKKHGNIPL
dtsR1	Streptomyces	ADD28194	SEPEEQQPDIHTTAGKLADLRRRIEEATHAGSAPAVEKQHAK	67
	coelicolor		GKLTARERIDLLLDEGSFVELDEFARIRSTNFGLDANRPYGG
			VVTGYGTVDGRPVAVFSQDFTVFGGALGEVYGQKIVKVMDFA
			LKTGCPVVGINDSGGARIQEGVASLGAYGEIFRRNTHASGIP
			QISLVVGPCAGGAVYSPAITDFTVMVDQTSHMFITGPDVIKT
			VTGEDVGFEELGGARTHNSTSGVAHHMAGDEKDAVEYVKQLL
			SYLPSNNLSEPPAFPEEADLAVTDEDAELDTIVPDSANQPYD
			MHSVIEHVLDDAEFFETQPLFAPNILTGFGRVEGRPVGIANQ
			PMQFAGCLDITASEKARFVRTCDAFNVPVLTFVDVPGFLPGV
			DQEHDGIIRRGAKLIFAYAEATVPLITVITRKAFGGADVMGS
			KHLGADLNLAWPTAQIAVMGAQGAVNILHRRTIADADDAEAT
			RARLIQEYEDALLNPYTAAERGYVDAVIMPSDTRRIVRGLRQ
			LRTKRESLPPKKHGNIPL
dtsR1	Mycobacterium	CAB07063	MTSVTDRSAHSAERSTEHTIDIHTTAGKLAELHKRREESLHP	68
	tuberculosis		VGEDAVEKVHAKGKLTARERIYALLDEDSFVELDALAKHRST
	(use this to clone		NFNLGEKRPLGDGVVTGYGTIDGRDVCIFSQDATVFGGSLGE
	M. smegmatis		VYGEKIVKVQELAIKTGRPLIGINDGAGARIQEGVVSLGLYS
	gene)		RIFRNNILASGVIPQISLIMGAAAGGHVYSPALTDFVIMVDQ
			TSQMFITGPDVIKTVTGEEVTMEELGGAHTHMAKSGTAHYAA
			SGEQDAFDYVRELLSYLPPNNSTDAPRYQAAAPTGPIEENLT
			DEDLELDTLIPDSPNQPYDMHEVITRLLDDEFLEIQAGYAQN
			IVVGFGRIDGRPVGIVANQPTHFAGCLDINASEKAARFVRTC
			DCFNIPIVMLVDVPGFLPGTDQEYNGIIRRGAKLLYAYGEAT
			VPKITVITRKAYGGAYCVMGSKDMGCDVNLAWPTAQIAVMGA
			SGAVGFVYRQQLAEAAANGEDIDKLRLRLQQEYEDTLVIPYV
			AAERGYVDAVIPPSHTRGYIGTALRLLERKIAQLPPKKHGNV
			PL
dtsR1	Mycobacterium	AAA85917	MTSVTDHSAHSMERAAEHTINIHTTAGKLAELHKRTEEALHP	69
	leprae (use this		VGAAAFEKVHAKGKFTARERIYALLDDDSFVELDALARHRST
	to clone M.		NFGLGERPVGDGVVTGYGTIDGRDVCIFSQDVTVFGGSLGEV
	smegmatis		YGEKIVKVQELAIKTGRPLIGINDGAGARIQEGVVSLGLYSR
	gene)		IFRNNILASGVIPQISLIMGAAAGGHVYSPALTDFVVMVDQT
			SQMFITGPDVIKTVTGEDVTMEELGGAHTHMAKSGTAHYVAS
			GEQDAFDWVRDVLSYLPSNNFTDAPRYSKPVPHGSIEDNLTA
			KDLELDTLIPDSPNQPYDMHEVVTRLLDEEEFLEVQAGYATN
			IVVGLGRIDDRPVGIVANQPIQFAGCLDINASEKAARFVRVC
			DCFNIPIVMLVDVPGFLPGTEQEYDGIIRRGAKLLFAYGEAT
			VPKITVITRKAYGGAYCVMGSKNMGCDVNLAWPTAQIAVMGA
			SGAVGFVYRKELAQAAKNGANVDELRLQLQQEYEDTLVNPYI
			AAERGYVDAVIPPSHTRGYIATALHLLERKIAHLPPKKHGNI
			PL
dtsR1	Coryne-	NP_599940	MTISSPLIDVANLPDINTTAGKIADLKARRAEANFPMGEKAV	221
	bacterium		EKVHAAGRLTARERLDYLLDEGSFIETDQLARHRTTAFGLGA
	glutamicum		KRPATDGIVTGWGTIDGREVCIFSQDGTVFGGALGEVYGEKM
			IKIMELAIDTGRPLIGLYEGAGARIQDGAVSLDFISQTFYQN
			IQASGVIPQISVIMGACAGGNAYGPALTDFVVMVDKTSKMFV
			TGPDVIKTVTGEEITQEELGGATTHMVTAGNSHYTAATDEEA
			LDWVQDLVSFLPSNNRSYAPMEDFDEEEGGVEENITADDLKL
			DEIIPDSATVPYDVRDVIECLTDDGEYLEIQADRAENVVIAF
			GRIEGQSVGFVANQPTQFAGCLDIDSSEKAARFVRTCDAFNI
			PIVMLVDVPGFLPGAGQEYGGILRRGAKLLYAYGEATVPKIT
			VTMRKAYGGAYCVMGSKGLGSDINLAWPTAQIAVMGAAGAVG
			FIYRKELMAADAKGLDTVALAKSFEREYEDHMLNPYHAAERG
			LIDAVILPSETRGQISRNLRLLKHKNVTRPARKHGNNPL
metH	Thermobifida	ZP_00059561	MSARLSFREVLGSRVLVADGAMGTMLQTYDLSMDDFEGHEGC	70
	fusca		NEVLNITRPDVVREIHEAYLQAGVDCVETNTFGANFGNLGEY
			GIAERTYELAEAGARLAREAADAYTTADHVRYVLGSVGPGTK
			LPTLGHAPYAVLRDHYEQCARGLIDGGVDAIVIETCQDLLQA
			KAAIVGARPARKAAGTDTPIIVQVTIETTGTMLVGSEIGAAL
			TSLEPLGVDMIGLNCATGPAEMSEHLRYLSHHSRIPLSCMPN
			AGLPELGADGAVYPLQPHELTEAHDTFIREFGLALVGGCCGT
			TPEHLAQVVERVQGRGVPDRKPHVEPAAASIYQSVPFRQDTS
			YLAIGERTNANGSKAFREANLAERYDDCVEIARQQIRDGAHM
			LDLCVDYVGRDGVRDMRELASRLATASTLPLVLDSTEVAVLE
			AGLEMLGGRAVLNSVNYEDGDGPDSRFAKVAALAVEHGAALM
			ALTIDEQGQARTAERKVEVAERLIRQLTTEYGIRKHDIIVDC
			LTFTIATGQEESRRDALETIEAIRELKRRHPDVQTTLGVSNV
			SFGLNPAARIVLNSVFLHECVQAGLDSAIVHASKILPINRIP
			EEQRQVALDMIYDRRTDDYDPLQRFLQLFEGVDAQAMRASRE
			EELAALPLWERLERRIVDGEAAGMEADLDEALTQRSALDIIN
			TTLLAGMKTVGDLFGSGQMQLPFVLKSAEVMKAAVAYLEPHM
			EKVDGDLGKGRIVLATVKGDVHDIGKNLVDIILSNNGYEVIN
			LGIKQPISAILEAAERHRADVIGMSGLLVKSTVVMRENLEEM
			NARGVADRYPVLLGGAALTRSYVEQDLAEIFKGEVRYARDAF
			EGLKLMDAIMAVKRGVKGAKLPPLRTRRVKRGAQLTVTEPEK
			MPTRSDVATDNPVPTPPFWGDRICKGIPLADYAAFLDERATF
			MGQWGLRGSRGDGPTYEELVETEGRPRLRMWLDRIQTEGWLE
			PAVVYGYYRCYSEGNDLVVLGEDENELTRFTFPRQRRDRNLC
			LADFFRPKESGELDTVAFQVVTVGSTISKATAELFEKNAYRD
			YLELHGLSVQLTEALAEYWHTRVRAELGFAGEDPDPADLDAY
			FKLGYRGARFSLGYGACPNLEDRAKIVALLRPERVGVTLSEE
			FQLVPEQSTDAIVVHHPEAKYFNV
metH	Streptomyces	CAC18788	MASSPSTPPADTRTRVSALREALATRVVVADGAMGTMLQAQN	71
	coelicolor		PTLDDFQQLEGCNEVLNLTRPDIVRSVHEEYFAAGVDCVETN
			TFGANHSALGEYDIPERVHELSEAGARVAREVADEFGARDGR
			QRWVLGSMGPGTKLPTLGHAPYTVLRDAYQRNAEGLVAGGAD
			ALLVETTQDLLQTKASVLGARRALDVLGLDLPLIVSVTVETT
			GTMLLGSEIGAALTALEPLGIDMIGLNCATGPAEMSEHLRYL
			ARHSRIPLTCMPNAGLPVLGKDGAHYPLTAPELADAHETFVR
			EYGLSLVGGCCGTTPEHLRQVVERVRDTAPTARDPRPEPGAA
			SLYQTVPFRQDTSYLAIGERTNANGSKKFREAMLDGRWDDCV
			EMARDQIREGAHMLDLCVDYVGRDGVADMEELAGRFATASTL
			PIVLDSTEVDVIRAGLEKLGGRAVINSVNYEDGAGPESRFAR
			VTKLAREHGAALIALTIDEVGQARTAEKKVEIAERLIDDLTG
			NWGIHESDILVDCLTFTICTGQEESRKDGLATIEGIRELKRR
			HPDVQTTLGLSNISFGLNPAARILLNSVFLDECVKAGLDSAI
			VHASKILPIARFDEEQVTTALDLIYDRRREGYDPLQKLMQLF
			EGATAKSLKASKAEELAALPLEERLKRRIIDGEKNGLEQDLD
			EALRERPALEIVNDTLLDGMKVVGELFGSGQMQLPFVLQSAE
			VMKTAVAHLEPHMEKTDDDGKGTIVLATVRGDVHDIGKNLVD
			IILSNNGYNVVNLGIKQPVSAILEAADEHRADVIGMSGLLVK
			STVIMKENLEELNQRKLAADYPVILGGAALTRAYVEQDLHEI
			YDGEVRYARDAFEGLRLMDALIGIKRGVPGAKLPELKQRRVR
			AATVEIDERPEEGHVRSDVATDNPVPTPPFRGTRVVKGIQLK
			EYASWLDEGALFKGQWGLKQARTGEGPSYEELVESEGRPRLR
			GLLDRLQTDNLLEAAVVYGYFPCVSKDDDLIVLDDDG~ERTR
			FTFPRQRRGRRLCLADFFRPEESGETDVVGFQVVTVGSRIGE
			ETARMFEANAYRDYLELHGLSVQLAEALAEYWHARVRSELGF
			AGEDPAEMEDMFALKYRGARFSLGYGACPDLEDPAKIAALLE
			PERIGVHLSEEFQLHPEQSTDAIVIHHPEAKYFNAR
metH	Mycobacterium	CAB10719	MTAADKHLYDTDLLDVLSQRVMVGDGANGTQLQAADLTLDDF	72
	tuberculosis (use		RGLEGCNEILNETRPDVLETIHRNYFEAGADAVETNTFGCNL
	this to clone M.		SNLGDYDIADRIRDLSQKGTAIARRVADELGSPDRKRYVLGS
	smegmatis		MGPGTKLPTLGHTEYAVIRDAYTEAALGMLDGGADAILVETC
	gene)		QDLLQLKAAVLGSRRANTRAGRHIPVFAHVTVETTGTMLLGS
			EIGAALTAVEPLGVDMIGLNCATGPAEMSEHLRHLSRHARIP
			VSVMPNAGLPVLGAKGAEYPLLPDELAEALAGFIAEFGLSLV
			GGCCGTTPAHIREVAAAVANIKRPERQVSYEPSVSSLYTAIP
			FAQDASVLVIGERTNANGSKGFREAMIAEDYQKCLDIAKDQT
			RDGAHLLDLCVDYVGRDGVADMKALASRLATSSTLPIMLDST
			ETAVLQAGLEHLGGRCAINSVNYEDGDGPESRFAKTMALVAE
			HGAAVVALTIDEEGQARTAQKKVEIAERLINDITGNWGVDES
			SILIDTLTFTIATGQEESRRDGIETIEAIRELKKRHPDVQTT
			LGLSNISFGLNPAARQVLNSVFLHECQEAGLDSAIVHASKIL
			PMNRIPEEQRNVALDLVYDRRREDYDPLQELMRLFEGVSAAS
			SKEDRLAELAGLPLFERLAQRIVDGERNGLDADLDEANTQKP
			PLQIINEHLLAGMKTVGELFGSGQMQLPFVLQSAEVMKAAVA
			YLEPHMERSDDDSGKGRIVLATVKGDVHDIGKNLVDIILSNN
			GYEVVNIGIKQPIATILEVAEDKSADVVGMSGLLVKSTVVMK
			ENLEEMNTRGVAEKFPVLLGGAALTRSYVENDLAEIYQGEVH
			YARDAFEGLKLMDTIMSAKRGEAPDENSPEAIKAREKEAERK
			ARHQRSKRIAAQRKAAEEPVEVPERSDVAADIEVPAPPFWGS
			RIVKGLAVADYTGLLDERALFLGQWGLRGQRGGEGPSYEDLV
			ETEGRPRLRYWLDRLSTDGILAHAAVVYGYFPAVSEGNDIVV
			LTEPKPDAPVRYRFHFPRQQRGRFLCIADFIRSRELAAERGE
			VDVLPFQLVTMGQPIADFANELFASNAYRDYLEVHGIGVQLT
			EALAEYWHRRIREELKFSGDRAMAAEDPEAKEDYFKLGYRGA
			RFAFGYGACPDLEDRAKMMALLEPERIGVTLSEELQLHPEQS
			TDAFVLHHPEAKYFNV
metH	Mycobacterium	AA17182.1	MRVTAANQHQYDTDLLETLAQRVMVGDGAMGTQLQDAELTLD	73
	leprae (use this		DFRGLEGCNEILNETRPDVLETIHRRYFEAGADLVETNTFGC
	to clone M.		NLSNLGDYDIADKIRDLSQRGTVIARRVADELTTPDHKRYVL
	smegmatis		GSMGPGTKLPTLGHTEYRVVRDAYTESALGMLDGGADAVLVE
	gene)		TCQDLLQLKAAVLGSRRANTQAGRHIPVFVHVTVETTGTMLL
			GSEIGAALAAVEPLGVDMIGLNCATGPAEMSEHLRHLSKHAR
			IPVSVMPNAGLPVLGAKGAEYPLQPDELAEALAGFIAEFGLS
			LVGGCCGTTPDHIREVAAAVARCNDGTVPRGERHVTYEPSVS
			SLYTAIPFAQKPSVLMIGERTNANGSKVFREANIAEDYQKCL
			DIAKDQTRGGAHLLDLCVDYVGRNGVADMKALAGRLATVSTL
			PIMLDSTEIPVLQAGLEHLGGRCVUJSVNYEDGDGPESRFVK
			TMELVAEHGAAVVALTIDEQGQARTVEKKVEVAERLINDITS
			NWGVDKSAILIDCLTFTIATGQEESRKDGIETIDAIRELKKR
			HPAVQTTLGLSNISFGLNPSARQVLNSVFLHECQEAGLDSAI
			VHASKILPINRIPEEQRQAALDLVYDRRREGYDPLQKLMWLF
			KGVSSPSSKETREAELAKLPLFDRLAQRIVDGERNGLDVDLD
			EAMTQKPPLAIINENLLDGMKTVGELFGSGQMQLPFVLQSAE
			VMKAAVAYLEPHMEKSDCDFGKGLAKGRIVLATVKGDVHDIG
			KNLVDIILSNNGYEVVNLGIKQPITNILEVAEDKSADVVGMS
			GLLVKSTVIMKENLEEMNTRGVAEKFPVLLGGAALTRSYVEN
			DLAEVYEGEVHYARDAFEGLKLMDTIMSAKRGEALAPGSPES
			LAAEADRNKETERKARHERSKRIAVQRKAAEEPVEVPERSDV
			PSDVEVPAPPFWGSRIIKGLAVADYTGFLDERALFLGQWGLR
			GVRGGAGPSYEDLVQTEGRPRLRYWLDRLSTYGVLAYAAVVY
			GYFPAVSEDNDIVVLAEPRPDAEQRYRFTFPRQQRGRFLCIA
			DFIRSRDLATERSEVDVLPFQLVTMGQPIADFVGELFVSNSY
			RDYLEVHGIGVQLTEALAEYWHRRIREELKFSGNRTMSADDP
			EAVEDYFKLGYRGARFAFGYGACPDLEDRIKMMELLQPERIG
			VTISEELQLHPEQSTDAFVLHHPAAKYFNV
metH	Lactobacillus	CAD63851	MKFKQALQQRVLVADGAMGTLLYGNYGINSAFENLNLTHPDT	74
	plantarum		ILRVHRSYIPAGADIIQTNTYAANRLKLTRYDLQDQVTTINQ
			AAVKIAATAREHADHPVYILGTIGGLAGDTDATVQRATPATI
			AASVTEQLTALLATNQLDGILLETYYDLPELLAALKIVKAHT
			DLPVITNVSMLAPGVLRNGTSFTDAIVQLNAAGADVIGTNCR
			LGPYYLAQSFENLAIPANVKLAVYPNAGLPGTDQDGAVVYDG
			EPSYFEEYAERFRQLGLNIIGGCCGTTPLHTSATVRGLSNRS
			IVAHDQPATKPQPPTLVTTKSQHRFLQKVATQKTALVELDPP
			RDFDTTKFFRGAERLKAAGVDGITLSDNSLATVRIANTTIAA
			QLKLNYGITPIVHLTTRDHNLIGLQSEIMGLHSLGIEDILAI
			TGDPAKLGDFPGATSVSDVRSVELMKLIKQFNSGIGPTGKSL
			KEASDFRVAGAFNPNAYRTSISTKSISRKLSYGCDYIITQPV
			YDLANVDALADALAANHVNVPVFVGVMPLVSRRNAEFLHHEV
			HGIRIPEPILTRMAEAEQTGNERAVGIAIAKELIDGICARFN
			GVHIVTPFNRFKTVIELVDYIQQKNLIKVQ
metH	Coryne-	CAD26709	MSTSVTSPAHNNAHSSEFLDALANHVLIGDGAMGTQLQGFDL	222
	bacterium		DVEKDFLDLEGCNEILNDTRPDVLRQIHRAYFEAGADLVETN
	glutamicum		TFGCNLPNLADYDIADRCRELAYKGTAVAREVADEMGPGRNG
			MRRFVVGSLGPGTKLPSLGHAPYADLRGHYKEAAWGIIDGGG
			DAFLIETAQDLLQVKAAVHGVQDANAELDTFLPIICHVTVET
			TGTNLMGSEIGAALTALQPLGIDMIGLNCATGPDEMSEHLRY
			LSKHADIPVSVMPNAGLPVLGKNGAEYPLEAEDLAQALAGFV
			SEYGLSMVGGCCGTTPEHIRAVRDAVVGVPEQETSTLTKIPA
			GPVEQASREVEKEDSVASLYTSVPLSQETGISMIGERTNSNG
			SKAFREAMLSGDWEKCVDIAKQQTRDGAHMLDLCVDYVGRDG
			TADMATLAALLATSSTLPIMIDSTEPEVIRTGLEHLGGRSIV
			NSVNFEDGDGPESRYQRIMKLVKQHGAAVVALTIDEEGQART
			AEHKVRIAKRLIDDITGSYGLDIKDIVVDCLTFPISTGQEET
			RRDGIETIEAIRELKKLYPEIHTTLGLSNISFGLNPAARQVL
			NSVFLNECIEAGLDSAIAHSSKILPMNRIDDRQREVALDMVY
			DRRTEDYDPLQEFMQLFEGVSAADAKDAPAEQLAAMPLFERL
			AQRIIDGDKRGLEDDLEAGMKEKSPIAIINEDLLNGMKTVGE
			LFGSGQMQLPFVLQSAETMKTAVAYLEPFMEEEAEATGSAQA
			EGKGKIVVATVKGDVHDIGKNLVDIILSNNGYDVVNLGIKQP
			LSAMLEAAEEHKADVIGMSGLLVKSTVVMKENLEEMNNAGAS
			NYPVILGGAALTRTYVENDLNEVYTGEVYYARDAFEGLRLMD
			EVMAEKRGEGLDPNSPEAIEQAKKKAERKARNERSRKIAAER
			KANAAPVIVPERSDVSTDTPTAAPPFWGTRIVKGLPLAEFLG
			NLDERALFMGQWGLKSTRGNEGPSYEDLVETEGRPRLRYWLD
			RLKSEGILDHVALVYGYFPAVAEGDDVVILESPDPHAAERMR
			FSFPRQQRGRFLCIADFIRPREQAVKDGQVDVMPFQLVTMGN
			PIADFANELFAANEYREYLEVHGIGVQLTEALAEYWHSRVRS
			ELKLNDGGSVADFDPEDKTKFFDLDYRGARFSFGYGSCPDLE
			DRAKLVELLEPGRIGVELSEELQLHPEQSTDAFVLYHPEAKY
			FNV
metH	Escherichia coli	P13009	MSSKVEQLPAQLNERILVLDGGMGTMIQSYRLNEADFRGERF	223
			ADWPCDLKGNNDLLVLSKPEVIAAIHNAYFEAGADIIETNTF
			NSTTIAMADYQMESLSAEINFAAAKLARRCADEWTARTPEKP
			RYVAGVLGPTNRTASISPDVNDPAFRNITFDGLVAAYRESTK
			ALVEGGADLILIETVFDTLNAKAAVFAVKTEFEALGVELPIM
			ISGTITDASGRTLSGQTTEAFYNSLRHAEALTFGLNCALGPD
			ELRQYVQELSRIAECYVTAHPNAGLPNAFGEYDLDADTMAKQ
			IREWAQAGFLNIVGGCCGTTPQHIAAMSRAVEGLAPRKLPEI
			PVACRLSGLEPLNIGEDSLFVNVGERTNVTGSAKFKRLIKEE
			KYSEALDVARQQVENGAQIIDINMDEGMLDAEAAMVRFLNLI
			AGEPDIARVPIMIDSSKWDVIEKGLKCIQGKGIVNSISMKEG
			VDAFIHHAKLLRRYGAAVVVMAFDEQGQADTRARKIEICRRA
			YKILTEEVGFPPEDIIFDPNIFAVATGIEEHNNYAQDFIGAC
			EDIKRELPHALISGGVSIVSFSFRGNDPVREAIHAVFLYYAI
			RNGMDMGIVNAGQLAIYDDLPAELRDAVEDVILNRRDDGTER
			LLELAEKYRGTKTDDTANAQQAEWRSWEVNKRLEYSLVKGIT
			EFIEQDTEEARQQATRPIEVIEGPLMDGMNVVGDLFGEGKMF
			LPQVVKSARVMKQAVAYLEPFIEASKEQGKTNGKMVIATVKG
			DVHDIGKNIVGVVLQCNNYEIVDLGVMVPAEKILRTAKEVNA
			DLIGLSGLITPSLDEMVNVAKEMERQGFTIPLLIGGATTSKA
			HTAVKIEQNYSGPTVYVQNASRTVGVVAALLSDTQRDDFVAR
			TRKEYETVRIQHGRKKPRTPPVTLEAARDNDFAFDWQAYTPP
			VAHRLGVQEVEASIETLRNYIDWTPFFMTWSLAGKYPRILED
			EVVGVEAQRLFKDANDMLDKLSAEKTLNPRGVVGLFPANRVG
			DDIEIYRDETRTHVINVSHHLRQQTEKTGFANYCLADFVAPK
			LSGKADYIGAFAVTGGLEEDALADAFEAQHDDYNKIMVKALA
			DRLAEAFAEYLHERVRKVYWGYAPNENLSNEELIRENYQGIR
			PAPGYPACPEHTEKATIWELLEVEKHTGMKLTESFAMWPGAS
			VSGWYFSHPDSKYYAVAQIQRDQVEDYARRKGMSVTEVERWL
			APNLGYDAD
metE	Mycobacterium	CAB09044	MTQPVRRQPFTATITGSPRIGPRRELKPATEGYWAGRTSRSE	75
	tuberculosis (use		LEAVAATLRRDTWSALAAAGLDSVPVNTFSYYDQMLDTAVLL
	this to clone M.		GALPPRVSPVSDGLDRYFAAARGTDQIAPLEMTKWFDTNYHY
	smegmatis		LVPEIGPSTTFTLHPGKVLAELKEALGQGIPARPVIIGPITF
	gene)		LLLSKAVDGAGAPIERLEELVPVYSELLSLLADGGAQWVQFD
			EPALVTDLSPDAPALAEAVYTALCSVSNRPAIYVATYFGDPG
			AALPALARTPVEAIGVDLVAGADTSVAGVPELAGKTLVAGVV
			DGRNVWRTDLEAALGTLATLLGSAATVAVSTSCSTLHVPYSL
			EPETDLDDALRSWLAFGAEKVREVVVLARALRDGHDAVADEI
			ASSRAAIASRKRDPRLHNGQIRAPIEAIVASGAHRGNAAQRR
			ASQDARLHLPPLPTTTIGSYPQTSAIRVARAALPAGEIDEAE
			YVRRMRQEITEVIALQERLGLDVLVHGEPERNDMVQYFAEQL
			AGFFATQNGWVQSYGSRCVRPPILYGDVSRPRAMTVEWITYA
			QSLTDKPVKGMLTGPVTILAWSFVRDDQPLADTANQVALAIR
			DETVDLQSAGIAVIQVDEPALRELLPLRRADQAEYLRWAVGA
			FRLATSGVSDATQIHTHLCYSEFGEVIGAIADLDADVTSTEA
			ARSHMEVLDDLNAIGFANGVGPGVYDIHSPRVPSAEEMADSL
			RAALRAVPAERLWVNPDCGLKTRNVDEVTASLHNMVAAAREV
			RAG
metE	Mycobacterium	CAB08123	MDELVTTQSFTATVTGSPRIGPRRELKRATEGYWAKRTSRSE	76
	leprae (use this		LESVASTLRRDMWSDLAAAGLDSVPVNTFSYYDQMLDTAFML
	to clone M.		GALPARVAQVSDDLDQYFALARGNNDIKPLEMTKWFDTNYHY
	smegmatis		LVPEIEPATTFSLNPGKILGELKEALEQRIPSRPVIIGPVTF
	gene)		LLLSKGINGGGAPIQRLEELVGIYCTLLSLLAENGARWVQFD
			EPALVTDLSPDAPALAEAVYTALGSVSKRPAIYVATYFGNPG
			ASLAGLARTPIEAIGVDFVCGADTSVAAVPELAGKTLVAGIV
			DGRNIWRTDLESALSKLATLLGSAATVAVSTSCSTLHVPYSL
			EPETDLDDNLRSWLAFGAEKVAEVVVLAPALRDGRDAVADEI
			AASNAAVASRRSDPRLHNGQVRARIDSIVASGTHRGDAAQRR
			TSQDARLHLPPLPTTTIGSYPQTSAIRKARAALQDAEIDEAE
			YISRMKKEVADAIKLQEQLGLDVLVHGEPERNDMVQYFAEQL
			GGFFATQNGWVQSYGSRCVRPPILYGDVSRPHPMTIEWITYA
			QSLTDKPVKGMLTGPVTILAWSFVRDDQPLADTANQVALAIR
			DETVDLQSAGIAIIQVDEPALRELLPLRRADQDEYLCWAVKA
			FRLATSGVADSTQIHTHLCYSEFGEVIGAIADLDADVTSIEA
			ARSHMEVLDDLNAVGFANSIGPGVYDIHSPRVPSTDEIAKSL
			RAALKAIPMQRLWVNPDCGLKTRSVDEVSASLQNMVAAARQV
			RAGA
metE	Streptomyces	CAC44335	MTAKSAAAAARATVYGYPRQGPNRELKKAIEGYWKGRVSAPE	77
	coelicolor		LRSLAADLRAANWRRLADAGIDEVPAGDFSYYDHVLDTTVMV
			GAIPERHRAAVAADALDGYFANARGTQEVAPLEMTKWFDTNY
			HYLVPELGPDTVFTADSTKQVTELAEAVALGLTARPVLVGPV
			TYLLLAKPAPGAPADFEPLTLLDRLLPVYAEVLTDLRAAGAE
			WVQLDEPAFVQDRTPAELNALERAYRELGALTDRPKLLVASY
			FDRLGDALPVLAKAPIEGLALDFTDAAATNLDALAAVGGLPG
			KRLVAGVVNGRNIWINDLQKSLSTLGTLLGLADRVDVSASCS
			LLHVPLDTGAERDIEPQILRWLAFARQKTAEIVTLAKGLAQG
			TDAITGELAASRADMASRAGSPITRNPAVRARAEAVTDDDAR
			RSQPYAERTAAQPAHLGLPPLPTTTIGSFPQTGEIRAARADL
			RDGRIDIAGYEERIPAEIQEVISFQEKTGLDVLVHGEpERND
			MVQYFAEQLTGYLATQHGWVQSYGTRYVRPPILAGDISRPEP
			MTVRWTTYAQSLTEKPVKGMLTGPVTMLAWSFVRDDQPLGDT
			ARQVALALRDEVNDLEAAGTSVIQVDEPALRETLPLPAADHT
			AYLAWATEAFRLTTSGVRPDTQIHTHMCYAEFGDIVQAIDDL
			DADVISLEAARSHMQVAHELATHGYPREAGPGVYDIHSPRVP
			SAEEAAALLRTGLKAIPAERLWVNPDCGLKTRGWPETRASLE
			NLVATARTLRGELSAS
metE	Coryne-	CAD26711	MTSNFSSTVAGLPRIGAKRELKFALEGYWNGSIEGRELAQTA	224
	bacterium		RQLVNTASDSLSGLDSVPFAGRSYYDAMLDTAAILGVLPERF
	glutamicum		DDIADHENDGLPLWIDRYFGAARGTETLPAQAMTKWFDTNYH
			YLVPELSADTRFVLDASALIEDLRCQQVRGVNARPVLVGPLT
			FLSLARTTDGSNPLDHLPALFEVYERLIKSFDTEWVQIDEPA
			LVTDVAPEVLEQVRAGYTTLAKRDGVFVNTYFGSGDQALNTL
			AGIGLGAIGVDLVTHGVTELAAWKGEELLVAGIVDGRNIWRT
			DLCAALASLKRLAARGPIAVSTSCSLLHVPYTLEAENIEPEV
			RDWLAFGSEKITEVKLLADALAGNIDAAAFDAASAAIASRRT
			SPRTAPITQELPGRSRGSFDTRVTLQEKSLELPALPTTTIGS
			FPQTPSIRSARARLRKESITLEQYEEAMREEIDLVIAKQEEL
			GLDVLVHGEPERNDMVQYFSELLDGFLSTANGWVQSYGSRCV
			RPPVLFGNVSRPAPMTVKWFQYAQSLTQKEVKGMLTGPVTIL
			AWSFVRDDQPLATTADQVALALRDEINDLIEAGAKIIQVDEP
			AIRELLPLRDVDKPAYLQWSVDSFRLATAGAPDDVQIHTHMC
			YSEFNEVISSVIALDADVTTIEAARSDMQVLAALKSSGFELG
			VGPGVWDIHSPRVPSAQEVDGLLEAALQSVDPRQLWVNpDCG
			LKTRGWPEVEASLKVLVESAKQAREKIGATI
metE	Escherichia coli	Q8FBM1	MTILNHTLGFPRVGLRRELKKAQESYWAGNSTREELLAVGRE	225
			LRARHWDQQKQAGIDLLPVGDFAWYDHVLTTSLLLGNVPPRH
			QNKDGSVDIDTLFRIGRGRAPTGEPAAAAEMTKWFNTNYHYM
			VPEFVKGQQFKLTWTQLLEEVDEALALGHKVKPVLLGPITYL
			WLGKVKGEQFDRLSLLNDILPVYQQVLAELAKRGIEwVQIDE
			PALVLELPQAWLDAYKPAYDALQGQVKLLLTTYFEGVTPNLD
			TITALPVQGLHVDLVHGKDDVAELHKRLPSDWLLSAGLINGR
			NVWRADLTEKYAQIKDIVGKRDLWVASSCSLLHSPIDLSVET
			RLDAEVKSWFAFALQKCHELALLRDALNSGDTAALAEWSAPI
			QARRHSTRVHNPAVEKRLAAITAQDSQRANVYEVRAEAQRAR
			FKLPAWPTTTIGSFPQTTEIRTLRLDFKKGNLDANNYRTGIA
			EHIKQAIVEQERLGLDVLVHGEAERNDMVEYFGEHLDGFVFT
			QNGWVQSYGSRCVKPPIVIGDVSRPAPITVEWAKYAQSLTDK
			PVKGMLTGPVTILCWSFPREDVSRETIAKQIALALRDEVADL
			EAAGIGIIQIDEPALREGLPLRRSDWDAYLQWGVEAFRINAA
			VAKDDTQIHTHMCYCEFNDIMDSIAALDADVITIETSRSDME
			LLESFEEFDYPNEIGPGVYDIHSPNVPSVEWIEALLKKAAKR
			IPAERLWVNPDCGLKTRGWPETRAALANMVQAAQNLRRG
glyA	Streptomyces	CAA20173	MSLLNTPLHELDPDVAAAVDAELDRQQSTLEMIASENFAPVA	78
	coelicolor		VMEAQGSVLTNKYAEGYPGRRYYGGCEHVDVVEQIAIDRVKA
			LFGAEHANVQPHSGAQANAAAMFALLKPGDTIMGLNLAHGGH
			LTHGMKINFSGKLYNVVPYHVGDDGQVDMAEVERLAKETKPK
			LIVAGWSAYPRQLDFAAFRKVADEVGAYLMVDMAHFAGLVAA
			GLHPNPVPHAHVVTTTTHKTLGGPRGGVILSTAELAKKINSA
			VFPGQQGGPLEHVVAAKAVAFKVAASEDFKERQGRTLEGARI
			LAERLVRDDAKAAGVSVLTGGTDVHLVLVDLRDSELDGQQAE
			DRLHEVGITVNRNAVPNDPRPPMVTSGLRIGTPALATRGFTA
			EDFAEVADVIAEALKPSYDAEALKARVKTLADKHPLYPGLNK
glyA	Thermobifide	ZP_00058615	MKVRKLMTAQSTSLTQSLAQLDPEVAAAVDAELARQRDTLEM	79
	fusca		IASENFAPPAVLEAQGTVLTNKYAEGYPGRRYYGGCEHVDVI
			EQLAIDRAKALFGAEHANVQPHSGAQANTAVYFALLQPGDTI
			LGLDLAHGGHLTHGMRINYSGKILNAVAYHVRESDGLIDYDE
			VEALAKEHQPKLIIAGWSAYPRQLDFARFREIADQTGALLMV
			DMAHFAGLVAAGLHPNPVPYADVVTTTTHKTLGGPRGGLILA
			KEELGKKIMSAVFPGMQGGPLQHVIAAKAVALKVAASEEFAE
			RQRRTLSGAKILAERLTQPDAAEAGIRVLTGGTDVHLVLVDL
			VNSELNGKEAEDRLHEIGITVNRNAVPNDPRPPMVTSGLRIG
			TPALATRGFGDADFAEVADIIAEALKPGFDAATLRSRVQALA
			AKHPLYPGL
glyA	Mycobacterium	AAK45383	MSAPLAEVDPDIAELLAKELGRQRDTLEMIASENFAPRAVLQ	80
	tuberculosis (use		AQGSVLThKYAEGLPGRRYYGGCEHVDVVENLARDRAKALFG
	this to clone M.		AEFANVQPHSGAQANAAVLHALMSPGERLLGLDLANGGHLTH
	smegmatis		GMRLHFSGKLYENGFYGVDPATHLIDMDAVPATALEFRPKVI
	gene)		IAGWSAYPRVLDFAAFRSIADEVGAKLLVDMAHFAGLVAAGL
			HPSPVPHADVVSTTVHKTLGGGRSGLIVGKQQYAKAINSAVF
			PGQQGGPLMHVIAGKAVALKIAATPEFADRQRRTLSGARIIA
			DRLMAPDVAKAGVSVVSGGTDVHLVLVDLRDSPLDGQAAEDL
			LHEVGITVNRNAVPNDPRPPMVTSGLRIGTPALATRGFGDTE
			FTEVADIIATALATGSSVDVSALKDRATRLARAFPLYDGLEE
			WSLVGR
glyA	Mycobacterium	CAB39828	MVAPLAEVDPDIAELLGKELGRQRDTLEMIASENFVPRSVLQ	81
	leprae (use this		AQGSVLTNKYAEGLPGRRYYDGCEHVDVVENIARDRAKALFG
	to clone M.		ADFANVQPHSGAQANAAVLHALMSPGERLLGLDLANGGHLTH
	smegmatis		GMRLNFSGKLYETGFYGVDATTHLIDMDAVRAKALEFRPKVL
	gene)		IAGWSAYPRILDFAAFRSIADEVGAKLWVDMAHFAGLVAVGL
			HPSPVPHADVVSTTVHKTLGGGRSGLILGKQEFATAINSAVF
			PGQQGGPLMHVIAGKAVALKIATTPEFTDRQQRTLAGARILA
			DRLTAADVTKAGVSVVSGGTDVHLVLVDLRNSPFDGQAAEDL
			LHEVGITVNRNVVPNDPRPPMVTSGLRIGTPALATRGFGEAE
			FTEVADIIATVLTTGGSVDVAALRQQVTRLARDFPLYGGLED
			WSLAGR
glyA	Lactobacillus	CAD64690	MNYQEQDPEVWAAISKEQARQQHNIELIASEHIVSKGVRAAQ	82
	plantarum		GSVLTNKYSEGYPGHRFYGGNEYIDQVETLAIERAKKLFGAE
			YANVQPHSGSQANAAAYMALIQPGDRVMGMSLDAGGHLTHGS
			SVNFSGKLYDFQGYGLDPETAELNYDAILAQAQDFQPKLIVA
			GASAYSRLIDFKKFREIADQVGALLMVDMAHIAGLVAAGLHP
			NPVPYADVVTTTTHKTLRGPRGGMILAKEKYGKKINSAVFPG
			NQGGPLDHVIAGKAIALGEDLQPEFKVYAQHIIDNAKAMAKV
			FNDSDLVRVISGGTDNHLMTIDVTKSGLNGRQVQDLLDTVYI
			TVNKEAIPNETLGAFKTSGIRLGTPAITTRGFDEADATKVAE
			LILQALQAPTDQANLDDVKQQAMALTAKHPIDVD
glyA	Coryne-	AAK60516	MTDAHQADDVRYQPLNELDPEVAAAIAGELARQRDTLEMIAS	226
	bacterium		ENFVPRSVLQAQGSVLTNKYAEGYPGRRYYGGCEQVDIIEDL
	glutamicum		ARDRAKALFGAEFANVQPHSGAQANAAVLMTLAEPGDKIMGL
			SLAHGGHLTHGMKLNFSGKLYEVVAYGVDPETMRVDMDQVRE
			IALKEQPKVIIAGWSAYPRHLDFEAFQSIAAEVGAKLWVDMA
			HFAGLVAAGLHPSPVPYSDVVSSTVHKTLGGPRSGIILAKQE
			YAKKLNSSVFPGQQGGPLMHAVAAKATSLKIAGTEQFRDRQA
			RTLEGARILAERLTASDAKAAGVDVLTGGTDVHLVLADLRNS
			QMDGQQAEDLLHEVGITVNRNAVPFDPRPPMVTSGLRIGTPA
			LATRGFDIPAFTEVADIIGTALANGKSADIESLRGRVAKLAA
			DYPLYEGLEDWTIV
glyA	Escherichia coli	P00477	MLKREMNIADYDAELWQAMEQEKVRQEEHIELIASENYTSPR	227
			VMQAQGSQLTNKYAEGYPGKRYYGGCEYVDIVEQLAIDRAKE
			LFGADYANVQPHSGSQANFAVYTALLEPGDTVLGMNLAHGGH
			LTHGSPVNFSGKLYNIVPYGIDATGHIDYADLEKQAKEHKPK
			MIIGGFSAYSGVVDWAKMREIADSIGAYLFVDMAHVAGLVAA
			GVYPNPVPHAHVVTTTTHKTLAGPRGGLILAKGGSEELYKKL
			NSAVFPGGQGGPLMHVIAGKAVALKEAMEPEFKTYQQQVAKN
			AKAMVEVFLERGYKVVSGGTDNHLFLVDLVDKNLTGKEADAA
			LGRANITVNKNSVPNDPKSPFVTSGIRVGTPAITRRGFKEAE
			AKELAGWMCDVLDSINDEAVIERIKGKVLDICARYPVYA
metE	Thermobifida	ZP_00056753	MASRAASTGSHSAPISSSSGRRLATKAASSASTRGRTKATGD	83
	fusca		KCEELIRAGYRLFRRPSSPRHTQTPPIWSITVGDMLGSPTPR
			PAPRPRRISELLARKEPTFSFEFFPPKTPEGERMLWRAIREI
			EALRPSFVSVTYGAGGSTRDRTVNVTEKIATNTTLLPVAHIT
			AVNHSVRELRHLIGRFAAAGVCNMLAIRGDPPGDPLGEWVKH
			PEGLTHAEELVRLIKESGDFCVGVAAFPYKHPRSPDVETDTD
			FFVRKCRAGADYAITQMFFEAEDYLRLRDRVAARGCDVPIIP
			EIMPVTKFSTIARSEQLSGAPFPRRLAEEFERVADDPEAVRA
			LGIEHATRLCERLLAEGAPGIHFITFNRSTATREVYHRLVGA
			TQPAAVAALP
metF	Streptomyces	CAB52012	MALGTASTRTDPARTVRDILATGKTTYSFEFSAPKTPKGERN	84
	coelicolor		LWSALRRVEAVAPDFVSVTYGAGGSTRAGTVRETQQIVADTT
			LTPVAHLTAVDHSVAELRNIIGQYADAGIRNMLAVRGDPPGD
			PNADWIAHPEGLTYAAELVRLIKESGDFCVGVAAFPEMHPRS
			ADWDTDVTNFVDKCRAGADYAITQMFFQPDSYLRLRDRVAAA
			GCATPVIPEVMPVTSVKMLERLPKLSNASFPAELKERILTAK
			DDPAAVRSIGIEFATEFCARLLAEGVPGLHFITLNNSTATLE
			IYENLGLHHPPPA
metE	Coryne-	CAD26762	MVEVNKCQRQSQQNTLITLRYPGMSLTNIPASSQWAISDVLK	228
	bacterium		RPSPGRVPFSVEFMPPRDDAAEERLYRAAEVFHDLGASFVSV
	glutamicum		TYGAGGSTRERTSRIARRLAKQPLTTLVHLTLVNBTREEMKA
			ILREYLELGLTNLLALRGDPPGDPLGDWVSTDGGLNYASELI
			DLIKSTPEFREFDLGIASFPEGHFRAKTLEEDTKYTLAKLRG
			GAEYSITQMFFDVEDYLRLRDRLVAADPIHGAKPIIPGIMPI
			TELRSVRRQVELSGAQLPSQLEESLVRAANGNEEANKDEIRK
			VGIEYSTNMAERLIAEGAEDLHFMTLNFTRATQEVLYNLGMA
			PAWGAEHGQDAVR
metF	Escherichia coli	NP_418376	MSFFHASQRDALNQSLAEVQGQINVSFEFFPPRTSEMEQTLW	229
			NSIDRLSSLKPKFVSVTYGANSGERDRTHSIIKGIKDRTGLE
			AAPHLTCIDATPDELRTIARDYWNNGIRHIVALRGDLPPGSG
			KPEMYASDLVTLLKEVADFDISVAAYPEVHPEAKSAQADLLN
			LKRKVDAGANPAITQFFFDVESYLRFRDRCVSAGIDVEIIPG
			ILPVSNFKQAKKFADMTNVRIPAWMAQMFDGLDDDAETRKLV
			GANIAMDMVKILSREGVKDFHFYTLNRAEMSYAICHTLGVRP
			GL
cysE	Mycobacterium	K46690	MLTAMRGDIRAARERDPAAPTALEVIFCYPGVHAVWGHRLAH	85
	tuberculosis (use		WLWQRGARLLAPAAAEFTRILTGVDIHPGAVIGARVFIDHAT
	this to clone M.		GVVIGETAEVGDDVTIYHGVTLGGSGMVGGKRHPTVGDRVII
	smegmatis		GAGAKVLGPIKIGEDSRIGANAVVVKPVPPSAVVVGVPGQVI
	gene)		GQSQPSPGGPFDWRLPDLVGASLDSLLTRVARLDALGGGPQA
			AGVIRPPEAGIWHGEDFSI
cysE	Mycobacterium	CAB11413	MFAAIRRDIQAARQRDPAQPTVLEVICCYPGVHAVWGHRISH	86
	leprae (use this		WLWNRRARLAARAFAELTRILTGVDIHPGAVLGAGLFIDHAT
	to clone M.		GVVIGETAEVGDDVTIFHGVTLGGTGRETGKRHPTIGDRVTI
	smegmatis		GAGAKVLGAIKIGEDSRIGANAVVVKEVPASAVAVGVPGQII
	gene)		SSDSPANGDDSVLPDFVGVSLQSLLTRVAKLEAEDGGSQTYR
			VIRLPEAGVWHGEDFSI
cysE	Lactobacillus	CAD62911	MFQTARAILNRDPAAINLRTVMLTYPGIHALAWYRVAHYFET	87
	plantarum		HRLPLLAALLSQHAARHTGILIHPAAQIGHRVFFDHGIGTVI
			GATAVIEDDVTILHGVTLGARKTEQAGRRHPYVCRGAFIGAH
			AQLLGPITIGANSKIGAGAIVLDSVPAHVTAVGNPAHLVATQ
			LHAYHEATSNQA
cysE	Coryne-	CAD34661	MLSTIKMIREDLANAREHDPAARGDLENAVVYSGLHAIWAHR	230
	bacterium		VANSWWKSGFRGPARVLAQFTRFLTGIEIHPGATIGRRFFID
	glutamicum		HGMGIVIGETAEIGEGVMLYHGVTLGGQVLTQTKRHPTLCDN
			VTVGAGAKILGPITIGEGSAIGANAVVTKDVPAEHIAVGIPA
			VARPRGKTEKIKLVDPDYYI
cysE	Escherichia coli	NP_418064	MSCEELEIVWNNIKAEARTLADCEPMLASFYHATLLKHENLG	231
			SALSYMLANKLSSPIMPAIAIREVVEEAYAADPEMIASAACD
			IQAVRTRDPAVDKYSTPLLYLKGFHALQAYRIGHWLWNQGRR
			ALAIFLQNQVSVTFQVDIHPAAKIGRGIMLDHATGIVVGETA
			VIENDVSILQSVTLGGTGKSGGDRHPKIREGVMIGAGAKILG
			NIEVGRGAKIGAGSVVLQPVPPHTTAAGVPARIVGKPDSDKP
			SMDMDQHFNGINHTFEYGDGI
serA	Mycobacterium	CAA16081	MSLPVVLIADKLAPSTVAALGDQVEVRWVDGPDRDKLLAAVP	88
	tuberculosis (use		EADALLVRSATTVDAEVLAAAPKLKIVARAGVGLDNVDVDAA
	this to clone M.		TARGVLVVNAPTSNIHSAAEHALALLLAASRQIPAADASLRE
	smegmatis		HTWKRSSFSGTEIFGKTVGVVGLGRIGQLVAQRIAAFGAYVV
	gene)		AYDPYVSPARAAQLGIELLSLDDLLARADFISVHLPKTPETA
			GLIDKEALAKTKPGVIIVNAARGGLVDEAALADAITGGHVRA
			AGLDVFATEPCTDSPLFELAQVVVTPHLGASTAEAQDRAGTD
			VAESVRLALAGEFVPDAVNVGGGVVNEEVAPWLDLVRKLGVL
			AGVLSDELPVSLSVQVRGELAAEEVEVLRLSALRGLFSAVIE
			DAVTFVNAPALAAERGVTAEICKASESPNHRSVVDVRAVGAD
			GSVVTVSGTLYGPQLSQKIVQINGRHFDLPAQGINLIIHYVD
			RPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQD
			VPDDVRTAIAAAVDAYKLEVVDLS
serA	Mycobacterium	CAB16440	MDLPVVLIADKLAQSTVAALGDQVEVRWVDGPDRTKLLAAVP	89
	leprae (use this		EADALLVRSATTVDAEVLAAAPKLKIVAPAGVGLDNVDVDAA
	to clone M.		TARGVLVVNAPTSNIHSAAEHALALLLAASRQIAEADASLRA
	smegmatis		HIWKRSSFSGTEIFGKTVGVVGLGRIGQLVAARIAAFGAHVI
	gene)		AYDPYVAPARAAQLGIELMSFDDLLARADFISVHLPKTPETA
			GLIDKEALAKTKPGVIIVNAARGGLVDEVALADAVRSGHVRA
			AGLDVFATEPCTDSPLFELSQVVVTPHLGASTAEAQDRAGTD
			VAESVRLALAGEFVPDAVNVDGGVVNEEVAPWLDLVCKLGVL
			VAALSDELPASLSVHVRGELASEDVEILRLSALRGLFSTVIE
			DAVTFVNAPALAAERGVSAEITTGSESPNHRSVVDVRAVASD
			GSVVNIAGTLSGPQLVQKIVQVNGRNFDLRAQGMNLVIRYVD
			QPGALGKIGTLLGAAGVNIQAAQLSEDTEGPGATILLRLDQD
			VPGDVRSAIVAAVSANKLEVVNLS
serA	Thermobifida	ZP_00057280	MAATAVEPTRTPSKEFVVPKPVVLVAEELSPAGIALLEEDFE	90
	fusca		VRHVNGADRSQLLPALAGVDALIVRSATKVDAEVLAAAPSLK
			VVARAGVGLDNVDVEAATKAGVLVVNAPTSNIISAAEQAINL
			LLATAPNTAAAHAALVRGEWKRSKYTGVELYDKTVGIVGLGR
			IGVLVAQRLQAFGTKLIAYDPFVQPARAAQLGVELVELDELL
			ERSDFITIHLPKTKDTIGLIGEEELRKVKPTVRIINAARGGI
			VDETALYHALKEGRVAGAGLDVFAKEPCTDSPLFELENVVVA
			PHLGASTHEAQEKAGTQVARSVKLALAGEFVPDAVNIQGKGV
			SEDIKPGLPLTEKLGRILAALADGAITRVEVEVRGEIVAHDV
			KVIELAALKGLFTDIVEEAVTYVNAPLVAKERGIEVSLTTEE
			ESPDWRNVITVRAILSDGQRVSVSGTLTGPRQLEKLVEVNGY
			TMEIAPSEHMAFFSYHDRPGVVGVVGQLLGQAQVNIAGMQVS
			RDKEGGAALIALTVDSAIPDETLETISKEIGAEISRVDLVD
serA	Streptomyces	CAB37591	MSSKPVVLIAEELSPATVDALGPDFEIRHCNGADRAELLPAI	91
	coelicolor		ADVDAILVRSATKVDAEAVAAAKKLKVVARAGVGLDNVDVSA
			ATKAGVMVVNAPTSHIVTAAELACGLIVATARNIPQANAALK
			NGEWKRSKYTGVELAEKTLGVVGLGRIGALVAQRMSAFGMKV
			VAYDPYVQPAPAAQMGVKVLSLDELLEVSDFITVHLPKTPET
			LGLIGDEALRKVKPSVRIVNAARGGIVDEEALYSALKEGRVA
			GAGLDVYAKEPCTDSPLFEFDQVVATPHLGASTDEAQEKAGI
			AVAKSVRLALAGELVPDAVNVQGGVIAEDVKPGLPLAERLGR
			IFTALAGEVAVRLDVEVYGEITQHDVKVLELSALKGVFEDVV
			DETVSYVNAPLFAQERGVEVRLTTSSESPEHRNVVIVRGTLS
			DGEEVSVSGTLAGPKHLQKIVAIGEYDVDLALADHMVVLRYE
			DRPGVVGTVGRIIGEAGLNIAGMQVARATVGGEALAVLTVDD
			TVPSGVLAEVAAEIGATSARSVNLV
serA	Lactobecilus	CAD63373	MTKVFIAGQLPAQANTLLLQSQLVIDTYTGDNLISHAELIRR	92
	plantarum		VADADFLIIPLSTQVDQDVLDHAPHLKLIANFGAGTNNIDIA
			AAAKRQIPVTNTPNVSAVATAESTVGLIISLAHRIVEGDHLM
			RTSGFNGWAPLFFLGHNLQGKTLGILGLGQIGQAVAKRLHAF
			DMPILYSQHHRLPISRETQLGATFVSQDELLQRADIVTLHLP
			LTTQTTHLIDNAAFSKMKSTALLINAARGPIVDEQALVTALQ
			QHQIAGAALDVYEHEPQVTPGLATMNNVILTPHLGNATVEAR
			DGMATIVAENVIAMAQHQPIKYVVNDVTPA
serA	Coryne-	BAB98677	MSQNGRPVVLIADKLAQSTVDALGDAVEVRWVDGPNRPELLD	232
	bacterium		AVKEADALLVRSATTVDAEVIAAAPNLKIVGRAGVGLDNVDI
	glutamicum		PAATEAGVMVANAPTSNIHSACEHAISLLLSTARQIPAADAT
			LREGEWKRSSFNGVEIFGKTVGIVGFGHIGQLFAQRLAAFET
			TIVAYDPYANPAPAAQLNVELVELDELMSRSDFVTIHLPKTK
			ETAGMFDAQLLAKSKKGQIIThAARGGLVDEQALADAIESGH
			IRGAGFDVYSTEPCTDSPLFKLPQVVVTPHLGASTEEAQDRA
			GTDVADSVLKALAGEFVADAVNVSGGRVGEEVAVWMDLARKL
			GLLAGKLVDAAPVSIEVEARGELSSEQVDALGLSAVRGLFSG
			IIEESVTFVNAPRIAEERGLDISVKThSESVTHRSVLQVKVI
			TGSGASATVVGALTGLERVEKITRINGRGLDLRAEGLNLFLQ
			YTDAPGALGTVGTKLGAAGINIEAAALTQAEKGDGAVLILRV
			ESAVSEELEAEINAELGATSFQVDLD
serA	Escherichia coli	NP_417388	MAKVSLEKDKIKFLLVEGVHQKALESLRAAGYTNIEFHKGAL	233
			DDEQLKESIRDAHFIGLRSRTHLTEDVINAAEKLVAIGCFCI
			GTNQVDLDAAAKRGIPVFNAPFSNTRSVAELVIGELLLLLRG
			VPEANAKAHRGVWNKLAAGSFEARGKKIGIIGYGHIGTQLGI
			LAESLGMYVYFYDIEMCLPLGNATQVQHLSDLLNMSDVVSLH
			VPENPSTKNMMGAKEISLMKPGSLLINASRGTVVDIPALCDA
			LASKHLAGAAIDVFPTEPATNSDPFTSPLCEFDNVLLTPHIG
			GSTQEAQENIGLEVAGKLIKYSDNGSTLSAVNFPEVSLPLHG
			GRRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGY
			VVIDIEADEDVAEKALQANKAIPGTIRARLLY
lysE	Mycobacterium	CAA98398	MNSPLVVGFLACFTLIAAIGAQNAFVLRQGIQREHVLPVVAL	93
	tuberculosis (use		CTVSDIVLIAAGIAGFGALIGAHPRALNVVKFGGAAFLIGYG
	this to clone M.		LLAARRAWRPVALIPSGATPVRLAEVLVTCAAFTFLNPHVYL
	smegmatis		DTVVLLGALANEHSDQRWLFGLGAVTASAVWFATLGFGAGRL
	gene)		RGLFTNPGSWRILDGLIAVMMVALGISLTVT
lysE	Mycobacterium	CAB00949	MMTLKVAIGPQNAFVLRQGIRREYVLVIVALCGIADGALIAA	94
	tuberculosis (use		GVGGFAALIHAHPNMTLVARFGGAAFLIGYALLAARNAWRPS
	this to clone M.		GLVPSESGPAALIGVVQMCLVVTFLNPHVYLDTVVLIGALAN
	smegmatis		EESDLRWFFGAGAWAASVVWFAVLGFSAGRLQPFFATPAAWR
	gene		ILDALVAVTMIGVAVVVLVTSPSVPTANVALII
lysE	Streptomyces	CAB93746	MNNALTAAAAGFGTGLSLIVAIGAQNAFVLRQGVRRDAVLAV	95
	coelicolor		VGICALSDAVLIALGVGGVGAVVVAWPGALTAVGWIGGAFLL
			CYGALAARRVFRPSGALRADGAAAGSRRRAVLTCLALTWLNP
			HVYLDTVFLLGSVAADRGPLRWTFGLGAAAASLVWFAALGFG
			ARYLGRFLSRPVAWRVLDGLVAATMIVLGVSLVAGA
lysE	Lactobacillus	CAD63877	MQVFLQGLLFGIVYIAPIGMQNLFVVSTAIEQPLQRALRVAL	96
	plantarum		IVIAFDTSLSLACFYGVGRLLQTTPWLELGVLLIGSLLVFYI
			GWNLLRKKATAMGTLDADFSYKAAILTAFSVAWLNPQALIDG
			SVLLAAFRVSIPAALTHFFMLGVILASIIWFIGLTSLISKFK
			LMQPRVLLWINRICGGIIILYGVQLLATFITKI
lysE	Coryne-	CAA65324	MEIFITGLLLGASLLLSIGPQNVLVIKQGIKREGLIAVLLVC	234
	bacterium		LISDVFLFIAGTLGVDLLSNAAPIVLDIMRWGGIAYLLWFAV
	glutamicum		MAAKDAMTNKVEAPQIIEETEPTVPDDTPLGGSAVATDTRNR
			VRVEVSVDKQRVWVKPMLMAIVLTWLNPNAYLDAFVFIGGVG
			AQYGDTGRWIFAAGAFAASLIWFPLVGFGAAALSRPLSSPKV
			WRWINVVVAVVMTALAIKLMLMG
metB	Mycobacterium	CAA17195	MSEDRTGHQGISGPATRAIHAGYRPDPATGAVNVPIYASSTF	97
	tuberculosis (use		AQDGVGGLRGGFEYARTGNPTRAALEASLAAVEEGAFAPAFS
	this to clone M.		SGMAATDCALRAMLRPGDHVVIPDDAYGGTFRLIDKVFTRWD
	smegmatis		VQYTPVRLADLDAVGAAITPRTRLIWVETPTNPLLSIADITA
	gene)		IAELGTDRSAKVLVDNTFASPALQQPLRLGADVVLHSTTKYI
			GGHSDVVGGALVTNDEELDEEFAFLQNGAGAVPGPFDAYLTM
			RGLKTLVLRMQRHSENACAVAEFLADHPSVSSVLYPGLPSHP
			GHEIAARQMRGFGGMVSVRMRAGRRAAQDLCAKTRVFILAES
			LGGVESLIEHPSAMTHASTAGSQLEVPDDLVRLSVGIEDIAD
			LLGDLEQALG
metB	Mycobacterium	AAA63036	MSEDYRGHHGITGLATKAIHAGYRPDPATGAVNVPIYASSTF	98
	leprae (use this		AQDGVGELRGGFEYARTGNPMRAALEASLATVEEGVFARAFS
	to clone M.		SGMAASDCALRVMLRPGDHVIIPDDVYGGTFRLIDKVFTQWN
	smegmatis		VDYTPVPLSDLDAVRAAITSRTRLIWVETPTNPLLSIADITS
	gene)		IGELGKKHSVKTLVDNTFASPALQQPLMLGALVVLHSTTKYI
			GGHSDVVGGALVTNDEELDQAFGFLQNGAGAVPSPFDAYLTM
			RGLKTLVLRMQRHNENAITVAEFLAGHPSVSAVLYPGLPSHP
			GHEVAARQMRGFGGMVSLRMRAGRLAAQDLCARTKVFTLAES
			LGGVESLIEQPSAMTHASTTGSQLEVPDDLVRLSVGIEDVGD
			LLCDLKQALN
metB	Streptomyces	CAD30944	MPMSDRHISQHFETLAIHAGNTADPLTGAVVPPIYQVSTYKQ	99
	coelicolor		DGVGGLRGGYEYSRSANPTRTALEENLAALEGGRRGLAFASG
			LAAEDCLLRTLLRPGDHVVIPNDAYGGTFRLFAKVATRWGVE
			WSVADTSDAAAVRAALTPKTKAVWVETPSNPLLGITDIAQVA
			QVARDAGARLVVDNTFATPYLQQPLALGADVVVHSLTKYMGG
			HSDVVGGALIVGDQELGEELAFHQNANGAVAGPFDSWLVLRG
			TKTLAVRMDRHSENATKVADMLSRHARVTSVLYPGLPEHPGH
			EVAAKQMKAFGGMVSFRVEGGEQAAVEVCNRAKVFTLGESLG
			GVESLIEHPGRMTHASAAGSALEVPADLVRLSVGIENADDLL
			ADLQQALG
metB	Thermobifida	ZP_00059348	MSYEGFETLAIHAGQEADAETGAVVVPIYQTSTYRQDGVGGL	100
	fusca		RGGYEYSRTANPTRTALEECLAALEGGVRGLAFASGMAAEDT
			LLRTIARPGDHLIIPNDAYGGTFRLVSKVFERWGVSWDAVDL
			SNPEAVRTAIRPETVAIWVETPTNPLLNIADIAALADIAHAA
			DALLVVDNTFASPYLQRPLSLGADVVVHSTTKYLGGHSDVVG
			GALVVADAELGERLAFHQNSMGAVAGPFDAWLTLRGIKTLGV
			RMDRHCANAERVVEALVGHPEVAEVLYPGLSDHPGHKVAVDQ
			MRAFGGMVSFRMRGGEEAALRVCAKTKVFTLAESLGGVESLI
			EHPGKMTHASTAGSLLEVPSDLVRLSVGIETVDDLVNDLLQA
			LEP
metB	Lactobacillus	CAD62912	MKFETQLIHGGISEDATTGATSVPIYMASTFRQTKIGQNQYE	101
	plantarum		YSRTGNPTRAAVEALIATLEHGSAGFAFASGSAAINTVFSLF
			SAGDHIIVGNDVYGGTFRLIDAVLKHFGMTFTAVDTRDLAAV
			EAAITPTTKAIYLETPTNPLLHITDIAAIAKLAQAHDLLSII
			DNTFASPYVQKPLDLGVDIVLHSASKYLGGHSDVIGGLVVTK
			TPALGEKIGYLQNAIGSILAPQESWLLQRGMKTLALRMQAHL
			NNAAKIFTYLKSHPAVTKIYYPGDPDNPDFSIAKQQMNGFGA
			MISFELQPGMNPQTFVEHLQVITLAESLGALESLIEIPALMT
			HGAIPRTIRLQNGIKDELIRLSVGVEASDDLLADLERGFASI
			QAD
metB	Coryne-	AAD54070	MSFDPNTQGFSTASIHAGYEPDDYYGSINTPIYASTTFAQNA	235
	bacterium		PNELRKGYEYTRVGNPTIVALEQTVAALEGAKYGRAFSSGMA
	glutamicum		ATDILFRIILKPGDHIVLGNDAYGGTYRLIDTVFTAWGVEYT
			VVDTSVVEEVKAAIKDNTKLIWVETPTNPALGITDIEAVAKL
			TEGTNAKLVVDNTFASPYLQQPLKLGAHAVLHSTTKYIGGHS
			DVVGGLVVTNDQEMDEELLFMQGGIGPIPSVFDAYLTARGLK
			TLAVRMDRHCDNAEKIAEFLDSRPEVSTVLYPGLKNHPGHEV
			AAKQMKRFGGMISVRFAGGEEAAKKFCTSTKLICLAESLGGV
			ESLLEHPATMTHQSAAGSQLEVPRDLVRISIGIEDIEDLLAD
			VEQALNNL
metB	Escherichia coli	NP_418374	MTRKQATIAVRSGLNDDEQYGCVVPPIHLSSTYNFTGFNEPR	236
			AHDYSRRGNPTRDVVQRALAELEGGAGAVLTNTGMSAIHLVT
			TVFLKPGDLLVAPHDCYGGSYRLFDSLAKRGCYRVLFVDQGD
			EQALRAALAEKPKNVLVESPSNPLLRVVDIAKICHLAREVGA
			VSVVDNTFLSPALQNPLALGADLVLHSCTKYLNGHSDVVAGV
			VIAKDPDVVTELAWWANNIGVTGGAFDSYLLLRGLRTLVPRM
			ELAQRNAQAIVKYLQTQPLVKKLYHPSLPENQGHEIAARQQK
			GFGANLSFELDGDEQTLRRFLGGLSLFTLAESLGGVESLISH
			AATMTHAGMAPEAPAAAGISETLLRISTGIEDGEDLIADLEN
			GFPAANKG
putative	Streptomyces	CAB40862	MAGIGAFWSVSFLLVLVPGADWAYAITAGLRHRSVLPAVGGM	102
threonine	coelicolor		LSGYVLLTAVVAAGLATAVAGSPTVLTALTAAGAAYLIWLGA
efflux			TTLARPAAPRAEEGDQGDGSGSLVGRAARGAGISGLNPKALL
protein 1			LFLALLPQFAARDADWPFAAQIVALGLVHTANCAVVYTGVGA
			TARRILGARPAVATAVSRFSGAAMILVGALLLVERLLAQGPT
threonine	Coryne-	NP_601855	MDAASWVAFALALLVANAVPGPDLVLVLHSATRGIRTGVMTA	196
efflux	bacterium		AGIMTGLMLHASLAIAGATALLLSAPGVLSAIQLLGAGVLLW
protein	glutamicum		MGTNMFRASQNTGESETAASQSSAGYFRGFITNATNPKALLF
			FAAILPQFIGNGEDMKMRTLANCATIVLGSGAWWLGTIALVR
			GIGLQKLPSADRIITLVGGIALFLIGAGLLVNTAYGLIT
hypothetical	Streptomyces	CAB42763	MSVPGSVAQVTEAEEPKPQSDEARSAFRQPSGIAASIDGESS	103
protein	coelicolor		TTSEFEIPQGFAVPRHAGTESETTSEFSLPDGLEVPQAPPAD
NCgl2533			TEGSAFTMPSTHSAWTAPTAFTPASGFPAVSLTDVPWQDRMR
related			AMLRMPVAERPAPEPSQKHDDETGPAVPRVLDLTLRIGELLL
			AGGEGAEDVEAANFAVCRSYGLDRCEPNVTFTLLSISYQPSL
			VEDPVTASRTVRRRGTDYTRLAAVFHLVDDLSDPDTNISLEE
			AYRRLAEIRRNRHPYPTWVLTVASGLLAGGASLLVGGGLTVF
			FAAMFGSMLGDRLAWLCAGRGLPEFYQFAVAAMPPAAMGVVL
			TVTHVDVKASAVITGGLFALLPGRALVAGVQDGLTGFYITAA
			ARLLEVMYFFVSIVAGVLVVLYFGVQLGAELHPDAKLGTGDE
			PFVQIFASMLLSLAFAILLQQERATVLAVTLNGGIAWCVYGA
			MNYAGDISPVASTAAAAGLVGLFGQLMSRYRFASALPYTTAA
			IGPLLPGSATYFGLLGIAQGEVDSGLLSLSNAVALAMAIAIG
			VNLGGEISRLFLKVPGAASAAGRRAAKRTRGF
hypotheti-	Mycobacterium	AAK48209	MDQDRSDNTALRRGLRIALRGRRDPLPVAGRRSRTSGGIGDL	104
cal	tuberculosis (use		HTRKVLDLTIRLAEVMLSSGSGTADVVATAQDVAQAYQLTDC
protein	this to clone M.		VVDITVTTIIVSALATTDTPPVTIMRSVRTRSTDYSRLAELD
NCgl2533	smegmatis		RLVQRITSGGVAVDQAHEANDELTERPHPYPRWLATAGAAGF
related	gene)		ALGVAMLLGGTWLTCVLAAVTSGVIDRLGRLLNRIGTPLFFQ
			RVFGAGIATLVAVAAYLIAGQDPTALVATGIVVLLSGMTLVG
			SMQDAVTGYMLTALARLGDALFLTAGIVVGILISLRGVTNAG
			IQIELHVDATTTLATPGMPLPILVAVSGAALSGVCLTIASYA
			PLRSVATAGLSAGLAELVLIGLGAAGFGRVVATWTAAIGVGF
			LATLISIRRQAPALVTATAGIMPMLPGLAVFRAVFAFAVNDT
			PDGGLTQLLEAAATALALGSGVVLGEFLASPLRYGAGRIGDL
			FRIEGPPGLRRAVGRVVRLQPAKSQQPTGTGGQRWRSVALEP
			TTADDVDAGYRGDWPATCTSATEVR
hypotheti-	Mycobacterium	CAA18059	MDQDRSDNTALRRGLRIALRGRRDPLPVAGRRSRTSGGIDDL	105
cal	tuberculosis (use		HTRKVLDLTIRLAEVMLSSGSGTADVVATAQDVAQAYQLTDC
protein	this to clone M.		VVDITVTTIIVSALATTDTPPVTIMRSVRTRSTDYSRLAELD
NCgl2533	smegmatis		RLVQRITSGGVAVDQAHEAMDELTERPHPYPRWLATAGAAGF
related	gene)		ALGVAMLLGGTWLTCVLAAVTSGVIDRLGRLLNRIGTPLFFQ
			RVFGAGIATLVAVAAYLIAGQDPTALVATGIVVLLSGMTLVG
			SMQDAVTGYMLTALARLGDALFLTAGIVVGILISLRGVTNAG
			IQIELHVDATTTLATPGMPLPILVAVSGAALSGVCLTIASYA
			PLRSVATAGLSAGLAELVLIGLGAAGFGRVVATWTAAIGVGF
			LATLISIRRQAPALVTATAGIMPMLPGLAVFRAVFAFAVNDT
			PDGGLTQLLEAAATALALGSGVVLGEFLASPLRYGAGRIGDL
			FRIEGPPGLRRAVGRVVRLQPAKSQQPTGTGGQRWRSVALEP
			TTADDVDAGYRGDWPATCTSATEVR
hypotheti-	Thermobifida	ZP_000595	MISYGPVADRCRVGATSAAWGTSPPMSFPFLPLVSHPLPYVP	106
cal	fusca		GLDASFPDGACVPLGRGPSRGGERRMNQAPRRSDTSHSPTLL
protein			TRLRDWRASRGVLDLEAEEFEDEAPRPDPRAMDLVLRVGELL
NCgl2533			LASGEATETVSDAMLSLAVAFELPRSEVSVTFTGITLSCHPG
related			GDEPPVTGERVVRRRSLDYHKVNELHALVEDAALGLLDVERA
			TARLHAIKRSRPHYPRWVIVAGLGLIASSASVMVGGGIIVAA
			TAFAATVLGDRAAGWLARRGVAEFYQMAVAALLAASTGMALL
			WVSEELELGLRAMAVITGSIVALLPGRPLVSSLQDGISGAYV
			SAAARLLEVFFMLGAIVAGVGAVAYTAVRLGLYVDLDNLPSA
			GTSLEPVVLAAAAGLALAFAVSLVAPVRALLPIGANGVLIWV
			CYAGLRELLAVPPVVGTGAGAVVVGVIGHWLARRTRRPPLTF
			IIPSIAPLLPGSILYRGLIEMSTGEPLAGVASLGEAVAVGLA
			LGAGVNLGGELVPAFSWGGLVGAGRRGRQAARRTRGGY
hypotheti-	Lactobacillus	CAD62758	MNKERKSVMPLSQRHHMTIPWKDFIRNEDVPAKHASLQERTS	107
cal	plantarum		IVGRVGILMLSCGTGAWRVRDAMNKIARSLNLTCSADIGLIS
protein			IQYTCFHHERSYTQVLSIPNTGVNTDKLNILEQFVKDFDAKY
NCgl2533			ARLTVAQVHAAIDEVQTRPKQYSPLVLGLAAGLACSGFIFLL
related			GGGIPEMICSFLGAGLGNYVRALMGKRSMTTVAGIAVSVAVA
			CLAYMVSFKIFEYNFQILAQHEAGYIGAMLFVIPGFPFITSM
			LDISKLDMRSGLERLAYAIMVTLIATLVGWLVATLVSFKPAL
			FLPLGLSPLAVLLLRLPASFCGVYGFSIMFNSSQKMAITAGF
			IGAIANTLRLELVDLTAMPPAAAAFCGALVAGLIASVVNRYN
			GYPRISLTVPSIVIMVPGLYIYRAIYSIGNNQIGVGSLWLTK
			AVLIIMFLPLGLFVAPALLDHEWRHFD
NCgl2533	Coryne-	NP_601823	MLSFATLRGRISTVDAAKAAPPPSPLAPIDLTDHSQVAGVMN	198
	bacterium		LAARIGDILLSSGTSNSDTKVQVRAVTSAYGLYYTHVDITLN
	glutamicum		TITIFTNIGVERKMPVNVFHVVGKLDTNFSKLSEVDRLIRSI
			QAGATPPEVAEKILDELEQSPASYGFPVALLGWAMMGGAVAV
			LLGGGWQVSLIAFITAFTIIATTSFLGKKGLPTFFQNVTGGF
			IATLPASIAYSLALQFGLEIKPSQIIASGIVVLLAGLTLVQS
			LQDGITGAPVTASARFFETLLFTGGIVAGVGLGIQLSEILHV
			MLPAMESAAAPNYSSTFARIIAGGVTAAAFAVGCYAEWSSVI
			IAGLTALMGSAFYYLFVVYLGPVSAAAIAATAVGFTGGLLAR
			RFLIPPLIVAIAGITPMLPGLAIYRGMYATLNDQTLMGFTNI
			AVALATASSLAAGVVLGEWIARRLRRPPRFNPYRAFTKANEF
			SFQEEAEQNQRRQRKRPKTNQRFGNKR
putative	Thermobifida	ZP_000569	MSGGVMADITRNRSSGLAFAIASALAFGGSGPVARPLIDAGL	108
membrane	fusca		DPLHVTWLRVAGAALLLLPVAFRHHRTLRTRPALLLAYGVFP
protein			MAGVQAFYFAAISRIPVGVALLIEFLGPVLVLLWTRLVRRIP
NCgl0580			VSRAASLGVALAVIGLGCLVEVWAGIRLDAVGLILALAAAVC
related			QATYFLLSDTARDDVDPLAVISYGALIATALLSLLARPWTLP
			WGILAQNVGFGGLDIPALILLVWLALVATTIAYLTGVAAVRR
			LSPVVAGGVAYLEVVTSIVLAWLLLGEALSVAQLVGAAAVVT
			GAFLAQTAVPDTSAAQGPETLPTAQDPAPQTGSAR
putative	Thermobifida	ZP_000594	MNSDSPGQSAPGPFSRAAALVRAAGTAIPATWLVGVSILSVQ	109
membrane	fusca		FGAGVAKNLFAVLPPSTVVWLRLLASALVLLCFAPPPLRGHS
protein			RTDWLVAVGFGTSLAVMNYAIYESFARIPLGVAVTIEFLGPL
NCgl0580			AVAVAGSRRWRDLVWVVLAGTGVALLGWDDGGVTLAGVAFAA
related			LAGAAWACYILLSAATGRRFPGTSGLTVASVIGAVLVAPMGL
			AHSSPALLDPSVLLTGLAVGLLSSVIPYSLEMQALRRIPPGV
			FGILMSLEPAAAALVGLVLLGEFLTVAQWAAVACVVVASVGA
			TRSARL
putative	Thermobifida	ZP_000580	MWTLDLPLKRNDSSTNGAWTETENRRHSGGMILSFVSLVRHA	110
membrane	fusca		HLRVPAPLLTVLSLVLLHMGSAGAVHLFAIAGPLEVTWLRLS
protein			WAALLLFAVGGRPLLRAARAATWSDLAATAALGVVSAGMTLL
NCgl0580			FSLALDRIPLGTAAAIEFLGPLTVSVLALRRRRDLLWIVLAV
related			AGVLLLTRPWHGEANLLGIAFGLGGAVCVALYIVFSQTVGSR
			LGVLPGLTLANTVSALVTAPLGLPGAMAAADRHLVAATLGLA
			LIYPLLPLLLEMVSLQRMNRGTFGILVSVDPAIGLLIGLLLI
			GQVPVPLQVAGMALVVAAGLGATRGTSGRTRGGADPHATDGE
			PEDRTPDRPAPDDAGHHTTDPVTV
putative	Streptomyces	CAB71821	MAATRPAVIALTALAPVSWGSTYAVTTEFLPPDRPLFTGLMR	111
membrane	coelicolor		ALPAGLLLLALARVLPRGAWWGKAAVLGVLNIGAFFPLLFLA
protein			AYRMPGGMAAVVGSVGPLLVVGLSALLLGQRPTTRSVLTGVA
NCgl0580			AASGVSLVVLEAAGALDPLGVLAALAATASMSTGTVLAGRWG
related			RPEGVGPLALTGWQLTAGGLLLAPLALLVEGAPPALDGPAVG
			GYLYLALANTALAYWLWFRGIGRLSATQVTFLGPLSPLTAAV
			IGWAALGEALGPVQLAGTALAFGATLVGQTVPSAPRTPPVAA
			GAGPFSSASRNGRKDSMDLTGAALRR
putative	Streptomyces	CAB95885	MPDGAPGGRFGALGPVGLVLAGGISVQFGAALAVSLMPRAGA	112
membrane	coelicolor		LGVVTLRLAVAAVVMLLVCRPRLRGHSRADWGTVVVFGIAMA
protein			GMNGLFYQAVDRIPLGPAVTLEVLGPLALSVFASRRAMNLVW
NCgl0580			AALALAGVFLLGGGGFDGLDPAGAAFALAAGAMWAAYIVFSA
related			RTGRRFPQADGLALAMAVGALLFLPLGIVESGSKLIDPVTLT
			LGAGVALLSSVLPYTLELLALRRLPAPTFAILMSLEPAIAAA
			AGFLILDQALTATQSAAIALVIAASMGAVRTQVGRRRAKALP
putative	Streptomyces	CAB46802	MMTTARTSPPAPWHRRPDLLAAGAATVTVVLWASAFVSIRSA	113
membrane	coelicolor		GEAYSPGALALGRLLSGVLTLGAIWLLRREGLPPRAAWRGIA
protein			ISGLLWFGFYMVVLNWGEQQVDAGTAALVVNVGPILIALLGA
NCgl0580			RLLGDALPPRLLTGMAVSFAGAVTVGLSMSGEGGSSLFGVVL
related			CLLAAVAYAGGVVAQKPALAHASALQVTTFGCLVGAVLCLPF
			AGQLVHEAAGAPVSATLNMVYLGVFPTALAFTTWAYALARTT
			AGRMGATTYAVPALVVLMSWLALGEVPGLLTLAGGALCLAGV
			AVSRSRRRPAAVPDRAAPTAEPRREDAGRA
putative	Streptomyces	CAC32287	MPVHTSDSARGSRGKGIGLGLALASAVAFGGSGVAAKPLIEA	114
membrane	coelicolor		GLDPLHVVWLRVAGAALVMLPLAVRHPALPRRRPALVAGYGL
protein			FAVAGVQACYFAAISRIPVGVALLVEYLAPALVLGWVRFVQR
NCgl0580			RPVTRAAALGVVLAVGGLACVVEVWSGLGFDALGLLLALGAA
related			CCQVGYFVLSDQGSDAGEEAPDPLGVIAYGLLVGAAVLTIVA
			RPWSMDWSVLAGSAPMDGTPVAAALLLAWIVLIATVLAYVTG
			IVAVRRLSPQVAGVVACLEAVIATVLAWVLLGEHLSAPQVVG
			GIVVLAGAFIAQSSTPAKGSADPVARGGPERELSSRGTST
putative	Erwinia	S35974	MKLKDFAFYAPCVWGTTYFVTTQFLPADKPLLAALIRALPAG	115
membrane	chrysanthemi		IILILGKNLPPVGWLWRLFVLGALNIGVFFVMLFFAAYRLPG
protein			GVVALVGSLQPLIVILLSFLLLTQPVLKKQMVAAVAGGIGIV
NCgl0580			LLISLPKAPLNPAGLVASALATMSMASGLVLTKKWGRPAGMT
related			MLTFTGWQLFCGGLVILPVQMLTEPLPDLVTLTNLAGYLYLA
			IPGSLLAYFMWFSGLEANSPVIMSLLGFLSPLVALLLGFLFL
			QQGLSGAQLVGVVFIFSALIIVQDISLFSRRKKVKPLEQSDC
			AVK
putative	regulatory	AAF74778	MKLKDFAFYAPCVWGTTYFVTTQFLPADKPLLAALIRALPAG	116
membrane	protein PecM		IILILGKTLPPVGWLWRLFVLGALNIGVFFVMLFFAAYRLPG
protein	[Pecto-bacterium		GVVALVGSLQPLIVILLSFLLLTQPVLKKQMVAAVAGGIGIA
NCgl0580	chrysanthemi]		LLISLPKAPLNPAGLVASALATVSMASGLVLTKKWGRPAGMT
related			MLTFTGWQLFCGGLVILPVQMLTEPLPDVVTLTNLAGYFYLA
			IPGSLLAYFMWFSGIEANSPVMMSMLGFLSPLVALFLGFLFL
			QQGLSGAQLVGVVFIFSAIIIVQDVSLFSRRKKVKQLEQSDC
			AVK
putative	Lactobacillus	CA063826	MKRLVGTLCGIISAALFGLGGILAQPLLSEQVLTPQQIVLLR	117
membrane	plantarum		LLIGGAMLLLYRNLFFKQARKSTKKIWTHWRILTRIMIYGIA
protein			GLCTAQIAFFSAINYSNAAVATVFQSTSPFILLVFTALKAKR
NCgl0580			LPSLLAGMSLISALMGIWLIVESGFKTGLIKPEAIIFGLIAA
related			IGVILYTKLPVPLLNQIAAVDILGWALVIGGVIALIHTPLPN
			LVRFSKTQLLAVLIIVILATVVAYDLYLESLKLIDGFLATMT
			GLFEPISSVLFGMLFLHQILVPQALVGIILNVGAIMILNLPH
			HITAPVPSKTCQCTMSNQ
putative	Lactobacillus	CAD62768	MKKIAPLFVGLGAISFGIPASLFKIARRQGVVNGPLLFWSFL	118
membrane	plantarum		SAVVILGVIQILRPARLRNQQTNWKQIGLVIAAGTASGFTNT
protein			FYIQALKLIPVAVAAVMLMQAVWISTLLGAVIHHRRPSRLQV
NCgl0580			VSIVLVLIGTILAAGLFPITQALSPWGLMLSFLAACSYACTM
related			QFTASLGNNLDPLSKTWLLCLGAFILIAIVWSPQLVTAPTTP
			ATVGWGVLIALFSMVFPLVMYSLFMPYLELGIGPILSSLELP
			ASIVVAFVLLDETIDWVQMVGVAIIITAVILPNVLNMRRVRP
putative	Lactobacillus	CAD65468	MTTNRYMKGIMWAMLASTLWGVSGTVMQFVSQNQAIPADWFL	119
membrane	plantarum		SVRTLSAGIILLAIGFVQQGTKIFKVFRSWASVGQLVAYATV
protein			GLMANMYTFYISIERGTAAAATILQYLSPLFIVLGTLLFKRE
NCgl0580			LPLRTDLIAFAVSLLGVFLAITKGNIHELAIPMDALVWGILS
related			GVTAALYVVLPRKIVAENSPVVILGWGTLIAGILFNLYHPIW
			IGAPKITPTLVTSIGAIVLIGTIFAFLSLLHSLQYAPSAVVS
			IVDAVQPVVTFVLSIIFLGLQVTWVEILGSLLVIVAIYILQQ
			YRSDPASD
NCgl0580	Coryne-	NP_599841	MNKQSAAVLMVMGSALSLQFGAAIGTQLFPLNGPWAVTSLRL	201
	bacterium		FIAGLIMCLVIRPRLRSWTKKQWIAVLLLGLSLGGMNSLFYA
	glutamicum		SIELIPLGTAVTIEFLGPLIFSAVLARTLKNGLCVALAFLGM
			ALLGIDSLSGETLDPLGVIFAAVAGIFWVCYILASKKIGQLI
			PGTSGLAVALITGAVAVFPLGATHMGPIFQTPTLLILALGTA
			LLGSLIPYSLELSALRRLPAPIFSILLSLEPAFAAAVGWILL
			DQTPTALKWAAIILVIAASIGVTWEPKKMLVDAPLHSKCNAK
			RRVHTPS
drug	Streptomyces	CAC32286	MSNAVSGLPVGRGLLYLIVAGVAWGTAGAAASLVYPASDLGP	120
permease	coelicolor		VALSFWRCANGLVLLLAVRPLRPRLRPRLRPRLRPAVREPFA
NCgl2065			RRTLRAGVTGVGLAVFQTAYFAAVQSTGLAVATVVTLGAGPV
related			LIALGARLALGEQLGAGGAAAVAGALAGLLVLVLGGGSATVR
			LPGVLLALLSAAGYSVMTLLTRWWGRGGGADAAGTSVGAFAV
			TSLCLLPFALAEGLVPHTAEPVRLLWLLAYVAAVPTALAYGL
			YFAGAAVVRSATVSVIMLLEPVSAAALAVLLLGEHLTAATLA
			GTLLMLGSVAGLAVAETRAAREARTRPAPA
drug	Streptomyces	CAA19979	MNVLLSAAFVLCWSSGFIGAKLGAQTAATPTLLMWRFLPLAV	121
permease	coelicolor		ALVAAAAVSRAAWRGLTPRDAGRQTAIGALSQSGYLLSVYYA
NCgl2065			IELGVSSGTTALIDGVQPLVAGALAGPLLRQYVSRGQWLGLW
related			LGLSGVATVTVADAGAAGAEVAWWAYLVPFLGMLSLVAATFL
			EGRTRVPVAPRVALTIHCATSAVLFSGLALGLGAAAPPAGSS
			FWLATAWLVVLPTFGGYGLYWLILRRSGITEVNTLMFLMAPV
			TAVWGALMFGEPFGVQTALGLAVGLAAVVVVRRGGGARRERP
			VRSGADRPAAGGPTADQPTNRPTDRPTAAGSTDRPTADRR
drug	Thermobifida	ZP_000581	MSDFRKGVLYGASSYFMWGFLPLYWPLLTPPATAFEVLLHRM	122
permease	fusca		IWSLVVTLVVLLVQRNWQWIRGVLRSPRRLLLLLASAALISL
NCgl2065			NWGAFITAVTTGHTLQSALAYFINPLVSVALGLLVFKERLRP
related			GQWAALLLGVLAVAVLTVDYGSLPWLALAMAFSFAVYGALKK
			FVGLDGVESLSAETAVLFLPALGGAVYLEVTGTGTFTSVSPL
			HALLLVGAGVVTAAPLMLFGAAAHRIPLTLVGLLQFMVPVMH
			FLIAWLVFGEDLSLGRWIGFAVVWTALVVFVVDMLRHARHTP
			RPAPSAPVAEEAEETAAS
drug	Streptomyces	CAC08293	MAGSSRSDQRVGLLNGFAAYGMWGLVPLFWPLLKPAGAGETL	123
permease	coelicolor		AHRMVWSLAFVAVALLFVRRWAWAGELLRQPRRLALVAVAAA
NCgl2065			VITVNWGVYIWAVNSGHVVEASLGYFINPLVTIAMGVLLLKE
related			RLRPAQWAAVGTGFAAVLVLAVGYGQPPWISLCLAFSFATYG
			LVKKKVNLGGVESLAAETAIQFLPALGYLLWLGAQGESTFTT
			EGAGHSALLAATGVVTAIPLVCFGAAAIRVPLSTLGLLQYLA
			PVFQFLLGVLYFGEAMPPERWAGFGLVWLALTLLTWDALRTA
			RRTAPALREQLDRSGAGVPPLKGAAAAREPRVVASGTPAPGA
			GDAPQQQQQQQQQQQQQQHGTRAGKP
drug	Lactobacillus	CAD63209	MKKAYLYIAISTLMFSSMEIALKMAGSAFNPIQLNLIRFFIG	124
permease	plantarum		AIVLLPFALRALKQTGRKLVSADWRLFALTGLVCVIVSMSLY
NCg12065			QLAITVDQASTVAVLFSCNPVFALLFSYLILRERLGRANLIS
related			VVISVIGLLIIVNPAHLTNGLGLLLAIGSAVTFGLYSIISRY
			GSVKRGLNGLTMTCFTFFAGAFELLVLAWITKIPAVANGLTA
			IGLRQFAAIPVLVNVNLNYFWLLFFIGVCVTGGGFAFYFLAM
			EQTDVSTASLVFFIKPGLAPILAALILHEQILWTTVVGIVVT
			LIGSVVTFVGNRFRERDTMGAIEQPTAAATDDEHVIKAAHAV
			SNQEN
NCgl2065	Coryne-	NP_601347	MNDAGLKTRNPVLAPILMVVNGVSLYAGAALAVGLFESFPPA	199
	bacterium		LVAWMRVAAAAVILLVLYRPAVRNFIGQTGFYAAVYGVSTLA
	glutamicum		MNITFYEAIARIPMGTAVAIEFLGPIAVAALGSKTLRDWAAL
			VLAGIGVIIISGAQWSANSVGVMFALAAALLWAAYIIAGNRI
			AGDASSSRTGMAVGFTWASVLSLPLAIWWWPGLGATELTLIE
			VIGLALGLGVLSAVIPYGLDQIVLRMAGRSYFALLLAILPIS
			AALMGALALGQMLSVAELVGIVLVVIAVALRRPS
predicted	19553330	NP_601332.1	MIFGVLAYLGWGMFPAFFPLLLPAGPFEILAHRILWTAVLMM	200
permease			IIISFTSGWKELKSADRGTWLRIILSSLFIAGNWLIYVIAVN
			SGQVTEAALGYFINPLLSVVLGIVFFKEQLRKLQISAVVIAA
			AGVLVLTFLGDKPPYLAITLAFTFGIYGALKKQVKMSAASSL
			CAETLVLLPIAVIYLIGLEASGHSTFFNNGSGHMALLICSGL
			VTAVPLLMFALAAKAIPLSTVGMLQYLTPTMQMLWALFVVNE
			SVEPMRWFGFVFIWIAVTIYITDSLLKK
hypotheti-	Thermobifida	P_000582	MNADTLLWSLLLGVIVVAAAAAIIIPTVRNSSTAPPPGAVGT	125
cal	fusca		ALGAALTAAALGIAGSGTAPASEVPAGSGQVRTVDVVLGDMT
membrane			VSPSHVTVAPGDSLVLRVRNEDTQVHDLVVETGARTPRLAPG
protein			DSATLQVGTVTEPIDAWCTVLGHSAAGMRMRIDTTDTADSAD
NCgl2829			SPDTPAGADSGPPAPLPLSAEMSDDWQPRDAVLPPAPDRTEH
related			EVEIRVTETELEVAPGVRQSVWTFGGDVPGPVLRGKVGDVFT
			VTFVNDGTMGHGIDFHASSLAPDEPMRTINPGERLTYRFRAE
			KAGAWVYHCSTSPMLQHIGNGMYGAVIIDPPDLEPVDREYLL
			VQGELYLGEPGSADQVARMRAGEPDAWVFNGVAAGYAHAPLT
			AEVGERVRIWVVAAGPTSGTSFHIVGAQFDTVYKEGAYLVRR
			GDAGGAQALDLAVAQGGFVETVFPEAGSYPFVDHDMRHAENG
			ARGFFTITE
NCgl2829	Coryne-	NP_602117	MVLVIAGIIHPLLPEYRWVLIHLFTLGAITNSIVVWSQHFTE	197
	bacterium		KFLHLKLEESKRPAQLLKIRVLNVGIIVTIIGQMIGQWIVTS
	glutamicum		VGATIVGGALAWHAGSLASQFRSAKRGQPFASAVIAYVASAC
			CLPFGAFAGALLSKELSGHLQERVLLTHTVINFLGFVGFAAL
			GSLSVLFAAIWRTKIRHNFTPWSVGIMAVSLPIIVTGILLNN
			GYVAATGLAAYVAAWLLAMVGWGKASISNLSFSTSTSTTAPL
			WLVGTLVWLAVQAVMHDGELYHVEVPTIALVIGFGAQLLIGV
			MSYLLPSTMGGGASAVRTGTHILNTAGLFRWTLINGGLAIWL
			LTDNSWLRVVVSLLSIGALAVFVILLPKAVRAQRGVITKKRE
			PITPPEEPRLNQITAGISVLALILAAFGGLNPGVAPVASSNE
			DVYAVTITAGDMVFIPDVIEVPAGKSLEVTMLNEDDMVHDLK
			FANGVQTGRVAPGDEITVTVGDISEDMDGWCTIAGHRAQGMD
			LEVKVAAPN
yggA	Escherichia coli	AAA69090	MFSYYFQGLALGAAMILPLGPQNAFVMNQGIRRQYHIMIALL	237
			CAISDLVLICAGIFGGSALLMQSPWLLALVTWGGVAFLLWYG
			FGAFKTANSSNIELASAEVMKQGRWKIIATMLAVTWLNPHVY
			LDTFVVLGSLGGQLDVEPKRWFALGTISASFLWFFGLALLAA
			WLAPRLRTAKAQRIThLVVGCVMWFIALQLARDGIAHAQ
			ALFS
McbR	C. glutamicum		MAASASGKSKTSAGANRRRNRPSPRQRLLDSATNLFTTEGIR	363
			VIGIDRILREADVAKASLYSLFGSKDALVIAYLENLDQLWRE
			AWRERTVGMKDPEDKIIAFFDQCIEEEPEKDFRGSHFQNAAS
			EYPRPETDSEKGIVAAVLEHREWCHKTLTDLLTEKNGYPGTT
			QANQLLVFLDGGLAGSRLVHNISPLETARDLARQLLSAPPAD
			YSI
ThrB	C. glutamicum	NP_600410.1	MAIELNVGRKVTVTVPGSSANLGPGFDTLGLALSVYDTVEVE	364
			IIPSGLEVEVFGEGQGEVPLDGSHLVVKAIRAGLKAADAEVP
			GLRVVCHNNIPQSRGLGSSAAAAVAGVAAANGLADFPLTQEQ
			IVQLSSAFEGHPDNAAASVLGGAVVSWTNLSIDGKSQPQYAA
			VPLEVQDNIRATALVPNFHASTEAVRRVLPTEVTHIDARFNV
			SRVAVMIVALQQRPDLLWEGTRDRLHQPYRAEVLPITSEW
			VNRLRNRGYAAYLSGAGPTAMVLSTEPIPDKVLEDARESGIK
			VLELEVAGPVKVEVNQP

TABLE 17
Nucleotide sequences of exemplary heterologous proteins for amino acid production in
Escherichia coli and coryneform bacteria. Note: This table provides coding sequences of each
gene. Some GenBank ® entries contain additional non-coding sequence associated with the gene.
		GenBank ®		SEQ ID
Gene	Organism	Nucleotide ID	NUCLEOTIDE SEQUENCE (CODING)	NO:
lysC	Mycobacterium	Z17372	GTGGCGCTCGTCGTACAGAAATACGGCGGATCCTCGGT	11
	smegmatis		GGCGGACGCCGAGAGGATCCGACGGGTCGCCGAGCGGA
			TCGTCGAGACCAAGAAGGCGGGCAACGACGTCGTCGTC
			GTCGTCTCCGCGATGGGTGACACCACCGATGACCTGCT
			GGACCTGGCGCGCCAGGTGTCGCCCGCGCCGCCGCCGC
			GCGAGATGGACATGCTGCTGACCGCCGGTGAGCGGATC
			TCCAACGCGCTGGTCGCGATGGCCATCGAATCGCTCGG
			CGCGCAGGCCCGGTCCTTCACCGGATCGCAGGCCGGTG
			TGATCACCACGGGCACGCACGGCAACGCCAAGATCATC
			GACGTCACCCCGGGCCGGTTGCGCGACGCGCTCGACGA
			GGGGCAGATCGTGCTGGTCGCCGGGTTCCAGGGCGTCA
			GCCAGGACAGCAAGGACGTCACCACGCTGGGACGCGGC
			GGTTCGGACACCACGGCCGTCGCCGTGGCTGCGGCACT
			CGATGCCGATGTCTGCGAGATCTACACCGACGTCGACG
			GCATCTTCACCGCGGACCCGCGCATCGTGCCCAACGCC
			CGCCACCTCGACACCGTCTCCTTCGAGGAGATGCTGGA
			GATGGCGGCCTGCGGCGCGAAAGTTCTGATGCTGCGCT
			GCGTCGAGTACGCCCGCCGCTACAACGTGCCCATCCAC
			GTCCGGTCGTCGTATTCGGACAAGCCCGGCACCATCGT
			CAAAGGATCGATCGAGGACATCCCCATGGAAGACGCCA
			TCCTGACCGGAGTAGCCCACGACCGCAGCGAGGCCAAG
			GTCACGGTGGTCGGTCTGCCCGACGTTCCCGGCTACGC
			CGCCAAGGTGTTCCGCGCGGTCGCCGAGGCCGACGTGA
			ACATCGACATGGTGCTGCAGAACATCTCGAAGATCGAG
			GACGGCAAGACCGACATCACGTTCACGTGTGCGCGTGA
			CAACGGCCCGCGGGCCGTAGAGAAGCTCTCGGCGCTCA
			AGAGCGAGATCGGTTTCAGCCAGGTGCTGTACGACGAC
			CACATCGGCAAGGTGTCGCTGATCGGCGCCGGTATGCG
			GTCGCATCCGGGCGTGACGGCCACGTTCTGCGAGGCGC
			TCGCGGAGGCCGGCATCAACATCGACCTGATCTCGACG
			TCGGAGATCCGTATCTCGGTGCTCATCAAGGACACCGA
			ACTGGACAAGGCGGTTTCGGCGCTGCACGAGGCGTTCG
			GCCTCGGCGGCGACGACGAAGCCGTGGTGTACGCGGGA
			ACGGGGCGCTGA
lysC	Amycolatopsis	AF134837	GTGGCCCTCGTGGTCCAGAAGTACGGCGGATCGTCGCT	31
	mediterranei		GGAAAGTGCCGACCGGATCAAGCGCGTGGCGGAGCGGA
			TCGTCGCGACGAAGAAGGCGGGCAACGACGTCGTCGTC
			GTCTGCTCGGCGATGGGTGACACCACCGACGAGCTGCT
			CGACCTGGCGCAGCAGGTCAACCCGGCGCCGCCGGAGC
			GGGAGATGGACATGCTGCTCACCGCCGGTGAGCGCATC
			TCGAACTCGCTGGTCGCGATGGCGATCGCGGCCCAGGG
			CGCCGAGGCGTGGTCGTTCACCGGTTCGCAGGCCGGCG
			TCGTCACGACGTCGGTGCACGGCAACGCGCGCATCATC
			GACGTCACGCCGAGCCGGGTCACCGAGGCGCTCGACCA
			GGGGTACATCGCGCTGGTGGCGGGCTTCCAGGGCGTCG
			CGCAGGACACCAAGGACATCACCACGCTGGGCCGCGGC
			GGCTCGGACACCACCGCCGTCGCGCTGGCCGCCGCGCT
			GAACGCCGACGTCTGCGAGATCTACTCCGATGTGGACG
			GTGTGTACACGGCGGACCCGCGGGTGGTGCCGGACGCG
			AAGAAGCTCGACACCGTCACGTACGAAGAGATGCTCGA
			GCTCGCCGCGAGCGGGTCGAAGATCCTGCACCTGCGTT
			CGGTCGAGTACGCGCGCCGCTACGGCGTCCCGATCCGA
			GTCCGTTCTTCCTACAGCGACAAGCCGGGCACGACGGT
			GACCGGTTCTATCGAGGAGATCCCCGTGGAACAAGCCC
			TGATCACCGGTGTGGCGCACGACCGCTCCGAAGCCAAG
			ATCACGGTCACCGGGGTGCCGGACCACACCGGCGCCGC
			GGCCCGGATCTTCCGCGTGATCGCCGACGCCGAGATCG
			ACATCGACATGGTGCTGCAGAACGTGTCCAGCACCGTC
			TCCGGCCGCACGGACATCACGTTCACGCTGTCGAAGGC
			CAACGGCGCCAAGGCCGTCAAGGAACTGGAGAAGGTCC
			AGGCGGAGATCGGCTTCGAGTCGGTCCTCTACGACGAC
			CACGTCGGCAAGGTGTCGGTGGTCGGCGCCGGGATGCG
			CTCGCACCCGGGTGTCACGGCGACGTTCTGCGAAGCGC
			TGGCCGAGGCCGGCGTCAACATCGAAATCATCAACACC
			TCGGAGATCCGCATTTCGGTGCTGATCCGCGACGCGCA
			GCTCGACGACGCCGTGCGCGCGATCCACGAGGCATTCG
			AACTCGGCGGCGACGAAGAAGCCGTCGTCTACGCGGGG
			AGTGGTCGCTGA
lysC	Streptomyces	AL939117.1	GTGGGCCTTGTCGTGCAGAAGTACGGAGGCTCCTCCGT	32
	coelicolor		AGCCGATGCCGAGGGCATCAAGCGCGTCGCCAAGCGGA
			TCGTGGAAGCGAAGAAGAACGGCAACCAGGTGGTCGCC
			GTCGTTTCCGCGATGGGCGACACGACGGACGAGCTGAT
			CGATCTCGCCGAGCAGGTTTCCCCGATCCCTGCCGGGC
			GTGAACTCGACATGCTGCTGACCGCCGGGGAGCGTATC
			TCCATGGCGCTGCTGGCCATGGCGATCAAAAACCTGGG
			CCACGAGGCCCAGTCGTTCACCGGCAGCCAGGCCGGAG
			TCATCACCGACTCGGTCCACAACAAGGCCCGGATCATC
			GACGTCACACCGGGTCGCATCCGCACCTCGGTCGACGA
			GGGCAACGTGGCCATCGTGGCCGGCTTCCAGGGCGTCA
			GCCAGGACAGCAAGGACATCACCACGCTGGGCCGCGGC
			GGGTCCGACACCACGGCCGTCGCCCTCGCCGCCGCGCT
			CGACGCGGACGTCTGCGAGATCTACACCGACGTCGACG
			GCGTGTTCACCGCCGACCCGCGCGTGGTGCCGAAGGCG
			AAGAAGATCGACTGGATCTCCTTCGAGGACATGCTGGA
			GCTCGCTGCCTCCGGCTCCAAGGTGCTGCTCCACCGTT
			GCGTGGAGTACGCCCGCCGGTACAACATCCCGATTCAC
			GTGCGGTCCAGCTTCAGCGGACTCCAGGGCACGTGGGT
			CAGCAGCGAGCCGATCAAGCAAGGGGAAAAGCACGTGG
			AGCAGGCCCTCATCTCCGGAGTCGCGCACGACACCTCC
			GAGGCCAAGGTCACGGTCGTCGGGGTGCCCGACAAGCC
			GGGCGAGGCGGCCGCGATCTTCCGCGCCATCGCCGACG
			CCCAGGTCAACATCGACATGGTCGTGCAGAACGTGTCC
			GCCGCCTCCACGGGCCTGACGGACATCTCGTTCACGCT
			CCCCAAGAGCGAGGGCCGCAAGGCCATCGACGCGCTGG
			AGAAGAACCGCCCGGGCATCGGCTTCGACTCGCTGCGC
			TACGACGACCAGATCGGCAAGATCTCGCTGGTCGGCGC
			CGGTATGAAGAGCAATCCGGGCGTCACCGCCGACTTCT
			TCACCGCGCTCTCCGACGCCGGGGTGAACATCGAGCTG
			ATCTCGACCTCCGAGATCCGCATCTCGGTCGTCACCCG
			CAAGGACGACGTGAACGAGGCCGTGCGCGCCGTGCACA
			CCGCCTTCGGGCTCGACTCCGACAGTGACGAGGCCGTG
			GTCTACGGGGGCACCGGGCGCTGA
lysC	Thermobifida	NZ_AAAQ010	GTGAATCTCCGATCACTAGACTGGCTGGTCGATTACCG	33
	fusca	00023.1	TGAACCCGATTCCTCAGGAGCGCCGACCGTGGCTTTGA
			TCGTGCAAAAGTACGGCGGGTCGTCCGTCGCTGATGCG
			GATGCCATTAAGCGGGTAGCCGAACGGATCGTCGCTCA
			GAAGAAAGCCGGATACGACGTGGTCGTCGTGGTCTCCG
			CCATGGGCGACACCACTGACGAGCTTCTCGACCTTGCG
			AAGCAGGTGAGTCCGCTCCCGCCGGGCCGGGAGTTGGA
			CATGCTGCTGACTGCCGGGGAGCGGATCTCGATGGCCC
			TGGTTGCGATGGCTATCGGGAACTTGGGCTATGAGGCC
			CGGTCGTTCACCGGTTCGCAGGCCGGGGTGATCACCAC
			GTCGCTGCACGGCAACGCGAAGATCATCGATGTCACCC
			CGGGGCGGATCAGGGATGCGCTCGCCGAAGGGGCGATC
			TGCATCGTCGCTGGCTTCCAAGGGGTGTCGCAGGACAG
			CAAGGACATCACCACGTTGGGCCGCGGTGGTTCGGACA
			CTACGGCTGTGGCGCTTGCTGCGGCGCTCAACGCCGAC
			TTGTGCGAGATCTACACCGACGTCGACGGGGTGTTCAC
			TGCTGATCCGCGTATCGTGCCCTCCGCTCGACGCATCC
			CCCAGATCTCCTACGAGGAGATGCTGGAGATGGCGGCC
			TCCGGCGCCAAGATCCTGCATCTGCGCTGCGTGGAGTA
			TGCGCGGCGGTACAACATTCCGCTGCACGTGCGCTCGT
			CTTTCAGTCAGAAGCCCGGTACCTGGGTCGTCTCGGAA
			GTTGAGGAAACCGAAGGCATGGAACAACCGATCATCTC
			CGGCGTGGCGCATGACCGGAGCGAAGCCAAGATCACGG
			TTGTGGGGGTGCCCGACCGTGTCGGCGAGGCAGCAGCG
			ATCTTCAAGGCGCTGGCCGACGCTGAGATCAACGTGGA
			CATGATCGTGCAGAACGTGTCCGCGGCTTCCACGTCGC
			GTACGGACATTTCTTTCACTCTGCCTGCCGACTCGGGG
			CAGAACGCGCTGGCCGCGTTGAAGAAGATCCAGGACAA
			GGTCGGTTTCGAGTCGCTGCTGTACAACGACCGGATCG
			GCAAGGTGTCGCTGATCGGCGCGGGGATGCGCTCCTAT
			CCGGGGGTGACTGCTCGGTTCTTTGACGCTGTGGCCCG
			CGAGGGCATCAACATCGAGATGATTTCCACTTCCGAGA
			TCCGCATCTCGATCGTGGTGGCGCAGGACGACGTGGAC
			GCCGCAGTGGCCGCCGCGCACCGTGAGTTCCAGTTGGA
			CGCCGACCAGGTCGAGGCCGTTGTGTATGGAGGTACCG
			GCCGATGA
lysC	Erwinia		ATGTCTGCTAACACTGATAACTCACTGATTATCGCCAA	34
	chrysanthemi		ATTCGGCGGCACCAGCGTCGCTGATTTCGACGCCATGA
			ACCGCAGCGCCGACATCGTGCTGTCCGACGCGCAGGTA
			CGGGTGGTGGTGCTGTCCGCCTCCGCCGGCGTGACCAA
			CCTGCTGGTGGCGCTGGCGGAAGGTTTACCGCCATCTG
			AACGCACCGCGCAACTGGAAAAACTGCGCCAGATTCAA
			TACGCCATCATCGACCGCCTCAACCAGCCGGCCGTCAT
			CCGTGAAGAAATCGACCGCATGCTGGACAACGTGGCCC
			GCCTGTCGGAAGCGGCGGCGCTGGCGACTTCCAACGCC
			CTGACCGACGAACTGGTCAGCCACGGCGAGCTGATATC
			CACCTTGCTGTTTGTGGAAATTCTGCGCGAGCGCAACG
			TCGCCGCCGAATGGTTCGACGTGCGTAAAATCATGCGT
			ACCAACGACCGCTTCGGCCGCGCCGAGCCGGACTGCGA
			CGCGCTGGGCGAACTGACCCGCAGCCAGCTGACGCCGC
			GTCTGGCGCAGGGGCTGATCATCACCCAGGGCTTCATC
			GGCAGCGAAGCTAAAGGCCGCACCACCACGCTGGGCCG
			CGGCGGCAGCGATTACACCGCCGCTCTGCTGGGCGAAG
			CGCTGCACGCCAGCCGTATCGACATCTGGACCGACGTT
			CCCGGCATCTACACCACCGACCCGCGCGTGGTGCCGTC
			CGCCCACCGCATCGACCAGATTACCTTTGAAGAAGCGG
			CCGAAATGGCCACCTTCGGCGCCAAGGTGCTGCACCCG
			GCCACACTGCTGCCTGCCGTACGCAGCGACATTCCGGT
			ATTCGTCGGCTCCAGCAAAGACCCGGCGGCCGGCGGCA
			CGCTGGTGTGCAACAACACCGAAAACCCGCCGCTGTTC
			CGCGCGCTGGCGCTGCGCCGCAAGCAGACGCTGCTGAC
			CCTGCATAGCCTTAACATGCTGCACGCGCGCGGCTTTC
			TGGCGGAAGTGTTCAGTATTCTGGCTCGCCACAACATC
			TCGGTGGATTTGATCACTACCTCCGAGGTGAACGTCGC
			GCTGACGCTGGACACCACCGGCTCGACCTCGACCGGCG
			ATAGCCTGCTGTCCAGCGCGCTGCTGACTGAACTGTCC
			TCGCTGTGTCGGGTGGAAGTGGAAGAGAACATGTCGCT
			GGTGGCGCTGATCGGCAACCAGCTGTCGCAGGCCTGCG
			GCGTCGGCAAAGAGGTGTTCGGGGTGCTGGAGCCATTT
			AATATCCGCCTCATCTGCTACGGCGCCAGCAGCCACAA
			CCTGTGCTTCCTGGTGCCGTCCAGCGATGCCGAGCAGG
			TGGTGCAGACGCTGCATCACAATCTGTTTGAATAA
lysC	Shewanella	AE015779.1	GTGCTCGAAAAACGAAAGCTTAGTGGTAGCAAGCTTTT	35
	oneidensis		TGTGAAGAAGTTTGGTGGCACTTCGGTGGGTTCAATTG
			AACGTATCGAAGTGGTTGCCGAACAGATTGCAAAGTCC
			GCTCACAGTGGTGAGCAGCAAGTATTAGTTCTTTCTGC
			TATGGCAGGGGAGACAAATAGGCTATTTGCGCTAGCAG
			CGCAAATCGATCCCCGCGCGAGTGCTCGGGAACTCGAT
			ATGTTGGTCTCAACGGGTGAGCAAATTAGTATTGCGTT
			GATGGCGATGGCGTTGCAGCGTCGCGGTATCAAGGCAA
			GATCGCTCACTGGCGATCAAGTGCAAATCCATACAAAT
			AGTCAGTTTGGTCGTGCCAGTATTGAGAGCGTCGATAC
			GGCGTACTTAACGTCCTTGCTCGAACAAGGCATTGTGC
			CGATTGTGGCAGGGTTTCAAGGGATCGATCCTAATGGC
			GATGTCACAACCTTAGGTCGTGGTGGTTCCGATACGAC
			GGCTGTAGCGCTCGCCGCAGCGTTAAGAGCCGATGAAT
			GCCAGATATTTACCGATGTTTCAGGGGTGTTTACTACA
			GACCCAAATATCGATAGTAGCGCAAGGCGTCTGGATGT
			GATTGGCTTTGACGTCATGCTTGAAATGGCAAAGTTAG
			GCGCTAAAGTACTTCATCCTGATTCTGTTGAATATGCA
			CAGCGTTTTAAAGTACCGCTTCGGGTGTTGTCGAGTTT
			CGAAGCTGGGCAAGGTACATTAATTCAATTTGGTGATG
			AATCTGAGCTTGCGATGGCCGCATCTGTACAAGGTATT
			GCGATCAACAAAGCCTTAGCAACGTTGACCATCGAAGG
			TTTGTTCACCAGCAGTGAGCGTTACCAAGCACTATTGG
			CTTGTTTGGCCCGACTGGAGGTAGATGTTGAATTTATC
			ACTCCTTTGAAATTGAATGAAATTTCTCCTGTTGAGTC
			AGTCAGTTTCATGTTAGCCGAAGCTAAAGTGGATATTT
			TATTGCACGAGCTTGAGGTTTTAAGCGAAAGTCTTGAT
			CTAGGGCAATTGATTGTTGAGCGCCAACGTGCAAAAGT
			GTCTTTAGTTGGCAAAGGTTTACAGGCAAAAGTTGGAT
			TATTGACTAAGATGTTAGATGTATTGGGTAACGAAACA
			ATTCATGCTAAGTTACTTTCGACATCGGAGAGTAAATT
			GTCAACTGTGATCGATGAAAGGGACTTGCACAAGGCGG
			TTCGGGCGTTGCATCATGCTTTCGAGCTAAATAAGGTG
lysC	Coryne-	AX720328	GTGGCCCTGGTCGTACAGAAATATGGCGGTTCCTCGCT	238
	bacterium		TGAGAGTGCGGAACGCATTAGAAACGTCGCTGAACGGA
	glutamicum		TCGTTGCCACCAAGAAGGCTGGAAATGATGTCGTGGTT
			GTCTGCTCCGCAATGGGAGACACCACGGATGAACTTCT
			AGAACTTGCAGCGGCAGTGAATCCCGTTCCGCCAGCTC
			GTGAAATGGATATGCTCCTGACTGCTGGTGAGCGTATT
			TCTAACGCTCTCGTCGCCATGGCTATTGAGTCCCTTGG
			CGCAGAAGCCCAATCTTTCACGGGCTCTCAGGCTGGTG
			TGCTCACCACCGAGCGCCACGGAAACGCACGCATTGTT
			GATGTCACTCCAGGTCGTGTGCGTGAAGCACTCGATGA
			GGGCAAGATCTGCATTGTTGCTGGTTTCCAGGGTGTTA
			ATAAAGAAACCCGCGATGTCACCACGTTGGGTCGTGGT
			GGTTCTGACACCACTGCAGTTGCGTTGGCAGCTGCTTT
			GAACGCTGATGTGTGTGAGATTTACTCGGACGTTGACG
			GTGTGTATACCGCTGACCCGCGCATCGTTCCTAATGCA
			CAGAAGCTGGAAAAGCTCAGCTTCGAAGAAATGCTGGA
			ACTTGCTGCTGTTGGCTCCAAGATTTTGGTGCTGCGCA
			GTGTTGAATACGCTCGTGCATTCAATGTGCCACTTCGC
			GTACGCTCGTCTTATAGTAATGATCCCGGCACTTTGAT
			TGCCGGCTCTATGGAGGATATTCCTGTGGAAGAAGCAG
			TCCTTACCGGTGTCGCAACCGACAAGTCCGAAGCCAAA
			GTAACCGTTCTGGGTATTTCCGATAAGCCAGGCGAGGC
			TGCGAAGGTTTTCCGTGCGTTGGCTGATGCAGAAATCA
			ACATTGACATGGTTCTGCAGAACGTCTCTTCTGTAGAA
			GACGGCACCACCGACATCACCTTCACCTGCCCTCGTTC
			CGACGGCCGCCGCGCGATGGAGATCTTGAAGAAGCTTC
			AGGTTCAGGGCAACTGGACCAATGTGCTTTACGACGAC
			CAGGTCGGCAAAGTCTCCCTCGTGGGTGCTGGCATGAA
			GTCTCACCCAGGTGTTACCGCAGAGTTCATGGAAGCTC
			TGCGCGATGTCAACGTGAACATCGAATTGATTTCCACC
			TCTGAGATTCGTATTTCCGTGCTGATCCGTGAAGATGA
			TCTGGATGCTGCTGCACGTGCATTGCATGAGCAGTTCC
			AGCTGGGCGGCGAAGACGAAGCCGTCGTTTATGCAGGC
			ACCGGACGC
aspartokinase	Escherichia	M11812	ATGTCTGAAATTGTTGTCTCCAAATTTGGCGGTACCAG	239
III	coli		CGTAGCCGATTTTGACGCCATGAACCGCAGCGCTGATA
			TTGTGCTTTCTGATGCCAACGTGCGTTTAGTTGTCCTC
			TCGGCTTCTGCTGGTATCACTAATCTGCTGGTCGCTTT
			AGCTGAAGGACTGGAACCTTGCGAGCGATTCGAAAAAC
			TCGACGCTATCCGCAACATCCAGTTTGCCATTCTGGAA
			CGTCTGCGTTACCCGAACGTTATCCGTGAAGAGATTGA
			ACGTCTGCTGGAGAACATTACTGTTCTGGCAGAAGCGG
			CGGCGCTGGCAACGTCTCCGGCGCTGACAGATGAGCTG
			GTCAGCCACGGCGAGCTGATGTCGACCCTGCTGTTTGT
			TGAGATCCTGCGCGAACGCGATGTTCAGGCACAGTGGT
			TTGATGTGCGTAAAGTGATGCGTACCAACGACCGATTT
			GGTCGTGCAGAGCCAGATATAGCCGCGCTGGCGGAACT
			GGCCGCGCTGCAGCTGCTCCCACGTCTCAATGAAGGCT
			TAGTGATCACCCAGGGATTTATCGGTAGCGAAAATAAA
			GGTCGTACAACGACGCTTGGCCGTGGAGGCAGCGATTA
			TACGGCAGCCTTGCTGGCGGAGGCTTTACACGCATCTC
			GTGTTGATATCTGGACCGACGTCCCGGGCATCTACACC
			ACCGATCCACGCGTAGTTTCCGCAGCAAAACGCATTGA
			TGAAATCGCGTTTGCCGAAGCGGCAGAGATGGCAACTT
			TTGGTGCAAAAGTACTGCATCCGGCAACGTTGCTACCC
			GCAGTACGCAGCGATATCCCGGTCTTTGTCGGCTCCAG
			CAAAGACCCACGCGCAGGTGGTACGCTGGTGTGCAATA
			AAACTGAAAATCCGCCGCTGTTCCGCGCTCTGGCGCTT
			CGTCGCAATCAGACTCTGCTCACTTTGCACAGCCTGAA
			TATGCTGCATTCTCGCGGTTTCCTCGCGGAAGTTTTCG
			GCATCCTCGCGCGGCATAATATTTCGGTAGACTTAATC
			ACCACGTCAGAAGTGAGCGTGGCATTAACCCTTGATAC
			CACCGGTTCAACCTCCACTGGCGATACGTTGCTGACAC
			AATCTCTGCTGATGGAGCTTTCCGCACTGTGTCGGGTG
			GAGGTGGAAGAAGGTCTGGCGCTGGTCGCGTTGATTGG
			CAATGACCTGTCAAAAGCGTGCGCCGTTGGCAAAGAGG
			TATTCGGCGTACTGGAACCGTTCAACATTCGCATGATT
			TGTTATGGCGCATCCAGCCATAACCTGTGCTTCCTGGT
			GCCCGGCGAAGATGCCGAGCAGGTGGTGCAAAAACTGC
			ATAGTAATTTGTTTGAGTAA
asd	Coryne-	X57226	ATGACCACCATCGCAGTTGTTGGTGCAACCGGCCAGGT	240
	bacterium		CGGCCAGGTTATGCGCACCCTTTTGGAAGAGCGCAATT
	glutamicum		TCCCAGCTGACACTGTTCGTTTCTTTGCTTCCCCACGT
			TCCGCAGGCCGTAAGATTGAATTCCGTGGCACGGAAAT
			CGAGGTAGAAGACATTACTCAGGCAACCGAGGAGTCCC
			TCAAGGACATCGACGTTGCGTTGTTCTCCGCTGGAGGC
			ACCGCTTCCAAGCAGTACGCTCCACTGTTCGCTGCTGC
			AGGCGCGACTGTTGTGGATAACTCTTCTGCTTGGCGCA
			AGGACGACGAGGTTCCACTAATCGTCTCTGAGGTGAAC
			CCTTCCGACAAGGATTCCCTGGTCAAGGGCATTATTGC
			GAACCCTAACTGCACCACCATGGCTGCGATGCCAGTGC
			TGAAGCCACTTCACGATGCCGCTGGTCTTGTAAAGCTT
			CACGTTTCCTCTTACCAGGCTGTTTCCGGTTCTGGTCT
			TGCAGGTGTGGAAACCTTGGCAAAGCAGGTTGCTGCAG
			TTGGAGACCACAACGTTGAGTTCGTCCATGATGGACAG
			GCTGCTGACGCAGGCGATGTCGGACCTTATGTTTCACC
			AATCGCTTACAACGTGCTGCCATTCGCCGGAAACCTCG
			TCGATGACGGCACCTTCGAAACCGATGAAGAGCAGAAG
			CTGCGCAACGAATCCCGCAAGATTCTCGGTCTCCCAGA
			CCTCAAGGTCTCAGGCACCTGCGTTCGCGTGCCGGTTT
			TCACCGGCCACACGCTGACCATTCACGCCGAATTCGAC
			AAGGCAATCACCGTGGACCAGGCGCAGGAGATCTTGGG
			TGCCGCTTCAGGCGTCAAGCTTGTCGACGTCCCAACCC
			CACTTGCAGCTGCCGGCATTGACGAATCCCTCGTTGGA
			CGCATCCGTCAGGACTCCACTGTCGACGATAACCGCGG
			TCTGGTTCTCGTCGTATCTGGCGACAACCTCCGCAAGG
			GTGCTGCGCTAAACACCATCCAGATCGCTGAGCTGCTG
			GTTAAGTAA
asd	Escherichia	NC_000913	ATGAAAAATGTTGGTTTTATCGGCTGGCGCGGTATGGT	241
	coli		CGGCTCCGTTCTCATGCAACGCATGGTTGAAGAGCGCG
			ACTTCGACGCCATTCGCCCTGTCTTCTTTTCTACTTCT
			CAGCTTGGCCAGGCTGCGCCGTCTTTTGGCGGAACCAC
			TGGCACACTTCAGGATGCCTTTGATCTGGAGGCGCTAA
			AGGCCCTCGATATCATTGTGACCTGTCAGGGCGGCGAT
			TATACCAACGAAATCTATCCAAAGCTTCGTGAAAGCGG
			ATGGCAAGGTTACTGGATTGACGCAGCATCGTCTCTGC
			GCATGAAAGATGACGCCATCATCATTCTTGACCCCGTC
			AATCAGGACGTCATTACCGACGGATTAAATAATGGCAT
			CAGGACTTTTGTTGGCGGTAACTGTACCGTAAGCCTGA
			TGTTGATGTCGTTGGGTGGTTTATTCGCCAATGATCTT
			GTTGATTGGGTGTCCGTTGCAACCTACCAGGCCGCTTC
			CGGCGGTGGTGCGCGACATATGCGTGAGTTATTAACCC
			AGATGGGCCATCTGTATGGCCATGTGGCAGATGAACTC
			GCGACCCCGTCCTCTGCTATTCTCGATATCGAACGCAA
			AGTCACAACCTTAACCCGTAGCGGTGAGCTGCCGGTGG
			ATAACTTTGGCGTGCCGCTGGCGGGTAGCCTGATTCCG
			TGGATCGACAAACAGCTCGATAACGGTCAGAGCCGCGA
			AGAGTGGAAAGGGCAGGCGGAAACCAACAAGATCCTCA
			ACACATCTTCCGTAATTCCGGTAGATGGTTTATGTGTG
			CGTGTCGGGGCATTGCGCTGCCACAGCCAGGCATTCAC
			TATTAAATTGAAAAAAGATGTGTCTATTCCGACCGTGG
			AAGAACTGCTGGCTGCGCACAATCCGTGGGCGAAAGTC
			GTTCCGAACGATCGGGAAATCACTATGCGTGAGCTAAC
			CCCAGCTGCCGTTACCGGCACGCTGACCACGCCGGTAG
			GCCGCCTGCGTAAGCTGAATATGGGACCAGAGTTCCTG
			TCAGCCTTTACCGTGGGCGACCAGCTGCTGTGGGGGGC
			CGCGGAGCCGCTGCGTCGGATGCTTCGTCAACTGGCG
ppc	Thermobifida	NZ_AAAQ010	ATGACACGCGACAGCGCCCGCCAGGAGATGCCCGACCA	36
	fusca	00037.1	GCTTCGCCGCGACGTCCGGTTGCTCGGCGAAATGCTCG
			GCACCGTACTTGCCGAGAGTGGCGGTCAAGACCTGCTT
			GACGATGTGGAACGACTCCGCCGCGCCGTCATCGGAGC
			TCGCGAGGGGACGGTCGAGGGCAAAGAGATCACCGAGC
			TCGTCGCCTCGTGGCCACTGGAACGCGCCAAGCAGGTG
			GCGCGTGCCTTCACCGTCTACTTCCACCTGGTCAACCT
			GGCTGAAGAGCACCACCGTATGCGCGCCCTGCGGGAAC
			GCGACGACGCGGCCACACCGCAGCGCGAATCGCTGGCT
			GCCGCAGTGCACTCCATCCGCGAAGACGCCGGGCCAGA
			GCGGCTGCGCGAACTCATCGCGGGCATGGAATTCCACC
			CGGTCCTGACCGCGCACCCCACCGAAGCGCGCCGTCGC
			GCCGTCTCCACCGCGATCCAGCGCATCAGTGCCCAACT
			GGAACGCCTGCACGCGGCCCACCCGGGAAGCGGCGCCG
			AAGCCGAGGCGCGTCGCAGACTCCTCGAAGAAATCGAC
			CTGCTGTGGCGAACATCACAGCTCCGCTATACGAAGAT
			GGACCCGCTCGACGAAGTGCGGACCGCCATGGCCGCCT
			TCGACGAGACCATCTTCACCGTCATCCCCGAGGTCTAC
			CGCAGCCTCGACCGGGCGCTCGACCCCGAAGGCTGCGG
			ACGGCGCCCCGCGCTGGCGAAAGCCTTCGTCCGCTACG
			GCAGTTGGATCGGCGGTGACCGCGACGGCAACCCCTTC
			GTCACCCACGAAGTGACGCGGGAAGCCATCACCATCCA
			GTCCGAGCACGTGCTGCGCGCCCTGGAAAACGCCTGCG
			AACGCATCGGCCGCACCCACACCGAGTACACCGGCCTC
			ACCCCGCCCAGCGCGGAACTGCGCGCCGCGCTGAGCAG
			CGCCCGGGCTGCCTACCCGCGCCTGATGCAGGAGATCA
			TCAAGCGCTCGCCCAACGAACCCCACCGCCAGCTCCTG
			CTGCTCGCCGCGGAACGGCTCCGCGCCACCCGGCTGCG
			CAACGCCGACCTCGGCTACCCCAACCCGGAAGCGTTCC
			TCGCCGACCTGCGGACCGTCCAAGAGTCGCTTGCTGCC
			GCGGGCGCTGTGCGCCAAGCCTACGGCGAACTCCAAAA
			CCTCATCTGGCAGGCCGAAACCTTCGGCTTCCACCTCG
			CGGAACTGGAAATCCGCCAGCACAGCGCAGTCCACGCC
			GCCGCACTCAAGGAGATACGCGCTGGCGGGGAACTGTC
			CGAACGTACCGAGGAAGTCCTCGCCACCCTGCGGGTCG
			TCGCCTGGATTCAGGAGCGGTTCGGCGTGGAAGCATGC
			CGCCGCTACATCGTCAGCTTCACCCAGTCCGCTGACGA
			CATCGCCGCCGTCTACGAGCTCGCCGAGCACGCCATGC
			CCCCGGGCAAGGCGCCCATCCTCGACGTCATCCCGCTC
			TTCGAAACCGGTGCCGACCTGGACGCGGCCCCCCAGGT
			CCTCGACGGCATGCTCCGCCTGCCCGCCGTCCAGCGCC
			GCCTCGAGCAGACCGGCCGCCGCATGGAAGTCATGCTC
			GGCTACAGCGACTCCGCCAAGGACGTCGGCCCGGTCAG
			CGCCACCCTGCGGCTCTACGACGCCCAGGCGCGGCTGG
			CCGAATGGGCGCGCGAGCACGACATCAAACTCACCCTG
			TTCCACGGCCGCGGCGGTGCCCTGGGCCGCGGCGGCGG
			GCCCGCCAACCGGGCCGTCCTCGCCCAGGCCCCCGGAT
			CGGTGGACGGCCGCTTCAAGGTCACCGAGCAGGGCGPA
			GTCATCTTCGCCCGCTACGGTCAGCGGGCGATCGCCCA
			CCGCCACATCGAACAGGTGGGCCACGCCGTGCTCATGG
			CCTCCACCGAAAGCGTGCAGCGGAGAGCCGCCGAGGCA
			GCCGCCCGGTTCCGCGGTATGGCTGACCGCATCGCCGA
			AGCCGCCCACGCCGCCTACCGCGCCCTCGTCGACACTG
			AAGGGTTCGCGGAGTGGTTCTCCCGGGTCAGCCCGTTG
			GAGGAGCTGAGTGAGCTGCGGCTGGGGTCGCGTCCGGC
			GCGCCGCTCGGCTGCCCGCGGCCTCGACGACCTCCGCG
			CTATCCCGTGGGTGTTCGCCTGGACCCAGACCCGGGTC
			AATCTGCCTGGCTGGTACGGGCTCGGCAGCGGCCTGGC
			CGCGGTCGACGACCTGGAAGCGCTGCACACCGCCTACA
			AGGAGTGGCCGCTGTTCGCCTCGCTGCTGGACAACGCC
			GAGATGAGCCTGGCCAAGACCGACCGGGTGATCGCCGA
			GCGCTACCTCGCGCTGGGCGGGCGTCCAGAGCTCACCG
			AACAGGTCCTCGCCGAATACGACCGCACCCGGGAACTG
			GTCCTCAAAGTCACGCGGCACACCCGCCTCCTCGAGAA
			CCGCCGGGTGCTGTCCCGCGCGGTCGACCTGCGCAACC
			CCTACGTGGACGCCCTTTCGCACCTGCAGCTGCGTGCT
			CTGGAAGCCCTGCGCACCGGGGAAGCCGACCGGCTGTC
			CGAGGAGGACCGCAACCACCTGGAACGGCTCCTGCTGC
			TCTCGGTCAACGGTGTGGCCGCAGGGCTCCAGAACACT
			GGG
ppc	Mycobacterium	AL583919.1	ATGGTTGAGTTTTCCGATGCTATACTGGAACCGATCGG	37
	leprae (can be		TGCTGTCCAGCGGACTCGAGTCGGTCGCGAGGCGACTG
	used to clone		AACCTATGCGGGCCGACATCAGGCTATTGGGTACCATT
	M. smegmatis		CTTGGTGATACTCTGCGTGAGCAGAACGGTGATGAGGT
	gene)		ATTCGATCTCGTCGAACGAGTCCGGGTCGAGTCGTTCC
			GGGTGCGGCGTTCTGAGATTGATCGGGCCGATATGGCG
			CGTATGTTCTCTGGTCTCGACATTCACCTGGCCATCCC
			GATCATCCGGGCGTTTAGCCATTTCGCATTGTTGGCCA
			ACGTTGCCGAGGACATCCACCGGGAGCGTCGGCGCCAT
			ATTCACCTCGACGCCGGCGAGCCACTGCGGGATAGCAG
			TTTAGCGGCCACTTACGCGAAACTTGATCTGGCAAAAC
			TAGATTCGGCCACCGTGGCAGATGCCCTTACTGGTGCA
			GTGGTCTCGCCGGTGATTACTGCGCATCCCACCGAGAC
			CCGTCGGCGTACCGTATTTGTTACCCAACGCCGGATTA
			CCGAGTTGATGCGGCTGCACGCGGAGGGACACACCGAA
			ACCGCCGATGGCCGCAGCATTGAGCGTGAATTGCGCCG
			TCAAATTCTCACGCTGTGGCAGACGGCATTGATTCGGT
			TGGCGCGATTGCAGATCTCCGACGAGATCGACGTAGGG
			CTGCGATATTACTCTGCCGCGCTTTTCCATGTGATTCC
			GCAGGTGAATTCCGAGGTGCGCAACGCGTTGCGTGCCC
			GGTGGCCCGACGCCGAGCTGCTGTCCGGCCCTATACTG
			CAACCCGGATCGTGGATCGGTGGTGACCGGGACGGAAA
			CCCGAACGTGACTGCCGACGTGGTGCGGCGAGCGACCG
			GCAGCGCTGCCTACACCGTGGTGGCGCACTATTTGGCT
			GAACTCACCCACCTCGAGCAGGAGCTGTCGATGTCGGC
			GCGACTGATAACCGTCACCCCTGAGCTGGCCACGCTGG
			CCGCTAGCTGTCAGGACGCGGCCTGTGCCGACGAGCCG
			TACCGGCGGGCATTGCGGGTGATCCGCGGTCGATTGTC
			CTCGACTGCCGCCCACATCCTGGATCAGCAGCCACCCA
			ACCAGCTTGGTCTGGGTTTGCCACCGTATTCGACGCCA
			GCCGAACTATGTGCCGATCTGGACACCATCGAAGCCTC
			CCTGTGCACGCACGGCGCCGCGTTGTTAGCCGACGATC
			GGTTGGCGCTGTTGCGAGAAGGTGTTGGAGTCTTTGGG
			TTTCACTTGTGCGGTCTGGATATGCGGCAAAATTCCGA
			CGTGCACGAAGAGGTGGTCGCTGAGCTGTTGGCGTGGG
			CCGGGATGCACCAGGACTACAGTTCGTTGCCCGAAGAT
			CAAAGAGTCAAGCTGCTGGTGGCCGAACTCGGTAACCG
			CCGCCCGTTGGTCGGGGATCGTGCGCAATTATCCGATT
			TGGCGCGCGGCGAGCTGGCCGTTCTTGCGGCCGCTGCC
			CACGCCGTTGAGCTCTACGGATCGGCCGCGGTGCCCAA
			CTACATCATCTCGATGTGTCAGTCTGTGTCGGATGTCC
			TGGAGGTCGCGATCCTCTTGAAGGAGACTGGCCTGTTA
			GACGCCTCCGGGTCGCAGCCGTACTGTCCGGTGGGCAT
			CTCGCCGCTGTTCGAGACGATCGACGATCTGCACAACG
			GGGCGGCCATTCTGCACGCGATGCTGGAACTTCCGCTA
			TATCGAACGCTGGTGGCTGCTCGCGGTAACTGGCAGGA
			AGTGATGCTCGGCTACTCCGATTCCAACAAAGATGGCG
			GCTATCTGGCCGCCAACTGGGCGGTTTACCGCGCCGAG
			CTCGCTCTGGTAGACGTGGCCCGCAAAACCGGAATCCG
			TTTGCGACTTTTCCATGGTCGTGGCGGCACTGTCGGAC
			GTGGCGGCGGTCCTAGCTATCAAGCTATTCTGGCGCAA
			CCCCCGGGGGCGGTAAACGGCTCGTTGCGTCTCACCGA
			GCAAGGCGAGGTCATAGCCGCCAAATACGCCGAACCGC
			AAATAGCACGACGAAACCTAGAGAGTTTGGTGGCCGCG
			ACCCTAGAATCAACTCTCTTGGATGTTGAAGGCTTAGG
			CGATGCGGCTGAATCTGCTTACGCCATACTCGATGAAG
			TAGCCGGCCTCGCGCGGCGATCCTACGCTGAATTAGTC
			AACACACCGGGTTTCGTTGACTATTTCCAAGCTTCCAC
			GCCGGTCAGCGAGATCGGATCGTTGAACATTGGCAACC
			GACCGACATCACGTAAGCCTACCACGTCGATCGCGGAT
			CTTCGTGCTATTCCGTGGGTACTGGCATGGAGCCAATC
			GCGAGTCATGCTCCCAGGTTGGTATGGCACCGGATCGG
			CGTTTCAGCAGTGGGTTGCGGCTGGACCCGAAAGTGAA
			TCACAGCGGGTAGAAATGCTGCATGACCTCTATCAGCG
			TTGGCCGTTCTTTCGAAGTGTGCTGTCGAACATGGCGC
			AGGTACTGGCCAAAAGTGATCTGGGCCTGGCGGCCCGC
			TATGCTGAGCTGGTGGTCGACGAAGCCTTGCGGCGCAG
			AGTGTTTGACAAGATCGCCGACGAGCATCGGCGAACCA
			TTGCCATCCACAAGCTCATTACGGGTCATGACGATCTG
			CTTGCTGACAACCCGGCTCTGGCGCGTTCGGTGTTCAA
			CCGCTTCCCGTATCTGGAGCCGTTAAACCACCTTCAGG
			TGGAGCTATTGCGCCGCTACCGCTCGGGTCACGACGAC
			GAAATGGTGCAACGCGGCATCCTTTTGACAATGAACGG
			ATTGGCCAGCGCGCTACGTAACAGCGGC
ppc	Streptomyces	AF177946.1	GTGAGCAGTGCCGACGACCAGACCACCACGACGACCAG	38
	coelicolor		CAGTGAACTGCGCGCCGACATCCGCCGGCTGGGTGATC
			TCCTCGGGGAGACCCTGGTCCGGCAGGAGGGCCCCGAA
			CTGCTGGAACTCGTCGAGAAGGTACGCCGACTCACCCG
			AGAGGACGGCGAGGCCGCCGCCGAACTGCTGCGCGGCA
			CCGAACTGGAGACCGCCGCCAAGCTCGTCCGCGCCTTC
			TCCACCTACTTCCACCTGGCCAACGTCACCGAGCAGGT
			CCACCGCGGCCGCGAGCTGGGCGCCAAGCGCGCCGCCG
			AGGGCGGACTGCTCGCCCGTACGGCCGACCGGCTGAAG
			GACGCCGACCCCGAGCACCTGCGCGAGACGGTCCGCAA
			CCTCAACGTGCGCCCCGTGTTCACCGCGCACCCCACCG
			AGGCCGCCCGCCGCTCCGTCCTCAACAAGCTGCGCCGC
			ATCGCCGCCCTCCTGGACACCCCGGTCAACGAGTCGGA
			CCGGCGCCGCCTGGACACCCGCCTCGCCGAGAACATCG
			ACCTCGTCTGGCAGACCGACGAGCTGCGCGTCGTGCGC
			CCCGAGCCCGCCGACGAGGCCCGCAACGCCATCTACTA
			CCTCGACGAGCTGCACCTGGGCGCCGTCGGCGACGTCC
			TCGAAGACCTCACCGCCGAGCTGGAGCGGGCCGGCGTC
			AAGCTCCCCGACGACACCCGCCCCCTCACCTTCGGCAC
			CTGGATCGGCGGCGACCGCGACGGCAACCCCAACGTCA
			CCCCCCAGGTGACCTGGGACGTCCTCATCCTCCAGCAC
			GAGCACGGCATCAACGACGCCCTGGAGATGATCGACGA
			GCTGCGCGGCTTCCTCTCCAACTCCATCCGGTACGCCG
			GTGCGACCGAGGAACTGCTCGCCTCGCTCCAGGCCGAC
			CTGGAACGCCTCCCCGAGATCAGCCCCCGCTACAAGCG
			CCTCAACGCCGAGGAGCCCTACCGGCTCAAGGCCACCT
			GCATCCGCCAGAAGCTGGAGAACACCAAGCAGCGCCTC
			GCCAAGGGCACCCCCCACGAGGACGGCCGCGACTACCT
			CGGCACCGCCCAGCTCATCGACGACCTGCGCATCGTCC
			AGACCTCGCTGCGCGAACACCGCGGCGGCCTGTTCGCC
			GACGGGCGCCTCGCCCGCACCATCCGCACCCTGGCCGC
			CTTCGGCCTCCAGCTCGCCACCATGGACGTCCGCGAGC
			ACGCCGACGCCCACCACCACGCCCTCGGCCAGCTCTTC
			GACCGGCTCGGCGAGGAGTCCTGGCGCTACGCCGACAT
			GCCGCGCGAGTACCGCACCAAGCTCCTCGCCAAGGAAC
			TGCGCTCCCGCAGGCCGCTGGCCCCCAGCCCCGCCCCC
			GTCGACGCGCCCGGCGAGAAGACCCTCGGCGTCTTCCA
			GACCGTCCGCCGCGCCCTGGAGGTCTTCGGCCCCGAGG
			TCATCGAGTCCTACATCATCTCCATGTGCCAGGGCGCC
			GACGACGTCTTCGCCGCGGCGGTACTGGCCCGCGAGGC
			CGGGCTGATCGACCTGCACGCCGGCTGGGCGAAGATCG
			GCATCGTGCCGCTGCTGGAGACCACCGACGAGCTGAAG
			GCCGCCGACACCATCCTGGAGGACCTGCTCGCCGACCC
			CTCCTACCGGCGCCTGGTCGCGCTGCGCGGCGACGTCC
			AGGAGGTCATGCTCGGCTACTCCGACTCCTCCAAGTTC
			GGCGGTATCACCACCAGCCAGTGGGAGATCCACCGCGC
			CCAGCGCCGGCTGCGCGACGTCGCCCACCGCTACGGCG
			TACGGCTGCGCCTCTTCCACGGCCGCGGCGGCACCGTC
			GGCCGCGGCGGCGGCCCCACCCACGACGCCATCCTCGC
			CCAGCCCTGGGGCACCCTGGAGGGCGAGATCAAGGTCA
			CCGAGCAGGGCGAGGTCATCTCCGACAAGTACCTCATC
			CCCGCCCTCGCCCGGGAGAACCTGGAGCTGACCGTCGC
			GGCCACCCTCCAGGCCTCCGCCCTGCACACCGCGCCCC
			GCCAGTCCGACGAGGCCCTGGCCCGCTGGGACGCCGCG
			ATGGACGTCGTCTCCGACGCCGCCCACACCGCCTACCG
			GCACCTGGTCGAGGACCCCGACCTGCCGACCTACTTCC
			TGGCCTCCACCCCGGTCGACCAGCTCGCCGACCTGCAC
			CTGGGCTCGCGGCCCTCCCGCCGCCCCGGCTCGGGCGT
			CTCGCTCGACGGACTGCGCGCCATCCCGTGGGTGTTCG
			GCTGGACCCAGTCCCGGCAGATCGTCCCCGGCTGGTAC
			GGCGTCGGCTCCGGCCTCAAGGCCCTGCGCGAGGCGGG
			CCTGGACACCGTGCTCGACGAGATGCACCAGCAGTGGC
			ACTTCTTCCGCAACTTCATCTCCAACGTCGAGATGACC
			CTCGCCAAGACCGACCTGCGCATCGCCCAGCACTACGT
			CGACACCCTCGTCCCGGACGAGCTCAAGCACGTCTTCG
			ACACCATCAAGGCCGAGCACGAGCTCACCGTCGCCGAG
			GTCCTGCGCGTCACCGGCGAGAGTGAACTGCTGGACGC
			CGACCCGGTCCTCAAGCAGACCTTCACCATCCGCGACG
			CCTACCTCGACCCCATCTCCTACCTCCAGGTCGCCCTC
			CTCGGCCGTCAGCGCGAGGCCGCCGCCGCGAACGAGGA
			CCCGGACCCCCTCCTCGCCCGAGCCCTCCTCCTCACCG
			TCAACGGCGTGGCAGCGGGCCTGCGCAACACCGGCTGA
ppc	Erwinia		ATGAATGAACAATATTCCGCCATGCGGAGCAATGTCAG	39
	chrysanthemi		CATGCTGGGTAAACTACTCGGCGACACCATCAAGGATG
			CGCTGGGCGCCAATATCCTTGAGCGTGTTGAAACAATC
			CGCAAGCTGTCCAAAGCCTCGCGGGCCGGCAGCGAAAC
			ACACCGTCAGGAACTGCTGACCACACTGCAGAACCTGT
			CCAACGATGAACTGCTGCCGGTCGCCCGCGCATTCAGC
			CAGTTCCTTAACCTGACCAACACCGCCGAGCAATACCA
			CAGTATCTCTCCGCACGGCGAAGCGGCCAGTAACCCGG
			AAGCGCTGGCGACGGTGTTTCGCAGTCTGAAAAGCCGC
			GACAACCTGAGCGACAAGGATATCCGCGACGCGGTGGA
			GTCGCTCTCCATCGAGCTGGTGTTGACCGCGCACCCGA
			CCGAAATCACCCGCCGTACGCTGATCCACAAACTGGTT
			GAAGTGAATACCTGCCTCAAGCAGCTCGATCACGACGA
			TCTGGCCGATTATGAACGCCACCAGATCATGCGCCGTC
			TGCGCCAGCTGATCGCCCAATACTGGCATACCGATGAA
			ATCCGCAAAATCCGCCCGACGCCGGTGGACGAAGCCAA
			GTGGGGTTTCGCGGTGGTGGAAAATAGCCTGTGGGAAG
			GGGTGCCGGCGTTTCTGCGCGAACTCGACGAGCAGATG
			GGTAAAGAGTTGGGCTACCGTCTGCCGGTGGATTCGGT
			GCCGGTGCGCTTCACCTCCTGGATGGGCGGCGACCGCG
			ACGGCAACCCGAACGTGACCTCTGAAGTCACCCGCCGC
			GTGCTGCTGCTAAGCCGCTGGAAAGCCGCGGACCTGTT
			CCTGCGCGACGTACAGGTGCTGGTTTCCGAACTGTCGA
			TGACCACCTGTACGCCGGAACTGCAACAACTGGCAGGC
			GGCGACGAGGTGCAGGAACCCTACCGCGAACTGATGAA
			AGCGCTGCGCGCACAGTTGACTGCTACCCTGGATTATC
			TGGACGCGCGTCTGAAAGATGAACAACGGATGCCGCCC
			AAAGATCTGCTGGTCACCAACGAGCAGTTATGGGAACC
			GCTGTACGCCTGTTACCAGTCGCTGCATGCCTGCGGCA
			TGGGCATCATCGCCGATGGTCAATTGCTCGATACCCTG
			CGCCGGGTGCGCTGCTTTGGCGTGCCGCTGGTGCGTAT
			CGACGTACGTCAGGAGAGCACCCGTCACACCGACGCGC
			TGGCGGAAATCACCCGCTATCTGGGGCTGGGAGACTAC
			GAAAGCTGGTCGGAATCCGACAAGCAGGCGTTCCTGAT
			CCGCGAACTTAACTCCAAGCGTCCGCTGCTGCCGCGCC
			AGTGGGAACCGAGCGCCGACACCCAGGAAGTGCTGGAA
			ACCTGCCGGGTGATCGCCGAAACCCCGCGCGACTCCAT
			CGCCGCCTATGTAATTTCGATGGCGCGCACCCCGTCCG
			ACGTGCTGGCGGTGCATTTGCTGCTGAAAGAAGCCGGC
			TGTCCGTACGCGCTGCCGGTGGCGCCGCTGTTCGAAAC
			GCTGGACGACCTGAATAACGCCGACAGCGTAATGATCC
			AGTTGCTCAACATCGACTGGTATCGCGGCTTCATTCAG
			GGCAAGCAGATGGTGATGATCGGCTATTCCGACTCCGC
			CAAAGACGCCGGGGTGATGGCGGCCTCCTGGGCGCAGT
			ACCGCGCGCAAGACGCACTGATCAAGACCTGCGAGAAA
			TACGGCATCGCCCTGACGCTGTTTCACGGTCGCGGCGG
			TTCGATTGGCCGCGGCGGCGCGCCGGCTCACGCCGCGC
			TGCTCTCCCAACCGCCGGGCAGCCTGAAAGGCGGCCTG
			CGCGTCACCGAACAGGGCGAGATGATCCGCTTTAAGTT
			CGGCCTGCCGGAAGTCACCATTAGCAGCCTGTCGCTCT
			ACACGTCCGCCATTCTGGAAGCCAACCTGTTGCCGCCG
			CCGGAGCCGAAGCAGGAGTGGCATCACATCATGAACGA
			GCTGTCGCGCATTTCCTGCGACATGTACCGCGGCTACG
			TACGGGAAAACCCGGATTTCGTGCCCTACTTCCGTGCC
			GCCACGCCGGAGCTGGAACTGGGCAAACTGCCGCTGGG
			GTCACGTCCGGCCAAGCGTCGGCCGAACGGCGGCGTGG
			AAAGCCTGCGCGCCATCCCGTGGATTTTCGCCTGGACC
			CAGAACCGCCTGATGCTGCCCGCCTGGTTGGGCGCCGG
			CGCCGCGCTGCAAAAAGTGATCGACGACGGTCACCAGA
			ACCAGCTGGAAGCCATGTGCCGCGACTGGCCGTTCTTC
			TCCACCCGTATCGGTATGCTGGAAATGGTATTCGCCAA
			GGCCGACCTATGGCTGGCGGAATACTACGATCAGCGGC
			TGGTGGACGAGAAACTGTGGTCGCTCGGCAAACAGCTG
			CGCGAACAGCTGGAAAGAGACATCAAAGCGGTGTTGAC
			CATCTCCAACGACGACCATCTGATGGCCGACCTGCCGT
			GGATCGCCGAATCCATCGCGCTACGCAACGTCTACACC
			GACCCGCTCAACGTGCTGCAGGCGGAGCTGCTGCACCG
			TTCACGCCAGCAGGAAACACTGGACCCGCAGGTGGAAC
			AGGCGCTGATGGTCACCATCGCCGGCGTCGCCGCCGGG
			ATGCGCAATACCGGCTAA
ppc	Coryne-	NC_003450	ATGACTGATTTTTTACGCGATGACATCAGGTTCCTCGG	242
	bacterium		TCAAATCCTCGGTGAGGTAATTGCGGAACAAGAAGGCC
	glutamicum		AGGAGGTTTATGAACTGGTCGAACAAGCGCGCCTGACT
			TCTTTTGATATCGCCAAGGGCAACGCCGAAATGGATAG
			CCTGGTTCAGGTTTTCGACGGCATTACTCCAGCCAAGG
			CAACACCGATTGCTCGCGCATTTTCCCACTTCGCTCTG
			CTGGCTAACCTGGCGGAAGACCTCTACGATGAAGAGCT
			TCGTGAACAGGCTCTCGATGCAGGCGACACCCCTCCGG
			ACAGCACTCTTGATGCCACCTGGCTGAAACTCAATGAG
			GGCAATGTTGGCGCAGAAGCTGTGGCCGATGTGCTGCG
			CAATGCTGAGGTGGCGCCGGTTCTGACTGCGCACCCAA
			CTGAGACTCGCCGCCGCACTGTTTTTGATGCGCAAAAG
			TGGATCACCACCCACATGCGTGAACGCCACGCTTTGCA
			GTCTGCGGAGCCTACCGCTCGTACGCAAAGCAAGTTGG
			ATGAGATCGAGAAGAACATCCGCCGTCGCATCACCATT
			TTGTGGCAGACCGCGTTGATTCGTGTGGCCCGCCCACG
			TATCGAGGACGAGATCGAAGTAGGGCTGCGCTACTACA
			AGCTGAGCCTTTTGGAAGAGATTCCACGTATCAACCGT
			GATGTGGCTGTTGAGCTTCGTGAGCGTTTCGGCGAGGG
			TGTTCCTTTGAAGCCCGTGGTCAAGCCAGGTTCCTGGA
			TTGGTGGAGACCACGACGGTAACCCTTATGTCACCGCG
			GAAACAGTTGAGTATTCCACTCACCGCGCTGCGGAAAC
			CGTGCTCAAGTACTATGCACGCCAGCTGCATTCCCTCG
			AGCATGAGCTCAGCCTGTCGGACCGCATGAATAAGGTC
			ACCCCGCAGCTGCTTGCGCTGGCAGATGCAGGGCACAA
			CGACGTGCCAAGCCGCGTGGATGAGCCTTATCGACGCG
			CCGTCCATGGCGTTCGCGGACGTATCCTCGCGACGACG
			GCCGAGCTGATCGGCGAGGACGCCGTTGAGGGCGTGTG
			GTTCAAGGTCTTTACTCCATACGCATCTCCGGAAGAAT
			TCTTAAACGATGCGTTGACCATTGATCATTCTCTGCGT
			GAATCCAAGGACGTTCTCATTGCCGATGATCGTTTGTC
			TGTGCTGATTTCTGCCATCGAGAGCTTTGGATTCAACC
			TTTACGCACTGGATCTGCGCCAAAACTCCGAAAGCTAC
			GAGGACGTCCTCACCGAGCTTTTCGAACGCGCCCAAGT
			CACCGCAAACTACCGCGAGCTGTCTGAAGCAGAGAAGC
			TTGAGGTGCTGCTGAAGGAACTGCGCAGCCCTCGTCCG
			CTGATCCCGCACGGTTCAGATGAATACAGCGAGGTCAC
			CGACCGCGAGCTCGGCATCTTCCGCACCGCGTCGGAGG
			CTGTTAAGAAATTCGGGCCACGGATGGTGCCTCACTGC
			ATCATCTCCATGGCATCATCGGTCACCGATGTGCTCGA
			GCCGATGGTGTTGCTCAAGGAATTCGGACTCATCGCAG
			CCAACGGCGACAACCCACGCGGCACCGTCGATGTCATC
			CCACTGTTCGAAACCATCGAAGATCTCCAGGCCGGCGC
			CGGAATCCTCGACGAACTGTGGAAAATTGATCTCTACC
			GCAACTACCTCCTGCAGCGCGACAACGTCCAGGAAGTC
			ATGCTCGGTTACTCCGATTCCAACAAGGATGGCGGATA
			TTTCTCCGCAAACTGGGCGCTTTACGACGCGGAACTGC
			AGCTCGTCGAACTATGCCGATCAGCCGGGGTCAAGCTT
			CGCCTGTTCCACGGCCGTGGTGGCACCGTCGGCCGCGG
			TGGCGGACCTTCCTACGACGCGATTCTTGCCCAGCCCA
			GGGGGGCTGTCCAAGGTTCCGTGCGCATCACCGAGCAG
			GGCGAGATCATCTCCGCTAAGTACGGCAACCCCGAAAC
			CGCGCGCCGAAACCTCGAAGCCCTGGTCTCAGCCACGC
			TTGAGGCATCGCTTCTCGACGTCTCCGAACTCACCGAT
			CACCAACGCGCGTACGACATCATGAGTGAGATCTCTGA
			GCTCAGCTTGAAGAAGTACGCCTCCTTGGTGCACGAGG
			ATCAAGGCTTCATCGATTACTTCACCCAGTCCACGCCG
			CTGCAGGAGATTGGATCCCTCAACATCGGATCCAGGCC
			TTCCTCACGCAAGCAGACCTCCTCGGTGGAAGATTTGC
			GAGCCATCCCATGGGTGCTCAGCTGGTCACAGTCTCGT
			GTCATGCTGCCAGGCTGGTTTGGTGTCGGAACCGCATT
			AGAGCAGTGGATTGGCGAAGGGGAGCAGGCCACCCAAC
			GCATTGCCGAGCTGCAAACACTCAATGAGTCCTGGCCA
			TTTTTCACCTCAGTGTTGGATAACATGGCTCAGGTGAT
			GTCCAAGGCAGAGCTGCGTTTGGCAAAGCTCTACGCAG
			ACCTGATCCCAGATACGGAAGTAGCCGAGCGAGTCTAT
			TCCGTCATCCGCGAGGAGTACTTCCTGACCAAGAAGAT
			GTTCTGCGTAATCACCGGCTCTGATGATCTGCTTGATG
			ACAACCCACTTCTCGCACGCTCTGTCCAGCGCCGATAC
			CCCTACCTGCTTCCACTCAACGTGATCCAGGTAGAGAT
			GATGCGACGCTACCGAAAAGGCGACCAAAGCGAGCAAG
			TGTCCCGCAACATTCAGCTGACCATGAACGGTCTTTCC
			ACTGCGCTGCGCAACTCCGGC
ppc	Escherichia	X05903	ATGAACGAACAATATTCCGCATTGCGTAGTAATGTCAG	243
	coli		TATGCTCGGCAAAGTGCTGGGAGAAACCATCAAGGATG
			CGTTGGGAGAACACATTCTTGAACGCGTAGAAACTATC
			CGTAAGTTGTCGAAATCTTCACGCGCTGGCAATGATGC
			TAACCGCCAGGAGTTGCTCACCACCTTACAAAATTTGT
			CGAACGACGAGCTGCTGCCCGTTGCGCGTGCGTTTAGT
			CAGTTCCTGAACCTGGCCAACACCGCCGAGCAATACCA
			CAGCATTTCGCCGAAAGGCGAAGCTGCCAGCAACCCGG
			AAGTGATCGCCCGCACCCTGCGTAAACTGAAAAACCAG
			CCGGAACTGAGCGAAGACACCATCAAAAAAGCAGTGGA
			ATCGCTGTCGCTGGAACTGGTCCTCACGGCTCACCCAA
			CCGAAATTACCCGTCGTACACTGATCCACAAAATGGTG
			GAAGTGAACGCCTGTTTAAAACAGCTCGATAACAAAGA
			TATCGCTGACTACGAACACAACCAGCTGATGCGTCGCC
			TGCGCCAGTTGATCGCCCAGTCATGGCATACCGATGAA
			ATCCGTAAGCTGCGTCCAAGCCCGGTAGATGAAGCCAA
			ATGGGGCTTTGCCGTAGTGGAAAACAGCCTGTGGCAAG
			GCGTACCAAATTACCTGCGCGAACTGAACGAACAACTG
			GAAGAGAACCTCGGCTACAAACTGCCCGTCGAATTTGT
			TCCGGTCCGTTTTACTTCGTGGATGGGCGGCGACCGCG
			ACGGCAACCCGAACGTCACTGCCGATATCACCCGCCAC
			GTCCTGCTACTCAGCCGCTGGAAAGCCACCGATTTGTT
			CCTGAAAGATATTCAGGTGCTGGTTTCTGAACTGTCGA
			TGGTTGAAGCGACCCCTGAACTGCTGGCGCTGGTTGGC
			GAAGAAGGTGCCGCAGAACCGTATCGCTATCTGATGAA
			AAACCTGCGTTCTCGCCTGATGGCGACACAGGCATGGC
			TGGAAGCGCGCCTGAAAGGCGAAGAACTGCCAAAACCA
			GAAGGCCTGCTGACACAAAACGAAGAACTGTGGGAACC
			GCTCTACGCTTGCTACCAGTCACTTCAGGCGTGTGGCA
			TGGGTATTATCGCCAACGGCGATCTGCTCGACACCCTG
			CGCCGCGTGAAATGTTTCGGCGTACCGCTGGTCCGTAT
			TGATATCCGTCAGGAGAGCACGCGTCATACCGAAGCGC
			TGGGCGAGCTGACCCGCTACCTCGGTATCGGCGACTAC
			GAAAGCTGGTCAGAGGCCGACAAACAGGCGTTCCTGAT
			CCGCGAACTGAACTCCAAACGTCCGCTTCTGCCGCGCA
			ACTGGCAACCAAGCGCCGAAACGCGCGAAGTGCTCGAT
			ACCTGCCAGGTGATTGCCGAAGCACCGCAAGGCTCCAT
			TGCCGCCTACGTGATCTCGATGGCGAAAACGCCGTCCG
			ACGTACTGGCTGTCCACCTGCTGCTGAAAGAAGCGGGT
			ATCGGGTTTGCGATGCCGGTTGCTCCGCTGTTTGAAAC
			CCTCGATGATCTGAACAACGCCAACGATGTCATGACCC
			AGCTGCTCAATATTGACTGGTATCGTGGCCTGATTCAG
			GGCAAACAGATGGTGATGATTGGCTATTCCGACTCAGC
			AAAAGATGCGGGAGTGATGGCAGCTTCCTGGGCGCAAT
			ATCAGGCACAGGATGCATTAATCAAAACCTGCGAAAAA
			GCGGGTATTGAGCTGACGTTGTTCCACGGTCGCGGCGG
			TTCCATTGGTCGCGGCGGCGCACCTGCTCATGCGGCGC
			TGCTGTCACAACCGCCAGGAAGCCTGAAAGGCGGCCTG
			CGCGTAACCGAACAGGGCGAGATGATCCGCTTTAAATA
			TGGTCTGCCAGAAATCACCGTCAGCAGCCTGTCGCTTT
			ATACCGGGGCGATTCTGGAAGCCAACCTGCTGCCACCG
			CCGGAGCCGAAAGAGAGCTGGCGTCGCATTATGGATGA
			ACTGTCAGTCATCTCCTGCGATGTCTACCGCGGCTACG
			TACGTGAAAACAAAGATTTTGTGCCTTACTTCCGCTCC
			GCTACGCCGGAACAAGAACTGGGCAAACTGCCGTTGGG
			TTCACGTCCGGCGAAACGTCGCCCAACCGGCGGCGTCG
			AGTCACTACGCGCCATTCCGTGGATCTTCGCCTGGACG
			CAAAACCGTCTGATGCTCCCCGCCTGGCTGGGTGCAGG
			TACGGCGCTGCAAAAAGTGGTCGAAGACGGCAAACAGA
			GCGAGCTGGAGGCTATGTGCCGCGATTGGCCATTCTTC
			TCGACGCGTCTCGGCATGCTGGAGATGGTCTTCGCCAA
			AGCAGACCTGTGGCTGGCGGAATACTATGACCAACGCC
			TGGTAGACAAAGCACTGTGGCCGTTAGGTAAAGAGTTA
			CGCAACCTGCAAGAAGAAGACATCAAAGTGGTGCTGGC
			GATTGCCAACGATTCCCATCTGATGGCCGATCTGCCGT
			GGATTGCAGAGTCTATTCAGCTACGGAATATTTACACC
			GACCCGCTGAACGTATTGCAGGCCGAGTTGCTGCACCG
			CTCCCGCCAGGCAGAAAAAGAAGGCCAGGAACCGGATC
			CTCGCGTCGAACAAGCGTTAATGGTCACTATTGCCGGG
			ATTGCGGCAGGTATGCGTAATACCGGCTAA
pyc	Streptomyces	AL939105.1	ATGGTCTCGTCACCCGGCAGGCTGAAGGGATCAAGAAT	40
	coelicolor		GTTCCGCAAGGTGCTGGTCGCCAACCGCGGTGAGATCG
			CGATCCGTGCGTTTCGGGCGGGCTACGAGCTCGGCGCG
			CGCACCGTCGCCGTCTTCCCGCACGAGGACCGCAATTC
			GCTGCACCGGCTCAAGGCCGACGAGGCCTACGAGATCG
			GGGAGCAGGGGCATCCCGTCCGCGCGTACCTCTCCGTG
			GAGGAGATCGTGCGCGCCGCCCGCCGTGCGGGGGCCGA
			CGCCGTCTACCCGGGCTACGGCTTCCTGTCCGAGAACC
			CCGAACTCGCCCGCGCCTGCGAGGAGGCCGGGATCACC
			TTCGTCGGTCCCAGCGCCCGGATCCTGGAACTGACCGG
			CAACAAGGCACGGGCCGTGGCCGCCGCCCGCGAGGCCG
			GAGTACCCGTGCTCGGCTCCTCGGCGCCCTCCACCGAC
			GTGGACGAACTCGTACGCGCCGCCGACGACGTCGGCTT
			CCCCGTGTTCGTCAAGGCGGTCGCGGGCGGCGGCGGGC
			GCGGCATGCGCCGCGTCGAGGAACCCGCCCAGCTGCGC
			GAGGCCATCGAGGCCGCCTCCCGCGAGGCCGCGTCCGC
			CTTCGGCGACTCCACCGTCTTCCTGGAGAAGGCGGTCG
			TCGAACCCCGCCACATCGAGGTGCAGATCCTCGCCGAC
			GGCGAGGGCGACGTCATCCACCTCTTCGAGCGGGACTG
			CTCGGTGCAGCGCCGCCACCAGAAGGTGATCGAGCTGG
			CGCCCGCGCCCAACCTCGACCCGGCCCTGCGGGAGCGG
			ATCTGCGCCGACGCCGTGAACTTCGCCCGGCAGATCGG
			CTACCGCAACGCGGGCACCGTCGAGTTCCTCGTCGACC
			GGGACGGCAACCACGTCTTCATCGAGATGAACCCGCGC
			ATCCAGGTCGAGCACACGGTCACCGAGGAGGTCACCGA
			CGTCGACCTGGTCCAGTCCCAGCTGCGCATCGCCGCCG
			GCCAGACGCTGGCCGACCTCGGACTCGCCCAGGAGAAC
			ATCACCCTGCGCGGTGCCGCACTCCAGTGCCGCATCAC
			CACCGAGGACCCGGCCAACGGCTTCCGCCCGGACACCG
			GGCAGATCAGCGCCTACCGTTCGCCGGGCGGCTCCGGC
			ATCCGGCTCGACGGCGGTACCACCCACGCCGGTACGGA
			GATCAGCGCGCACTTCGACTCGATGCTGGTCAAGCTCT
			CCTGCCGGGGACGGGACTTCACCACCGCGGTGAACCGC
			GCCCGGCGTGCGGTCGCCGAGTTCCGCATCCGCGGCGT
			CGCCACCAACATCCCCTTCCTCCAGGCGGTCCTGGACG
			ACCCCGACTTCCAGGCCGGCCGGGTCACCACCTCGTTC
			ATCGAACAGCGCCCGCACCTGCTGACCGCCCGGCACTC
			CGCCGACCGCGGCACCAAGCTGCTGACCTACCTCGCCG
			ACGTCACGGTGAACAAGCCGCACGGCGAGCGCCCCGAG
			CTGGTCGACCCGCTGACCAAGCTGCCGACGGCGTCCGC
			CGGTGAACCGCCCGCCGGGTCCCGCCAGTTGCTGGCCG
			AGCTGGGGCCGGAGGGGTTCGCCCGCCGACTGCGCGAG
			TCGTCCACCATCGGCGTCACCGACACCACCTTCCGCGA
			CGCCCACCAGTCGCTGCTCGCCACCCGGGTGCGCACCA
			AGGACATGCTCGCCGTGGCGCCCGTCGTCGCCCGCACC
			CTGCCCCAGCTGCTGTCCCTGGAGTGCTGGGGCGGCGC
			CACCTACGACGTCGCCCTGCGCTTCCTCGCCGAGGACC
			CCTGGGAGCGGCTAGCCGCGCTGCGCGAGGCGGTGCCC
			AACCTCTGCCTCCAGATGCTGCTGCGCGGCCGCAACAC
			CGTGGGCTACACCCCGTACCCGACCGAGGTGACCGACG
			CCTTCGTGCAGGAGGCCGCCGCCACCGGCATCGACATC
			TTCCGCATCTTCGACGCCCTCAACGACGTCGAGCAGAT
			GCGGCCCGCCATCGAGGCCGTACGGCAGACCGGCAGCG
			CCGTCGCCGAGGTCGCGCTCTGCTACACCGCCGACCTG
			TCCGACCCCTCCGAGCGGCTCTACACCCTCGACTACTA
			CCTGCGGCTCGCCGAGCAGATCGTGAACGCCGGAGCGC
			ACGTGCTGGCCGTCAAGGACATGGCCGGGCTGCTGCGC
			GCACCGGCCGCCGCGACCCTGGTGTCCGCGCTGCGCCG
			GGAGTTCGACCTGCCGGTGCACCTGCACACCCACGACA
			CCACCGGCGGCCAGCTCGCCACCTACCTGGCCGCGATC
			CAGGCGGGCGCGGACGCCGTCGACGGTGCGGTGGCGTC
			CATGGCGGGCACCACTTCGCAGCCGTCGCTGTCGGCGA
			TCGTGGCCGCCACCGACCACACCGAGCGGCCCACCGGC
			CTCGACCTCCAGGCCGTCGGCGACCTGGAGCCGTACTG
			GGAGAGCGTCCGCAAGGTCTACGCCCCGTTCGAGGCCG
			GCCTGGCCTCCCCGACCGGCCGGGTCTACCACCACGAG
			ATTCCCGGCGGCCAGCTCTCCAACCTGCGCACCCAGGC
			CGTCGCGCTCGGCCTCGGCGACCGCTTCGAGGACATCG
			AGGCCATGTACGCCGCCGCCGACCGGATGCTGGGCCGC
			CTGGTGAAGGTCACCCCGTCCTCCAAGGTGGTCGGCGA
			CCTGGCCCTGCATCTGGTGGGCGCCGGTGTCTCCCCGG
			CGGACTTCGAGCAGGACCCCGACCGGTTCGACATCCCG
			GACTCCGTGGTCGGCTTCCTGCGCGGCGAGCTGGGCAC
			CCCGCCCGGCGGCTGGCCCGAGCCGTTCCGCAGCAAGG
			CGCTGCGCGGCCGCGCCGAGGCCAGGCCGCTCGCCGAG
			CTGTCCGAGGACGACCGCGACGGCCTCGGCAAGGACCG
			CCGGGCGACGCTCAACCGGCTGCTGTTCCCGGGACCGG
			CCCGCGAGTTCGACACCCACCGCGCCTCGTACGGCGAC
			ACCAGCATCCTCGACAGCAAGGACTTCTTCTACGGGCT
			GCGCCCGGGCAAGGAGTACACGGTCGACCTCGACCCCG
			GCGTCCGGCTGCTCATCGAACTCCAGGCGGTCGGCGAC
			GCCGACGAGCGCGGCATGCGCACCGTGATGTCCTCCCT
			GAACGGACAGCTCCGCCCCATCCAGGTCCGCGACCGGT
			CGGCCGCCACCGACGTCCCGGTGACGGAGAAGGCCGAC
			CGGGCGAACCCCGGCCACGTCGCGGCGCCGTTCGCCGG
			TGTGGTGACCCTCGCCGTCGCCGAGGGCGACGAGGTGG
			AGGCCGGGGCCACCGTGGCCACCATCGAGGCGATGAAG
			ATGGAGGCGTCGATCACGGCCCCGAAGTCCGGCACGGT
			GACCAGGCTCGCCATCAACCGCATCCAGCAGGTCGAGG
			GCGGCGATCTTCTCGTCCAACTCGCC
pyc	Mycobacterium	AF262949	GTGATCTCCAAGGTGCTCGTCGCCAACCGCGGCGAAAT	41
	smegmatis		CGCGATCCGCGCATTCCGTGCTGCGTACGAGATGGGCA
			TCGCCACGGTGGCGGTGTATCCGTACGAGGACCGGAAT
			TCGCTCCATCGGCTCAAGGCCGACGAGTCATATCAGAT
			CGGCGAGGTGGGTCATCCCGTCCGCGCGTATCTGTCGG
			TCGACGAGATCATCCGCGTCGCCAAGCATTCGGGCGCC
			GACGCGGTGTACCCGGGCTACGGCTTCCTGTCGGAGAA
			CCCCGATCTGGCGGCCAAGTGCGCCGAGGCGGGTATCA
			CGTTCGTGGGACCGTCCGCCGAGGTGCTGCAGCTCACG
			GGTAACAAGGCACGCGCGATCGCCGCGGCGCGCGCCGC
			GGGCCTTCCCGTGCTGAGTTCGTCGGAGCCGTCGTCGT
			CGGTGGACGAGTTGATGGCCGCTGCCGCCGACATGGAG
			TTCCCGCTGTTCGTCAAGGCGGTCTCGGGTGGCGGCGG
			GCGCGGCATGCGCCGCGTCACCGACCGCGAGTCCCTGG
			CCGAGGCGATCGAGGCGGCCTCGCGGGAGGCCGAGTCG
			GCGTTCGGCGACGCGTCGGTGTACCTGGAGCAGGCCGT
			GCTCAACCCGCGTCACATCGAGGTGCAGATCCTCGCCG
			ACGGCGCGGGCAACGTCATGCACCTGTTCGAGCGTGAC
			TGCAGCGTGCAGCGCAGGCATCAGAAGGTCGTCGAGCT
			GGCGCCCGCGCCCAACCTGAGTGACGAACTGCGCCAAC
			AGATCTGCGCCGACGCCGTGGCCTTCGCGCGCCAGATC
			GGGTACTCGTGCGCGGGCACCGTCGAGTTCCTGCTCGA
			CGAGCGCGGCCATCACGTGTTCATCGAGTGCAATCCGC
			GAATCCAGGTGGAGCACACGGTGACCGAGGAGATCACC
			GACGTGGACCTGGTGTCCTCGCAGTTGCGCATCGCCGC
			GGGCGAGACGCTCGCCGATCTCGGTCTGTCCCAGGACC
			GGCTCGTGGTGCGTGGCGCGGCCATGCAGTGCCGCATC
			ACCACCGAGGTCCCGGCCAACGGCTTCCGACCCGACAC
			CGGCCGCATCACCGCGTACCGCTCGCCGGGCGGCGCGG
			GCATCCGCCTCGACGGCGGCACCAACCTGGGTGCGGAG
			ATCTCGGCGCACTTCGACTCCATGCTGGTCAAGCTGAC
			GTGCCGGGGACGCGACTTCTCGGCCGCGGCCTCGCGCG
			CGCGCCGCGCCCTGGCGGAGTTCCGCATCCGCGGTGTG
			TCGACCAACATCCCGTTCCTGCAGGCGGTCATCGACGA
			TCCGGACTTCCGCGCCGGACGGGTGACGACGTCGTTCA
			TCGACGACCGGCCGCATCTATTGACCTCGCGGTCTCCT
			GCCGACCGCGGCACCAGGATCCTCAACTACCTGGCCGA
			CATCACGGTCAACAAGCCGCACGGCGAACGGCCTTCGA
			CGGTTTACCCGCAGGACAAGCTGCCGCCGCTGGATCTG
			CAGGCGCCGCCGCCCGCGGGATCCAAACAGCGCCTCGT
			GGAACTGGGGCCCGAGGGTTTCGCGGGCTGGCTGCGCG
			AATCCAAGGCCGTCGGCGTCACCGACACGACGTTCCGC
			GACGCGCACCAGTCGCTGCTGGCCACGCGTGTGCGCAC
			CACCGGTCTGCTGATGGTGGCGCCGTACGTCGCACGCT
			CCATGCCGCAGTTGCTGTCGATCGAGTGCTGGGGCGGC
			GCGACCTACGATGTGGCCCTTCGCTTCCTGAAGGAAGA
			CCCGTGGGAGCGGCTGGCGGCGCTGCGCGAGAGCGTGC
			CCAACATCTGCCTGCAGATGCTGCTGCGGGGACGCAAC
			ACCGTGGGCTACACGCCGTACCCGGAACTGGTCACCTC
			GGCGTTCGTCGAGGAGGCCGCGGCGACCGGTATCGACA
			TCTTCCGGATCTTCGACGCGCTCAACAACGTCGAGTCG
			ATGCGGCCCGCGATCGACGCGGTGCGGGAAACCGGTTC
			GACCATCGCCGAAGTCGCGATGTGCTACACGGGCGACC
			TCAGCGATCCCGCGGAGAACCTCTACACGCTCGACTAC
			TACCTGAAGCTGGCCGAGCAGATCGTCGAGGCCGGCGC
			CCACGTGCTGGCGATCAAGGACATGGCCGGTCTGCTGC
			GCGCCCCGGCCGCCCACACGCTCGTGAGCGCGTTGCGC
			AGCCGGTTCGATCTGCCCGTGCACGTGCACACCCACGA
			CACCCCGGGCGGTCAGCTCGCGACGTACCTCGCGGCGT
			GGTCGGCCGGCGCGGACGCGGTGGACGGCGCCTCGGCG
			CCGATGGCCGGGACCACGAGCCAGCCCGCGCTGAGCTC
			GATCGTCGCGGCGGCCGCGCACACCCAGTACGACACGG
			GCCTGGACCTGCGTGCGGTGTGCGACCTTGAGCCCTAC
			TGGGAGGCGGTGAGAAAGGTCTACGCGCCGTTCGAGTC
			CGGGCTGCCCGGGCCAACCGGCCGCGTCTACACCCACG
			AGATTCCCGGTGGGCAGTTGAGCAACCTGCGTCAGCAG
			GCCATCGCGTTGGGCCTCGGCGACCGGTTCGAGGAGAT
			CGAGGCCAATTACGCTGCGGCCGACCGGGTTCTGGGAC
			GGCTCGTGAAGGTGACCCCGTCGTCGAAGGTGGTCGGG
			GACCTGGCGCTGGCGCTCGTGGGTGCGGGCATCACCGC
			CGAGGAGTTCGCCGAGGATCCCGCGAAGTACGACATCC
			CCGACAGCGTGATCGGCTTCCTGCGCGGTGAACTCGGG
			GATCCGCCGGGCGGATGGCCGGAACCGTTGCGCACCAA
			GGCGCTCCAGGGCCGCGGACCGGCCCGGCCGGTCGAGA
			AGCTGACCGCCGACGACGAGGCGTTGCTCGCCCAGCCC
			GGGCCCAAGCGGCAGGCCGCGTTGAACCGCCTGCTTTT
			CCCCGGGCCCACCGCCGAGTTCGAGGCGCACCGCGAAA
			CCTACGGCGACACCTCATCCCTCAGCGCGAACCAGTTC
			TTCTACGGGCTGCGCTACGGCGAGGAGCACCGCGTGCA
			ACTCGAACGTGGCGTGGAACTGCTGATCGGGCTTGAGG
			CGATCTCGGAGGCCGACGAGCGCGGCATGCGCACCGTG
			ATGTGCATCATCAACGGTCAGCTGCGCCCGGTTCTCGT
			GCGCGACCGCAGCATCGCCAGCGAGGTGCCCGCCGCCG
			AAAAGGCCGACCGCAACAATGCCGACCACATCGCCGCG
			CCCTTCGCCGGTGTGGTGACCGTCGGTGTCGCAGAAGG
			TGACTCGGTGGACGCGGGACAAACCATCGCGACGATCG
			AGGCGATGAAGATGGAGGCCGCCATCACCGCGCCCAAG
			GCAGGCACCGTCGCGCGCGTCGCGGTCGCGGCGACCGC
			CCAGGTCGAGGGCGGCGATCTGCTGGTGGTGGTCAGCT
			GA
pyc	Coryne-	Y09548	GTGTCGACTCACACATCTTCAACGCTTCCAGCATTCAA	244
	bacterium		AAAGATCTTGGTAGCAAACCGCGGCGAAATCGCGGTCC
	glutamicum		GTGCTTTCCGTGCAGCACTCGAAACCGGTGCAGCCACG
			GTAGCTATTTACCCCCGTGAAGATCGGGGATCATTCCA
			CCGCTCTTTTGCTTCTGAAGCTGTCCGCATTGGTACCG
			AAGGCTCACCAGTCAAGGCGTACCTGGACATCGATGAA
			ATTATCGGTGCAGCTAAAAAAGTTAAAGCAGATGCCAT
			TTACCCGGGATACGGCTTCCTGTCTGAAAATGCCCAGC
			TTGCCCGCGAGTGTGCGGAAAACGGCATTACTTTTATT
			GGCCCAACCCCAGAGGTTCTTGATCTCACCGGTGATAA
			GTCTCGCGCGGTAACCGCCGCGAAGAAGGCTGGTCTGC
			CAGTTTTGGCGGAATCCACCCCGAGCAAAAACATCGAT
			GAGATCGTTAAAAGCGCTGAAGGCCAGACTTACCCCAT
			CTTTGTGAAGGCAGTTGCCGGTGGTGGCGGACGCGGTA
			TGCGTTTTGTTGCTTCACCTGATGAGCTTCGCAAATTA
			GCAACAGAAGCATCTCGTGAAGCTGAAGCGGCTTTCGG
			CGATGGCGCGGTATATGTCGAACGTGCTGTGATTAACC
			CTCAGCATATTGAAGTGCAGATCCTTGGCGATCACACT
			GGAGAAGTTGTACACCTTTATGAACGTGACTGCTCACT
			GCAGCGTCGTCACCAAAAAGTTGTCGAAATTGCGCCAG
			CACAGCATTTGGATCCAGAACTGCGTGATCGCATTTGT
			GCGGATGCAGTAAAGTTCTGCCGCTCCATTGGTTACCA
			GGGCGCGGGAACCGTGGAATTCTTGGTCGATGAAAAGG
			GCAACCACGTCTTCATCGAAATGAACCCACGTATCCAG
			GTTGAGCACACCGTGACTGAAGAAGTCACCGAGGTGGA
			CCTGGTGAAGGCGCAGATGCGCTTGGCTGCTGGTGCAA
			CCTTGAAGGAATTGGGTCTGACCCAAGATAAGATCAAG
			ACCCACGGTGCAGCACTGCAGTGCCGCATCACCACGGA
			AGATCCAAACAACGGCTTCCGCCCAGATACCGGAACTA
			TCACCGCGTACCGCTCACCAGGCGGAGCTGGCGTTCGT
			CTTGACGGTGCAGCTCAGCTCGGTGGCGAAATCACCGC
			ACACTTTGACTCCATGCTGGTGAAAATGACCTGCCGTG
			GTTCCGACTTTGAAACTGCTGTTGCTCGTGCACAGCGC
			GCGTTGGCTGAGTTCACCGTGTCTGGTGTTGCAACCAA
			CATTGGTTTCTTGCGTGCGTTGCTGCGGGAAGAGGACT
			TCACTTCCAAGCGCATCGCCACCGGATTCATTGCCGAT
			CACCCGCACCTCCTTCAGGCTCCACCTGCTGATGATGA
			GCAGGGACGCATCCTGGATTACTTGGCAGATGTCACCG
			TGAACAAGCCTCATGGTGTGCGTCCAAAGGATGTTGCA
			GCTCCTATCGATAAGCTGCCTAACATCAAGGATCTGCC
			ACTGCCACGCGGTTCCCGTGACCGCCTGAAGCAGCTTG
			GCCCAGCCGCGTTTGCTCGTGATCTCCGTGAGCAGGAC
			GCACTGGCAGTTACTGATACCACCTTCCGCGATGCACA
			CCAGTCTTTGCTTGCGACCCGAGTCCGCTCATTCGCAC
			TGAAGCCTGCGGCAGAGGCCGTCGCAAAGCTGACTCCT
			GAGCTTTTGTCCGTGGAGGCCTGGGGCGGCGCGACCTA
			CGATGTGGCGATGCGTTTCCTCTTTGAGGATCCGTGGG
			ACAGGCTCGACGAGCTGCGCGAGGCGATGCCGAATGTA
			AACATTCAGATGCTGCTTCGCGGCCGCAACACCGTGGG
			ATACACCCCGTACCCAGACTCCGTCTGCCGCGCGTTTG
			TTAAGGAAGCTGCCAGCTCCGGCGTGGACATCTTCCGC
			ATCTTCGACGCGCTTAACGACGTCTCCCAGATGCGTCC
			AGCAATCGACGCAGTCCTGGAGACCAACACCGCGGTAG
			CCGAGGTGGCTATGGCTTATTCTGGTGATCTCTCTGAT
			CCAAATGAAAAGCTCTACACCCTGGATTACTACCTAAA
			GATGGCAGAGGAGATCGTCAAGTCTGGCGCTCACATCT
			TGGCCATTAAGGATATGGCTGGTCTGCTTCGCCCAGCT
			GCGGTAACCAAGCTGGTCACCGCACTGCGCCGTGAATT
			CGATCTGCCAGTGCACGTGCACACCCACGACACTGCGG
			GTGGCCAGCTGGCAACCTACTTTGCTGCAGCTCAAGCT
			GGTGCAGATGCTGTTGACGGTGCTTCCGCACCACTGTC
			TGGCACCACCTCCCAGCCATCCCTGTCTGCCATTGTTG
			CTGCATTCGCGCACACCCGTCGCGATACCGGTTTGAGC
			CTCGAGGCTGTTTCTGACCTCGAGCCGTACTGGGAAGC
			AGTGCGCGGACTGTACCTGCCATTTGAGTCTGGAACCC
			CAGGCCCAACCGGTCGCGTCTACCGCCACGAAATCCCA
			GGCGGACAGTTGTCCAACCTGCGTGCACAGGCCACCGC
			ACTGGGCCTTGCGGATCGTTTCGAACTCATCGAAGACA
			ACTACGCAGCCGTTAATGAGATGCTGGGACGCCCAACC
			AAGGTCACCCCATCCTCCAAGGTTGTTGGCGACCTCGC
			ACTCCACCTCGTTGGTGCGGGTGTGGATCCAGCAGACT
			TTGCTGCCGATCCACAAAAGTACGACATCCCAGACTCT
			GTCATCGCGTTCCTGCGCGGCGAGCTTGGTAACCCTCC
			AGGTGGCTGGCCAGAGCCACTGCGCACCCGCGCACTGG
			AAGGCCGCTCCGAAGGCAAGGCACCTCTGACGGAAGTT
			CCTGAGGAAGAGCAGGCGCACCTCGACGCTGATGATTC
			CAAGGAACGTCGCAATAGCCTCAACCGCCTGCTGTTCC
			CGAAGCCAACCGAAGAGTTCCTCGAGCACCGTCGCCGC
			TTCGGCAACACCTCTGCGCTGGATGATCGTGAATTCTT
			CTACGGCCTGGTCGAAGGCCGCGAGACTTTGATCCGCC
			TGCCAGATGTGCGCACCCCACTGCTTGTTCGCCTGGAT
			GCGATCTCTGAGCCAGACGATAAGGGTATGCGCAATGT
			TGTGGCCAACGTCAACGGCCAGATCCGCCCAATGCGTG
			TGCGTGACCGCTCCGTTGAGTCTGTCACCGCAACCGCA
			GAAAAGGCAGATTCCTCCAACAAGGGCCATGTTGCTGC
			ACCATTCGCTGGTGTTGTCACCGTGACTGTTGCTGAAG
			GTGATGAGGTCAAGGCTGGAGATGCAGTCGCAATCATC
			GAGGCTATGAAGATGGAAGCAACAATCACTGCTTCTGT
			TGACGGCAAAATCGATCGCGTTGTGGTTCCTGCTGCAA
			CGAAGGTGGAAGGTGGCGACTTGATCGTCGTCGTTTCC
			TAA
dapA	Thermobifida	NZ_AAAQQ10	ATGGTAGGCAGTACGACGCCGAACGCGCCCTTCGGCCA	42
	fusca	00040.1	GATGTTGACCGCGATGATCACCCCCATGCTCGACAATG
			GGGAGGTGGACTACGACGGGGTGGCCCGCCTCGCGACC
			TACCTCGTCGATGAGCAGCGCAACGACGGCCTCATCGT
			CAACGGAACCACCGGAGAGTCCGCCACCACCAGCGATG
			AGGAGAAGGAGCGCATCCTCCGCACCGTGATCGACGCG
			GTCGGCGACCGCGCCACCATCGTTGCCGGAGCGGGCAG
			CAACGACACCAGGCACAGTATTGAACTCGCGCGGACCG
			CGGAACGCGCCGGAGCAGACGGCCTGCTGCTCGTCACC
			CCCTACTACAACCGGCCGCCCCAAGAAGGCCTGCTGCG
			GCACTTCACGGCCATTGCCGACGCCACAGGGCTGCCGA
			TCATGCTCTACGACATTCCTGGCCGCACAGGCACGCCG
			ATCGACTCCGAAACCCTGGTCCGGCTCGCCGAGCACCC
			CCGCATCGTCGCCAACAAGGACGCCAAAGACGACCTCG
			GCGCCAGCTCGTGGGTGATGTCCCGCACCGACCTCGCC
			TACTACAGCGGCAGCGACATGCTCAACCTGCCGCTGCT
			GTCCATCGGCGCCGCGGGCTTCGTCAGCGTGGTCGGCC
			ATGTCGTCGGCTCCGAACTGCACGACATGATCGACGCC
			TACCGGGCCGGGGACGTGGCCCGGGCTTTGGACATCCA
			CCGCCGCCTGATCCCCGTCTACCGGGGCATGTTCCGCA
			CCCAGGGAGTCATCACCACTAAGGCGGTGCTCGCCATG
			TTCGGGCTGCCCGCCGGAGTGGTCCGCGCCCCCCTGCT
			CGACGCGTCCCCCGAACTCAAAGAGCTGCTCCGCGAAG
			ACCTCGCCATGGCCGGGGTGAAGGGCCCCACTGGCCTT
			GCCTCCGCTCACGAGGACGCGGCCAGCGGGAGGGAAGC
			GGAACGACTCACGGAGGGGACCGCA
dapA	Mycobacterium	AL583922.1	GTGACCACTGTCGGATTCGACGTCCCCGCACGTTTGGG	43
	leprae (can be		GACCCTGCTTACTGCGATGGTGACACCGTTTGACGCTG
	used to clone		ATGGTTCTGTTGACACTGCGGCTGCGACGCGGCTGGCG
	M. smegmatis		AACCGCCTGGTCGACGCGGGTTGTGATGGTCTGGTGCT
	gene)		CTCGGGCACCACCGGCGAGTCGCCGACCACTACTGACG
			ACGAGAAACTCCAACTGTTGCGTGTCGTACTTGAGGCG
			GTAGGTGACCGAGCTAGAGTCATCGCCGGCGCAGGTAG
			TTATGACACAGCTCATAGTGTCCGACTCGTCAAGGCCT
			GTGCGGGTGAGGGCGCGCACGGACTTCTGGTGGTTACC
			CCTTACTACTCGAAGCCGCCGCAGACCGGGCTGTTTGC
			GCACTTCACCGCTGTGGCCGACGCGACTGAGCTACCAG
			TGTTGCTCTACGACATTCCCGGGCGGTCGGTCGTGCCG
			ATCGAGCCTGACACGATTCGCGCGCTGGCGTCGCATCC
			CAACATCGTCGGAGTCAAAGAGGCCAAGGCTGATTTAT
			ACAGCGGTGCCCGGATCATGGCTGACACCGGCCTGGCC
			TACTATTCCGGCGACGACGCACTGAACCTGCCCTGGCT
			GGCGGTGGGTGCCATCGGCTTCATCAGTGTGATTTCTC
			ATCTAGCCGCAGGACAGCTTCGAGAGCTGTTATCCGCT
			TTTGGTTCTGGGGATATTACCACTGCCCGAAAGATCAA
			CGTCGCGATCGGCCCGCTGTGCAGCGCGATGGACCGCT
			TGGGTGGGGTGACGATGTCCAAGGCAGGTCTGCGGCTT
			CAGGGTATCGACGTCGGTGATCCGCGGTTGCCGCAGAT
			GCCGGCAACAGCGGAGCAGATCGATGAGTTGGCTGTCG
			ATATGCGTGCAGCCTCGGTGCTTAGG
dapA	Mycobacterium	AL008967.1	GTGACCACCGTCGGATTCGACGTCGCAGCGCGCCTAGG	44
	tuberculosis		AACCCTGCTGACCGCGATGGTGACACCGTTTAGCGGCG
	(can be used to		ATGGCTCCCTGGACACCGCCACCGCGGCGCGGCTGGCC
	clone M.		AACCACCTGGTCGATCAGGGGTGCGACGGTCTGGTGGT
	smegmatis		CTCGGGCACCACCGGCGAGTCGCCGACCACCACCGACG
	gene)		GGGAGAAAATCGAGCTGCTGCGGGCCGTCTTGGAAGCG
			GTGGGGGACCGGGCCCGTGTTATCGCCGGTGCCGGCAC
			CTATGACACCGCGCACAGCATCCGGCTGGCCAAGGCTT
			GTGCGGCCGAGGGTGCGCACGGGCTGCTGGTGGTCACG
			CCCTACTATTCCAAGCCGCCGCAGCGGGGGCTGCAAGC
			CCATTTCACCGCCGTCGCCGACGCGACCGAGCTGCCGA
			TGCTGCTCTATGACATCCCGGGGCGGTCGGCGGTGCCG
			ATCGAGCCCGACACGATCCGCGCGTTGGCGTCGCATCC
			GAACATCGTCGGAGTCAAGGACGCCAAAGCCGACCTGC
			ACAGCGGCGCCCAAATCATGGCCGACACCGGACTGGCC
			TACTATTCCGGCGACGACGCGCTCAACCTGCCCTGGCT
			GGCCATGGGCGCCACGGGCTTCATCAGCGTGATTGCCC
			ACCTGGCAGCCGGGCAGCTTCGAGAGTTGTTGTCCGCC
			TTCGGTTCTGGGGATATCGCCACCGCCCGCAAGATCAA
			CATTGCGGTCGCCCCGCTGTGCAACGCGATGAGCCGCC
			TGGGTGGGGTGACGTTGTCCAAGGCGGGCTTGCGGCTG
			CAGGGCATCGACGTCGGTGATCCCCGGCTGCCCCAGGT
			GGCCGCGACACCGGAGCAGATCGACGCGTTGGCCGCCG
			ACATGCGCGCGGCCTCGGTGCTTCGG
dapA	Streptomyces	AL939124.1	ATGGCTCCGACCTCCACTCCGCAGACCCCCTTCGGGCG	45
	coelicolor		GGTCCTCACCGCCATGGTCACGCCCTTCACGGCGGACG
			GCGCACTCGACCTCGACGGCGCCCAGCGGCTCGCCGCC
			CACCTGGTGGACGCAGGCAACGACGGCCTGATCATCAA
			CGGCACCACCGGCGAGTCCCCGACCACCAGCGACGCGG
			AGAAAGCGGACCTCGTACGGGCCGTCGTGGAGGCGGTC
			GGCGACCGGGCGCACGTGGTGGCCGGAGTCGGCACCAA
			CAACACCCAGCACAGCATCGAGCTGGCCCGCGCCGCCG
			AGCGCGTCGGCGCCCACGGCCTGCTGCTCGTCACGCCG
			TACTACAACAAGCCCCCGCAGGAGGGCCTGTACCTGCA
			CTTCACGGCCATCGCCGACGCCGCCGGGCTGCCGGTCA
			TGCTCTACGACATCCCCGGCCGCAGCGGCGTCCCGATC
			AACACCGAGACCCTGGTCCGCCTCGCGGAGCACCCGCG
			GATCGTCGCCAACAAGGACGCCAAGGGCGACCTCGGCC
			GGGCCAGCTGGGCCATCGCGCGCTCCGGCCTCGCCTGG
			TACTCCGGCGACGACATGCTCAACCTGCCGCTGCTCGC
			CGTGGGCGCGGTCGGCTTCGTCTCCGTCGTGGGCCACG
			TCGTCACCCCGGAGCTGCGCGCCATGGTGGACGCGCAC
			GTCGCCGGTGACGTACAGAAGGCCCTGGAGATCCACCA
			GAAGCTGCTCCCCGTCTTCACCGGCATGTTCCGCACCC
			AGGGCGTCATGACCACCAAGGGCGCGCTCGCCCTCCAG
			GGACTGCCCGCGGGACCGCTGCGCGCCCCCATGGTCGG
			CCTCACGCCCGAGGAAACCGAGCAGCTCAAGATCGATC
			TTGCCGCCGGCGGGGTACAGCTC
dapA	Erwinia		ATGTTTACGGGTAGTATTGTTGCTCTGGTTACGCCGAT	46
	chrysanthemi		GGACGACAAAGGTGCCGTTGATCGCGCGAGCTTGAAAA
			AACTGATTGATTATCATGTCGCTAGCGGAACTTCCGCG
			ATTGTGTCGGTGGGTACCACCGGCGAATCCGCCACCTT
			GAGTCACGATGAGCATGGCGACGTGGTGATGCTGACGC
			TGGAATTGAGCGATGGCCGCATCCCGGTCATCGCCGGC
			ACCGGCGCCAATTCGACCGCTGAGGCGATTTCCCTCAC
			CCAGCGTTTCAACGACACGGGCGTGGCCGGGTGCCTGA
			CCGTGACGCCGTATTACAATAAGCCGACCCAAAACGGC
			TTGTTCCTGCACTTCAAGGCGATTGCCGAGCACACCGA
			CCTGCCGCAAATCCTCTACAACGTGCCGTCCCGTACCG
			GTTGCGACATGTTGCCGGAAACCGTCGCCCGTCTGTCG
			GAAATCAAAAATATTGTCGCAATCAAGGAAGCGACCGG
			GAACTTAAGCCGGGTCAGTCAGATCCAAGAGCTGGTTC
			ATGAAGATTTCATTTTGCTGAGCGGCGACGACGCCAGC
			TCGCTGGACTTCATGCAACTGGGTGGCGACGGCGTGAT
			TTCCGTGACAGCCAACATCGCGGCCCGCGAAATGGCGG
			CGCTGTGCGAGCTGGCGGCGCAAGGGAATTTCGTTGAA
			GCCCGCCGTCTGAATCAGCGTCTGATGCCGCTGCATCA
			GAAACTGTTTGTTGAACCCAATCCGATTCCGGTGAAAT
			GGGCCTGTAAGGCATTGGGATTGATGGCGACCGACACG
			CTTCGTCTGCCGATGACGCCGCTGACCGATGCCGGTCG
			CGACGTGATGGAGCAGGCCATGAAGCAGGCGGGTCTGC
			TGTAA
dapA	Coryne-	X53993	ATGAGCACAGGTTTAACAGCTAAGACCGGAGTAGAGCA	128
	bacterium		CTTCGGCACCGTTGGAGTAGCAATGGTTACTCCATTCA
	glutamicum		CGGAATCCGGAGACATCGATATCGCTGCTGGCCGCGAA
			GTCGCGGCTTATTTGGTTGATAAGGGCTTGGATTCTTT
			GGTTCTCGCGGGCACCACTGGTGAATCCCCAACGACAA
			CCGCCGCTGAAAAACTAGAACTGCTCAAGGCCGTTCGT
			GAGGAAGTTGGGGATCGGGCGAAGCTCATCGCCGGTGT
			CGGAACCAACAACACGCGGACATCTGTGGAACTTGCGG
			AAGCTGCTGCTTCTGCTGGCGCAGACGGCCTTTTAGTT
			GTAACTCCTTATTACTCCAAGCCGAGCCAAGAGGGATT
			GCTGGCGCACTTCGGTGCAATTGCTGCAGCAACAGAGG
			TTCCAATTTGTCTCTATGACATTCCTGGTCGGTCAGGT
			ATTCCAATTGAGTCTGATACCATGAGACGCCTGAGTGA
			ATTACCTACGATTTTGGCGGTCAAGGACGCCAAGGGTG
			ACCTCGTTGCAGCCACGTCATTGATCAAAGAAACGGGA
			CTTGCCTGGTATTCAGGCGATGACCCACTAAACCTTGT
			TTGGCTTGCTTTGGGCGGATCAGGTTTCATTTCCGTAA
			TTGGACATGCAGCCCCCACAGCATTACGTGAGTTGTAC
			ACAAGCTTCGAGGAAGGCGACCTCGTCCGTGCGCGGGA
			AATCAACGCCAAACTATCACCGCTGGTAGCTGCCCAAG
			GTCGCTTGGGTGGAGTCAGCTTGGCAAAAGCTGCTTCG
			CGTCTGCAGGGCATCAACGTAGGAGATCCTCGACTTCC
			AATTATGGCTCCAAATGAGCAGGAACTTGAGGCTCTCC
			GAGAAGACATGAAAAAAGCTGGAGTTCTATAA
dapA	Escherichia		ATGTTCACGGGAAGTATTGTCGCGATTGTTACTCCGAT	129
	coli		GGATGAAAAAGGTAATGTCTGTCGGGCTAGCTTGAAAA
			AACTGATTGATTATCATGTCGCCAGCGGTACTTCGGCG
			ATCGTTTCTGTTGGCACCACTGGCGAGTCCGCTACCTT
			AAATCATGACGAACATGCTGATGTGGTGATGATGACGC
			TGGATCTGGCTGATGGGCGCATTCCGGTAATTGCCGGG
			ACCGGCGCTAACGCTACTGCGGAAGCCATTAGCCTGAC
			GCAGCGCTTCAATGACAGTGGTATCGTCGGCTGCCTGA
			CGGTAACCCCTTACTACAATCGTCCGTCGCAAGAAGGT
			TTGTATCAGCATTTCAAAGCCATCGCTGAGCATACTGA
			CCTGCCGCAAATTCTGTATAATGTGCCGTCCCGTACTG
			GCTGCGATCTGCTCCCGGAAACGGTGGGCCGTCTGGCG
			AAAGTAAAAAATATTATCGGAATCAAAGAGGCAACAGG
			GAACTTAACGCGTGTAAACCAGATCAAAGAGCTGGTTT
			CAGATGATTTTGTTCTGCTGAGCGGCGATGATGCGAGC
			GCGCTGGACTTCATGCAATTGGGCGGTCATGGGGTTAT
			TTCCGTTACGACTAACGTCGCAGCGCGTGATATGGCCC
			AGATGTGCAAACTGGCAGCAGAAGAACATTTTGCCGAG
			GCACGCGTTATTAATCAGCGTCTGATGCCATTACACAA
			CAAACTATTTGTCGAACCCAATCCAATCCCGGTGAAAT
			GGGCATGTAAGGAACTGGGTCTTGTGGCGACCGATACG
			CTGCGCCTGCCAATGACACCAATCACCGACAGTGGTCG
			TGAGACGGTCAGAGCGGCGCTTAAGCATGCCGGTTTGC
			TGTAA
dapA	Coryne-	X53993	ATGAGCACAGGTTTAACAGCTAAGACCGGAGTAGAGCA	245
	bacterium		CTTCGGCACCGTTGGAGTAGCAATGGTTACTCCATTCA
	glutamicum		CGGAATCCGGAGACATCGATATCGCTGCTGGCCGCGAA
			GTCGCGGCTTATTTGGTTGATAAGGGCTTGGATTCTTT
			GGTTCTCGCGGGCACCACTGGTGAATCCCCAACGACAA
			CCGCCGCTGAAAAACTAGAACTGCTCAAGGCCGTTCGT
			GAGGAAGTTGGGGATCGGGCGAAGCTCATCGCCGGTGT
			CGGAACCAACAACACGCGGACATCTGTGGAACTTGCGG
			AAGCTGCTGCTTCTGCTGGCGCAGACGGCCTTTTAGTT
			GTAACTCCTTATTACTCCAAGCCGAGCCAAGAGGGATT
			GCTGGCGCACTTCGGTGCAATTGCTGCAGCAACAGAGG
			TTCCAATTTGTCTCTATGACATTCCTGGTCGGTCAGGT
			ATTCCAATTGAGTCTGATACCATGAGACGCCTGAGTGA
			ATTACCTACGATTTTGGCGGTCAAGGACGCCAAGGGTG
			ACCTCGTTGCAGCCACGTCATTGATCAAAGAAACGGGA
			CTTGCCTGGTATTCAGGCGATGACCCACTAAACCTTGT
			TTGGCTTGCTTTGGGCGGATCAGGTTTCATTTCCGTAA
			TTGGACATGCAGCCCCCACAGCATTACGTGAGTTGTAC
			ACAAGCTTCGAGGAAGGCGACCTCGTCCGTGCGCGGGA
			AATCAACGCCAAACTATCACCGCTGGTAGCTGCCCAAG
			GTCGCTTGGGTGGAGTCAGCTTGGCAAAAGCTGCTTCG
			CGTCTGCAGGGCATCAACGTAGGAGATCCTCGACTTCC
			AATTATGGCTCCAAATGAGCAGGAACTTGAGGCTCTCC
			GAGAAGACATGAAAAAAGCTGGAGTTCTATAA
dapA	Escherichia	M12844	ATGTTCACGGGAAGTATTGTCGCGATTGTTACTCCGAT	246
	coli		GGATGAAAAAGGTAATGTCTGTCGGGCTAGCTTGAAAA
			AACTGATTGATTATCATGTCGCCAGCGGTACTTCGGCG
			ATCGTTTCTGTTGGCACCACTGGCGAGTCCGCTACCTT
			AAATCATGACGAACATGCTGATGTGGTGATGATGACGC
			TGGATCTGGCTGATGGGCGCATTCCGGTAATTGCCGGG
			ACCGGCGCTAACGCTACTGCGGAAGCCATTAGCCTGAC
			GCAGCGCTTCAATGACAGTGGTATCGTCGGCTGCCTGA
			CGGTAACCCCTTACTACAATCGTCCGTCGCAAGAAGGT
			TTGTATCAGCATTTCAAAGCCATCGCTGAGCATACTGA
			CCTGCCGCAAATTCTGTATAATGTGCCGTCCCGTACTG
			GCTGCGATCTGCTCCCGGAAACGGTGGGCCGTCTGGCG
			AAAGTAAAAAATATTATCGGAATCAAAGAGGCAACAGG
			GAACTTAACGCGTGTAAACCAGATCAAAGAGCTGGTTT
			CAGATGATTTTGTTCTGCTGAGCGGCGATGATGCGAGC
			GCGCTGGACTTCATGCAATTGGGCGGTCATGGGGTTAT
			TTCCGTTACGACTAACGTCGCAGCGCGTGATATGGCCC
			AGATGTGCAAACTGGCAGCAGAAGAACATTTTGCCGAG
			GCACGCGTTATTAATCAGCGTCTGATGCCATTACACAA
			CAAACTATTTGTCGAACCCAATCCAATCCCGGTGAAAT
			GGGCATGTAAGGAACTGGGTCTTGTGGCGACCGATACG
			CTGCGCCTGCCAATGACACCAATCACCGACAGTGGTCG
			TGAGACGGTCAGAGCGGCGCTTAAGCATGCCGGTTTGC
			TGTAA
hom	Streptomyces	AL939123.1	ATGATGCGTACGCGTCCGCTGAAGGTGGCGCTGCTGGG	47
	coelicolor		CTGTGGAGTGGTCGGCTCAAAGGTGGCGCGCATCATGA
			CGACGCACGCCGCCGACCTCGCCGCCCGGATCGGGGCC
			CCGGTGGAGCTCGCGGGCGTCGCCGTACGGCGGCCCGA
			CAAGGTGCGGGAGGGGATCGACCCGGCCCTCGTCACCA
			CCGACGCCACCGCGCTCGTCAAGCGCGGGGACATCGAC
			GTCGTCGTCGAGGTCATCGGGGGGATCGAGCCCGCGCG
			GACGCTCATCACCACCGCCTTCGCGCACGGCGCCTCCG
			TGGTCTCCGCCAACAAGGCGCTCATCGCCCAGGACGGC
			GCCGCCCTGCACGCCGCCGCCGACGAGCACGGCAAGGA
			CCTGTACTACGAGGCCGCCGTCGCCGGTGCCATCCCGC
			TGATCCGGCCGCTGCGCGAGTCCCTCGCCGGCGACAAG
			GTCAACCGGGTGCTCGGCATCGTCAACGGGACCACCAA
			CTTCATCCTCGACGCCATGGACTCGACCGGGGCCGGCT
			ATCAGGAAGCGCTCGACGAGGCCACGGCCCTCGGGTAC
			GCCGAGGCCGACCCGACCGCCGACGTCGAGGGCTTCGA
			CGCCGCAGCCAAGGCCGCCATCCTCGCCGGGATCGCCT
			TCCACACGCGCGTACGCCTCGACGACGTCTACCGCGAG
			GGCATGACCGAGGTCACCGCCGCCGACTTCGCCTCCGC
			CAAGGAGATGGGCTGCACCATCAAGCTGCTCGCCATCT
			GCGAGCGGGCGGCGGACGGAGGGTCGGTCACCGCACGC
			GTGCATCCCGCGATGATCCCGCTCAGCCATCCGCTGGC
			CAACGTGCGCGAGGCGTACAACGCCGTGTTCGTGGAGT
			CCGACGCCGCCGGTCAGCTCATGTTCTACGGGCCCGGC
			GCCGGCGGTTCGCCGACCGCGTCCGCCGTGCTCGGCGA
			CCTGGTGGCCGTGTGCCGCAACCGGCTGGGCGGAGCGA
			CCGGACCCGGTGAGTCCGCGTACGCCGCCCTGCCCGTC
			TCCCCGATGGGCGACGTCGTCACGCGCTACCACATCAG
			CCTCGACGTGGCCGACAAACCGGGCGTGCTCGCCCAGG
			TCGCGACCGTGTTCGCGGAGCACGGTGTCTCCATCGAC
			ACCGTGCGGCAGTCCGGCAAGGACGGCGAGGCATCCCT
			CGTCGTCGTCACCCATCGCGCGTCCGACGCCGCCCTCG
			GCGGTACGGTCGAGGCGCTGCGCAAGCTCGACACCGTG
			CGGGGTGTCGCCAGCATCATGCGGGTTGAAGGAGAG
hom	Mycobacterium	AF126720	ATGAGTAAGAAGCCCATCGGGGTAGCGGTACTGGGCCT	48
	smegmatis		GGGGAACGTCGGCAGCGAGGTCGTGCGCATCATCGCCG
			ACAGCGCGGACGATCTCGCGGCGCGCATCGGTGCGCCG
			CTGGAACTGCGCGGCGTCGGCGTGCGCCGTGTGGCCGA
			CGACCGCGGCGTGCCCACGGAACTGCTCACCGACGACA
			TCGACGCGCTGGTGTCGCGTGACGACGTCGACATCGTC
			GTCGAGGTCATGGGCCCCGTCGAACCGGCACGCAAGGC
			CATCCTGTCGGCGCTGGAGCAGGGCAAGTCGGTGGTCA
			CCGCCAACAAGGCGCTGATGGCCATGTCCACCGGCGAG
			CTCGCCCAGGCCGCCGAGAAGGCCCACGTGGACCTGTA
			TTTCGAGGCCGCAGTGGCCGGCGCCATCCCGGTGATCC
			GCCCGCTGACCCAGTCGCTGGCCGGTGACACGGTGCGC
			CGCGTGGCCGGCATCGTCAACGGCACCACCAACTACAT
			CCTGTCCGAGATGGACAGCACCGGCGCCGATTACACCA
			GCGCGCTGGCCGATGCGAGCGCCCTCGGTTACGCCGAG
			GCCGATCCCACCGCCGACGTCGAGGGCTACGACGCCGC
			GGCCAAGGCCGCGATCCTCGCTTCGATCGCGTTCCACA
			CCCGTGTGACCGCCGACGACGTGTACCGCGAGGGCATC
			ACCACGGTCAGCGCCGAGGACTTCGCGTCGGCACGCGC
			GCTGGGCTGCACCATCAAACTGCTCGCGATCTGCGAGC
			GGCTCACCTCCGACGAGGGCAAGGACCGGGTCTCGGCC
			CGCGTCTACCCGGCGCTCGTCCCGCTGACCCACCCGCT
			GGCCGCGGTCAACGGTGCGTTCAACGCGGTGGTGGTGG
			AAGCCGAGGCGGCCGGGCGGCTCATGTTCTACGGTCAA
			GGCGCCGGCGGTGCCCCCACCGCCTTTGCGGTGATGGG
			AGACGTGGTCATGGCGGCTCGCAACCGTGTCCAGGGCG
			GCCGTGGCCCGCGCGAATCGAAGTACGCCAAGCTGCCG
			ATCGCGCCCATCGGGTTCATCCCGACGCGCTACTACGT
			CAACATGAACGTGGCCGACCGGCCCGGCGTGTTGTCCG
			CTGTGGCAGCCGAATTC
hom	Thermobifida	NZ_AAAQ010	ATGCGCCGCCCAGAACCTGCCGGTGCCGCGGATCGCGG	49
	fusca	00037.1	TCGAACCCGGCCGCGCCATCGCCGGACCGGCGGGCATC
			ACCCTCTACGAGGTCGGCACGGTCAAGGACGTGGAGGG
			GATCCGCACCTATGTCAGTGTCGACGGCGGTATGAGCG
			ACAACATCCGCACCGCGCTGTACGGTGCGGAGTACACC
			TGTGTGCTGGCCTCGCGGCACAGCGACGCCGAGCCGAT
			GCTGTCCCGCCTGGTCGGCAAGCACTGCGAGAGCGGCG
			ACATCGTCGTGCGCGACCTCTACCTCCCTGCCGACCTG
			CGTCCCGGCGACCTGGTAGCAGTGGCCGCCACCGGCGC
			CTACTGCTACTCCATGGCCAGCAACTACAACCACGTGC
			CCCGGCCTGCCGTGGTCGCGGTCCGCGAGAAGAACGCC
			CGCGTCCTGGTGCGACGGGAAACCGAAGAAGACCTGTT
			GCGGCTGGACGTAGGCTGAGCAGTGGCCGACGACGCTC
			TGGCCACCACGACGAGGTTCTGGATACGGACAATGAAC
			GACGAAACGGGAGTCACCCCCTCATGGCACTGAAGGTG
			GCGCTGCTGGGTTGCGGCGTTGTGGGTTCTCAGGTGGT
			CCGGCTGCTCAACGAGCAGTCGCGTGAACTTGCGGAGC
			GCATCGGAACGCCCCTGGAGATCGGAGGCATCGCGGTG
			CGCCGCCTGGACCGCGCCCGGGGGACGGGCGTGGACCC
			CGACCTCCTCACCACCGACGCCATGGGTCTTGTGACCA
			GAGACGACATCGACCTCGTGGTGGAGGTCATCGGCGGC
			ATCGAGCCCGCCCGGTCGCTCATCCTGGCCGCGATCCA
			GAAGGGCAAGTCTGTGGTGACCGCCAACAAGGCGCTGC
			TCGCCGAGGACGGCGCGACCATCCACGCCGCTGCCCGG
			GAAGCGGGAGTTGACGTGTACTACGAGGCCAGCGTCGC
			CGGGGCCATCCCGCTGCTGCGGCCGCTGCGTGACTCCC
			TGGCCGGGGACCGCGTCAACCGGGTCTTGGGCATCGTC
			AACGGCACCACCAACTACATCCTGGACCGGATGGACAG
			CCTGGGCGCCGGCTTCACCGAGTCACTGGAGGAAGCCC
			AGGCCCTGGGATACGCCGAAGCCGACCCGACCGCCGAC
			GTGGAGGGCTTCGACGCCGCCGCTAAAGCCGCGATCCT
			GGCCCGGCTCGCCTTCCACACACCGGTGACCGCTGCCG
			ATGTGCACCGCGAAGGCATCACCGAGGTCTCCGCGGCC
			GACATCGCCAGCGCCAAGGCCATGGGCTGCGTGGTGAA
			ACTCCTCGCGATCTGCCAGCGCTCCGACGACGGCTCCA
			GCATCGGCGTGCGCGTCCACCCGGTGATGCTGCCCCGC
			GAACACCCGCTCGCCAGCGTCAAAGGCGCCTACAACGC
			GGTGTTCGTGGAAGCCGAGTCCGCCGGGCAGCTCATGT
			TCTACGGCGCGGGCGCGGGAGGCGTCCCCACCGCCAGC
			GCAGTCCTCGGCGACCTGGTCGCGGTGGCACGGAACCG
			CCTGGCCCGCACTTTCGTGGCCGACGGCCGGGCCGACG
			CGAAACTGCCCGTCCACCCCATGGGGGAGACCATCACC
			AGCTACCACGTGGCGCTGGACGTTGCCGACCGGCCCGG
			CGTGCTCGCCGGGGTCGCCAAAGTCTTCGCGGCCAACG
			GCGTGTCGATCAAGCACGTCCGCCAGGAAGGCCGCGGG
			GACGACGCCCAGCTCGTCCTGGTCAGCCACACCGCGCC
			GGATGCCGCCCTGGCCCGGACCGTGGAGCAACTGCGCA
			ACCACGAGGACGTCCGCGCGGTCGCCAGCGTGATGCGG
			GTCGAAACCTTCGACAACGAACGA
hom	Coryne-	Y00546	ATGACCTCAGCATCTGCCCCAAGCTTTAACCCCGGCAA	247
	bacterium		GGGTCCCGGCTCAGCAGTCGGAATTGCCCTTTTAGGAT
	glutamicum		TCGGAACAGTCGGCACTGAGGTGATGCGTCTGATGACC
			GAGTACGGTGATGAACTTGCGCACCGCATTGGTGGCCC
			ACTGGAGGTTCGTGGCATTGCTGTTTCTGATATCTCAA
			AGCCACGTGAAGGCGTTGCACCTGAGCTGCTCACTGAG
			GACGCTTTTGCACTCATCGAGCGCGAGGATGTTGACAT
			CGTCGTTGAGGTTATCGGCGGCATTGAGTACCCACGTG
			AGGTAGTTCTCGCAGCTCTGAAGGCCGGCAAGTCTGTT
			GTTACCGCCAATAAGGCTCTTGTTGCAGCTCACTCTGC
			TGAGCTTGCTGATGCAGCGGAAGCCGCAAACGTTGACC
			TGTACTTCGAGGCTGCTGTTGCAGGCGCAATTCCAGTG
			GTTGGCCCACTGCGTCGCTCCCTGGCTGGCGATCAGAT
			CCAGTCTGTGATGGGCATCGTTAACGGCACCACCAACT
			TCATCTTGGACGCCATGGATTCCACCGGCGCTGACTAT
			GCAGATTCTTTGGCTGAGGCAACTCGTTTGGGTTACGC
			CGAAGCTGATCCAACTGCAGACGTCGAAGGCCATGACG
			CCGCATCCAAGGCTGCAATTTTGGCATCCATCGCTTTC
			CACACCCGTGTTACCGCGGATGATGTGTACTGCGAAGG
			TATCAGCAACATCAGCGCTGCCGACATTGAGGCAGCAC
			AGCAGGCAGGCCACACCATCAAGTTGTTGGCCATCTGT
			GAGAAGTTCACCAACAAGGAAGGAAAGTCGGCTATTTC
			TGCTCGCGTGCACCCGACTCTATTACCTGTGTCCCACC
			CACTGGCGTCGGTAAACAAGTCCTTTAATGCAATCTTT
			GTTGAAGCAGAAGCAGCTGGTCGCCTGATGTTCTACGG
			AAACGGTGCAGGTGGCGCGCCAACCGCGTCTGCTGTGC
			TTGGCGACGTCGTTGGTGCCGCACGAAACAAGGTGCAC
			GGTGGCCGTGCTCCAGGTGAGTCCACCTACGCTAACCT
			GCCGATCGCTGATTTCGGTGAGACCACCACTCGTTACC
			ACCTCGACATGGATGTGGAAGATCGCGTGGGGGTTTTG
			GCTGAATTGGCTAGCCTGTTCTCTGAGCAAGGAATCTC
			CCTGCGTACAATCCGACAGGAAGAGCGCGATGATGATG
			CACGTCTGATCGTGGTCACCCACTCTGCGCTGGAATCT
			GATCTTTCCCGCACCGTTGAACTGCTGAAGGCTAAGCC
			TGTTGTTAAGGCAATCAACAGTGTGATCCGCCTCGAAA
			GGGACTAA
metL	Escherichia	V00305	AGTGTGATTGCGCAGGCAGGGGCGAAAGGTCGTCAGCT	248
	coli		GCATAAATTTGGTGGCAGTAGTCTGGCTGATGTGAAGT
			GTTATTTGCGTGTCGCGGGCATTATGGCGGAGTACTCT
			CAGCCTGACGATATGATGGTGGTTTCCGCCGCCGGTAG
			CACCACTAACCGGTTGATTAGCTGGTTGAAACTAAGCC
			AGACCGATCGTCTCTCTGCGCATCAGGTTCAACAAACG
			CTGCGTCGCTATCAGTGCGATCTGATTAGCGGTCTGCT
			ACCCGCTGAAGAAGCCGATAGCCTCATTAGCGCTTTTG
			TCAGCGACCTTGAGCGCCTGGCGGCGCTGCTCGACAGC
			GGTATTAACGACGCAGTGTATGCGGAAGTGGTGGGCCA
			CGGGGAAGTATGGTCGGCACGTCTGATGTCTGCGGTAC
			TTAATCAACAAGGGCTGCCAGCGGCCTGGCTTGATGCC
			CGCGAGTTTTTACGCGCTGAACGCGCCGCACAACCGCA
			GGTTGATGAAGGGCTTTCTTACCCGTTGCTGCAACAGC
			TGCTGGTGCAACATCCGGGCAAACGTCTGGTGGTGACC
			GGATTTATCAGCCGCAACAACGCCGGTGAAACGGTGCT
			GCTGGGGCGTAACGGTTCCGACTATTCCGCGACACAAA
			TCGGTGCGCTGGCGGGTGTTTCTCGCGTAACCATCTGG
			AGCGACGTCGCCGGGGTATACAGTGCCGACCCGCGTAA
			AGTGAAAGATGCCTGCCTGCTGCCGTTGCTGCGTCTGG
			ATGAGGCCAGCGAACTGGCGCGCCTGGCGGCTCCCGTT
			CTTCACGCCCGTACTTTACAGCCGGTTTCTGGCAGCGA
			AATCGACCTGCAACTGCGCTGTAGCTACACGCCGGATC
			AAGGTTCCACGCGCATTGAACGCGTGCTGGCCTCCGGT
			ACTGGTGCGCGTATTGTCACCAGCCACGATGATGTCTG
			TTTGATTGAGTTTCAGGTGCCCGCCAGTCAGGATTTCA
			AACTGGGGCATAAAGAGATCGACCAAATCCTGAAACGC
			GCGCAGGTACGCCCGCTGGCGGTTGGCGTACATAACGA
			TCGCCAGTTGCTGCAATTTTGCTACACCTCAGAAGTGG
			CCGACAGTGCGCTGAAAATCCTCGACGAAGCGGGATTA
			CCTGGCGAACTGCGCCTGCGTCAGGGGCTGGCGCTGGT
			GGCGATGGTCGGTGCAGGCGTCACCCGTAACCCGCTGC
			ATTGCCACCGCTTCTGGCAGCAACTGAAAGGCCAGCCG
			GTCGAATTTACCTGGCAGTCCGATGACGGCATCAGCCT
			GGTGGCAGTACTGCGCACCGGCCCGACCGAAAGCCTGA
			TTCAGGGGCTGCATCAGTCCGTCTTCCGCGCAGAAAAA
			CGCATCGGCCTGGTATTGTTCGGTAAGGGCAATATCGG
			TTCCCGTTGGCTGGAACTGTTCGCCCGTGAGCAGAGCA
			CGCTTTCGGCACGTACCGGCTTTGAGTTTGTGCTGGCA
			GGTGTGGTGGACAGCCGCCGCAGCCTGTTGAGCTATGA
			CGGGCTGGACGCCAGCCGCGCGTTAGCCTTCTTCAACG
			ATGAAGCGGTTGAGCAGGATGAAGAGTCGTTGTTCCTG
			TGGATGCGCGCCCATCCGTATGATGATTTAGTGGTGCT
			GGACGTTACCGCCAGCCAGCAGCTTGCTGATCAGTATC
			TTGATTTCGCCAGCCACGGTTTCCACGTTATCAGCGCC
			AACAAACTGGCGGGAGCCAGCGACAGCAATAAATATCG
			CCAGATCCACGACGCCTTCGAAAAAACCGGGCGTCACT
			GGCTGTACAATGCCACCGTCGGTGCGGGCTTGCCGATC
			AACCACACCGTGCGCGATCTGATCGACAGCGGCGATAC
			TATTTTGTCGATCAGCGGGATCTTCTCCGGCACGCTCT
			CCTGGCTGTTCCTGCAATTCGACGGTAGCGTGCCGTTT
			ACCGAGCTGGTGGATCAGGCGTGGCAGCAGGGCTTAAC
			CGAACCTGACCCGCGTGACGATCTCTCTGGCAAAGACG
			TGAGTCGCAAGCTGGTGATTCTGGCGCGTGAAGCAGGT
			TACAACATCGAACCGGATCAGGTACGTGTGGAATCGCT
			GGTGCCTGCTCATTGCGAAGGCGGCAGCATCGACCATT
			TCTTTGAAAATGGCGATGAACTGAACGAGCAGATGGTG
			CAACGGCTGGAAGCGGCCCGCGAAATGGGGCTGGTGCT
			GCGCTACGTGGCGCGTTTCGATGCCAACGGTAAAGCGC
			GTGTAGGCGTGGAAGCGGTGCGTGAAGATCATCCGTTG
			CGATCACTGCTGCCGTGCGATAACGTCTTTGCCATCGA
			AAGCCGCTGGTATCGCGATAACCCTCTGGTGATCCGCG
			GACCTGGCGCTGGGCGCGACGTCACCGCCGGGGCGATT
			CAGTCGGATATCAACCGGCTGGCACAGTTGTTGTAA
thrA	Escherichia	U14003	ATGCGAGTGTTGAAGTTCGGCGGTACATCAGTGGCAAA	249
	coli		TGCAGAACGTTTTCTGCGTGTTGCCGATATTCTGGAAA
			GCAATGCCAGGCAGGGGCAGGTGGCCACCGTCCTCTCT
			GCCCCCGCCAAAATCACCAACCACCTGGTGGCGATGAT
			TGAAAAAACCATTAGCGGCCAGGATGCTTTACCCAATA
			TCAGCGATGCCGAACGTATTTTTGCCGAACTTTTGACG
			GGACTCGCCGCCGCCCAGCCGGGGTTCCCGCTGGCGCA
			ATTGAAAACTTTCGTCGATCAGGAATTTGCCCAAATAA
			AACATGTCCTGCATGGCATTAGTTTGTTGGGGCAGTGC
			CCGGATAGCATCAACGCTGCGCTGATTTGCCGTGGCGA
			GAAAATGTCGATCGCCATTATGGCCGGCGTATTAGAAG
			CGCGCGGTCACAACGTTACTGTTATCGATCCGGTCGAA
			AAACTGCTGGCAGTGGGGCATTACCTCGAATCTACCGT
			CGATATTGCTGAGTCCACCCGCCGTATTGCGGCAAGCC
			GCATTCCGGCTGATCACATGGTGCTGATGGCAGGTTTC
			ACCGCCGGTAATGAAAAAGGCGAACTGGTGGTGCTTGG
			ACGCAACGGTTCCGACTACTCTGCTGCGGTGCTGGCTG
			CCTGTTTACGCGCCGATTGTTGCGAGATTTGGACGGAC
			GTTGACGGGGTCTATACCTGCGACCCGCGTCAGGTGCC
			CGATGCGAGGTTGTTGAAGTCGATGTCCTACCAGGAAG
			CGATGGAGCTTTCCTACTTCGGCGCTAAAGTTCTTCAC
			CCCCGCACCATTACCCCCATCGCCCAGTTCCAGATCCC
			TTGCCTGATTAAAAATACCGGAAATCCTCAAGCACCAG
			GTACGCTCATTGGTGCCAGCCGTGATGAAGACGAATTA
			CCGGTCAAGGGCATTTCCAATCTGAATAACATGGCAAT
			GTTCAGCGTTTCTGGTCCGGGGATGAAAGGGATGGTCG
			GCATGGCGGCGCGCGTCTTTGCAGCGATGTCACGCGCC
			CGTATTTCCGTGGTGCTGATTACGCAATCATCTTCCGA
			ATACAGCATCAGTTTCTGCGTTCCACAAAGCGACTGTG
			TGCGAGCTGAACGGGCAATGCAGGAAGAGTTCTACCTG
			GAACTGAAAGAAGGCTTACTGGAGCCGCTGGCAGTGAC
			GGAACGGCTGGCCATTATCTCGGTGGTAGGTGATGGTA
			TGCGCACCTTGCGTGGGATCTCGGCGAAATTCTTTGCC
			GCACTGGCCCGCGCCAATATCAACATTGTCGCCATTGC
			TCAGGGATCTTCTGAACGCTCAATCTCTGTCGTGGTAA
			ATAACGATGATGCGACCACTGGCGTGCGCGTTACTCAT
			CAGATGCTGTTCAATACCGATCAGGTTATCGAAGTGTT
			TGTGATTGGCGTCGGTGGCGTTGGCGGTGCGCTGCTGG
			AGCAACTGAAGCGTCAGCAAAGCTGGCTGAAGAATAAA
			CATATCGACTTACGTGTCTGCGGTGTTGCCAACTCGAA
			GGCTCTGCTCACCAATGTACATGGCCTTAATCTGGAAA
			ACTGGCAGGAAGAACTGGCGCAAGCCAAAGAGCCGTTT
			AATCTCGGGCGCTTAATTCGCCTCGTGAAAGAATATCA
			TCTGCTGAACCCGGTCATTGTTGACTGCACTTCCAGCC
			AGGCAGTGGCGGATCAATATGCCGACTTCCTGCGCGAA
			GGTTTCCACGTTGTCACGCCGAACAAAAAGGCCAACAC
			CTCGTCGATGGATTACTACCATCAGTTGCGTTATGCGG
			CGGAAAAATCGCGGCGTAAATTCCTCTATGACACCAAC
			GTTGGGGCTGGATTACCGGTTATTGAGAACCTGCAAAA
			TCTGCTCAATGCAGGTGATGAATTGATGAAGTTCTCCG
			GCATTCTTTCTGGTTCGCTTTCTTATATCTTCGGCAAG
			TTAGACGAAGGCATGAGTTTCTCCGAGGCGACCACGCT
			GGCGCGGGAAATGGGTTATACCGAACCGGACCCGCGAG
			ATGATCTTTCTGGTATGGATGTGGCGCGTAAACTATTG
			ATTCTCGCTCGTGAAACGGGACGTGAACTGGAGCTGGC
			GGATATTGAAATTGAACCTGTGCTGCCCGCAGAGTTTA
			ACGCCGAGGGTGATGTTGCCGCTTTTATGGCGAATCTG
			TCACAACTCGACGATCTCTTTGCCGCGCGCGTGGCGAA
			GGCCCGTGATGAAGGAAAAGTTTTGCGCTATGTTGGCA
			ATATTGATGAAGATGGCGTCTGCCGCGTGAAGATTGCC
			GAAGTGGATGGTAATGATCCGCTGTTCAAAGTGAAAAA
			TGGCGAAAACGCCCTGGCCTTCTATAGCCACTATTATC
			AGCCGCTGCCGTTGGTACTGCGCGGATATGGTGCGGGC
			AATGACGTTACAGCTGCCGGTGTCTTTGCTGATCTGCT
			ACGTACCCTCTCATGGAAGTTAGGAGTCTGA
metA	Mycobacterium	AL021841.1	ATGACGATCTCCGATGTACCCACCCAGACGCTGCCCGC	50
	tuberculosis		CGAAGGCGAAATCGGCCTGATAGACGTCGGCTCGCTGC
	(can be used to		AACTGGAAAGCGGGGCGGTGATCGACGATGTCTGTATC
	clone M.		GCCGTGCAACGCTGGGGCAAATTGTCGCCCGCACGGGA
	smegmatis		CAACGTGGTGGTGGTCTTGCACGCGCTCACCGGCGACT
	gene)		CGCACATCACTGGACCCGCCGGACCCGGCCACCCCACC
			CCCGGCTGGTGGGACGGGGTGGCCGGGCCGGGTGCGCC
			GATTGACACCACCCGCTGGTGCGCGGTAGCTACCAATG
			TGCTCGGCGGCTGCCGCGGCTCCACCGGGCCCAGCTCG
			CTTGCCCGCGACGGAAAGCCTTGGGGCTCAAGATTTCC
			GCTGATCTCGATACGTGACCAGGTGCAGGCGGACGTCG
			CGGCGCTGGCCGCGCTGGGCATCACCGAGGTCGCCGCC
			GTCGTCGGCGGCTCCATGGGCGGCGCCCGGGCCCTGGA
			ATGGGTGGTCGGCTACCCGGATCGGGTCCGAGCCGGAT
			TGCTGCTGGCGGTCGGTGCGCGTGCCACCGCAGACCAG
			ATCGGCACGCAGACAACGCAAATCGCGGCCATCAAAGC
			CGACCCGGACTGGCAGAGCGGCGACTACCACGAGACGG
			GGAGGGCACCAGACGCCGGGCTGCGACTCGCCCGCCGC
			TTCGCGCACCTCACCTACCGCGGCGAGATCGAGCTCGA
			CACCCGGTTCGCCAACCACAACCAGGGCAACGAGGATC
			CGACGGCCGGCGGGCGCTACGCGGTGCAAAGTTATCTG
			GAACACCAAGGAGACAAACTGTTATCCCGGTTCGACGC
			CGGCAGCTACGTGATTCTCACCGAGGCGCTCAACAGCC
			ACGACGTCGGCCGCGGCCGCGGCGGGGTCTCCGCGGCT
			CTGCGCGCCTGCCCGGTGCCGGTGGTGGTGGGCGGCAT
			CACCTCCGACCGGCTCTACCCGCTGCGCCTGCAGCAGG
			AGCTGGCCGACCTGCTGCCGGGCTGCGCCGGGCTGCGA
			GTCGTCGAGTCGGTCTACGGACACGACGGCTTCCTGGT
			GGAAACCGAGGCCGTGGGCGAATTGATCCGCCAGACAC
			TGGGATTGGCTGATCGTGAAGGCGCGTGTCGGCGG
metA	Mycobacterium	Z98271.1	ATGACAATCTCCAAGGTCCCTACCCAGAAGCTGCCGGC	51
	leprae (can be		CGAAGGCGAGGTCGGCTTGGTCGACATCGGCTCACTTA
	used to clone		CCACCGAAAGCGGTGCCGTCATCGACGATGTCTGCATC
	M. smegmatis		GCCGTTCAGCGCTGGGGGGAATTGTCGCCCACGCGAGA
	gene)		CAACGTAGTGATGGTACTGCATGCACTCACCGGTGACT
			CGCACATCACCGGGCCCGCCGGACCGGGACATCCCACA
			CCCGGCTGGTGGGACTGGATAGCTGGACCGGGTGCACC
			AATCGACACCAACCGCTGGTGCGCGATAGCCACCAACG
			TGCTGGGCGGTTGCCGTGGCTCCACCGGCCCTAGTTCG
			CTTGCCCGCGACGGAAAGCCTTGGGGTTCAAGATTTCC
			GCTGATATCTATACGCGACCAGGTAGAGGCAGATATCG
			CTGCACTGGCCGCCATGGGAATTACAAAGGTTGCCGCC
			GTCGTTGGAGGATCTATGGGCGGGGCGCGTGCACTGGA
			ATGGATCATCGGCCACCCGGACCAAGTCCGGGCCGGGC
			TGTTGCTGGCGGTCGGTGTGCGCGCCACCGCCGACCAG
			ATCGGCACCCAAACCACCCAAATCGCAGCCATCAAGAC
			AGACCCGAACTGGCAAGGCGGTGACTACTACGAGACAG
			GGAGGGCACCAGAGAACGGCTTGACAATTGCCCGCCGC
			TTCGCCCACCTGACCTACCGCAGCGAGGTCGAGCTCGA
			CACCCGGTTTGCCAACAACAACCAAGGCAATGAGGACC
			CGGCGACGGGCGGGCGTTACGCAGTGCAGAGTTACCTA
			GAGCACCAGGGTGACAAGCTATTGGCCCGCTTTGACGC
			AGGCAGCTACGTGGTCTTGACCGAAACGCTGAACAGCC
			ACGACGTTGGCCGGGGCCGCGGAGGGATCGGTACAGCG
			CTGCGCGGGTGCCCGGTACCGGTGGTGGTGGGTGGCAT
			TACCTCGGATCGGCTCTACCCACTGCGCTTGCAGCAGG
			AGCTGGCCGAGATGCTGCCGGGCTGCACCGGGCTGCAG
			GTTGTAGACTCCACCTACGGGCACGACGGCTTCCTGGT
			GGAATCCGAGGCCGTCGGCAAATTGATCCGTCAAACCC
			TCGAATTGGCCGACGTGGGTTCCAAGGAAGACGCGTGT
			TCGCAATGA
metA	Thermobifida	NZ_AAAQ010	GTGAGTCACGACACCACCCCTCCCCTTCCCGCGACCGG	52
	fusca	00035.1	CGCGTGGCGGGAAGGGGACCCTCCGGGCGACCGGCGCT
			GGGTCGAACTGTCCGAACCTCTGCCGCTGGAGACCGGG
			GGTGAACTTCCCGGGGTCCGCCTGGCCTACGAGACGTG
			GGGCAGTCTCAACGAGGACCGCTCCAACGCGGTCCTCG
			TGCTGCACGCCCTCACCGGCGACAGCCACGTCGTAGGC
			CCGGAAGGCCCCGGGCACCCCAGCCCAGGCTGGTGGGA
			AGGCATCATCGGCCCCGGGCTGGCACTCGACACCGACC
			GGTACTTCGTGGTCGCCCCCAACGTGCTGGGCGGCTGC
			CAAGGCAGCACCGGGCCGTCGTCGACCGCGCCCGACGG
			CAGGCCGTGGGGGTCCCGGTTCCCGAGGATCACCATCC
			GCGACACGGTGCGCGCCGAGTTCGCCCTGCTGCGCGAA
			TTCGGCATCCACTCGTGGGCCGCGGTCCTCGGCGGGTC
			CATGGGCGGGATGCGTGCCCTCGAATGGGCGGCCACCT
			ACCCGGAGCGGGTGCGTCGCCTCCTGCTGCTGGCCAGC
			CCTGCGGCCAGCTCCGCACAGCAGATCGCCTGGGCCGC
			CCCCCAGTTGCACGCCATCCGGTCTGATCCGTACTGGC
			ACGGTGGCGACTACTACGACCGTCCCGGTCCGGGACCG
			GTCACCGGCATGGGGATCGCCCGCCGTATCGCGCACAT
			CACCTACCGGGGTGCCACCGAGTTCGACGAACGGTTCG
			GCCGCAACCCCCAAGACGGGGAAGACCCGATGGCCGGG
			GGCCGGTTCGCTGTCGAGTCGTACCTGGACCACCACGC
			GGTCAAACTCGCCCGCCGGTTCGACGCGGGCAGCTACG
			TCGTGCTCACCCAAGCCATGAACACCCACGACGTGGGT
			CGGGGCCGCGGCGGGGTGGCGCAGGCGCTGCGCCGGGT
			CACCGCCCGCACCATGGTGGCCGGGGTGAGCAGCGACT
			TCCTGTACCCCCTCGCCCAGCAGCAGGAGCTCGCCGAC
			GGTATTCCCGGGGCCGACGAAGTCCGCGTCATCGAATC
			AGCCTCGGGCCACGACGGGTTCCTCACCGAGATC~CC
			AAGTGTCGGTCCTCATCAAAGAACTGCTGGCGCAG
metA	Coryne-	AF052652	ATGCCCACCCTCGCGCCTTCAGGTCAACTTGAAATCCA	250
	bacterium		AGCGATCGGTGATGTCTCCACCGAAGCCGGAGCAATCA
	glutamicum		TTACAAACGCTGAAATCGCCTATCACCGCTGGGGTGAA
			TACCGCGTAGATAAAGAAGGACGCAGCAATGTCGTTCT
			CATCGAACACGCCCTCACTGGAGATTCCAACGCAGCCG
			ATTGGTGGGCTGACTTGCTCGGTCCCGGCAAAGCCATC
			AACACTGATATTTACTGCGTGATCTGTACCAACGTCAT
			CGGTGGTTGCAACGGTTCCACCGGACCTGGCTCCATGC
			ATCCAGATGGAAATTTCTGGGGTAATCGCTTCCCCGCC
			ACGTCCATTCGTGATCAGGTAAACGCCGAAAAACAATT
			CCTCGACGCACTCGGCATCACCACGGTCGCCGCAGTAG
			TACTACTTGGTGGTTCCATGGGTGGTGCCCGCACCCTA
			GAGTGGGCCGCAATGTACCCAGAAACTGTTGGCGCAGC
			TGCTGTTCTTGCAGTTTCTGCACGCGCCAGCGCCTGGC
			AAATCGGCATTCAATCCGCCCAAATTAAGGCGATTGAA
			AACGACCACCACTGGCACGAAGGCAACTACTACGAATC
			CGGCTGCAACCCAGCCACCGGACTCGGCGCCGCCCGAC
			GCATCGCCCACCTCACCTACCGTGGCGAACTAGAAATC
			GACGAACGCTTCGGCACCAAAGCCCAAAAGAACGAAAA
			CCCACTCGGTCCCTACCGCAAGCCCGACCAGCGCTTCG
			CCGTGGAATCCTACTTGGACTACCAAGCAGACAAGCTA
			GTACAGCGTTTCGACGCCGGCTCCTACGTCTTGCTCAC
			CGACGCCCTCAACCGCCACGACATTGGTCGCGACCGCG
			GAGGCCTCAACAAGGCACTCGAATCCATCAAAGTTCCA
			GTCCTTGTCGCAGGCGTAGATACCGATATTTTGTACCC
			CTACCACCAGCAAGAACACCTCTCCAGAAACCTGGGAA
			ATCTACTGGCAATGGCAAAAATCGTATCCCCTGTCGGC
			CACGATGCTTTCCTCACCGAAAGCCGCCAAATGGATCG
			CATCGTGAGGAACTTCTTCAGCCTCATCTCCCCAGACG
			AAGACAACCCTTCGACCTACATCGAGTTCTACATCTAA
metA	Escherichia	NC_000913	ATGCCGATTCGTGTGCCGGACGAGCTACCCGCCGTCAA	251
	coli		TTTCTTGCGTGAAGAAAACGTCTTTGTGATGACAACTT
			CTCGTGCGTCTGGTCAGGAAATTCGTCCACTTAAGGTT
			CTGATCCTTAACCTGATGCCGAAGAAGATTGAAACTGA
			AAATCAGTTTCTGCGCCTGCTTTCAAACTCACCTTTGC
			AGGTCGATATTCAGCTGTTGCGCATCGATTCCCGTGAA
			TCGCGCAACACGCCCGCAGAGCATCTGAACAACTTCTA
			CTGTAACTTTGAAGATATTCAGGATCAGAACTTTGACG
			GTTTGATTGTAACTGGTGCGCCGCTGGGCCTGGTGGAG
			TTTAATGATGTCGCTTACTGGCCGCAGATCAAACAGGT
			GCTGGAGTGGTCGAAAGATCACGTCACCTCGACGCTGT
			TTGTCTGCTGGGCGGTACAGGCCGCGCTCAATATCCTC
			TACGGCATTCCTAAGCAAACTCGCACCGAAAAACTCTC
			TGGCGTTTACGAGCATCATATTCTCCATCCTCATGCGC
			TTCTGACGCGTGGCTTTGATGATTCATTCCTGGCACCG
			CATTCGCGCTATGCTGACTTTCCGGCAGCGTTGATTCG
			TGATTACACCGATCTGGAAATTCTGGCAGAGACGGAAG
			AAGGGGATGCATATCTGTTTGCCAGTAAAGATAAGCGC
			ATTGCCTTTGTGACGGGCCATCCCGAATATGATGCGCA
			AACGCTGGCGCAGGAATTTTTCCGCGATGTGGAAGCCG
			GACTAGACCCGGATGTACCGTATAACTATTTCCCGCAC
			AATGATCCGCAAAATACACCGCGAGCGAGCTGGCGTAG
			TCACGGTAATTTACTGTTTACCAACTGGCTCAACTATT
			ACGTCTACCAGATCACGCCATACGATCTACGGCACATG
			AATCCAACGCTGGAT
metA K233A	C. glutamicum	n/a	atgcccaccctcgcgccttcaggtcaacttgaaatccaagcg	294
			atcggtgatgtctccaccgaagccggagcaatcattacaaac
			gctgaaatcgcctatcaccgctggggtgaataccgcgtagat
			aaagaaggacgcagcaatgtcgttctcatcgaacacgccctc
			actggagattccaacgcagccgattggtgggctgacttgctc
			ggtcccggcaaagccatcaacactgatatttactgcgtgatc
			tgtaccaacgtcatcggtggttgcaacggttccaccggacct
			ggctccatgcatccagatggaaatttctggggtaatcgcttc
			cccgccacgtccattcgtgatcaggtaaacgccgaaaaacaa
			ttcctcgacgcactcggcatcaccacggtcgccgcagtactt
			ggtggttccatgggtggtgcccgcaccctagagtgggccgca
			atgtacccagaaactgttggcgcagctgctgttcttgcagtt
			tctgcacgcgccagcgcctggcaaatcggcattcaatccgcc
			caaattaaggcgattgaaaacgaccaccactggcacgaaggc
			aactactacgaatccggctgcaacccagccaccggactcggc
			gccgcccgacgcatcgcccacctcacctaccgtggcgaacta
			gaaatcgacgaacgcttcggcaccgcagcccaaaagaacgaa
			aacccactcggtccctaccgcaagcccgaccagcgcttcgcc
			gtggaatcctacttggactaccaagcagacaagctagtacag
			cgtttcgacgccggctcctacgtcttgctcaccgacgccctc
			aaccgccacgacattggtcgcgaccgcggaggcctcaacaag
			gcactcgaatccatcaaagttccagtccttgtcgcaggcgta
			gataccgatattttgtacccctaccaccagcaagaacacctc
			tccagaaacctgggaaatctactggcaatggcaaaaatcgta
			tcccctgtcggccacgatgctttcctcaccgaaagccgccaa
			atggatcgcatcgtgaggaacttcttcagcctcatctcccca
			gacgaagacaacccttcgacctacatcgagttctacatctaa
metY	Thermobifida	NZ_AAAQ010	GTGGCACTGCGTCCTGACAGGAGCATCATGACCGCTGA	53
	fusca	00035.1	AGACACCACGCCTGAATCCACCGCGGCCGACAAGTGGT
			CGTTCGAAACCAAGCAGATCCACGCCGGAGCGGCCCCC
			GATCCGGCCACCAACGCACGGGCCACCCCCATCTACCA
			GACCACGTCGTACGTCTTCCGGGACACGCAGCACGGGG
			CCGACCTGTTCTCGCTCGCAGAGCCGGGCAACATCTAC
			ACGCGGATCATGAACCCCACCCAGGACGTGCTGGAAAA
			GCGGGTCGCGGCTCTGGAAGGCGGGGTCGCCGCGGTCG
			CGTTCGCGTCCGGGTCAGCTGCCATCACCGCTGCCGTC
			CTCAACCTGGCGGGTGCGGGTGACCACATCGTGTCCAG
			CCCGTCCCTGTACGGCGGCACCTACAACCTGTTCCGCT
			ACACCCTGCCCAAGCTCGGCATCGAGGTCACCTTCATC
			AAAGACCAGGACGACCTCGACGAGTGGCGTGCCGCGGC
			CCGCGACAACACCAAGCTGTTCTTCGCGGAAACCCTGC
			CCAACCCGGCGAACAACGTGCTCGACGTGCGCGCGGTG
			GCGGACGTCGCCCACGAGGTCGGTGTGCCGCTCATGGT
			CGACAACACCGTGCCCACCCCCTACCTGCAGCGGCCCA
			TCGACCACGGCGCGGACATCGTGGTGCACTCGGCCACC
			AAGTTCCTCGGCGGCCACGGCACCACGATCGCGGGCAT
			CGTGGTGGACGCCGGCACCTTCGACTTCGGCGCCCACG
			GCGACCGGTTCCCCGGCTTCGTCGAACCCGACCCCAGC
			TACCATGGCCTGAAGTACTGGGAGGCGCTGGGACCGGG
			TGCCTACGCTGCCAAGCTGCGGGTGCAACTGCTCCGCG
			ACACGGGCGCGGCCATCTCGCCGTTCAACAGCTTCCTG
			ATCCTCCAGGGGATCGAAACGCTGTCGCTGCGCATGGA
			ACGGCACGTCGCCAACGCCCAGGCGCTCGCCGAGTGGC
			TGGAATCCCGCGACGAGGTGGCGAAGGTCTACTACCCG
			GGCCTGCCTTCCAGCCCCTACTACGAGGCTGCAAAGAA
			GTACCTGCCCAAGGGGGCGGGTGCGATCGTCTCCTTTG
			AGCTGCACGGCGGTATCGAGGCCGGACGCGCCTTCGTG
			GACGGCACCGAACTGTTCAGCCAGCTCGTCAACATCGG
			TGACGTGCGCAGCCTCATCGTCCACCCGGCCAGCACCA
			CGCACAGCCAGCTCACCCCCGAAGAGCAGCTCGCCAGc
			GGGGTCACTCCCGGCCTCGTGCGGCTGTCCGTGGGCTT
			GGAACACGTTGACGACCTTCGCGCAGACTTGGAGGCCG
			GGCTGCGCGCAGCCAAGGCATACCAGTGA
metY	Mycobacterium	AL021841.1	ATGAGCGCCGACAGCAATAGCACCGACGCCGATCCGAC	54
	tuberculosis		CGCGCATTGGTCGTTCGAAACCAAACAGATACACGCTG
	(can be used to		GTCAGCACCCTGATCCGACCACCAACGCCCGGGCTCTG
	clone M.		CCGATCTATGCGACCACGTCGTACACCTTCGACGACAC
	smegmatis		CGCGCACGCCGCCGCCCTGTTCGGACTGGAAATTCCGG
	gene)		GCAATATCTACACCCGGATCGGCAACCCCACCACCGAC
			GTCGTCGAGCAGCGCATCGCCGCGCTCGAGGGCGGTGT
			GGCCGCGCTGTTCCTGTCGTCGGGGCAGGCCGCGGAGA
			CGTTCGCCATCTTGAACCTGGCCGGCGCGGGCGATCAC
			ATCGTGTCCAGCCCGCGCCTGTACGGCGGCACCTACAA
			CCTGTTCCACTATTCGCTGGCCAAGCTCGGCATCGAGG
			TCAGCTTCGTCGACGATCCGGACGATCTGGACACCTGG
			CAGGCGGCGGTACGGCCCAACACCAAGGCGTTCTTCGC
			CGAGACCATCTCCAACCCGCAGATCGACCTGCTGGACA
			CCCCGGCGGTTTCCGAGGTCGCCCATCGCAACGGGGTG
			CCGTTGATCGTCGACAACACCATCGCCACGCCATACCT
			GATCCAACCGTTGGCCCAGGGCGCCGACATCGTCGTGC
			ATTCGGCCACCAAGTACCTGGGCGGGCACGGTGCCGCC
			ATCGCGGGTGTGATCGTCGACGGCGGCAACTTCGATTG
			GACCCAGGGCCGCTTCCCCGGCTTCACCACCCCCGACC
			CCAGCTACCACGGCGTGGTGTTCGCCGAGCTGGGTCCA
			CCGGCGTTTGCGCTCAAAGCTCGAGTGCAGCTGCTCCG
			TGACTACGGCTCGGCGGCTTCGCCGTTCAACGCGTTCT
			TGGTGGCGCAGGGTCTGGAAACGCTGAGCCTGCGGATC
			GAGCGGCACGTCGCCAACGCGCAGCGCGTCGCCGAGTT
			CCTGGCCGCCCGCGACGACGTGCTTTCGGTCAACTATG
			CGGGGCTGCCCTCCTCGCCCTGGCATGAGCGGGCCAAG
			AGGCTGGCGCCCAAGGGAACCGGGGCCGTGCTGTCCTT
			CGAGTTGGCCGGCGGCATCGAGGCCGGCAAGGCATTCG
			TGAACGCGTTGAAGCTGCACAGCCACGTCGCCAACATC
			GGTGACGTGCGCTCGCTGGTGATCCACCCGGCATCGAC
			CACTCATGCCCAGCTGAGCCCGGCCGAGCAGCTGGCGA
			CCGGGGTCAGCCCGGGCCTGGTGCGTTTGGCTGTGGGC
			ATCGAAGGTATCGACGATATCCTGGCCGACCTGGAGCT
			TGGCTTTGCCGCGGCCCGCAGATTCAGCGCCGACCCGC
			AGTCCGTGGCGGCGTTCTGA
metY	Coryne-	AF220150	ATGCCAAAGTACGACAATTCCAATGCTGACCAGTGGGG	252
	bacterium		CTTTGAAACCCGCTCCATTCACGCAGGCCAGTCAGTAG
	glutamicum		ACGCACAGACCAGCGCACGAAACCTTCCGATCTACCAA
			TCCACCGCTTTCGTGTTCGACTCCGCTGAGCACGCCAA
			GCAGCGTTTCGCACTTGAGGATCTAGGCCCTGTTTACT
			CCCGCCTCACCAACCCAACCGTTGAGGCTTTGGAAAAC
			CGCATCGCTTCCCTCGAAGGTGGCGTCCACGCTGTAGC
			GTTCTCCTCCGGACAGGCCGCAACCACCAACGCCATTT
			TGAACCTGGCAGGAGCGGGCGACCACATCGTCACCTCC
			CCACGCCTCTACGGTGGCACCGAGACTCTATTCCTTAT
			CACTCTTAACCGCCTGGGTATCGATGTTTCCTTCGTGG
			AAAACCCCGACGACCCTGAGTCCTGGCAGGCAGCCGTT
			CAGCCAAACACCAAAGCATTCTTCGGCGAGACTTTCGC
			CAACCCACAGGCAGACGTCCTGGATATTCCTGCGGTGG
			CTGAAGTTGCGCACCGCAACAGCGTTCCACTGATCATC
			GACAACACCATCGCTACCGCAGCGCTCGTGCGCCCGCT
			CGAGCTCGGCGCAGACGTTGTCGTCGCTTCCCTCACCA
			AGTTCTACACCGGCAACGGCTCCGGACTGGGCGGCGTG
			CTTATCGACGGCGGAAAGTTCGATTGGACTGTCGAAAA
			GGATGGAAAGCCAGTATTCCCCTACTTCGTCACTCCAG
			ATGCTGCTTACCACGGATTGAAGTACGCAGACCTTGGT
			GCACCAGCCTTCGGCCTCAAGGTTCGCGTTGGCCTTCT
			ACGCGACACCGGCTCCACCCTCTCCGCATTCAACGCAT
			GGGCTGCAGTCCAGGGCATCGACACCCTTTCCCTGCGC
			CTGGAGCGCCACAACGAAAACGCCATCAAGGTTGCAGA
			ATTCCTCAACAACCACGAGAAGGTGGAAAAGGTTAACT
			TCGCAGGCCTGAAGGATTCCCCTTGGTACGCAACCAAG
			GAAAAGCTTGGCCTGAAGTACACCGGCTCCGTTCTCAC
			CTTCGAGATCAAGGGCGGCAAGGATGAGGCTTGGGCAT
			TTATCGACGCCCTGAAGCTACACTCCAACCTTGCAAAC
			ATCGGCGATGTTCGCTCCCTCGTTGTTCACCCAGCAAC
			CACCACCCATTCACAGTCCGACGAAGCTGGCCTGGCAC
			GCGCGGGCGTTACCCAGTCCACCGTCCGCCTGTCCGTT
			GGCATCGAGACCATTGATGATATCATCGCTGACCTCGA
			AGGCGGCTTTGCTGCAATCTAG
metY D231A	C. glutamicum	N/a	ATGCCAAAGTACGACAATTCCAATGCTGACCAGTGGGGCTTT	295
			GAAACCCGCTCCATTCACGCAGGCCAGTCAGTAGACGCACAG
			ACCAGCGCACGAAACCTTCCGATCTACCAATCCACCGCTTTC
			GTGTTCGACTCCGCTGAGCACGCCAAGCAGCGTTTCGCACTT
			GAGGATCTAGGCCCTGTTTACTCCCGCCTCACCAACCCAACC
			GTTGAGGCTTTGGAAAACCGCATCGCTTCCCTCGAAGGTGGC
			GTCCACGCTGTAGCGTTCTCCTCCGGACAGGCCGCAACCACC
			AACGCCATTTTGAACCTGGCAGGAGCGGGCGACCACATCGTC
			ACCTCCCCACGCCTCTACGGTGGCACCGAGACTCTATTCCTT
			ATCACTCTTAACCGCCTGGGTATCGATGTTTCCTTCGTGGAA
			AACCCCGACGACCCTGAGTCCTGGCAGGCAGCCGTTCAGCCA
			AACACCAAAGCATTCTTCGGCGAGACTTTCGCCAACCCACAG
			GCAGACGTCCTGGATATTCCTGCGGTGGCTGAAGTTGCGCAC
			CGCAACAGCGTTCCACTGATCATCGACAACACCATCGCTACC
			GCAGCGCTCGTGCGCCCGCTCGAGCTCGGCGCAGACGTTGTC
			GTCGCTTCCCTCACCAAGTTCTACACCGGCAACGGCTCCGGA
			CTGGGCGGCGTGCTTATCGCCGGCGGAAAGTTCGATTGGACT
			GTCGAAAAGGATGGAAAGCCAGTATTCCCCTACTTCGTCACT
			CCAGATGCTGCTTACCACGGATTGAAGTACGCAGACCTTGGT
			GCACCAGCCTTCGGCCTCAAGGTTCGCGTTGGCCTTCTACGC
			GACACCGGCTCCACCCTCTCCGCATTCAACGCATGGGCTGCA
			GTCCAGGGCATCGACACCCTTTCCCTGCGCCTGGAGCGCCAC
			AACGAAAACGCCATCAAGGTTGCAGAATTCCTCAACAACCAC
			GAGAAGGTGGAAAAGGTTAACTTCGCAGGCCTGAAGGATTCC
			CCTTGGTACGCAACCAAGGAAAAGCTTGGCCTGAAGTACACC
			GGCTCCGTTCTCACCTTCGAGATCAAGGGCGGCAAGGATGAG
			GCTTGGGCATTTATCGACGCCCTGAAGCTACACTCCAACCTT
			GCAAACATCGGCGATGTTCGCTCCCTCGTTGTTCACCCAGCA
			ACCACCACCCATTCACAGTCCGACGAAGCTGGCCTGGCACGC
			GCGGGCGTTACCCAGTCCACCGTCCGCCTGTCCGTTGGCATC
			GAGACCATTGATGATATCATCGCTGACCTCGAAGGCGGCTTT
			GCTGCAATCTAG
metY G232A	C. glutamicum	N/a	ATGCCAAAGTACGACAATTCCAATGCTGACCAGTGGGGCTTT	296
			GAAACCCGCTCCATTCACGCAGGCCAGTCAGTAGACGCACAG
			ACCAGCGCACGAAACCTTCCGATCTACCAATCCACCGCTTTC
			GTGTTCGACTCCGCTGAGCACGCCAAGCAGCGTTTCGCACTT
			GAGGATCTAGGCCCTGTTTACTCCCGCCTCACCAACCCAACC
			GTTGAGGCTTTGGAAAACCGCATCGCTTCCCTCGAAGGTGGC
			GTCCACGCTGTAGCGTTCTCCTCCGGACAGGCCGCAACCACC
			AACGCCATTTTGAACCTGGCAGGAGCGGGCGACCACATCGTC
			ACCTCCCCACGCCTCTACGGTGGCACCGAGACTCTATTCCTT
			ATCACTCTTAACCGCCTGGGTATCGATGTTTCCTTCGTGGAA
			AACCCCGACGACCCTGAGTCCTGGCAGGCAGCCGTTCAGCCA
			AACACCAAAGCATTCTTCGGCGAGACTTTCGCCAACCCACAG
			GCAGACGTCCTGGATATTCCTGCGGTGGCTGAAGTTGCGCAC
			CGCAACAGCGTTCCACTGATCATCGACAACACCATCGCTACC
			GCAGCGCTCGTGCGCCCGCTCGAGCTCGGCGCAGACGTTGTC
			GTCGCTTCCCTCACCAAGTTCTACACCGGCAACGGCTCCGGA
			CTGGGCGGCGTGCTTATCGACGCCGGAAAGTTCGATTGGACT
			GTCGAAAAGGATGGAAAGCCAGTATTCCCCTACTTCGTCACT
			CCAGATGCTGCTTACCACGGATTGAAGTACGCAGACCTTGGT
			GCACCAGCCTTCGGCCTCAAGGTTCGCGTTGGCCTTCTACGC
			GACACCGGCTCCACCCTCTCCGCATTCAACGCATGGGCTGCA
			GTCCAGGGCATCGACACCCTTTCCCTGCGCCTGGAGCGCCAC
			AACGAAAACGCCATCAAGGTTGCAGAATTCCTCAACAACCAC
			GAGAAGGTGGAAAAGGTTAACTTCGCAGGCCTGAAGGATTCC
			CCTTGGTACGCAACCAAGGAAAAGCTTGGCCTGAAGTACACC
			GGCTCCGTTCTCACCTTCGAGATCAAGGGCGGCAAGGATGAG
			GCTTGGGCATTTATCGACGCCCTGAAGCTACACTCCAACCTT
			GCAAACATCGGCGATGTTCGCTCCCTCGTTGTTCACCCAGCA
			ACCACCACCCATTCACAGTCCGACGAAGCTGGCCTGGCACGC
			GCGGGCGTTACCCAGTCCACCGTCCGCCTGTCCGTTGGCATC
			GAGACCATTGATGATATCATCGCTGACCTCGAAGGCGGCTTT
			GCTGCAATCTAG
metK	Mycobacterium	Z80108.1	GTGAGCGAAAAGGGTCGGCTGTTTACCAGTGAGTCGGT	55
	tuberculosis		GACAGAGGGACATCCCGACAAGATCTGTGACGCCATCA
	(can be used to		GCGACTCGGTTCTGGACGCGCTTCTAGCGGCGGACCCG
	clone M.		CGCTCACGTGTCGCGGTCGAGACGCTGGTGACCACCGG
	smegmatis		GCAGGTGCACGTGGTGGGTGAGGTGACCACCTCGGCTA
	gene)		AGGAGGCGTTTGCCGACATCACCAACACGGTCCGCGCA
			CGGATCCTCGAGATCGGCTACGACTCGTCGGACAAGGG
			TTTCGACGGGGCGACCTGCGGGGTGAACATCGGCATCG
			GCGCACAGTCACCCGACATCGCCCAGGGGGTCGACACC
			GCCCACGAGGCCCGGGTCGAGGGCGCGGCCGATCCGCT
			GGACTCCCAGGGCGCCGGTGACCAGGGCCTGATGTTCG
			GCTACGCGATCAATGCCACCCCGGAACTGATGCCACTG
			CCCATCGCGCTGGCCCACCGACTGTCGCGGCGGCTGAC
			CGAGGTCCGCAAGAACGGGGTGCTGCCCTACCTGCGTC
			CGGATGGCAAGACGCAGGTCACTATCGCCTACGAGGAC
			AACGTTCCGGTGCGGCTGGATACCGTGGTCATCTCCAC
			CCAGCACGCGGCCGATATCGACCTGGAGAAGACGCTTG
			ATCCCGACATCCGGGAAAAGGTGCTCAACACCGTGCTC
			GACGACCTGGCCCACGAAACCCTGGACGCGTCGACGGT
			GCGGGTGCTGGTGAACCCGACCGGCAAGTTCGTGCTCG
			GCGGGCCGATGGGCGATGCCGGGCTCACCGGCCGCAAG
			ATCATCGTCGACACCTACGGCGGCTGGGCCCGCCACGG
			CGGCGGCGCCTTCTCCGGCAAGGATCCGTCCAAGGTGG
			ACCGGTCGGCGGCGTACGCGATGCGCTGGGTGGCCAAG
			AATGTCGTCGCCGCCGGGTTGGCTGAACGGGTCGAGGT
			GCAGGTGGCCTACGCCATCGGTAAAGCGGCACCCGTCG
			GCCTGTTCGTCGAGACGTTCGGTACCGAGACGGAAGAC
			CCGGTCAAGATCGAGAAGGCCATCGGCGAGGTATTCGA
			CCTGCGCCCCGGTGCCATCATCCGCGACCTGAACCTGT
			TGCGCCCGATCTATGCGCCGACCGCCGCCTACGGGCAC
			TTCGGCCGCACCGACGTCGAATTACCGTGGGAGCAGCT
			CGACAAGGTCGACGACCTCAAGCGCGCCATCTAG
metK	Mycobacterium	AL583918.1	GTGAGTGAGAAGGGTCGGCTGTTCACTAGCGAGTCGGT	56
	leprae (can be		GACTGAGGGACATCCCGACAAGATCTGTGATGCGATCA
	used to clone		GCGACTCGATCCTTGACGCACTTTTGGCGGAGGATCCT
	M. smegmatis		TGCTCACGTGTCGCGGTCGAGACGTTGGTCACCACCGG
	gene)		GCAGGTGCATGTGGTGGGTGAAGTGACGACGTTGGCCA
			AGACGGCGTTCGCTGATATCAGTAATACGGTCCGCGAA
			CGTATTCTCGATATCGGCTACGACTCGTCGGACAAGGG
			CTTCGATGGGGCGTCGTGCGGAGTTAACATTGGCATCG
			GCGCTCAGTCGTCTGACATTGCTCAAGGCGTCAATACC
			GCCCATGAAGTACGCGTCGAGGGCGCGGCGGATCCGCT
			GGACGCCCAGGGTGCTGGTGACCAAGGCCTGATGTTCG
			GTTACGCGATCAATGACACCCCGGAACTGATGCCGCTA
			CCGATTGCACTGGCCCACCGACTGGCGCGAAGGCTGAC
			CGAGGTACGCAAGAACGGCGTGCTGCCCTACCTGCGTT
			CCGACGGCAAGACCCAGGTCACTATCGCCTACGAGGAC
			AATGTCCCAGTGCGTTTGGACACTGTGGTCATCTCcAC
			TCAGCACGCCGCTGGTGTCGACCTGGATGCCACGCTGG
			CTCCTGATATCCGGGAGAAGGTGCTCAACACCGTTATT
			GACGATCTGTCTCATGACACCTTGGATGTATCGTCGGT
			GCGGGTGCTGGTAAACCCGACCGGCAAGTTCGTGCTAG
			GTGGGCCGATGGGCGATGCCGGGCTCACCGGTCGCAAG
			ATCATCGTCGACACCTACGGTGGCTGGGCGCGTCACGG
			CGGCGGCGCCTTCTCTGGCAAGGATCCGTCCAAGGTGG
			ACCGGTCGGCAGCCTACGCGATGCGCTGGGTGGCCAAG
			AACATCGTCGCTGCCGGGCTGGCGGAGCGAATCGAGGT
			GCAGGTGGCATACGCCATCGGCAAAGCCGCCCCGGTCG
			GTTTGTTCGTCGAGACCTTTGGCACTGAGGCGGTCGAT
			CCGGCCAAAATCGAGAAAGCCATCGGCGAGGTGTTCGA
			TCTGCGTCCCGGCGCGATCATCCGCGACCTGCATCTGC
			TGCGCCCAATTTACGCGCAAACCGCTGCCTATGGGCAC
			TTCGGTCGCACTGACGTCGAACTGCCATGGGAGCAGCT
			CAACAAAGTCGACGATCTCAAGCGCGCCATC
metK	Thermobifida	NZ_AAAQ010	GTGTCCCGTCGACTTTTCACCTCCGAGTCGGTCACCGA	57
	fusca	00031.1	AGGCCACCCCGACAAGATCGCTGACCAGATCAGTGACG
			CGATCCTCGACTCGATGCTCAGGGATGACCCCCACAGC
			CGGGTCGCGGTGGAGACCCTCATCACGACCGGCCTGGT
			CCACGTCGCCGGCGAAGTGACCACATCCACCTACGTCG
			ACATTCCCACCATCATCCGCGAGAAGATCCTGGAGATC
			GGCTACGACTCCTCGGCCAAGGGGTTCGACGGCGCCTC
			CTGCGGAGTGTCCGTGTCGATCGGCGGGCAGTCACCCG
			ACATCGCCCAGGGCGTCGACAACGCCTACGAGGCCCGG
			GAGGAAGAGATCTTCGACGACCTCGACCGGCAGGGCGC
			AGGCGACCAAGGCCTCATGTTCGGCTACGCCAACAACG
			AGACCCCGGAGCTGATGCCGCTGCCGATCACGCTGGCC
			CACGCCCTGTCGCAGCGACTCGCTGAAGTGCGCCGCGA
			CGGGACCATCCCCTACCTGCGGCCCGACGGCAAGACCC
			AGGTCACCGTGGAGTACGACGGGAACCGGCCCGTCCGG
			TTGGACACCGTGGTGGTCTCCAGCCAGCACGCGCCCGA
			CATCGACCTGCGGGAACTGCTCACCCCGGACATCAAGG
			AGCACGTGGTCGACCCGGTAGTGGCCCGCTACAACCTG
			GAGGCCGACAACTACCGACTGCTCGTCAACCCCACCGG
			ACGGTTCGAGATCGGCGGCCCGATGGGTGACGCCGGGC
			TGACCGGCCGCAAGATCATCGTCGACACCTACGGCGGC
			TACGCCCGCCACGGCGGTGGCGCGTTCTCCGGCAAGGA
			CCCGTCCAAGGTGGACCGCTCCGCCGCGTACGCCACCC
			GCTGGGTCGCGAAGAACATCGTCGCCGCCGGGCTCGCC
			GACCGAGTCGAAGTCCAGGTCGCCTACGCGATCGGCAA
			AGCCCACCCGGTCGGCGTGTTCCTGGAGACCTTCGGCA
			CCGAGAAGGTCGCCCCGGAGCAGTTGGAGAAGGCGGTG
			CTGGAGGTCTTCGACCTGCGTCCCGCCGCGATCATCCG
			CGACCTGGACCTGCTGCGCCCCATCTACTCCCAGACCT
			CGGTCTACGGCCACTTCGGCCGGGAGCTGCCCGACTTC
			ACCTGGGAGCGCACCGACCGCGTCGACGCTCTCAAGGC
			TGCCGTGGGCGCCTGA
metk	Streptomyces	AL939109.1	GTGTCCCGTCGCCTGTTCACCTCGGAGTCCGTGACCGA	58
	coelicolor		AGGTCACCCCGACAAGATCGCTGACCAGATCAGCGACA
			CGATTCTCGACGCGCTTCTGCGCGAGGACCCGACCTCC
			CGGGTCGCCGTCGAAACCCTGATCACCACCGGTCTGGT
			GCACGTGGCCGGCGAGGTCACCACCAAGGCCTACGCGG
			ACATCGCCAACCTGGTCCGCGGCAAGATCCTGGAGATC
			GGCTACGACTCCTCCAAGAAGGGCTTCGACGGCGCCTC
			CTGCGGCGTCTCGGTCTCCATCGGCGCGCAGTCCCCGG
			ACATCGCGCAGGGCGTCGACACGGCGTACGAGAACCGG
			GTGGAGGGCGACGAGGACGAGCTGGACCGCCAGGGTGC
			CGGCGACCAGGGCCTGATGTTCGGCTACGCGTCCGACG
			AGACGCCGACGCTGATGCCGCTGCCGGTCTTCCTGGCG
			CACCGCCTGTCCAAGCGCCTGTCCGAGGTCCGCAAGAA
			CGGCACCATCCCGTACCTGCGTCCGGACGGCAAGACCC
			AGGTCACCATCGAGTACGACGGCGACAAGGCCGTCCGT
			CTGGACACGGTCGTCGTCTCCTCCCAGCACGCGAGCGA
			CATCGACCTGGAGTCGCTGCTGGCGCCGGACATCAAGG
			AGTTCGTCGTCGAGCCGGAGCTGAAGGCGCTCCTCGAG
			GACGGCATCAAGATCGACACGGAGAACTACCGCCTCCT
			GGTCAACCCGACCGGCCGCTTCGAGATCGGCGGCCCGA
			TGGGCGACGCCGGTCTGACCGGCCGCAAGATCATCATC
			GACACCTACGGCGGCATGGCCCGGCACGGCGGCGGCGC
			CTTCTCCGGCAAGGACCCGTCGAAGGTCGACCGCTCCG
			CGGCGTACGCGATGCGCTGGGTCGCCAAGAACGTCGTG
			GCCGCGGGTCTCGCCGCGCGCTGCGAGGTCCAGGTCGC
			CTACGCCATCGGCAAGGCCGAGCCCGTGGGTCTGTTCG
			TGGAGACCTTCGGTACCGCCAAGGTCGACACCGAGAAG
			ATCGAGAAGGCGATCGACGAGGTCTTCGACCTGCGCCC
			GGCCGCCATCATCCGCGCTCTCGACCTGCTCCGCCCGA
			TCTACGCCCAGACCGCGGCGTACGGTCACTTCGGCCGT
			GAGCTGCCCGACTTCACGTGGGAGCGCACCGACCGCGT
			GGACGCGCTGCGCGAGGCCGCGGGCCTGTAA
metK	Coryne-	AP005279	GTGGCTCAGCCAACCGCCGTCCGTTTGTTCACCAGTGA	253
	bacterium		ATCTGTAACTGAGGGACATCCAGACAAAATATGTGATG
	glutamicum		CTATTTCCGATACCATTTTGGACGCGCTGCTCGAAAAA
			GATCCGCAGTCGCGCGTCGCAGTGGAAACTGTGGTCAC
			CACCGGAATCGTCCATGTTGTTGGCGAGGTCCGTACCA
			GCGCTTACGTAGAGATCCCTCAATTAGTCCGCAACAAG
			CTCATCGATATCGGATTCAACTCCTCTGAGGTTGGATT
			CGACGGACGCACCTGTGGCGTCTCAGTATCCATCGGTG
			AGCAGTCCCAGGAAATCGCTGACGGCGTGGATAACTCC
			GACGAAGCCCGCACCAACGGCGACGTTGAAGAAGACGA
			CCGCGCAGGTGCTGGCGACCAGGGCCTGATGTTCGGCT
			ACGCCACCAACGAAACCGAAGAGTACATGCCTCTTCCT
			ATCGCGTTGGCGCACCGACTGTCACGTCGTCTGACCCA
			GGTTCGTAAAGAGGGCATCGTTCCTCACCTGCGTCCAG
			ACGGAAAAACCCAGGTCACCTTCGCATACGATGCGCAA
			GACCGCCCTAGCCACCTGGATACCGTTGTCATCTCCAC
			CCAGCACGACCCAGAAGTTGACCGTGCATGGTTGGAAA
			CCCAACTGCGCGAACACGTCATTGATTGGGTAATCAAA
			GACGCAGGCATTGAGGATCTGGCAACCGGTGAGATCAC
			CGTGTTGATCAACCCTTCAGGTTCCTTCATTCTGGGTG
			GCCCCATGGGTGATGCGGGTCTGACCGGCCGCAAGATC
			ATCGTGGATACCTACGGTGGCATGGCTCGCCATGGTGG
			TGGAGCATTCTCCGGTAAGGATCCAAGCAAGGTGGACC
			GCTCTGCTGCATACGCCATGCGTTGGGTAGCAAAGAAC
			ATCGTGGCAGCAGGCCTTGCTGATCGCGCTGAAGTTCA
			GGTTGCATACGCCATTGGACGCGCAAAGCCAGTCGGAC
			TTTACGTTGAAACCTTTGACACCAACAAGGAAGGCCTG
			AGCGACGAGCAGATTCAGGCTGCCGTGTTGGAGGTCTT
			TGACCTGCGTCCAGCAGCAATTATCCGTGAGCTTGATC
			TGCTTCGTCCGATCTACGCTGACACTGCTGCCTACGGC
			CACTTTGGTCGCACTGATTTGGACCTTCCTTGGGAGGC
			TATCGACCGCGTTGATGAACTTCGCGCAGCCCTCAAGT
			TGGCC
metK	Escherichia	U28377	ATGGCAAAACACCTTTTTACGTCCGAGTCCGTCTCTGA	254
	coli		AGGGCATCCTGACAAAATTGCTGACCAAATTTCTGATG
			CCGTTTTAGACGCGATCCTCGAACAGGATCCGAAAGCA
			CGCGTTGCTTGCGAAACCTACGTAAAAACCGGCATGGT
			TTTAGTTGGCGGCGAAATCACCACCAGCGCCTGGGTAG
			ACATCGAAGAGATCACCCGTAACACCGTTCGCGAAATT
			GGCTATGTGCATTCCGACATGGGCTTTGACGCTAACTC
			CTGTGCGGTTCTGAGCGCTATCGGCAAACAGTCTCCTG
			ACATCAACCAGGGCGTTGACCGTGCCGATCCGCTGGAA
			CAGGGCGCGGGTGACCAGGGTCTGATGTTTGGCTACGC
			AACTAATGAAACCGACGTGCTGATGCCAGCACCTATCA
			CCTATGCACACCGTCTGGTACAGCGTCAGGCTGAAGTG
			CGTAAAAACGGCACTCTGCCGTGGCTGCGCCCGGACGC
			GAAAAGCCAGGTGACTTTTCAGTATGACGACGGCAAAA
			TCGTTGGTATCGATGCTGTCGTGCTTTCCACTCAGCAC
			TCTGAAGAGATCGACCAGAAATCGCTGCAAGAAGCGGT
			AATGGAAGAGATCATCAAGCCAATTCTGCCCGCTGAAT
			GGCTGACTTCTGCCACCAAATTCTTCATCAACCCGACC
			GGTCGTTTCGTTATCGGTGGCCCAATGGGTGACTGCGG
			TCTGACTGGTCGTAAAATTATCGTTGATACCTACGGCG
			GCATGGCGCGTCACGGTGGCGGTGCATTCTCTGGTAAA
			GATCCATCAAAAGTGGACCGTTCCGCAGCCTACGCAGC
			ACGTTATGTCGCGAAAAACATCGTTGCTGCTGGCCTGG
			CCGATCGTTGTGAAATTCAGGTTTCCTACGCAATCGGC
			GTGGCTGAACCGACCTCCATCATGGTAGAAACTTTCGG
			TACTGAGAAAGTGCCTTCTGAACAACTGACCCTGCTGG
			TACGTGAGTTCTTCGACCTGCGCCCATACGGTCTGATT
			CAGATGCTGGATCTGCTGCACCCGATCTACAAAGAAAC
			CGCAGCATACGGTCACTTTGGTCGTGAACATTTCCCGT
			GGGAAAAAACCGACAAAGCGCAGCTGCTGCGCGATGCT
			GCCGGTCTGAAG
metC	Mycobacterium	AL021428.1	ATGCAGGACAGCATCTTCAATCTGTTGACCGAGGAACA	130
	tuberculosis		GCTTCGGGGTCGCAACACGCTCAAGTGGAACTATTTCG
	(use this to		GGCCCGATGTAGTGCCACTGTGGCTGGCGGAGATGGAC
	clone M.		TTTCCCACCGCACCGGCTGTGCTCGACGGGGTGCGGGC
	smegmatis		GTGCGTCGACAACGAGGAGTTCGGCTACCCGCCGTTGG
	gene)		GCGAGGACAGCCTGCCGAGGGCGACGGCCGATTGGTGC
			CGACAACGCTACGGTTGGTGCCCCCGACCGGACTGGGT
			CCGCGTCGTGCCGGATGTCCTGAAGGGGATGGAAGTCG
			TCGTCGAATTCCTTACCCGGCCGGAGAGTCCGGTCGCG
			TTGCCGGTTCCGGCTTACATGCCGTTTTTCGACGTCCT
			GCACGTCACCGGCCGCCAACGAGTGGAAGTCCCAATGG
			TGCAGCAAGACTCGGGACGCTACCTGCTGGACCTGGAC
			GCTCTGCAGGCCGCGTTCGTCCGCGGTGCCGGATCGGT
			GATTATCTGCAATCCGAATAACCCACTGGGTACGGCGT
			TCACCGAAGCCGAGCTACGTGCGATTGTGGATATCGCG
			GCCCGCCACGGCGCCCGGGTGATCGCGGATGAGATCTG
			GGCACCGGTGGTCTACGGATCGCGCCATGTCGCCGCCG
			CTTCGGTGTCGGAGGCGGCGGCTGAAGTCGTGGTCACG
			TTGGTGTCGGCGTCCAAAGGCTGGAACTTGCCGGGTCT
			GATGTGCGCTCAGGTGATCCTGTCTAACCGCCGTGACG
			CCCACGACTGGGACCGGATCAACATGTTGCACCGCATG
			GGCGCATCAACGGTCGGTATCCGCGCGAACATCGCCGC
			CTACCATCATGGCGAATCTTGGTTGGACGAGCTGCTCC
			CTTATCTGCGGGCGAACCGTGATCATCTGGCACGGGCG
			CTGCCGGAGTTAGCTCCCGGGGTAGAGGTCAACGCTCC
			GGACGGTACCTACCTGTCGTGGGTGGATTTCCGTGCGC
			TGGCTCTGCCGTCTGAACCGGCGGAATACCTGCTCTCG
			AAGGCGAAGGTGGCGCTGTCGCCTGGCATTCCGTTCGG
			CGCCGCGGTGGGCTCGGGATTTGCGCGGCTGAACTTCG
			CCACCACCCGCGCAATACTGGATCGGGCGATCGAGGCT
			ATCGCGGCCGCCCTGCGCGACATCATCGATTAA
metC	Bifidobacterium	NZ_AABM020	ATGAGCATGAACAACATTCCCCAGTCAACGACTGTGAG	131
	longum	00009.1	CAACGCAACCGCCGACGTCTCTTGCTTTGATGCCAATC
			ACATCGACGTGACGACCATCGAGGATCTGAAGCAGGTC
			GGTTCGGATAAATGGACCCGCTACCCCGGCTGCATCGG
			CGCATTCATCGCCGAGATGGATTACGGTCTGGCACCAT
			GCGTGGCCGAAGCCATCGAAGAGGCCACCGAACGTGGC
			GCGCTCGGCTACATTCCCGACCCGTGGAAGAAGGAGGT
			CGCCCGCTCGTGCGCCGCATGGCAGCGCCGCTACGGCT
			GGGATGTGGATCCGACGTGCATCCGCCCGGTGCCGGAC
			GTGCTGGAGGCGTTCGAAGTGTTCCTGCGCGAGATCGT
			GCGCGCCGGCAACTCCATCGTGGTACCGACTCCGGCCT
			ATATGCCGTTCCTGAGCGTGCCGCGTCTGTATGGCGTG
			GAGGTCCTTGAGATTCCGATGCTGTGCGCGGGCGCCAG
			CGAGAGCAGCGGGCGCAATGATGAATGGCTGTTCGATT
			TCGACGCCATTGAGCAGGCGTTCGCGAACGGCTGCCAT
			GCCTTCGTGCTGTGCAACCCGCACAACCCGATCGGCAA
			GGTATTGACGCGCGAGGAAATGCTGCGATTGTCCGATC
			TGGCCGCCAAGTACAACGTGCGTATATTCTCCGATGAG
			ATTCACGCGCCGTTCGTCTACCAAGGCCACACGCATGT
			GCCATTCGCCTCAATCAACCGGCAGACGGCCATGCAGG
			CTTTCACCTCCACTTCAGCCTCGAAGTCGTTCAACATT
			CCCGGCACCAAGTGCGCGCAGGTGATTCTCACCAATCC
			GGACGATCTGGAACTATGGATGAGGAACGCGGAATGGT
			CCGAGCACCAGACGGCCACCATCGGTGCCATAGCCACC
			ACTGCGGCCTATGACGGCGGCGCGGCATGGTTCGAGGG
			CGTGATGGCATATATCGAGCGCAATATCGCGCTGGTCA
			ACGAGCAGATGCGCACGAGATTCGCCAAGGTGCGCTAT
			GTGGAGCCGCAGGGCACGTATATCGCGTGGCTGGATTT
			CTCGCCACTGGGCATCGGCGACCCGGCCAACTATTTCT
			TTAAGAAGGCCAACGTGGCGTTGACAGACGGCCGTGAA
			TGCGGCGAGGTCGGGCGCGGTTGCGTGCGTATGAACTT
			CGCCATGCCCTACCCGCTACTGGAGGAATGCTTCGACC
			GCATGGCCGCCGCACTTGAGGCGGACGGGTTGTTGTAG
metC	Lactobacillus	L935262	ATGCAATATGATTTTAATAAGGTTATAAATCGTAGAGG	132
	plantarum		GACATACAGTACTCAGTGGGATTATATTCAAGATCGCT
			TTGGTCGTTCTGACATTCTACCATTTTCAATTTCAGAT
			ACTGACTTTCCGGTTCCCGTTGGCGTCCAAGAGGCGCT
			TGAACAGCGTATTAAGCATCCTATTTATGGTTATACAC
			GCTGGAATAATGAGGATTACAAAAATAGTATTATTAAT
			TGGTTTAGCTCTCAAAATCAAGTTACTATAAACCCAGA
			TTGGATTTTATATAGTCCCAGTGTTGTTTTTTCAATTG
			CCACCTTTATTCGAATGAAGTCAGCCGTTGGAGAAAGT
			GTAGCGGTCTTCACTCCTATGTATGACGCCTTTTATCA
			TGTGATTGAGGATAATCAGCGGGTGTTAGCGCCGGTCA
			GACTAGGCAGTGCACAACAAGACTATAGTATCGATTGG
			GATACTTTGAAAGCTGTTTTAAAGCAAACAGCAACAAA
			AATTTTACTTTTGACTAATCCACATAATCCTACCGGGA
			AGGTCTTTTCAGATGATGAATTGAAGCATATAGTTGCA
			CTATGTCAACAATATAATGTCTTTATAATTTCAGATGA
			TATTCATAAGGACATTGTGTATCAAAAGGCAGCATATA
			CGCCTGTAACCGAATTTACAACTAAGAATGTGGTCCTA
			TGTTGTTCAGCTACTAAAACTTTTAATACCCCTGGGTT
			GATTGGCGCATATTTATTTGAGCCTGAGGCTGAACTAC
			GTGAGATGTTTTTATGTGAATTAAAGCAAAAAAATGCT
			TTATCATCAGCTAGCATCCTTGGAATTGAATCTCAGAT
			GGCTGCTTATAATACTGGAAGTGACTATTTAGTACAAC
			TCATAACGTATTTGCAAAATAACTTTGATTATCTATCT
			ACTTTCTTAAAAAGTCAGTTACCAGAGATTAGATTTAA
			GCAGCCTGAAGCGACTTATTTGGCTTGGATGGATGTCT
			CGCAATTGGGGCTAACGGCTGAAAAACTACAAGATAAA
			CTTGTTAATACGGGTCGAGTTGGGATCATGTCGGGGAC
			AACATATGGTGACAGTCATTATTTACGTATGAATATTG
			CTTGTCCTATTTCTAAATTGCAGGAAGGACTGAAAAGA
			ATGGAGTACGGGATCCGTTCGTAA
metC	Coryne-	F276227	ATGCGATTTCCTGAACTCGAAGAATTGAAGAATCGCCG	255
	bacterium		GACCTTGAAATGGACCCGGTTTCCAGAAGACGTGCTTC
	glutamicum		CTTTGTGGGTTGCGGAAAGTGATTTTGGCACCTGCCCG
			CAGTTGAAGGAAGCTATGGCAGATGCCGTTGAGCGCGA
			GGTCTTCGGATACCCACCAGATGCTACTGGGTTGAATG
			ATGCGTTGACTGGATTCTACGAGCGTCGCTATGGGTTT
			GGCCCAAATCCGGAAAGTGTTTTCGCCATTCCGGATGT
			GGTTCGTGGCCTGAAGCTTGCCATTGAGCATTTCACTA
			AGCCTGGTTCGGCGATCATTGTGCCGTTGCCTGCATAC
			CCTCCTTTCATTGAGTTGCCTAAGGTGACTGGTCGTCA
			GGCGATCTACATTGATGCGCATGAGTACGATTTGAAGG
			AAATTGAGAAGGCCTTCGCTGACGGTGCGGGATCACTG
			TTGTTCTGCAATCCACACAACCCACTGGGCACGGTCTT
			TTCTGAAGAGTACATCCGCGAGCTCACCGATATTGCGG
			CGAAGTACGATGCCCGCATCATCGTCGATGAGATCCAC
			GCGCCACTGGTTTATGAAGGCACCCATGTGGTTGCTGC
			TGGTGTTTCTGAGAACGCTGCAAACACTTGCATCACCA
			TCACCGCAACTTCTAAGGCGTGGAACACTGCTGGTTTG
			AAGTGTGCTCAGATCTTCTTCAGTAATGAAGCCGATGT
			GAAGGCCTGGAAGAATTTGTCGGATATTACCCGTGACG
			GTGTGTCCATCCTTGGATTGATCGCTGCGGAGACAGTG
			TACAACGAGGGCGAAGAATTCCTTGATGAGTCAATTCA
			GATTCTCAAGGACAACCGTGACTTTGCGGCTGCTGAAC
			TGGAAAAGCTTGGCGTGAAGGTCTACGCACCGGACTCC
			ACTTATTTGATGTGGTTGGACTTCGCTGGCACCAAGAT
			CGAAGAGGCGCCTTCTAAAATTCTTCGTGAGGAGGGTA
			AGGTCATGCTGAATGATGGCGCAGCTTTTGGTGGTTTC
			ACCACCTGCGCTCGTCTTAATTTTGCGTGTTCCAGAGA
			GACCCTTGAGGAGGGGCTGCGCCGTATCGCCAGCGTGT
			TGTAA
metC	Escherichia coli	E000383	ATGGCGGACAAAAAGCTTGATACTCAACTGGTGAATGC	256
			AGGACGCAGCAAAAAATACACTCTCGGCGCGGTAAATA
			GCGTGATTCAGCGCGCTTCTTCGCTGGTCTTTGACAGT
			GTAGAAGCCAAAAAACACGCGACACGTAATCGCGCCAA
			TGGAGAGTTGTTCTATGGACGGCGCGGAACGTTAACCC
			ATTTCTCCTTACAACAAGCGATGTGTGAACTGGAAGGT
			GGCGCAGGCTGCGTGCTATTTCCCTGCGGGGCGGCAGC
			GGTTGCTAATTCCATTCTTGCTTTTATCGAACAGGGCG
			ATCATGTGTTGATGACCAACACCGCCTATGAACCGAGT
			CAGGATTTCTGTAGCAAAATCCTCAGCAAACTGGGCGT
			AACGACATCATGGTTTGATCCGCTGATTGGTGCCGATA
			TCGTTAAGCATCTGCAGCCAAACACTAAAATCGTGTTT
			CTGGAATCGCCAGGCTCCATCACCATGGAAGTCCACGA
			CGTTCCGGCGATTGTTGCCGCCGTACGCAGTGTGGTGC
			CGGATGCCATCATTATGATCGACAACACCTGGGCAGCC
			GGTGTGCTGTTTAAGGCGCTGGATTTTGGCATCGATGT
			TTCTATTCAAGCCGCCACCAAATATCTGGTTGGGCATT
			CAGATGCGATGATTGGCACTGCCGTGTGCAATGCCCGT
			TGCTGGGAGCAGCTACGGGAAAATGCCTATCTGATGGG
			CCAGATGGTCGATGCCGATACCGCCTATATAACCAGCC
			GTGGCCTGCGCACATTAGGTGTGCGTTTGCGTCAACAT
			CATGAAAGCAGTCTGAAAGTGGCTGAATGGCTGGCAGA
			ACATCCGCAAGTTGCGCGAGTTAACCACCCTGCTCTGC
			CTGGCAGTAAAGGTCACGAATTCTGGAAACGAGACTTT
			ACAGGCAGCAGCGGGCTATTTTCCTTTGTGCTTAAGAA
			AAAACTCAATAATGAAGAGCTGGCGAACTATCTGGATA
			ACTTCAGTTTATTCAGCATGGCCTACTCGTGGGGCGGG
			TATGAATCGTTGATCCTGGCAAATCAACCAGAACATAT
			CGCCGCCATTCGCCCACAAGGCGAGATCGATTTTAGCG
			GGACCTTGATTCGCCTGCATATTGGTCTGGAAGATGTC
			GACGATCTGATTGCCGATCTGGACGCCGGTTTTGCGCG
			AATTGTA
gdh	Streptomyces	L939121.1	GTGCCCGCCGTGCCAGAAAGGGCCCCTGTGACGACGCG	133
	coelicolor		AAGCGAGACGCAGTCCACCCTCGACCACCTCCTCACCG
			AGATCGAGCTGCGCAACCCGGCCCAGCCCGAGTTCCAC
			CAGGCGGCCCACGAGGTCCTGGAGACCCTGGCGCCGGT
			CGTCGCGGCCCGCCCCGAGTACGCCGAGCCGGGCCTCA
			TCGAGCGGCTGGTCGAGCCGGAGCGCCAGGTGATGTTC
			CGGGTGCCGTGGCAGGACGACCAGGGCCGCGTCCGCGT
			CAACCGGGGCTTCCGGGTCGAGTTCAACAGCGCGCTGG
			GCCCGTACAAGGGCGGTCTGCGCTTCCATCCGTCCGTC
			AACCTGGGCGTCATCAAGTTCCTGGGCTTCGAGCAGAT
			CTTCAAGAACGCGCTGACCGGCCTCGGCATCGGCGGCG
			GCAAGGGCGGCAGCGACTTCGACCCGCACGGGCGCAGC
			GACGCGGAGGTCATGCGGTTCTGCCAGTCCTTCATGAC
			GGAGCTGTACCGGCACATCGGCGAGCACACGGACGTCC
			CGGCGGGGGACATCGGCGTCGGGGGCCGCGAGATCGGC
			TACCTCTTCGGCCAGTACCGGCGGATCACCAACCGCTG
			GGAGTCCGGCGTCCTGACCGGCAAGGGCCAGGGCTGGG
			GCGGCTCGCTGATCCGCCCGGAGGCGACCGGCTACGGC
			AACGTGCTGTTCGCGGCGGCGATGCTGCGGGAGCGCGG
			CGAGGACCTGGAGGGCCAGACCGCGGTCGTCTCCGGCT
			CCGGCAACGTGGCGATCTACACCATCGAGAAGCTGACC
			GCCCTCGGCGCCAACGCCGTCACCTGCTCGGACTCCTC
			CGGCTACGTCGTCGACGAGAAGGGCATCGACCTCGACC
			TGCTCAAGCAGATCAAGGAGGTCGAGCGCGGCCGCGTC
			GACGCGTACGCCGAGCGCCGGGGCGCCTCGGCCCGCTT
			CGTGCCCGGCGGCAGCGTCTGGGACGTTCCGGCCGACC
			TTGCCCTCCCCTCCGCCACGCAGAACGAGCTGGACGAG
			AACGCCGCCGCCACGCTCGTCCGCAACGGCGTCAAGGC
			GGTCTCCGAGGGCGCGAACATGCCGACCACCCCCGAGG
			CCGTCCACCTGCTCCAGAAGGCGGGCGTCGCCTTCGGC
			CCCGGCAAGGCGGCCAACGCGGGCGGCGTCGCGGTCAG
			CGCCCTGGAGATGGCGCAGAACCACGCCCGTACCTCGT
			GGACGGCGGCGCGGGTCGAGGAGGAGCTGGCCGACATC
			ATGACCAGCATCCACACCACCTGCCACGAGACCGCCGA
			GCGCTACGACGCCCCCGGCGACTACGTCACCGGCGCGA
			ACATCGCCGGCTTCGAGCGGGTGGCCGACGCGATGCTG
			GCGCAGGGCGTCATCTGA
gdh	Thermobifida	NZ_AAAQ010	GTGCGCCCCGAACCGGAGGCGACCATGTCGGCGAATCT	134
	fusca	00033.1	CGATGAGAAACTGTCCCCGATCTACGAGGAAATCCTGC
			GGCGTAACCCGGGGGAGGTCGAGTTCCACCAGGCTGTT
			CGCGAAGTCCTGGAGTGCCTCGGCCCCGTGGTGGCCAA
			GAACCCTGACATCAGCCACGCCAAGATCATCGAGCGGC
			TCTGTGAGCCGGAGCGCCAGCTGATCTTCCGGGTGCCC
			TGGATGGACGACTCCGGTGAGATCCACGTCAACCGGGG
			TTTCCGGGTGGAGTTCAGCAGCTCTTTGGGACCTTACA
			AGGGCGGGCTGCGGTTCCACCCGTCGGTGAACCTGAGC
			ATCATCAAGTTCCTCGGGTTCGAGCAGATCTTCAAGAA
			CTCGCTGACCGGATTGCCGATCGGCGGTGCGAAAGGCG
			GCAGCGACTTCGACCCGAAGGGCCGTTCCGACGCCGAG
			ATCATGCGGTTCTGCCAGTCGTTCATGACGGAGCTGTA
			CCGGCACCTGGGTGAGCACACGGACGTGCCTGCCGGTG
			ACATCGGCGTGGGCCAGCGTGAGATCGGCTACCTGTTC
			GGCCAGTACAAGCGGATCACCAACCGCTACGAGTCGGG
			CGTGTTCACCGGTAAGGGCCTCAGTTGGGGCGGTTCCC
			AGGTGCGTCGTGAGGCCACCGGGTACGGCTGTGTGCTC
			TTCACTGCGGAGATGCTGCGAGCCCGCGGCGACTCGCT
			GGAAGGCAAGCGGGTCTCGGTGTCGGGTTCGGGCAATG
			TGGCGATCTACGCGATCGAGAAGGCCCAGCAGCTCGGC
			GCGCATGTGGTGACCTGCTCGGACTCCAACGGCTACGT
			GGTGGACGAGAAGGGGATCGACCTGGAGCTGCTCAAGC
			AGGTCAAGGAGGTCGAACGCGGCCGGGTGTCCGACTAC
			GCCAAGCGGCGCGGCTCCCACGTCCGCTACATCGACTC
			GTCGTCGTCCAGCGTGTGGGAGGTGCCCTGCGACATCG
			CGCTGCCGTGCGCGACGCAGAACGAGCTGACCGGCCGC
			GACGCTATCACCCTGGTGCGCAACGGGGTGGGCGCGGT
			GGCGGAGGGCGCGAACATGCCCACGACCCCGGAGGGGA
			TCCGGGTGTTCGCGGAGGCGGGCGTAGCGTTCGCGCCG
			GGCAAGGCCGCGAACGCGGGCGGGGTGGCGACGAGCGC
			GTTGGAGATGCAGCAGAACGCGTCCCGCGACTCGTGGT
			CGTTCGAGTACACCGAGAAGCGGCTCGCGGAAATCATG
			CGCCACATCCACGACACCTGCTATGAGACGGCGGAACG
			CTATGGGCGGCCCGGCGACTATGTGGCAGGTGCCAACA
			TCGCTGCTTTCGAGATCGTCGCTGAGGCGATGCTCGCT
			CAGGGCCTGATCTGA
gdh	Lactobacillus	AL935255.1	TTGAGTCAAGCAACCGATTATGTCCAACATGTTTACCA	135
	plantarum		AGTCATTGAACACCGTGATCCGAACCAAACCGAATTTT
			TAGAGGCCATCAACGACGTCTTCAAAACGATCACGCCA
			GTCCTCGAACAACATCCAGAATATATCGAAGCCAATAT
			TTTGGAACGTTTGACCGAACCAGAACGGATTATTCAAT
			TCCGGGTTCCTTGGCTCGACGATGCTGGTCATGCACGA
			GTCAACCGTGGGTTCCGAGTACAATTTAACTCAGCAAT
			CGGTCCTTACAAGGGCGGCTTACGGTTACACCCATCCG
			TTAATCTGAGTATCGTCAAATTCTTGGGCTTTGAACAG
			ATCTTCAAAAATGCCCTGACCGGCCTACCAATTGGCGG
			TGGTAAAGGGGGCTCTGATTTCGACCCTAAGGGCAAAT
			CAGACAACGAAATTATGCGCTTCTGTCAGAGTTTCATG
			ACCGAACTGAGCAAGTACATTGGTCTCGATACTGACGT
			TCCTGCTGGTGATATCGGTGTTGGTGGCCGCGAAATCG
			GCTTTTTATACGGCCAATACAAGCGACTCCGGGGCGCT
			GACCGCGGCGTACTCACCGGTAAAGGATTGAACTATGG
			CGGTTCGTTAGCCCGGACTGAAGCTACCGGTTATGGTC
			TCGCCTACTATACCAACGAAATGCTCAAGGCCAACCAA
			CTTTCCTTCCCTGGTCAACGCGTTGCCATTTCTGGTGC
			TGGTAATGTCGCCATCTACGCGATTCAAAAGGTTGAAG
			AACTCGGTGGCAAGGTGATTACTTGCTCCGACTCAAAC
			GGTTACGTTATTGACGAAAACGGTATCGACTTCAAGAT
			CGTTAAGCAGATCAAGGAAGTTGAACGCGGTCGTATCA
			AAGACTATGCCGACCGTGTAGCCAGTGCCAGCTATTAC
			GAAGGTTCCGTCTGGGACGCCCAAGTAGCTTATGATAT
			CGCGTTACCTTGCGCCACCCAAAACGAAATCAGCGGTG
			ATCAAGCCAAGAACTTGATTGCCAATGGTGCCAAGGTC
			GTTGCCGAAGGGGCTAACATGCCTAGCAGTCCAGAAGC
			CATTGCGACATACCAAGCTGCCAGCTTGCTATATGGTC
			CGGCCAAAGCTGCCAATGCTGGTGGCGTTGCCGTTTCC
			GCCCTTGAAATGAGCCAAAATAGTATGCGTTTGAGCTG
			GACTTTTGAAGAAGTCGATAATCGCCTCAAGCAAATCA
			TGCAAGATATCTTTGCACACTCCGTTGCCGCTGCCGAC
			GAATACCACGTTAGCGGTGATTACCTGAGTGGTGCTAA
			CATTGCTGGCTTCACAAAAGTTGCTGACGCCATGTTAG
			CGCAAGGCTTAGTTTAA
gdh	Corynebacterium	X59404	ATGACAGTTGATGAGCAGGTCTCTAACTATTACGACAT	257
	glutamicum		GCTTCTGAAGCGCAATGCTGGCGAGCCTGAATTTCACC
			AGGCAGTGGCAGAGGTTTTGGAATCTTTGAAGCTCGTC
			CTGGAAAAGGACCCTCATTACGCTGATTACGGTCTCAT
			CCAGCGCCTGTGCGAGCCTGAGCGTCAGCTCATCTTCC
			GTGTGCCTTGGGTTGATGACCAGGGCCAGGTCCACGTC
			AACCGTGGTTTCCGCGTGCAGTTCAACTCTGCACTTGG
			ACCATACAAGGGCGGCCTGCGCTTCCACCCATCTGTAA
			ACCTGGGCATTGTGAAGTTCCTGGGCTTTGAGCAGATC
			TTTAAAAACTCCCTAACCGGCCTGCCAATCGGTGGTGG
			CAAGGGTGGATCCGACTTCGACCCTAAGGGCAAGTCCG
			ATCTGGAAATCATGCGTTTCTGCCAGTCCTTCATGACC
			GAGCTACACCGCCACATCGGTGAGTACCGCGACGTTCC
			TGCAGGTGACATCGGAGTTGGTGGCCGCGAGATCGGTT
			ACCTGTTTGGCCACTACCGTCGCATGGCTAACCAGCAC
			GAGTCCGGCGTTTTGACCGGTAAGGGCCTGACCTGGGG
			TGGATCCCTGGTCCGCACCGAGGCAACTGGCTACGGCT
			GCGTTTACTTCGTGAGTGAAATGATCAAGGCTAAGGGC
			GAGAGCATCAGCGGCCAGAAGATCATCGTTTCCGGTTC
			CGGCAACGTAGCAACCTACGCGATTGAAAAGGCTCAGG
			AACTCGGCGCAACCGTTATTGGTTTCTCCGATTCCAGC
			GGTTGGGTTCATACCCCTAACGGCGTTGACGTGGCTAA
			GCTCCGCGAAATCAAGGAAGTTCGTCGCGCACGCGTAT
			CCGTGTACGCCGACGAAGTTGAAGGCGCAACCTACCAC
			ACCGACGGTTCCATCTGGGATCTCAAGTGCGATATCGC
			TCTTCCTTGTGCAACTCAGAACGAGCTCAACGGCGAGA
			ACGCTAAGACTCTTGCAGACAACGGCTGCCGTTTCGTT
			GCTGAAGGCGCGAACATGCCTTCCACCCCTGAGGCTGT
			TGAGGTCTTCCGTGAGCGCGACATCCGCTTCGGACCAG
			GCAAGGCCACCCCTGAGGCTGTTGAGGTCTTCCGTGAG
			CGCGACATCCGCTTCGGACCAGGCAAGGCAGTCAACGT
			CGGTGGCGTTGCAACCTCCGCTCTGGAGATGCAGCAGA
			ACGCTTCGCGCGAGACCTGTGCAGAGACCGCAGCAGAG
			TATGGACACGAGAACGATTACGTTGTCGGCGCTAACAT
			TGCTGGCTTCAAGAAGGTAGCTGACGCGATGCTGGCAC
			AGGGCGTCATCTAA
gdh	Escherichia coli	D90819	ATGGATCAGACATATTCTCTGGAGTCATTCCTCAACCA	258
			TGTCCAAAAGCGCGACCCGAATCAAACCGAGTTCGCGC
			AAGCCGTTCGTGAAGTAATGACCACACTCTGGCCTTTT
			CTTGAACAAAATCCAAAATATCGCCAGATGTCATTACT
			GGAGCGTCTGGTTGAACCGGAGCGCGTGATCCAGTTTC
			GCGTGGTATGGGTTGATGATCGCAACCAGATACAGGTC
			AACCGTGCATGGCGTGTGCAGTTCAGCTCTGCCATCGG
			CCCGTACAAAGGCGGTATGCGCTTCCATCCGTCAGTTA
			ACCTTTCCATTCTCAAATTCCTCGGCTTTGAACAAACC
			TTCAAAAATGCCCTGACTACTCTGCCGATGGGCGGTGG
			TAAAGGCGGCAGCGATTTCGATCCGAAAGGAAAAAGCG
			AAGGTGAAGTGATGCGTTTTTGCCAGGCGCTGATGACT
			GAACTGTATCGCCACCTGGGCGCGGATACCGACGTTCC
			GGCAGGTGATATCGGGGTTGGTGGTCGTGAAGTCGGCT
			TTATGGCGGGGATGATGAAAAAGCTCTCCAACAATACC
			GCCTGCGTCTTCACCGGTAAGGGCCTTTCATTTGGCGG
			CAGTCTTATTCGCCCGGAAGCTACCGGCTACGGTCTGG
			TTTATTTCACAGAAGCAATGCTAAAACGCCACGGTATG
			GGTTTTGAAGGGATGCGCGTTTCCGTTTCTGGCTCCGG
			CAACGTCGCCCAGTACGCTATCGAAAAAGCGATGGAAT
			TTGGTGCTCGTGTGATCACTGCGTCAGACTCCAGCGGC
			ACTGTAGTTGATGAAAGCGGATTCACGAAAGAGAAACT
			GGCACGTCTTATCGAAATCAAAGCCAGCCGCGATGGTC
			GAGTGGCAGATTACGCCAAAGAATTTGGTCTGGTCTAT
			CTCGAAGGCCAACAGCCGTGGTCTCTACCGGTTGATAT
			CGCCCTGCCTTGCGCCACCCAGAATGAACTGGATGTTG
			ACGCCGCGCATCAGCTTATCGCTAATGGCGTTAAAGCC
			GTCGCCGAAGGGGCAAATATGCCGACCACCATCGAAGC
			GACTGAACTGTTCCAGCAGGCAGGCGTACTATTTGCAC
			CGGGTAAAGCGGCTAATGCTGGTGGCGTCGCTACATCG
			GGCCTGGAAATGGCACAAAACGCTGCGCGCCTGGGCTG
			GAAAGCCGAGAAAGTTGACGCACGTTTGCATCACATCA
			TGCTGGATATCCACCATGCCTGTGTTGAGCATGGTGGT
			GAAGGTGAGCAAACCAACTACGTGCAGGGCGCGAACAT
			TGCCGGTTTTGTGAAGGTTGCCGATGCGATGCTGGCGC
			AGGGTGTGATT
ddh	Bacillus	AB030649	ATGAGTGCAATTCGAGTAGGTATTGTCGGTTATGGAAA	136
	sphaericus		TTTAGGGCGCGGTGTTGAATTCGCTATTTCACAAAATC
			CAGATATGGAATTAGTAGCGGTATTCACTCGTCGCGAT
			CCTTCAACAGTGAGCGTTGCAAGTAACGCGAGCGTATA
			TTTAGTAGATGATGCTGAAAAATTTCAAGATGACATTG
			ATGTAATGATTTTATGTGGTGGCTCTGCAACAGATTTA
			CCTGAGCAAGGTCCACACTTTGCGCAATGGTTTAATAC
			AATTGATAGTTTTGATACTCATGCGAAAATTCCAGAGT
			TTTTCGATGCGGTTGACGCTGCTGCTCAAAAATCTGGT
			AAAGTATCTGTTATCTCTGTAGGTTGGGATCCAGGTCT
			ATTTTCTTTAAATCGTGTTTTAGGCGAGGCAGTATTAC
			CTGTAGGTACAACGTATACATTCTGGGGTGATGGCTTA
			AGTCAAGGTCACTCGGATGCAGTTCGTCGTATTGAAGG
			GGTTAAAAATGCTGTACAGTATACATTACCTATCAAAG
			ATGCTGTTGAACGTGTTCGTAATGGTGAGAATCCAGAG
			CTTACTACACGTGAAAAGCATGCACGTGAATGCTGGGT
			AGTGCTTGAAGAAGGTGCAGATGCGCCAAAAGTAGAGC
			AAGAAATTGTAACAATGCCGAACTATTTCGATGAGTAT
			AACACAACTGTAAACTTTATCTCTGAAGATGAGTTTAA
			TGCCAACCATACAGGCATGCCACATGGTGGCTTCGTTA
			TTCGTAGTGGTGAAAGCGGCGCTAATGATAAACAAATT
			TTAGAATTCTCGTTAAAACTTGAAAGTAATCCAAACTT
			CACGTCAAGTGTCCTTGTGGCTTATGCACGTGCAGCAC
			ACCGCTTAAGTCAAGCGGGTGAAAAAGGTGCAAAAACA
			GTATTCGATATTCCGTTCGGTCTGTTATCTCCAAAATC
			AGCTGCACAATTACGTAAGGAACTATTATAA
dtsR1	Thermobifida	NZ_AAAQ010	ATGGCGACCCAAGCCCCTGAACCGCTGCCCGCGGACCA	137
	fusca	00037.1	GATCGACATTCGCACCACCGCGGGCAAACTCGCAGACC
			TGCAGCGACGCCGCTACGAGGCGGTCCACGCAGGCTCC
			GAACGAGCCGTAGCAAAACAGCACGCCAAGGGCAAGAT
			GACCGCCCGCGAGCGCATCGACGCCCTGCTCGACCCGG
			GCTCCTTCGTGGAGTTCGACGCCTTCGCGCGTCACCGG
			TCCACCAACTTCGGCTTGGAGAAGAACCGCCCCTACGG
			CGACGGCGTCGTCACCGGCTACGGCACCATCGACGGCC
			GACCGGTCGCCGTGTTCAGCCAGGACGTCACCGTCTTC
			GGCGGTTCCCTCGGCGAGGTCTACGGCGAGAAGATCGT
			CAAAGTCCTCGACCATGCGCTCAAAACCGGCTGCCCGG
			TCATCGGCATCAACGAAGGCGGCGGCGCGCGCATCCAA
			GAGGGCGTGGTGGCGCTGGGCCTCTACGCCGAGATTTT
			CAAACGCAACACCCACGCCTCCGGGGTCATCCCCCAGA
			TCTCGCTCGTCATGGGGGCAGCAGCAGGCGGCCACGTC
			TACTCGCCCGCCCTCACCGACTTCATCGTCATGGTCGA
			CCAGACCTCCCAGATGTTCATCACCGGGCCCGACGTCA
			TCAAGACGGTCACCGGTGAAGACGTCACCATGGAGGAG
			CTGGGCGGCGCACGCACCCACAACACCAAGTCGGGCGT
			GGCCCACTACATGGCCTCCGACGAGCACGACGCCCTGG
			AGTACGTCAAGGCGCTGCTGTCCTACCTGCCCTCCAAC
			AACCTGGACGAGCCGCCCGTCGAACCCGTCCAGGTGAC
			CCTGGAGGTGACCGAGGAAGACCGGGAGCTGGACACCT
			TCATCCCCGACTCGGCCAACCAGCCCTACGACATGCGC
			CGCGTCATCGAACACATCGTGGACGACGGGGAGTTCCT
			GGAAGTCCACGAACTGTTCGCGCAGAACATCATCGTGG
			GCTTCGGCCGGGTCGAAGGCCACCCGGTAGGTGTCGTC
			GCCAACCAGCCGATGAACCTCGCGGGCTGCCTGGACAT
			CGACGCCTCCGAGAAAGCCGCCCGGTTCGTCCGCACCT
			GCGACGCCTTCAACATCCCCGTGCTGACCCTGGTCGAC
			GTCCCCGGCTTCCTGCCCGGAACCGACCAGGAGTTCGG
			CGGCATCATCCGGCGCGGCGCCAAACTGCTCTACGCCT
			ACGCTGAGGCGACCGTCCCCCTGGTGACCATCATCACC
			CGCAAAGCGTTCGGCGGCGCCTACGACGTCATGGGCTC
			CAAGCACCTGGGTGCAGACATCAACCTGGCGTGGCCGA
			CCGCGCAGATCGCGGTCATGGGAGCCCAGGGTGCCGTC
			AACATCCTGCACCGGCGTACCCTCGCCGCCGCCGACGA
			CGTCGAAGCGACCCGCGCCCAGCTCATCGCCGAATACG
			AAGACACTCTGCTCAACCCGTACAGCGCGGCCGAACGG
			GGCTACGTCGACAGCGTCATCATGCCGTCGGAAACCCG
			CACGTCCGTCATCAAAGCCCTGCGTGCGCTGCGCGGCA
			AACGCAAGCAGCTCCCGCCCAAGAAGCACGGGAATATC
			CCACTCTGA
dtsR1	Streptomyces	AF113605.1	ATGTCCGAGCCGGAAGAGCAGCAGCCCGACATCCACAC	138
	coelicolor		GACCGCGGGCAAGCTCGCGGATCTCAGGCGCCGTATCG
			AGGAAGCGACGCACGCCGGTTCCGCACGCGCCGTCGAG
			AAGCAGCACGCCAAGGGCAAGCTGACGGCTCGTGAACG
			CATCGACCTCCTCCTCGACGAGGGTTCCTTCGTCGAGC
			TGGACGAGTTCGCCCGGCACCGCTCCACCAACTTCGGC
			CTCGACGCCAACCGCCCCTACGGCGACGGCGTCGTCAC
			CGGCTACGGCACCGTCGACGGCCGCCCCGTGGCCGTCT
			TCTCCCAGGACTTCACCGTCTTCGGCGGCGCGCTGGGC
			GAGGTCTACGGCCAGAAGATCGTCAAGGTGATGGACTT
			CGCCCTCAAGACCGGCTGCCCGGTCGTCGGCATCAACG
			ACTCCGGCGGCGCCCGCATCCAGGAGGGCGTGGCCTCC
			CTCGGCGCCTACGGCGAGATCTTCCGCCGCAACACCCA
			CGCCTCCGGCGTGATCCCGCAGATCAGCCTGGTCGTCG
			GCCCGTGTGCGGGCGGCGCGGTGTACTCCCCCGCGATC
			ACCGACTTCACGGTGATGGTGGACCAGACCAGCCACAT
			GTTCATCACCGGTCCCGACGTCATCAAGACGGTCACCG
			GCGAGGACGTCGGCTTCGAGGAGCTGGGCGGCGCCCGC
			ACCCACAACTCCACCTCGGGCGTGGCCCACCACATGGC
			CGGCGACGAGAAGGACGCGGTCGAGTACGTCAAGCAGC
			TCCTGTCGTACCTGCCGTCCAACAACCTCTCCGAGCCC
			CCCGCCTTCCCGGAGGAGGCGGACCTCGCGGTCACGGA
			CGAGGACGCCGAGCTGGACACGATCGTCCCGGACTCGG
			CGAACCAGCCCTACGACATGCACTCCGTCATCGAGCAC
			GTCCTGGACGACGCCGAGTTCTTCGAGACGCAACCCCT
			CTTCGCGCCGAACATCCTCACCGGCTTCGGCCGCGTGG
			AGGGCCGCCCGGTCGGCATCGTCGCCAACCAGCCCATG
			CAGTTCGCCGGCTGCCTGGACATCACGGCCTCCGAGAA
			GGCGGCCCGCTTCGTGCGCACCTGCGACGCCTTCAACG
			TCCCCGTCCTCACCTTCGTGGACGTCCCCGGCTTCCTG
			CCCGGCGTCGACCAGGAGCACGACGGCATCATCCGCCG
			CGGCGCCAAGCTGATCTTCGCCTACGCCGAGGCCACGG
			TGCCGCTCATCACGGTCATCACCCGCAAGGCCTTCGGC
			GGCGCCTACGACGTCATGGGCTCCAAGCACCTGGGCGC
			CGACCTCAACCTGGCCTGGCCCACCGCCCAGATCGCCG
			TCATGGGCGCCCAAGGCGCGGTCAACATCCTGCACCGC
			CGCACCATCGCCGACGCCGGTGACGACGCCGAGGCCAC
			CCGGGCCCGCCTGATCCAGGAGTACGAGGACGCCCTCC
			TCAACCCCTACACGGCGGCCGAACGCGGCTACGTCGAC
			GCCGTGATCATGCCCTCCGACACTCGCCGCCACATCGT
			CCGCGGCCTGCGCCAGCTGCGCACCAAGCGCGAGTCCC
			TGCCCCCGAAGAAGCACGGCAACATCCCCCTGTAA
dtsR1	Mycobacterium	Z92771.1	ATGACAAGCGTTACCGACCGCTCGGCTCATTCCGCAGA	139
	tuberculosis		GCGGTCCACCGAGCACACCATCGACATCCACACCACCG
	(use this to		CGGGCAAGCTGGCGGAGCTGCACAAACGCAGGGAAGAG
	clone M.		TCGCTGCACCCCGTCGGTGAGGATGCCGTCGAAAAAGT
	smegmatis		ACACGCCAAGGGCAAGCTGACGGCTCGCGAGCGTATCT
	gene)		ACGCGTTGCTGGATGAGGATTCGTTCGTCGAGCTGGAC
			GCGCTGGCCAAACACCGCAGCACCAACTTCAATCTCGG
			TGAAAAACGCCCGCTCGGCGACGGCGTGGTCACCGGCT
			ACGGCACCATCGACGGGCGCGACGTGTGCATCTTCAGC
			CAGGACGCCACGGTGTTTGGCGGCAGCCTTGGCGAGGT
			GTACGGCGAGAAAATCGTCAAGGTCCAGGAACTGGCGA
			TCAAGACCGGCCGTCCGCTCATCGGCATCAACGACGGT
			GCTGGCGCGCGCATCCAGGAAGGTGTCGTCTCGCTGGG
			CCTGTACAGCCGTATCTTTCGCAACAACATCCTGGCCT
			CCGGCGTCATCCCGCAAATCTCGTTGATCATGGGAGCC
			GCCGCCGGTGGGCACGTCTACTCCCCCGCCCTGACCGA
			CTTCGTGATCATGGTCGATCAGACCAGCCAGATGTTCA
			TCACCGGGCCCGACGTCATCAAGACCGTCACCGGCGAG
			GAAGTCACCATGGAAGAACTCGGCGGCGCCCACACCCA
			CATGGCCAAGTCGGGTACGGCACACTACGCCGCATCGG
			GCGAACAGGACGCCTTCGACTACGTTCGCGAGCTGCTG
			AGCTACCTGCCGCCCAACAACTCCACCGACGCGCCCCG
			ATACCAAGCCGCAGCCCCGACAGGGCCCATCGAGGAGA
			ACCTCACCGACGAGGACCTCGAATTGGATACGCTGATC
			CCGGACTCGCCCAACCAGCCCTATGACATGCACGAGGT
			GATCACCCGGCTCCTCGACGACGAATTCCTGGAGATAC
			AGGCCGGTTACGCCCAAAACATCGTGGTGGGGTTCGGG
			CGCATCGACGGCCGGCCAGTCGGCATTGTCGCCAACCA
			GCCGACACACTTCGCCGGCTGCCTGGATATCAACGCCT
			CGGAGAAAGCGGCCCGGTTTGTGCGGACCTGCGACTGC
			TTCAATATCCCCATCGTCATGCTGGTGGACGTCCCGGG
			CTTCCTGCCGGGCACCGACCAGGAATACAACGGCATCA
			TCCGGCGCGGCGCCAAGCTGCTCTACGCCTACGGCGAG
			GCCACCGTGCCAAAGATCACGGTCATCACCCGCAAGGC
			CTACGGCGGTGCGTACTGCGTTATGGGCTCCAAAGACA
			TGGGCTGCGACGTCAACCTGGCGTGGCCGACCGCGCAG
			ATCGCGGTGATGGGCGCCTCCGGCGCAGTGGGCTTCGT
			GTACCGCCAGCAGCTGGCCGAGGCCGCCGCCAACGGCG
			AGGACATCGACAAGCTGCGGCTGCGGCTCCAGCAGGAG
			TACGAGGACACACTGGTCAACCCGTACGTGGCCGCCGA
			ACGCGGATACGTCGACGCGGTGATCCCGCCGTCGCATA
			CTCGCGGCTACATCGGGACCGCGCTGCGGCTGCTGGAA
			CGCAAGATCGCGCAGCTGCCGCCCAAAAAGCATGGGAA
			CGTGCCCCTGTGA
dtsR1	Mycobacterium	U00012.1	ATGACAAGCGTTACCGACCACTCGGCTCATTCAATGGA	140
	leprae (use this		ACGCGCTGCCGAGCACACGATCAATATCCACACCACGG
	to clone M.		CAGGCAAGCTGGCCGAGCTGCATAAGCGGACCGAAGAA
	smegmatis		GCGCTGCATCCGGTCGGTGCAGCTGCCTTCGAGAAGGT
	gene)		ACACGCTAAGGGTAAGTTTACCGCCCGCGAGCGCATCT
			ACGCCCTATTGGACGACGACTCATTCGTCGAACTCGAC
			GCACTGGCCAGACACCGCAGCACCAACTTCGGCCTCGG
			TGAAAACCGCCCGGTAGGCGATGGCGTGGTCACCGGCT
			ACGGCACCATCGACGGCCGCGACGTATGCATCTTCAGC
			CAGGACGTCACGGTGTTCGGCGGCAGCCTGGGCGAAGT
			GTATGGCGAGAAGATCGTCAAGGTCCAGGAACTGGCGA
			TCAAGACCGGCCGTCCGCTTATCGGCATCAACGACGGC
			GCGGGCGCGCGTATCCAAGAAGGCGTCGTCTCGCTCGG
			CCTGTACAGCCGGATTTTCCGCAACAATATCTTGGCCT
			CCGGCGTCATCCCGCAGATCTCGCTGATCATGGGAGCG
			GCCGCCGGTGGACACGTGTATTCCCCAGCACTGACCGA
			CTTCGTGGTTATGGTCGACCAAACCAGCCAGATGTTCA
			TCACCGGACCCGACGTCATCAAGACCGTCACCGGCGAG
			GACGTCACCATGGAGGAGCTGGGTGGCGCCCATACCCA
			CATGGCCAAGTCGGGTACCGCACACTATGTAGCATCGG
			GCGAGCAAGACGCCTTCGATTGGGTGCGCGATGTGTTG
			AGCTACCTGCCGTCAAACAACTTCACCGACGCGCCGCG
			GTATTCTAAGCCCGTTCCTCACGGCTCCATTGAAGACA
			ACCTGACCGCTAAAGACTTGGAGTTGGACACGCTTATC
			CCGGACTCGCCGAACCAACCGTACGACATGCACGAAGT
			GGTGACCCGCCTCCTCGACGAGGAAGAGTTCCTTGAGG
			TGCAAGCCGGTTACGCCACCAACATCGTCGTCGGGCTC
			GGACGCATAGATGACCGACCGGTGGGCATCGTTGCCAA
			CCAACCCATCCAGTTCGCCGGCTGTCTAGACATCAACG
			CCTCGGAAAAGGCAGCCCGATTTGTGCGGGTCTGCGAC
			TGCTTCAACATCCCGATCGTGATGTTGGTGGATGTTCC
			AGGCTTCCTGCCTGGCACCGAGCAAGAATATGATGGCA
			TCATCCGACGCGGCGCAAAGCTGCTCTTCGCCTACGGC
			GAAGCCACCGTACCCAAGATCACCGTCATCACCCGCAA
			GGCCTACGGTGGCGCTTACTGCGTGATGGGCTCCAAAA
			ATATGGGCTGCGACGTCAACCTGGCTTGGCCGACCGCA
			CAGATTGCGGTGATGGGTGCCTCCGGCGCAGTAGGCTT
			CGTGTACCGCAAGGAACTGGCCCAAGCGGCCAAGAACG
			GCGCCAATGTTGATGAGCTACGCCTGCAGCTGCAGCAA
			GAGTACGAGGACACCCTGGTGAACCCGTACATCGCCGC
			CGAACGAGGTTACGTCGATGCGGTGATCCCGCCGTCAC
			ACACTCGCGGCTACATTGCCACGGCGCTTCACCTGTTG
			GAGCGCAAGATCGCACACCTTCCCCCCAAGAAGCACGG
			GAACATTCCGCTGTGA
dtsR1	Corynebacterium	NC_003450	ATGACCATTTCCTCACCTTTGATTGACGTCGCCAACCT	259
	glutamicum		TCCAGACATCAACACCACTGCCGGCAAGATCGCCGACC
			TTAAGGCTCGCCGCGCGGAAGCCCATTTCCCCATGGGT
			GAAAAGGCAGTAGAGAAGGTCCACGCTGCTGGACGCCT
			CACTGCCCGTGAGCGCTTGGATTACTTACTCGATGAGG
			GCTCCTTCATCGAGACCGATCAGCTGGCTCGCCACCGC
			ACCACCGCTTTCGGCCTGGGCGCTAAGCGTCCTGCAAC
			CGACGGCATCGTGACCGGCTGGGGCACCATTGATGGAC
			GCGAAGTCTGCATCTTCTCGCAGGACGGCACCGTATTC
			GGTGGCGCGCTTGGTGAGGTGTACGGCGAAAAGATGAT
			CAAGATCATGGAGCTGGCAATCGACACCGGCCGCCCAT
			TGATCGGTCTTTACGAAGGCGCTGGCGCTCGTATTCAG
			GACGGCGCTGTCTCCCTGGACTTCATTTCCCAGACCTT
			CTACCAAAACATTCAGGCTTCTGGCGTTATCCCACAGA
			TCTCCGTCATCATGGGCGCATGTGCAGGTGGCAACGCT
			TACGGCCCAGCTCTGACCGACTTCGTGGTCATGGTGGA
			CAAGACCTCCAAGATGTTCGTTACCGGCCCAGACGTGA
			TCAAGACCGTCACCGGCGAGGAAATCACCCAGGAAGAG
			CTTGGCGGAGCAACCACCCACATGGTGACCGCTGGTAA
			CTCCCACTACACCGCTGCGACCGATGAGGAAGCACTGG
			ATTGGGTACAGGACCTGGTGTCCTTCCTCCCATCCAAC
			AATCGCTCCTACGCACCGATGGAAGACTTCGACGAGGA
			AGAAGGCGGCGTTGAAGAAAACATCACCGCTGACGATC
			TGAAGCTCGACGAGATCATCCCAGATTCCGCGACCGTT
			CCTTACGACGTCCGCGATGTCATCGAATGCCTCACCGA
			CGATGGCGAATACCTGGAAATCCAGGCAGACCGCGCAG
			AAAACGTTGTTATTGCATTCGGCCGCATCGAAGGCCAG
			TCCGTTGGCTTTGTTGCCAACCAGCCAACCCAGTTCGC
			TGGCTGCCTGGACATCGACTCCTCTGAGAAGGCAGCTC
			GCTTCGTCCGCACCTGCGACGCGTTCAACATCCCAATC
			GTCATGCTTGTCGACGTCCCCGGCTTCCTCCCAGGCGC
			AGGCCAGGAGTACGGTGGCATTCTGCGTCGTGGCGCAA
			AGCTGCTCTACGCATACGGCGAAGCAACCGTTCCAAAG
			ATCACCGTCACCATGCGTAAGGCTTACGGCGGAGCGTA
			CTGCGTGATGGGTTCCAAGGGCTTGGGCTCTGACATCA
			ACCTTGCATGGCCAACCGCACAGATCGCCGTCATGGGC
			GCTGCTGGCGCAGTTGGATTCATCTACCGCAAGGAGCT
			CATGGCAGCTGATGCCAAGGGCCTCGATACCGTAGCTC
			TGGCTAAGTCCTTCGAGCGCGAGTATGAAGACCACATG
			CTCAACCCGTACCACGCTGCAGAACGTGGCCTGATCGA
			CGCCGTGATCCTGCCAAGCGAAACCCGCGGACAGATTT
			CCCGCAACCTTCGCCTGCTCAAGCACAAGAACGTCACT
			CGCCCTGCTCGCAAGCACGGCAACATGCCACTG
metH	Thermobifida	NZ_AAAQ010	ATGAGCGCTCGACTCTCCTTCCGTGAAGTCCTCGGTTC	141
	fusca	00042.1	CCGCGTCCTCGTCGCCGACGGGGCGATGGGAACGATGC
			TTCAGACATACGACCTGAGCATGGACGACTTCGAGGGA
			CACGAGGGGTGTAACGAGGTCCTCAACATCACCCGGCC
			CGACGTGGTCCGGGAGATCCACGAGGCCTACCTGCAGG
			CCGGCGTCGACTGTGTCGAAACCAACACGTTCGGCGCG
			AACTTCGGAAACCTCGGCGAATACGGCATCGCGGAACG
			CACCTACGAACTGGCTGAAGCCGGTGCCCGCCTGGCCC
			GCGAAGCCGCCGACGCGTACACCACTGCCGATCACGTC
			CGCTACGTCCTCGGCTCTGTGGGGCCCGGGACGAAGCT
			GCCCACCCTTGGCCACGCCCCGTACGCTGTGCTGCGCG
			ACCACTACGAACAGTGCGCACGCGGGCTCATTGACGGC
			GGTGTCGACGCGATCGTGATCGAAACCTGCCAGGACTT
			GCTGCAGGCGAAAGCCGCGATCGTGGGGGCACGGCGGG
			CCCGCAAGGCCGCGGGTACCGACACGCCGATCATCGTC
			CAGGTGACGATTGAAACCACGGGGACCATGCTGGTGGG
			CTCCGAGATCGGTGCGGCACTGACCTCGCTGGAACCGC
			CAGGGGTCGACATGATCGGCCTCAACTGCGCTACCGGT
			CCAGCAGAGATGAGCGAGCACCTGCGCTACCTCTCCCA
			CCACTCCCGCATCCCCCTCTCCTGCATGCCGAACGCGG
			GCCTGCCTGAGCTGGGGGCGGACGGGGCCGTCTACCCG
			CTGCAGCCGCATGAGCTCACCGAAGCACACGACACGTT
			CATCCGCGAGTTTGGCCTGGCCCTGGTGGGCGGCTGCT
			GCGGCACCACCCCTGAGCACCTCGCCCAAGTGGTGGAG
			CGGGTGCAGGGACGCGGCGTGCCGGACCGCAAACCGCA
			CGTCGAACCCGCCGCCGCCTCTATCTACCAGAGCGTCC
			CGTTCCGCCAGGACACCAGCTACCTGGCGATCGGGGAA
			CGCACCAACGCCAACGGCTCCAAGGCGTTCCGCGAAGC
			CATGCTCGCGGAACGCTACGACGACTGTGTGGAGATCG
			CCCGCCAGCAGATCCGCGACGGCGCGCACATGCTCGAC
			CTGTGCGTCGACTATGTGGGACGCGACGGGGTGCGCGA
			TATGCGGGAGCTGGCTTCCCGGCTGGCCACCGCCTCCA
			CGCTGCCGCTCGTACTGGACTCCACCGAAGTAGCGGTA
			CTGGAAGCTGGACTGGAGATGCTGGGCGGGCGCGCCGT
			GCTCAACTCGGTCAACTACGAGGACGGCGACGGCCCTG
			ACTCCCGGTTCGCCAAGGTCGCCGCGCTGGCGGTGGAG
			CACGGGGCGGCCCTCATGGCGCTGACCATCGACGAGCA
			GGGGCAGGCGCGGACCGCGGAACGGAAAGTGGAGGTCG
			CCGAGCGGCTCATCCGGCAGCTCACCACCGAGTACGGC
			ATCCGCAAGCACGACATCATCGTGGACTGCCTGACCTT
			CACGATCGCAACCGGACAGGAGGAGTCGCGGCGCGACG
			CTCTGGAAACCATCGAGGCGATCCGTGAACTGAAGCGG
			CGCCACCCGGACGTGCAGACCACGCTGGGCGTGTCCAA
			CGTCTCCTTCGGGCTCAACCCGGCTGCCCGCATTGTGC
			TCAACTCGGTGTTCCTCCACGAGTGCGTCCAGGCCGGC
			TTGGACTCCGCGATCGTGCACGCCTCCAAGATCCTGCC
			GATCAACCGCATCCCCGAGGAGCAGCGGCAGGTGGCGT
			TGGACATGATCTACGACCGCCGCACCGATGACTACGAC
			CCGCTGCAACGCTTCCTGCAGCTTTTCGAAGGAGTGGA
			CGCGCAGGCGATGCGCGCCTCGCGCGAGGAAGAGCTGG
			CCGCGCTGCCGCTGTGGGAGCGCCTGGAGCGCCGTATC
			GTCGACGGGGAAGCCGCCGGCATGGAAGCGGACCTGGA
			CGAAGCGCTCACCCAGCGGTCCGCGCTGGACATCATCA
			ACACCACGCTGCTGGCGGGGATGAAGACCGTCGGCGAC
			CTGTTCGGCTCCGGGCAGATGCAGCTCCCGTTCGTGCT
			GAAGTCGGCCGAGGTGATGAAGGCCGCCGTGGCCTATC
			TGGAGCCGCACATGGAGAAGGTGGACGGCGACCTCGGC
			AAGGGGCGGATCGTGCTGGCCACGGTCAAGGGCGACGT
			CCACGACATCGGCAAGAACCTTGTGGACATCATCCTGT
			CCAACAACGGCTACGAGGTCATCAACCTGGGGATCAAG
			CAGCCCATCTCCGCGATTCTGGAGGCGGCCGAGCGGCA
			CCGCGCCGACGTGATCGGCATGTCCGGCCTGCTGGTGA
			AGTCCACGGTGGTGATGCGGGAGAACCTGGAGGAGATG
			AACGCCCGCGGGGTCGCTGACCGCTACCCGGTCCTGCT
			GGGCGGTGCCGCGTTGACCCGCTCCTATGTGGAACAGG
			ACCTCGCCGAGATTTTCAAAGGCGAGGTGCGCTATGCC
			CGCGACGCTTTTGAAGGCTTGAAGCTCATGGACGCCAT
			CATGGCGGTCAAACGCGGGGTGAAGGGGGCTAAGCTGC
			CGCCGCTGCGCACCCGCCGGGTGAAGCGGGGCGCACAG
			CTTACCGTCACCGAGCCGGAGAAGATGCCGACGCGCAG
			CGACGTGGCCACCGACAACCCGGTGCCGACCCCGCCGT
			TCTGGGGGGACCGCATCTGCAAGGGGATTCCGCTCGCC
			GACTACGCGGCTTTCCTGGATGAGCGCGCCACGTTCAT
			GGGCCAGTGGGGGCTGCGCGGCTCCCGCGGCGACGGCC
			CCACCTACGAGGAGCTGGTGGAGACGGAGGGGCGGCCG
			CGGCTGCGCATGTGGCTGGACCGGATCCAGACCGAGGG
			GTGGCTGGAGCCGGCGGTCGTCTACGGCTACTACCGCT
			GCTACAGCGAAGGCAACGACCTGGTCGTCCTCGGTGAG
			GACGAAAACGAGCTGACCCGGTTCACGTTCCCGCGGCA
			GCGCCGCGACCGGCACCTGTGCCTGGCTGACTTCTTCC
			GCCCCAAGGAGTCCGGGGAACTGGACACGGTGGCGTTC
			CAGGTCGTCACCGTCGGTTCGACGATCAGCAAGGCGAC
			CGCGGAGCTGTTCGAGAAGAACGCGTACCGGGACTACT
			TGGAGCTCCACGGGCTGTCCGTGCAGTTGACGGAGGCA
			CTCGCGGAGTACTGGCACACCCGGGTCCGCGCCGAGCT
			GGGCTTCGCCGGGGAGGATCCCGACCCGGCCGATTTGG
			ACGCCTACTTTAAGCTCGGCTATCGAGGCGCCCGTTTC
			TCCCTGGGGTACGGGGCCTGCCCCAACTTGGAGGACCG
			CGCCAAGATCGTGGCCCTGCTGCGTCCGGAACGGGTTG
			GGGTGACGTTGTCCGAGGAGTTCCAGCTTGTTCCCGAA
			CAGTCCACTGACGCGATCGTTGTCCATCACCCCGAGGC
			GAAATACTTCAACGTATGA
metH	Streptomyces	AL939109.1	ATGGCCTCGTCGCCATCCACCCCGCCCGCCGACACCCG	142
	coelicolor		CACCCGCGTGTCCGCCCTCCGAGAGGCCCTCGCCACCC
			GCGTGGTGGTCGCCGACGGCGCCATGGGCACCATGCTC
			CAGGCCCAGAACCCCACGCTGGACGACTTCCAGCAGCT
			CGAAGGGTGCAACGAGGTCCTGAACCTCACCCGGCCCG
			ACATCGTCCGCTCGGTGCACGAGGAGTACTTCGCGGCC
			GGCGTCGACTGCGTCGAGACCAACACCTTCGGCGCCAA
			CCACTCCGCCCTGGGCGAGTACGACATCCCCGAGCGCG
			TCCACGAACTGTCCGAGGCCGGCGCCCGCGTCGCCCGC
			GAGGTCGCCGACGAGTTCGGCGCCCGCGACGGCCGGCA
			GCGCTGGGTGCTGGGCTCCATGGGCCCCGGCACCAAGC
			TCCCCACCCTCGGCCACGCCCCGTACACCGTCCTGCGC
			GACGCCTACCAGCGCAACGCCGAGGGACTGGTCGCGGG
			CGGCGCGGACGCACTGCTGGTGGAGACCACGCAGGACC
			TGCTCCAGACCAAGGCCTCGGTGCTCGGCGCCCGGCGC
			GCCCTGGACGTCCTCGGCCTCGACCTGCCGCTCATCGT
			GTCCGTCACCGTCGAGACCACCGGCACCATGCTGCTCG
			GCTCGGAGATCGGCGCCGCGCTCACCGCGCTGGAACCG
			CTCGGCATCGACATGATCGGCCTGAACTGCGCCACCGG
			CCCCGCCGAGATGAGCGAGCACCTGCGCTACCTCGCCC
			GGCACTCCCGCATCCCGCTGACCTGCATGCCCAACGCC
			GGTCTGCCCGTCCTCGGCAAGGACGGCGCCCACTACCC
			GCTGACCGCGCCCGAGCTGGCCGACGCACACGAGACCT
			TCGTGCGCGAGTACGGCCTGTCCCTGGTCGGCGGCTGC
			TGCGGCACCACGCCCGAGCACCTGCGCCAGGTCGTCGA
			GCGGGTCCGGGACACCGCCCCCACCGCACGCGACCCGC
			GCCCCGAGCCCGGCGCCGCCTCGCTCTACCAGACCGTG
			CCCTTCCGCCAGGACACCTCCTACCTGGCCATCGGCGA
			GCGCACCAACGCCAACGGGTCCAAGAAGTTCCGCGAGG
			CCATGCTGGACGGCCGCTGGGACGACTGCGTCGAGATG
			GCCCGCGACCAGATCCGCGAAGGCGCGCACATGCTCGA
			CCTCTGCGTCGACTACGTCGGCCGGGACGGCGTCGCCG
			ACATGGAGGAACTGGCCGGCCGGTTCGCCACCGCCTCC
			ACGCTGCCGATCGTCCTCGACTCCACCGAGGTCGACGT
			CATCCGGGCCGGCCTGGAGAAGCTCGGCGGCCGCGCGG
			TGATCAACTCGGTCAACTACGAGGACGGCGCCGGCCCC
			GAGTCCCGGTTCGCCCGCGTCACGAAGCTCGCCCGGGA
			GCACGGCGCCGCGCTGATCGCGCTGACCATCGACGAGG
			TGGGACAGGCCCGCACCGCCGAGAAGAAGGTCGAGATC
			GCCGAACGGCTCATCGACGACCTCACCGGCAACTGGGG
			CATCCACGAGTCCGACATCCTCGTCGACTGCCTGACCT
			TCACCATCTGCACCGGCCAGGAGGAGTCCCGCAAGGAC
			GGCCTGGCCACCATCGAGGGCATCCGGGAACTCAAGCG
			GCGCCACCCGGACGTGCAGACCACGCTCGGCCTGTCGA
			ACATCTCCTTCGGCCTCAACCCGGCCGCCCGCATCCTG
			CTCAACTCCGTCTTCCTCGACGAATGCGTCAAGGCCGG
			CCTGGACTCGGCCATCGTGCACGCGAGCAAGATCCTGC
			CGATCGCCCGCTTCGACGAGGAGCAGGTCACCACCGCC
			CTCGACTTGATCTACGACCGCCGCCGCGAGGGCTACGA
			CCCCCTGCAAAAGCTCATGCAGCTCTTCGAGGGCGCCA
			CCGCCAAGTCGCTGAAGGCCTCCAAGGCCGAGGAACTG
			GCCGCCCTCCCGCTGGAGGAGCGCCTCAAGCGCCGCAT
			CATCGACGGCGAGAAGAACGGCCTCGAACAGGACCTCG
			ACGAGGCCCTCCGGGAGCGCCCGGCCCTCGAGATCGTC
			AACGACACCCTGCTCGACGGTATGAAGGTCGTCGGCGA
			GCTGTTCGGCTCCGGCCAGATGCAGCTGCCGTTCGTGC
			TCCAGTCCGCCGAGGTCATGAAGACCGCGGTGGCCCAC
			CTGGAGCCGCACATGGAGAAGACCGACGACGACGGCAA
			GGGCACGATCGTGCTGGCCACCGTCCGCGGCGACGTCC
			ACGACATCGGCAAGAACCTCGTCGACATCATCCTGTCC
			AACAACGGCTACAACGTCGTCAACCTCGGCATCAAGCA
			GCCCGTCTCCGCGATCCTGGAAGCGGCCGACGAGCACC
			GGGCCGACGTCATCGGCATGTCCGGCCTCCTCGTCAAG
			TCCACGGTGATCATGAAGGAGAACCTGGAGGAGCTGAA
			CCAGCGCAAGCTGGCCGCCGACTACCCGGTCATCCTCG
			GCGGCGCCGCCCTCACCAGGGCCTACGTCGAACAGGAC
			CTGCACGAGATCTACGACGGCGAGGTCCGCTACGCCCG
			CGACGCCTTCGAGGGCCTGCGCCTCATGGACGCCCTCA
			TCGGCATCAAGCGCGGCGTGCCCGGCGCCAAGCTGCCG
			GAGCTGAAGCAGCGCCGGGTGCGGGCCGCCACCGTCGA
			GATCGACGAGCGCCCCGAGGAAGGCCACGTCCGCTCCG
			ACGTCGCCACCGACPACCCGGTCCCGACCCCGCCCTTC
			CGCGGCACCCGCGTCGTCAAGGGCATCCAGCTCAAGGA
			GTACGCCTCCTGGCTCGACGAGGGCGCCCTCTTCAAGG
			GCCAGTGGGGCCTCAAGCAGGCCCGCACCGGCGAGGGA
			CCCTCCTACGAGGAACTGGTCGAGTCCGAGGGCCGGCC
			GCGGCTGCGCGGCCTGCTCGACCGGCTCCAGACGGACA
			ACCTTTTGGAGGCGGCCGTGGTCTACGGCTACTTCCCC
			TGCGTCTCCAAGGACGACGACCTGATCGTCCTCGACGA
			CGACGGCAACGAACGCACCCGCTTCACCTTCCCCCGCC
			AGCGCCGCGGCCGGCGCCTGTGCCTGGCCGACTTCTTC
			CGCCCGGAGGAGTCCGGCGAGACCGACGTGGTCGGCTT
			CCAGGTCGTCACCGTCGGCTCCCGCATCGGCGAGGAGA
			CGGCCCGCATGTTCGAGGCCAACGCCTACCGCGACTAT
			CTCGAGCTGCACGGCCTGTCCGTGCAGCTCGCCGAGGC
			CCTCGCCGAGTACTGGCACGCGCGCGTGCGCTCGGAAC
			TCGGCTTCGCCGGGGAGGACCCGGCCGAGATGGAGGAC
			ATGTTCGCCCTGAAGTACCGGGGTGCCCGCTTCTCCCT
			CGGCTACGGCGCCTGCCCCGACCTGGAGGACCGCGCCA
			AGATCGCCGCCCTGCTGGAGCCCGAGCGCATCGGCGTC
			CACCTATCCGAGGAGTTCCAGCTCCACCCCGAGCAGTC
			CACCGACGCCATCGTCATCCACCACCCGGAGGCCAAGT
			ACTTCAACGCCCGCTGA
metH	Mycobacterium	Z97559.1	GTGACTGCGGCCGACAAGCACCTCTACGACACCGATCT	143
	tuberculosis		GCTCGACGTCTTGTCGCAGCGAGTGATGGTCGGCGACG
	(use this to		GTGCAATGGGAACCCAACTACAGGCCGCGGACCTCACG
	clone M.		CTCGACGACTTCCGCGGCCTGGAGGGCTGCAACGAGAT
	smegmatis		CCTCAACGAAACCCGCCCTGACGTGCTGGAAACCATTC
	gene)		ACCGCAACTATTTCGAAGCGGGCGCCGACGCCGTCGAG
			ACGAACACGTTTGGCTGCAACCTGTCCAACCTCGGCGA
			CTACGACATCGCCGACAGGATCCGCGATCTATCACAGA
			AGGGCACCGCGATCGCACGCCGGGTGGCCGACGAGCTG
			GGCAGTCCCGACCGCAAGCGCTACGTGCTGGGGTCGAT
			GGGGCCGGGCACCAAGCTGCCGACTCTGGGCCACACCG
			AATACGCGGTGATCCGCGACGCCTACACCGAGGCCGCG
			CTGGGCATGCTGGACGGCGGAGCCGACGCCATCCTGGT
			GGAAACCTGCCAGGACCTACTGCAGCTGAAGGCGGCGG
			TGTTGGGGTCGCGGCGGGCGATGACGCGGGCCGGGCGG
			CACATTCCGGTGTTTGCCCACGTCACCGTCGAGACCAC
			CGGCACCATGCTGCTGGGCAGCGAGATCGGGGCGGCGT
			TGACCGCTGTCGAGCCGCTCGGTGTGGACATGATCGGC
			TTGAACTGCGCGACGGGTCCGGCCGAGATGAGCGAGCA
			CCTGCGCCACCTGTCCCGGCACGCCCGCATCCCGGTGT
			CGGTGATGCCCAACGCCGGGTTGCCGGTGCTGGGCGCC
			AAGGGCGCCGAATATCCGTTGCTGCCCGACGAATTGGC
			CGAGGCGCTGGCCGGCTTCATCGCCGAGTTCGGGCTCT
			CGCTGGTCGGTGGCTGCTGCGGCACCACCCCGGCCCAT
			ATCCGCGAAGTGGCTGCCGCGGTTGCGAACATCAAGCG
			TCCCGAGCGACAGGTCAGCTACGAGCCGTCGGTGTCGT
			CGCTGTACACCGCAATCCCGTTCGCCCAGGACGCCTCG
			GTTCTGGTGATCGGGGAGCGAACGAACGCCAACGGCTC
			CAAGGGTTTTCGTGAGGCGATGATCGCCGAGGACTACC
			AGAAGTGCCTGGACATCGCCAAGGACCAGACCCGCGAC
			GGCGCCCACCTGCTGGACCTGTGTGTGGACTACGTGGG
			CCGCGACGGTGTGGCCGACATGAAGGCGCTGGCCAGCC
			GGCTGGCCACGTCCTCGACGCTGCCGATCATGCTGGAC
			TCCACCGAAACCGCGGTGCTGCAGGCGGGTTTGGAGCA
			TCTGGGTGGCCGTTGCGCGATCAACTCGGTGAACTACG
			AGGACGGCGACGGCCCGGAATCGCGCTTTGCCAAGACC
			ATGGCGCTGGTCGCCGAGCACGGCGCGGCGGTGGTCGC
			GCTGACCATCGACGAAGAGGGCCAGGCCCGCACCGCGC
			AGAAGAAGGTCGAGATCGCCGAGCGGCTGATCAACGAC
			ATCACCGGCAACTGGGGCGTCGACGAATCATCCATCCT
			CATCGACACCTTGACGTTCACCATCGCCACCGGTCAGG
			AGGAGTCCCGCCGCGACGGCATCGAGACCATCGAGGCG
			ATCCGCGAACTGAAAAAGCGCCACCCGGATGTGCAGAC
			CACACTTGGTCTGTCCAACATCTCGTTTGGTCTCAATC
			CCGCAGCGCGCCAGGTGCTCAACTCGGTGTTCCTGCAC
			GAATGCCAAGAAGCGGGGCTGGATTCGGCGATCGTGCA
			CGCGTCGAAGATCCTGCCGATGAACCGGATTCCCGAGG
			AGCAACGCAACGTCGCCCTGGATCTGGTCTACGACCGC
			CGCCGCGAGGACTACGATCCGCTGCAGGAGCTGATGCG
			GCTGTTCGAAGGCGTGTCGGCGGCCTCCTCGAAAGAGG
			ACCGACTGGCTGAACTAGCTGGGCTGCCGCTGTTCGAA
			CGGCTGGCCCAACGCATCGTCGACGGCGAGCGCAACGG
			CCTGGACGCCGATCTCGACGAGGCGATGACGCAAAAGC
			CGCCGCTTCAGATCATCAACGAACATCTGCTGGCCGGC
			ATGAAGACGGTCGGCGAGCTCTTCGGCTCCGGCCAGAT
			GCAGCTGCCGTTCGTGCTGCAGTCGGCGGAGGTAATGA
			AAGCCGCCGTCGCGTATCTGGAACCGCACATGGAGCGC
			TCGGACGACGATTCGGGCAAGGGACGCATCGTGCTGGC
			CACCGTCAAGGGCGACGTGCACGACATCGGCAAGAACC
			TGGTCGACATCATCTTGAGCAACAACGGCTACGAAGTG
			GTCAACATCGGCATCAAGCAGCCAATCGCCACCATCCT
			CGAAGTCGCCGAGGACAAGAGCGCCGACGTGGTCGGCA
			TGTCGGGCCTGCTGGTGAAGTCGACCGTGGTGATGAAG
			GAAAACCTCGAGGAGATGAACACCCGGGGAGTCGCCGA
			AAAGTTCCCGGTGCTGCTCGGCGGCGCGGCGTTGACGC
			GCAGCTATGTCGAAAACGACCTGGCCGAGATCTACCAG
			GGCGAAGTGCATTACGCGCGAGACGCTTTCGAGGGCCT
			GAAGTTGATGGACACCATCATGAGCGCCAAGCGCGGCG
			AGGCGCCCGACGAAAACAGCCCGGAAGCCATTAAGGCG
			CGTGAGAAAGAAGCCGAACGTAAGGCCCGCCACCAGCG
			ATCCAAACGCATTGCCGCACAGCGCAAAGCCGCCGAAG
			AACCAGTCGAGGTGCCCGAACGCTCCGATGTCGCGGCC
			GACATCGAGGTCCCGGCGCCGCCGTTCTGGGGTTCGCG
			GATCGTCAAGGGCCTGGCGGTGGCCGACTACACCGGTC
			TGCTCGATGAGCGCGCATTGTTTTTGGGCCAGTGGGGT
			TTACGCGGCCAGCGCGGCGGTGAGGGTCCGTCCTACGA
			AGATCTCGTCGAGACCGAGGGCCGGCCGCGGCTGCGGT
			ACTGGTTGGACCGGCTGTCCACCGACGGCATCTTGGCG
			CACGCCGCCGTGGTGTACGGCTATTTCCCGGCGGTGTC
			CGAGGGCAACGACATCGTGGTGCTCACCGAGCCCAAGC
			CCGACGCCCCGGTGCGCTACCGGTTTCACTTCCCGCGC
			CAGCAGCGCGGTCGGTTTTTGTGCATTGCCGATTTCAT
			CCGCTCGCGGGAGCTGGCCGCCGAGCGTGGCGAGGTTG
			ACGTGCTGCCGTTCCAGCTGGTGACCATGGGTCAGCCG
			ATCGCGGATTTCGCCAACGAGCTGTTCGCGTCCAACGC
			CTACCGCGACTACCTGGAGGTGCACGGTATCGGCGTGC
			AGCTCACCGAGGCGCTGGCCGAGTACTGGCACCGGCGG
			ATCCGTGAGGAGCTCAAGTTCTCCGGGGATCGGGCGAT
			GGCGGCCGAGGATCCGGAGGCGAAAGAAGACTATTTCA
			AGCTCGGCTACCGCGGTGCTCGCTTTGCCTTCGGCTAC
			GGCGCATGCCCGGATCTGGAGGACCGCGCCAAGATGAT
			GGCGCTGCTGGAGCCCGAACGCATCGGTGTGACGTTAT
			CCGAGGAATTACAGCTGCATCCCGAACAGTCGACCGAC
			GCGTTCGTCCTGCACCATCCGGAAGCCAAGTACTTCAA
			CGTTTAA
metH	Mycobacterium	AL583921.1	ATGCGTGTAACTGCCGCTAACCAACATCAGTACGACAC	144
	leprae (use this		CGATCTCCTCGAGACTTTGGCGCAGCGTGTGATGGTGG
	to clone M.		GTGACGGCGCAATGGGTACTCAGCTCCAGGACGCGGAA
	smegmatis		CTTACGTTAGATGATTTCCGCGGCCTGGAGGGCTGCAA
	gene)		CGAGATTCTCAACGAAACGCGTCCTGACGTGCTGGAAA
			CCATCCACCGACGCTACTTCGAGGCAGGTGCGGACCTC
			GTCGAGACCAACACTTTCGGCTGCAACCTGTCCAACCT
			TGGTGACTACGACATCGCCGACAAGATCAGGGACTTGT
			CGCAGCGGGGCACCGTGATTGCGCGACGGGTCGCCGAC
			GAGCTGACCACCCCCGACCACAAGCGATACGTGCTGGG
			GTCGATGGGACCAGGCACCAAGTTGCCCACCCTGGGCC
			ACACCGAGTACCGGGTCGTTCGAGACGCCTACACCGAG
			TCGGCGTTAGGCATGCTGGACGGTGGCGCTGACGCCGT
			ACTGGTTGAAACCTGTCAGGACTTGCTGCAGCTCAAGG
			CTGCGGTGCTGGGCTCGCGGCGCGCGATGACACAGGCC
			GGTCGGCACATTCCGGTCTTCGTCCACGTGACTGTCGA
			GACGACCGGAACGATGCTGCTGGGAAGTGAGATCGGCG
			CTGCACTGGCTGCCGTCGAGCCGCTCGGTGTCGACATG
			ATCGGTTTGAACTGCGCAACGGGCCCCGCTGAGATGAG
			TGAGCATCTGCGGCACTTGTCCAAGCATGCCCGCATCC
			CGGTGTCGGTGATGCCCAACGCCGGGCTGCCGGTGCTG
			GGTGCCAAGGGAGCTGAATACCCGCTGCAGCCCGACGA
			ATTGGCCGAAGCTTTGGCTGGGTTCATCGCTGAATTTG
			GTCTTTCGTTGGTAGGTGGCTGCTGTGGTACCACCCCG
			GACCACATCCGGGAAGTGGCCGCAGCGGTAGCCAGATG
			CAACGACGGGACAGTGCCACGCGGTGAGCGTCATGTGA
			CCTATGAGCCGTCGGTATCGTCGCTGTATACAGCCATT
			CCATTCGCCCAAAAACCCTCGGTTCTGATGATCGGTGA
			GCGTACGAATGCCAACGGCTCCAAGGTTTTTCGTGAGG
			CAATGATCGCCGAGGACTATCAAAAGTGTCTAGATATC
			GCCAAGGACCAAACCCGTGGCGGCGCACACCTGCTGGA
			TCTGTGTGTCGATTACGTCGGCCGCAACGGTGTGGCCG
			ACATGAAGGCGTTGGCCGGTCGGCTTGCAACGGTGTCG
			ACATTGCCGATCATGCTGGACTCTACCGAAATACCGGT
			GCTGCAGGCAGGTTTGGAGCACCTGGGCGGGCGCTGCG
			TGATCAATTCCGTCAACTACGAGGACGGTGACGGTCCC
			GAGTCACGGTTTGTCAAGACCATGGAGCTGGTCGCCGA
			GCACGGAGCGGCGGTGGTTGCGCTGACCATCGACGAAC
			AGGGTCAGGCCCGCACCGTTGAGAAGAAGGTCGAAGTC
			GCGGAGCGGCTTATCAATGACATTACGAGTAACTGGGG
			CGTTGATAAATCGGCGATTCTCATCGATTGCTTGACTT
			TTACTATTGCCACTGGCCAGGAGGAGTCACGCAAAGAC
			GGCATTGAGACCATCGACGCGATTCGTGAGCTGAAGAA
			GCGGCACCCAGCGGTGCAGACTACGCTGGGGTTGTCCA
			ACATCTCCTTCGGTCTCAATCCTTCTGCACGCCAAGTT
			CTTAACTCTGTTTTTCTACATGAATGTCAGGAAGCAGG
			ACTGGATTCGGCGATTGTGCACGCTTCAAAGATATTGC
			CCATCAACCGGATACCCGAAGAACAGCGCCAGGCTGCG
			CTGGATCTAGTGTATGACCGCCGTCGCGAAGGCTACGA
			CCCATTGCAGAAGCTGATGTGGTTATTCAAAGGTGTGT
			CGTCGCCATCGTCGAAGGAAACACGGGAGGCAGAACTC
			GCTAAGCTGCCGTTGTTCGACCGGTTAGCACAGCGGAT
			CGTCGACGGCGAGCGCAACGGGTTAGATGTTGATCTCG
			ACGAGGCAATGACCCAGAAACCGCCGTTGGCGATCATC
			AACGAGAACCTGCTGGACGGCATGAAGACAGTCGGTGA
			ATTGTTCGGCTCTGGGCAGATGCAGCTGCCTTTCGTGT
			TGCAGTCGGCCGAGGTTATGAAAGCAGCGGTGGCTTAT
			CTAGAACCGCACATGGAGAAATCCGACTGTGACTTCGG
			TAAGGGGTTAGCCAAAGGACGGATTGTGCTGGCTACCG
			TCAAAGGAGATGTGCACGATATTGGCAAAAACCTCGTC
			GATATCATTCTGAGCAACAACGGCTACGAAGTGGTAAA
			CCTCGGCATCAAGCAGCCGATTACCAACATTCTCGAGG
			TGGCCGAGGACAAAAGCGCCGACGTAGTCGGGATGTCG
			GGCTTGCTGGTGAAATCGACTGTGATCATGAAGGAAAA
			CCTCGAGGAGATGAACACTCGCGGAGTCGCTGAGAAAT
			TCCCAGTGCTGCTCGGCGGCGCGGCGTTGACCCGCAGC
			TATGTGGAAAACGACCTGGCCGAAGTCTATGAGGGCGA
			AGTGCATTACGCACGAGACGCTTTCGAGGGTTTGAAGT
			TGATGGACACCATTATGAGCGCCAAGCGCGGCGAGGCG
			CTTGCGCCGGGGAGCCCGGAGTCCTTAGCTGCAGAAGC
			AGACCGCAATAAGGAAACTGAGCGCAAGGCACGTCATG
			AGCGGTCCAAACGCATTGCAGTGCAGCGTAAGGCTGCC
			GAAGAGCCAGTTGAGGTTCCCGAACGCTCCGATGTTCC
			GAGTGATGTCGAGGTTCCGGCGCCGCCGTTCTGGGGTT
			CGCGGATCATCAAGGGTCTGGCGGTGGCCGACTATACC
			GGGTTCCTCGACGAGCGCGCGTTGTTCTTGGGTCAGTG
			GGGATTACGTGGTGTGCGCGGCGGTGCGGGGCCCTCGT
			ACGAGGATTTGGTGCAGACCGAGGGCCGGCCGCGGTTG
			CGCTACTGGCTAGACCGATTGTCCACCTACGGCGTCTT
			GGCGTACGCCGCCGTGGTGTACGGTTACTTCCCGGCGG
			TGTCCGAAGACAACGATATTGTCGTGCTCGCTGAGCCG
			AGACCGGACGCCGAGCAGCGGTACCGGTTCACCTTCCC
			GCGTCAGCAACGCGGTCGGTTCCTGTGCATTGCCGATT
			TTATTCGATCCCGGGATCTGGCGACCGAGCGGAGTGAG
			GTGGATGTTTTGCCGTTCCAGCTGGTGACCATGGGTCA
			ACCCATTGCTGACTTCGTTGGCGAGTTGTTCGTGTCCA
			ATTCCTATCGTGATTATCTTGAAGTGCATGGCATCGGT
			GTGCAGCTAACCGAGGCGCTGGCCGAATACTGGCACCG
			GCGCATTCGTGAAGAGCTGAAATTCTCCGGAAACCGGA
			CGATGTCGGCTGACGATCCCGAGGCCGTCGAGGACTAT
			TTCAAGCTCGGCTACCGAGGTGCCCGCTTCGCGTTCGG
			GTATGGAGCATGCCCGGACCTGGAGGACCGGATCAAGA
			TGATGGAGCTGCTTCAACCCGAACGCATCGGTGTAACG
			ATATCTGAAGAGTTGCAGTTACATCCCGAGCAATCGAC
			TGATGCGTTCGTGCTGCACCATCCGGCGGCTAAGTACT
			TCAACGTCTGA
metH	Lactobacillus	AL935256	ATGAAGTTTAAACAAGCACTCCAGCAACGGGTCCTCGT	145
	plantarum		TGCCGATGGCGCAATGGGCACCCTTTTATATGGTAACT
			ATGGCATCAATTCGGCTTTTGAAAACCTGAATTTGACG
			CATCCCGACACGATCTTACGCGTTCACCGATCGTACAT
			TCGGGCTGGTGCCGATATTATTCAAACCAACACCTACG
			CTGCGAACCGCCTAAAGTTGACCCGGTATGATTTACAA
			GACCAAGTCACCACCATCAATCAGGCCGCTGTGAAAAT
			TGCAGCGACCGCACGGGAACACGCGGATCACCCCGTTT
			ACATTCTGGGAACGATCGGTGGACTAGCCGGCGATACC
			GATGCAACTGTTCAACGGGCGACACCAGCAACGATTGC
			TGCCAGCGTGACTGAACAACTTACCGCCCTTCTAGCCA
			CCAACCAGTTAGATGGCATCTTGCTCGAAACATATTAT
			GATTTGCCAGAACTACTCGCCGCGTTAAAAATCGTGAA
			GGCCCATACTGACTTGCCCGTCATCACGAATGTTTCAA
			TGTTAGCCCCCGGCGTCTTACGAAACGGTACGAGCTTC
			ACTGATGCCATCGTCCAACTCAACGCTGCCGGCGCCGA
			CGTAATCGGCACGAACTGTCGCCTGGGACCTTACTATT
			TAGCTCAGTCATTTGAAAACTTGGCGATTCCAGCTAAC
			GTTAAACTAGCCGTTTACCCAAACGCTGGCTTGCCTGG
			CACTGATCAGGACGGTGCGGTGGTCTACGATGGTGAAC
			CAAGCTATTTCGAAGAATATGCCGAACGCTTTCGTCAG
			CTCGGTCTGAACATTATTGGTGGTTGTTGTGGGACCAC
			ACCTTTGCATACCAGCGCAACCGTCCGCGGTCTAAGTA
			ATCGCAGCATCGTTGCTCATGACCAGCCGGCTACAAAA
			CCACAGCCACCAACGCTCGTCACGACAAAGAGTCAGCA
			CCGGTTTCTGCAAAAAGTTGCGACCCAAAAAACGGCGT
			TAGTCGAACTCGATCCACCCCGCGATTTTGATACGACT
			AAATTTTTCCGGGGTGCTGAACGATTAAAAGCCGCTGG
			TGTCGATGGCATTACACTGTCTGACAATTCGTTAGCAA
			CGGTCCGGATTGCTAATACGACGATTGCGGCGCAGCTC
			AAGTTGAACTACGGCATCACGCCGATCGTTCACTTGAC
			GACCCGCGACCACAATCTAATCGGCTTACAATCAGAGA
			TCATGGGTCTACACAGCCTGGGTATTGAGGACATCTTA
			GCTATCACTGGCGATCCGGCCAAACTCGGTGATTTTCC
			GGGAGCCACTTCGGTCAGCGATGTGCGCTCCGTTGAAC
			TGATGAAGTTGATCAAGCAATTCAATAGCGGCATCGGA
			CCAACGGGTAAGTCGCTTAAAGAAGCCAGTGACTTTCG
			GGTCGCAGGCGCCTTTAATCCTAACGCTTATCGCACTT
			CCATATCGACCAAGTCAATCAGTCGGAAGTTAAGTTAT
			GGTTGTGACTACATTATCACCCAACCCGTGTATGATCT
			TGCAAACGTTGACGCTTTGGCGGATGCTCTAGCGGCTA
			ATCACGTGAATGTGCCAGTGTTCGTTGGTGTTATGCCA
			CTCGTCTCACGGCGTAATGCTGAATTTCTACACCATGA
			AGTCCATGGCATTCGGATTCCAGAGCCTATCTTGACAC
			GCATGGCAGAAGCCGAACAGACCGGAAACGAACGGGCA
			GTGGGCATTGCTATTGCAAAGGAATTGATTGATGGTAT
			CTGTGCGCGCTTCAACGGCGTTCACATCGTCACACCGT
			TTAACCGCTTTAAAACGGTCATTGAATTAGTCGATTAC
			ATCCAACAGAAAAACTTAATTAAAGTACAATAA
metH	Coryne-	AX371329	ATGTCTACTTCAGTTACTTCACCAGCCCACAACAACGC	260
	bacterium		ACATTCCTCCGAATTTTTGGATGCGTTGGCAAACCATG
	glutamicum		TGTTGATCGGCGACGGCGCCATGGGCACCCAGCTCCAA
			GGCTTTGACCTGGACGTGGAAAAGGATTTCCTTGATCT
			GGAGGGGTGTAATGAGATTCTCAACGACACCCGCCCTG
			ATGTGTTGAGGCAGATTCACCGCGCCTACTTTGAGGCG
			GGAGCTGACTTGGTTGAGACCAATACTTTTGGTTGCAA
			CCTGCCGAACTTGGCGGATTATGACATCGCTGATCGTT
			GCCGTGAGCTTGCCTACAAGGGCACTGCAGTGGCTAGG
			GAAGTGGCTGATGAGATGGGGCCGGGCCGAAACGGCAT
			GCGGCGTTTCGTGGTTGGTTCCCTGGGACCTGGAACGA
			AGCTTCCATCGCTGGGCCATGCACCGTATGCAGATTTG
			CGTGGGCACTACAAGGAAGCAGCGCTTGGCATCATCGA
			CGGTGGTGGCGATGCCTTTTTGATTGAGACTGCTCAGG
			ACTTGCTTCAGGTCAAGGCTGCGGTTCACGGCGTTCAA
			GATGCCATGGCTGAACTTGATACATTCTTGCCCATTAT
			TTGCCACGTCACCGTAGAGACCACCGGCACCATGCTCA
			TGGGTTCTGAGATCGGTGCCGCGTTGACAGCGCTGCAG
			CCACTGGGTATCGACATGATTGGTCTGAACTGCGCCAC
			CGGCCCAGATGAGATGAGCGAGCACCTGCGTTACCTGT
			CCAAGCACGCCGATATTCCTGTGTCGGTGATGCCTAAC
			GCAGGTCTTCCTGTCCTGGGTAAAAACGGTGCAGAATA
			CCCACTTGAGGCTGAGGATTTGGCGCAGGCGCTGGCTG
			GATTCGTCTCCGAATATGGCCTGTCCATGGTGGGTGGT
			TGTTGTGGCACCACACCTGAGCACATCCGTGCGGTCCG
			CGATGCGGTGGTTGGTGTTCCAGAGCAGGAAACCTCCA
			CACTGACCAAGATCCCTGCAGGCCCTGTTGAGCAGGCC
			TCCCGCGAGGTGGAGAAAGAGGACTCCGTCGCGTCGCT
			GTACACCTCGGTGCCATTGTCCCAGGAAACCGGCATTT
			CCATGATCGGTGAGCGCACCAACTCCAACGGTTCCAAG
			GCATTCCGTGAGGCAATGCTGTCTGGCGATTGGGAAAA
			GTGTGTGGATATTGCCAAGCAGCAAACCCGCGATGGTG
			CACACATGCTGGATCTTTGTGTGGATTACGTGGGACGA
			GACGGCACCGCCGATATGGCGACCTTGGCAGCACTTCT
			TGCTACCAGCTCCACTTTGCCAATCATGATTGACTCCA
			CCGAGCCAGAGGTTATTCGCACAGGCCTTGAGCACTTG
			GGTGGACGAAGCATCGTTAACTCCGTCAACTTTGAAGA
			CGGCGATGGCCCTGAGTCCCGCTACCAGCGCATCATGA
			AACTGGTAAAGCAGCACGGTGCGGCCGTGGTTGCGCTG
			ACCATTGATGAGGAAGGCCAGGCACGTACCGCTGAGCA
			CAAGGTGCGCATTGCTAAACGACTGATTGACGATATCA
			CCGGCAGCTACGGCCTGGATATCAAAGACATCGTTGTG
			GACTGCCTGACCTTCCCGATCTCTACTGGCCAGGAAGA
			AACCAGGCGAGATGGCATTGAAACCATCGAAGCCATCC
			GCGAGCTGAAGAAGCTCTACCCAGAAATCCACACCACC
			CTGGGTCTGTCCAATATTTCCTTCGGCCTGAACCCTGC
			TGCACGCCAGGTTCTTAACTCTGTGTTCCTCAATGAGT
			GCATTGAGGCTGGTCTGGACTCTGCGATTGCGCACAGC
			TCCAAGATTTTGCCGATGAACCGCATTGATGATCGCCA
			GCGCGAAGTGGCGTTGGATATGGTCTATGATCGCCGCA
			CCGAGGATTACGATCCGCTGCAGGAATTCATGCAGCTG
			TTTGAGGGCGTTTCTGCTGCCGATGCCAAGGATGCTCG
			CGCTGAACAGCTGGCCGCTATGCCTTTGTTTGAGCGTT
			TGGCACAGCGCATCATCGACGGCGATAAGAATGGCCTT
			GAGGATGATCTGGAAGCAGGCATGAAGGAGAAGTCTCC
			TATTGCGATCATCAACGAGGACCTTCTCAACGGCATGA
			AGACCGTGGGTGAGCTGTTTGGTTCCGGACAGATGCAG
			CTGCCATTCGTGCTGCAATCGGCAGAAACCATGAAAAC
			TGCGGTGGCCTATTTGGAACCGTTCATGGAAGAGGAAG
			CAGAAGCTACCGGATCTGCGCAGGCAGAGGGCAAGGGC
			AAAATCGTCGTGGCCACCGTCAAGGGTGACGTGCACGA
			TATCGGCAAGAACTTGGTGGACATCATTTTGTCCAACA
			ACGGTTACGACGTGGTGAACTTGGGCATCAAGCAGCCA
			CTGTCCGCCATGTTGGAAGCAGCGGAAGAACACAAAGC
			AGACGTCATCGGCATGTCGGGACTTCTTGTGAAGTCCA
			CCGTGGTGATGAAGGAAAACCTTGAGGAGATGAACAAC
			GCCGGCGCATCCAATTACCCAGTCATTTTGGGTGGCGC
			TGCGCTGACGCGTACCTACGTGGAAAACGATCTCAACG
			AGGTGTACACCGGTGAGGTGTACTACGCCCGTGATGCT
			TTCGAGGGCCTGCGCCTGATGGATGAGGTGATGGCAGA
			AAAGCGTGGTGAAGGACTTGATCCCAACTCACCAGAAG
			CTATTGAGCAGGCGAAGAAGAAGGCGGAACGTAAGGCT
			CGTAATGAGCGTTCCCGCAAGATTGCCGCGGAGCGTAA
			AGCTAATGCGGCTCCCGTGATTGTTCCGGAGCGTTCTG
			ATGTCTCCACCGATACTCCAACCGCGGCACCACCGTTC
			TGGGGAACCCGCATTGTCAAGGGTCTGCCCTTGGCGGA
			GTTCTTGGGCAACCTTGATGAGCGCGCCTTGTTCATGG
			GGCAGTGGGGTCTGAAATCCACCCGCGGCAACGAGGGT
			CCAAGCTATGAGGATTTGGTGGAAACTGAAGGCCGACC
			ACGCCTGCGCTACTGGCTGGATCGCCTGAAGTCTGAGG
			GCATTTTGGACCACGTGGCCTTGGTGTATGGCTACTTC
			CCAGCGGTCGCGGAAGGCGATGACGTGGTGATCTTGGA
			ATCCCCGGATCCACACGCAGCCGAACGCATGCGCTTTA
			GCTTCCCACGCCAGCAGCGCGGCAGGTTCTTGTGCATC
			GCGGATTTCATTCGCCCACGCGAGCAAGCTGTCAAGGA
			CGGCCAAGTGGACGTCATGCCATTCCAGCTGGTCACCA
			TGGGTAATCCTATTGCTGATTTCGCCAACGAGTTGTTC
			GCAGCCAATGAATACCGCGAGTACTTGGAAGTTCACGG
			CATCGGCGTGCAGCTCACCGAAGCATTGGCCGAGTACT
			GGCACTCCCGAGTGCGCAGCGAACTCAAGCTGAACGAC
			GGTGGATCTGTCGCTGATTTTGATCCAGAAGACAAGAC
			CAAGTTCTTCGACCTGGATTACCGCGGCGCCCGCTTCT
			CCTTTGGTTACGGTTCTTGCCCTGATCTGGAAGACCGC
			GCAAAGCTGGTGGAATTGCTCGAGCCAGGCCGTATCGG
			CGTGGAGTTGTCCGAGGAACTCCAGCTGCACCCAGAGC
			AGTCCACAGACGCGTTTGTGCTCTACCACCCAGAGGCA
			AAGTACTTTAACGTCTAA
metH	Escherichia coli	AE000475	GTGAGCAGCAAAGTGGAACAACTGCGTGCGCAGTTAAA	261
			TGAACGTATTCTGGTGCTGGACGGCGGTATGGGCACCA
			TGATCCAGAGTTATCGACTGAACGAAGCCGATTTTCGT
			GGTGAACGCTTTGCCGACTGGCCATGCGACCTCAAAGG
			CAACAACGACCTGCTGGTACTCAGTAAACCGGAAGTGA
			TCGCCGCTATCCACAACGCCTACTTTGAAGCGGGCGCG
			GATATCATCGAAACCAACACCTTCAACTCCACGACCAT
			TGCGATGGCGGATTACCAGATGGAATCCCTGTCGGCGG
			AAATCAACTTTGCGGCGGCGAAACTGGCGCGAGCTTGT
			GCTGACGAGTGGACCGCGCGCACGCCAGAGAAACCGCG
			CTACGTTGCCGGTGTTCTCGGCCCGACCAACCGCACGG
			CGTCTATTTCTCCGGACGTCAACGATCCGGCATTTCGT
			AATATCACTTTTGACGGGCTGGTGGCGGCTTATCGAGA
			GTCCACCAAAGCGCTGGTGGAAGGTGGCGCGGATCTGA
			TCCTGATTGAAACCGTTTTCGACACCCTTAACGCCAAA
			GCGGCGGTATTTGCGGTGAAAACGGAGTTTGAAGCGCT
			GGGCGTTGAGCTGCCGATTATGATCTCCGGCACCATCA
			CCGACGCCTCCGGGCGCACGCTCTCCGGGCAGACCACC
			GAAGCATTTTACAACTCATTGCGCCACGCCGAAGCTCT
			GACCTTTGGCCTGAACTGTGCGCTGGGGCCCGATGAAC
			TGCGCCAGTACGTGCAGGAGCTGTCACGGATTGCGGAA
			TGCTACGTCACCGCGCACCCGAACGCCGGGCTACCCAA
			CGCCTTTGGTGAGTACGATCTCGACGCCGACACGATGG
			CAAAACAGATACGTGAATGGGCGCAAGCGGGTTTTCTC
			AATATCGTCGGCGGCTGCTGTGGCACCACGCCACAACA
			TATTGCAGCGATGAGTCGTGCAGTAGAAGGATTAGCGC
			CGCGCAAACTGCCGGAAATTCCCGTAGCCTGCCGTTTG
			TCCGGCCTGGAGCCGCTGAACATTGGCGAAGATAGCCT
			GTTTGTGAACGTGGGTGAACGCACCAACGTCACCGGTT
			CCGCTAAGTTCAAGCGCCTGATCAAAGAAGAGAAATAC
			AGCGAGGCGCTGGATGTCGCGCGTCAACAGGTGGAAAA
			CGGCGCGCAGATTATCGATATCAACATGGATGAAGGGA
			TGCTCGATGCCGAAGCGGCGATGGTGCGTTTTCTCAAT
			CTGATTGCCGGTGAACCGGATATCGCTCGCGTGCCGAT
			TATGATCGACTCCTCAAAATGGGACGTCATTGAAAAAG
			GTCTGAAGTGTATCCAGGGCAAAGGCATTGTTAACTCT
			ATCTCGATGAAAGAGGGCGTCGATGCCTTTATCCATCA
			CGCGAAATTGTTGCGTCGCTACGGTGCGGCAGTGGTGG
			TAATGGCCTTTGACGAACAGGGACAGGCCGATACTCGC
			GCACGGAAAATCGAGATTTGCCGTCGGGCGTACAAAAT
			CCTCACCGAAGAGGTTGGCTTCCCGCCAGAAGATATCA
			TCTTCGACCCAAACATCTTCGCGGTCGCAACTGGCATT
			GAAGAGCACAACAACTACGCGCAGGACTTTATCGGCGC
			GTGTGAAGACATCAAACGCGAACTGCCGCACGCGCTGA
			TTTCCGGCGGCGTATCTAACGTTTCTTTCTCGTTCCGT
			GGCAACGATCCGGTGCGCGAAGCCATTCACGCAGTGTT
			CCTCTACTACGCTATTCGCAATGGCATGGATATGGGGA
			TCGTCAACGCCGGGCAACTGGCGATTTACGACGACCTA
			CCCGCTGAACTGCGCGACGCGGTGGAAGATGTGATTCT
			TAATCGTCGCGACGATGGCACCGAGCGTTTACTGGAGC
			TTGCCGAGAAATATCGCGGCAGCAAAACCGACGACACC
			GCCAACGCCCAGCAGGCGGAGTGGCGCTCGTGGGAAGT
			GAATAAACGTCTGGAATACTCGCTGGTCAAAGGCATTA
			CCGAGTTTATCGAGCAGGATACCGAAGAAGCCCGCCAG
			CAGGCTACGCGCCCGATTGAAGTGATTGAAGGCCCGTT
			GATGGACGGCATGAATGTGGTCGGCGACCTGTTTGGCG
			AAGGGAAAATGTTCCTGCCACAGGTGGTCAAATCGGCG
			CGCGTCATGAAACAGGCGGTGGCCTACCTCGAACCGTT
			TATTGAAGCCAGCAAAGAGCAGGGCAAAACCAACGGCA
			AGATGGTGATCGCCACCGTGAAGGGCGACGTCCACGAC
			ATCGGTAAAAATATCGTTGGTGTGGTGCTGCAATGTAA
			CAACTACGAAATTGTCGATCTCGGCGTTATGGTGCCTG
			CGGAAAAAATTCTCCGTACCGCTAAAGAAGTGAATGCT
			GATCTGATTGGCCTTTCGGGGCTTATCACGCCGTCGCT
			GGACGAGATGGTTAACGTGGCGAAAGAGATGGAGCGTC
			AGGGCTTCACTATTCCGTTACTGATTGGCGGCGCGACG
			ACCTCAAAAGCGCACACGGCGGTGAAAATCGAGCAGAA
			CTACAGCGGCCCGACGGTGTATGTGCAGAATGCCTCGC
			GTACCGTTGGTGTGGTGGCGGCGCTGCTTTCCGATACC
			CAGCGTGATGATTTTGTCGCTCGTACCCGCAAGGAGTA
			CGAAACCGTACGTATTCAGCACGGGCGCAAGAAACCGC
			GCACACCACCGGTCACGCTGGAAGCGGCGCGCGATAAC
			GATTTCGCTTTTGACTGGCAGGCTTACACGCCGCCGGT
			GGCGCACCGTCTCGGCGTGCAGGAAGTCGAAGCCAGCA
			TCGAAACGCTGCGTAATTACATCGACTGGACACCGTTC
			TTTATGACCTGGTCGCTGGCCGGGAAGTATCCGCGCAT
			TCTGGAAGATGAAGTGGTGGGCGTTGAGGCGCAGCGGC
			TGTTTAAAGACGCCAACGACATGCTGGATAAATTAAGC
			GCCGAGAAAACGCTGAATCCGCGTGGCGTGGTGGGCCT
			GTTCCCGGCAAACCGTGTGGGCGATGACATTGAAATCT
			ACCGTGACGAAACGCGTACCCATGTGATCAACGTCAGC
			CACCATCTGCGTCAACAGACCGAAAAAACAGGCTTCGC
			TAACTACTGTCTCGCTGACTTCGTTGCGCCGAAGCTTT
			CTGGTAAAGCAGATTACATCGGCGCATTTGCCGTGACT
			GGCGGGCTGGAAGAGGACGCACTGGCTGATGCCTTTGA
			AGCGCAGCACGATGATTACAACAAAATCATGGTGAAAG
			CGCTTGCCGACCGTTTAGCCGAAGCCTTTGCGGAGTAT
			CTCCATGAGCGTGTGCGTAAAGTCTACTGGGGCTATGC
			GCCGAACGAGAACCTCAGCAACGAAGAGCTGATCCGCG
			AAAACTACCAGGGCATCCGTCCGGCACCGGGCTATCCG
			GCCTGCCCGGAACATACGGAAAAAGCCACCATCTGGGA
			GCTGCTGGAAGTGGAAAAACACACTGGCATGAAACTCA
			CAGAATCTTTCGCCATGTGGCCCGGTGCATCGGTTTCG
			GGTTGGTACTTCAGCCACCCGGACAGCAAGTACTACGC
			TGTAGCACAAATTCAGCGCGATCAGGTTGAAGATTATG
			CCCGCCGTAAAGGTATGAGCGTTACCGAAGTTGAGCGC
			TGGCTGGCACCGAATCTGGGGTATGACGCGGACTGA
metE	Mycobacterium	Z95585.1	GTGACCCAGCCTGTACGTCGTCAACCCTTTACCGCAAC	146
	tuberculosis		CATCACCGGCTCCCCGCGCATCGGCCCGCGCCGCGAAC
	(use this to		TCAAGCGCGCCACCGAAGGCTACTGGGCCGGACGTACC
	clone M.		AGCCGATCCGAGCTGGAGGCCGTCGCCGCCACGTTACG
	smegmatis		CCGCGACACCTGGTCGGCCCTGGCCGCGGCCGGTCTGG
	gene)		ACTCGGTGCCGGTGAACACCTTCTCCTACTACGACCAA
			ATGCTCGATACCGCGGTGCTGCTCGGCGCGCTGCCGCC
			CCGAGTGAGCCCGGTTTCCGACGGGCTGGACCGCTATT
			TCGCCGCGGCGCGGGGCACCGACCAGATCGCGCCGCTG
			GAGATGACGAAGTGGTTCGACACCAACTACCACTACCT
			GGTACCCGAGATCGGGCCGTCGACCACGTTCACGCTGC
			ACCCCGGCAAGGTGCTCGCCGAACTCAAAGAGGCGTTA
			GGGCAAGGCATTCCCGCACGTCCGGTGATCATCGGGCC
			GATCACCTTCCTGCTGCTGAGCAAGGCCGTCGACGGCG
			CGGGGGCGCCGATCGAACGCCTCGAAGAGTTGGTTCCG
			GTCTATTCGGAGCTGCTGTCGCTGCTTGCCGACGGCGG
			CGCCCAGTGGGTGCAGTTCGACGAGCCGGCGCTGGTGA
			CCGACCTCTCCCCCGACGCGCCCGCCCTGGCTGAAGCG
			GTGTACACCGCGCTGTGCTCGGTGAGCAACCGGCCTGC
			GATCTATGTCGCCACCTACTTCGGGGACCCGGGCGCGG
			CCCTACCGGCGCTGGCTCGCACCCCGGTCGAAGCCATC
			GGCGTCGACCTGGTGGCCGGTGCCGACACCTCGGTGGC
			CGGGGTACCCGAGCTGGCCGGCAAGACGCTGGTGGCCG
			GGGTCGTCGACGGGCGCAACGTCTGGCGCACCGACCTG
			GAGGCGGCGTTGGGCACGTTGGCGACCCTGCTGGGTTC
			GGCGGCTACCGTGGCCGTCTCGACGTCGTGCTCGACAC
			TGCACGTGCCGTACTCGCTGGAACCGGAAACCGACCTG
			GATGACGCGTTGCGGAGCTGGCTGGCGTTCGGTGCCGA
			AAAGGTGCGCGAAGTCGTCGTTCTCGCGCGTGCCCTGC
			GCGACGGACACGACGCGGTCGCCGACGAGATCGCGTCG
			TCCCGCGCCGCCATCGCGTCCCGCAAGCGCGACCCGCG
			GTTACACAATGGGCAAATCCGGGCGCGCATCGAGGCGA
			TCGTCGCGTCCGGAGCCCACCGCGGCAATGCCGCCCAG
			CGCCGCGCCAGCCAAGACGCGCGACTGCACCTGCCGCC
			GCTGCCGACCACGACGATCGGCTCCTACCCGCAGACCT
			CGGCGATCCGCGTTGCGCGTGCGGCGCTGCGGGCCGGT
			GAGATCGACGAGGCCGAGTACGTGCGCCGGATGCGGCA
			AGAGATCACCGAGGTGATCGCGCTACAGGAGCGGCTCG
			GGCTCGACGTGCTGGTGCACGGCGAACCGGAGCGCAAC
			GACATGGTGCAGTACTTCGCCGAGCAATTGGCGGGTTT
			CTTCGCTACCCAGAACGGCTGGGTGCAGTCCTACGGCA
			GCCGCTGTGTGCGTCCGCCGATCCTGTACGGCGACGTG
			TCCCGGCCGCGGGCGATGACGGTCGAGTGGATCACCTA
			CGCGCAGTCGCTGACCGACAAACCGGTGAAGGGCATGT
			TGACCGGGCCGGTGACGATTCTGGCGTGGTCGTTCGTG
			CGTGACGACCAGCCGTTGGCCGATACCGCCAACCAGGT
			GGCGCTGGCGATTCGCGACGAGACCGTGGATTTGCAGT
			CCGCCGGCATCGCGGTCATCCAGGTCGACGAGCCTGCG
			CTGCGTGAACTGCTGCCGCTGCGTCGCGCCGACCAGGC
			CGAGTACTTGCGTTGGGCGGTAGGGGCTTTCCGGTTGG
			CCACCTCCGGCGTCTCGGACGCCACCCAGATCCACACG
			CATCTGTGCTACTCGGAGTTCGGCGAGGTGATCGGCGC
			GATCGCCGATCTGGACGCGGACGTCACGTCCATCGAGG
			CGGCCCGGTCACACATGGAGGTGCTCGACGACCTGAAC
			GCGATCGGCTTCGCCAACGGTGTGGGCCCGGGCGTCTA
			TGACATTCACTCGCCACGGGTGCCCTCCGCTGAGGAGA
			TGGCCGACTCGTTGCGGGCCGCGTTGCGCGCGGTGCCG
			GCCGAGCGGCTGTGGGTCAACCCCGACTGCGGACTGAA
			GACCCGCAATGTCGACGAGGTGACCGCGTCGCTGCACA
			ACATGGTCGCCGCCGCCCGGGAGGTGCGCGCGGGCTAG
metE	Mycobacterium	Z94723.1	ATGGACGAACTCGTGACCACTCAATCATTCACCGCAAC	147
	leprae (use this		CGTAACTGGCTCTCCACGCATTGGCCCGCGCCGCGAAC
	to clone M.		TTAAACGGGCGACCGAAGGCTATTGGGCCAAGCGTACC
	smegmatis		AGCCGATCAGAACTGGAGTCCGTCGCCTCAACATTGCG
	gene)		CCGCGACATGTGGTCGGACTTAGCCGCCGCCGGCCTGG
			ACTCCGTACCGGTGAACACCTTCTCTTACTACGACCAG
			ATGCTCGACACGGCATTCATGCTCGGCGCGCTGCCTGC
			CCGGGTAGCACAAGTGTCCGACGACCTAGATCAGTACT
			TCGCCCTCGCACGCGGCAACAACGACATCAAGCCGCTG
			GAGATGACTAAGTGGTTCGACACCAACTACCACTACCT
			GGTTCCTGAAATCGAGCCCGCGACCACCTTCTCACTGA
			ACCCAGGCAAGATACTCGGTGAGCTGAAAGAAGCACTT
			GAGCAAAGAATTCCGTCCCGACCGGTCATTATCGGTCC
			GGTCACCTTCCTGTTACTGAGCAAGGGCATCAATGGCG
			GGGGCGCACCGATACAGCGGCTCGAGGAGCTGGTGGGA
			ATCTACTGCACGCTGCTATCACTGCTCGCCGAGAATGG
			CGCACGATGGGTACAGTTCGACGAGCCGGCGCTGGTGA
			CTGATCTATCCCCCGATGCACCGGCGTTGGCGGAAGCA
			GTTTACACTGCACTCGGCTCAGTTAGCAAACGACCCGC
			CATTTACGTGGCCACTTACTTCGGTAACCCCGGCGCTT
			CCTTGGCGGGGCTAGCCCGCACGCCCATCGAGGCGATC
			GGTGTCGACTTCGTTTGTGGTGCCGACACGTCGGTCGC
			GGCGGTGCCCGAGCTGGCCGGCAAGACTCTGGTGGCTG
			GCATCGTCGACGGACGCAACATCTGGCGCACTGACCTG
			GAATCGGCGTTGAGCAAGTTGGCTACTCTGCTGGGTTC
			AGCAGCCACCGTTGCTGTTTCGACGTCGTGCTCTACGC
			TGCATGTGCCGTATTCGTTGGAACCAGAAACCGACCTG
			GACGACAATTTGCGCAGCTGGCTGGCGTTCGGTGCGGA
			AAAGGTGGCCGAAGTCGTTGTGCTGGCACGCGCACTTC
			GCGACGGGCGCGACGCGGTCGCCGATGAGATCGCGGCG
			TCCAATGCCGCCGTTGCCTCGCGACGCAGCGACCCGCG
			GCTGCACAACGGGCAGGTACGCGCGCGTATTGACTCGA
			TTGTCGCTTCCGGTACGCACCGCGGTGACGCAGCGCAG
			CGCCGCACCAGCCAGGACGCGCGCCTACACTTACCGCC
			GCTGCCGACCACGACGATCGGCTCCTACCCGCAGACCT
			CAGCGATCCGCAAAGCGCGAGCGGCACTGCAGGACGCT
			GAGATCGACGAGGCCGAGTACATCAGCAGGATGAAAAA
			AGAAGTCGCCGACGCCATCAAACTGCAGGAGCAACTCG
			GGCTAGATGTACTGGTCCATGGCGAGCCGGAGCGCAAC
			GACATGGTACAGTATTTCGCTGAGCAACTGGGCGGCTT
			CTTCGCCACGCAGAACGGTTGGGTGCAGTCCTACGGCA
			GCCGTTGTGTACGTCCGCCGATCCTCTACGGTGACGTG
			TCCCGGCCTCACCCGATGACAATCGAGTGGATCACCTA
			CGCGCAGTCCCTAACTGACAAGCCAGTTAAGGGCATGT
			TGACCGGACCGGTCACGATCTTAGCCTGGTCGTTTGTT
			CGTGACGACCAGCCGCTGGCCGATACCGCGAACCAAGT
			AGCACTGGCGATTCGCGATGAGACCGTAGATCTACAAT
			CCGCCGGTATCGCAATCATCCAGGTTGACGAGCCCGCG
			CTACGTGAGCTGCTGCCGCTGCGTAGGGCTGATCAAGA
			CGAATACTTATGTTGGGCAGTAAAGGCTTTCCGCCTAG
			CTACCTCGGGGGTCGCCGACTCGACGCAAATCCACACT
			CATCTGTGCTACTCCGAGTTCGGCGAAGTGATTGGAGC
			TATCGCCGACCTGGACGCCGACGTCACATCCATCGAAG
			CGGCGCGCTCACACATGGAAGTATTGGATGACCTGAAC
			GCAGTCGGCTTCGCTAACAGCATAGGCCCGGGAGTCTA
			CGACATCCACTCGCCGCGGGTACCAAGCACTGACGAGA
			TTGCCAAGTCGCTACGCGCAGCATTAAAAGCCATACCG
			ATGCAACGGCTTTGGGTTAACCCCGACTGCGGGCTGAA
			GACCCGATCAGTTGACGAGGTGAGCGCGTCGCTGCAGA
			ACATGGTCGCAGCAGCACGCCAGGTGCGGGCAGGGGCC
			TAA
metE	Streptomyces	AL939107.1	GTGACAGCGAAGTCCGCAGCCGCGGCAGCACGGGCCAC	148
	coelicolor		CGTGTACGGCTACCCCCGCCAGGGCCCGAACCGGGAAC
			TGAAGAAGGCGATCGAGGGCTACTGGAAGGGCCGCGTC
			AGCGCGCCCGAACTCCGGTCCCTCGCCGCGGACCTGCG
			CGCCGCGAACTGGCGCCGACTGGCCGACGCCGGCATCG
			ACGAGGTGCCCGCCGGCGACTTCTCGTACTACGACCAC
			GTCCTCGACACCACCGTCATGGTCGGTGCGATCCCCGA
			GCGCCACCGCGCCGCCGTCGCGGCCGACGCCCTGGACG
			GCTACTTCGCCATGGCCCGCGGCACCCAGGAGGTCGCG
			CCGCTGGAGATGACCAAGTGGTTCGACACCAACTACCA
			CTATCTGGTTCCGGAGTTGGGTCCGGACACCGTCTTCA
			CGGCCGACTCCACCAAGCAGGTCACCGAGCTGGCGGAA
			GCCGTCGCCCTGGGCCTGACCGCCCGCCCCGTGCTGGT
			CGGCCCGGTCACCTATCTCCTGCTGGCCAAGCCGGCCC
			CCGGCGCCCCCGCGGACTTCGAGCCGCTCACCCTGCTC
			GACCGGCTCCTGCCGGTGTACGCCGAGGTCCTCACCGA
			CCTGCGCGCGGCCGGCGCCGAGTGGGTCCAGCTGGACG
			AGCCCGCCTTCGTGCAGGACCGCACCCCGGCGGAACTG
			AACGCCCTGGAACGCGCCTACCGGGAACTCGGCGCCCT
			GACCGACCGGCCCAAGCTGCTCGTCGCCTCCTACTTCG
			ACCGCCTCGGCGACGCGCTGCCCGTCCTGGCCAAGGCA
			CCGATCGAGGGTCTTGCCCTGGACTTCACCGACGCCGC
			CGCGACCAACCTGGACGCCTTGGCCGCCGTCGGCGGAC
			TGCCCGGCAAGCGCCTCGTCGCCGGTGTCGTCAACGGC
			CGCAACATCTGGATCAACGACCTGCAGAAGTCGTTGTC
			CACGCTCGGCACGCTGCTGGGTCTCGCGGACCGGGTCG
			ACGTGTCCGCCTCCTGCTCCCTCCTCCATGTGCCCCTC
			GACACCGGGGCGGAGCGGGACATCGAGCCGCAGATCCT
			GCGCTGGCTGGCCTTCGCCCGGCAGAAGACCGCCGAGA
			TCGTCACCCTCGCCAAGGGCCTCGCCCAGGGCACCGAC
			GCCATCACCGGCGAACTCGCCGCCAGCCGCGCCGACAT
			GGCCTCCCGCGCCGGCTCACCGATCACCCGCAACCCGG
			CCGTACGAGCCCGTGCCGAGGCCGTGACGGACGACGAC
			GCCCGTCGCTCCCAGCCGTACGCCGAACGGACCGCCGC
			CCAGCGGGCACACCTGGGGCTGCCGCCGCTGCCGACCA
			CGACCATCGGCTCGTTCCCGCAGACCGGCGAGATCCGG
			GCCGCCCGTGCCGACCTGCGCGACGGCCGCATCGACAT
			CGCCGGCTACGAGGAACGGATCCGGGCCGAGATCCAGG
			AGGTGATCTCCTTCCAGGAGAAGACCGGCCTGGACGTC
			CTGGTGCACGGCGAGCCCGAACGCAACGACATGGTCCA
			GTACTTCGCCGAACAGCTGACCGGGTATCTGGCCACGC
			AGCACGGCTGGGTCCAGTCCTACGGCACCCGCTACGTC
			CGCCCGCCGATCCTGGCCGGGGACATCTCCCGCCCCGA
			GCCGATGACGGTGCGCTGGACGACGTACGCCCAGTCGC
			TCACCGAGAAGCCGGTCAAGGGCATGCTCACCGGCCCG
			GTGACCATGCTCGCATGGTCCTTCGTCCGCGACGACCA
			GCCCCTCGGTGACACCGCCCGCCAGGTCGCCCTCGCCC
			TGCGCGACGAGGTGAACGACCTGGAGGCGGCCGGGACC
			TCGGTCATCCAGGTCGACGAACCCGCCCTGCGCGAGAC
			ACTGCCGCTGCGGGCCGCCGACCACACCGCCTACCTGG
			CCTGGGCGACGGAGGCGTTCCGGCTGACCACCTCTGGC
			GTCCGCCCGGACACCCAGATCCACACCCACATGTGCTA
			CGCCGAGTTCGGCGACATCGTCCAGGCCATCGACGACC
			TCGACGCCGACGTCATCAGCCTGGAAGCCGCTCGCTCA
			CACATGCAGGTAGCCCACGAACTCGCTACCCACGGCTA
			CCCGCGCGAAGCCGGACCCGGCGTGTACGACATCCACT
			CCCCGCGCGTCCCGAGCGCCGAGGAAGCCGCCGCACTG
			CTGCGCACCGGCCTCAAGGCGATTCCTGCCGAACGGCT
			GTGGGTCAACCCCGACTGCGGTCTGAAGACCCGCGGCT
			GGCCCGAGACCCGCGCCTCCCTGGAGAACCTGGTCGCC
			ACCGCCCGCACCCTCCGCGGAGAGCTGTCCGCTTCCTGA
metE	Coryne-	AX371335	ATGACTTCCAACTTTTCTTCCACTGTCGCTGGTCTTCC	262
	bacterium		TCGCATCGGAGCGAAGCGTGAACTGAAGTTCGCGCTCG
	glutamicum		AAGGCTACTGGAATGGATCAATTGAAGGTCGCGAACTT
			CGGCAGACCGCCCGCCAATTGGTCAACACTGCATCGGA
			TTCTTTGTCTGGATTGGATTCCGTTCCGTTTGCAGGAC
			GTTCCTACTACGACGCAATGCTCGATACCGCCGCTATT
			TTGGGTGTGCTGCCGGAGCGTTTTGATGACATCGCTGA
			TCATGAAAACGATGGTCTCCCACTGTGGATTGACCGCT
			ACTTTGGCGCTGCTCGCGGTACTGAGACCCTGCCTGCA
			CAGGCAATGACCAAGTGGTTTGATACCAACTACCACTA
			CCTCGTGCCGGAGTTGTCTGCGGATACACGTTTCGTTT
			TGGATGCGTCCGCGCTGATTGAGGATCTCCGTTGCCAG
			CAGGTTCGTGGCGTTAATGCCCGCCCTGTTCTGGTTGG
			TCCACTGACTTTCCTTTCCCTTGCTCGCACCACTGATG
			GTTCCAATCCTTTGGATCACCTGCCTGCACTGTTTGAG
			GTCTACGAGCGCCTCATCAAGTCTTTCGATACTGAGTG
			GGTTCAGATCGATGAGCCTGCGTTGGTCACCGATGTTG
			CTCCTGAGGTTTTGGAGCAGGTCCGCGCTGGTTACACC
			ACTTTGGCTAAGCGCGATGGCGTGTTTGTCAATACTTA
			CTTCGGCTCTGGCGATCAGGCGCTGAACACTCTTGCGG
			GCATCGGCCTTGGCGCGATTGGCGTTGACTTGGTCACC
			CATGGCGTCACTGAGCTTGCTGCGTGGAAGGGTGAGGA
			GCTGCTGGTTGCGGGCATCGTTGATGGTCGTAACATTT
			GGCGCACCGACCTGTGTGCTGCTCTTGCTTCCCTGAAG
			CGCCTGGCAGCTCGCGGCCCAATCGCAGTGTCTACCTC
			TTGTTCACTGCTGCACGTTCCTTACACCCTCGAGGCTG
			AGAACATTGAGCCTGAGGTCCGCGACTGGCTTGCCTTC
			GGCTCGGAGAAGATCACCGAGGTCAAGCTGCTTGCCGA
			CGCCCTAGCCGGCAACATCGACGCGGCTGCGTTCGATG
			CGGCGTCCGCAGCAATTGCTTCTCGACGCACCTCCCCA
			CGCACCGCACCAATCACGCAGGAACTCCCTGGCCGTAG
			CCGTGGATCCTTCGACACTCGTGTTACGCTGCAGGAGA
			AGTCACTGGAGCTTCCAGCTCTGCCAACCACCACCATT
			GGTTCTTTCCCACAGACCCCATCCATTCGTTCTGCTCG
			CGCTCGTCTGCGCAAGGAATCCATCACTTTGGAGCAGT
			ACGAAGAGGCAATGCGCGAAGAAATCGATCTGGTCATC
			GCCAAGCAGGAAGAACTTGGTCTTGATGTGTTGGTTCA
			CGGTGAGCCAGAGCGCAACGACATGGTTCAGTACTTCT
			CTGAACTTCTCGACGGTTTCCTCTCAACCGCCAACGGC
			TGGGTCCAAAGCTACGGCTCCCGCTGTGTTCGTCCTCC
			AGTGTTGTTCGGAAACGTTTCCCGCCCAGCGCCAATGA
			CTGTCAAGTGGTTCCAGTACGCACAGAGCCTGACCCAG
			AAGCATGTCAAGGGAATGCTCACCGGTCCAGTCACCAT
			CCTTGCATGGTCCTTCGTTCGCGATGATCAGCCGCTGG
			CTACCACTGCTGACCAGGTTGCACTGGCACTGCGCGAT
			GAAATTAACGATCTCATCGAGGCTGGCGCGAAGATCAT
			CCAGGTGGATGAGCCTGCGATTCGTGAACTGTTGCCGC
			TACGAGACGTCGATAAGCCTGCCTACCTGCAGTGGTCC
			GTGGACTCCTTCCGCCTGGCGACTGCCGGCGCACCCGA
			CGACGTCCAAATCCACACCCACATGTGCTACTCCGAGT
			TCAACGAAGTGATCTCCTCGGTCATCGCGTTGGATGCC
			GATGTCACCACCATCGAAGCAGCACGTTCCGACATGCA
			GGTCCTCGCTGCTCTGAAATCTTCCGGCTTCGAGCTCG
			GCGTCGGACCTGGTGTGTGGGATATCCACTCCCCGCGC
			GTTCCTTCCGCGCAGGAAGTGGACGGTCTCCTCGAGGC
			TGCACTGCAGTCCGTGGATCCTCGCCAGCTGTGGGTCA
			ACCCAGACTGTGGTCTGAAGACCCGTGGATGGCCAGAA
			GTGGAAGCTTCCCTAAAGGTTCTCGTTGAGTCCGCTAA
			GCAGGCTCGTGAGAAAATCGGAGCAACTATCTAA
metE	Escherichia coli	AE016769	ATGACAATTCTTAATCACACCCTCGGTTTCCCTCGCGT	263
			TGGCCTGCGTCGCGAGCTGAAAAAAGCGCAAGAGAGTT
			ATTGGGCGGGGAACTCCACGCGTGAAGAACTGCTGGCG
			GTAGGGCGTGAATTGCGTGCTCGTCACTGGGATCAACA
			AAAGCAAGCGGGTATCGACCTGCTGCCGGTGGGCGATT
			TTGCCTGGTACGATCATGTACTGACCACCAGTCTGCTG
			CTGGGTAATGTTCCGCCACGTCATCAGAACAAAGATGG
			TTCGGTAGATATCGACACCCTGTTCCGTATTGGTCGTG
			GACGTGCACCGACTGGCGAACCTGCGGCGGCAGCGGAA
			ATGACCAAATGGTTTAACACCAACTATCACTACATGGT
			GCCGGAGTTCGTTAAAGGCCAACAGTTCAAACTGACCT
			GGACGCAGCTGCTGGAGGAAGTGGACGAGGCGCTGGCG
			CTGGGCCACAAGGTGAAACCTGTGCTGCTGGGGCCGAT
			TACCTACCTGTGGCTGGGTAAAGTGAAAGGTGAACAGT
			TTGATCGCCTGAGCCTGCTGAACGACATTCTGCCGGTT
			TATCAGCAAGTGCTGGCAGAACTGGCGAAACGCGGCAT
			CGAGTGGGTACAGATTGATGAACCCGCGTTGGTACTGG
			AACTGCCGCAGGCGTGGCTGGACGCATACAAACCCGCT
			TACGACGCGCTCCAGGGACAGGTGAAACTGCTGCTGAC
			CACCTATTTTGAAGGCGTAACGCCAAACCTCGACACGA
			TTACTGCGCTGCCTGTTCAGGGTCTGCATGTCGATCTc
			GTACATGGTAAAGATGACGTTGCTGAACTGCACAAGCG
			TCTGCCTTCTGACTGGCTGCTGTCTGCGGGTCTTATCA
			ATGGTCGTAACGTCTGGCGCGCCGATCTTACCGAGAAA
			TATGCGCAAATTAAGGACATTGTCGGCAAACGCGATTT
			GTGGGTGGCATCTTCCTGCTCGTTGCTGCACAGCCCCA
			TCGACTTGAGCGTGGAAACGCGTCTTGATGCAGAAGTG
			AAAAGCTGGTTTGCCTTCGCCCTGCAAAAATGTCATGA
			ACTGGCATTGCTGCGCGATGCGTTGAACAGTGGTGATA
			CGGCAGCTCTGGCAGAGTGGAGCGCTCCGATTCAGGCG
			CGTCGTCACTCTACTCGTGTACATAATCCGGCAGTAGA
			AAAGCGTCTGGCGGCGATCACCGCCCAGGACAGTCAGC
			GTGCGAATGTCTATGAAGTGCGTGCTGAAGCTCAGCGT
			GCGCGTTTTAAACTGCCCGCGTGGCCGACCACCACGAT
			TGGTTCCTTCCCGCAAACCACGGAGATTCGTACCCTGC
			GTCTGGATTTTAAAAAGGGTAATCTCGACGCCAATAAC
			TACCGCACGGGCATTGCGGAACATATCAAGCAGGCCAT
			TGTTGAGCAGGAACGTTTGGGACTGGATGTGCTGGTAC
			ATGGCGAGGCCGAGCGTAATGACATGGTGGAATACTTT
			GGCGAGCATCTGGATGGCTTTGTCTTTACGCAAAACGG
			TTGGGTACAGAGCTACGGTTCCCGCTGCGTGAAGCCAC
			CGATTGTTATTGGTGACGTTAGCCGCCCGGCACCGATT
			ACCGTGGAGTGGGCAAAATATGCGCAATCCCTGACTGA
			TAAACCGGTGAAAGGGATGTTGACCGGCCCGGTGACTA
			TTCTCTGCTGGTCGTTCCCGCGTGAAGATGTCAGCCGT
			GAAACCATCGCCAAACAAATTGCGCTGGCGCTGCGTGA
			TGAAGTCGCGGACCTGGAAGCCGCTGGAATTGGCATCA
			TTCAGATTGACGAACCGGCATTGCGCGAAGGTTTACCA
			CTGCGTCGCAGCGACTGGGATGCCTATCTCCAGTGGGG
			CGTGGAGGCTTTCCGTATCAACGCCGCCGTGGCGAAAG
			ATGACACACAAATCCACACTCACATGTGTTACTGCGAG
			TTCAACGACATCATGGATTCGATTGCGGCGCTGGACGC
			AGACGTCATCACCATCGAAACCTCGCGTTCCGACATGG
			AGTTGCTGGAGTCGTTTGAAGAGTTTGATTATCCAAAT
			GAAATCGGTCCTGGCGTCTATGACATTCACTCGCCAAA
			CGTACCGAGCGTGGAATGGATTGAAGCCTTGCTGAAGA
			AAGCGGCAAAACGCATTCCGGCAGAGCGTCTGTGGGTC
			AACCCGGACTGTGGCCTGAAAACGCGCGGCTGGCCAGA
			AACCCGCGCGGCACTGGCGAACATGGTGCAGGCGGCGC
			AGAATTTGCGTCGGGGA
glyA	Streptomyces	AL939123	ATGTCGCTTCTGAACACACCCCTGCACGAGCTGGACCC	149
	coelicolor		GGACGTCGCCGCCGCCGTCGACGCCGAGCTGGACCGCC
			AGCAGTCCACCCTCGAGATGATCGCGTCGGAGAACTTC
			GCCCCGGTCGCGGTCATGGAGGCCCAGGGCTCGGTCCT
			CACCAACAAGTACGCCGAGGGCTACCCCGGCCGCCGCT
			ACTACGGCGGCTGCGAGCACGTCGACGTGGTCGAGCAG
			ATCGCCATCGACCGGGTCAAGGCGCTCTTCGGCGCCGA
			GCACGCCAACGTGCAGCCGCACTCGGGCGCCCAGGCCA
			ACGCGGCCGCGATGTTCGCGCTGCTCAAGCCCGGCGAC
			ACGATCATGGGTCTGAACCTCGCGCACGGCGGGCACCT
			GACCCACGGCATGAAGATCAACTTCTCCGGCAAGCTCT
			ACAACGTGGTCCCCTACCACGTCGGCGACGACGGCCAG
			GTCGACATGGCCGAGGTGGAGCGCCTGGCCAAGGAGAC
			CAAGCCGAAGCTGATCGTGGCGGGCTGGTCGGCCTACC
			CGCGTCAGCTGGACTTCGCCGCGTTCCGCAAGGTCGCG
			GACGAGGTCGGCGCGTACCTGATGGTCGACATGGCGCA
			CTTCGCCGGTCTGGTCGCGGCGGGCCTGCACCCGAACC
			CGGTCCCGCACGCCCACGTCGTCACCACGACCACCCAC
			AAGACGCTGGGCGGTCCGCGCGGCGGTGTGATCCTCTC
			CACGGCCGAGCTGGCCAAGAAGATCAACTCCGCCGTCT
			TCCCCGGTCAGCAGGGTGGCCCGCTGGAGCACGTGGTG
			GCCGCCAAGGCCGTCGCCTTCAAGGTCGCCGCGAGCGA
			GGACTTCAAGGAGCGCCAGGGCCGTACGCTGGAGGGTG
			CCCGCATCCTGGCCGAGCGCCTGGTGCGGGACGACGCG
			AAGGCCGCGGGCGTCTCCGTCCTGACCGGCGGCACGGA
			CGTCCACCTGGTCCTGGTGGACCTGCGCGACTCCGAGC
			TGGACGGACAGCAGGCCGAGGACCGCCTCCACGAGGTC
			GGCATCACGGTCAACCGCAACGCCGTCCCGAACGACCC
			GCGCCCGCCGATGGTGACCTCCGGTCTGCGCATCGGTA
			CGCCGGCCCTGGCGACCCGCGGCTTCACCGCCGAGGAC
			TTCGCCGAGGTCGCGGACGTGATCGCCGAGGCGCTGAA
			GCCGTCCTACGACGCGGAGGCCCTCAAGGCCCGGGTGA
			AGACCCTGGCCGACAAGCACCCGCTGTACCCGGGTCTG
			AACAAGTAG
glyA	Thermobifida	NZ_AAAQ010	GTGAAGGTTAGGAAACTCATGACCGCCCAGAGCACTTC	150
	fusca	00038	GCTCACCCAGTCGCTGGCTCAGCTCGACCCTGAGGTCG
			CGGCAGCCGTGGACGCCGAGCTCGCCCGCCAGCGCGAC
			ACCTTGGAGATGATCGCCTCCGAAAACTTTGCGCCCCG
			GGCGGTGCTGGAGGCGCAAGGCACGGTGCTGACCAACA
			AGTACGCGGAAGGCTACCCGGGCCGCCGCTACTACGGC
			GGGTGTGAGCACGTGGACGTCATCGAACAGCTGGCCAT
			CGACCGTGCCAAGGCCCTGTTCGGTGCCGAGCACGCCA
			ACGTGCAGCCGCACTCGGGCGCTCAGGCGAACACCGCC
			GTGTACTTTGCGCTGCTGCAGCCGGGCGACACCATCCT
			GGGCCTGGACCTCGCACACGGCGGGCACCTCACCCACG
			GCATGCGGATCAACTACTCCGGCAAGATCCTCAACGCC
			GTGGCCTACCACGTACGCGAGTCCGACGGCCTGATCGA
			CTACGACGAGGTCGAAGCGCTAGCCAAGGAGCACCAGC
			CGAAACTGATCATCGCGGGCTGGTCGGCGTACCCGCGC
			CAGTTGGACTTTGCCCGGTTCCGGGAGATCGCCGACCA
			GACAGGCGCCCTCCTCATGGTGGATATGGCGCATTTCG
			CGGGTCTGGTCGCGGCTGGACTGCACCCCAACCCGGTC
			CCCTACGCCGACGTAGTGACCACCACCACCCACAAGAC
			CTTGGGCGGGCCGCGAGGCGGGCTCATCCTGGCCAAGG
			AGGAGCTGGGCAAGAAGATCAACTCGGCGGTGTTCCCG
			GGGATGCAGGGCGGTCCGCTCCAGCACGTCATCGCTGC
			CAAGGCCGTAGCGTTGAAGGTCGCGGCCAGCGAAGAGT
			TCGCTGAGCGGCAGCGGCGCACCCTTTCCGGCGCGAAG
			ATCCTCGCCGAGCGGCTCACCCAGCCTGACGCGGCCGA
			GGCCGGTATTCGGGTGCTGACCGGCGGCACCGACGTCC
			ACCTGGTCCTGGTCGACCTGGTCAACTCGGAACTCAAC
			GGCAAAGAGGCGGAGGACCGGCTGCACGAGATCGGTAT
			CACGGTCAACCGCAACGCGGTCCCCAACGACCCGCGGC
			CGCCCATGGTCACGTCGGGACTGCGGATCGGCACCCCG
			GCTCTCGCCACCCGCGGTTTCGGCGACGCCGACTTCGC
			TGAGGTCGCCGACATCATCGCTGAGGCGCTCAAGCCGG
			GCTTCGACGCGGCGACCCTGCGCTCCCGCGTCCAGGCG
			CTGGCCGCCAAGCACCCGCTCTACCCTGGACTGTGA
glyA	Mycobacterium	E006993	ATGTCTGCCCCGCTCGCTGAGGTTGACCCCGATATCGC	151
	tuberculosis		CGAGTTGCTGGCCAAGGAGCTTGGTCGGCAACGAGACA
	(use this to		CCCTGGAGATGATCGCCTCGGAGAACTTCGCACCGCGC
	clone M.		GCTGTGCTGCAGGCCCAGGGCAGTGTGCTGACCAACAA
	smegmatis		GTACGCCGAGGGACTGCCCGGGCGGCGCTACTACGGCG
	gene)		GTTGTGAGCACGTCGACGTGGTGGAAAACCTCGCCCGC
			GACCGAGCCAAGGCGTTGTTCGGTGCCGAATTCGCCAA
			TGTGCAACCGCATTCGGGCGCTCAGGCCAACGCCGCGG
			TGCTGCATGCGCTGATGTCACCCGGCGAGCGGCTGTTG
			GGTCTGGACCTGGCCAACGGTGGTCACCTGACCCATGG
			CATGCGGCTGAACTTCTCCGGCAAGCTCTACGAGAATG
			GCTTCTACGGCGTCGACCCGGCGACACATCTGATCGAC
			ATGGATGCGGTGCGGGCCACCGCACTCGAATTCCGCCC
			GAAGGTGATCATCGCCGGCTGGTCGGCCTACCCGCGGG
			TGCTCGACTTCGCGGCGTTCCGGTCGATCGCCGACGAG
			GTCGGGGCCAAGTTGCTCGTGGACATGGCGCATTTCGC
			GGGTCTGGTCGCCGCGGGGTTGCACCCGTCGCCGGTGC
			CGCACGCGGATGTGGTGTCCACCACCGTGCACAAGACG
			CTCGGCGGCGGCCGCTCCGGCCTGATCGTCGGTAAGCA
			GCAGTACGCCAAGGCGATCAACTCGGCGGTGTTTCCCG
			GGCAGCAGGGCGGTCCGCTCATGCACGTCATTGCCGGC
			AAGGCGGTCGCGTTGAAGATCGCCGCCACACCCGAATT
			TGCCGACCGGCAGCGGCGCACGCTGTCCGGGGCCCGGA
			TCATTGCCGATCGACTGATGGCTCCCGATGTCGCCAAG
			GCCGGTGTGTCGGTGGTCAGCGGCGGCACCGACGTCCA
			CCTGGTGCTGGTCGATCTGCGTGATTCCCCACTGGATG
			GCCAGGCCGCCGAGGACCTGCTGCACGAGGTCGGCATC
			ACGGTCAACCGCAACGCCGTCCCCAATGATCCCCGACC
			GCCGATGGTGACCTCGGGCCTGCGGATAGGCACGCCCG
			CGCTGGCGACCCGCGGCTTCGGCGACACCGAGTTCACC
			GAGGTCGCCGACATTATTGCGACCGCGCTGGCGACCGG
			CAGTTCCGTTGATGTGTCGGCGCTTAAGGATCGGGCGA
			CCCGGCTGGCCAGGGCGTTTCCGCTCTACGACGGGCTC
			GAGGAGTGGAGTCTGGTCGGCCGCTGA
glyA	Mycobacterium	AL049491	ATGGTCGCGCCGCTGGCTGAAGTCGACCCGGATATCGC	152
	leprae (use this		CGAGCTACTGGGCAAAGAGCTAGGCCGGCAACGGGACA
	to clone M.		CCTTGGAGATGATCGCTTCAGAGAACTTTGTGCCGCGC
	smegmatis		TCGGTTCTACAGGCCCAAGGCAGCGTGCTGACCAACAA
	gene)		GTACGCTGAGGGGTTGCCCGGCCGACGCTATTACGACG
			GCTGCGAGCACGTCGACGTCGTGGAGAACATCGCCCGC
			GACCGGGCCAAGGCGCTGTTCGGTGCCGACTTCGCCAA
			CGTGCAGCCGCACTCGGGGGCCCAGGCCAACGCCGCGG
			TACTGCACGCGCTGATGTCTCCGGGGGAGCGGCTGCTG
			GGTCTGGATCTCGCCAATGGCGGTCATCTGACGCATGG
			CATGCGGCTGAACTTCTCCGGCAAGCTGTATGAAACCG
			GCTTTTATGGCGTCGACGCGACAACGCATCTCATCGAT
			ATGGACGCGGTGCGGGCCAAGGCGCTCGAATTCCGCCC
			GAAGGTGCTGATCGCTGGCTGGTCGGCCTATCCGCGGA
			TTCTGGACTTCGCTGCTTTTCGGTCGATCGCAGACGAA
			GTCGGCGCCAAGCTGTGGGTCGACATGGCGCATTTCGC
			GGGCCTGGTTGCGGTGGGGTTGCACCCGTCTCCAGTGC
			CGCATGCAGATGTGGTGTCCACGACCGTTCACAAGACT
			CTTGGCGGGGGCCGTTCCGGTTTGATCCTGGGCAAGCA
			GGAGTTCGCCACGGCCATCAACTCAGCGGTGTTTCCTG
			GCCAGCAGGGTGGACCGCTTATGCATGTCATCGCGGGC
			AAGGCGGTCGCGCTGAAGATTGCTACCACGCCTGAGTT
			CACCGACCGGCAGCAGCGCACGCTGGCCGGCGCCCGGA
			TTCTCGCCGATCGGCTTACCGCCGCTGATGTCACCAAG
			GCCGGGGTGTCGGTGGTCAGTGGTGGCACTGACGTCCA
			CCTAGTGCTGGTCGACCTGCGCAACTCCCCGTTCGACG
			GCCAGGCAGCAGAAGATCTGCTGCACGAGGTCGGCATC
			ACTGTCAACCGCAACGTGGTTCCCAATGACCCCCGGCC
			GCCGATGGTGACCTCAGGCCTGCGGATAGGAACCCCCG
			CGCTGGCAACCCGAGGGTTCGGTGAAGCGGAGTTCACC
			GAGGTCGCGGACATCATCGCGACGGTGCTGACCACTGG
			TGGCAGTGTCGATGTGGCCGCGCTGCGGCAGCAGGTTA
			CCCGACTTGCCAGGGACTTCCCGCTCTACGGGGGACTT
			GAGGACTGGAGCTTGGCCGGTCGCTAG
glyA	Lactobacillus	AL935258	ATGAATTACCAGGAACAAGATCCAGAAGTATGGGCTGC	153
	plantarum		GATTAGTAAGGAACAGGCACGGCAACAACATAATATTG
			AGTTGATTGCTTCTGAGAACATCGTTTCAAAGGGCGTC
			CGGGCAGCGCAGGGGAGTGTGCTGACCAATAAATACTC
			TGAAGGCTATCCGGGTCACCGCTTTTACGGTGGTAACG
			AATACATTGACCAAGTGGAAACCTTAGCAATTGAACGG
			GCTAAGAAATTATTTGGTGCGGAATATGCTAATGTGCA
			ACCACACTCTGGTTCCCAAGCCAATGCGGCTGCATATA
			TGGCACTGATTCAACCTGGTGACCGGGTGATGGGGATG
			TCACTAGATGCTGGGGGACACTTAACACATGGATCTAG
			TGTGAACTTCTCTGGTAAACTTTACGATTTTCAAGGTT
			ATGGGCTCGATCCTGAAACCGCAGAATTAAACTATGAT
			GCAATTCTTGCACAAGCACAAGATTTTCAACCAAAGTT
			AATCGTTGCGGGGGCTTCTGCTTATAGTCGATTGATTG
			ATTTCAAGAAGTTTCGCGAGATTGCAGATCAAGTTGGG
			GCCTTATTGATGGTTGATATGGCTCATATTGCCGGCTT
			AGTTGCGGCCGGGCTACATCCTAATCCAGTGCCATATG
			CTGATGTGGTTACGACAACGACGCACAAAACGTTACGG
			GGGCCCCGTGGCGGTATGATTTTAGCGAAAGAAAAGTA
			TGGCAAGAAGATCAACTCAGCCGTTTTCCCTGGCAATC
			AGGGTGGGCCGTTGGATCACGTAATTGCGGGTAAAGCG
			ATTGCTTTGGGCGAAGACTTACAGCCTGAGTTTAAGGT
			TTATGCCCAACATATCATTGATAATGCCAAGGCAATGG
			CGAAGGTCTTCAATGACTCTGACTTGGTTCGGGTTATT
			TCTGGTGGCACGGACAATCATTTAATGACGATTGATGT
			CACTAAGTCTGGTTTGAACGGTCGCCAAGTACAAGATC
			TGTTAGATACGGTTTATATTACGGTCAACAAAGAAGCG
			ATTCCGAATGAGACGTTAGGGGCTTTCAAGACCTCTGG
			TATTCGGTTGGGAACACCTGCGATTACGACCCGTGGTT
			TTGACGAAGCTGATGCAACTAAGGTCGCTGAATTGATT
			TTGCAAGCGTTACAAGCACCGACAGATCAAGCAAATCT
			AGATGACGTTAAACAGCAAGCAATGGCTTTAACAGCGA
			AGCACCCGATCGATGTTGATTAA
glyA	Corynebacterium	AF327063	ATGACCGATGCCCACCAAGCGGACGATGTCCGTTACCA	264
	glutamicum		GCCACTGAACGAGCTTGATCCTGAGGTGGCTGCTGCCA
			TCGCTGGGGAACTTGCCCGTCAACGCGATACATTAGAG
			ATGATCGCGTCTGAGAACTTCGTTCCCCGTTCTGTTTT
			GCAGGCGCAGGGTTCTGTTCTTACCAATAAGTATGCCG
			AGGGTTACCCTGGCCGCCGTTACTACGGTGGTTGCGAA
			CAAGTTGACATCATTGAGGATCTTGCACGTGATCGTGC
			GAAGGCTCTCTTCGGTGCAGAGTTCGCCAATGTTCAGC
			CTCACTCTGGCGCACAGGCTAATGCTGCTGTGCTGATG
			ACTTTGGCTGAGCCAGGCGACAAGATCATGGGTCTGTC
			TTTGGCTCATGGTGGTCACTTGACCCACGGAATGAAGT
			TGAACTTCTCCGGAAAGCTGTACGAGGTTGTTGCGTAC
			GGTGTTGATCCTGAGACCATGCGTGTTGATATGGATCA
			GGTTCGTGAGATTGCTCTGAAGGAGCAGCCAAAGGTAA
			TTATCGCTGGCTGGTCTGCATACCCTCGCCACCTTGAT
			TTCGAGGCTTTCCAGTCTATTGCTGCGGAAGTTGGCGC
			GAAGCTGTGGGTCGATATGGCTCACTTCGCTGGTCTTG
			TTGCTGCTGGTTTGCACCCAAGCCCAGTTCCTTACTCT
			GATGTTGTTTCTTCCACTGTCCACAAGACTTTGGGTGG
			ACCTCGTTCCGGCATCATTCTGGCTAAGCAGGAGTACG
			CGAAGAAGCTGAACTCTTCCGTATTCCCAGGTCAGCAG
			GGTGGTCCTTTGATGCACGCAGTTGCTGCGAAGGCTAC
			TTCTTTGAAGATTGCTGGCACTGAGCAGTTCCGTGACc
			GTCAGGCTCGCACGTTGGAGGGTGCTCGCATTCTTGCT
			GAGCGTCTGACTGCTTCTGATGCGAAGGCCGCTGGCGT
			GGATGTCTTGACCGGTGGCACTGATGTGCACTTGGTTT
			TGGCTGATCTGCGTAACTCCCAGATGGATGGCCAGCAG
			GCGGAAGATCTGCTGCACGAGGTTGGTATCACTGTGAA
			CCGTAACGCGGTTCCTTTCGATCCTCGTCCACCAATGG
			TTACTTCTGGTCTGCGTATTGGTACTCCTGCGCTGGCT
			ACCCGTGGTTTCGATATTCCTGCATTCACTGAGGTTGC
			AGACATCATTGGTACTGCTTTGGCTAATGGTAAGTCCG
			CAGACATTGAGTCTCTGCGTGGCCGTGTAGCAAAGCTT
			GCTGCAGATTACCCACTGTATGAGGGCTTGGAAGACTG
			GACCATCGTCTAA
glyA	Escherichia coli	V00283	ATGTTAAAGCGTGAAATGAACATTGCCGATTATGATGC	265
			CGAACTGTGGCAGGCTATGGAGCAGGAAAAAGTACGTC
			AGGAAGAGCACATCGAACTGATCGCCTCCGAAAACTAC
			ACCAGCCCGCGCGTAATGCAGGCGCAGGGTTCTCAGCT
			GACCAACAAATATGCTGAAGGTTATCCGGGCAAACGCT
			ACTACGGCGGTTGCGAGTATGTTGATATCGTTGAACAA
			CTGGCGATCGATCGTGCGAAAGAACTGTTCGGCGCTGA
			CTACGCTAACGTCCAGCCGCACTCCGGCTCCCAGGCTA
			ACTTTGCGGTCTACACCGCGCTGCTGGAACCAGGTGAT
			ACCGTTCTGGGTATGAACCTGGCGCATGGCGGTCACCT
			GACTCACGGTTCTCCGGTTAACTTCTCCGGTAAACTGT
			ACAACATCGTTCCTTACGGTATCGATGCTACCGGTCAT
			ATCGACTACGCCGATCTGGAAAAACAAGCCAAAGAACA
			CAAGCCGAAAATGATTATCGGTGGTTTCTCTGCATATT
			CCGGCGTGGTGGACTGGGCGAAAATGCGTGAAATCGCT
			GACAGCATCGGTGCTTACCTGTTCGTTGATATGGCGCA
			CGTTGCGGGCCTGGTTGCTGCTGGCGTCTACCCGAACC
			CGGTTCCTCATGCTCACGTTGTTACTACCACCACTCAC
			AAAACCCTGGCGGGTCCGCGCGGCGGCCTGATCCTGGC
			GAAAGGTGGTAGCGAAGAGCTGTACAAAAAACTGAACT
			CTGCCGTTTTCCCTGGTGGTCAGGGCGGTCCGTTGATG
			CACGTAATCGCCGGTAAAGCGGTTGCTCTGAAAGAAGC
			GATGGAGCCTGAGTTCAAAACTTACCAGCAGCAGGTCG
			CTAAAAACGCTAAAGCGATGGTAGAAGTGTTCCTCGAG
			CGCGGCTACAAAGTGGTTTCCGGCGGCACTGATAACCA
			CCTGTTCCTGGTTGATCTGGTTGATAAAAACCTGACCG
			GTAAAGAAGCAGACGCCGCTCTGGGCCGTGCTAACATC
			ACCGTCAACAAAAACAGCGTACCGAACGATCCGAAGAG
			CCCGTTTGTGACCTCCGGTATTCGTGTAGGTACTCCGG
			CGATTACCCGTCGCGGCTTTAAAGAAGCCGAAGCGAAA
			GAACTGGCTGGCTGGATGTGTGACGTGCTGGACAGCAT
			CAATGATGAAGCCGTTATCGAGCGCATCAAAGGTAAAG
			TTCTCGACATCTGCGCACGTTACCCGGTTTACGCATAA
metE	Thermobifida	NZ_AAAQ010	ATGGCTTCGAGGGCGGCCAGCACCGGTTCCCACTCCGC	154
	fusca	00010	GCCGATCTCCAGCAGCAGCGGGCGTCGGCTCGCGACGA
			AGGCCGCCAGTTCGGCATCGACAAGGGGGCGCACGAAG
			GCGACGGGAGACAAGTGCGAGGAGCTCATAAGGGCAGG
			CTACCGATTGTTCCGCCGCCCGTCTTCACCACGACACA
			CCCAAACCCCACCGATATGGTCGATTACAGTGGGAGAC
			ATGCTCGGATCACCCACGCCGCGCCCGGCGCCTCGTCC
			GCGCCGTATCAGCGAACTGTTGGCGCGTAAAGAGCCCA
			CGTTCTCCTTCGAGTTCTTCCCCCCGAAAACGCCCGAG
			GGGGAGCGCATGCTTTGGCGGGCGATCCGGGAGATCGA
			GGCCCTACGCCCTTCCTTCGTCTCGGTGACCTACGGTG
			CGGGCGGCAGCACCCGGGACCGGACCGTGAACGTCACC
			GAGAAGATCGCCACCAACACCACTCTGCTGCCCGTGGC
			GCACATCACCGCGGTCAACCACTCGGTGCGGGAGCTCC
			GCCACCTCATCGGCCGGTTCGCGGCGGCGGGGGTGTGC
			AACATGCTCGCGCTGCGCGGCGACCCGCCCGGCGACCC
			GCTGGGCGAATGGGTCAAGCACCCGGAGGGCCTCACCC
			ACGCCGAAGAACTGGTGCGGCTGATCAAGGAGAGCGGT
			GACTTCTGCGTCGGGGTGGCCGCATTCCCCTACAAGCA
			CCCCCGCTCCCCCGACGTGGAGACCGACACGGACTTCT
			TCGTCCGCAAATGCCGGGCAGGAGCGGACTACGCGATC
			ACCCAGATGTTCTTCGAAGCCGAGGACTACCTGCGGCT
			GCGGGACCGGGTCGCGGCCCGGGGCTGCGACGTGCCCA
			TCATCCCTGAGATCATGCCGGTCACGAAGTTCAGCACG
			ATCGCCCGCTCCGAGCAGTTGTCGGGAGCGCCGTTCCC
			CCGCAGGCTGGCGGAAGAGTTCGAACGGGTCGCCGACG
			ACCCCGAGGCGGTGCGCGCGCTCGGTATCGAGCACGCC
			ACTCGGCTGTGCGAACGGCTCCTCGCCGAAGGGGCGCC
			GGGCATCCACTTCATCACGTTCAACCGTTCGACGGCGA
			CCCGCGAGGTCTACCACCGGCTCGTGGGCGCCACCCAG
			CCGGCAGCGGTAGCTGCGCTGCCATGA
metE	Streptomyces	AL939111	ATGGCCCTCGGAACCGCAAGCACGAGGACGGATCGCGC	155
	coelicolor		CCGCACGGTGCGTGACATCCTCGCCACCGGCAAGACGA
			CGTACTCGTTCGAGTTCTCGGCGCCGAAGACGCCCAAG
			GGCGAGAGGAACCTCTGGAGCGCGCTGCGGCGGGTCGA
			GGCCGTGGCCCCGGACTTCGTCTCCGTGACCTACGGCG
			CCGGCGGCTCCACGCGCGCCGGCACGGTCCGCGAGACC
			CAGCAGATCGTCGCCGACACCACGCTGACCCCGGTGGC
			CCACCTCACCGCCGTCGACCACTCCGTCGCCGAGCTGC
			GCAACATCATCGGCCAGTACGCCGACGCCGGGATCCGC
			AACATGCTGGCCGTGCGCGGCGACCCGCCCGGCGACCC
			GAACGCCGACTGGATCGCGCACCCCGAGGGCCTGACCT
			ACGCGGCCGAACTGGTCAGGCTCATCAAGGAGTCGGGC
			GACTTCTGCGTCGGCGTCGCGGCCTTCCCCGAGATGCA
			CCCGCGCTCCGCCGACTGGGACACGGACGTCACGAACT
			TCGTCGACAAGTGCCGGGCCGGCGCCGACTACGCCATC
			ACCCAGATGTTCTTCCAGCCCGACTCCTATCTCCGGCT
			GCGCGACCGGGTCGCCGCGGCCGGCTGCGCGACCCCGG
			TCATCCCCGAGGTCATGCCGGTGACCAGTGTGAAGATG
			CTGGAGAGGTTGCCGAAGCTCAGCAACGCCTCGTTCCC
			GGCGGAGTTGAAAGAGCGGATCCTCACAGCCAAGGACG
			ATCCGGCGGCTGTACGCTCGATCGGCATCGAGTTCGCC
			ACGGAGTTCTGCGCGCGGCTGCTGGCCGAGGGAGTGCC
			AGGACTGCACTTCATCACGCTCAACAACTCCACGGCGA
			CGCTGGAAATCTACGAGAACCTGGGCCTGCACCACCCA
			CCGCGGGCCTAG
metE	Coryne-	AX374883	TTGGTGGAGGTGAATAAATGCCAGAGGCAGTCCCAACA	266
	bacterium		AAACACTCTCATCACACTAAGATACCCAGGCATGTCCC
	glutamicum		TAACGAACATCCCAGCCTCATCTCAATGGGCAATTAGC
			GACGTTTTGAAGCGTCCTTCACCCGGCCGAGTACCTTT
			TTCTGTCGAGTTTATGCCACCCCGCGACGATGCAGCTG
			AAGAGCGTCTTTACCGCGCAGCAGAGGTCTTCCATGAC
			CTCGGTGCATCGTTTGTCTCCGTGACTTATGGTGCTGG
			CGGATCAACCCGTGAGAGAACCTCACGTATTGCTCGAC
			GATTAGCGAAACAACCGTTGACCACTCTGGTGCACCTG
			ACCCTGGTTAACCACACTCGCGAAGAGATGAAGGCAAT
			TCTTCGGGAATACCTAGAGCTGGGATTAACAAACCTGT
			TGGCGCTTCGAGGAGATCCGCCTGGAGACCCATTAGGC
			GATTGGGTGAGCACCGATGGAGGACTGAACTATGCCTC
			TGAGCTCATCGATCTTATTAAGTCCACTCCTGAGTTCC
			GGGAATTCGACCTCGGTATCGCCTCCTTCCCCGAAGGG
			CATTTCCGGGCGAAAACTCTAGAAGAAGACACCAAATA
			CACTCTGGCGAAGCTGCGTGGAGGGGCAGAGTACTCCA
			TCACGCAGATGTTCTTTGATGTGGAAGACTACCTGCGA
			CTTCGTGATCGCCTTGTCGCTGCAGACCCCATTCATGG
			TGCGAAGCCAATCATTCCTGGCATCATGCCCATTACCG
			AGCTGCGGTCTGTGCGTCGACAGGTCGAACTCTCTGGT
			GCTCAATTGCCGAGCCAACTAGAAGAATCACTTGTTCG
			AGCTGCAAACGGCAATGAAGAAGCGAACAAAGACGAGA
			TCCGCAAGGTGGGCATTGAATATTCCACCAATATGGCA
			GAGCGACTCATTGCCGAAGGTGCGGAAGATCTGCACTT
			CATGACGCTTAACTTCACCCGTGCAACCCAAGAAGTGT
			TGTACAACCTTGGCATGGCGCCTGCTTGGGGAGCAGAG
			CACGGCCAAGACGCGGTGCGTTAA
metE	Escherichia coli	NC_000913	ATGAGCTTTTTTCACGCCAGCCAGCGGGATGCCCTGAA	267
			TCAGAGCCTGGCAGAAGTCCAGGGGCAGATTAACGTTT
			CGTTCGAGTTTTTCCCGCCGCGTACCAGTGAAATGGAG
			CAGACCCTGTGGAACTCCATCGATCGCCTTAGCAGCCT
			GAAACCGAAGTTTGTATCGGTGACCTATGGCGCGAACT
			CCGGCGAGCGCGACCGTACGCACAGCATTATTAAAGGC
			ATTAAAGATCGCACTGGTCTGGAAGCGGCACCGCATCT
			TACTTGCATTGATGCGACGCCCGACGAGCTGCGCACCA
			TTGCACGCGACTACTGGAATAACGGTATTCGTCATATC
			GTGGCGCTGCGTGGCGATCTGCCGCCGGGAAGTGGTAA
			GCCAGAAATGTATGCTTCTGACCTGGTGACGCTGTTAA
			AAGAAGTGGCAGATTTCGATATCTCCGTGGCGGCGTAT
			CCGGAAGTTCACCCGGAAGCAAAAAGCGCTCAGGCGGA
			TTTGCTTAATCTGAAACGCAAAGTGGATGCCGGAGCCA
			ACCGCGCGATTACTCAGTTCTTCTTCGATGTCGAAAGC
			TACCTGCGTTTTCGTGACCGCTGTGTATCGGCGGGCAT
			TGATGTGGAAATTATTCCGGGAATTTTGCCGGTATCTA
			ACTTTAAACAGGCGAAGAAATTTGCCGATATGACCAAC
			GTGCGTATTCCGGCGTGGATGGCGCAAATGTTCGACGG
			TCTGGATGATGATGCCGAAACCCGCAAACTGGTTGGCG
			CGAATATTGCCATGGATATGGTGAAGATTTTAAGCCGT
			GAAGGAGTGAAAGATTTCCACTTCTATACGCTTAACCG
			TGCTGAAATGAGTTACGCGATTTGCCATACGCTGGGGG
			TTCGACCTGGTTTA
cysE	Mycobacterium	AE007080	ATGCTGACGGCCATGCGGGGCGACATCCGAGCAGCCCG	156
	tuberculosis		GGAGCGGGATCCGGCGGCCCCTACCGCGCTGGAAGTCA
	(use this to		TCTTCTGCTACCCGGGCGTGCACGCCGTGTGGGGCCAC
	clone M.		CGCCTCGCCCACTGGCTGTGGCAGCGTGGCGCCAGGCT
	smegmatis		GCTCGCGCGGGCAGCTGCCGAATTCACTCGCATCCTGA
	gene)		CCGGTGTAGATATCCACCCCGGTGCCGTCATCGGTGCT
			CGCGTGTTCATCGACCACGCGACCGGCGTGGTGATCGG
			AGAAACCGCGGAGGTCGGCGACGACGTCACGATCTATC
			ACGGCGTCACTCTCGGCGGCAGTGGCATGGTTGGCGGG
			AAACGCCATCCCACCGTCGGTGACCGCGTGATCATCGG
			CGCCGGGGCCAAGGTCCTCGGTCCGATCAAGATCGGCG
			AGGACAGCCGGATCGGCGCCAATGCCGTCGTGGTCAAG
			CCCGTCCCGCCGAGCGCGGTGGTGGTCGGGGTGCCCGG
			GCAGGTCATCGGCCAAAGCCAGCCCAGTCCCGGCGGCC
			CGTTTGATTGGAGGCTGCCCGATCTCGTGGGAGCCAGC
			CTCGATTCGCTGCTCACCAGGGTGGCCAGGCTGGACGC
			CCTCGGCGGCGGCCCGCAAGCAGCAGGAGTCATCCGGC
			CACCCGAAGCCGGGATATGGCACGGCGAGGACTTCTCG
			ATCTGA
cysE	Mycobacterium	Z98741	ATGTTTGCGGCAATCCGGCGTGATATCCAGGCAGCAAG	157
	leprae (use this		ACAGCGAGATCCGGCACAGCCCACGGTGCTGGAGGTCA
	to clone M.		TCTGCTGCTACCCAGGCGTGCACGCCGTCTGGGGTCAT
	smegmatis		CGAATCAGTCACTGGTTGTGGAATCGTCGCGCCAGACT
	gene)		GGCCGCGCGGGCGTTCGCCGAACTCACCCGCATCCTGA
			CTGGGGTCGACATCCACCCCGGTGCCGTGCTCGGAGCC
			GGCCTGTTCATCGATCACGCGACCGGCGTGGTGATCGG
			GGAAACCGCGGAAGTGGGCGATGACGTCACCATCTTCC
			ATGGAGTCACTCTCGGCGGCACCGGCCGGGAAACGGGT
			AAACGTCACCCAACCATCGGGGATCGAGTAACCATCGG
			CGCCGGCGCCAAGGTCCTCGGTGCCATCAAGATCGGCG
			AGGACAGCCGGATTGGCGCCAACGCAGTCGTGGTCAAG
			GAGGTCCCAGCCAGCGCTGTGGCCGTCGGGGTTCCCGG
			ACAAATCATCAGCAGCGACAGCCCGGCCAACGGGGACG
			ATTCTGTGCTGCCCGACTTCGTGGGCGTCAGCCTGCAA
			TCCCTGCTCACCAGGGTGGCCAAGCTGGAAGCCGAAGA
			CGGCGGTTCGCAAACCTACCGCGTCATCCGGCTACCCG
			AAGCCGGGGTTTGGCACGGCGAGGACTTCTCAATCTGA
cysE	Lactobacillus	AL935252	GTGTTTCAGACGGCTCGTGCCATTCTCAATCGTGACCC	158
	plantarum		CGCCGCGATCAATTTGCGGACAGTTATGTTGACCTATC
			CTGGTATTCACGCGCTCGCCTGGTACCGGGTTGCCCAT
			TATTTTGAAACACACCGTTTACCATTATTGGCCGCCTT
			GCTGAGCCAACATGCGGCCCGGCATACCGGGATTCTGA
			TTCACCCGGCCGCGCAAATTGGTCACCGGGTCTTCTTT
			GACCATGGTATTGGTACTGTCATTGGTGCAACGGCGGT
			CATTGAAGACGACGTTACAATTTTACACGGCGTCACTT
			TAGGCGCACGTAAAACCGAACAAGCTGGGCGCCGGCAT
			CCCTATGTTTGTCGCGGTGCTTTCATTGGTGCCCACGC
			CCAACTCTTGGGCCCTATTACGATTGGCGCCAACAGTA
			AAATTGGTGCTGGTGCGATTGTTTTAGACAGCGTTCCC
			GCCCACGTTACTGCGGTCGGTAACCCGGCCCATCTAGT
			TGCCACTCAATTGCATGCTTATCATGAAGCAACCAGCA
			ATCAAGCTTGA
cysE	Corynebacterium	AX405283	ATGCTCTCGACAATAAAAATGATCCGTGAAGATCTCGC	268
	glutamicum		AAACGCTCGTGAACACGATCCAGCAGCCCGAGGCGATT
			TAGAAAACGCAGTGGTTTACTCCGGACTCCACGCCATC
			TGGGCACATCGAGTTGCCAACAGCTGGTGGAAATCCGG
			TTTCCGCGGCCCCGCCCGCGTATTAGCCCAATTCACCC
			GATTCCTCACCGGCATTGAAATTCACCCCGGTGCCACC
			ATTGGTCGTCGCTTTTTTATTGACCACGGAATGGGAAT
			CGTCATCGGCGAAACCGCTGAAATCGGCGAAGGCGTCA
			TGCTCTACCACGGCGTCACCCTCGGCGGACAGGTTCTC
			ACCCAAACCAAGCGCCACCCCACGCTCTGCGACAACGT
			GACAGTCGGCGCGGGCGCAAAAATCTTAGGTCCCATCA
			CCATCGGCGAAGGCTCCGCAATTGGCGCCAATGCAGTT
			GTCACCAAAGACGTGCCGGCAGAACACATCGCAGTCGG
			AATTCCTGCGGTAGCACGCCCACGTGGCAAGACAGAGA
			AGATCAAGCTCGTCGATCCGGACTATTACATTTAA
cysE	Escherichia coli	NC_000913	ATGTCGTGTGAAGAACTGGAAATTGTCTGGAACAATAT	269
			TAAAGCCGAAGCCAGAACGCTGGCGGACTGTGAGCCAA
			TGCTGGCCAGTTTTTACCACGCGACGCTACTCAAGCAC
			GAAAACCTTGGCAGTGCACTGAGCTACATGCTGGCGAA
			CAAGCTGTCATCGCCAATTATGCCTGCTATTGCTATCC
			GTGAAGTGGTGGAAGAAGCCTACGCCGCTGACCCGGAA
			ATGATCGCCTCTGCGGCCTGTGATATTCAGGCGGTGCG
			TACCCGCGACCCGGCAGTCGATAAATACTCAACCCCGT
			TGTTATACCTGAAGGGTTTTCATGCCTTGCAGGCCTAT
			CGCATCGGTCACTGGTTGTGGAATCAGGGGCGTCGCGC
			ACTGGCAATCTTTCTGCAAAACCAGGTTTCTGTGACGT
			TCCAGGTCGATATTCACCCGGCAGCAAAAATTGGTCGC
			GGTATCATGCTTGACCACGCGACAGGCATCGTCGTTGG
			TGAAACGGCGGTGATTGAAAACGACGTATCGATTCTGC
			AATCTGTGACGCTTGGCGGTACGGGTAAATCTGGTGGT
			GACCGTCACCCGAAAATTCGTGAAGGTGTGATGATTGG
			CGCGGGCGCGAAAATCCTCGGCAATATTGAAGTTGGGC
			GCGGCGCGAAGATTGGCGCAGGTTCCGTGGTGCTGCAA
			CCGGTGCCGCCGCATACCACCGCCGCTGGCGTTCCGGC
			TCGTATTGTCGGTAAACCAGACAGCGATAAGCCATCAA
			TGGATATGGACCAGCATTTCAACGGTATTAACCATACA
			TTTGAGTATGGGGATGGGATC
serA	Mycobacterium	AL021287	GTGAGCCTGCCTGTTGTGTTGATCGCCGACAAACTTGC	159
	tuberculosis		CCCATCAACGGTTGCCGCCTTGGGAGATCAGGTCGAGG
	(use this to		TGCGCTGGGTTGACGGTCCGGACCGAGACAAGCTGCTG
	clone M.		GCCGCGGTGCCCGAAGCGGACGCGCTGCTGGTGCGATC
	smegmatis		GGCCACCACGGTTGACGCCGAGGTGCTGGCCGCCGCCC
	gene)		CCAAGCTCAAGATCGTCGCGCGCGCCGGCGTCGGGCTG
			GACAACGTCGACGTGGACGCCGCGACGGCCCGCGGCGT
			GCTGGTGGTCAACGCCCCGACGTCGAACATCCACAGCG
			CCGCGGAGCATGCGCTGGCGCTGCTGCTGGCCGCCTCA
			CGCCAGATTCCGGCGGCCGACGCGTCGCTGCGCGAGCA
			CACCTGGAAGCGTTCGTCGTTTTCCGGTACCGAGATCT
			TCGGCAAAACCGTCGGCGTGGTGGGTCTGGGCCGCATC
			GGGCAGTTGGTCGCCCAGCGGATCGCTGCGTTCGGCGC
			TTACGTCGTCGCCTATGACCCGTACGTTTCGCCGGCCC
			GTGCGGCGCAGCTGGGCATCGAACTGCTGTCCCTGGAC
			GACCTGCTGGCCCGCGCCGATTTCATCTCGGTGCACCT
			ACCGAAAACACCGGAGACGGCGGGACTGATCGACAAGG
			AGGCGCTGGCGAAGACCAAGCCGGGCGTCATCATCGTC
			AACGCCGCGCGCGGCGGCCTGGTGGACGAGGCGGCACT
			GGCCGACGCGATCACCGGCGGCCACGTGCGGGCGGCCG
			GTCTGGACGTGTTCGCCACCGAACCGTGCACCGACAGC
			CCGCTGTTCGAGCTGGCACAGGTGGTGGTCACACCGCA
			TCTGGGTGCGTCCACCGCGGAGGCGCAGGACCGGGCGG
			GCACCGACGTCGCCGAGAGCGTGCGGCTGGCCCTGGCA
			GGGGAATTCGTGCCCGACGCGGTCAACGTCGGCGGCGG
			AGTGGTCAACGAGGAGGTGGCGCCCTGGCTGGATCTGG
			TGCGTAAGCTCGGCGTGCTGGCGGGTGTGTTGTCCGAC
			GAACTGCCGGTGTCGTTGTCGGTGCAGGTGCGCGGTGA
			GCTGGCCGCCGAAGAGGTTGAGGTGCTGCGCCTTTCGG
			CGCTGCGCGGCCTGTTCTCGGCGGTGATCGAGGATGCG
			GTGACATTTGTCAACGCACCGGCATTGGCCGCCGAACG
			TGGCGTCACCGCCGAGATCTGTAAGGCCTCGGAAAGCC
			CCAACCACCGCAGCGTCGTCGACGTTCGCGCGGTCGGC
			GCGGACGGTTCGGTGGTGACCGTCTCGGGCACGCTGTA
			TGGCCCACAGCTGTCGCAGAAGATCGTGCAGATCAACG
			GCCGCCACTTTGATCTGCGCGCCCAGGGGATCAACCTG
			ATCATCCACTACGTCGACCGGCCGGGAGCGCTGGGCAA
			GATCGGCACGTTGCTGGGGACGGCCGGGGTGAATATCC
			AGGCCGCGCAGCTCTCCGAAGACGCCGAAGGCCCGGGC
			GCGACGATTCTGCTGCGGCTGGACCAAGACGTGCCCGA
			CGACGTGCGGACGGCGATCGCGGCGGCGGTGGACGCCT
			ACAAGCTCGAGGTTGTCGATCTGTCGTGA
serA	Mycobacterium	Z99263	GTGGACCTGCCTGTTGTGTTAATTGCCGACAAACTCGC	160
	leprae (use this		CCAATCAACCGTGGCTGCCCTGGGAGACCAAGTCGAGG
	to clone M.		TGCGGTGGGTGGACGGTCCAGACCGGACGAAGCTGTTA
	smegmatis		GCTGCAGTACCCGAGGCCGACGCGTTGTTGGTGCGGTC
	gene)		GGCCACTACTGTCGACGCCGAGGTGCTGGCAGCCGCTC
			CTAAGCTCAAGATCGTCGCCCGTGCCGGGGTAGGGCTA
			GACAACGTTGATGTCGATGCCGCCACCGCGCGCGGTGT
			CCTGGTAGTCAACGCCCCAACGTCGAACATTCACAGCG
			CCGCTGAGCACGCGTTGGCGCTGCTATTGGCAGCTTCT
			CGGCAGATCGCGGAGGCCGACGCCTCACTGCGTGCACA
			CATCTGGAAACGGTCGTCGTTCTCCGGCACCGAAATTT
			TCGGCAAGACCGTCGGCGTGGTGGGGCTGGGTCGGATT
			GGGCAGTTGGTTGCCGCACGGATAGCAGCGTTCGGGGC
			TCACGTTATCGCTTACGACCCGTATGTGGCGCCGGCAC
			GGGCCGCGCAGCTTGGTATCGAGCTGATGTCTTTTGAC
			GATCTCCTAGCCCGGGCCGATTTTATCTCAGTGCATTT
			GCCGAAGACGCCCGAGACGGCGGGCCTGATCGACAAGG
			AGGCGCTGGCCAAAACCAAGCCCGGTGTCATCATTGTC
			AATGCCGCACGCGGCGGCTTAGTGGACGAGGTGGCGCT
			AGCCGATGCGGTGCGCAGCGGACATGTTCGGGCGGCCG
			GTCTAGATGTGTTTGCCACCGAACCGTGCACCGATAGC
			CCGCTGTTTGAACTATCGCAGGTGGTGGTGACACCGCA
			TCTGGGGGCGTCTACCGCCGAAGCCCAGGATCGAGCAG
			GTACTGATGTGGCCGAAAGCGTGCGGCTGGCGCTGGCG
			GGGGAGTTTGTGCCTGACGCGGTCAACGTGGACGGGGG
			CGTGGTCAACGAAGAGGTGGCTCCCTGGCTGGACTTGG
			TGTGCAAGCTTGGGGTGCTGGTAGCCGCGTTATCCGAT
			GAACTGCCGGCGTCGTTGTCGGTGCACGTGCGTGGCGA
			GTTGGCTTCTGAAGACGTTGAAATATTGCGGCTTTCGG
			CCCTACGTGGGCTTTTCTCGACGGTCATAGAGGATGCT
			GTGACGTTCGTCAACGCACCGGCACTGGCCGCCGAACG
			AGGTGTGTCCGCTGAAATCACTACGGGCTCGGAGAGCC
			CCAACCATCGCAGTGTGGTCGACGTGCGGGCGGTCGCC
			TCCGACGGCTCGGTGGTCAACATAGCCGGTACGTTGTC
			TGGGCCGCAACTGGTGCAGAAGATCGTGCAGGTCAATG
			GTCGTAACTTTGATTTGCGTGCGCAGGGCATGAACTTG
			GTGATCAGGTATGTCGACCAACCTGGCGCTCTGGGCAA
			GATTGGCACTTTGCTGGGCGCGGCCGGGGTGAATATCC
			AAGCTGCTCAGCTGTCTGAGGACACCGAGGGGCCAGGT
			GCGACGATTCTGTTGAGGCTGGATCAAGACGTGCCGGG
			TGATGTGCGGTCGGCGATCGTGGCAGCGGTGAGTGCCA
			ACAAGCTTGAGGTAGTCAATCTGTCATGA
serA	Thermobifida	NZ_AAAQ010	GTGGCTGCGACCGCAGTCGAACCCACACGCACTCCCTC	161
	fusca	00025	TAAGGAATTCGTTGTGCCCAAGCCAGTCGTCCTGGTCG
			CGGAAGAACTTTCGCCCGCAGGAATCGCGCTGTTGGAA
			GAGGACTTTGAAGTCCGCCACGTCAACGGCGCCGACCG
			TTCCCAGCTCCTTCCCGCGCTCGCCGGAGTCGACGCGC
			TGATCGTGCGCAGCGCCACCAAAGTGGACGCTGAGGTG
			CTGGCCGCGGCGCCCTCCCTCAAGGTTGTGGCGCGTGC
			GGGCGTCGGACTGGACAACGTGGATGTCGAGGCCGCCA
			CCAAGGCGGGCGTGCTCGTCGTCAACGCGCCCACCTCC
			AACATCATCAGTGCAGCGGAACAGGCCATCAACCTGCT
			CTTGGCCACGGCCCGCAACACTGCTGCTGCCCACGCGG
			CCCTCGTGCGCGGCGAGTGGAAGCGTTCCAAGTACACC
			GGCGTCGAACTGTACGACAAAACCGTCGGCATCGTGGG
			CCTGGGACGGATCGGCGTGCTCGTCGCCCAGCGGCTCC
			AGGCGTTCGGCACCAAGCTGATCGCCTACGACCCCTTC
			GTGCAGCCTGCCCGGGCCGCGCAGCTGGGGGTGGAGCT
			CGTCGAGCTCGACGAGCTGCTGGAGCGCAGCGACTTCA
			TCACGATCCACCTGCCCAAGACGAAGGACACGATCGGC
			CTGATCGGCGAGGAAGAGCTGCGCAAGGTCAAGCCGAC
			GGTCCGGATCATCAACGCTGCGCGCGGCGGGATCGTGG
			ACGAGACGGCCCTCTACCACGCGCTCAAGGAAGGTCGT
			GTGGCCGGCGCTGGGCTGGACGTGTTCGCCAAGGAGCC
			TTGCACGGACAGCCCGCTGTTCGAGCTGGAGAACGTGG
			TGGTGGCTCCGCACCTGGGGGCCAGCACGCACGAGGCG
			CAGGAGAAGGCCGGGACCCAGGTGGCCCGGTCCGTCAA
			GCTTGCGCTCGCCGGCGAGTTCGTGCCGGACGCGGTCA
			ACATCCAGGGCAAGGGCGTGGCCGAGGACATCAAGCCG
			GGGCTGCCGCTGACGGAGAAGCTCGGCCGTATCCTCGC
			CGCGCTCGCCGACGGTGCGATCACCCGGGTCGAGGTGG
			AGGTCCGGGGCGAGATCGTCGCCCACGACGTCAAGGTG
			ATCGAGCTGGCCGCGCTCAAGGGCCTCTTCACGGACAT
			CGTGGAAGAGGCTGTGACCTACGTGAACGCGCCTCTGG
			TAGCCAAGGAGCGCGGTATCGAGGTGAGCCTGACCACC
			GAGGAGGAGAGCCCCGACTGGCGCAACGTCATCACGGT
			GCGGGCCATCCTCTCCGACGGCCAGCGCGTGTCGGTCT
			CGGGCACGCTGACCGGGCCGCGCCAGTTGGAGAAGCTT
			GTCGAGGTCAACGGCTACACCATGGAGATCGCGCCCAG
			CGAGCACATGGCGTTCTTCTCCTACCACGACCGTCCCG
			GTGTGGTCGGCGTAGTCGGCCAACTGCTCGGACAGGCG
			CAGGTGAACATCGCCGGCATGCAGGTCAGCCGGGACAA
			GGAGGGCGGTGCGGCGCTGATCGCGCTGACCGTGGACT
			CGGCGATCCCCGACGAGACCCTCGAGACGATCTCCAAG
			GAGATCGGCGCCGAGATCAGCCGCGTGGACTTGGTTGA
			CTGA
serA	Streptomyces	AL939124	GTGAGCTCGAAACCCGTCGTACTCATCGCTGAAGAGCT	162
	coelicolor		GTCGCCCGCGACCGTGGACGCACTCGGCCCCGACTTCG
			AGATCCGCCACTGCAACGGCGCGGACCGGGCCGAACTG
			CTCCCCGCCATCGCCGACGTGGACGCGATCCTGGTCCG
			CTCCGCGACCAAGGTCGACGCCGAGGCCGTGGCCGCCG
			CCAAGAAGCTCAAGGTCGTCGCGCGCGCCGGGGTCGGC
			CTGGACAACGTCGACGTCTCCGCCGCCACCAAGGCCGG
			CGTGATGGTGGTCAACGCCCCGACCTCCAACATCGTCA
			CCGCCGCCGAGCTGGCCTGCGGCCTGATCGTCGCCACC
			GCCCGCAACATCCCGCAGGCCAACGCCGCGCTGAAGAA
			CGGCGAGTGGAAGCGCAGCAAGTACACCGGCGTGGAGC
			TGGCCGAGAAGACCCTCGGCGTCGTCGGCCTCGGCCGC
			ATCGGCGCGCTCGTCGCGCAGCGCATGTCGGCCTTCGG
			CATGAAGGTCGTCGCCTACGACCCCTACGTGCAGCCCG
			CGCGGGCCGCGCAGATGGGCGTCAAGGTGCTGTCCCTG
			GACGAGCTGCTGGAGGTCTCCGACTTCATCACGGTCCA
			CCTGCCCAAGACCCCCGAGACCCTCGGCCTGATCGGCG
			ACGAGGCGCTGCGCAAGGTCAAGCCGAGCGTCCGCATC
			GTCAACGCCGCGCGCGGCGGCATCGTCGACGAGGAGGC
			GCTGTACTCGGCGCTCAAGGAGGGCCGCGTCGCCGGCG
			CCGGCCTCGACGTGTACGCCAAGGAGCCCTGCACCGAC
			TCGCCGCTGTTCGAGTTCGACCAGGTGGTCGCCACCCC
			GCACCTCGGCGCCTCCACCGACGAGGCCCAGGAGAAGG
			CCGGCATCGCCGTCGCCAAGTCGGTCCGCCTGGCCCTC
			GCCGGTGAGCTGGTCCCCGACGCGGTCAACGTCCAGGG
			CGGTGTCATCGCCGAGGACGTCAAGCCCGGTCTGCCGC
			TCGCCGAGCGCCTCGGCCGCATCTTCACCGCGCTCGCG
			GGTGAGGTCGCCGTCCGCCTCGACGTCGAGGTCTACGG
			CGAGATCACCCAGCACGACGTGAAGGTGCTGGAGCTGT
			CCGCCCTCAAGGGCGTCTTCGAGGACGTCGTCGACGAG
			ACGGTGTCGTACGTCAACGCCCCGCTGTTCGCCCAGGA
			GCGCGGCGTCGAGGTCCGGCTGACCACCAGCTCGGAGT
			CCCCGGAGCACCGCAACGTCGTCATCGTGCGCGGCACC
			CTCTCGGACGGCGAGGAGGTGTCGGTCTCCGGCACGCT
			GGCCGGCCCGAAGCACCTCCAGAAGATCGTCGCCATCG
			GCGAGTACGACGTGGACCTCGCCCTCGCCGACCACATG
			GTCGTCCTGCGCTACGAGGACCGTCCCGGCGTCGTCGG
			CACCGTCGGCCGGATCATCGGCGAGGCGGGTCTCAACA
			TCGCCGGCATGCAGGTCGCCCGCGCGACGGTCGGCGGC
			GAGGCGCTGGCCGTCCTCACCGTCGACGACACGGTGCC
			CTCCGGGGTTCTGGCGGAGGTCGCGGCGGAGATCGGCG
			CCACGTCCGCCCGGTCCGTCAACCTCGTCTGA
serA	Lactobacillus	AL935254	ATGACAAAAGTCTTTATTGCTGGTCAGCTTCCAGCCCA	163
	plantarum		AGCTAATACGTTACTTTTACAAAGTCAGTTAGTCATTG
			ATACTTATACCGGCGATAACCTGATCAGTCACGCGGAA
			CTCATCCGTCGAGTCGCTGATGCCGACTTTTTGATTAT
			CCCACTCTCAACTCAAGTAGATCAAGATGTCTTAGACC
			ACGCCCCACACCTTAAACTGATTGCTAATTTTGGTGCT
			GGCACTAATAACATCGATATCGCGGCAGCAGCTAAGCG
			CCAGATTCCAGTCACGAACACGCCAAACGTTTCGGCGG
			TCGCAACCGCTGAATCAACGGTCGGTTTGATTATCAGC
			CTAGCGCATCGTATCGTGGAAGGCGATCACTTAATGCG
			AACTAGCGGCTTTAACGGTTGGGCGCCACTATTCTTTC
			TCGGCCACAACTTACAAGGCAAGACACTCGGCATCTTA
			GGCCTTGGCCAAATTGGTCAAGCCGTTGCCAAACGATT
			ACACGCCTTTGACATGCCCATCTTATACAGCCAACACC
			ACCGCCTACCGATTAGCCGTGAAACGCAACTTGGCGCA
			ACCTTTGTCTCCCAGGATGAACTTTTACAGCGTGCCGA
			CATCGTCACTTTACACCTGCCGCTTACCACACAAACAA
			CCCATCTAATCGATAACGCTGCTTTTAGCAAAATGAAG
			TCCACGGCGCTCCTCATCAACGCCGCACGGGGGCCAAT
			TGTCGACGAGCAAGCACTTGTGACGGCGCTGCAACAAC
			ATCAAATTGCTGGCGCTGCACTCGACGTCTACGAACAT
			GAACCGCAAGTCACACCTGGTTTGGCCACGATGAACAA
			CGTCATTTTGACACCTCATCTTGGCAACGCAACGGTCG
			AAGCTCGCGATGGCATGGCTACCATTGTCGCGGAGAAT
			GTGATTGCGATGGCCCAACATCAGCCAATCAAGTACGT
			GGTTAACGACGTAACACCAGCATAG
serA	Coryne-	AP005278	GTGCGTTCTGCTACCACTGTCGATGCTGAAGTCATCGC	270
	bacterium		CGCTGCCCCTAACTTGAAGATCGTCGGTCGTGCCGGCG
	glutamicum		TGGGCTTGGACAACGTTGACATCCCTGCTGCCACTGAA
			GCTGGCGTCATGGTTGCTAACGCACCGACCTCTAATAT
			TCACTCCGCTTGTGAGCACGCAATTTCTTTGCTGCTGT
			CTACTGCTCGCCAGATCCCTGCTGCTGATGCGACGCTG
			CGTGAGGGCGAGTGGAAGCGGTCTTCTTTCAACGGTGT
			GGAAATTTTCGGAAAAACTGTCGGTATCGTCGGTTTTG
			GCCACATTGGTCAGTTGTTTGCTCAGCGTCTTGCTGCG
			TTTGAGACCACCATTGTTGCTTACGATCCTTACGCTAA
			CCCTGCTCGTGCGGCTCAGCTGAACGTTGAGTTGGTTG
			AGTTGGATGAGCTGATGAGCCGTTCTGACTTTGTCACC
			ATTCACCTTCCTAAGACCAAGGAAACTGCTGGCATGTT
			TGATGCGCAGCTCCTTGCTAAGTCCAAGAAGGGCCAGA
			TCATCATCAACGCTGCTCGTGGTGGCCTTGTTGATGAG
			CAGGCTTTGGCTGATGCGATTGAGTCCGGTCACATTCG
			TGGCGCTGGTTTCGATGTGTACTCCACCGAGCCTTGCA
			CTGATTCTCCTTTGTTCAAGTTGCCTCAGGTTGTTGTG
			ACTCCTCACTTGGGTGCTTCTACTGAAGAGGCTCAGGA
			TCGTGCGGGTACTGACGTTGCTGATTCTGTGCTCAAGG
			CGCTGGCTGGCGAGTTCGTGGCGGATGCTGTGAACGTT
			TCCGGTGGTCGCGTGGGCGAAGAGGTTGCTGTGTGGAT
			GGATCTGGCTCGCAAGCTTGGTCTTCTTGCTGGCAAGC
			TTGTCGACGCCGCCCCAGTCTCCATTGAGGTTGAGGCT
			CGAGGCGAGCTTTCTTCCGAGCAGGTCGATGCACTTGG
			TTTGTCCGCTGTTCGTGGTTTGTTCTCCGGAATTATCG
			AAGAGTCCGTTACTTTCGTCAACGCTCCTCGCATTGCT
			GAAGAGCGTGGCCTGGACATCTCCGTGAAGACCAACTC
			TGAGTCTGTTACTCACCGTTCCGTCCTGCAGGTCAAGG
			TCATTACTGGCAGCGGCGCGAGCGCAACTGTTGTTGGT
			GCCCTGACTGGTCTTGAGCGCGTTGAGAAGATCACCCG
			CATCAATGGCCGTGGCCTGGATCTGCGCGCAGAGGGTC
			TGAACCTCTTCCTGCAGTACACTGACGCTCCTGGTGCA
			CTGGGTACCGTTGGTACCAAGCTGGGTGCTGCTGGCAT
			CAACATCGAGGCTGCTGCGTTGACTCAGGCTGAGAAGG
			GTGACGGCGCTGTCCTGATCCTGCGTGTTGAGTCCGCT
			GTCTCTGAAGAGCTGGAAGCTGAAATCAACGCTGAGTT
			GGGTGCTACTTCCTTCCAGGTTGATCTTGAC
serA	Escherichia coli	NC_000913	ATGGCAAAGGTATCGCTGGAGAAAGACAAGATTAAGTT	271
			TCTGCTGGTAGAAGGCGTGCACCAAAAGGCGCTGGAAA
			GCCTTCGTGCAGCTGGTTACACCAACATCGAATTTCAC
			AAAGGCGCGCTGGATGATGAACAATTAAAAGAATCCAT
			CCGCGATGCCCACTTCATCGGCCTGCGATCCCGTACCC
			ATCTGACTGAAGACGTGATCAACGCCGCAGAAAAACTG
			GTCGCTATTGGCTGTTTCTGTATCGGAACAAACCAGGT
			TGATCTGGATGCGGCGGCAAAGCGCGGGATCCCGGTAT
			TTAACGCACCGTTCTCAAATACGCGCTCTGTTGCGGAG
			CTGGTGATTGGCGAACTGCTGCTGCTATTGCGCGGCGT
			GCCGGAAGCCAATGCTAAAGCGCACCGTGGCGTGTGGA
			ACAAACTGGCGGCGGGTTCTTTTGAAGCGCGCGGCAAA
			AAGCTGGGTATCATCGGCTACGGTCATATTGGTACGCA
			ATTGGGCATTCTGGCTGAATCGCTGGGAATGTATGTTT
			ACTTTTATGATATTGAAAATAAACTGCCGCTGGGCAAC
			GCCACTCAGGTACAGCATCTTTCTGACCTGCTGAATAT
			GAGCGATGTGGTGAGTCTGCATGTACCAGAGAATCCGT
			CCACCAAAAATATGATGGGCGCGAAAGAAATTTCACTA
			ATGAAGCCCGGCTCGCTGCTGATTAATGCTTCGCGCGG
			TACTGTGGTGGATATTCCGGCGCTGTGTGATGCGCTGG
			CGAGCAAACATCTGGCGGGGGCGGCAATCGACGTATTC
			CCGACGGAACCGGCGACCAATAGCGATCCATTTACCTC
			TCCGCTGTGTGAATTCGACAACGTCCTTCTGACGCCAC
			ACATTGGCGGTTCGACTCAGGAAGCGCAGGAGAATATC
			GGCCTGGAAGTTGCGGGTAAATTGATCAAGTATTCTGA
			CAATGGCTCAACGCTCTCTGCGGTGAACTTCCcGGAAG
			TCTCGCTGCCACTGCACGGTGGGCGTCGTCTGATGCAC
			ATCCACGAAAACCGTCCGGGCGTGCTAACTGCGCTGAA
			CAAAATCTTCGCCGAGCAGGGCGTCAACATCGCCGCGC
			AATATCTGCAAACTTCCGCCCAGATGGGTTATGTGGTT
			ATTGATATTGAAGCCGACGAAGACGTTGCCGAAAAAGC
			GCTGCAGGCAATGAAAGCTATTCCGGGTACCATTCGCG
			CCCGTCTGCTGTAC
lysE	Mycobacterium	Z74025	GTGAACTCACCACTGGTCGTCGGCTTCCTGGCCTGCTT	164
	tuberculosis		CACGCTGATCGCCGCGATTGGCGCGCAGAACGCATTCG
	(use this to		TGCTGCGGCAGGGAATCCAGCGTGAGCACGTGCTGCCG
	clone M.		GTGGTGGCGCTGTGCACGGTGTCCGACATCGTGCTGAT
	smegmatis		CGCCGCCGGTATCGCGGGGTTCGGCGCATTGATCGGCG
	gene)		CACATCCGCGTGCGCTCAATGTCGTCAAGTTTGGCGGC
			GCCGCCTTCCTAATCGGCTACGGGCTACTTGCGGCCCG
			GCGGGCGTGGCGACCTGTTGCGCTGATCCCATCTGGCG
			CCACGCCGGTTCGCTTAGCCGAGGTCCTGGTGACCTGT
			GCGGCATTCACGTTCCTCAACCCACACGTCTACCTCGA
			CACCGTCGTGTTGCTAGGCGCGCTGGCCAACGAGCACA
			GCGACCAGCGCTGGCTGTTCGGCCTCGGCGCGGTCACA
			GCCAGTGCGGTATGGTTCGCCACCCTCGGGTTCGGAGC
			CGGCCGGTTGCGCGGGCTGTTCACCAACCCCGGCTCGT
			GGAGAATCCTCGACGGCCTGATCGCGGTCATGATGGTT
			GCGCTGGGAATCTCGCTGACCGTGACCTAG
lysE	Mycobacterium	Z77162	ATGATGACGCTCAAGGTCGCGATCGGCCCGCAAAACGC	165
	tuberculosis		ATTTGTCCTGCGCCAAGGAATTAGGCGAGAATACGTGC
	(use this to		TGGTCATTGTGGCGCTGTGCGGGATCGCTGATGGGGCA
	clone M.		CTGATTGCCGCGGGCGTTGGCGGCTTCGCTGCGCTGAT
	smegmatis		TCACGCTCATCCCAATATGACTTTGGTTGCCCGATTTG
	gene)		GCGGCGCAGCGTTCTTGATTGGCTACGCGCTATTGGCC
			GCGCGGAACGCGTGGCGCCCGAGCGGGCTGGTGCCGTC
			GGAATCGGGGCCGGCTGCGCTGATCGGCGTGGTGCAAA
			TGTGCCTGGTGGTGACCTTTCTCAACCCACACGTCTAT
			CTGGACACTGTGGTGTTGATCGGTGCCCTCGCCAATGA
			GGAATCAGATCTGCGGTGGTTTTTCGGAGCCGGTGCCT
			GGGCCGCCAGCGTCGTATGGTTCGCCGTGTTGGGATTT
			AGCGCGGGCCGGCTACAGCCATTCTTCGCAACTCCAGC
			TGCTTGGCGCATTCTTGATGCGCTGGTTGCCGTGACGA
			TGATTGGGGTCGCCGTCGTTGTGCTCGTCACGTCACCA
			AGTGTGCCGACGGCCAATGTCGCACTGATCATTTGA
lysE	Streptomyces	AL939131	ATGAACAACGCCCTCACGGCGGCCGCCGCCGGTTTCGG	166
	coelicolor		CACCGGCCTCTCGCTCATCGTCGCCATCGGCGCCCAGA
			ACGCCTTCGTCCTGCGGCAGGGGGTCCGCCGTGACGCG
			GTGCTCGCCGTGGTCGGCATCTGCGCGCTGTCCGACGC
			CGTGCTCATCGCCCTGGGCGTCGGCGGGGTCGGCGCCG
			TGGTGGTGGCGTGGCCGGGCGCGCTGACCGCCGTCGGC
			TGGATCGGCGGCGCGTTCCTGCTCTGCTACGGAGCCCT
			GGCGGCCCGGCGGGTGTTCCGGCCGTCCGGGGCGCTGC
			GGGCGGACGGCGCCGCCGCGGGCTCGCGCCGCCGGGCC
			GTGCTCACCTGCCTGGCGCTGACCTGGCTCAACCCGCA
			CGTCTACCTCGACACCGTGTTCCTGCTGGGCTCCGTCG
			CCGCCGACCGGGGGCCGCTGCGCTGGACCTTCGGCCTC
			GGAGCCGCCGCCGCCAGCCTGGTCTGGTTCGCCGCGCT
			CGGCTTCGGCGCCCGCTACCTCGGCCGCTTCCTGTCCC
			GGCCCGTCGCCTGGCGGGTCCTCGACGGACTGGTGGCC
			GCCACCATGATCGTCCTCGGCGTCTCCCTCGTCGCCGG
			GGCCTGA
lysE	Lactobacillus	AL935256	ATGCAAGTGTTTTTACAAGGATTATTATTTGGAATTGT	167
	plantarum		TTACATTGCACCAATCGGGATGCAAAACTTATTTGTGG
			TTTCGACAGCTATTGAACAACCATTGCAACGGGCATTG
			CGGGTGGCTTTAATTGTAATTGCGTTCGATACGTCGCT
			CTCCCTGGCTTGCTTTTATGGGGTGGGCCGATTGTTGC
			AGACCACTCCCTGGCTCGAATTAGGGGTGTTGTTGATT
			GGGAGTTTATTGGTCTTTTACATTGGCTGGAATCTGTT
			GCGGAAAAAGGCCACGGCAATGGGGACCCTCGACGCGG
			ACTTTTCATATAAAGCAGCGATTCTGACAGCTTTTTCG
			GTAGCATGGCTGAATCCGCAAGCACTGATTGATGGTTC
			CGTGTTGTTGGCGGCGTTTCGGGTGTCAATCCCGGCGG
			CACTGACCCATTTCTTTATGTTGGGGGTCATCCTAGCA
			TCCATTATTTGGTTCATCGGTCTGACCAGCTTGATCAG
			TAAGTTTAAACATCTCATGCAACCACGAGTCCTACTCT
			GGATCAATCGAATCTGTGGTGGCATCATTATTCTATAC
			GGCGTGCAGTTGCTAGCAACCTTCATCACGAAAATATAG
lysE	Coryne-	X96471	ATGGAAATCTTCATTACAGGTCTGCTTTTGGGGGCCAG	272
	bacterium		TCTTTTACTGTCCATCGGACCGCAGAATGTACTGGTGA
	glutamicum		TTAAACAAGGAATTAAGCGCGAAGGACTCATTGCGGTT
			CTTCTCGTGTGTTTAATTTCTGACGTCTTTTTGTTCAT
			CGCCGGCACCTTGGGCGTTGATCTTTTGTCCAATGCCG
			CGCCGATCGTGCTCGATATTATGCGCTGGGGTGGCATC
			GCTTACCTGTTATGGTTTGCCGTCATGGCAGCGAAAGA
			CGCCATGACAAACAAGGTGGAAGCGCCACAGATCATTG
			AAGAAACAGAACCAACCGTGCCCGATGACACGCCTTTG
			GGCGGTTCGGCGGTGGCCACTGACACGCGCAACCGGGT
			GCGGGTGGAGGTGAGCGTCGATAAGCAGCGGGTTTGGG
			TAAAGCCCATGTTGATGGCAATCGTGCTGACCTGGTTG
			AACCCGAATGCGTATTTGGACGCGTTTGTGTTTATCGG
			CGGCGTCGGCGCGCAATACGGCGACACCGGACGGTGGA
			TTTTCGCCGCTGGCGCGTTCGCGGCAAGCCTGATCTGG
			TTCCCGCTGGTGGGTTTCGGCGCAGCAGCATTGTCACG
			CCCGCTGTCCAGCCCCAAGGTGTGGCGCTGGATCAACG
			TCGTCGTGGCAGTTGTGATGACCGCATTGGCCATCAAA
			CTGATGTTGATGGGTTAG
metB	Mycobacterium	AL021897	ATGAGCGAAGACCGCACGGGACACCAGGGAATCAGCGG	168
	tuberculosis		ACCGGCCACCCGCGCCATCCACGCTGGCTACCGCCCGG
	(use this to		ATCCGGCGACCGGGGCGGTGAACGTGCCGATCTACGCC
	clone M.		AGCAGCACCTTCGCCCAAGACGGCGTCGGCGGTCTGCG
	smegmatis		TGGCGGTTTCGAATACGCACGCACCGGCAACCCCACCC
	gene)		GGGCCGCATTGGAGGCCTCGCTGGCGGCAGTCGAGGAG
			GGTGCTTTCGCGCGGGCATTCAGTTCCGGGATGGCCGC
			GACCGACTGCGCCCTGCGGGCGATGTTACGGCCCGGAG
			ACCACGTCGTCATTCCCGATGACGCCTACGGCGGCACA
			TTCCGGTTGATAGACAAGGTGTTCACCCGGTGGGATGT
			CCAGTACACGCCGGTGCGGCTTGCCGATCTGGATGCGG
			TGGGTGCCGCGATTACTCCGCGCACCCGGCTGATTTGG
			GTGGAGACGCCCACCAATCCGCTACTGTCGATCGCCGA
			TATCACGGCCATTGCCGAGCTGGGCACAGACAGATCGG
			CAAAAGTATTGGTGGACAATACCTTTGCCTCACCCGCG
			TTGCAGCAGCCGTTGCGGCTGGGCGCCGATGTGGTGTT
			GCACTCGACTACCAAGTACATCGGCGGCCATTCCGACG
			TGGTGGGAGGTGCGCTGGTCACCAACGACGAAGAGCTG
			GACGAGGAGTTCGCTTTCTTGCAGAACGGCGCCGGCGC
			GGTGCCCGGACCATTCGACGCCTACCTGACCATGCGCG
			GCCTGAAGACCTTGGTGCTGCGGATGCAGCGGCACAGT
			GAAAATGCCTGTGCGGTAGCGGAATTCCTCGCTGATCA
			TCCGTCGGTGAGTTCTGTGTTGTATCCGGGTTTGCCCA
			GTCATCCCGGGCATGAGATTGCCGCGCGACAGATGCGC
			GGCTTCGGCGGCATGGTTTCGGTGCGGATGCGGGCCGG
			TCGGCGTGCGGCGCAGGACCTGTGTGCCAAGACCCGCG
			TCTTCATCCTGGCCGAGTCGCTGGGTGGGGTGGAGTCG
			CTGATCGAACATCCCAGCGCCATGACCCATGCGTCGAC
			GGCCGGTTCGCAATTGGAGGTGCCCGACGATCTGGTGC
			GGCTTTCGGTCGGTATCGAAGACATTGCCGACCTGCTC
			GGCGATCTCGAACAGGCCCTGGGTTAA
metB	Mycobacterium	U15183	ATGAGCGAAGATTACCGGGGACACCACGGCATTACCGG	169
	leprae (use this		ACTAGCCACCAAAGCCATCCATGCTGGCTATCGTCCGG
	to clone M.		ATCCGGCAACAGGGGCAGTGAATGTCCCGATTTATGCC
	smegmatis		AGTAGTACTTTTGCCCAAGATGGCGTCGGTGAGTTGCG
	gene)		TGGCGGATTCGAATACGCGCGTACCGGCAACCCCATGC
			GCGCCGCTTTAGAGGCATCCTTGGCCACGGTCGAAGAG
			GGCGTTTTTGCGCGAGCCTTCAGTTCCGGAATGGCTGC
			TAGCGACTGTGCCTTGCGGGTCATGCTGCGGCCGGGGG
			ACCACGTGATCATCCCGGATGACGTCTACGGCGGCACC
			TTCCGGCTGATAGACAAGGTCTTTACTCAATGGAACGT
			TGACTACACGCCGGTACCGCTGTCTGATTTGGACGCGG
			TCCGCGCCGCGATCACATCACGGACCCGGCTGATATGG
			GTGGAAACACCGACCAATCCGCTGCTGTCCATCGCAGA
			TATCACCAGCATCGGCGAACTAGGCAAAAAGCACTCAG
			TAAAGGTGTTGGTGGACAACACCTTTGCTTCACCCGCG
			CTGCAACAGCCGCTGATGCTGGGGGCAGACGTCGTGTT
			GCACTCGACCACAAAGTACATCGGCGGCCACTCTGATG
			TGGTGGGCGGCGCGCTAGTCACCAACGACGAAGAGCTG
			GACCAGGCTTTCGGCTTCTTGCAGAACGGAGCCGGTGC
			GGTGCCGAGCCCGTTCGACGCGTACCTAACGATGCGCG
			GATTGAAGACTTTAGTGCTGCGGATGCAGCGGCACAAC
			GAAAATGCCATTACTGTAGCGGAATTCCTGGCTGGGCA
			TCCGTCGGTGAGCGCCGTGCTGTATCCGGGCTTGCCCA
			GCCATCCCGGGCATGAGGTCGCTGCACGGCAGATGCGC
			GGCTTCGGCGGCATGGTTTCGTTGCGGATGCGAGCCGG
			CCGACTAGCCGCCCAGGATCTGTGTGCCCGCACCAAGG
			TGTTTACCTTGGCTGAATCCTTGGGTGGAGTGGAGTCG
			CTGATTGAGCAGCCCAGTGCCATGACGCACGCGTCGAC
			AACCGGGTCGCAATTGGAAGTACCCGACGACCTGGTGC
			GGCTTTCGGTCGGTATTGAAGACGTCGGCGACCTGCTG
			TGCGACCTCAAGCAGGCGTTAAACTAA
metB	Streptomyces	AL939122	GTGCCCATGAGCGACAGGCACATCAGTCAGCACTTCGA	170
	coelicolor		GACGCTCGCGATCCACGCGGGCAACACCGCCGATCCCC
			TGACGGGCGCGGTCGTCCCGCCGATCTATCAGGTGTCG
			ACCTACAAGCAGGACGGCGTCGGCGGATTGCGCGGCGG
			CTACGAGTACAGCCGCAGCGCCAACCCGACCCGTACCG
			CGCTGGAGGAGAACCTCGCCGCCCTGGAGGGCGGCCGC
			CGCGGCCTCGCGTTCGCGTCCGGACTGGCGGCCGAGGA
			CTGCCTGTTGCGTACGCTGCTGCGCCCCGGCGACCACG
			TGGTGATCCCGAACGACGCGTACGGCGGCACCTTCCGC
			CTCTTCGCCAAGGTCGCCACCCGGTGGGGTGTGGAGTG
			GTCCGTGGCCGACACGAGCGACGCCGCCGCCGTGCGGG
			CCGCCCTCACCCCGAAGACCAAGGCGGTGTGGGTGGAG
			ACGCCCTCCAACCCGCTGCTCGGCATCACCGACATCGC
			GCAGGTCGCCCAGGTCGCCCGGGACGCCGGCGCCCGGC
			TCGTCGTCGACAACACCTTCGCCACCCCGTACCTCCAG
			CAGCCGCTGGCCCTCGGCGCCGACGTCGTCGTGCACTC
			GCTGACCAAGTACATGGGCGGGCACTCGGACGTCGTGG
			GCGGCGCGCTGATCGTGGGCGACCAGGAGCTGGGCGAG
			GAGCTGGCGTTCCACCAGAACGCGATGGGCGCGGTCGC
			CGGACCCTTCGACTCCTGGCTGGTGCTGCGCGGCACCA
			AGACCCTCGCCGTGCGCATGGACCGGCACAGCGAGAAC
			GCGACCAAGGTCGCCGACATGCTCTCCCGGCACGCGCG
			CGTGACGAGCGTGCTGTACCCGGGGCTGCCCGAGCACC
			CGGGGCACGAGGTCGCCGCCAAGCAGATGAAGGCGTTC
			GGCGGCATGGTGTCGTTCCGCGTCGAGGGCGGCGAGCA
			GGCCGCCGTCGAGGTGTGCAACCGCGCGAAGGTCTTCA
			CGCTCGGCGAGTCCCTCGGCGGCGTCGAGTCGCTGATC
			GAGCACCCGGGCCGGATGACGCACGCCTCCGCGGCGGG
			CTCGGCCCTGGAGGTGCCCGCCGACCTGGTGCGGCTGT
			CGGTCGGCATCGAGAACGCCGACGACCTGCTGGCCGAC
			CTCCAGCAGGCGCTGGGCTAG
metB	Thermobifida	NZ_AAAQ010	ATGAGTTACGAGGGGTTTGAGACACTGGCCATCCACGC	171
	fusca	00041	CGGTCAGGAGGCAGACGCCGAGACCGGGGCCGTGGTGG
			TCCCCATCTACCAGACGAGCACCTACCGCCAAGACGGG
			GTGGGCGGGCTGCGCGGCGGCTACGAGTACTCCCGCAC
			CGCCAACCCGACCCGCACGGCACTGGAAGAATGCCTGG
			CCGCGCTGGAAGGCGGGGTGCGGGGCCTGGCGTTCGCT
			TCCGGCATGGCCGCAGAGGACACCCTGCTCCGCACCAT
			CGCCCGACCCGGCGACCACCTCATCATCCCCAACGACG
			CCTACGGCGGCACGTTCCGCCTCGTCTCCAAGGTCTTC
			GAACGGTGGGGAGTGAGCTGGGACGCCGTCGACCTGTC
			CAACCCGGAGGCGGTGCGGACCGCAATCCGCCCGGAAA
			CCGTGGCGATCTGGGTGGAAACCCCCACCAACCCGCTG
			CTCAACATTGCGGACATCGCCGCGCTCGCGGACATCGC
			GCACGCCGCTGACGCGCTGCTGGTGGTCGACAACACCT
			TCGCCTCCCCGTACCTGCAGCGGCCGCTCAGCCTCGGT
			GCGGACGTGGTCGTGCACTCCACCACCAAATACCTGGG
			CGGCCACTCCGACGTGGTCGGCGGCGCCCTCGTGGTCG
			CCGACGCGGAACTGGGAGAGCGCCTCGCCTTCCACCAG
			AACTCGATGGGCGCGGTCGCGGGACCGTTCGACGCCTG
			GCTGACCCTGCGCGGCATCAAAACCCTCGGCGTGCGCA
			TGGACCGGCACTGCGCCAACGCGGAACGCGTCGTGGAA
			GCGCTCGTCGGCCACCCGGAAGTCGCCGAAGTGCTCTA
			CCCGGGCCTGTCCGACCACCCCGGCCACAAGGTGGCGG
			TCGACCAGATGCGCGCCTTCGGTGGCATGGTGTCGTTC
			CGCATGCGCGGCGGGGAGGAAGCCGCGTTGCGGGTGTG
			CGCGAAAACGAAAGTGTTCACCCTCGCTGAATCCTTGG
			GCGGGGTGGAGTCGCTGATCGAACACCCGGGGAAGATG
			ACCCACGCCTCCACCGCGGGCTCCCTCCTGGAAGTGCC
			CAGCGACCTGGTCCGGCTCTCCGTGGGTATCGAAACCG
			TCGACGACCTCGTCAACGACCTGCTCCAAGCATTGGAG
			CCGTAG
metB	Lactobacillus	AL935252	ATGAAATTTGAAACCCAATTAATTCACGGTGGTATCAG	172
	plantarum		TGAGGATGCCACTACTGGCGCGACTTCGGTACCCATCT
			ACATGGCCTCGACCTTCCGCCAAACAAAAATCGGTCAA
			AATCAATACGAATATTCACGGACGGGAAATCCAACCCG
			GGCCGCCGTCGAAGCATTAATTGCCACCCTCGAACATG
			GCAGCGCTGGCTTCGCATTTGCTTCTGGCTCCGCTGCC
			ATTAATACCGTCTTCTCACTATTCTCGGCTGGTGATCA
			CATTATTGTGGGAAATGATGTCTACGGTGGCACCTTCC
			GCTTGATCGACGCCGTTTTGAAACACTTTGGCATGACT
			TTTACAGCCGTAGATACGCGTGACTTGGCCGCCGTTGA
			AGCCGCAATTACCCCCACAACTAAGGCGATTTATTTGG
			AAACACCGACGAACCCGTTATTACACATTACGGATATT
			GCTGCCATTGCGAAGCTCGCGCAAGCACACGATTTACT
			GAGTATCATCGACAACACCTTCGCCTCCCCATACGTCC
			AGAAGCCCCTGGATTTAGGCGTTGACATTGTTTTACAC
			AGTGCTTCCAAGTATCTCGGTGGTCACAGTGATGTTAT
			CGGTGGCTTGGTTGTCACCAAGACGCCAGCACTTGGCG
			AAAAAATCGGCTACTTGCAAAATGCCATCGGTAGTATT
			TTGGCCCCGCAAGAAAGCTGGCTATTACAACGTGGTAT
			GAAGACTCTGGCATTGCGCATGCAAGCCCACCTG~TA
			ATGCCGCTAAAATCTTTACTTACTTAAAGTCTCACCCA
			GCAGTTACTAAGATTTACTATCCAGGCGATCCTGATAA
			TCCCGATTTTTCGATTGCCAAGCAACAGATGAATGGCT
			TCGGCGCAATGATCTCGTTTGAATTACAACCAGGAATG
			AACCCCCAGACCTTCGTTGAACATTTACAAGTCATCAC
			GCTCGCCGAAAGTCTCGGAGCATTGGAAAGTTTAATTG
			AAATTCCAGCCTTAATGACTCACGGTGCCATCCCACGC
			ACAATTCGGCTACAGAATGGCATCAAAGACGAGCTGAT
			TCGCTTATCAGTCGGTGTTGAAGCCAGTGACGATTTGT
			TAGCAGACCTTGAGCGCGGGTTCGCTAGCATTCAGGCA
			GATTAA
metB	Coryne-	AF126953	TTGTCTTTTGACCCAAACACCCAGGGTTTCTCCACTGC	273
	bacterium		ATCGATTCACGCTGGGTATGAGCCAGACGACTACTACG
	glutamicum		GTTCGATTAACACCCCAATCTATGCCTCCACCACCTTC
			GCGCAGAACGCTCCAAACGAACTGCGCAAAGGCTACGA
			GTACACCCGTGTGGGCAACCCCACCATCGTGGCATTAG
			AGCAGACCGTCGCAGCACTCGAAGGCGCAAAGTATGGC
			CGCGCATTCTCCTCCGGCATGGCTGCAACCGACATCCT
			GTTCCGCATCATCCTCAAGCCGGGCGATCACATCGTCC
			TCGGCAACGATGCTTACGGCGGAACCTACCGCCTGATC
			GACACCGTATTCACCGCATGGGGCGTCGAATACACCGT
			TGTTGATACCTCCGTCGTGGAAGAGGTCAAGGCAGCGA
			TCAAGGACAACACCAAGCTGATCTGGGTGGAAACCCCA
			ACCAACCCAGCACTTGGCATCACCGACATCGAAGCAGT
			AGCAAAGCTCACCGAAGGCACCAACGCCAAGCTGGTTG
			TTGACAACACCTTCGCATCCCCATACCTGCAGCAGCCA
			CTAAAACTCGGCGCACACGCAGTCCTGCACTCCACCAC
			CAAGTACATCGGAGGACACTCCGACGTTGTTGGCGGCC
			TTGTGGTTACCAACGACCAGGAAATGGACGAAGAACTG
			CTGTTCATGCAGGGCGGCATCGGACCGATCCCATCAGT
			TTTCGATGCATACCTGACCGCCCGTGGCCTCAAGACCC
			TTGCAGTGCGCATGGATCGCCACTGCGACAACGCAGAA
			AAGATCGCGGAATTCCTGGACTCCCGCCCAGAGGTCTC
			CACCGTGCTCTACCCAGGTCTGAAGAACCACCCAGGCC
			ACGAAGTCGCAGCGAAGCAGATGAAGCGCTTCGGCGGC
			ATGATCTCCGTCCGTTTCGCAGGCGGCGAAGAAGCAGC
			TAAGAAGTTCTGTACCTCCACCAAACTGATCTGTCTGG
			CCGAGTCCCTCGGTGGCGTGGAATCCCTCCTGGAGCAC
			CCAGCAACCATGACCCACCAGTCAGCTGCCGGCTCTCA
			GCTCGAGGTTCCCCGCGACCTCGTGCGCATCTCCATTG
			GTATTGAAGACATTGAAGACCTGCTCGCAGATGTCGAG
			CAGGCCCTCAATAACCTTTAG
metB	Escherichia coli	NC_000913	ATGACGCGTAAACAGGCCACCATCGCAGTGCGTAGCGG	274
			GTTAAATGACGACGAACAGTATGGTTGCGTTGTCCCAC
			CGATCCATCTTTCCAGCACCTATAACTTTACCGGATTT
			AATGAACCGCGCGCGCATGATTACTCGCGTCGCGGCAA
			CCCAACGCGCGATGTGGTTCAGCGTGCGCTGGCAGAAC
			TGGAAGGTGGTGCTGGTGCAGTACTTACTAATACCGGC
			ATGTCCGCGATTCACCTGGTAACGACCGTCTTTTTGAA
			ACCTGGCGATCTGCTGGTTGCGCCGCACGACTGCTACG
			GCGGTAGCTATCGCCTGTTCGACAGTCTGGCGAAACGC
			GGTTGCTATCGCGTGTTGTTTGTTGATCAAGGCGATGA
			ACAGGCATTACGGGCAGCGCTGGCAGAAAAACCCAAAC
			TGGTACTGGTAGAAAGCCCAAGTAATCCATTGTTACGC
			GTCGTGGATATTGCGAAAATCTGCCATCTGGCAAGGGA
			AGTCGGGGCGGTGAGCGTGGTGGATAACACCTTCTTAA
			GCCCGGCATTACAAAATCCGCTGGCATTAGGTGCCGAT
			CTGGTGTTGCATTCATGCACGAAATATCTGAACGGTCA
			CTCAGACGTAGTGGCCGGCGTGGTGATTGCTAAAGACC
			CGGACGTTGTCACTGAACTGGCCTGGTGGGCAAACAAT
			ATTGGCGTGACGGGCGGCGCGTTTGACAGCTATCTGCT
			GCTACGTGGGTTGCGAACGCTGGTGCCGCGTATGGAGC
			TGGCGCAGCGCAACGCGCAGGCGATTGTGAAATACCTG
			CAAACCCAGCCGTTGGTGAAAAAACTGTATCACCCGTC
			GTTGCCGGAAAATCAGGGGCATGAAATTGCCGCGCGCC
			AGCAAAAAGGCTTTGGCGCAATGTTGAGTTTTGAACTG
			GATGGCGATGAGCAGACGCTGCGTCGTTTCCTGGGCGG
			GCTGTCGTTGTTTACGCTGGCGGAATCATTAGGGGGAG
			TGGAAAGTTTAATCTCTCACGCCGCAACCATGACACAT
			GCAGGCATGGCACCAGAAGCGCGTGCTGCCGCCGGGAT
			CTCCGAGACGCTGCTGCGTATCTCCACCGGTATTGAAG
			ATGGCGAAGATTTAATTGCCGACCTGGAAAATGGCTTC
			CGGGCTGCAAACAAGGGG
putative	Streptomyces	AL939116	ATGGCCGGCATCGGGGCCTTCTGGTCGGTGTCCTTCCT	173
threonine	coelicolor		GCTGGTGCTGGTCCCGGGCGCGGACTGGGCCTACGCGA
efflux protein			TCACGGCGGGACTGCGCCACCGGTCGGTGCTGCCCGCC
1			GTCGGCGGCATGCTGAGCGGATACGTCCTGCTGACCGC
			CGTGGTCGCCGCGGGCCTGGCGACCGCGGTCGCCGGTT
			CACCGACGGTGCTGACCGCGCTGACGGCCGCCGGTGCG
			GCCTATCTGATCTGGCTAGGCGCCACGACCCTGGCCCG
			CCCCGCGGCGCCCCGGGCCGAGGAGGGCGACCAGGGAG
			ACGGCTCCGGCTCGTTGGTGGGCCGTGCGGCCAGAGGG
			GCGGGCATCAGCGGCCTCAACCCCAAGGCGCTGCTGCT
			GTTCCTCGCCCTGCTGCCGCAGTTCGCCGCCCGGGACG
			CGGACTGGCCCTTTGCCGCGCAGATCGTCGCCCTCGGC
			CTGGTGCACACGGCCAACTGCGCCGTGGTCTACACGGG
			CGTCGGCGCCACGGCACGCCGGATCCTGGGCGCCCGCC
			CGGCCGTTGCCACCGCGGTGTCCCGATTCTCGGGCGCC
			GCGATGATCCTCGTCGGTGCCCTGTTGCTGGTGGAGCG
			GCTGCTCGCCCAGGGGCCGACACATTAG
threonine	Corynebacterium	NC_003450	GTGGACGCAGCATCATGGGTCGCATTCGCACTCGCATT	275
efflux protein	glutamicum		ATTGGTGGCATTAGCGGTGCCCGGACCTGACCTTGTTC
			TTGTTCTACATTCTGCAACCCGCGGGATCCGCACGGGG
			GTCATGACTGCGGCAGGAATCATGACGGGACTGATGTT
			ACATGCGAGTCTTGCGATAGCCGGAGCAACTGCATTAT
			TGCTATCAGCTCCGGGAGTATTGAGCGCTATTCAACTT
			CTTGGTGCGGGAGTGCTTTTGTGGATGGGCACGAACAT
			GTTTCGTGCTTCCCAAAATACCGGGGAATCTGAAACTG
			CTGCTAGTCAATCGAGTGCAGGTTATTTTCGAGGATTT
			ATCACCAATGCCACGAACCCGAAAGCGCTGTTGTTCTT
			TGCAGCGATTCTTCCTCAGTTCATTGGGAATGGGGAAG
			ATATGAAAATGAGGACCTTGGCATTGTGTGCCACCATC
			GTGCTTGGCTCAGGAGCGTGGTGGTTGGGAACAATCGC
			ATTGGTCAGGGGTATTGGTCTGCAAAAGTTACCGTCTG
			CGGATCGCATTATCACCCTGGTTGGTGGCATCGCACTG
			TTTCTCATTGGTGCCGGATTACTGGTTAATACTGCTTA
			TGGGCTTATCACT
hypo-thetical	Streptomyces	AL939116	GTGTCGGTACCAGGGAGCGTTGCGCAGGTGACGGAGGC	174
protein	coelicolor		GGAGGAGCCCAAACCACAGTCGGACGAGGCCCGCAGTG
NCgl2533			CCTTCCGGCAGCCCAGCGGGATCGCGGCGTCGATCGAC
related			GGCGAGTCGTCGACGACGTCCGAGTTCGAGATCCCGCA
			GGGGTTCGCCGTCCCGCGGCACGCCGGCACCGAGTCCG
			AGACGACCTCGGAGTTCTCGCTCCCCGACGGCCTGGAG
			GTGCCGCAGGCCCCGCCCGCGGACACCGAGGGCTCGGC
			ATTCACCATGCCGAGCACGCACAGCGCGTGGACCGCCC
			CGACCGCCTTCACCCCGGCGAGCGGCTTCCCGGCGGTG
			AGCCTGACGGACGTGCCCTGGCAGGACCGGATGCGCGC
			CATGCTGCGCATGCCGGTGGCCGAGCGGCCCGCGCCGG
			AGCCCTCGCAGAAGCACGACGACGAGACCGGCCCCGCC
			GTGCCGCGCGTGTTGGACCTGACGCTGCGTATCGGGGA
			GCTGCTGCTGGCGGGCGGTGAGGGCGCCGAGGACGTGG
			AGGCGGCCATGTTCGCCGTCTGCCGGTCCTACGGCCTG
			GACCGCTGCGAGCCGAACGTCACCTTCACCCTGCTGTC
			GATCTCCTACCAGCCGTCCCTGGTCGAGGACCCGGTGA
			CGGCGTCGCGGACGGTGCGCCGCCGCGGCACCGACTAC
			ACGCGGCTCGCGGCCGTCTTCCACCTGGTGGACGACCT
			CAGCGACCCCGACACGAACATCTCCCTGGAGGAGGCCT
			ACCGGCGTCTCGCGGAGATCCGCCGOAACCGCCACCCG
			TACCCCACCTGGGTGCTGACGGTGGCCAGCGGTCTGCT
			CGCGGGCGGGGCCTCGCTGCTCGTCGGTGGCGGGCTGA
			CCGTGTTCTTCGCGGCGATGTTCGGCTCGATGCTCGGC
			GACCGGCTGGCGTGGCTGTGCGCCGGGCGCGGGCTGCC
			GGAGTTCTACCAGTTCGCGGTGGCCGCGATGCCGCCCG
			CCGCGATGGGTGTCGTGCTGACGGTGACGCACGTCGAC
			GTGAAGGCGTCCGCGGTCATCACCGGTGGGCTGTTCGC
			GCTGCTGCCCGGGCGGGCGCTGGTCGCGGGGGTGCAGG
			ACGGTCTGACCGGCTTCTACATCACCGCCGCGGCCCGT
			CTGCTGGAGGTCATGTACTTCTTCGTCAGCATCGTCGC
			CGGGGTGCTGGTGGTGCTGTACTTCGGGGTCCAGCTGG
			GCGCCGAGCTCAACCCGGACGCCAAGCTCGGCACCGGT
			GACGAACCGTTCGTGCAGATCTTCGCCTCGATGCTGCT
			GTCGCTGGCCTTCGCGATCCTGCTCCAGCAGGAACGGG
			CCACCGTCCTCGCGGTGACCCTGAACGGCGGCATCGCC
			TGGTGCGTGTACGGCGCCATGAACTACGCCGGCGACAT
			CTCTCCGGTGGCCTCCACGGCCGCCGCGGCGGGGCTCG
			TGGGCCTGTTCGGGCAGCTGATGTCCAGGTACCGGTTC
			GCGTCGGCCCTGCCGTACACGACGGCGGCGATCGGGCC
			GCTGCTGCCCGGTTCGGCGACGTACTTCGGTCTGCTGG
			GGATCGCGCAGGGCGAGGTCGACTCGGGGCTGCTGTCG
			CTGTCCAACGCGGTGGCGCTGGCGATGGCCATCGCGAT
			CGGGGTGAACCTGGGCGGGGAGATCTCCCGGCTGTTCC
			TGAAGGTGCCCGGCGCCGCGAGTGCGGCGGGACGCCGG
			GCGGCCAAGCGGACGCGAGGGTTCTAG
hypo-thetical	Mycobacterium	AE007180	ATGGATCAAGATCGATCGGACAACACGGCATTGCGCCG	175
protein	tuberculosis		TGGTCTGCGAATTGCCCTGCGCGGGCGCCGCGATCCGC
NCgl2533	(use this to		TGCCCGTGGCGGGCCGGCGGAGCCGGACCTCCGGCGGA
related	clone M.		ATCGGTGACCTGCACACCCGGAAGGTGCTTGACCTGAC
	smegmatis		CATCCGGCTCGCCGAGGTGATGTTGTCGTCCGGCTCTG
	gene)		GCACCGCGGATGTCGTCGCCACAGCCCAGGACGTGGCT
			CAGGCCTACCAGCTCACCGATTGCGTTGTCGACATCAC
			CGTTACCACCATCATCGTGTCCGCGCTAGCGACCACAG
			ACACTCCGCCGGTCACCATCATGCGGTCGGTCCGGACC
			CGGTCCACTGACTACAGCCGGCTGGCCGAACTCGATCG
			ACTCGTTCAGCGGATAACCTCCGGTGGCGTCGCAGTCG
			ACCAGGCTCACGAGGCTATGGACGAGTTGACCGAACGG
			CCCCACCCCTACCCGCGCTGGCTCGCGACCGCGGGGGC
			GGCGGGCTTCGCACTCGGCGTCGCCATGTTGCTCGGCG
			GAACCTGGCTGACCTGCGTCTTGGCTGCCGTGACGTCT
			GGCGTGATCGACCGACTGGGCCGGCTGCTGAACCGGAT
			CGGGACCCCGTTGTTCTTCCAGCGCGTGTTCGGCGCGG
			GGATCGCGACCCTGGTCGCGGTGGCGGCTTACCTGATC
			GCCGGCCAGGATCCGACCGCGCTGGTGGCCACCGGAAT
			CGTTGTGCTGCTGTCTGGGATGACCTTGGTGGGTTCGA
			TGCAGGACGCGGTCACCGGGTACATGCTCACCGCACTC
			GCCCGGCTTGGCGACGCCCTGTTCCTGACCGCAGGGAT
			CGTCGTCGGCATCCTCATCTCGTTGCGGGGCGTCACCA
			ATGCCGGCATCCAGATCGAACTGCATGTCGACGCAACC
			ACGACGCTCGCCACCCCGGGCATGCCGCTACCGATTCT
			CGTCGCGGTAAGCGGTGCGGCGCTGTCCGGCGTGTGCC
			TGACGATCGCGAGCTATGCGCCGCTACGTTCTGTGGCC
			ACCGCCGGACTCTCGGCCGGACTCGCCGAACTGGTGCT
			CATCGGACTCGGCGCGGCCGGGTTCGGCCGAGTGGTCG
			CCACCTGGACCGCCGCGATCGGCGTCGGCTTCTTGGCC
			ACCCTGATCTCAATCCGTCGGCAGGCTCCCGCCTTGGT
			GACGGCCACCGCCGGCATCATGCCGATGCTGCCGGGCC
			TTGCGGTCTTCCGTGCCGTGTTCGCGTTCGCCGTCAAT
			GACACACCCGACGGCGGTCTGACCCAGCTGCTGGAAGC
			GGCCGCGACTGCACTCGCGCTTGGCAGCGGGGTGGTGT
			CGGGCGAGTTCCTCGCCTCACCATTGCGGTACGGCGCC
			AGCCGGATCGGCGACCTCTTTCGGATCGAGGGTCCACC
			CGGGCTCCGGCGGGCGGTCGGCCGTGTGGTGCGCCTAC
			AGCCGGCCAAGAGCCAGCAGCCGACCGGCACCGGTGGC
			CAACGGTGGCGAAGCGTCGCGCTGGAGCCGACGACGGC
			CGACGACGTGGACGCCGGCTATCGCGGCGATTGGCCCG
			CTACCTGCACCAGCGCGACCGAGGTGCGCTAG
hypo-thetical	Mycobacterium	AL022121	ATGGATCAAGATCGATCGGACAACACGGCATTGCGCCG	176
protein	tuberculosis		TGGTCTGCGAATTGCCCTGCGCGGGCGCCGCGATCCGC
NCgl2533	(use this to		TGCCCGTGGCGGGCCGGCGGAGCCGGACCTCCGGCGGA
related	clone M.		ATCGATGACCTGCACACCCGGAAGGTGCTTGACCTGAC
	smegmatis		CATCCGGCTCGCCGAGGTGATGTTGTCGTCCGGCTCTG
	gene)		GCACCGCGGATGTCGTCGCCACAGCCCAGGACGTGGCT
			CAGGCCTACCAGCTCACCGATTGCGTTGTCGACATCAC
			CGTTACCACCATCATCGTGTCCGCGCTAGCGACCACAG
			ACACTCCGCCGGTCACCATCATGCGGTCGGTCCGGACC
			CGGTCCACTGACTACAGCCGGCTGGCCGAACTCGATCG
			ACTCGTTCAGCGGATAACCTCCGGTGGCGTCGCAGTCG
			ACCAGGCTCACGAGGCTATGGACGAGTTGACCGAACGG
			CCCCACCCCTACCCGCGCTGGCTCGCGACCGCGGGGGC
			GGCGGGCTTCGCACTCGGCGTCGCCATGTTGCTCGGCG
			GAACCTGGCTGACCTGCGTCTTGGCTGCCGTGACGTCT
			GGCGTGATCGACCGACTGGGCCGGCTGCTGAACCGGAT
			CGGGACCCCGTTGTTCTTCCAGCGCGTGTTCGGCGCGG
			GGATCGCGACCCTGGTCGCGGTGGCGGCTTACCTGATC
			GCCGGCCAGGATCCGACCGCGCTGGTGGCCACCGGAAT
			CGTTGTGCTGCTGTCTGGGATGACCTTGGTGGGTTCGA
			TGCAGGACGCGGTCACCGGGTACATGCTCACCGCACTC
			GCCCGGCTTGGCGACGCCCTGTTCCTGACCGCAGGGAT
			CGTCGTCGGCATCCTCATCTCGTTGCGGGGCGTCACCA
			ATGCCGGCATCCAGATCGAACTGCATGTCGACGCAACC
			ACGACGCTCGCCACCCCGGGCATGCCGCTACCGATTCT
			CGTCGCGGTAAGCGGTGCGGCGCTGTCCGGCGTGTGCC
			TGACGATCGCGAGCTATGCGCCGCTACGTTCTGTGGCC
			ACCGCCGGACTCTCGGCCGGACTCGCCGAACTGGTGCT
			CATCGGACTCGGCGCGGCCGGGTTCGGCCGAGTGGTCG
			CCACCTGGACCGCCGCGATCGGCGTCGGCTTCTTGGCC
			ACCCTGATCTCAATCCGTCGGCAGGCTCCCGCCTTGGT
			GACGGCCACCGCCGGCATCATGCCGATGCTGCCGGGCC
			TTGCGGTCTTCCGTGCCGTGTTCGCGTTCGCCGTCAAT
			GACACACCCGACGGCGGTCTGACCCAGCTGCTGGAAGC
			GGCCGCGACTGCACTCGCGCTTGGCAGCGGGGTGGTGT
			TGGGCGAGTTCCTCGCCTCACCATTGCGGTACGGCGCC
			GGCCGGATCGGCGACCTCTTTCGGATCGAGGGTCCACC
			CGGGCTCCGGCGGGCGGTCGGCCGTGTGGTGCGCCTAC
			AGCCGGCCAAGAGCCAGCAGCCGACCGGCACCGGTGGC
			CAACGGTGGCGAAGCGTCGCGCTGGAGCCGACGACGGC
			CGACGACGTGGACGCCGGCTATCGCGGCGATTGGCCCG
			CTACCTGCACCAGCGCGACCGAGGTGCGCTAG
hypo-thetical	Thermobifida	NZ_AAAQ010	GTGATCTCATACGGTCCGGTGGCGGATCGGTGCAGGGT	177
protein	fusca	00042	GGGGGCAACTTCGGCGGCGTGGGGAACGTCTCCCCCAA
NCgl2533			TGAGCTTTCCGTTTCTTCCCCTTGTATCCCACCCACTC
related			CCTTATGTCCCAGGTTTGGATGCGTCATTCCCGGATGG
			AGCATGCGTCCCGTTGGGCAGGGGTCCCTCCCGAGGAG
			GTGAGCGCCGGATGAACCAGGCACCGCGGCGTTCCGAC
			ACATCGCACTCCCCCACCCTGCTGACCCGGTTGCGGGA
			CTGGCGTGCCAGCCGCGGCGTGCTCGACCTGGAAGCAG
			AAGAGTTCGAAGACGAAGCGCCGCGTCCCGATCCGCGG
			GCCATGGACCTCGTCCTGCGGGTAGGGGAACTGCTGCT
			GGCCAGCGGGGAAGCCACCGAGACGGTCAGCGACGCGA
			TGCTGAGTCTGGCGGTGGCGTTCGAATTGCCCCGCAGC
			GAAGTGTCGGTGACGTTCACCGGCATCACCCTGTCGTG
			CCACCCCGGCGGGGATGAGCCCCCGGTGACCGGGGAGC
			GCGTGGTGCGCCGCCGCTCCCTCGACTACCACAAGGTC
			AACGAGCTGCACGCGCTGGTGGAAGACGCTGCGTTGGG
			CCTGCTCGACGTGGAGCGCGCAACCGCGCGGCTCCACG
			CCATCAAACGCTCCCGGCCGCACTATCCCCGCTGGGTG
			ATCGTGGCCGGGCTGGGGCTGATCGCCAGCAGCGCCAG
			TGTCATGGTGGGCGGTGGGATCATCGTGGCGGCCACGG
			CGTTCGCCGCCACCGTGCTCGGGGACCGGGCCGCGGGC
			TGGCTGGCTCGACGCGGGGTGGCCGAGTTCTACCAGAT
			GGCGGTGGCCGCGCTGTTGGCGGCGAGCACCGGCATGG
			CGCTGCTGTGGGTGAGCGAGGAGCTGGAGTTGGGGCTT
			CGCGCGAACGCGGTGATCACCGGGAGCATTGTGGCGCT
			GCTACCGGGGCGTCCCCTGGTCTCCAGCCTGCAAGACG
			GGATCAGCGGCGCGTACGTGTCGGCGGCGGCCCGCCTC
			TTGGAGGTCTTCTTCATGTTGGGGGCGATCGTCGCGGG
			GGTTGGCGCGGTCGCCTATACCGCGGTGCGGCTAGGGC
			TTTATGTGGACCTCGACAATCTGCCGTCGGCGGGGACG
			TCACTGGAGCCGGTCGTGCTGGCAGCTGCGGCAGGTTT
			GGCGCTCGCGTTCGCGGTGTCCCTGGTCGCGCCGGTGC
			GGGCCCTGCTGCCGATCGGCGCGATGGGGGTGCTGATC
			TGGGTGTGCTATGCGGGGCTGCGGGAACTGCTCGCCGT
			GCCGCCTGTGGTGGGGACCGGGGCGGGCGCGGTCGTGG
			TCGGGGTGATCGGCCACTGGCTGGCCCGGCGGACCCGG
			CGTCCTCCGCTCACCTTCATCATTCCGTCGATCGCTCC
			GCTGCTGCCGGGAAGCATCCTGTACCGGGGACTGATCG
			AGATGAGCACGGGGGAGCCGCTGGCCGGGGTGGCGAGC
			CTCGGTGAGGCGGTCGCGGTCGGCCTGGCTCTGGGTGC
			GGGGGTGAACCTCGGTGGTGAGCTGGTGCGGGCCTTCT
			CGTGGGGCGGTCTCGTGGGTGCGGGGCGCCGGGGTCGG
			CAGGCGGCCCGCCGGACCCGGGGAGGCTACTAG
hypo-thetical	Lactobacillus	AL935252	ATGAATAAAGAGCGTAAGTCGGTGATGCCGCTATCACA	178
protein	plantarum		ACGACATCATATGACAATTCCATGGAAGGACTTTATCC
NC9l2533			GTAATGAAGATGTTCCCGCTAAGCATGCTAGCTTACAA
related			GAGCGAACATCAATTGTTGGTCGAGTTGGTATTTTAAT
			GTTGTCGTGTGGGACGGGAGCGTGGCGGGTTCGTGATG
			CGATGAATAAGATTGCTCGCAGCCTGAATTTAACGTGC
			TCGGCAGATATCGGGTTGATTTCGATTCAGTACACGTG
			TTTTCATCATGAACGTAGTTATACGCAAGTATTATCGA
			TACCAAATACTGGTGTAAATACGGATAAACTAAATATT
			CTTGAACAGTTTGTCAAAGACTTTGATGCGAAATATGC
			ACGGTTAACGGTGGCACAAGTGCATGCAGCAATTGATG
			AAGTTCAGACGCGTCCTAAACAGTATTCGCCACTGGTT
			CTTGGGTTGGCAGCTGGCTTAGCCTGTAGTGGATTTAT
			CTTCTTACTTGGTGGAGGTATTCCCGAGATGATTTGTT
			CCTTTTTGGGCGCGGGCCTTGGTAACTATGTTCGGGCG
			CTGATGGGTAAACGGTCGATGACGACGGTTGCCGGGAT
			TGCGGTCAGCGTTGCGGTAGCGTGTTTGGCTTATATGG
			TTAGTTTTAAGATTTTTGAATATAATTTCCAAATTCTT
			GCCCAGCATGAGGCGGGGTATATTGGTGCCATGTTATT
			CGTGATTCCGGGTTTTCCGTTCATTACGAGTATGTTGG
			ATATCTCTAAGTTGGATATGCGCTCAGGACTGGAGCGC
			TTAGCTTACGCGATTATGGTTACCCTGATTGCAACTCT
			CGTCGGCTGGCTAGTCGCGACACTGGTGAGCTTCAAGC
			CAGCTGATTTCTTACCGCTAGGACTTTCACCGTTAGCG
			GTACTTTTATTACGATTACCAGCTAGTTTTTGCGGTGT
			TTACGGGTTCTCAATAATGTTTAATAGCTCGCAAAAAA
			TGGCCATTACCGCGGGATTTATTGGGGCCATTGCGAAT
			ACATTGCGCCTTGAACTAGTTGACTTGACAGCAATGCC
			ACCGGCCGCGGCCGCCTTTTGTGGGGCGCTCGTTGCCG
			GCTTGATCGCATCGGTGGTTAATCGTTATAACGGCTAT
			CCCCGGATTTCATTGACGGTACCTTCAATCGTAATTAT
			GGTTCCGGGATTATATATTTATCGTGCAATTTATAGTA
			TTGGCAATAATCAAATTGGTGTCGGTTCACTATGGCTG
			ACGAAGGCCGTGTTAATCATCATGTTTTTACCGCTCGG
			GCTATTTGTAGCGCGTGCGTTGTTGGATCACGAATGGC
			GACACTTTGATTAA
NCgl2533	Coryne-	NC_003450	ATGTTGAGTTTTGCGACCCTTCGTGGCCGCATTTCAAC	276
		bacterium		AGTTGACGCTGCAAAAGCCGCACCTCCGCCATCGCCAC
	glutamicum		TAGCCCCGATTGATCTCACTGACCATAGTCAAGTGGCC
			GGTGTGATGAATTTGGCTGCGAGAATTGGCGATATTTT
			GCTTTCTTCAGGTACGTCAAATAGTGACACCAAGGTAC
			AAGTTCGAGCAGTGACCTCTGCGTACGGTTTGTACTAC
			ACGCACGTGGATATCACGTTGAATACGATCACCATCTT
			CACCAACATCGGTGTGGAGAGGAAGATGCCGGTCAACG
			TGTTTCATGTTGTAGGCAAGTTGGACACCAACTTCTCC
			AAACTGTCTGAGGTTGACCGTTTGATCCGTTCCATTCA
			GGCTGGTGCGACCCCGCCTGAGGTTGCCGAGAAAATCC
			TGGACGAGTTGGAGCAATCCCCTGCGTCTTATGGTTTC
			CCTGTTGCGTTGCTTGGCTGGGCAATGATGGGTGGTGC
			TGTTGCTGTGCTGTTGGGTGGTGGATGGCAGGTTTCCC
			TAATTGCTTTTATTACCGCGTTCACGATCATTGCCACG
			ACGTCATTTTTGGGAAAGAAGGGTTTGCCTACTTTCTT
			CCAAAATGTTGTTGGTGGTTTTATTGCCACGCTGCCTG
			CATCGATTGCTTATTCTTTGGCGTTGCAATTTGGTCTT
			GAGATCAAACCGAGCCAGATCATCGCATCTGGAATTGT
			TGTGCTGTTGGCAGGTTTGACACTCGTGCAATCTCTGC
			AGGACGGCATCACGGGCGCTCCGGTGACAGCAAGTGCA
			CGATTTTTCGAAACACTCCTGTTTACCGGCGGCATTGT
			TGCTGGCGTGGGTTTGGGCATTCAGCTTTCTGAAATCT
			TGCATGTCATGTTGCCTGCCATGGAGTCCGCTGCAGCA
			CCTAATTATTCGTCTACATTCGCCCGCATTATCGCTGG
			TGGCGTCACCGCAGCGGCCTTCGCAGTGGGTTGTTACG
			CGGAGTGGTCCTCGGTGATTATTGCGGGGCTTACTGCG
			CTGATGGGTTCTGCGTTTTATTACCTCTTCGTTGTTTA
			TTTAGGCCCCGTCTCTGCCGCTGCGATTGCTGCAACAG
			CAGTTGGTTTCACTGGTGGTTTGCTTGCCCGTCGATTC
			TTGATTCCACCGTTGATTGTGGCGATTGCCGGCATCAC
			ACCAATGCTTCCAGGTCTAGCAATTTACCGCGGAATGT
			ACGCCACCCTGAATGATCAAACACTCATGGGTTTCACC
			AACATTGCGGTTGCTTTAGCCACTGCTTCATCACTTGC
			CGCTGGCGTGGTTTTGGGTGAGTGGATTGCCCGCAGGC
			TACGTCGTCCACCACGCTTCAACCCATACCGTGCATTT
			ACCAAGGCGAATGAGTTCTCCTTCCAGGAGGAAGCTGA
			GCAGAATCAGCGCCGGCAGAGAAAACGTCCAAAGACTA
			ATCAGAGATTCGGTAATAAAAGG
putative	Thermobifida	NZ_AAAQ010	ATGTCAGGGGGAGTCATGGCCGACATCACCAGAAACCG	179
mem-brane	fusca	00018	GTCCTCCGGGTTGGCATTCGCGATCGCCTCTGCACTTG
protein			CCTTCGGCGGCTCCGGCCCCGTGGCCCGGCCGCTCATC
NCgL0580			GACGCCGGACTCGACCCCCTGCACGTCACGTGGCTCCG
related			GGTAGCCGGAGCAGCTCTACTCCTGCTTCCCGTCGCTT
			TCCGCCACCACCGCACCCTGCGTACCCGCCCCGCCCTT
			CTCCTCGCCTACGGCGTCTTCCCGATGGCGGGAGTCCA
			AGCCTTCTACTTCGCAGCCATTTCCCGGATCCCCGTGG
			GGGTGGCGCTCCTCATCGAATTCCTCGGCCCCGTCCTC
			GTCCTGCTGTGGACCCGCCTCGTGCGGCGCATCCCCGT
			GTCCCGCGCCGCATCCCTCGGCGTGGCCCTGGCAGTCA
			TCGGCCTGGGCTGCCTCGTCGAAGTCTGGGCAGGCATC
			CGCCTGGACGCGGTCGGCCTGATCCTCGCGCTGGCTGC
			AGCGGTCTGCCAGGCCACCTACTTCCTGCTGTCGGACA
			CGGCCCGCGACGACGTCGACCCTCTCGCTGTCATCTCC
			TACGGCGCGCTCATCGCCACCGCACTCCTGAGCCTCCT
			CGCCCGCCCGTGGACCCTGCCGTGGGGCATCCTGGCCC
			AGAATGTCGGGTTCGGCGGGCTGGACATCCCCGCCCTC
			ATCCTCCTGGTGTGGCTTGCCCTGGTCGCCACCACCAT
			CGCCTACCTCACCGGGGTGGCCGCGGTACGGCGGCTGT
			CCCCTGTCGTCGCCGGGGGAGTGGCCTACCTGGAGGTC
			GTAACCTCTATCGTCCTGGCCTGGCTGCTGCTCGGGGA
			AGCGTTGAGCGTCGCCCAGCTTGTCGGGGCGGCCGCCG
			TGGTGACCGGTGCGTTCCTCGCCCAGACCGCGGTCCCC
			GACACCAGTGCCGCGCAAGGCCCGGAGACGCTGCCCAC
			CGCCCAGGACCCGGCCCCGCAGACCGGTTCCGCCCGCT
			GA
putative	Thermobifida	NZ_AAAQ010	GTGAATAGCGACTCTCCTGGGCAGTCTGCACCGGGTCC	180
mem-brane	fusca	00042	GTTCTCCCGGGCTGCGGCGCTCGTCCGCGCCGCGGGCA
protein			CTGCCATCCCGGCGACCTGGCTGGTCGGGGTGAGCATC
NCgl0580			CTGTCGGTCCAGTTCGGCGCAGGGGTGGCGAAGAACCT
related			GTTCGCGGTCCTCCCCCCAAGCACCGTGGTGTGGCTGC
			GCCTGCTGGCTTCGGCCCTGGTGCTGCTGTGCTTCGCC
			CCTCCCCCACTGCGCGGGCACTCTCGCACGGACTGGCT
			GGTCGCGGTCGGTTTCGGCACGTCGCTGGCGGTCATGA
			ACTACGCCATCTACGAATCGTTTGCGCGCATCCCGCTG
			GGCGTGGCCGTGACCATCGAATTCCTGGGCCCGCTGGC
			CGTGGCCGTGGCGGGATCGCGCCGCTGGCGGGACCTGG
			TGTGGGTGGTGCTCGCCGGCACGGGGGTTGCGCTGCTG
			GGATGGGACGACGGCGGGGTCACCCTGGCAGGGGTGGC
			GTTCGCCGCCCTCGCGGGCGCTGCGTGGGCGTGCTAcA
			TCCTGCTCAGCGCAGCCACCGGCCGACGCTTCCCCGGG
			ACTTCCGGACTGACGGTGGCCAGTGTGATCGGCGCAGT
			GCTCGTCGCGCCGATGGGCCTCGCCCACAGCAGCCCGG
			CCCTGCTCGACCCGAGCGTGCTGCTGACCGGTCTTGCC
			GTGGGGCTGCTCTCCTCGGTCATCCCCTACTCCCTGGA
			AATGCAGGCGTTGCGCCGCATTCCGCCCGGGGTGTTCG
			GCATCCTGATGAGCCTAGAACCGGCGGCGGCCGCACTC
			GTGGGCCTGGTCCTGCTCGGGGAATTCCTCACCGTCGC
			CCAGTGGGCCGCGGTGGCCTGCGTGGTGGTCGCCAGTG
			TGGGTGCGACCCGCTCCGCCCGGCTGTGA
putative	Thermobifida	NZ_AAAQ010	GTGTGGACGCTAGATCTTCCGCTAAAGAGAAACGATTC	181
mem-brane	fusca	00033	ATCAACTAACGGTGCCTGGACGGAAACAGAGAATAGGA
protein			GACACAGTGGTGGGATGATCCTCTCTTTTGTCTCGTTG
NCgl0580			GTTCGGCATGCCCACCTGAGGGTCCCAGCCCCGCTGCT
related			CACCGTCCTCAGCCTGGTCCTGCTGCACATGGGCAGCG
			CGGGAGCCGTGCACCTGTTCGCCATCGCGGGACCGCTC
			GAAGTCACCTGGCTGCGGCTGAGCTGGGCTGCGCTCCT
			CCTCTTCGCCGTCGGCGGGCGCCCCCTGCTCCGCGCGG
			CACGGGCCGCAACCTGGTCGGATCTCGCCGCTACCGCC
			GCCCTCGGCGTAGTCAGCGCGGGGATGACCCTCCTGTT
			CTCCCTCGCCCTCGACCGCATCCCGCTCGGCACCGCAG
			CCGCGATCGAGTTCCTCGGCCCCCTCACCGTCTCCGTG
			CTCGCCCTGCGCCGCCGCCGCGACCTGCTGTGGATCGT
			CCTCGCCGTAGCCGGAGTGCTCCTGCTCACCCGCCCGT
			GGCACGGGGAAGCCGACCTGCTCGGCATCGCCTTCGGC
			CTAGGCGGGGCCGTCTGCGTGGCGCTCTACATCGTCTT
			CTCCCAGACCGTCGGCTCCCGGCTGGGCGTCCTCCCCG
			GCCTCACCCTCGCAATGACCGTGTCCGCCCTGGTCACC
			GCCCCGCTGGGTCTGCCGGGGGCGATGGCGGCCGCCGA
			CCGGCACCTGGTGGCAGCCACCCTAGGGCTCGCACTGA
			TCTACCCCCTGCTGCCCCTCCTGCTGGAGATGGTGAGC
			CTGCAACGGATGAACCGCGGCACCTTCGGCATTCTCGT
			CTCCGTCGACCCCGCCATCGGGCTGCTCATCGGCCTGC
			TCCTGATCGGCCAGGTCCCCGTCCCCCTCCAAGTGGCG
			GGCATGGCCCTGGTGGTCGCCGCCGGGCTGGGCGCCAC
			CAGAGGCACCAGCGGACGCACACGCGGAGGCGCAGACC
			CGCACGCCACCGACGGGGAGCCGGAAGACCGCACCCCG
			GACCGCCCTGCTCCCGACGACGCCGGGCACCACACCAC
			CGACCCCGTCACAGTGTGA
putative	Streptomyces	SC0939113	ATGGCCGCCACCCGCCCCGCCGTCATCGCGCTCACCGC	182
mem-brane	coelicolor		CCTCGCCCCCGTCTCCTGGGGCAGCACCTACGCCGTGA
protein			CCACCGAGTTCCTGCCGCCCGACCGGCCCCTGTTCACC
NCgl0580			GGGCTGATGCGGGCTCTGCCCGCCGGCCTGCTGCTGCT
related			CGCCCTCGCCCGGGTGCTGCCGCGCGGCGCCTGGTGGG
			GGAAGGCGGCGGTGCTGGGGGTGCTGAACATCGGGGCC
			TTCTTCCCGCTGCTGTTCCTCGCCGCCTACCGGATGCC
			CGGCGGAATGGCCGCCGTCGTCGGCTCGGTCGGCCCGC
			TCCTCGTCGTCGGCCTCTCGGCCCTCCTGCTCGGGCAG
			CGGCCCACCACCCGGTCCGTTCTCACCGGTGTCGCCGC
			CGCGTCCGGCGTCAGCCTGGTGGTGCTGGAGGCGGCCG
			GGGCGCTGGACCCGCTCGGCGTGCTGGCGGCCCTCGCC
			GCCACCGCCTCCATGTCCACCGGCACCGTGCTCGCGGG
			GCGCTGGGGCCGCCCCGAAGGCGTCGGCCCGCTCGCCC
			TCACCGGCTGGCAACTGACCGCGGGCGGCCTGCTCCTG
			GCACCGCTCGCCCTGCTGGTCGAGGGTGCCCCGCCCGC
			CCTGGACGGCCCGGCCGTCGGCGGCTACCTCTACCTGG
			CGCTGGCCAACACGGCGCTGGCGTACTGGCTCTGGTTC
			CGCGGCATCGGCCGGCTCTCGGCCACTCAGGTCACCTT
			CCTCGGACCGCTCTCGCCGCTGACCGCCGCCGTGATCG
			GCTGGGCGGCACTCGGCGAGGCGCTCGGCCCGGTGCAA
			CTGGCGGGGACGGCGCTGGCCTTCGGAGCGACCCTCGT
			GGGCCAGACGGTACCGAGCGCGCCGCGCACGCCGCCGG
			TCGCCGCGGGCGCCGGTCCGTTCAGTTCTGCTTCACGA
			AACGGTCGAAAAGATTCGATGGACCTGACGGGTGCGGC
			CCTGCGACGGTAG
putative	Streptomyces	AL939119	ATGCCGGACGGCGCGCCGGGCGGACGGTTCGGCGCCCT	183
mem-brane	coelicolor		CGGACCCGTCGGCCTGGTCCTCGCCGGTGGCATCTCCG
protein			TGCAGTTCGGCGCCGCGCTGGCGGTGAGTCTGATGCCG
NCgl0580			CGGGCCGGGGCGCTCGGCGTGGTGACCCTGCGGCTCGC
related			CGTGGCCGCCGTCGTCATGCTCCTGGTCTGCCGGCCCC
			GGCTGCGCGGCCACTCCCGGGCCGACTGGGGCACGGTC
			GTCGTCTTCGGCATCGCCATGGCCGGCATGAACGGCCT
			CTTCTACCAGGCCGTCGACCGCATCCCGCTCGGCCCCG
			CGGTCACCCTGGAGGTGCTCGGCCCGCTCGCCCTGTCC
			GTCTTCGCCTCCCGCCGTGCGATGAACCTGGTCTGGGC
			CGCGCTCGCCCTGGCCGGTGTCTTCCTGCTGGGCGGCG
			GCGGCTTCGACGGCCTCGACCCGGCCGGTGCCGCCTTC
			GCCCTGGCGGCGGGCGCCATGTGGGCGGCGTACATCGT
			CTTCAGTGCCCGCACCGGACGCCGCTTCCCGCAGGCCG
			ACGGGCTGGCGCTGGCGATGGCGGTCGGCGCGCTGCTG
			TTCCTGCCGCTCGGCATCGTCGAGTCGGGGTCGAAGCT
			GATCGACCCGGTGACGCTCACGCTGGGCGCCGGCGTCG
			CCCTGCTCTCCTCCGTCCTGCCCTACACCCTCGAACTC
			CTCGCGCTGCGCCGTCTGCCAGCGCCGACCTTCGCCAT
			CCTCATGAGCCTGGAGCCCGCCATCGCCGCGGCGGCCG
			GTTTCCTCATCCTCGACCAGGCACTGACCGCCACCCAG
			TCCGCCGCCATCGCCCTGGTCATCGCGGCGAGCATGGG
			AGCGGTGCGGACCCAGGTGGGGCGGCGCCGGGCGAAGG
			CGCTTCCCGAGTAG
putative	Streptomyces	AL939110	ATGATGACCACCGCCCGCACGTCCCCTCCCGCCCCCTG	184
mem-brane	coelicolor		GCACCGTCGTCCCGACCTGCTCGCGGCCGGCGCGGCCA
protein			CCGTCACCGTCGTGCTGTGGGCATCCGCGTTCGTCTCC
NCgl0580			ATCCGCAGCGCGGGCGAGGCGTACTCGCCGGGCGCGCT
related			GGCGCTCGGCCGGCTGCTGTCGGGCGTCCTGACGCTCG
			GGGCGATCTGGCTGCTGCGCCGGGAGGGGCTGCCGCcG
			CGCGCGGCCTGGCGGGGGATCGCGATATCGGGGCTGCT
			GTGGTTCGGGTTCTACATGGTCGTCCTGAACTGGGGCG
			AGCAGCAGGTGGACGCCGGCACGGCCGCCCTCGTGGTC
			AACGTCGGCCCGATCCTCATCGCGCTGCTCGGCGCGCG
			GCTGCTGGGCGACGCGCTGCCGCCACGGCTGTTGACGG
			GGATGGCGGTGTCGTTCGCCGGTGCGGTGACCGTGGGC
			CTGTCCATGTCCGGCGAGGGCGGTTCCTCGCTGTTCGG
			GGTGGTGCTGTGCCTGCTGGCCGCGGTGGCGTACGCGG
			GCGGGGTGGTGGCCCAGAAGCCCGCGCTGGCGCACGCG
			AGCGCCCTTCAGGTGACGACGTTCGGGTGCCTGGTCGG
			GGCGGTGCTCTGCCTGCCGTTCGCCGGGCAGCTGGTGC
			ACGAGGCGGCCGGCGCGCCGGTCTCCGCCACGCTCAAC
			ATGGTCTACCTGGGCGTGTTCCCGACCGCCCTGGCGTT
			CACGACGTGGGCCTACGCCCTGGCCCGTACGACCGCCG
			GCCGCATGGGTGCGACCACGTACGCCGTGCCCGCGCTG
			GTCGTGCTGATGTCGTGGCTGGCACTGGGCGAGGTCCC
			GGGGCTGCTCACCCTGGCGGGCGGAGCGCTGTGCCTGG
			CGGGCGTGGCCGTGTCCCGCTCGCGCAGGCGCCCGGCC
			GCGGTCCCCGACCGGGCCGCGCCCACGGCGGAGCCACG
			GCGCGAGGACGCGGGGCGGGCCTAG
putative	Streptomyces	AL939108	GTGCCGGTGCATACGTCTGACAGCGCCCGCGGCAGCCG	185
mem-brane	coelicolor		CGGCAAGGGCATCGGGCTCGGCCTGGCACTGGCCTCCG
protein			CGGTCGCCTTCGGAGGTTCCGGAGTCGCGGCCAAACCG
NCgl0580			CTCATCGAGGCCGGGCTCGATCCGCTCCACGTGGTCTG
related			GCTGCGCGTCGCGGGCGCGGCCCTGGTGATGCTGCCGC
			TCGCCGTGCGCCACCGCGCCCTGCCGCGCCGCCGTCCC
			GCGCTGGTCGCCGGGTACGGACTGTTCGCCGTGGCCGG
			TGTCCAGGCGTGCTACTTCGCGGCCATCTCGCGCATCC
			CCGTCGGCGTCGCCCTGCTGGTCGAGTACCTGGCGCCC
			GCTCTGGTCCTCGGCTGGGTGCGGTTCGTGCAACGGCG
			GCCGGTCACACGCGCCGCCGCGCTCGGCGTGGTCCTGG
			CGGTCGGCGGCCTCGCCTGCGTGGTCGAGGTCTGGTCG
			GGGCTGGGCTTCGACGCCCTCGGACTGCTGCTCGCCCT
			CGGCGCCGCTTGCTGCCAGGTCGGCTACTTCGTCCTGT
			CCGACCAGGGCAGCGACGCCGGCGAGGAGGCGCCCGAC
			CCGCTCGGCGTCATCGCCTACGGCCTGCTGGTCGGCGC
			CGCCGTGCTCACCATCGTCGCCCGGCCCTGGTCGATGG
			ACTGGTCCGTCCTCGCCGGCTCGGCACCCATGGACGGC
			ACACCCGTCGCCGCCGCCCTGCTGCTGGCCTGGATCGT
			GCTCATCGCCACGGTGCTCGCCTACGTCACCGGAATCG
			TGGCCGTACGTCGGCTGTCGCCGCAGGTCGCCGGAGTC
			GTGGCGTGCCTGGAAGCGGTCATCGCGACGGTCCTGGC
			GTGGGTGCTGCTGGGCGAGCACCTCTCCGCCCCGCAGG
			TCGTCGGCGGCATCGTGGTGCTGGCGGGCGCCTTCATC
			GCCCAGTCCTCGACCCCGGCGAAGGGCTCCGCGGACCC
			GGTGGCCAGGGGCGGTCCCGAAAGGGAGTTGTCGAGCC
			GGGGAACGTCGACCTAG
putative	regulatory	AF265211	GTGAAATTAAAAGATTTCGCTTTTTACGCCCCCTGTGT	186
mem-brane	protein PecM		CTGGGGAACCACCTACTTTGTCACCACCCAATTTCTGC
protein	[Pectobacterium		CTGCCGACAAACCGCTGTTGGCTGCCCTGATCCGGGCG
NCgl0580			TTGCCTGCTGGTATTATTCTCATTCTCGGTAAAACTCT
related	chrysanthemi]		GCCGCCGGTCGGCTGGCTGTGGCGCTTGTTTGTACTGG
			GCGCACTCAATATCGGCGTGTTCTTTGTGATGCTGTTT
			TTTGCTGCTTATCGCCTGCCTGGCGGCGTGGTGGCGCT
			GGTGGGGTCGCTTCAGCCGCTGATCGTCATCCTGTTGT
			CTTTCCTGTTGCTGACGCAGCCGGTGCTGAAAAAGCAG
			ATGGTGGCGGCCGTGGCCGGCGGCATCGGTATTGCGTT
			GCTGATTTCGCTGCCGAAAGCGCCGCTGAACCCCGCCG
			GGCTGGTGGCATCGGCATTGGCGACGGTGAGTATGGCG
			TCCGGTCTGGTGCTGACTAAAAAGTGGGGGCGCCCGGC
			CGGAATGACGATGCTGACGTTTACCGGCTGGCAGCTGT
			TTTGCGGCGGGCTGGTGATTCTGCCGGTGCAGATGCTG
			ACAGAGCCGTTGCCGGATGTGGTGACCCTGACCAACCT
			TGCCGGTTATTTTTACCTGGCGATTCCCGGCTCTTTAC
			TGGCGTATTTCATGTGGTTCTCCGGTATTGAAGCTAAT
			TCGCCGGTGATGATGTCGATGCTGGGTTTTCTCAGCCC
			GTTGGTCGCGCTGTTTCTGGGCTTTTTATTTCTTCAAC
			AAGGACTTTCCGGAGCACAATTGGTCGGAGTGGTATTC
			ATTTTCTCGGCGATTATTATTGTTCAGGATGTTTCGTT
			ATTTAGCAGAAGAAAAAAAGTGAAGCAGTTGGAGCAAT
			CTGACTGTGCTGTCAAATAA
putative	Lactobacillus	AL935255	ATGAAGCGTTTAGTTGGAACTCTGTGCGGTATTATTAG	187
mem-brane	plantarum		TGCCGCTTTATTTGGGCTAGGTGGAATACTAGCACAGC
protein			CTTTGTTAAGTGAGCAAGTTCTGACTCCGCAACAGATT
NCgl0580			GTATTGTTACGGCTGTTAATCGGTGGGGCAATGTTGTT
related			GCTATATCGTAACTTGTTTTTCAAGCAGGCTAGAAAAA
					GCACGAAAAAGATTTGGACACATTGGCGAATTTTAACA
			CGAATTATGATATACGGCATCGCCGGCTTGTGCACGGC
			ACAAATTGCCTTTTTTTCTGCGATTAATTACAGTAATG
			CAGCAGTTGCAACTGTTTTTCAGTCCACTAGTCCGTTT
			ATTCTGCTTGTATTTACCGCGCTGAAAGCGAAAAGACT
			TCCCAGTTTATTAGCAGGAATGAGCTTAATAAGCGCAT
			TGATGGGAATCTGGCTTATTGTTGAATCCGGATTTAAG
			ACCGGATTAATAAAACCGGAAGCAATTATTTTTGGCCT
			GATTGCGGCTATCGGGGTTATCTTATACACCAAACTAC
			CTGTTCCATTGTTAAACCAAATTGCCGCAGTGGATATT
			TTGGGATGGGCACTAGTTATTGGCGGTGTGATAGCGTT
			GATTCACACACCGTTACCAAATTTAGTTAGATTTTCAA
			AAACGCAGCTTTTAGCGGTTCTTATCATTGTTATTCTA
			GCCACCGTTGTTGCGTATGATCTTTATTTAGAAAGTTT
			AAAGCTAATAGACGGATTTCTGGCAACTATGACTGGAC
			TATTTGAACCAATCAGTTCCGTACTTTTTGGCATGTTA
			TTCTTGCACCAAATCTTGGTTCCTCAGGCCTTGGTTGG
			TATTATATTGGTTGTGGGTGCAATTATGATACTGAATT
			TACCTCACCATATCACGGCACCTGTTCCCAGCAAAACC
			TGTCAATGTACGATGTCTAATCAATAG
putative	Lactobacillus	AL935252	GTGAAGAAAATTGCGCCCCTGTTCGTTGGCTTAGGGGC	188
mem-brane	plantarum		CATTAGTTTTGGAATTCCGGCGTCACTATTTAAAATTG
protein			CGCGTCGGCAGGGGGTTGTCAATGGCCCATTGCTATTC
NCgl0580			TGGTCCTTTCTGAGTGCGGTTGTGATTTTAGGTGTGAT
related			TCAAATTTTACGCCGTGCACGTTTGCGTAATCAGCAAA
			CGAATTGGAAGCAAATCGGACTGGTAATTGCGGCTGGA
			ACGGCTTCGGGATTTACTAACACCTTTTACATACAGGC
			GTTAAAGCTTATCCCAGTTGCTGTGGCCGCGGTAATGT
			TGATGCAGGCGGTCTGGATATCAACATTACTAGGAGCA
			GTGATTCATCATCGGCGTCCCTCCCGACTGCAAGTGGT
			TAGCATTGTTTTGGTATTGATAGGCACGATTTTAGCTG
			CTGGTCTGTTTCCAATTACGCAGGCGCTCTCGCCGTGG
			GGCTTGATGTTAAGTTTTTTAGCGGCATGCTCGTATGC
			TTGCACGATGCAGTTTACGGCTAGCTTAGGCAATAACT
			TAGACCCGTTATCGAAAACATGGTTACTGTGTTTGGGC
			GCTTTCATACTCATTGCTATCGTGTGGTCACCGCAATT
			AGTTACGGCACCCACCACGCCAGCAACAGTCGGCTGGG
			GAGTACTGATTGCACTATTCTCAATGGTTTTCCCACTG
			GTTATGTATTCATTGTTTATGCCGTACTTAGAGCTTGG
			CATTGGCCCAATCCTTTCTTCTTTAGAATTACCAGCCT
			CGATTGTTGTTGCATTTGTACTGCTTGATGAAACTATT
			GATTGGGTGCAAATGGTTGGCGTGGCCATTATTATTAC
			GGCCGTAATTCTGCCAAACGTGTTAAATATGCGACGAG
			TTCGGCCATAG
putative	Lactobacillus	AL935261	ATGACAACTAACCGTTATATGAAGGGCATCATGTGGGC	189
mem-brane	plantarum		GATGTTGGCCTCGACCCTGTGGGGAGTCTCAGGTACAG
protein			TGATGCAGTTCGTATCACAAAACCAAGCCATCCCGGCT
NCgl0580			GATTGGTTCTTATCTGTAAGGACGTTATCTGCTGGAAT
related			CATTCTGTTAGCGATTGGATTTGTGCAACAGGGTACCA
			AAATCTTCAAAGTCTTTAGATCTTGGGCGTCGGTTGGA
			CAATTAGTGGCATACGCGACAGTGGGATTGATGGCGAA
			TATGTATACTTTTTACATCAGTATTGAGCGCGGAACAG
			CCGCTGCCGCCACTATTTTACAATACTTAAGTCCTTTG
			TTTATTGTACTAGGAACGTTGCTGTTTAAACGGGAACT
			GCCTTTACGGACTGATTTAATTGCGTTTGCGGTCTCCT
			TGTTGGGGGTGTTTTTAGCAATCACTAAGGGTAATATT
			CATGAGTTGGCGATTCCGATGGATGCACTCGTCTGGGG
			AATCCTTTCGGGGGTAACAGCGGCCTTGTACGTAGTCT
			TGCCGCGAAAGATTGTAGCCGAAAATTCACCGGTCGTG
			ATTCTTGGTTGGGGGACATTGATTGCGGGAATCCTATT
			TAATTTATATCACCCAATTTGGATCGGTGCACCAAAAA
			TTACACCAACGCTAGTGACTTCAATTGGCGCCATCGTT
			TTAATCGGGACGATTTTTGCTTTCTTATCGTTGCTACA
			TAGTCTACAGTACGCGCCGTCTGCGGTGGTCAGTATTG
			TTGATGCCGTCCAACCAGTAGTGACTTTTGTACTAAGT
			ATTATTTTCTTAGGCTTACAAGTGACATGGGTCGAAAT
			CCTCGGCTCGTTATTGGTGATTGTCGCGATTTATATCT
			TGCAGCAGTATCGGAGTGATCCGGCTAGTGATTAG
NCgl0580	Coryne-	NC_003450	ATGAATAAACAGTCCGCTGCAGTGTTGATGGTGATGGG	277
	bacterium		TTCCGCCCTATCCCTGCAATTTGGTGCTGCCATTGGAA
	glutamicum		CGCAGCTTTTCCCCCTCAACGGCCCCTGGGCTGTCACC
			TCTTTAAGGCTGTTCATCGCAGGCTTGATCATGTGCCT
			GGTGATCCGCCCGCGACTTCGTTCCTGGACTAAAAAAC
			AATGGATCGCCGTGCTGCTGTTGGGATTATCTCTTGGC
			GGAATGAACAGCCTGTTTTACGCATCCATCGAACTCAT
			CCCGCTGGGTACCGCCGTGACCATTGAGTTCCTCGGCC
			CCCTGATTTTCTCCGCGGTGTTAGCCCGCACGCTGAAA
			AACGGATTGTGCGTGGCTTTAGCGTTTCTCGGCATGGC
			ACTACTGGGTATCGATTCCCTCAGCGGCGAAACCCTTG
			ACCCACTCGGCGTCATTTTCGCAGCCGTCGCAGGAATC
			TTCTGGGTGTGCTACATCCTGGCATCAAAGAAAATCGG
			CCAACTCATCCCCGGAACAAGCGGCCTGGCCGTCGCAC
			TGATTATCGGCGCAGTGGCAGTATTTCCACTGGGTGCT
			ACACACATGGGCCCGATTTTCCAGACCCCAACCCTACT
			CATCCTGGCGCTTGGCACAGCACTTCTCGGGTCGCTTA
			TCCCCTATTCGCTGGAATTATCGGCACTGCGCCGACTC
			CCCGCCCCCATTTTCAGTATTCTGCTCAGCCTCGAACC
			GGCATTCGCCGCCGCCGTCGGCTGGATCCTGCTTGATC
			AAACCCCCACCGCGCTCAAGTGGGCCGCGATCATCCTT
			GTCATCGCGGCCAGCATCGGCGTCACGTGGGAGCCTAA
			AAAGATGCTTGTCGACGCGCCCCTCCACTCAAAATGCA
			ACGCGAAGAGGCGAGTACACACACCTAGT
drug	Streptomyces	AL939108	GTGTCGAATGCCGTCTCCGGCCTGCCCGTAGGGCGTGG	190
permease	coelicolor		CCTCCTCTATCTGATCGTCGCCGGTGTCGCCTGGGGCA
NCgl2065			CCGCCGGTGCCGCCGCCTCGCTGGTCTACCGGGCCAGC
related			GACCTGGGGCCCGTCGCCCTGTCGTTCTGGCGTTGCGC
			GATGGGGCTCGTGCTGCTGCTCGCCGTCCGCCCGCTGC
			GCCCGCGGCTGCGCCCGCGGCTGCGCCCGCGGCTGCGC
			CCGGCGGTCCGCGAACCGTTCGCCCGCAGGACGCTTCG
			GGCCGGTGTCACCGGTGTCGGGCTCGCGGTGTTCCAGA
			CCGCCTACTTCGCCGCCGTGCAGTCCACCGGACTCGCC
			GTCGCCACGGTGGTCACCCTCGGCGCGGGGCCCGTACT
			GATCGCCCTCGGCGCGCGCCTCGCCCTCGGTGAACAGC
			TGGGAGCGGGGGGTGCCGCGGCCGTGGCCGGCGCCCTC
			GCCGGGCTCCTGGTGCTCGTCCTCGGCGGCGGAAGCGC
			GACCGTCCGCCTGCCGGGTGTGCTCCTCGCGCTGCTGT
			CCGCCGCCGGGTACTCGGTGATGACGCTGCTCACCCGT
			TGGTGGGGACGGGGCGGCGGGGCGGACGCGGCCGGTAC
			GTCCGTGGGGGCGTTCGCCGTCACGAGTCTGTGCCTGC
			TGCCGTTCGCCCTGGCCGAGGGCCTGGTGCCGCACACC
			GCGGAACCGGTCCGGCTGCTGTGGCTCCTCGCCTACGT
			CGCGGCCGTCCCGACCGCGCTGGCCTACGGGCTCTACT
			TCGCCGGCGCGGCCGTCGTCCGGTCCGCGACGGTCTCC
			GTGATCATGCTCCTGGAGCCGGTCAGTGCGGCCGCGCT
			CGCCGTCCTGCTGCTCGGCGAGCACCTCACGGCCGCGA
			CCCTGGCCGGCACGCTGCTGATGCTCGGCTCGGTCGCG
			GGTCTCGCGGTGGCGGAGACCCGGGCGGCGCGGGAGGc
			GAGGACGCGGCCGGCGCCCGCGTGA
drug	Streptomyces	AL939124	GTGAACGTCCTGCTCTCGGCCGCCTTCGTTCTGTGCTG	191
permease	coelicolor		GAGCTCCGGCTTCATCGGCGCCAAGCTCGGTGCTCAGA
NCgl2065			CCGCGGCCACACCCACCCTCCTGATGTGGCGCTTCCTG
related			CCTCTCGCCGTGGCCCTGGTCGCCGCGGCGGCCGTCTC
			CCGGGCCGCCTGGCGGGGCCTGACACCGCGGGACGCCG
			GCCGGCAGATCGCCATCGGCGCCCTGTCGCAGAGCGGC
			TATCTGCTCAGCGTCTACTACGCCATCGAACTGGGCGT
			CTCCAGCGGCACCACCGCCCTCATCGACGGCGTCCAGC
			CACTCGTCGCCGGCGCGCTCGCCGGTCCCCTGCTGCGC
			CAGTACGTCTCGCGCGGGCAGTGGCTCGGACTGTGGCT
			GGGCTGTCGGGCGTGGCCACCGTGACGGTCGCCGACG
			CCGGGGCGGCGGGCGCGGAGGTGGCCTGGTGGGCGTAT
			CTCGTCCCGTTTCTCGGCATGCTGTCGCTGGTGGCGGC
			CACCTTCCTGGAGGGCCGCACAAGGGTGCCGGTCGCGC
			CCCGCGTCGCCCTGACGATCCACTGTGCGACCAGTGCC
			GTCCTCTTCTCCGGACTGGCCCTGGGCCTCGGGGCGGC
			GGCACCGCCGGCCGGTTCCTCGTTCTGGCTGGCGACCG
			CCTGGCTGGTGGTCCTGCCGACCTTCGGCGGCTACGGC
			CTGTACTGGCTGATCCTGCGCCGGTCCGGCATCACCGA
			GGTCAACACCCTCATGTTCCTCATGGCCCCGGTCACGG
			CCGTGTGGGGCGCCCTCATGTTCGGTGAGCCGTTCGGC
			GTCCAGACCGCCCTCGGCCTGGCGGTCGGCCTCGCGGC
			CGTGGTCGTCGTCCGGCGCGGGGGCGGCGCGCGCCGGG
			AGCGGCCCGTGCGGTCCGGCGCGGACCGTCCGGCGGCC
			GGAGGGCCGACGGCGGACCAGCCGACGAACAGGCCGAC
			CGACAGGCCGACGGCGGCCGGGTCGACCGACAGGCCGA
			CGGCGGACAGGCGCTGA
drug	Thermobifida	NZ_AAAQ010	ATGTCTGATTTCCGCAAGGGTGTGCTCTATGGCGCCAG	192
permease	fusca	00034	TTCGTACTTCATGTGGGGCTTTCTGCCGCTCTACTGGC
NCgI2065			CGCTGCTGACCCCGCCTGCCACGGCCTTTGAGGTCCTC
related			TTACATAGGATGATCTGGTCATTGGTTGTCACGCTCGT
			GGTGCTGCTGGTGCAGCGGAACTGGCAGTGGATCCGCG
			GCGTGCTGCGGAGCCCGCGGCGCCTGCTGCTGCTCCTC
			GCCTCGGCCGCACTCATCTCCCTGAACTGGGGCGCTTT
			CATCACCGCCGTGACGACCGGGCACACCCTGCAATCGG
			CACTCGCCTACTTCATCAACCCGCTGGTGAGCGTGGCG
			CTAGGGCTGCTGGTGTTCAAAGAGCGGCTGCGCCCAGG
			CCAGTGGGCCGCACTGCTGCTCGGCGTCCTCGCCGTAG
			CCGTGCTGACCGTCGACTACGGCTCCCTGCCTTGGTTG
			GCGCTGGCCATGGCGTTCTCCTTCGCCGTCTACGGCGC
			GCTGAAGAAGTTCGTGGGCTTGGACGGGGTGGAGAGCC
			TCAGCGCGGAGACCGCGGTCCTGTTCCTGCCTGCGCTG
			GGCGGCGCGGTCTACCTGGAAGTGACCGGTACCGGCAC
			CTTCACCTCGGTCTCCCCCCTCCACGCGTTGCTGCTGG
			TGGGCGCCGGAGTGGTGACCGCGGCGCCGCTCATGCTG
			TTCGGCGCGGCAGCGCACCGCATCCCGCTGACCCTGGT
			CGGGCTGCTGCAGTTCATGGTTCCGGTGATGCACTTCC
			TCATCGCCTGGCTGGTCTTCGGGGAGGACCTGTCACTT
			GGCCGGTGGATCGGGTTCGCCGTGGTGTGGACCGCGCT
			CGTGGTGTTCGTCGTCGACATGCTCCGCCACGCACGCC
			ACACCCCCCGCCCTGCCCCGTCAGCCCCTGTCGCTGAG
			GAAGCCGAGGAAACTGCGGCTAGTTGA
drug	Streptomyces	AL939120	GTGGCCGGGTCGTCCAGGAGTGATCAGCGAGTAGGCCT	193
permease	coelicolor		GCTGAACGGCTTCGCGGCGTACGGGATGTGGGGGCTCG
NCgl2065			TCCCGCTGTTCTGGCCGCTGCTCAAGCCCGCCGGGGCC
related			GGGGAGATCCTCGCCCACCGGATGGTGTGGTCCCTCGC
			CTTCGTCGCCGTCGCCCTCCTCTTCGTACGGCGCTGGG
			CCTGGGCCGGCGAGCTGCTGCGGCAGCCGCGCAGGCTC
			GCCCTGGTCGCGGTGGCCGCCGCGGTCATCACCGTCAA
			CTGGGGCGTCTACATCTGGGCCGTGAACAGCGGCCATG
			TCGTCGAGGCCTCGCTCGGCTACTTCATCAACCCGCTG
			GTCACCATCGCGATGGGCGTGCTGTTGCTCAAGGAGCG
			GCTGCGGCCCGCGCAGTGGGCGGCGGTCGGCACCGGCT
			TCGCGGCCGTGCTCGTGCTCGCCGTCGGCTACGGCCAG
			CCGCCGTGGATCTCGCTCTGCCTCGCCTTCTCCTTCGC
			CACGTACGGCCTGGTGAAGAAGAAGGTCAACCTCGGGG
			GTGTCGAGTCGCTGGCCGCCGAGACGGCGATCCAGTTC
			CTTCCGGCGCTCGGCTACCTGCTGTGGCTGGGCGCGCA
			GGGCGAGTCGACCTTCACCACGGAGGGCGCCGGACACT
			CGGCCCTGCTCGCCGCGACCGGCGTCGTCACGGCGATC
			CCGCTGGTCTGCTTCGGCGCGGCGGCGATCCGCGTCCC
			GCTGTCCACACTGGGGCTGCTGCAATACCTGGCGCCGG
			TCTTCCAGTTCCTGCTCGGCGTCCTCTACTTCGGCGAG
			GCCATGCCGCCCGAGCGCTGGGCCGGCTTCGGGCTGGT
			CTGGCTGGCGCTGACGCTGCTCACCTGGGACGCGTTGC
			GCACGGCCCGCCGGACCGCACGGGCGCTGAGGGAACAA
			CTGGACCGGTCGGGCGCGGGCGTACCACCGCTCAAGGG
			GGCCGCCGCCGCGCGGGAGCCGAGGGTCGTGGCCTCGG
			GGACTCCGGCACCGGGCGCCGGCGACGCACCGCAGCAA
			CAGCAACAGCAACAGCAACAGCAACAGCAACAGCAACA
			CGGAACCAGGGCCGGGAAGCCGTAG
drug	Lactobacillus	AL935253	GTGAAGAAAGCATATCTTTACATTGCAATTTCGACCTT	194
permease	plantarum		AATGTTTAGTTCGATGGAAATTGCGCTAAAGATGGCCG
NCgl2065			GCAGTGCCTTTAACCCAATCCAATTGAATCTAATTCGA
related			TTTTTTATTGGGGCAATTGTGTTACTGCCATTTGCATT
			GCGGGCATTAAAGCAAACCGGACGAAAGTTAGTGAGTG
			CTGACTGGCGGCTATTTGCTTTAACCGGGCTAGTGTGT
			GTCATTGTCAGTATGTCGCTTTACCAACTCGCGATTAC
			GGTCGATCAAGCTTCGACTGTGGCCGTATTGTTTAGTT
			GTAATCCGGTATTTGCGCTATTATTCTCCTATTTAATT
			CTGCGAGAACGGTTGGGTCGAGCTAACTTGATCTCCGT
			CGTGATTTCTGTGATTGGGTTGTTGATCATTGTTAATC
			CGGCCCATTTGACGAATGGGCTCGGGCTGCTATTAGCC
			ATCGGGTCTGCCGTGACTTTTGGGCTGTACAGTATCAT
			CTCGCGTTATGGGTCTGTTAAACGGGGCTTGAATGGGC
			TGACGATGACTTGTTTTACTTTCTTTGCTGGTGCGTTT
			GAACTTCTAGTTTTAGCTTGGATTACTAAGATTCCGGC
			TGTCGCCAATGGGTTGACGGCCATCGGTTTGCGGCAAT
			TTGCTGCCATTCCGGTTTTGGTGAATGTTAATCTCAAC
			TATTTCTGGTTACTATTTTTTATCGGCGTTTGTGTTAC
			TGGTGGGGGCTTCGCGTTTTATTTCTTGGCAATGGAAC
			AAACCGATGTTTCAACGGCTTCCCTAGTATTCTTCATT
			AAGCCGGGGTTGGCGCCAATCTTAGCAGCGTTGATCCT
			CCATGAACAAATTTTGTGGACGACAGTGGTCGGAATTG
			TTGTGATTTTGATTGGTTCCGTCGTGACCTTTGTCGGT
			AATCGGTTCCGTGAACGGGATACGATGGGTGCGATTGA
			GCAGCCAACAGCGGCCGCCACTGATGATGAACATGTCA
			TCAAAGCCGCACACGCCGTTTCAAATCAAGAAAATTAA
NCgl2065	Coryne-	NC_003450	GTGAATGATGCTGGCTTGAAGACGCGAAACCCGGTGcT	278
	bacterium		TGCCCCCATTTTGATGGTGGTTAACGGCGTGTCCCTTT
	glutamicum		ATGCCGGAGCAGCGTTGGCGGTGGGGCTGTTTGAGAGT
			TTCCCACCCGCGTTGGTTGCGTGGATGCGAGTAGCAGC
			GGCTGCGGTGATTTTGCTTGTGCTGTATCGGCCTGCAG
			TGCGAAATTTTATTGGGCAGACCGGGTTTTATGCGGCG
			GTGTATGGCGTTTCCACGCTTGCCATGAACATCACGTT
			CTATGAGGCGATCGCCCGCATTCCGATGGGTACCGCGG
			TGGCCATTGAGTTCTTGGGACCTATTGCAGTGGCCGCG
			TTGGGCAGTAAGACGCTGCGGGATTGGGCTGCGTTGGT
			TTTAGCTGGCATCGGAGTGATAATTATTAGCGGTGCGC
			AGTGGTCGGCCAACAGCGTGGGCGTCATGTTTGCACTG
			GCAGCAGCATTACTGTGGGCTGCGTACATCATCGCGGG
			AAACCGCATTGCAGGCGATGCCTCCTCAAGTAGAACCG
			GCATGGCGGTGGGATTCACGTGGGCATCAGTGTTGTCT
			TTGCCGTTGGCGATCTGGTGGTGGCCGGGTCTGGGAGC
			AACGGAACTTACGTTAATCGAGGTCATCGGATTAGCAC
			TTGGTTTGGGCGTGCTGTCGGCGGTGATTCCTTATGGC
			CTTGACCAGATTGTGCTCCGCATGGCCGGGCGATCCTA
			CTTTGCGCTGCTCCTGGCTATTTTGCCGATCAGCGCCG
			CGCTCATGGGAGCGCTTGCGCTGGGCCAAATGTTGTCG
			GTGGCTGAGCTTGTCGGCATTGTGCTGGTTGTCATCGC
			AGTTGCTTTGCGACGCCCCTCC
hypo-thetical	Thermobifida	NZ_AAAQ010	GTGAACGCCGACACCCTCCTGTGGTCCCTGCTGCTCGG	195
mem-brane	fusca	00035	CGTCATCGTCGTCGCTGCCGCGGCGGCGATCATCATCC
protein			CCACCGTGCGGAACAGCAGCACGGCTCCCCCGCCCGGG
NCgl2829			GCGGTAGGGACCGCGCTGGGTGCGGCGCTCACCGCCGC
related			TGCCCTCGGCATAGCGGGCAGCGGAACCGCTCCCGCCT
			CCGAAGTGCCCGCGGGCTCCGGCCAGGTCCGTACCGTC
			GACGTGGTGCTGGGCGACATGACCGTCTCCCCGTCCCA
			CGTCACCGTCGCGCCCGGCGACTCCCTCGTCCTCCGCG
			TGCGCAACGAGGACACTCAAGTCCACGACTTGGTGGTG
			GAGACCGGGGCCCGCACGCCCCGGCTTGCGCCAGGTGA
			CAGCGCCACCCTGCAGGTCGGCACGGTGACCGAGCCCA
			TCGACGCCTGGTGCACTGTGCTCGGGCACAGCGCCGCG
			GGCATGCGGATGCGGATCGACACCACTGACACTGCGGA
			CAGCGCTGACAGCCCCGACACGCCCGCTGGTGCGGACA
			GCGGTCCGCCCGCACCGCTCCCCCTGTCCGCGGAGATG
			AGCGACGACTGGCAGCCCCGCGACGCTGTCCTGCCGCC
			CGCGCCGGACCGCACCGAACACGAAGTGGAGATCCGGG
			TCACCGAAACCGAGCTGGAGGTCGCCCCCGGGGTGCGG
			CAGAGCGTGTGGACGTTCGGCGGCGACGTCCCCGGCCC
			TGTGCTGCGCGGCAAGGTCGGCGACGTGTTCACCGTGA
			CCTTCGTCAACGACGGCACGATGGGCCACGGCATCGAC
			TTCCACGCCAGCAGTCTCGCCCCGGACGAGCCGATGCG
			CACGATCAATCCGGGCGAGCGCCTCACCTACCGGTTCC
			GCGCGGAGAAAGCCGGTGCCTGGGTGTACCACTGTTCG
			ACCTCGCCCATGCTGCAGCACATCGGCAACGGCATGTA
			CGGCGCGGTCATCATCGACCCGCCCGACCTTGAGCCGG
			TCGACCGTGAATACCTGCTGGTCCAAGGAGAGCTGTAC
			CTGGGCGAGCCGGGCAGCGCCGACCAGGTCGCCCGGAT
			GCGGGCGGGTGAGCCGGACGCGTGGGTGTTCAACGGGG
			TCGCCGCCGGCTACGCCCACGCGCCGTTGACCGCCGAG
			GTCGGGGAGCGCGTCCGGATCTGGGTGGTGGCGGCCGG
			TCCCACCAGCGGAACGTCTTTCCACATCGTCGGCGCCC
			AGTTCGACACCGTCTACAAGGAGGGTGCCTACCTGGTG
			CGCCGTGGCGACGCCGGGGGCGCGCAAGCGCTCGACCT
			GGCGGTCGCCCAAGGCGGTTTTGTCGAAACAGTGTTCC
			CCGAAGCGGGCTCCTATCCCTTTGTCGACCATGACATG
			CGGCATGCCGAGAACGGGGCCCGCGGCTTCTTCACGAT
			CACGGAGTGA
NCgl2829	Coryne-	NC_003450	ATGGTTCTGGTAATCGCCGGAATAATCCACCCGCTCCT	279
	bacterium		GCCGGAATACCGTTGGGTTCTCATTCACCTTTTCACCC
	glutamicum		TTGGTGCCATCACCAATTCGATTGTGGTGTGGTCGCAG
			CATTTCACGGAAAAGTTTCTGCATTTAAAGCTTGAGGA
			ATCGAAACGCCCTGCGCAGCTACTGAAAATTCGGGTGC
			TGAATGTGGGAATTATCGTCACGATTATTGGGCAGATG
			ATCGGTCAGTGGATCGTCACCAGTGTCGGCGCGACGAT
			TGTGGGCGGTGCTTTGGCGTGGCACGCAGGCAGTTTGG
			CATCACAGTTCCGGAGCGCAAAACGCGGTCAGCCTTTC
			GCGTCGGCAGTGATCGCGTATGTTGCCAGCGCGTGCTG
			CCTGCCGTTTGGCGCATTTGCCGGAGCGTTGTTGTCCA
			AGGAGCTGTCGGGACATCTCCAGGAACGAGTCCTTCTC
			ACCCACACGGTGATTAATTTTCTAGGTTTCGTGGGATT
			TGCTGCGCTCGGTTCGCTGTCGGTGCTGTTCGCCGCGA
			TTTGGCGCACCAAAATTCGCCACAATTTCACCCCGTGG
			TCTGTGGGGATCATGGCGGTGAGCCTGCCGATCATCGT
			CACGGGCATCCTGCTCAACAACGGCTATGTCGCCGCCA
			CAGGCCTGGCCGCGTACGTGGCAGCATGGTTGCTGGCC
			ATGGTGGGGTGGGGGAAGGCGTCGATAAGCAATTTAAG
			CTTTTCGACGTCCACCTCCACCACCGCACCCCTTTGGC
			TCGTGGGCACGCTTGTGTGGCTGGCGGTGCAGGCGGTG
			ATGCATGACGGCGAGCTTTACCATGTGGAAGTTCCCAC
			GATTGCGCTGGTCATCGGCTTTGGCGCGCAGCTTCTGA
			TCGGTGTGATGAGTTATCTACTGCCGTCGACGATGGGT
			GGCGGCGCGAGCGCGGTGCGGACTGGAACGCACATTTT
			AAACACTGCGGGGCTGTTTAGGTGGACGCTGATCAACG
			GTGGCCTGGCGATTTGGCTGCTCACCGACAATTCGTGG
			CTGCGCGTCGTGGTGTCTCTGCTGAGTATCGGAGCGTT
			GGCAGTTTTTGTCATTCTGCTGCCCAAGGCTGTGCGGG
			CGCAGCGCGGAGTGATCACCAAAAAGCGCGAACCAATT
			ACTCCGCCGGAGGAGCCTCGACTCAATCAAATTACCGC
			GGGAATCTCTGTGCTTGCCCTGATTTTGGCAGCATTCG
			GTGGGCTCAACCCCGGTGTTGCGCCGGTGGCAAGCTCA
			AATGAAGACGTCTATGCTGTGACCATTACCGCAGGTGA
			CATGGTGTTTATCCCTGATGTGATTGAAGTGCCTGCTG
			GTAAATCACTCGAAGTCACGATGCTCAACGAAGACGAC
			ATGGTGCACGATCTGAAATTTGCCAACGGTGTGCAAAC
			CGGACGTGTGGCGCCAGGTGATGAAATTACGGTGACCG
			TCGGCGATATTTCCGAAGACATGGACGGCTGGTGCACC
			ATCGCTGGGCACCGCGCGCAAGGAATGGATCTGGAAGT
			AAAGGTTGCGGCTCCGAAT
yggA	Escherichia coli	U28377	GTGTTTTCTTATTACTTTCAAGGTCTTGCACTTGGGGC	280
			GGCTATGATCCTACCGCTCGGTCCACAAAATGCTTTTG
			TGATGAATCAGGGCATACGTCGTCAGTACCACATTATG
			ATTGCCTTACTTTGTGCTATCAGCGATTTGGTCCTGAT
			TTGCGCCGGGATTTTTGGTGGCAGCGCGTTATTGATGC
			AGTCGCCGTGGTTGCTGGCGCTGGTCACCTGGGGCGGC
			GTAGCCTTCTTGCTGTGGTATGGTTTTGGCGCTTTTAA
			AACAGCAATGAGCAGTAATATTGAGTTAGCCAGCGCCG
			AAGTCATGAAGCAAGGCAGATGGAAAATTATCGCCACC
			ATGTTGGCAGTGACCTGGCTGAATCCGCATGTTTACCT
			GGATACTTTTGTTGTACTGGGCAGCCTTGGCGGGCAAC
			TTGATGTGGAACCAAAACGCTGGTTTGCACTCGGGACA
			ATTAGCGCCTCTTTCCTGTGGTTCTTTGGTCTGGCTCT
			TCTCGCAGCCTGGCTGGCACCGCGTCTGCGCACGGCAA
			AAGCACAGCGCATTATCAATCTGGTTGTGGGATGTGTT
			ATGTGGTTTATTGCCTTGCAGCTGGCGAGAGACGGTAT
			TGCTCATGCACAAGCCTTGTTCAGT

A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.

Claims

1. An Enterobacteriaceae or coryneform bacterium comprising at least one of: (a) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial aspartokinase polypeptide or a functional variant thereof; (b) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (d) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial pyruvate carboxylase polypeptide or a functional variant thereof; (e) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof; (f) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (g) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine O-acetyltransferase polypeptide or a functional variant thereof; (h) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; (i) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial methionine adenosyltransferase polypeptide or a functional variant thereof; (j) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial mcbR gene product polypeptide or a functional variant thereof; (k) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-succinylhomoserine/acetylhomoserine (thiol)-lyase polypeptide or a functional variant thereof; (l) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial cystathionine beta-lyase polypeptide or a functional variant thereof; (m) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; and (n) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof.

2. The bacterium of claim 1, wherein the bacterium is an Escherichia coli bacterium.

3. The bacterium of claim 1, wherein the bacterium is a Corynebacterium glutamicum bacterium.

4. The bacterium of claim 1, wherein the sequence encodes a polypeptide with reduced feedback inhibition.

5. The bacterium of claim 1, wherein the polypeptide is selected from an Enterobacteriaceae polypeptide, an Actinomycetes polypeptide, or a variant thereof.

6. The bacterium of claim 5, wherein the polypeptide is a polypeptide of one of the following Actinomycetes species: Mycobacterium smegmatis, Streptomyces coelicolor, Thermobifida fusca, Amycolatopsis mediterranei and coryneform bacteria, including Corynebacterium glutamicum.

7. The bacterium of claim 5, wherein the polypeptide is a polypeptide of one of the following Enterobacteriaceae species: Erwinia chysanthemi and Escherichia coli.

8. The bacterium of claim 1, wherein the heterologous bacterial aspartokinase polypeptide or functional variant thereof is chosen from: (a) a Mycobacterium smegmatis aspartokinase polypeptide or a functional variant thereof; (b) an Amycolatopsis mediterranei aspartokinase polypeptide or a functional variant thereof; (c) a Streptomyces coelicolor aspartokinase polypeptide or a functional variant thereof; (d) a Thermobifida fusca aspartokinase polypeptide or a functional variant thereof; (e) an Erwinia chrysanthemi aspartokinase polypeptide or a functional variant thereof; and (f) a Shewanella oneidensis aspartokinase polypeptide or a functional variant thereof.

9. The bacterium of claim 1, wherein the heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide or functional variant thereof is chosen from: (a) a Mycobacterium smegmatis aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (b) an Amycolatopsis mediterranei aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a Streptomyces coelicolor aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; and (d) a Thermobifida fusca aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof.

10. The bacterium of claim 1, wherein the heterologous bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof is chosen from: (a) a Mycobacterium smegmatis phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (b) a Streptomyces coelicolor phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (c) a Thermobifida fusca phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; and (d) an Erwinia chrysanthemi phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof.

11. The bacterium of claim 1, wherein the heterologous bacterial pyruvate carboxylase polypeptide or a functional variant thereof is chosen from: (a) a Mycobacterium smegmatis pyruvate carboxylase polypeptide or a functional variant thereof; and (b) a Streptomyces coelicolor pyruvate carboxylase polypeptide or a functional variant thereof.

12. The bacterium of claim 1, wherein the bacterium comprises at least two of: (a) a nucleic acid molecule encoding a heterologous bacterial aspartokinase polypeptide or a functional variant thereof; (b) a nucleic acid molecule encoding a heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a nucleic acid molecule encoding a heterologous bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (d) a nucleic acid molecule encoding a heterologous bacterial pyruvate carboxylase polypeptide or a functional variant thereof; (e) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof; (f) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (g) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine O-acetyltransferase polypeptide or a functional variant thereof; (h) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; (i) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial methionine adenosyltransferase polypeptide or a functional variant thereof; (j) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial mcbR gene product polypeptide or a functional variant thereof; (k) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-succinylhomoserine/acetylhomoserine (thiol)-lyase polypeptide or a functional variant thereof; (l) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial cystathionine beta-lyase polypeptide or a functional variant thereof; (m) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; and (n) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof.

13. The bacterium of claim 1, wherein the bacterium comprises at least three of: (a) a nucleic acid molecule encoding a heterologous bacterial aspartokinase polypeptide or a functional variant thereof; (b) a nucleic acid molecule encoding a heterologous bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a nucleic acid molecule encoding a heterologous bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; and (d) a nucleic acid molecule encoding a heterologous bacterial pyruvate carboxylase polypeptide or a functional variant thereof; (e) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof; (f) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (g) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine O-acetyltransferase polypeptide or a functional variant thereof; (h) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; (i) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial methionine adenosyltransferase polypeptide or a functional variant thereof; (j) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial mcbR gene product polypeptide or a functional variant thereof; (k) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-succinylhomoserine/acetylhomoserine (thiol)-lyase polypeptide or a functional variant thereof; (l) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial cystathionine beta-lyase polypeptide or a functional variant thereof; (m) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; and (n) a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof.

14. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule comprising a sequence encoding a heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof.

15. The bacterium of claim 14 wherein the heterologous bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof is chosen from: (a) a Mycobacterium smegmatis dihydrodipicolinate synthase polypeptide or a functional variant thereof; (b) a Streptomyces coelicolor dihydrodipicolinate synthase polypeptide or a functional variant thereof; (c) a Thermobifida fusca dihydrodipicolinate synthase polypeptide or a functional variant thereof; and (d) an Erwinia chrysanthemi dihydrodipicolinate synthase polypeptide or a functional variant thereof.

16. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule comprising a sequence encoding a heterologous bacterial homoserine dehydrogenase polypeptide or a functional variant thereof.

17. The bacterium of claim 16, wherein the heterologous bacterial homoserine dehydrogenase polypeptide is chosen from: (a) a Mycobacterium smegmatis homoserine dehydrogenase polypeptide or functional variant thereof; (b) a Streptomyces coelicolor homoserine dehydrogenase polypeptide or a functional variant thereof; (c) a Thermobifida fusca homoserine dehydrogenase polypeptide or a functional variant thereof; and (d) an Erwinia chrysanthemi homoserine dehydrogenase polypeptide or a functional variant thereof.

18. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule comprising a sequence encoding a heterologous bacterial O-homoserine acetyltransferase polypeptide or a functional variant thereof.

19. The bacterium of claim 18, wherein the heterologous bacterial O-homoserine acetyltransferase polypeptide is chosen from: (a) a Mycobacterium smegmatis O-homoserine acetyltransferase polypeptide or functional variant thereof; (b) a Streptomyces coelicolor O-homoserine acetyltransferase polypeptide or a functional variant thereof; (c) a Thermobifida fusca O-homoserine acetyltransferase polypeptide or a functional variant thereof; and (d) an Erwinia chrysanthemi O-homoserine acetyltransferase polypeptide or a functional variant thereof.

20. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule that encodes a heterologous bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof.

21. The bacterium of claim 20, wherein the heterologous bacterial O-acetylhomoserine sulfhydrolase polypeptide is chosen from: (a) a Mycobacterium smegmatis O-acetylhomoserine sulfhydrylase polypeptide or functional variant thereof; (b) a Streptomyces coelicolor O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; and (c) a Thermobifida fusca O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof.

22. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof.

23. The bacterium of claim 22, wherein the heterologous bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide is chosen from: (a) a bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide that is at least 80% identical to SEQ ID No:72 or 73, or a functional variant thereof, from a species of the genus Mycobacterium; (b) a Streptomyces coelicolor 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof (c) a Thermobifida fusca 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; and (d) a Lactobacillus plantarum 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof.

24. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule comprising a sequence encoding a heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof.

25. The bacterium of claim 24, wherein the heterologous bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide is chosen from: (a) a bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide that is at least 80% identical to SEQ ID No:75 or 76, or a functional variant thereof, from a species of the genus Mycobacterium; (b) a Streptomyces coelicolor 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof; (c) a Thermobifida fusca 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof; and (d) a Lactobacillus plantarum 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof.

26. An Escherichia coli or coryneform bacterium comprising a nucleic acid molecule comprising a sequence encoding a heterologous bacterial methionine adenosyltransferase polypeptide or a functional variant thereof.

27. The bacterium of claim 26, wherein the heterologous bacterial methionine adenosyltransferase polypeptide is chosen from: (a) a Mycobacterium smegmatis methionine adenosyltransferase polypeptide or functional variant thereof; (b) a Streptomyces coelicolor methionine adenosyltransferase polypeptide or a functional variant thereof; (c) a Thermobifida fusca methionine adenosyltransferase polypeptide or a functional variant thereof; and (d) an Erwinia chrysanthemi methionine adenosyltransferase polypeptide or a functional variant thereof.

28. An Escherichia coli or coryneform bacterium comprising at least two of: (a) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartokinase polypeptide or a functional variant thereof; (b) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (c) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; and (d) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial dihydrodipicolinate synthase polypeptide or a functional variant thereof.

29. The bacterium of claim 28, wherein at least one of the at least two genetically altered nucleic acid molecules encodes a heterologous polypeptide.

30. The bacterium of claim 28, wherein the bacterium comprises (a) and (b), (a) and (c), (a) and (d), (b) and (c), (b) and (d), or (c) and (d).

31. The bacterium of claim 30, wherein the bacterium comprises at least three of (a)-(e).

32. The bacterium of claim 28, wherein the bacterium has reduced activity of one or more of the following polypeptides, relative to a control: (a) a homoserine dehydrogenase polypeptide; (b) a homoserine kinase polypeptide; and (c) a phosphoenolpyruvate carboxykinase polypeptide.

33. The bacterium of claim 32, wherein the bacterium comprises a mutation in an endogenous hom gene or an endogenous thrB gene.

34. The bacterium of claim 32, wherein the bacterium comprises a mutation in an endogenous hom gene and an endogeous thrB gene.

35. The bacterium of claim 32, wherein the bacterium comprises a mutation in an endogenous pck gene.

36. An Escherichia coli or coryneform bacterium comprising at least two of: (a) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (b) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartokinase polypeptide or a functional variant thereof; (c) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof (d) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial homoserine dehydrogenase polypeptide or a functional variant thereof; (e) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial homoserine O-acetyltransferase polypeptide or a functional variant thereof; (f) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial O-acetylhomoserine sulfhydrylase polypeptide or a functional variant thereof; (g) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial 5-methyltetrahydrofolate homocysteine methyltransferase polypeptide or a functional variant thereof; (h) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial O-succinylhomoserine (thio)-lyase polypeptide or a functional variant thereof; (i) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase polypeptide or a functional variant thereof; (j) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial methionine adenosyltransferase polypeptide or a functional variant thereof; (k) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial serine hydroxylmethyltransferase polypeptide or a functional variant thereof; and (l) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial cystathionine beta-lyase polypeptide or a functional variant thereof.

37. The bacterium of claim 36, wherein at least one of the at least two genetically altered nucleic acid molecules encodes a heterologous polypeptide.

38. The bacterium of claim 36, wherein the bacterium comprises (a) and at least one of (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), and (l).

39. The bacterium of claim 36, wherein the bacterium comprises (b) and at least one of (c), (d), (e), (f), (g), (h), (i), (j), (k), and (l).

40. The bacterium of claim 36, wherein the bacterium comprises (c) and at least one of (d), (e), (f), (g), (h), (i), (j), (k), and (l).

41. The bacterium of claim 36, wherein the bacterium comprises (d) and at least one of (e), (f), (g), (h), (i), (j), (k), and (l).

42. The bacterium of claim 36, wherein the bacterium comprises (e) and at least one of (f), (g), (h), (i), (j), (k), and (l).

43. The bacterium of claim 36, wherein the bacterium comprises (f) and at least one of (g), (h), (i), (j), (k), and (l).

44. The bacterium of claim 36, wherein the bacterium comprises (g) and at least one of (h), (i), (j), (k), and (l).

45. The bacterium of claim 36, wherein the bacterium comprises (h) and at least one of (i), (j), (k), and (1).

46. The bacterium of claim 36, wherein the bacterium comprises (i) and at least one of (j) (k), and (1).

47. The bacterium of claim 36, wherein the bacterium comprises (j) and at least one of (k), and (l).

48. The bacterium of claim 36, wherein the bacterium comprises (k) and (l).

49. The bacterium of claim 36, wherein the bacterium comprises at least three of (a)-(l).

50. The bacterium of claim 36, wherein the bacterium has reduced activity of one or more of the following polypeptides, relative to a control: (a) a homoserine kinase polypeptide; (b) a phosphoenolpyruvate carboxykinase polypeptide; (c) a homoserine dehydrogenase polypeptide; and (d) a mcbR gene product polypeptide.

51. The bacterium of claim 50, wherein the bacterium comprises a mutation in an endogenous hom gene, an endogenous thrB gene, an endogenous pck gene, or an endogenous mcbR gene.

52. The bacterium of claim 50, wherein the bacterium comprises a mutation in an endogenous hom gene and an endogeous thrB gene.

53. The bacterium of claim 50, wherein the bacterium comprises a mutation in two or more of an endogenous hom gene, an endogenous thrB gene, an endogenous pck gene, or an endogenous mcbR gene.

54. An Escherichia coli or coryneform bacterium comprising at least two of: (a) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial phosphoenolpyruvate carboxylase polypeptide or a functional variant thereof; (b) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartokinase polypeptide or a functional variant thereof; (c) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial aspartate semialdehyde dehydrogenase polypeptide or a functional variant thereof; (d) a genetically altered nucleic acid molecule comprising a sequence encoding a bacterial homoserine dehydrogenase polypeptide or a functional variant thereof.

55. The bacterium of claim 54, wherein at least one of the at least two polypeptides encodes a heterologous polypeptide.

56. The bacterium of claim 54, wherein the bacterium comprises (a) and (b), (a) and (c), (a) and (d), (b) and (c), (b) and (d), or (c) and (d).

57. The bacterium of claim 54, wherein the bacterium comprises at least three of (a)-(d).

58. The bacterium of claim 54, wherein the bacterium has reduced activity of one or more of the following polypeptides, relative to a control: (a) a phosphoenolpyruvate carboxykinase polypeptide; and (b) a mcbR gene product polypeptide.

59. The bacterium of claim 58, wherein the bacterium comprises a mutation in an endogenous pck gene or an endogenous mcbR gene.

60. The bacterium of claim 58, wherein the bacterium comprises a mutation in an endogenous pck gene and an endogenous mcbR gene.

61. A method of producing an amino acid or a related metabolite, the method comprising: cultivating a bacterium according to claim 1 under conditions that allow the amino acid the metabolite to be produced, and collecting a composition that comprises the amino acid or related metabolite from the culture.

62. The method of claim 61, further comprising fractionating at least a portion of the culture to obtain a fraction enriched in the amino acid or the metabolite.

63. A method for producing L-lysine or a related metabolite, the method comprising: cultivating a bacterium according to claim 1 or 28 under conditions that allow L-lysine to be produced, and collecting a composition that comprises the amino acid or related metabolite from the culture.

64. The method of claim 63, further comprising fractionating at least a portion of the culture to obtain a fraction enriched in L-lysine.

65. A method for producing methionine or S-adenosylmethionine, the method comprising: cultivating a bacterium according to claim 36 under conditions that allow methionine or S-adenosylmethionine to be produced, and collecting a composition that comprises the methionine or S-adenosylmethionine from the culture.

66. The method of claim 65, further comprising fractionating at least a portion of the culture to obtain a fraction enriched in methionine or S-adenosylmethionine.

67. A method for producing isoleucine or threonine, the method comprising: cultivating a bacterium according to claim 54 under conditions that allow isoleucine or threonine to be produced, and collecting a composition that comprises the a isoleucine or threonine from the culture.

68. The method of claim 67, further comprising fractionating at least a portion of the culture to obtain a fraction enriched in isoleucine or threonine.

69. An isolated nucleic acid encoding a variant bacterial protein, wherein the bacterial protein regulates the production of an amino acid from the aspartic acid family of amino acids or related metabolites, and wherein the variant protein has enhanced activity, relative to a wild type form of the protein

70. The nucleic acid of claim 69, wherein the bacterial protein regulates the production of an amino acid from the aspartic acid family of amino acids or related metabolites, and wherein the variant protein has reduced feedback inhibition by S-adenosylmethionine relative to a wild type form of the protein.

71. An isolated nucleic acid encoding a variant of a bacterial protein, wherein the bacterial protein comprises the following amino acid sequence:

72. The nucleic acid of claim 71, wherein feedback inhibition of the variant of the bacterial protein by S-adenosylmethionine is reduced relative to the bacterial protein.

73. The nucleic acid of claim 71, wherein the amino acid change is a change to an alanine.

74. A polypeptide encoded by the nucleic acid of claim 69.

75. A polypeptide encoded by the nucleic acid of claim 71.

76. A bacterium comprising the nucleic acid of claim 69.

77. A bacterium comprising the nucleic acid of claim 71.

78. A method for producing an amino acid or a related metabolite, the method comprising: cultivating a genetically modified bacterium comprising the nucleic acid of claim 69 under conditions in which the nucleic acid is expressed and that allow the amino acid to be produced, and collecting a composition that comprises the amino acid or related metabolite from the culture.

79. A method for producing an amino acid or a related metabolite, the method comprising: cultivating a genetically modified bacterium comprising the nucleic acid of claim 71 under conditions in which the nucleic acid is expressed and that allow the amino acid to be produced, and collecting a composition that comprises the amino acid or related metabolite from the culture.

80. An isolated nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is a variant of a homoserine O-acetyltransferase comprising the following amino acid sequence:

81. An isolated nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase, wherein the variant O-acetylhomoserine sulfhydrylase is a variant of an O-acetylhomoserine sulfhydrylase comprising the following amino acid sequence:

82. An isolated nucleic acid encoding a variant bacterial mcbR gene product, wherein the variant mcbR gene product is a variant of an mcbR gene product comprising the following amino acid sequence:

83. An isolated nucleic acid encoding a variant bacterial aspartokinase, wherein the variant aspartokinase is a variant of an aspartokinase comprising the following amino acid sequence:

84. An isolated nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase, wherein the variant O-succinylhomoserine (thiol)-lyase is a variant of an O-succinylhomoserine (thiol)-lyase comprising the following amino acid sequence:

85. An isolated nucleic acid encoding a variant bacterial cystathionine beta-lyase, wherein the variant cystathionine beta-lyase is a variant of a cystathionine beta-lyase comprising the following amino acid sequence:

86. An isolated nucleic acid encoding a variant bacterial 5-methyltetrahydrofolate homocysteine methyltransferase, wherein the variant 5-methyltetrahydrofolate homocysteine methyltransferase is a variant of a 5-methyltetrahydrofolate homocysteine methyltransferase comprising the following amino acid sequence:

87. An isolated nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase, wherein the variant S-adenosylmethionine synthetase is a variant of an S-adenosylmethionine synthetase comprising the following amino acid sequence:

88. A bacterium comprising two or more of the following: a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase with reduced feedback inhibition relative to a wild-type form of the homoserine O-acetyltransferase; a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase with reduced feedback inhibition relative to a wild-type form of the O-acetylhomoserine sulfhydrylase; a nucleic acid encoding a variant bacterial McbR gene product with reduced feedback inhibition relative to a wild-type form of the McbR gene product; a nucleic acid encoding a variant bacterial aspartokinase with reduced feedback inhibition relative to a wild-type form of the aspartokinase; a nucleic acid encoding a variant bacterial O-succinylhomoserine (thiol)-lyase with reduced feedback inhibition relative to a wild-type form of the O-succinylhomoserine (thiol)-lyase; a nucleic acid encoding a variant bacterial cystathionine beta-lyase with reduced feedback inhibition relative to a wild-type form of the cystathionine beta-lyase; a nucleic acid encoding a variant bacterial homocysteine methyltransferase with reduced feedback inhibition relative to a wild-type form of the 5-methyltetrahydrofolate homocysteine methyltransferase; and a nucleic acid encoding a variant bacterial S-adenosylmethionine synthetase with reduced feedback inhibition relative to a wild-type form of the S-adenosylmethionine synthetase.

89. A bacterium comprising two or more of the following: (a) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is a variant of a homoserine O-acetyltransferase comprising the following amino acid sequence: (SEQ ID NO:360)G1-X2-K3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X13a-X13b-X13c-X13d-X13e-X13f-X13g-X13h-X13i-X13j-X13k-X13l-F14-X15-Z16-X17-X18-X19-X20-X21-X21a-X21b-X21c-X21d-X21e-X21f-X21g-X21h-X21i-X21j-X21k-X21l-X21m-X21n-X21o-X21p-X21q-X21r-X21s-X21t-D22,wherein each of X2, X4—X13, X15, and X17—X20 is, independently, any amino acid, wherein each of X13a—X13l is, independently, any amino acid or absent, wherein each of X21a—X21t is, independently, any amino acid or absent, and wherein Z16 is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant homoserine O-acetyltransferase comprises an amino acid change at one or more of G1, K3, F14, Z16, or D22 of SEQ ID NO:360; (b) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase, wherein the variant O-acetylhomoserine sulfhydrylase is a variant of an O-acetylhomoserine sulfhydrylase comprising the following amino acid sequence: (SEQ ID NO:360)G1-X2K3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X13a-X13b-X13c-X13d-X13e-X13f-X13g-X13h-X13i-X13j-X13k-X13l-F14-X15-Z16-X17-X18-X19-X20-X21-X21a-X21b-X21c-X21d-X21e-X21f-X21g-X21h-X21i-X21j-X21k-X21l-X21m-X21n-X21o-X21p-X21q-X21r-X21s-X21t-D22,wherein each of X2, X4—X13, X15, and X17—X20 is, independently, any amino acid, wherein each of X13a—X13l is, independently, any amino acid or absent, wherein each of X21a—X21t is, independently, any amino acid or absent, and wherein Z16 is selected from valine, aspartate, glycine, isoleucine, and leucine; wherein the variant O-acetylhomoserine sulfhydrylase comprises an amino acid change at one or more of G1, K3, F14, Z16, or D22 of SEQ ID NO:360; and (c) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase, wherein the variant O-acetylhomoserine sulfhydrylase is a variant of a O-acetylhomoserine sulfhydrylase comprising the following amino acid sequence: L1-X2—X3-G4-G5-X6—F7—X8—X9—X10—X11 (SEQ ID NO:361), wherein X is any amino acid, wherein X8 is selected from valine, leucine, isoleucine, and aspartate, and wherein X11 is selected from valine, leucine, isoleucine, phenylalanine, and methionine; wherein the variant of the bacterial protein comprises an amino acid change at one or more of L1, G4, X8, X11 of SEQ ID NO:361.

90. A bacterium comprising two or more of the following: (a) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is a C. glutamicum homoserine O-acetyltransferase comprising an amino acid change in one or more of the following residues of SEQ ID NO:212 Glycine 231, Lysine 233, Phenylalanine 251, and Valine 253; (b) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is a T. fusca homoserine O-acetyltransferase comprising an amino acid change in one or more of the following residues of SEQ ID NO:24: Glycine 81, Aspartate 287, Phenylalanine 269; (c) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is an E. coli homoserine O-acetyltransferase comprising an amino acid change at Glutamate 252 of SEQ ID NO:213; (d) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is a mycobacterial homoserine O-acetyltransferase comprising an amino acid change in a residue corresponding to one or more of the following residues of M. leprae homoserine O-acetyltransferase set forth in SEQ ID NO: 23: Glycine 73, Aspartate 278, and Tyrosine 260; (e) a nucleic acid encoding a variant bacterial homoserine O-acetyltransferase, wherein the variant homoserine O-acetyltransferase is an M. tuberculosis homoserine O-acetyltransferase comprising an amino acid change in one or more of the following residues of SEQ ID NO:22: Glycine 73, Tyrosine 260, and Aspartate 278; (f) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase, wherein the variant O-acetylhomoserine sulfhydrylase is a C. glutamicum O-acetylhomoserine sulfhydrylase comprising an amino acid change in one or more of the following residues of SEQ ID NO:214: Glycine 227, Leucine 229, Aspartate 231, Glycine 232, Glycine 233, Phenylalanine 235, Aspartate 236, Valine 239, Phenylalanine 368, Aspartate 370, Aspartate 383, Glycine 346, and Lycine 348; and (g) a nucleic acid encoding a variant bacterial O-acetylhomoserine sulfhydrylase, wherein the variant O-acetylhomoserine sulfhydrylase is a T. fusca O-acetylhomoserine sulfhydrylase comprising an amino acid change in one or more of the following residues of SEQ ID NO:25: Glycine 240, Aspartate 244, Phenylalanine 379, and Aspartate 394.

91. A bacterium comprising a nucleic acid encoding an episomal homoserine O-acetyltransferase, or a variant thereof, and an episomal O-acetylhomoserine sulfhydrylase, or a variant thereof.

92. The bacterium of claim 91, wherein the episomal homoserine O-acetyltransferase and the episomal O-acetylhomoserine sulfhydrylase are of a different species than the bacterium.

93. A method for the preparation of animal feed additives containing an aspartate-derived amino acid(s) comprising: (a) cultivating a bacterium according to any of claims 1, 28, 36, and 54 under conditions that allow the aspartate-derived amino acid(s) to be produced; (b) collecting a composition that comprises at least a portion of the aspartate-derived amino acid(s) that result from cultivating said bacterium; (c) concentrating the collected composition to enrich for the aspartate-derived amino acid(s); and (d) optionally, adding one or more substances to obtain the desired animal feed additive.

94. The method of claim 93, wherein the bacterium is Escherichia coli or a coryneform bacterium.

95. The method of claim 94, wherein the bacterium is Corynebacterium glutamicum.

96. The method of claim 93, wherein the aspartate-derived amino acid one or more of lysine, methionine, threonine or isoleucine.